Any feedback?
Information on EC 2.6.1.2 - alanine transaminase and Organism(s) Homo sapiens and UniProt Accession P24298
for references in articles please use BRENDA:EC2.6.1.2Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
2.6.1.2 alanine transaminaseIUBMB Comments
A pyridoxal-phosphate protein. 2-Aminobutanoate can act slowly instead of alanine.
Specify your search results
Word Map
- 2.6.1.2
-
alt
- bilirubin
- necrosis
- cholesterol
-
hepatotoxicity
- creatinine
- triglyceride
- albumin
- hepatocytes
- fibrosis
- cirrhosis
- malondialdehyde
- dismutase
- bile
- nafld
- wistar
- lipoprotein
- platelet
- steatosis
-
nonalcoholic
- hemoglobin
- sod
-
hepatoprotective
- gg
-
gamma-glutamyl
- ccl4
-
tetrachloride
-
anti-hcv
- acetaminophen
- seroconversion
- transaminases
-
c-reactive
- gamma-glutamyltransferase
-
portal
-
ccl4-induced
- prothrombin
-
uric
- transpeptidase
-
reperfusion
-
hbeag
-
virological
- steatohepatitis
- lamivudine
-
waist
- synthesis
- ribavirin
-
homa-ir
- analysis
- viremia
- medicine
- tenofovir
- cholestasis
- agriculture
- jaundice
The taxonomic range for the selected organisms is: Homo sapiens
The expected taxonomic range for this enzyme is: Eukaryota, Bacteria, Archaea
The expected taxonomic range for this enzyme is: Eukaryota, Bacteria, Archaea
Synonyms
alanine aminotransferase, alanine transaminase, alat, pyruvate transaminase, glutamic-pyruvic transaminase, glutamate-pyruvate transaminase, alanine-aminotransferase, alaat, l-alanine aminotransferase, c-aat, 
more
topPlease wait a moment until the data is sorted. This message will disappear when the data is sorted.
SYNONYM 
ORGANISM
UNIPROT
COMMENTARY 
LITERATURE
alanine aminotransferase
-
-
-
-
alanine-alpha-ketoglutarate aminotransferase
-
-
-
-
alanine-pyruvate aminotransferase
-
-
-
-
ALT
aminotransferase, alanine
-
-
-
-
beta-alanine aminotransferase
-
-
-
-
glutamic acid-pyruvic acid transaminase
-
-
-
-
glutamic-alanine transaminase
-
-
-
-
glutamic-pyruvic aminotransferase
-
-
-
-
glutamic-pyruvic transaminase
-
-
-
-
GPT
-
-
-
-
L-alanine aminotransferase
-
-
-
-
L-alanine transaminase
-
-
-
-
L-alanine-alpha-ketoglutarate aminotransferase
-
-
-
-
pyruvate transaminase
-
-
-
-
pyruvate-alanine aminotransferase
-
-
-
-
pyruvate-glutamate transaminase
-
-
-
-
ALT
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
amino group transfer
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PATHWAY SOURCE
PATHWAYS
KEGG
-
-, -, -, -, -, -, -, -
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SYSTEMATIC NAME
IUBMB Comments
L-alanine:2-oxoglutarate aminotransferase
A pyridoxal-phosphate protein. 2-Aminobutanoate can act slowly instead of alanine.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CAS REGISTRY NUMBER
COMMENTARY
9000-86-6
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SUBSTRATE
PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate)
(Substrate)
LITERATURE
(Substrate)
(Substrate)
COMMENTARY
(Product)
(Product)
LITERATURE
(Product)
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
L-alanine + glyoxylate
pyruvate + glycine
L-glutamate and L-alanine are by far the best amino-group donors
-
-
?
L-glutamate + glyoxylate
2-oxoglutarate + glycine
L-glutamate and L-alanine are by far the best amino-group donors
-
-
?
L-alanine + 2-oxoglutarate
pyruvate + L-glutamate
-
mitochondrial isoenzyme shows higher affinity for L-alanine, mainly functions in the direction of conversion of alanine to pyruvate whereas the cytosolic isoenzyme would function in both directions
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate)
(Substrate)
LITERATURE
(Substrate)
(Substrate)
COMMENTARY
(Product)
(Product)
LITERATURE
(Product)
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
L-alanine + 2-oxoglutarate
pyruvate + L-glutamate
-
mitochondrial isoenzyme shows higher affinity for L-alanine, mainly functions in the direction of conversion of alanine to pyruvate whereas the cytosolic isoenzyme would function in both directions
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
COFACTOR
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
vigabatrin
-
structural analogue to gamma-amino butyric acid, anti-epilepsy drug, 1 mM, approx. 80% inhibition in vitro, in vivo alanine aminotransferase activity is reduced 30-40% 1-2h after administration
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Aberrant Crypt Foci
Licochalcone A, a licorice flavonoid: antioxidant, cytotoxic, genotoxic, and chemopreventive potential.
Abruptio Placentae
Maternal serum uric acid level and maternal and neonatal complications in preeclamptic women: A cross-sectional study.
Abruptio Placentae
[Serum soluble Endoglin, plasma endothelin-1 and coagulation function in early onset severe preeclampsia with organ dysfunction]
Abscess
Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.
Acanthosis Nigricans
Models Predictive of Metabolic Syndrome Components in Obese Pediatric Patients.
Acanthosis Nigricans
[Fatty liver disease, insulin resistance and adiponectin in an obese pediatric population.]
Acidosis
16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.
Acidosis
A pilot study of indocyanine green clearance as an early predictor of graft function.
Acidosis
Acute toxicity of cyclohexylmethylphosphonofluoridate (CMPF) in rhesus monkeys: serum biochemical and hematologic changes.
Acidosis
Changes in the profile of liver enzymes in newborn calves induced by experimental, subclinical acidosis in pregnant cows and osmotic diarrhoea.
Acidosis
Clinical analysis and long-term treatment monitoring of 3 patients with glycogen storage disease type Ib.
Acidosis
Experience with the use of HIPEC in advanced serous ovarian cancer after complete and optimal cytoreduction.
Acidosis
Hyperchloremic metabolic acidosis due to deferasirox in a patient with beta thalassemia major.
Acidosis
Lethal peracute rhabdomyolysis associated with stress and general anesthesia in three dystrophin-deficient cats.
Acidosis
Physiological and molecular responses of the goldfish (Carassius auratus) kidney to metabolic acidosis, and potential mechanisms of renal ammonia transport.
Acidosis
Protective effect of early enteral feeding on postburn impairment of liver function and its mechanism in rats.
Acidosis
The kidney of chicken adapts to chronic metabolic acidosis: in vivo and in vitro studies.
Acidosis
Troglitazone acts by PPARgamma and PPARgamma-independent pathways on LLC-PK1-F+ acid-base metabolism.
Acidosis
Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation.
Acidosis
Using characteristic changes in laboratory values to assist in the diagnosis of hemorrhagic shock and encephalopathy syndrome.
Acidosis
[The prognostic importance of temperature monitoring in patients with decompensated endotoxicosis]
Acidosis, Lactic
Evaluating Mortality Risk Adjustment Among Children Receiving Extracorporeal Support for Respiratory Failure.
Acidosis, Lactic
Severe renal tubulopathy in a newborn due to BCS1L gene mutation: Effects of different treatment modalities on the clinical course.
Acidosis, Respiratory
Malignant Hyperthermia in Bariatric Surgery: A Case Study With Clinical, Pathophysiological, Biochemical and Biophysical Correlations.
Acne Vulgaris
Association between leptin gene rs7799039 polymorphism and lipid profile changes induced by isotretinoin treatment in acne patients.
Acne Vulgaris
Dietary Supplements, Isotretinoin, and Liver Toxicity in Adolescents: A Retrospective Case Series.
Acne Vulgaris
Dose-effect analysis of treatment by modified Zhibaidihuang decoction on polycystic ovary syndrome hyperandrogenism.
Acneiform Eruptions
A Phase II Study of XELOX and Cetuximab as First-Line Therapy in Patients With KRAS Wild Type Metastatic Colorectal Cancer (FLEET2 Study).
Acquired Immunodeficiency Syndrome
Changes in the incidence of severe thrombocytopenia and its predisposing conditions in HIV-infected patients since the introduction of highly active antiretroviral therapy.
Acquired Immunodeficiency Syndrome
Enzyme abnormalities of patients with acquired immunodeficiency syndrome.
Acquired Immunodeficiency Syndrome
Evaluation of laboratory markers of progression of HIV disease to death.
Acquired Immunodeficiency Syndrome
Increased hepatotoxicity among HIV-infected adults co-infected with Schistosoma mansoni in Tanzania: A cross-sectional study.
Acquired Immunodeficiency Syndrome
No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients.
Acquired Immunodeficiency Syndrome
Prevalence and Risk Factors for Significant Liver Fibrosis in Patients with HIV Infection.
Acquired Immunodeficiency Syndrome
Prevalence of liver injury among patients with acquired immunodeficiency syndrome treated with highly active antiretroviral therapy in China.
Acquired Immunodeficiency Syndrome
[Research on risk factors of short-term outcome in AIDS patients with pneumocystis pneumonia].
Acromegaly
Effect of pituitary surgery in patients with acromegaly on adiponectin serum concentrations and alanine aminotransferase activity.
Acute Coronary Syndrome
Elevated serum transaminases in patients with acute coronary syndromes: Do we need a revision of exclusion criteria for clinical trials?
Acute Coronary Syndrome
Phase 1, open-label, dose-escalation study of sorafenib in combination with eribulin in patients with advanced, metastatic, or refractory solid tumors.
Acute Kidney Injury
Acute renal failure due to rhabdomyolysis in a child with McArdle disease.
Acute Kidney Injury
Acute respiratory failure in adult patients with dengue virus infection.
Acute Kidney Injury
ANNALS EXPRESS: A retrospective pilot study to examine the potential of aspartate aminotransferase to alanine aminotransferase ratio as a predictor of post-operative acute kidney injury in patients with hepatocellular carcinoma.
Acute Kidney Injury
Assessment of liver and renal functions in human immunodeficiency virus-infected persons on highly active antiretroviral therapy: A mixed cohort study.
Acute Kidney Injury
Cardiac output, renal blood flow and hepatic blood flow in rats with glycerol-induced acute renal failure.
Acute Kidney Injury
Clinical characteristics and outcome of toxicity from Amanita mushroom poisoning.
Acute Kidney Injury
Clinical profiles and factors associated with mortality in adults with yellow fever admitted to an intensive care unit in Minas Gerais, Brazil.
Acute Kidney Injury
Does Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predict Acute Kidney Injury After Cardiac Surgery?
Acute Kidney Injury
Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
Acute Kidney Injury
Hepatitis A-induced diabetes mellitus, acute renal failure, and liver failure.
Acute Kidney Injury
Myostatin deficiency not only prevents muscle wasting but also improves survival in septic mice.
Acute Kidney Injury
Novel Prediction Score Including Pre- and Intraoperative Parameters Best Predicts Acute Kidney Injury after Liver Surgery.
Acute Kidney Injury
Predictors of fifty days in-hospital mortality in patients with culture negative neutrocytic ascites.
Acute Kidney Injury
Risk factors for mortality from severe community-acquired pneumonia in hospitalized children transferred to the pediatric intensive care unit.
Acute Kidney Injury
Spectrum of corrosive esophageal injury after intentional paraquat ingestion.
Acute Kidney Injury
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Acute Kidney Injury
Therapeutic dose of acetaminophen with fatal hepatic necrosis and acute renal failure.
Acute Kidney Injury
[Race of experimental animals and development of renal failure in animal model of hepatorenal syndrome]
Acute Lung Injury
Propofol vs desflurane on the cytokine, matrix metalloproteinase-9, and heme oxygenase-1 response during living donor liver transplantation: A pilot study.
Acute Radiation Syndrome
[Behavior of aspartate aminotransferase (EC 2.6.1.1) and alanine aminotransferase (EC 2.6.1.2) in rat serum during the course of acute radiation syndrome following whole body X-irradiation]
Acute-On-Chronic Liver Failure
Efficacy of short-term dexamethasone therapy in acute-on-chronic pre-liver failure.
Acute-On-Chronic Liver Failure
Prognostic factors of the short-term outcomes of patients with hepatitis B virus-associated acute-on-chronic liver failure.
Acute-On-Chronic Liver Failure
[Diagnostic criteria for HBV-related acute-on-chronic pre-liver failure].
Adenocarcinoma
Probing Regenerative Potential of Moringa oleifera Aqueous Extracts Using In vitro Cellular Assays.
Adenoma
High serum alanine aminotransferase is associated with the risk of colorectal adenoma in Korean men.
Adenoma
Hypertension is an important predictor of recurrent colorectal adenoma after screening colonoscopy with adenoma polypectomy.
Adenoma
Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice.
Adenoviridae Infections
Possible role of cytotoxic T cells in acute liver injury in hepatitis C virus cDNA transgenic mice mediated by Cre/loxP system.
Adrenal Insufficiency
Immune-related adverse events following administration of anti-cytotoxic T-lymphocyte-associated protein-4 drugs: a comprehensive systematic review and meta-analysis.
Adrenocortical Hyperfunction
Adult-onset demodicosis in two dogs due to Demodex canis and a short-tailed demodectic mite.
Agammaglobulinemia
[Successful treatment of chronic active hepatitis with high-dose intravenous immunoglobulins in agammaglobulinemia]
Agranulocytosis
Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
Agranulocytosis
Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention.
Agranulocytosis
[Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature]
alanine transaminase deficiency
Alanine aminotransferase deficiency in a hepatitis B surface antigen positive patient presenting with acute hepatitis.
alanine transaminase deficiency
Case report: Alanine aminotransferase deficiency detected in a patient with chronic hepatitis C.
alanine transaminase deficiency
Genotype-confirmed alanine aminotransferase deficiency in a Chinese patient with acute liver failure: a potential diagnostic pitfall.
alanine transaminase deficiency
The first known case of alanine aminotransferase deficiency diagnosed during pregnancy.
Albuminuria
A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Albuminuria
A phase I study of recombinant interferon-beta in patients with advanced malignant disease.
Albuminuria
Association between hepatitis B/C viral infection, chronic kidney disease and insulin resistance in individuals undergoing general health screening.
Albuminuria
Diabetes based on 2-h plasma glucose among those classified as having prediabetes based on fasting plasma glucose or A1c.
Albuminuria
Relationship between genotypes and clinical manifestation, pathology, and cccDNA in Chinese children with hepatitis B virus-associated glomerulonephritis.
Albuminuria
Relationships between lifestyle patterns and cardio-renal-metabolic parameters in patients with type 2 diabetes mellitus: A cross-sectional study.
Albuminuria
[Clinical and pathological differences between children with various genotypes of hepatitis B virus-associated glomerulonephritis].
Alcohol Withdrawal Delirium
Delirium tremens: some clinico-chemical features. A study of alanine-aminotransferase, alcaline phosphatase, prothrombine and enolase.
Alcohol Withdrawal Seizures
Validity of carbohydrate deficient transferrin and other markers as diagnostic aids in the detection of alcohol related seizures.
Alopecia
A medicinal and edible formula YH0618 ameliorates the toxicity induced by Doxorubicin via regulating the expression of Bax/Bcl-2 and FOXO4.
Alopecia
A Multicenter Study of Docetaxel at a Dose of 100 mg/m2 in Japanese Patients with Advanced or Recurrent Breast Cancer.
Alopecia
Efficacies and adverse reactions of modified vitamin supplement programs before pemetrexed chemotherapy as a second-line treatment against epidermal growth factor receptor (EGFR) mutant wild-type lung adenocarcinoma.
Alopecia
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer.
Alopecia
Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
Alopecia
Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization--single-center experience.
Alopecia
Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
Alopecia
Single-center study to determine the safety and efficacy of CT-707 in Chinese patients with advanced anaplastic lymphoma kinase-rearranged non-small-cell lung cancer.
Alopecia
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
alpha 1-Antitrypsin Deficiency
Liver disease in alpha-1-antitrypsin deficiency: prognostic indicators.
Alveolar Bone Loss
Decrease of Pericytes is Associated With Liver Disease Caused by Ligature-Induced Periodontitis in Rats.
Alveolar Bone Loss
One or two ligatures inducing periodontitis are sufficient to cause fatty liver.
Alveolar Bone Loss
Steatosis caused by experimental periodontitis is reversible after removal of ligature in rats.
Alveolar Bone Loss
Sulfated polysaccharides from the marine algae Gracilaria caudata prevent tissue damage caused by ligature-induced periodontitis.
Alzheimer Disease
Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer's disease and myocardial infarction.
Alzheimer Disease
Amino acids and transaminases activity in ventricular CSF and in brain of normal and Alzheimer patients.
Alzheimer Disease
Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients.
Alzheimer Disease
Molecular and genetic association of interleukin-6 in tacrine-induced hepatotoxicity.
Alzheimer Disease
Neurodegenerative and Hepatorenal Disorders Induced Via Aluminum Chloride in Murine System: Impact of ?-Secretase, MAPK, and KIM.
Alzheimer Disease
Tacrine induces apoptosis through lysosome- and mitochondria-dependent pathway in HepG2 cells.
Alzheimer Disease
Tacrine inhibits topoisomerases and DNA synthesis to cause mitochondrial DNA depletion and apoptosis in mouse liver.
Amyotrophic Lateral Sclerosis
Assessing Effects of BHV-0223 40?mg Zydis® Sublingual Formulation and Riluzole 50?mg Oral Tablet on Liver Function Test Parameters Utilizing DILIsym®.
Anaphylaxis
A case of idiosyncratic liver injury after oxaliplatin-induced thrombocytopenia.
Anaphylaxis
Comparison of clinical findings between dogs with suspected anaphylaxis and dogs with confirmed sepsis.
Anaphylaxis
Elevation of alanine transaminase and gallbladder wall abnormalities as biomarkers of anaphylaxis in canine hypersensitivity patients.
Anaphylaxis
One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency.
Anemia
A case of massive hepatic infarction in severe preeclampsia as part of the HELLP syndrome.
Anemia
A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer.
Anemia
A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma.
Anemia
A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC).
Anemia
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors.
Anemia
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers.
Anemia
A Phase I-II Study of the Oral Poly(ADP-ribose) Polymerase Inhibitor Rucaparib in Patients with Germline BRCA1/2-mutated Ovarian Carcinoma or Other Solid Tumors.
Anemia
A phase II trial of dose-dense (biweekly) paclitaxel plus carboplatin as neoadjuvant chemotherapy for operable breast cancer.
Anemia
A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902).
Anemia
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer.
Anemia
A review of phase II studies of ZD9331 treatment for relapsed or refractory solid tumours.
Anemia
A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue Sarcoma.
Anemia
Acute Hepatic Phenotype of Wilson Disease: Clinical Features of Acute Episodes and Chronic Lesions Remaining in Survivors.
Anemia
An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma.
Anemia
An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma.
Anemia
Anemia, myopathy, and pansteatitis in vitamin E-deficient captive marmosets (Callithrix spp.).
Anemia
Association between Alcohol Intake and Hemoglobin A1c in the Korean Adults: The 2011-2013 Korea National Health and Nutrition Examination Survey.
Anemia
Baseline laboratory test abnormalities are common in early arthritis but rarely contraindicate methotrexate: Study of three cohorts (ESPOIR, VErA, and Brittany).
Anemia
Caecocolic intussusception associated with a caecal polyp and concurrent hepatocellular carcinoma in a cat.
Anemia
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials.
Anemia
Canine hepatic neuroendocrine carcinoma: an immunohistochemical and electron microscopic study.
Anemia
Clinical and laboratory characterization of Basenjis with immunoproliferative small intestinal disease.
Anemia
Clinical Benefits and Safety of FMS-Like Tyrosine Kinase 3 Inhibitors in Various Treatment Stages of Acute Myeloid Leukemia: A Systematic Review, Meta-Analysis, and Network Meta-Analysis.
Anemia
Clinical features in coronavirus disease 2019 (COVID-19) patients with early clearance and prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA.
Anemia
Clinical, morphological, and molecular characterization of an undetermined Babesia species in a maned wolf (Chrysocyon brachyurus).
Anemia
Comparison of efficacy and safety of S-1 and capecitabine in patients with metastatic colorectal carcinoma: A systematic review and meta-analysis.
Anemia
Comparison of the toxicity of inorganic and liver-incorporated cadmium: a 4-wk feeding study in rats.
Anemia
Determinants of Anemia Among Human Immunodeficiency Virus-Positive Adults at Care and Treatment Clinics in Dar es Salaam, Tanzania.
Anemia
Dexamethasone treatment improves morphological and hematological parameters in chronic experimental schistosomiasis.
Anemia
Duvelisib, a novel oral dual inhibitor of PI3K-?,?, is clinically active in advanced hematologic malignancies.
Anemia
Effect of subacute poisoning with bifenthrin on locomotor activity, memory retention, haematological, biochemical and histopathological parameters in mice.
Anemia
Efficacies and adverse reactions of modified vitamin supplement programs before pemetrexed chemotherapy as a second-line treatment against epidermal growth factor receptor (EGFR) mutant wild-type lung adenocarcinoma.
Anemia
Efficacy and safety assessment of S-1-based regimens comparing to intravenous fluorouracil-based ones in Asian patients with metastatic colorectal carcinoma: A system review and meta-analysis.
Anemia
Efficacy and tolerability of trastuzumab emtansine in advanced human epidermal growth factor receptor 2-positive breast cancer.
Anemia
Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma.
Anemia
Erythema multiforme major and disseminated intravascular coagulation in a dog following application of a d-limonene-based insecticidal dip.
Anemia
Etiopathological and hematobiochemical profiles in goats with gastrointestinal disorders.
Anemia
Evaluation of clinically asymptomatic high risk infants with congenital cytomegalovirus infection.
Anemia
Extending knowledge of the clinical picture of Balkan adder (Vipera berus bosniensis) envenoming: The first photographically-documented neurotoxic case from South-Western Hungary.
Anemia
Factors associated with acute renal failure in falciparum malaria infected patients.
Anemia
FDA Approval: Alectinib for the Treatment of Metastatic ALK-Positive Non-Small Cell Lung Cancer Following Crizotinib.
Anemia
Fever of unknown origin-predictors of outcome. A prospective multicenter study on 164 patients.
Anemia
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study.
Anemia
First-Line Pazopanib Treatment in Metastatic Renal Cell Carcinoma: Real-World Data From a Single Chinese Center.
Anemia
Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase 3, Randomized, Open-label, Multi-center FESTnd Study.
Anemia
Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study.
Anemia
Hepatic function tests in children with sickle cell anaemia during vaso occlusive crisis.
Anemia
Hepatotoxicity and secondary photosensitization in a red kangaroo (Megaleia rufus) due to ingestion of Lantana camara.
Anemia
How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk?
Anemia
Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.
Anemia
Is there any difference in pyogenic liver abscess caused by Streptococcus milleri and Klebsiella spp?: Retrospective analysis over a 10-year period in a regional hospital.
Anemia
Jaundice and Elevated Beta-Human Chorionic Gonadotropin in a Female: Duodenal Choriocarcinoma, Not Pregnancy.
Anemia
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.
Anemia
Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO study.
Anemia
Lower Body Mass Index is a Risk Factor for In-Hospital Mortality of Elderly Japanese Patients Treated with Ampicillin/sulbactam.
Anemia
Molecular evidence and hematological alterations associated with the occurrence of coronavirus in domestic dogs in Pakistan.
Anemia
Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial.
Anemia
Naturally Acquired Infectious Canine Hepatitis in Two Captive Maned Wolf (Chrysocyon brachyurus) Puppies.
Anemia
Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease.
Anemia
Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial.
Anemia
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.
Anemia
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials.
Anemia
Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization--single-center experience.
Anemia
NTP Toxicology and Carcinogenesis Studies of Chloroprene (CAS No. 126-99-8) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
Anemia
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study.
Anemia
OUTPATIENT ANALYTIC ASSESSMENT OF ANOREXIA NERVOSA - THE IMPORTANCE OF VENOUS BLOOD GASES.
Anemia
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial.
Anemia
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
Anemia
Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan.
Anemia
Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
Anemia
Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: A Children's Oncology Group study.
Anemia
Phase I dose-escalation and pharmacokinetic study of ispinesib, a kinesin spindle protein inhibitor, administered on days 1 and 15 of a 28-day schedule in patients with no prior treatment for advanced breast cancer.
Anemia
Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer.
Anemia
Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer.
Anemia
Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065).
Anemia
Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study.
Anemia
Pregnancy After Liver Transplant: Neonatal Outcomes and Long-Term Maternal Follow-up.
Anemia
Prevalence and predictors of anemia in patients with HIV infection at the initiation of combined antiretroviral therapy in Xinjiang, China.
Anemia
Pure red cell aplasia associated with autoimmune hepatitis successfully treated with cyclosporine A.
Anemia
Pure red cell aplasia responsive to interferon-alpha in a patient with hepatitis C virus infection.
Anemia
Real-World Delivery of Rucaparib to Patients with Ovarian Cancer: Recommendations Based on an Integrated Safety Analysis of ARIEL2 and Study 10.
Anemia
Recreational Exposure during Algal Bloom in Carrasco Beach, Uruguay: A Liver Failure Case Report.
Anemia
Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison.
Anemia
Results of a phase II multicenter trial of single-agent gemcitabine in patients with relapsed or chemotherapy-refractory Hodgkin's lymphoma.
Anemia
Retrospective study of 46 cases of feline haemobartonellosis in Israel and their relationships with FeLV and FIV infections.
Anemia
Revisiting clinico-epidemiological pattern of human rickettsial infections in the central region of Sri Lanka: a hospital based descriptive study.
Anemia
Risk Factors of Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease: A Meta-Analysis of Case-Control Studies.
Anemia
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.
Anemia
Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES.
Anemia
Safety, pharmacokinetics, and preliminary efficacy of the PARP inhibitor talazoparib in Japanese patients with advanced solid tumors: phase 1 study.
Anemia
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study.
Anemia
Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review.
Anemia
Serotonin syndrome masquerading as disease flare in lupus nephritis with end-stage renal disease.
Anemia
Sex Differences in Physiological Stress Induced by a Long-Lasting Adventure Race: A Prospective Observational Analytical Study.
Anemia
Side effects of CDK4/6 inhibitors in the treatment of HR+/HER2- advanced breast cancer: a systematic review and meta-analysis of randomized controlled trials.
Anemia
Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients.
Anemia
Subchronic toxicity and toxicokinetics of LZB, a new proton pump inhibitor, after 13-week repeated oral administration in dogs.
Anemia
The First Study Evaluating the Safety of Pre-Surgery Administration of Metformin in Patients with Colorectal and other Gastrointestinal Cancers and Effect on Cancer Stem Cells.
Anemia
The Indian langur: preliminary report of a new nonhuman primate host for visceral leishmaniasis.
Anemia
Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma - systematic review and meta-analysis.
Anemia
Thrombotic Microangiopathy Associated with Macrophage Activation Syndrome: A Multinational Study of 23 Patients.
Anemia
Toxoplasma gondii-like organisms in skin aspirates from a cat with disseminated protozoal infection.
Anemia
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.
Anemia
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
Anemia
Trabectedin plus pegylated liposomal doxorubicin: retrospective analysis in heavily pretreated platinum-sensitive ovarian cancer.
Anemia
Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial.
Anemia
Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in Korea.
Anemia
Trypanosoma evansi infection in a German shepherd dog - Apparent successful treatment using serial low dose of diminazene aceturate.
Anemia
U.S. Food and Drug Administration Approval Summary: Atezolizumab for Metastatic Non-Small Cell Lung Cancer.
Anemia
Use of pre-ART laboratory screening to identify renal, hepatic and haematological abnormalities in Côte d'Ivoire.
Anemia
Using characteristic changes in laboratory values to assist in the diagnosis of hemorrhagic shock and encephalopathy syndrome.
Anemia
Utility of Laboratory Test Result Monitoring in Patients Taking Oral Terbinafine or Griseofulvin for Dermatophyte Infections.
Anemia
Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment.
Anemia
Zidovudine prophylaxis after accidental exposure to HIV: the Italian experience. The Italian Study Group on Occupational Risk of HIV Infection.
Anemia
[A case report of acute Q fever showing Kawasaki disease-like symptoms in a 9-year-old girl]
Anemia
[Efficacy and safety of neoadjuvant apatinib in combination with dose-dense paclitaxel and carboplatin in locally advanced triple negative breast cancer patients].
Anemia, Aplastic
Liver function abnormality following treatment with antithymocyte globulin for aplastic anaemia.
Anemia, Hemolytic
Maternal and fetal parameters including umbilical artery PI and fibrinogen/CRP ratio as predictive factors of perinatal outcome in women with HELLP syndrome.
Anemia, Hypochromic
Response of broiler chicks to dietary Rhazya stricta and Nigella sativa.
Anemia, Hypochromic
Synergistic ameliorative effects of sesame oil and alpha-lipoic acid against subacute diazinon toxicity in rats: hematological, biochemical, and antioxidant studies.
Anemia, Iron-Deficiency
[Serum and hepatic glutamic-oxalacetic and glutamic-pyruvic transaminase activity in experimental iron-deficiency anemia in guinea pigs]
Anemia, Sickle Cell
Hepatic function tests in children with sickle cell anaemia during vaso occlusive crisis.
Aneurysm
Activity of enzymes with different subcellular localization in the blood plasma of patients with aortic aneurysm.
Aneurysm
Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease.
Angioedema
A phase I dose-escalation study of the polyamine analog PG-11047 in patients with advanced solid tumors.
Antiphospholipid Syndrome
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Anuria
Renal failure and hepatitis following ingestion of raw grass carp gallbladder: A case report.
Apnea
Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea.
argininosuccinate lyase deficiency
Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency.
Argininosuccinic Aciduria
Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency.
Arrhythmias, Cardiac
Durable response but prolonged cytopenia after cladribine treatment in relapsed patients with indolent non-Hodgkin's lymphomas: results of a Japanese phase II study.
Arrhythmias, Cardiac
Short-term laboratory and related safety outcomes for the multiple sclerosis oral disease-modifying therapies: an observational study.
Arrhythmias, Cardiac
[Efficacy and safety of neoadjuvant apatinib in combination with dose-dense paclitaxel and carboplatin in locally advanced triple negative breast cancer patients].
Arteriosclerosis
Correlative evaluation of serum lipid, blood glucose, blood pressure, serum immunoreactive insulin, and liver function in persons undergoing regularly scheduled health evaluations.
Arteriosclerosis
[Peripheral blood albumin level in significantly correlated with the severity of atherosclerosis in hypertensive patients].
Arteriosclerosis Obliterans
[Effect of lumbar sympathectomy on blood alanine aminotransferase activity in patients with arteritis obliterans and arteriosclerosis obliterans of the lower extremities]
Arteritis
[Effect of lumbar sympathectomy on blood alanine aminotransferase activity in patients with arteritis obliterans and arteriosclerosis obliterans of the lower extremities]
Arthralgia
A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.
Arthralgia
Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial.
Arthralgia
Differences in clinical and laboratory characteristics and disease severity between children and adults with dengue virus infection in Taiwan, 2002.
Arthralgia
Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients.
Arthralgia
Hepatitis C virus genotypes and clinical features in hepatitis C virus-related mixed cryoglobulinemia.
Arthralgia
Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients.
Arthralgia
Revisiting clinico-epidemiological pattern of human rickettsial infections in the central region of Sri Lanka: a hospital based descriptive study.
Arthralgia
The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation.
Arthralgia
The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients.
Arthralgia
U.S. Food and Drug Administration Approval Summary: Atezolizumab for Metastatic Non-Small Cell Lung Cancer.
Arthritis
Adult Kawasaki's disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels.
Arthritis
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Arthritis
Arthritis in a patient with psoriasis after interferon-alpha therapy for chronic hepatitis C.
Arthritis
Baseline laboratory test abnormalities are common in early arthritis but rarely contraindicate methotrexate: Study of three cohorts (ESPOIR, VErA, and Brittany).
Arthritis
[Morphological and biochemical changes in the blood of lambs with experimental Erysipelothrix polyarthritis]
Arthritis, Psoriatic
Association between tumor necrosis factor inhibitor (TNFi) therapy and changes in C-reactive protein (CRP), blood pressure, and alanine aminotransferase (ALT) among patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis.
Arthritis, Rheumatoid
Alkaline phosphatase isoenzyme activities in rheumatoid arthritis: hepatobiliary enzyme dissociation and relation to disease activity.
Arthritis, Rheumatoid
Association between tumor necrosis factor inhibitor (TNFi) therapy and changes in C-reactive protein (CRP), blood pressure, and alanine aminotransferase (ALT) among patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis.
Arthritis, Rheumatoid
Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate.
Arthritis, Rheumatoid
High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy.
Arthritis, Rheumatoid
Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice.
Arthritis, Rheumatoid
MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis.
Arthritis, Rheumatoid
Rheumatoid arthritis, alcohol, leflunomide and methotrexate. Can changes to the BSR guidelines for leflunomide and methotrexate on alcohol consumption be justified?
Arthritis, Rheumatoid
[Investigation of the risk of hepatitis B virus reactivation in arthritis patients undergoing anti-tumour necrosis factor alpha therapy].
Asthma
Concurrent Incidental Presentation of Primary Retroperitoneal Follicular Lymphoma With Acute Pancreatitis.
Asthma
Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits.
Asthma
Patterns of serum aspartic and alanine aminotransferase as well as aldolase activity in attacks of bronchial asthma, paroxysmal tachycardia and pulmonary edema.
Asthma
The effect of 1g of acetaminophen twice daily for 12 weeks on alanine transaminase levels--A randomized placebo-controlled trial.
Asthma
[Behavior of the activity of aspartate aminotransferase and alanine aminotransferase in attacks of bronchial asthma, pulmonary edema and paroxysmal tachycardia]
Asthma
[Pattern of activity of aspartic aminotransferase, alanine aminotransferase and aldolase in attacks of bronchial asthma, paroxysmal tachycardia and pulmonary edema]
Asymptomatic Infections
Ongoing subclinical infection of hepatitis E virus among blood donors with an elevated alanine aminotransferase level in Japan.
Asymptomatic Infections
Unchanged high prevalence of antibodies to hepatitis E virus (HEV) and HEV RNA among blood donors with an elevated alanine aminotransferase level in Japan during 1991-2006.
Ataxia
Acute, subchronic and chronic 2,4-dichlorophenoxyacetic acid (2,4-D) intoxication in rats.
Atherosclerosis
Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study.
Atherosclerosis
Association Between High-Normal Levels of Alanine Aminotransferase and Risk Factors for Atherogenesis.
Atherosclerosis
Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene-Environment Interaction Study.
Atherosclerosis
Association of Lactate Dehydrogenase with In-Hospital Mortality in Patients with Acute Aortic Dissection: A Retrospective Observational Study.
Atherosclerosis
Discriminatory value of alanine aminotransferase for diabetes prediction: the Insulin Resistance Atherosclerosis Study.
Atherosclerosis
Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
Atherosclerosis
Gugulipid causes hypercholesterolemia leading to endothelial dysfunction, increased atherosclerosis, and premature death by ischemic heart disease in male mice.
Atherosclerosis
Hepatic steatosis, carotid atherosclerosis and metabolic syndrome: the STEATO Study.
Atherosclerosis
Intervention Effects of Atorvastatin Combined with Panax notoginseng Saponins on Rats with Atherosclerosis Complicated with Hepatic Injury.
Atherosclerosis
The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the Insulin Resistance Atherosclerosis Study.
Atrial Fibrillation
Biochemical markers of myocardial damage after radiofrequency ablation.
Atrial Fibrillation
Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong.
Atrial Fibrillation
Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials.
Atrial Fibrillation
Use of apixaban after development of suspected rivaroxaban-induced hepatic steatosis; a case report.
Autoimmune Diseases
Interferon-alpha treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children.
Autoimmune Diseases
Risk factors for recurrence of autoimmune hepatitis after liver transplantation.
Autoimmune Diseases
Role of age in presentation, response to therapy and outcome of autoimmune hepatitis.
Autoimmune Diseases
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Azotemia
A retrospective evaluation of eastern coral snake envenomation and antivenom administration in cats: 30 cases (2012-2019).
Azotemia
Antioxidant status in a squirrel monkey (Saimiri sciureus) with chronic pancreatitis and degenerative myopathy.
Azotemia
Clinical, morphological, and molecular characterization of an undetermined Babesia species in a maned wolf (Chrysocyon brachyurus).
Azotemia
Erythema multiforme major and disseminated intravascular coagulation in a dog following application of a d-limonene-based insecticidal dip.
Azotemia
Retrospective study of 46 cases of feline haemobartonellosis in Israel and their relationships with FeLV and FIV infections.
Azotemia
Review of exertional rhabdomyolysis and a case in a rhesus monkey (Macaca mulatta).
Azotemia
Toxoplasma gondii inclusions in peripheral blood leukocytes of a red-necked wallaby (Macropus rufogriseus).
Babesiosis
Clinical, morphological, and molecular characterization of an undetermined Babesia species in a maned wolf (Chrysocyon brachyurus).
Babesiosis
The effect of pyridoxal-5-phosphate on serum alanine aminotransferase activity in dogs suffering from canine babesiosis.
Bacteremia
Analysis of early-onset bloodstream infection due to Escherichia coli infection in premature babies.
Bacteremia
Clinical characteristics, risk factors, and outcomes in adults experiencing dengue hemorrhagic fever complicated with acute renal failure.
Bacteremia
High-dose intravenous methylprednisolone therapy for patients with Diamond-Blackfan anemia refractory to conventional doses of prednisone.
Bacterial Infections
Acute respiratory failure in adult patients with dengue virus infection.
Bacterial Infections
Chest radiographic presentation in patients with dengue hemorrhagic Fever.
Bacterial Infections
[Clinical study on hepatitis D virus-positive patients died from severe hepatitis B]
Bacterial Infections
[Postoperative intraabdominal suppurations due to Ristella. Clinical, bacteriological and therapeutic characteristics]
Bacterial Infections
[Research on risk factors of short-term outcome in AIDS patients with pneumocystis pneumonia].
Basal Ganglia Cerebrovascular Disease
Evaluation of clinically asymptomatic high risk infants with congenital cytomegalovirus infection.
beta-Thalassemia
Association of gingival crevicular fluid and serum intracytoplasmic enzyme levels in periodontally healthy homozygous (major) beta-thalassemia patients.
beta-Thalassemia
Characterization of thalassemia major and diabetes mellitus patients at a reference center in Brazil.
beta-Thalassemia
Efficacy Of Interrupted And Modified Deferasirox Dose Among Paediatric Patients With ?- Thalassemia Major And High Alanine Aminotransferase Level.
beta-Thalassemia
Hyperchloremic metabolic acidosis due to deferasirox in a patient with beta thalassemia major.
beta-Thalassemia
Iron overload correlates with serum liver fibrotic markers and liver dysfunction: Potential new methods to predict iron overload-related liver fibrosis in thalassemia patients.
Biliary Atresia
Clinical and biochemical characteristics of infants with prolonged neonatal jaundice.
Biliary Atresia
Immunosuppressive effect of chenodeoxycholic acid on natural killer cell activity in patients with biliary atresia and hepatitis C virus-related liver cirrhosis.
Biliary Atresia
The impact of serum total bilirubin, alanine transaminase and gamma-glutamyl transferase on survival of biliary atresia patients following Kasai procedure.
Biliary Tract Diseases
Biliary tract disease and acute non-A-E hepatitis in Hong Kong: prospective study.
Biliary Tract Diseases
Oxygen derived free radicals in patients with chronic pancreatic and other digestive diseases.
Biliary Tract Diseases
[Serum iron and copper levels and serum activity of phosphohexoisomerase and glutamic-pyruvic transaminase in patients with liver and biliary tract disease]
Blindness
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Blister
Protective effect of nitric oxide on isolated rat hepatocytes submitted to an oxidative stress.
Bluetongue
Evaluation of oxidative stress via total antioxidant status, sialic acid, malondialdehyde and RT-PCR findings in sheep affected with bluetongue.
Bone Diseases, Metabolic
Is Alanine Aminotransferase Associated with Osteopenia in Middle-Aged and Elderly Chinese?
Bradycardia
Clinical profiles and factors associated with mortality in adults with yellow fever admitted to an intensive care unit in Minas Gerais, Brazil.
Bradycardia
Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?
Brain Death
Effects of cortisol administration on hepatic circulation during brain death in rabbits.
Brain Death
Estimating the Number of Organ Donors in Australian Hospitals--Implications for Monitoring Organ Donation Practices.
Brain Death
High peak alanine aminotransferase determines extra risk for nonanastomotic biliary strictures after liver transplantation with donation after circulatory death.
Brain Death
Hypothermic Oxygenated Machine Perfusion (HOPE) Reduces Early Allograft Injury and Improves Post-Transplant Outcomes in Extended Criteria Donation (ECD) Liver Transplantation from Donation After Brain Death (DBD): Results from a Multicenter Randomized Controlled Trial (HOPE ECD-DBD).
Brain Diseases
A pilot study of indocyanine green clearance as an early predictor of graft function.
Brain Diseases
Baseline Factors Associated with Improvements in Decompensated Cirrhosis After Direct-acting Antiviral Therapy for HCV Infection.
Brain Diseases
Clinical profiles and factors associated with mortality in adults with yellow fever admitted to an intensive care unit in Minas Gerais, Brazil.
Brain Diseases
Defining hepatocellular chimerism in a liver failure patient bridged with hepatocyte infusion.
Brain Diseases
Description of breed ancestry and genetic health traits in arctic sled dog breeds.
Brain Diseases
Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting.
Brain Diseases
Differentiation of typhoid fever from fulminant hepatic failure in patients presenting with jaundice and encephalopathy.
Brain Diseases
Fulminant hepatitis after 10 days of acetaminophen treatment at recommended dosage in an infant.
Brain Diseases
Hepatocyte and nuclear areas and fatty infiltration of the liver in chronic alcoholic liver disease.
Brain Diseases
Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury.
Brain Diseases
Incidence of posterior reversible encephalopathy syndrome in eclamptic and patients with preeclampsia with neurologic symptoms.
Brain Diseases
Living donor liver transplantation for acute liver failure in pediatric patients caused by the ingestion of fireworks containing yellow phosphorus.
Brain Diseases
Loss of function mutation in glutamic pyruvate transaminase 2 (GPT2) causes developmental encephalopathy.
Brain Diseases
Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction.
Brain Diseases
Mortality risk factors in children with severe influenza virus infection admitted to the pediatric intensive care unit.
Brain Diseases
Presentation and Outcome of Acute Necrotizing Encephalopathy of Childhood: A 10-Year Single-Center Retrospective Study From Hong Kong.
Brain Diseases
Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.
Brain Diseases
Survival predictors in patients treated with a molecular adsorbent recirculating system.
Brain Diseases
The Clinical and Imaging Characteristics Associated With Neurological Sequelae of Pediatric Patients With Acute Necrotizing Encephalopathy.
Brain Diseases
[Changes in serotonin and noradrenaline in hepatic encephalopathy as a result of liver failure in rat]
Brain Edema
30-day and 60-day rates and predictors of mortality among adult stroke patients: Prospective cohort study.
Brain Injuries
The correlation of dystonia severity and serum transaminases in a child with a brain injury.
Brain Injuries
Time trends in organ donation after neurologic determination of death: a cohort study.
Brain Injuries, Traumatic
Multiplexing of injury codes for the parallel operation of enzyme logic gates.
Brain Ischemia
Human umbilical cord blood-derived CD34+ cells cause attenuation of multiorgan dysfunction during experimental heatstroke.
Brain Ischemia
Pyruvate's blood glutamate scavenging activity contributes to the spectrum of its neuroprotective mechanisms in a rat model of stroke.
Brain Neoplasms
Preoperative 5-aminolevulinic acid administration for brain tumor surgery is associated with an increase in postoperative liver enzymes: a retrospective cohort study.
Breast Neoplasms
A review of phase II studies of ZD9331 treatment for relapsed or refractory solid tumours.
Breast Neoplasms
Allele increasing susceptibility to human breast cancer may be linked to the glutamate-pyruvate transaminase locus.
Breast Neoplasms
Clinical significance of fatty liver disease induced by tamoxifen and toremifene in breast cancer patients.
Breast Neoplasms
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C.
Breast Neoplasms
Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits.
Breast Neoplasms
Factors Predicting Requirement of High-Dose Transdermal Fentanyl in Opioid Switching From Oral Morphine or Oxycodone in Patients With Cancer Pain.
Breast Neoplasms
Genetic epidemiology of breast cancer and associated cancers in high-risk families. II. Linkage analysis.
Breast Neoplasms
Glutamic Pyruvate Transaminase GPT2 Promotes Tumorigenesis of Breast Cancer Cells by Activating Sonic Hedgehog Signaling.
Breast Neoplasms
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial.
Breast Neoplasms
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ?50%: real-world data.
Breast Neoplasms
Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer.
Breast Neoplasms
The salubrious effect of tamoxifen [correction of Tamaxifen] on serum marker enzymes, glycoproteins, and lysosomal enzymes level in breast cancer woman.
Bronchitis
Population-Level Prediction of Type 2 Diabetes From Claims Data and Analysis of Risk Factors.
Bronchopulmonary Dysplasia
Serum enzyme activities in premature infants with bronchopulmonary dysplasia.
Brucellosis
Brucellosis-related acute pancreatitis: A rare complication of a universal disease.
Brucellosis
Effect of Doxycycline-Loaded Solid Lipid Nanoparticles on Serum Level of Trace Elements, Biochemical and Hematological Parameters in Acute and Chronic Brucellosis.
Budd-Chiari Syndrome
Levels and Initial Course of Serum Alanine Aminotransferase Can Predict Outcome of Patients With Budd-Chiari Syndrome.
Candidemia
Prevalence and risk factors for endogenous fungal endophthalmitis in adult patients with candidemia at a tertiary care hospital in the Republic of Korea over 13 years.
Candidiasis, Oral
Prevalence and predictors of anemia in patients with HIV infection at the initiation of combined antiretroviral therapy in Xinjiang, China.
carboxypeptidase taq deficiency
Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet.
Carcinogenesis
Biochemical and biophysical study of chemopreventive and chemotherapeutic anti-tumor potential of some Egyptian plant extracts.
Carcinogenesis
Comparative effect of dietary olive, safflower, and linseed oils on spontaneous liver tumorigenesis in C3H/He mice.
Carcinogenesis
Evaluation of carcinogenic activities and sperm abnormalities of Gram-negative bacterial metabolites isolated from cancer patients after subcutaneous injection in albino rats.
Carcinogenesis
Glutamic Pyruvate Transaminase GPT2 Promotes Tumorigenesis of Breast Cancer Cells by Activating Sonic Hedgehog Signaling.
Carcinogenesis
Incidence of hepatocellular carcinoma in chronic hepatitis C after interferon therapy.
Carcinogenesis
Induction of steatohepatitis and liver tumorigenesis by enforced Snail expression in hepatocytes.
Carcinogenesis
LRH-1-dependent programming of mitochondrial glutamine processing drives liver cancer.
Carcinogenesis
Relation between incidence of hepatic carcinogenesis and integration value of alanine aminotransferase in patients with hepatitis C virus infection.
Carcinoma
A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy.
Carcinoma
Artemisia capillaris formula inhibits hepatic steatosis via an miR?122?induced decrease in fatty acid synthase expression in vivo and in vitro.
Carcinoma
Aspartate transaminase/alanine transaminase (De Ritis ratio) predicts survival in major burn patients.
Carcinoma
DEPRESSION OF ALANINE TRANSAMINASE ACTIVITY IN THE LIVER OF RATS BEARING WALKER CARCINOMA 256.
Carcinoma
Inhibition of alanine aminotransferase in silico and in vivo promotes mitochondrial metabolism to impair malignant growth.
Carcinoma
Leucine amino peptidase a better indicator of carcinoma of liver, biliary tract and pancreas.
Carcinoma
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis.
Carcinoma
Predicting the risk of postoperative acute kidney injury: development and assessment of a novel predictive nomogram.
Carcinoma
Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model.
Carcinoma
The current state of chronic dialysis treatment in Japan (as of December 31, 2000).
Carcinoma
The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis.
Carcinoma
[Description of highly purified glutamic-pyruvic transaminase from dog liver and its effect on the anaerobic glycolysis of the Ehrlich mouse ascites carcinoma cell]
Carcinoma 256, Walker
Corticosteroids and transaminase activity. III. A relationship between changes in alanine transaminase activity and the growth of Walker carcinosarcoma 256.
Carcinoma 256, Walker
DEPRESSION OF ALANINE TRANSAMINASE ACTIVITY IN THE LIVER OF RATS BEARING WALKER CARCINOMA 256.
Carcinoma, Bronchogenic
Vectorcardiography in the diagnosis of postoperative myocardial infarction.
Carcinoma, Hepatocellular
A Dynamic Aspartate-to-Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease.
Carcinoma, Hepatocellular
A new plasma biomarker enhance the clinical prediction of postoperative acute kidney injury in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
A new triterpene and protective effect of Periploca somaliensis Browicz fruits against CCl?-induced injury on human hepatoma cell line (Huh7).
Carcinoma, Hepatocellular
A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels.
Carcinoma, Hepatocellular
A Patient-Centered Hepatitis B Virus (HBV) Educational Intervention Improves HBV Care Among Underserved Safety-Net Populations.
Carcinoma, Hepatocellular
Abundance of immunologically active alanine aminotransferase in sera of liver cirrhosis and hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
Carcinoma, Hepatocellular
Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase.
Carcinoma, Hepatocellular
Alanine aminotransferase level as a predictor of hepatitis C virus-associated hepatocellular carcinoma incidence in a community-based population in Japan.
Carcinoma, Hepatocellular
Alanine aminotransferase to hemoglobin ratio is an indicator for disease progression for hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization.
Carcinoma, Hepatocellular
ANNALS EXPRESS: A retrospective pilot study to examine the potential of aspartate aminotransferase to alanine aminotransferase ratio as a predictor of post-operative acute kidney injury in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
Carcinoma, Hepatocellular
Anticancer effect of ursolic acid stearoyl glucoside in chemically induced hepatocellular carcinoma.
Carcinoma, Hepatocellular
Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference.
Carcinoma, Hepatocellular
Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.
Carcinoma, Hepatocellular
Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection.
Carcinoma, Hepatocellular
Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis.
Carcinoma, Hepatocellular
ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
Carcinoma, Hepatocellular
Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
Carcinoma, Hepatocellular
Changes in glutamic-alanine transaminase activity in response to corticoid treatment in hepatoma and the precancerous liver of rats induced by 3'-methyl-4-dimethyl amino-azo benzene.
Carcinoma, Hepatocellular
Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Characteristics of hepatitis C viral genome associated with disease progression.
Carcinoma, Hepatocellular
Characteristics of hepatocellular carcinoma in hemodialysis patients in hepatitis B endemic area.
Carcinoma, Hepatocellular
Chemical aspects of coumarin compounds for the prevention of hepatocellular carcinomas.
Carcinoma, Hepatocellular
Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C.
Carcinoma, Hepatocellular
Clinical importance of serum hepatitis B surface antigen levels in chronic hepatitis B.
Carcinoma, Hepatocellular
Clinical outcomes in a prospective study of community-acquired hepatitis C virus infection in Northern Norway.
Carcinoma, Hepatocellular
Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis.
Carcinoma, Hepatocellular
Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Comparable Ten-Year Outcome in Hemodialysis Patients with Hepatitis C Virus and Hepatitis B Virus Coinfection and Single Hepatitis B Virus Infection.
Carcinoma, Hepatocellular
Correlation between serum enzymes and serum unsaturated vitamin B12 binding proteins in primary liver carcinoma.
Carcinoma, Hepatocellular
Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.
Carcinoma, Hepatocellular
Description and analysis of differential sensitivity to glucocorticoids in Fao cells.
Carcinoma, Hepatocellular
Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C.
Carcinoma, Hepatocellular
Detection of serum hepatitis B, C, and D viral nucleic acids and its implications in hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Detection of tumor glutamate metabolism in vivo using (13)C magnetic resonance spectroscopy and hyperpolarized [1-(13)C]glutamate.
Carcinoma, Hepatocellular
Development and Validation of CAGIB Score for Evaluating the Prognosis of Cirrhosis with Acute Gastrointestinal Bleeding: A Retrospective Multicenter Study.
Carcinoma, Hepatocellular
Development of hepatocellular carcinoma in a woman with HBV- and HCV-negative autoimmune hepatitis with unsatisfactory response to Corticosteroid.
Carcinoma, Hepatocellular
Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levels.
Carcinoma, Hepatocellular
Diagnostic value of the ?-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic value of gamma-glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma-glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha-fetoprotein-negative hepatocellular carcinoma.
Carcinoma, Hepatocellular
Dracocephalum: novel anticancer plant acting on liver cancer cell mitochondria.
Carcinoma, Hepatocellular
Earlier Alanine Aminotransferase Normalization During Antiviral Treatment Is Independently Associated With Lower Risk of Hepatocellular Carcinoma in Chronic Hepatitis B.
Carcinoma, Hepatocellular
Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV Patients.
Carcinoma, Hepatocellular
Eating quickly is associated with a low aspartate aminotransferase to alanine aminotransferase ratio in middle-aged adults: a large-scale cross-sectional survey in Japan.
Carcinoma, Hepatocellular
Effect of selenium-enriched malt on hepatocarcinogenesis, paraneoplastic syndrome and the hormones regulating blood glucose in rats treated by diethylnitrosamine.
Carcinoma, Hepatocellular
Effect of silymarin on N-nitrosodiethylamine induced hepatocarcinogenesis in rats.
Carcinoma, Hepatocellular
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.
Carcinoma, Hepatocellular
Effects of vitamins B1, B2, B6 and C on erythrocyte enzymes in South African Bantu.
Carcinoma, Hepatocellular
Efficacy of intra-tumor injection of Xiao-Zhi-Ling on transplanted hepatoma in rats.
Carcinoma, Hepatocellular
Elevated Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predicts Poor Outcome in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Elevated perioperative transaminase level predicts intrahepatic recurrence in hepatitis B-related hepatocellular carcinoma after curative hepatectomy.
Carcinoma, Hepatocellular
Expression of differentiated functions in hepatoma cell hybrids: alanine aminotransferase.
Carcinoma, Hepatocellular
Expression of hepatitis B virus nuclear core antigen in young cirrhotic patients is associated with an unfavourable long-term outcome.
Carcinoma, Hepatocellular
Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection.
Carcinoma, Hepatocellular
Fine Particle Pollution, Alanine Transaminase, and Liver Cancer: A Taiwanese Prospective Cohort Study (REVEAL-HBV).
Carcinoma, Hepatocellular
Genotype Distribution of Vitamin D Receptor Polymorphisms among Indonesian Patients with Chronic Hepatitis B.
Carcinoma, Hepatocellular
Glutamic-Pyruvic Transaminase 1 Facilitates Alternative Fuels for Hepatocellular Carcinoma Growth-A Small Molecule Inhibitor, Berberine.
Carcinoma, Hepatocellular
HBeAg-negative chronic hepatitis patients should be monitored more strictly: a cross-sectional retrospective study on antiviral treatment-naïve patients.
Carcinoma, Hepatocellular
Hepatitis B surface antigen-negative, but HBV DNA-positive patients in Bangladesh.
Carcinoma, Hepatocellular
Hepatitis B virus genotypes and clinical manifestation among hepatitis B carriers in Thailand.
Carcinoma, Hepatocellular
Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease.
Carcinoma, Hepatocellular
Hepatoprotective effects of limb ischemic post-conditioning in hepatic ischemic rat model and liver cancer patients via PI3K/ERK pathways.
Carcinoma, Hepatocellular
High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase-Lowering Effect of a HSD17B13 Variant.
Carcinoma, Hepatocellular
High serum alanine aminotransferase levels for the first three successive years can predict very high incidence of hepatocellular carcinoma in patients with Child Stage A HCV-associated liver cirrhosis.
Carcinoma, Hepatocellular
High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis.
Carcinoma, Hepatocellular
Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
Carcinoma, Hepatocellular
Highly liver-specific heme oxygenase-1 induction by interleukin-11 prevents carbon tetrachloride-induced hepatotoxicity.
Carcinoma, Hepatocellular
Identification and expression profiles of genes and protens in SMMC-7721 cells.
Carcinoma, Hepatocellular
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
Carcinoma, Hepatocellular
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV cirrhosis with Normal Alanine Transaminase.
Carcinoma, Hepatocellular
Incidence of hepatocellular carcinoma in chronic hepatitis C after interferon therapy.
Carcinoma, Hepatocellular
Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines.
Carcinoma, Hepatocellular
Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels.
Carcinoma, Hepatocellular
Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values.
Carcinoma, Hepatocellular
Induction of alanine transaminase by adrenal steroids in cultured hepatoma cells.
Carcinoma, Hepatocellular
Influence of Alanine Transaminase Levels on Alpha-Fetoprotein for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Infection.
Carcinoma, Hepatocellular
Influence of serum HBV DNA load on recurrence of hepatocellular carcinoma after treatment with percutaneous radiofrequency ablation.
Carcinoma, Hepatocellular
Interaction and joint effect of ALT and chronic liver disease on liver cancer in type 2 diabetes patients.
Carcinoma, Hepatocellular
Interferon reduces the risk of hepatocellular carcinoma in hepatitis C virus-related chronic hepatitis/liver cirrhosis.
Carcinoma, Hepatocellular
Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
Carcinoma, Hepatocellular
Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.
Carcinoma, Hepatocellular
Interleukin-28B polymorphism in hepatitis C and liver transplantation.
Carcinoma, Hepatocellular
Is liver resection for hepatocellular carcinoma in cirrhotic patients with high preoperative serum alanine aminotransferase level unadvisable?
Carcinoma, Hepatocellular
Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis B virus-related liver disease.
Carcinoma, Hepatocellular
Letter: elevated aspartate aminotransferase and aspartate aminotransferase to alanine aminotransferase ratio predicts poor survival in hepatocellular carcinoma after resection-Authors' reply.
Carcinoma, Hepatocellular
Letter: elevated aspartate aminotransferase and aspartate aminotransferase to alanine aminotransferase ratio predicts poor survival in hepatocellular carcinoma after resection.
Carcinoma, Hepatocellular
Leucine amino peptidase a better indicator of carcinoma of liver, biliary tract and pancreas.
Carcinoma, Hepatocellular
Long term follow-up of a group of chronic hepatitis C patients treated with anti-inflammatory drugs following initial interferon therapy.
Carcinoma, Hepatocellular
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years.
Carcinoma, Hepatocellular
Long-term follow-up of patients with hepatitis B e antigen negative chronic hepatitis B.
Carcinoma, Hepatocellular
Long-term responders without eradication of hepatitis C virus after interferon therapy: characterization of clinical profiles and incidence of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis.
Carcinoma, Hepatocellular
Maintenance interferon therapy in chronic hepatitis C patients who failed initial antiviral therapy: A meta-analysis.
Carcinoma, Hepatocellular
Management of Chronic Hepatitis B: Knowledge and Practices of Physicians in Pakistan.
Carcinoma, Hepatocellular
Multienzyme control serum (Seraclear-HE) containing human enzymes from established cell lines and other sources. 1: Preparation and properties.
Carcinoma, Hepatocellular
Occurrence and Recurrence of Hepatocellular Carcinoma Were Not Rare Events during Phlebotomy in Older Hepatitis C Virus-Infected Patients.
Carcinoma, Hepatocellular
Overexpression of miRNA-21 Promotes the Proliferation and Invasion in Hepatocellular Carcinoma Cells via Suppressing SMAD7.
Carcinoma, Hepatocellular
Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis.
Carcinoma, Hepatocellular
Posthepatectomy hepatitis shortens tumor-free intervals in hepatitis C virus-associated hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation.
Carcinoma, Hepatocellular
Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy.
Carcinoma, Hepatocellular
Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals.
Carcinoma, Hepatocellular
Prognostic Value of ALT, AST, and AAR in Hepatocellular Carcinoma with B-Type Hepatitis-Associated Cirrhosis after Radical Hepatectomy.
Carcinoma, Hepatocellular
Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus.
Carcinoma, Hepatocellular
Prostate-specific antigen in acute hepatitis and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Provider, Patient, and Practice Factors Shape Hepatitis B Prevention and Management by Primary Care Providers.
Carcinoma, Hepatocellular
Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.
Carcinoma, Hepatocellular
Ratio of serum ornithine carbamoyltransferase to alanine aminotransferase as a potent indicator for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis.
Carcinoma, Hepatocellular
Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
Carcinoma, Hepatocellular
Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC.
Carcinoma, Hepatocellular
Retrospective analysis of hepatitis B virus chronic infection in 247 patients: clinical stages, response to treatment and poor prognostic factors.
Carcinoma, Hepatocellular
Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin.
Carcinoma, Hepatocellular
Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI.
Carcinoma, Hepatocellular
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
Carcinoma, Hepatocellular
Risk of hepatocellular carcinoma in cirrhotic hepatitis B virus patients during nucleoside/nucleotide analog therapy.
Carcinoma, Hepatocellular
Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver.
Carcinoma, Hepatocellular
Serum alanine aminotransferase levels and survival after hepatectomy in patients with hepatocellular carcinoma and hepatitis C virus-associated liver cirrhosis.
Carcinoma, Hepatocellular
Serum level of ornithine carbamoyltransferase is influenced by the state of Kupffer cells.
Carcinoma, Hepatocellular
Serum levels of macrophage colony stimulating factor (M-CSF) in liver disease.
Carcinoma, Hepatocellular
Serum Metabolomics Reveals ?-Glutamyl Dipeptides as Biomarkers for Discrimination among Different Forms of Liver Disease.
Carcinoma, Hepatocellular
Six-way decomposition of causal effects: Unifying mediation and mechanistic interaction.
Carcinoma, Hepatocellular
Smoking and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase.
Carcinoma, Hepatocellular
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician's Guide.
Carcinoma, Hepatocellular
Sustained low alanine aminotransferase levels can predict the survival for 10 years without hepatocellular carcinoma development in patients with hepatitis C virus-associated liver cirrhosis of child stage A.
Carcinoma, Hepatocellular
Synthesis of platinum(II) and palladium(II) complexes with 9,9-dihexyl-4,5-diazafluorene and their in vivo antitumour activity against Hep3B xenografted mice.
Carcinoma, Hepatocellular
T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
Carcinoma, Hepatocellular
The Clinical Presentation of Chronic Hepatitis B Virus (HBV) Infection in Asian Americans: A Single Center Retrospective Study.
Carcinoma, Hepatocellular
Time-related changes in full-length hepatitis C virus sequences and hepatitis activity.
Carcinoma, Hepatocellular
Treatment of HBeAg-positive patients with nucleos/tide analogues.
Carcinoma, Hepatocellular
Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Carcinoma, Lewis Lung
Inhibition of alanine aminotransferase in silico and in vivo promotes mitochondrial metabolism to impair malignant growth.
Carcinoma, Non-Small-Cell Lung
Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing.
Carcinoma, Non-Small-Cell Lung
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ?50%: real-world data.
Carcinoma, Non-Small-Cell Lung
Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer.
Carcinoma, Renal Cell
Aspartate transaminase/alanine transaminase (De Ritis ratio) predicts survival in major burn patients.
Carcinoma, Renal Cell
Cytoplasmic enzyme activities in human hypernephroma compared with normal renal cortical tissue.
Carcinoma, Renal Cell
Predicting the risk of postoperative acute kidney injury: development and assessment of a novel predictive nomogram.
Carcinosarcoma
Corticosteroids and transaminase activity. III. A relationship between changes in alanine transaminase activity and the growth of Walker carcinosarcoma 256.
Cardiac Output, Low
Amiodarone-induced complications after cardiac operation for obstructive hypertrophic cardiomyopathy.
Cardiomyopathies
Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.
Cardiomyopathies
[Acute hepatic ischemia and cardiogenic shock in patients with dilated cardiomyopathy]
Cardiomyopathy, Dilated
Description of breed ancestry and genetic health traits in arctic sled dog breeds.
Cardiomyopathy, Hypertrophic
[Clinical characteristics and GAA gene mutation in children with glycogen storage disease type II: an analysis of 3 cases].
Cardiotoxicity
Addition of Zoledronate to Chemotherapy in Patients with Osteosarcoma Treated with Limb-Sparing Surgery: A Phase III Clinical Trial.
Cardiotoxicity
Induction of metallothionein by zinc protects from daunorubicin toxicity in rats.
Cardiotoxicity
Protective effect of DL-alpha-lipoic acid on cyclophosphamide induced oxidative cardiac injury.
Cardiotoxicity
Reported Signs, Symptoms, and Diagnostic Tests Before Cardiotoxicity Among Women With Breast Cancer: A Pilot Study.
Cardiotoxicity
TXNIP/TRX/NF-?B and MAPK/NF-?B pathways involved in the cardiotoxicity induced by Venenum Bufonis in rats.
Cardiotoxicity
[Study of rat blood serum biochemical indicators of cardiotoxic action of novel antitumor 4-thiazolidinone derivatives and doxorubicin in complexes with polyethylene glycol-containing polymeric carrier in the rat blood serum].
Cardiovascular Diseases
A longitudinal genetic study of uric Acid and liver enzymes in adolescent twins.
Cardiovascular Diseases
Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
Cardiovascular Diseases
Alanine aminotransferase is associated with atherothrombotic risk factors in a British South Asian population.
Cardiovascular Diseases
Alanine aminotransferase, metabolic syndrome, and cardiovascular disease: a missing link?
Cardiovascular Diseases
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Cardiovascular Diseases
Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.
Cardiovascular Diseases
Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study.
Cardiovascular Diseases
Association between serum ?-glutamyltransferase and chronic kidney disease in urban Han Chinese: a prospective cohort study.
Cardiovascular Diseases
Association of Cardiometabolic Risk Factors and Hepatic Enzymes in a National Sample of Iranian Children and Adolescents: The CASPIAN-III Study.
Cardiovascular Diseases
Association of serum VLDL level with hyperhomocysteinemia in hypertensive patients: A cross-sectional study.
Cardiovascular Diseases
Association of the Aspartate Aminotransferase to Alanine Aminotransferase Ratio with BNP Level and Cardiovascular Mortality in the General Population: The Yamagata Study 10-Year Follow-Up.
Cardiovascular Diseases
Association of TSH Elevation with All-Cause Mortality in Elderly Patients with Chronic Kidney Disease.
Cardiovascular Diseases
AST/ALT Ratio and Peripheral Artery Disease in a Chinese Hypertensive Population: A Cross-Sectional Study.
Cardiovascular Diseases
Bi-directional and temporal relationship between elevated alanine aminotransferase and hypertension in a longitudinal study of Chinese adults.
Cardiovascular Diseases
Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease.
Cardiovascular Diseases
Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study.
Cardiovascular Diseases
Clinical features in coronavirus disease 2019 (COVID-19) patients with early clearance and prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA.
Cardiovascular Diseases
Complex association of serum alanine aminotransferase with the risk of future cardiovascular disease in type 2 diabetes.
Cardiovascular Diseases
Development and Validation of a Prediction Score for Postoperative Acute Renal Failure Following Liver Resection.
Cardiovascular Diseases
Diet as moderator in the association of adiposity with inflammatory biomarkers among adolescents in the HELENA study.
Cardiovascular Diseases
Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans.
Cardiovascular Diseases
Health-related quality of life in Chinese population with non-alcoholic fatty liver disease: a national multicenter survey.
Cardiovascular Diseases
Healthy Range of Serum Alanine Aminotransferase and its Predictive Power for Cardiovascular Risk in Children and Adolescents.
Cardiovascular Diseases
Ideal cardiovascular health predicts lower risk of abnormal liver enzymes levels in the Chilean National Health Survey (2009-2010).
Cardiovascular Diseases
Implication of liver enzymes on incident cardiovascular diseases and mortality: A nationwide population-based cohort study.
Cardiovascular Diseases
Incretin mimetics as a novel therapeutic option for hepatic steatosis.
Cardiovascular Diseases
Inverse linear associations between liver aminotransferases and incident cardiovascular disease risk: The PREVEND study.
Cardiovascular Diseases
Liver enzyme variability and risk of heart disease and mortality: A nationwide population-based study.
Cardiovascular Diseases
Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.
Cardiovascular Diseases
Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study.
Cardiovascular Diseases
Liver Enzymes and Risk of Ischemic Heart Disease and Type 2 Diabetes Mellitus: A Mendelian Randomization Study.
Cardiovascular Diseases
Mendelian randomization estimates of alanine aminotransferase with cardiovascular disease: Guangzhou Biobank Cohort study.
Cardiovascular Diseases
Multiple biomarkers and their relative contributions to identifying metabolic syndrome.
Cardiovascular Diseases
Novel Prediction Score Including Pre- and Intraoperative Parameters Best Predicts Acute Kidney Injury after Liver Surgery.
Cardiovascular Diseases
Prevalence of metabolic syndrome increases with the increase in blood levels of gamma glutamyltransferase and alanine aminotransferase in Japanese men and women.
Cardiovascular Diseases
Relation of Alanine Aminotransferase Levels to Cardiovascular Events and Statin Efficacy.
Cardiovascular Diseases
Relationship between a self-reported health questionnaire and laboratory tests at initial office visits.
Cardiovascular Diseases
Serum alanine aminotransferase activity and risk factors for cardiovascular disease in a Caucasian population: the Tromsø study.
Cardiovascular Diseases
Serum Alanine Aminotransferase Is Associated with Metabolic Syndrome and 10-year Risk of Cardiovascular Disease.
Cardiovascular Diseases
Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population.
Cardiovascular Diseases
Serum gamma-glutamyl transferase activity predicts future development of metabolic syndrome defined by 2 different criteria.
Cardiovascular Diseases
Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men.
Cardiovascular Diseases
Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.
Cardiovascular Diseases
Soluble ST2, a biomarker of fibrosis, is associated with multiple risk factors, chronic diseases and total mortality in the OPERA study.
Cardiovascular Diseases
The association between AST/ALT ratio and all-cause and cardiovascular mortality in patients with hypertension.
Cardiovascular Diseases
The Effect of the Mediterranean Diet on Metabolic Health: A Systematic Review and Meta-Analysis of Controlled Trials in Adults.
Cardiovascular Diseases
The potential role of angiopoietin-like protein-8 in type 2 diabetes mellitus: a possibility for predictive diagnosis and targeted preventive measures?
Cardiovascular Diseases
The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment.
Cardiovascular Diseases
Usefulness of Triglyceride to High-Density Lipoprotein Ratio and Alanine Aminotransferase for Predicting Insulin Resistance and Metabolic Syndrome in the Japanese Population.
Carotid Artery Diseases
Association of serum Sestrin2 level with metabolic risk factors in newly diagnosed drug-naïve type 2 diabetes.
Carotid Artery Diseases
Hepatic steatosis, carotid atherosclerosis and metabolic syndrome: the STEATO Study.
Carotid Artery Diseases
Normal range of alanine aminotransferase concentration is associated with carotid atherosclerosis.
Carotid Artery Diseases
The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels.
Carotid Stenosis
Predictive Value of Neutrophil-to-Lymphocyte, Aspartate-to-Alanine Aminotransferase, Lymphocyte-to-Monocyte and Platelet-to-Lymphocyte Ratios in Severity and Side of Carotid Artery Stenosis: Are Those Significant?
Cataract
Metabolic evidence for the involvement of enzymatic bioactivation in the cataractogenicity of acetaminophen in genetically susceptible (C57BL/6) and resistant (DBA/2) murine strains.
Cataract
Pure red cell aplasia associated with autoimmune hepatitis successfully treated with cyclosporine A.
Cataract
Safety and Antitumor Activity of Repeated ASP3026 Administration in Japanese Patients with Solid Tumors: A Phase I Study.
Cataract
Some plasma constituents correlate with human cataract location and nuclear colour.
Celiac Disease
Liver abnormalities associated with celiac sprue. How common are they, what is their significance, and what do we do about them?
Celiac Disease
Prevalence and associated factors of abnormal liver values in children with celiac disease.
Cerebral Hemorrhage
Association between alanine aminotransferase and intracerebral hemorrhage in East Asian populations.
Cerebral Infarction
[The glutamic-oxalacetic and glutamic-pyruvic transaminase activity of the serum in experimental cerebral infarction.]
Cerebrovascular Disorders
[Significance of circulating tumor cell monitoring in targeted therapy for gastrointestinal stromal tumors].
Chagas Disease
The identification by isoenzyme patterns of two distinct strain-groups of Trypanosoma cruzi, circulating independently in a rural area of Brazil.
Chemical and Drug Induced Liver Injury
A paper-based multiplexed transaminase test for low-cost, point-of-care liver function testing.
Chemical and Drug Induced Liver Injury
A pre-marketing ALT signal predicts post-marketing liver safety.
Chemical and Drug Induced Liver Injury
A prospective study of the incidence of drug-induced liver injury by the modern volatile anaesthetics sevoflurane and desflurane.
Chemical and Drug Induced Liver Injury
An artificial intelligence algorithm for analyzing acetaminophen-associated toxic hepatitis.
Chemical and Drug Induced Liver Injury
Assessment of emerging biomarkers of liver injury in human subjects.
Chemical and Drug Induced Liver Injury
Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential action.
Chemical and Drug Induced Liver Injury
Blood alanine aminotransferase levels >1,000 IU/l - causes and outcomes.
Chemical and Drug Induced Liver Injury
Characterization of release profile of ornithine carbamoyltransferase from primary rat hepatocytes treated with hepatotoxic drugs: Implications for its unique potential as a drug-induced liver injury biomarker.
Chemical and Drug Induced Liver Injury
Choleretic activity of 2-demethoxycarbonyl-2-ethoxycarbonyl-11-deoxymisoprostol on the model of CCl4-induced hepatitis.
Chemical and Drug Induced Liver Injury
Comparison of Different Liver Test Thresholds for Drug-Induced Liver Injury: Updated RUCAM versus Other Methods.
Chemical and Drug Induced Liver Injury
Contrasting model mechanisms of alanine aminotransferase (ALT) release from damaged and necrotic hepatocytes as an example of general biomarker mechanisms.
Chemical and Drug Induced Liver Injury
Cross hepatotoxicity between tricyclic antidepressants and phenothiazines.
Chemical and Drug Induced Liver Injury
Drug-induced hepatotoxicity: incidence of abnormal liver function tests consistent with volatile anaesthetic hepatitis in trauma patients.
Chemical and Drug Induced Liver Injury
Drug-induced Liver Disease in Patients with Diabetes Mellitus.
Chemical and Drug Induced Liver Injury
Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
Chemical and Drug Induced Liver Injury
Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injury.
Chemical and Drug Induced Liver Injury
Hepatitis E: an expanding epidemic with a range of complications.
Chemical and Drug Induced Liver Injury
HLA-DR7 and HLA-DQ2: Transgenic mouse strains tested as a model system for ximelagatran hepatotoxicity.
Chemical and Drug Induced Liver Injury
Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts.
Chemical and Drug Induced Liver Injury
Markedly Elevated Liver Enzymes in Choledocholithiasis in the absence of Hepatocellular Disease: Case Series and Literature Review.
Chemical and Drug Induced Liver Injury
Novel bead-based platform for direct detection of unlabelled nucleic acids through Single Nucleobase Labelling.
Chemical and Drug Induced Liver Injury
Risk factors for Acetaminophen-induced liver injury: A Single-center study from Japan.
Chemical and Drug Induced Liver Injury
Serum Metabolomics Reveals ?-Glutamyl Dipeptides as Biomarkers for Discrimination among Different Forms of Liver Disease.
Chemical and Drug Induced Liver Injury
Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore.
Chemical and Drug Induced Liver Injury
The effects of dietary iron overload on fumonisin B1-induced cancer promotion in the rat liver.
Chemical and Drug Induced Liver Injury
The role of hepatitis E virus testing in drug-induced liver injury.
Chemical and Drug Induced Liver Injury
The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.
Chemical and Drug Induced Liver Injury
What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI).
Chemical and Drug Induced Liver Injury
[A Case of Lead Poisoning with Drug-induced Liver Injury after Ingestion of Herbal Medicine].
Chemical and Drug Induced Liver Injury
[Activity of the marker liver enzymes under the conditions of toxic hepatitis and alimentary deprivation of protein].
Chemical and Drug Induced Liver Injury
[Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature]
Chemical and Drug Induced Liver Injury
[Effect of enterosorption effects on hepatic enzyme spectrum in experimental toxic hepatitis]
Chemical and Drug Induced Liver Injury
[Effectiveness of dietary non-starch polysaccharides in experimental toxic hepatitis]
Chemical and Drug Induced Liver Injury
[Hepatoprotective properties of liquid extract of Rhodiola rosea]
Cholangiocarcinoma
Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study.
Cholangiocarcinoma
Elevated Serum Bilirubin Level Correlates With the Development of Cholangiocarcinoma, Subsequent Liver Transplantation, and Death in Patients With Primary Sclerosing Cholangitis.
Cholangiocarcinoma
Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma.
Cholangitis
Clinical characteristics of antimitochondrial antibody-positive patients at a safety net health care system in Arizona.
Cholangitis
Consideration of endoscopic retrograde cholangiopancreatography in cases of acute biliary pancreatitis.
Cholangitis
Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer.
Cholangitis
Initial response to portoenterostomy determines long-term outcome in patients with biliary atresia.
Cholangitis
Preoperative determinants of common bile duct stones during laparoscopic cholecystectomy.
Cholangitis
Real-World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis.
Cholangitis
Use of a microcomputer in the assessment of diagnosis and risk in obstructive jaundice.
Cholangitis
[Usefulness of endoscopic cholangiography and sphincterotomy in patients with biliary lithiasis]
Cholangitis, Sclerosing
Diagnosis of primary sclerosing cholangitis in a blood donor with elevated serum alanine aminotransferase.
Cholangitis, Sclerosing
Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study.
Cholangitis, Sclerosing
High aspartate to alanine aminotransferase ratio is an indicator of cirrhosis and poor outcome in patients with primary sclerosing cholangitis.
Cholangitis, Sclerosing
IgG4 subclass and gamma-glutamyl transferase in children with ulcerative colitis with primary sclerosing cholangitis and without sclerosing cholangitis.
Cholangitis, Sclerosing
Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
Cholangitis, Sclerosing
Overlap syndrome between autoimmune hepatitis and primary sclerosing cholangitis in two cases.
Cholecystitis
Acute transient hepatocellular injury in cholelithiasis and cholecystitis without evidence of choledocholithiasis.
Cholecystitis
CLINICAL AND GENETIC PREDICTORS AND PROGNOSTIC MODEL OF RAPIDLY PROGRESSIVE HEPATIC FIBROSIS IN CHRONIC HEPATITIS C.
Cholecystitis
Liver enzyme elevation and normal pulmonary function in an adult with a declining forced expiratory volume in 1 second.
Cholecystitis
Phase I/II Multicenter Study of Transarterial Chemoembolization with a Cisplatin Fine Powder and Porous Gelatin Particles for Unresectable Hepatocellular Carcinoma: Japan Interventional Radiology in Oncology Study Group Study 0401.
Cholecystitis
Relationship between clinical and histopathological features of patients undergoing cholecystectomy.
Cholecystitis
Risk assessment scales and predictors for simple versus severe cholecystitis in performing laparoscopic cholecystectomy.
Cholecystitis
[The bile cholate-cholesterol coefficient for assessing the causes of a protracted convalescence in patients with viral hepatitis]
Cholecystitis
[The blood level of cobalamin as an indicator of the functional status of the liver in jaundice of different etiologies]
Cholecystitis, Acute
Automated development of artificial neural networks for clinical purposes: Application for predicting the outcome of choledocholithiasis surgery.
Cholecystitis, Acute
Consideration of endoscopic retrograde cholangiopancreatography in cases of acute biliary pancreatitis.
Cholecystitis, Acute
Is preoperative MRCP necessary for patients with gallstones? An analysis of the factors related to missed diagnosis of choledocholithiasis by preoperative ultrasound.
Cholecystitis, Acute
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial.
Cholecystitis, Acute
Risk factors for conversion of laparoscopic cholecystectomy to open cholecystectomy.
Choledocholithiasis
A scoring system for the prediction of choledocholithiasis: a prospective cohort study.
Choledocholithiasis
A significant proportion of patients with choledocholithiasis have markedly elevated alanine aminotransferase.
Choledocholithiasis
Marked elevation in serum transaminases: an atypical presentation of choledocholithiasis.
Choledocholithiasis
[Usefulness of endoscopic cholangiography and sphincterotomy in patients with biliary lithiasis]
Cholelithiasis
Acute transient hepatocellular injury in cholelithiasis and cholecystitis without evidence of choledocholithiasis.
Cholelithiasis
ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
Cholelithiasis
Effect of hepatic function on the EC50 of midazolam and the BIS50 at the time of loss of consciousness.
Cholelithiasis
Exploring the diagnosis markers for gallbladder cancer based on clinical data.
Cholelithiasis
The biochemical detection of biliary etiology of acute pancreatitis on admission: a revisit in the modern era of biliary imaging.
Cholelithiasis
The Prevalence of Gallstone Disease Is Significantly Lower in Natives than in Migrants of Jeju Island.
Cholelithiasis
[The effect of diabetes and cholelithiasis on the course and consequences of acute viral hepatitis type B]
Cholestasis
14-Week toxicity and cell proliferation of methyleugenol administered by gavage to F344 rats and B6C3F1 mice.
Cholestasis
A New Paradigm in Gallstones Diseases and Marked Elevation of Transaminases: An Observational Study.
Cholestasis
Aberrant Expression of Keratin 7 in Hepatocytes as a Predictive Marker of Rapid Progression to Hepatic Failure in Asymptomatic Primary Biliary Cirrhosis.
Cholestasis
Activities of APh, gamma-GT, GlDH and GPT and bile acid concentrations in serum after bile duct obstruction and cycloheximide in the rat.
Cholestasis
Alteration of Bile Acid and Cholesterol Biosynthesis and Transport by Perfluorononanoic Acid (PFNA) in Mice.
Cholestasis
An unusual complication after endovascular aneurysm repair for giant abdominal aortic aneurysm with aortocaval fistula: High bilirubin levels.
Cholestasis
Association of plasma level of thiobarbituric acid reactive substances with extent of hepatocellular injury in preterm infants with cholestatic jaundice.
Cholestasis
Calculus Bovis Sativus up-regulates hepatic protein 2 (Mrp2) and Mrp4 in 17?-ethynylestradiol-induced cholestasis via a regulatory effect on ER signaling.
Cholestasis
Characterization of the protective effects of melatonin and related indoles against alpha-naphthylisothiocyanate-induced liver injury in rats.
Cholestasis
Conservative Management of Alloimmune Hemolysis and Cholestasis With Extreme Laboratory Abnormalities.
Cholestasis
Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats.
Cholestasis
Effects of sphingosylphosphorylcholine against cholestatic oxidative stress and liver damage in the common bile duct ligated rats.
Cholestasis
Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis.
Cholestasis
Ethyl acetate extract of herpetospermum pedunculosum alleviates ?-naphthylisothiocyanate-induced cholestasis by activating the farnesoid x receptor and suppressing oxidative stress and inflammation in rats.
Cholestasis
Evaluation of ameliorative ability of Silibinin against zidovudine and isoniazid-induced hepatotoxicity and hyperlipidaemia in rats: Role of Silibinin in Phase I and II drug metabolism.
Cholestasis
Evaluation of graft viability in heterotopic auxiliary liver transplantation in the rat.
Cholestasis
Evaluation of the diagnostic value of serum bile acid in the detection and functional assessment of liver diseases.
Cholestasis
Extrapancreatic organ impairment during acute pancreatitis induced by bile-pancreatic duct obstruction. Effect of N-acetylcysteine.
Cholestasis
Hematologic and biochemical abnormalities associated with induced extrahepatic bile duct obstruction in the cat.
Cholestasis
Hepatic damage in biliary-obstructed rats is ameliorated by leflunomide treatment.
Cholestasis
Hepatic steatosis and neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) in Taiwanese infants.
Cholestasis
Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.
Cholestasis
Identification of potential biomarkers in cholestasis and the therapeutic effect of melatonin by metabolomics, multivariate data and pathway analyses.
Cholestasis
Induction of chronic cholestasis without liver cirrhosis - Creation of an animal model.
Cholestasis
Intestinal Hypoganglionosis Leading to Intestinal Failure and the Compassionate Use of Omegaven.
Cholestasis
Investigations of Free Anthraquinones from Rhubarb Against alpha-Naphthylisothiocyanate-induced Cholestatic Liver Injury in Rats.
Cholestasis
Liver dysfunction associated with artificial nutrition in critically ill patients.
Cholestasis
Low phospholipid-associated cholelithiasis syndrome: A rare cause of acute pancreatitis that should not be neglected.
Cholestasis
Measurement of serum bile acids concentrations for diagnosis of hepatobiliary disease in cats.
Cholestasis
Mechanisms of resistance of hepatocyte retinoid X receptor alpha-null mice to WY-14,643-induced hepatocyte proliferation and cholestasis.
Cholestasis
Melatonin versus vitamin E as protective treatment against oxidative stress after extra-hepatic bile duct ligation in rats.
Cholestasis
Mutation spectrum and biochemical features in infants with neonatal Dubin-Johnson syndrome.
Cholestasis
Obstetrical and neonatal outcomes among women infected with hepatitis C and their infants.
Cholestasis
Prevalence and genomic variability of transfusion transmitted virus in Italian cryptogenic chronic liver disease and healthy blood donors.
Cholestasis
Prevalence and Prognostic Value of Abnormal Liver Test Results in Critically Ill Children and the Impact of Delaying Parenteral Nutrition.
Cholestasis
Prognostic value of biochemical liver parameters in neonatal sepsis-associated cholestasis.
Cholestasis
Protective effect of glycyrrhizin, glycyrrhetic acid and matrine on acute cholestasis induced by alpha-naphthyl isothiocyanate in rats.
Cholestasis
Protective effect of melatonin against oxidative stress induced by ligature of extra-hepatic biliary duct in rats: comparison with the effect of S-adenosyl-L-methionine.
Cholestasis
Recurrent acalculous cholecystitis and sclerosing cholangitis in a patient with X-linked hyper-immunoglobulin M syndrome.
Cholestasis
Serologic assay for secretory component distinguishes mechanical from hepatocellular cholestasis in humans.
Cholestasis
Severe hepatocellular injury with apoptosis induced by a hepatitis C polymerase inhibitor.
Cholestasis
Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy?
Cholestasis
Value of serum alkaline phosphatase, aminotransferases, gamma-glutamyl transferase, leucine aminopeptidase, and bilirubin in the distinction between benign and malignant diseases causing jaundice and cholestasis: results from a prospective study.
Cholestasis
Yinchenhao Decoction Ameliorates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis in Rats by Regulating Phase II Metabolic Enzymes and Transporters.
Cholestasis
Zidovudine and isoniazid induced liver toxicity and oxidative stress: Evaluation of mitigating properties of silibinin.
Cholestasis
[Clinical effect of multi-oil fat emulsion for parenteral nutrition support in extremely low birth weight infants].
Cholestasis
[Comparative efficacy of clinical use of reamberin, remaxol and ademethionine in patients with tuberculosis of the respiratory organs and liver drug-injury].
Cholestasis
[Congenital extrahepatic biliary atresia as a cause of cholestasis in newborns and infants]
Cholestasis
[Infant with 3?-hydroxy-?(5)-C27 steroid dehydrogenase deficiency: report of two cases and literatures review].
Cholestasis
[The state of cytokine status in patients with mechanical jaundice of benign origin].
Cholestasis, Extrahepatic
Effect of hepatic artery ligation in rats with chronic extrahepatic cholestasis.
Cholestasis, Extrahepatic
Liver stiffness in extrahepatic cholestasis correlates positively with bilirubin and negatively with alanine aminotransferase.
Cholestasis, Extrahepatic
Serum transaminase levels in the acute phase of chronic extrahepatic cholestasis.
Cholestasis, Intrahepatic
Alanine aminopeptidase in serum: automated optimized assay, and effects of age, sex, smoking, and alcohol consumption in a selected population.
Cholestasis, Intrahepatic
Alanine aminotransferase as a predictor of adverse perinatal outcomes in women with intrahepatic cholestasis of pregnancy.
Cholestasis, Intrahepatic
Lignans from Schisandra sphenanthera protect against lithocholic acid-induced cholestasis by pregnane X receptor activation in mice.
Cholestasis, Intrahepatic
[Nested casejcontrol study on the influence factors of perinatal stage transmission of hepatitis B virus]
Choline Deficiency
Effects of choline deficiency and methotrexate treatment upon rat liver.
Chorioretinitis
Evaluation of clinically asymptomatic high risk infants with congenital cytomegalovirus infection.
Chronic Periodontitis
Effects on the clinical indices and gingival crevicular fluid enzyme activities of the cyclical regimen of low-dose doxycycline therapy for adult periodontitis.
Chronic Periodontitis
Evaluation of serum alanine aminotransferase and aspartate aminotransferase enzyme levels in women patients with chronic periodontitis.
coagulation factor viia deficiency
Description of breed ancestry and genetic health traits in arctic sled dog breeds.
Coccidiosis
[Alteration of enzyme activities in serum of Eimeria stiedai infected rabbits (author's transl)]
Coinfection
A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997-1999.
Coinfection
A prospective study of transfusion-transmitted virus transmission by blood transfusion.
Coinfection
Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance.
Coinfection
Antiretroviral therapy hepatotoxicity: Prevalence, risk factors, and clinical characteristics in a cohort of Han Chinese.
Coinfection
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study.
Coinfection
Characteristics of Hepatitis B Co-infection and Disease Evolution in HIV-Positive Paediatric Patients in Romania.
Coinfection
Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome.
Coinfection
Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.
Coinfection
Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence.
Coinfection
Clinical significance of hepatitis G virus infection in patients on long-term haemodialysis.
Coinfection
Clinical significance of T.T. virus infection in maintenance hemodialysis patients of an endemic area for hepatitis C infection.
Coinfection
Clinical, virological and histological implications of GB virus-C/hepatitis G virus infection in patients with chronic hepatitis C virus infection: a multicentre study based on 671 patients.
Coinfection
Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.
Coinfection
Comparative serum biochemical changes in mongrel dogs following single and mixed infections of Trypanosoma congolense and Trypanosoma brucei brucei.
Coinfection
Correlation of biological serum markers with the degree of hepatic fibrosis and necroinflammatory activity in hepatitis C and schistosomiasis patients.
Coinfection
Detection of antibodies to E2-protein of GB virus-C/hepatitis G virus in patients with acute posttransfusion hepatitis.
Coinfection
Does Malaria Co-Infection Alter the Clinical Course in Children Infected with Dengue? Analysis from 623 Indian Children Admitted with Dengue Infection.
Coinfection
Effect of TT virus co-infection on interferon response in chronic hepatitis C patients.
Coinfection
Elevated alanine aminotransferase levels in HIV-infected persons without hepatitis B or C virus coinfection.
Coinfection
Fatty Liver Disease in a Prospective North American Cohort of Adults with HIV and Hepatitis B Coinfection.
Coinfection
GB virus-C/hepatitis G virus infection in a hepatitis C virus endemic village: prevalence in residents with low educational attainment and frequent recovery in females.
Coinfection
Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania.
Coinfection
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy.
Coinfection
High prevalence of hepatitis G virus infection in multiply transfused children with thalassaemia.
Coinfection
High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
Coinfection
High rates of hepatitis G virus infection in multitransfused patients with hemophilia.
Coinfection
HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection.
Coinfection
HIV/hepatitis C virus-coinfected patients with normal alanine aminotransferase levels.
Coinfection
Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa.
Coinfection
Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
Coinfection
Infection with HIV and HCV enhances the release of fatty acid synthase into circulation: evidence for a novel indicator of viral infection.
Coinfection
Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection.
Coinfection
Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevation.
Coinfection
Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
Coinfection
Molecular characterization and histo-physiological alterations induced by concurrent helminthosis in the liver of urban commensal rodents in Punjab, India.
Coinfection
Non-F HBV/HDV-3 coinfection is associated with severe liver disease in Western Brazilian Amazon.
Coinfection
Obstetrical and neonatal outcomes among women infected with hepatitis C and their infants.
Coinfection
Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.
Coinfection
Poor efficacy of preemptive amoxicillin clavulanate for preventing secondary infection from Bothrops snakebites in the Brazilian Amazon: A randomized controlled clinical trial.
Coinfection
Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients.
Coinfection
Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study.
Coinfection
Prevalence and genomic variability of transfusion transmitted virus in Italian cryptogenic chronic liver disease and healthy blood donors.
Coinfection
Prevalence and laboratory analysis of malaria and dengue co-infection: a systematic review and meta-analysis.
Coinfection
Prevalence of and risk factors for Plasmodium spp. co-infection with hepatitis B virus: a systematic review and meta-analysis.
Coinfection
Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
Coinfection
Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study.
Coinfection
Prevalence patterns and genotypes of GB virus C/hepatitis G virus among imprisoned intravenous drug users.
Coinfection
Reactivation of hepatitis B virus during interferon-free therapy with daclatasvir and asunaprevir in patient with hepatitis B virus/hepatitis C virus co-infection.
Coinfection
Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus.
Coinfection
SEN and hepatitis virus infections in nontransfused children and pediatric thalassemia patients with multiple transfusions in Taiwan.
Coinfection
Significance of hepatitis C virus coinfection with persistently normal alanine aminotransferase levels in HIV-1-infected patients.
Coinfection
The common risk factors for progression and mortality in COVID-19 patients: a meta-analysis.
Coinfection
The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis.
Coinfection
Treatment of chronic hepatitis B and C with alpha interferon in a renal transplant patient.
Coinfection
[Studies on mother-to-infant transmission of hepatitis C virus (HCV) and hepatitis G virus (HGV) co-infection]
Colic
Automated development of artificial neural networks for clinical purposes: Application for predicting the outcome of choledocholithiasis surgery.
Colic
Incidental hepatic steatosis on unenhanced computed tomography performed for suspected renal colic: Gaps in reporting and documentation.
Colitis
Antitumor Activity and Treatment-Related Toxicity Associated With Nivolumab Plus Ipilimumab in Advanced Malignancies: A Systematic Review and Meta-Analysis.
Colitis
CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations.
Colitis
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.
Colitis
Immune-related adverse events following administration of anti-cytotoxic T-lymphocyte-associated protein-4 drugs: a comprehensive systematic review and meta-analysis.
Colitis
Immune-related adverse events with PD-1 versus PD-L1 inhibitors: a meta-analysis of 8730 patients from clinical trials.
Colitis
Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial.
Colitis
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study.
Colitis
Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients.
Colitis
SARC025 arms 1 and 2: A phase 1 study of the poly(ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma.
Colitis
Therapeutic Benefits of Ipilimumab among Japanese Patients with Nivolumab-Refractory Mucosal Melanoma: A Case Series Study.
Colonic Neoplasms
Metformin prevents hormonal and metabolic disturbances and 1,2-dimethylhydrazine-induced colon carcinogenesis in non-diabetic rats.
Colorectal Neoplasms
Arginase as a useful factor for the diagnosis of colorectal cancer liver metastases.
Colorectal Neoplasms
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer.
Colorectal Neoplasms
The pattern of recurrent colorectal cancer in a prospective randomised study and the characteristics of diagnostic tests.
Coma
Clinical characteristics and predictors of mortality in 67 patients with primary pyomyositis: a study from North India.
Coma
Ketone Body Therapy Protects From Lipotoxicity and Acute Liver Failure Upon Ppar? Deficiency.
Communicable Diseases
Elevated Values of Clinically Relevant Transferases Induced by Imported Infectious Diseases: A Controlled Cross-Sectional Study of 14,559 Diseased German Travelers Returning from the Tropics and Subtropics.
Communicable Diseases
Pre-clinical toxicity assessment of tumor-targeted interleukin-12 low-intensity electrogenetherapy.
Communicable Diseases
Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity.
Communicable Diseases
Tissue enzyme activities in the loggerhead sea turtle (Caretta caretta).
Communicable Diseases, Imported
Elevated Values of Clinically Relevant Transferases Induced by Imported Infectious Diseases: A Controlled Cross-Sectional Study of 14,559 Diseased German Travelers Returning from the Tropics and Subtropics.
Conjunctivitis
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
Coronary Aneurysm
Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease.
Coronary Artery Disease
Alanine aminotransferase and gamma-glutamyl transferase are associated with the metabolic syndrome but not with angiographically determined coronary atherosclerosis.
Coronary Artery Disease
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Coronary Artery Disease
Atherosclerosis and Liver Function Tests in Coronary Angiography Patients.
Coronary Artery Disease
Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.
Coronary Artery Disease
Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography.
Coronary Artery Disease
Inverse association of alanine aminotransferase within normal range with prognosis in patients with coronary artery disease.
Coronary Artery Disease
Liver Enzymes and Risk of Ischemic Heart Disease and Type 2 Diabetes Mellitus: A Mendelian Randomization Study.
Coronary Artery Disease
Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).
Coronary Disease
Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.
Coronary Disease
Correlation of serum alanine aminotransferase and aspartate aminotransferase with coronary heart disease.
Coronary Disease
Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels.
Coronary Disease
Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States.
Coronary Disease
Gastrointestinal bleeding in patients admitted to cardiology: risk factors and a new risk score.
Coronary Disease
Serum Alanine Aminotransferase Level as a Risk Factor for Coronary Heart Disease Prediction in Koreans: Analysis of the Korea National Health and Nutrition Examination Survey (V-1, 2010 and V-2, 2011).
Coronavirus Infections
The impact of coronavirus disease 2019 (COVID-19) on liver injury in China: A systematic review and meta-analysis.
Cough
Clinical Benefits and Safety of FMS-Like Tyrosine Kinase 3 Inhibitors in Various Treatment Stages of Acute Myeloid Leukemia: A Systematic Review, Meta-Analysis, and Network Meta-Analysis.
Cough
Clinical features and prognostic factors of intensive and non-intensive 1014 COVID-19 patients: an experience cohort from Alahsa, Saudi Arabia.
Cough
Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses.
Cough
Efficacy and safety of acupuncture for elderly patients with coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis.
Cough
Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy.
Cough
Risk Factors in Patients with Diabetes Hospitalized for COVID-19: Findings from a Multicenter Retrospective Study.
Cough
Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES.
Cough
Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature.
Cough
The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation.
Cough
The importance of overweight in COVID-19: A retrospective analysis in a single center of Wuhan, China.
Cough
U.S. Food and Drug Administration Approval Summary: Atezolizumab for Metastatic Non-Small Cell Lung Cancer.
Cough
[Clinical analysis of pregnancy in second and third trimesters complicated severe acute respiratory syndrome]
COVID-19
?-Glutamyltransferase Elevations Are Frequent in Patients With COVID-19: A Clinical Epidemiologic Study.
COVID-19
A Danish population-based case series of patients with liver cirrhosis and coronavirus disease 2019.
COVID-19
A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19).
COVID-19
Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis.
COVID-19
Abnormal liver function tests in COVID-19 patients: relevance and potential pathogenesis.
COVID-19
Abnormal Liver Function Tests of Patients with Coronavirus Disease 2019 in Mainland China: A Systematic Review and Meta- Analysis.
COVID-19
Analysis of Risk Factors for 24 Patients With COVID-19 Developing From Moderate to Severe Condition.
COVID-19
Biochemistry tests in hospitalized COVID-19 patients: Experience from a Canadian tertiary care centre.
COVID-19
Blood biochemical characteristics of patients with coronavirus disease 2019 (COVID-19): a systemic review and meta-analysis.
COVID-19
Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19.
COVID-19
Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries.
COVID-19
Clinical and Laboratory Predictors of Severity, Criticality, and Mortality in COVID-19: A Multisystem Disease.
COVID-19
Clinical Characteristics and Risk Factors in Coronavirus Disease 2019 Patients with Liver Injury.
COVID-19
Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study.
COVID-19
Clinical Features and Risk Factors of ICU Admission for COVID-19 Patients with Diabetes.
COVID-19
Comprehensive Profiling of Inflammatory Factors Revealed That Growth Differentiation Factor-15 Is an Indicator of Disease Severity in COVID-19 Patients.
COVID-19
Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
COVID-19
Coronavirus Disease 2019 versus Influenza A in Children: An Observational Control Study in China.
COVID-19
Correlation of Low Levels of ?-1 Antitrypsin and Elevation of Neutrophil to Lymphocyte Ratio with Higher Mortality in Severe COVID-19 Patients.
COVID-19
Correlation of Severity of COVID-19 Disease With Gastrointestinal Manifestations and Liver Injury - A North Brooklyn Community Hospital Experience: A Retrospective Cohort Study.
COVID-19
COVID-19 and liver dysfunction: A systematic review and meta-analysis of retrospective studies.
COVID-19
COVID-19 prognosis: what we know of the significance and prognostic value of liver-related laboratory parameters in SARS-CoV-2 infection.
COVID-19
Covid-19: contribution of clinical characteristics and laboratory features for early detection of patients with high risk of severe evolution.
COVID-19
East-West differences in clinical manifestations of COVID-19 patients: A systematic literature review and meta-analysis.
COVID-19
Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay.
COVID-19
Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity.
COVID-19
Evaluation of the Role of Routine Laboratory Biomarkers in COVID-19 Patients: Perspective from a Tertiary Care Hospital in India.
COVID-19
Features Discriminating COVID-19 From Community-Acquired Pneumonia in Pediatric Patients.
COVID-19
Gastrointestinal Infection is the Risk Factor for COVID-19 Inpatients with Assisted Ventilation.
COVID-19
Gastrointestinal predictors of severe COVID-19: systematic review and meta-analysis.
COVID-19
Gastrointestinal Symptoms and Elevation in Liver Enzymes in COVID-19 Infection: A Systematic Review and Meta-Analysis.
COVID-19
Hematological profile and biochemical markers of COVID-19 non-survivors: A retrospective analysis.
COVID-19
Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis.
COVID-19
Hepatotropic Properties of SARS-CoV-2-Preliminary Results of Cross-Sectional Observational Study from the First Wave COVID-19 Pandemic.
COVID-19
High aspartate aminotransferase to alanine aminotransferase ratio on admission as risk factor for poor prognosis in COVID-19 patients.
COVID-19
Higher Mortality and Intensive Care Unit Admissions in COVID-19 Patients with Liver Enzyme Elevations.
COVID-19
Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity.
COVID-19
Impact of liver injury on the severity of COVID-19: a systematic review with meta-analysis.
COVID-19
Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19.
COVID-19
Incidence, patterns, risk factors, and histopathological findings of liver injury in coronavirus disease 2019 (COVID-19): a scoping review.
COVID-19
Laboratory analysis of symptomatic and asymptomatic pregnant patients with SARS-CoV-2 infection.
COVID-19
Liver Chemistries in Patients with COVID-19 Who Discharged alive or Died: A Meta-analysis.
COVID-19
Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis.
COVID-19
Liver Injury in Liver Transplant Recipients with Coronavirus Disease 2019 (COVID-19): US Multicenter Experience.
COVID-19
Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of retrospective studies.
COVID-19
Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019.
COVID-19
Longitudinal analysis of the utility of liver biochemistry in hospitalised COVID-19 patients as prognostic markers.
COVID-19
Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study.
COVID-19
Multi-organ Dysfunction in Patients with COVID-19: A Systematic Review and Meta-analysis.
COVID-19
No association between COVID-19 related liver injury and the course of disease: a retrospective study.
COVID-19
Obesity is a potential risk factor contributing to clinical manifestations of COVID-19.
COVID-19
Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients: A series of 43 cases.
COVID-19
Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients.
COVID-19
Percutaneous microwave ablation applications for liver tumors: recommendations for COVID-19 patients.
COVID-19
Potential Effects of COVID-19 on Cytochrome P450-Mediated Drug Metabolism and Disposition in Infected Patients.
COVID-19
Pre-existing Liver Diseases and On-Admission Liver-Related Laboratory Tests in COVID-19: A Prognostic Accuracy Meta-Analysis With Systematic Review.
COVID-19
Predictive criteria of severe cases in COVID-19 patients of early stage: A retrospective observational study.
COVID-19
Risk stratification of hospitalized COVID-19 patients through comparative studies of laboratory results with influenza.
COVID-19
Sex- and age-specific clinical and immunological features of coronavirus disease 2019.
COVID-19
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients.
COVID-19
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
COVID-19
[Effectiveness of convalescent plasma for treatment of coronavirus disease 2019 patients].
COVID-19
[Evaluation of the effects of immunotherapy and mesenchymal stem cells transplantation in the treatment of critically ill coronavirus disease 2019 patients].
Craniocerebral Trauma
Pyruvate's blood glutamate scavenging activity contributes to the spectrum of its neuroprotective mechanisms in a rat model of stroke.
Craniocerebral Trauma
[Enzymes and metabolic products in the cerebrospinal fluid in acute craniocerebral trauma]
Crohn Disease
A possible mechanism for hepatotoxicity induced by BIRB-796, an orally active p38 mitogen-activated protein kinase inhibitor.
Crohn Disease
Subnormal alanine aminotransferase values in blood of patients with Crohn disease.
Cross Infection
The Significance of Prolonged and Saddleback Fever in Hospitalised Adult Dengue.
Crush Syndrome
Aspartate aminotransferase and alanine aminotransferase activities of rat brain during crush syndrome.
Cryoglobulinemia
Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection.
Cryoglobulinemia
Factors predisposing to the occurrence of cryoglobulinemia in two cohorts of Egyptian and Japanese patients with chronic hepatitis C infection: ethnic and genotypic influence.
Cryoglobulinemia
Hepatitis C virus (HCV)-related cryoglobulinemia after liver transplantation for HCV cirrhosis.
Cryoglobulinemia
IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus.
Cryoglobulinemia
Influence of age and autoimmunity on liver disease in HCV-associated type II mixed cryoglobulinemia.
Cryoglobulinemia
Polyneuropathy with demyelinating features in mixed cryoglobulinemia with hepatitis C virus infection.
Cryoglobulinemia
Prevalence of cryoglobulinemia and autoimmune markers in liver transplant patients.
Cysts
Biochemical and hormonal composition, cytological examination of thyroid cyst fluid, and comparison according to gender and color of cyst fluid.
Cysts
Can biliary-cyst communication be predicted before surgery for hepatic hydatid disease: does size matter?
Cysts
Comparison of LPO-AOS Indices and Biochemical Composition of Animal Blood in Biogeochemical Provinces with Different Levels of Selenium.
Cysts
Effects of mebendazole, albendazole and praziquantel on alanine aminotransferase and aspartate aminotransferase of Echinococcus granulosus cyst wall harbored in mice.
Cysts
Results of alcohol and albendazole injections in hepatic hydatidosis: experimental study.
Cysts
Sarcocystis fusiformis: some protein metabolic enzymes in various fractions of sarcocysts of buffalo (Bubalus bubalis).
Cytomegalovirus Infections
Prevalence and Impact of Reformed and De Novo Anti-HLA Donor-Specific Antibodies in Liver Transplantation.
Deglutition Disorders
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer.
Deglutition Disorders
U.S. Food and Drug Administration Approval Summary: Atezolizumab for Metastatic Non-Small Cell Lung Cancer.
Dehydration
A Phase I dose-escalation study of afatinib combined with nintedanib in patients with advanced solid tumors.
Dehydration
Carp Edema Virus Infection Is Associated With Severe Metabolic Disturbance in Fish.
Dehydration
First case of erysipelas in a free-ranging bottlenose dolphin (Tursiops truncatus) stranded in the Mediterranean Sea.
Dehydration
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials.
Dehydration
NTP Toxicity Studies of Sodium Selenate and Sodium Selenite (CAS Nos. 13410-01-0 and 10102-18-8) Administered in Drinking Water to F344/N Rats and B6C3F1 Mice.
Dehydration
Osmoregulation and body fluid compartmentalization in dehydrated heat-exposed pigeons.
Dehydration
Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumors.
Dehydration
Retrospective study of 46 cases of feline haemobartonellosis in Israel and their relationships with FeLV and FIV infections.
Dehydration
Supplementation of potassium alleviates water stress-induced changes in Sorghum bicolor L.
Dementia
Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong.
Dementia
Low Liver Enzymes and Risk of Dementia: The Atherosclerosis Risk in Communities (ARIC) Study.
Dengue
Clinical characteristics, risk factors, and outcomes in adults experiencing dengue hemorrhagic fever complicated with acute renal failure.
Dengue
Clinical relevance and discriminatory value of elevated liver aminotransferase levels for dengue severity.
Dengue
Differences in clinical and laboratory characteristics and disease severity between children and adults with dengue virus infection in Taiwan, 2002.
Dengue
Fever after a stay in the tropics: diagnostic predictors of the leading tropical conditions.
Dengue
Fulminant hepatic failure and paracetamol overuse with therapeutic intent in febrile children.
Dengue
Is excessive acetaminophen intake associated with transaminitis in adult patients with dengue fever?
Dengue
Non-invasive diagnosis of risk in dengue patients using bioelectrical impedance analysis and artificial neural network.
Dengue
Prevalence and laboratory analysis of malaria and dengue co-infection: a systematic review and meta-analysis.
Dengue
Role of C- reactive proteins and liver function tests in assessing the severity of dengue fever.
Dengue
Serum transaminase level changes in dengue Fever and its correlation with disease severity.
Dengue
Trajectories of hepatic and coagulation dysfunctions related to a rapidly fatal outcome among hospitalized patients with dengue fever in Tainan, 2015.
Dengue
[Correlation analysis between serum ferritin level and liver damage in acute stage of dengue fever].
Dental Caries
[Salivary aspartate aminotransferase and alanine aminotransferase activity and dental caries]
Dermatitis
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial.
Dermatitis
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.
Dermatitis
Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050).
Dermatitis
Safety and efficacy of first-line dacomitinib in Japanese patients with advanced non-small cell lung cancer.
Dermatitis
Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.
Dermatomycoses
Top POEMs of 2019 Consistent with the Principles of the Choosing Wisely Campaign.
Dermatomyositis
Correlation between tests of muscle involvement and clinical muscle weakness in polymyositis and dermatomyositis.
Dermatomyositis
Hepatitis C virus (HCV) reactivation caused by steroid therapy for dermatomyositis.
Diabetes Mellitus
8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Diabetes Mellitus
Abdominal obesity validates the association between elevated alanine aminotransferase and newly diagnosed diabetes mellitus.
Diabetes Mellitus
Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
Diabetes Mellitus
Alanine aminotransferase is associated with atherothrombotic risk factors in a British South Asian population.
Diabetes Mellitus
Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.
Diabetes Mellitus
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Diabetes Mellitus
Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.
Diabetes Mellitus
Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
Diabetes Mellitus
Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.
Diabetes Mellitus
Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
Diabetes Mellitus
Association of TSH Elevation with All-Cause Mortality in Elderly Patients with Chronic Kidney Disease.
Diabetes Mellitus
Change in Serum Bilirubin Level as a Predictor of Incident Metabolic Syndrome.
Diabetes Mellitus
Characterization of thalassemia major and diabetes mellitus patients at a reference center in Brazil.
Diabetes Mellitus
Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese.
Diabetes Mellitus
Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B.
Diabetes Mellitus
Combined associations of liver enzymes and obesity with diabetes mellitus prevalence: The Tohoku Medical Megabank Community-based Cohort Study.
Diabetes Mellitus
Combined effect of serum alanine aminotransferase and gamma-glutamyltransferase on incidence of diabetes mellitus: A longitudinal study.
Diabetes Mellitus
Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients.
Diabetes Mellitus
Curcumin anti-diabetic effect mainly correlates with its anti-apoptotic actions and PI3K/Akt signal pathway regulation in the liver.
Diabetes Mellitus
Development of a Multivariable Prediction Model for Citrate Accumulation in Liver Transplant Patients Undergoing Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation.
Diabetes Mellitus
Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong.
Diabetes Mellitus
Differing clinical phenotype for higher alanine-aminotransferase (ALT) compared with high-risk NAFLD fibrosis score in type 2 diabetes mellitus.
Diabetes Mellitus
Effect of Dapagliflozin on Alanine Aminotransferase Improvement in Type 2 Diabetes Mellitus with Non-alcoholic Fatty Liver Disease.
Diabetes Mellitus
Effects of Bardoxolone Methyl on Hepatic Enzymes in Patients with Type 2 Diabetes Mellitus and Stage 4 CKD.
Diabetes Mellitus
Effects of hepatitis B virus infection, alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase on prediabetes and diabetes mellitus: A cohort study.
Diabetes Mellitus
Elevated alanine aminotransferase is associated with metabolic syndrome but not consistently associated with impaired fasting glucose or type 2 diabetes mellitus.
Diabetes Mellitus
Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes mellitus.
Diabetes Mellitus
Elevated serum ferritin concentration is associated with incident type 2 diabetes mellitus in a Chinese population: A prospective cohort study.
Diabetes Mellitus
Estimating Risk of Mechanical Ventilation and Mortality Among Adult COVID-19 patients Admitted to Mass General Brigham: The VICE and DICE Scores.
Diabetes Mellitus
Factors associated with elevated serum alanine aminotransferase in patients with type 1 diabetes mellitus.
Diabetes Mellitus
Factors predictive of liver cirrhosis in patients with chronic hepatitis B: a multivariate analysis in a longitudinal study.
Diabetes Mellitus
Glucose intolerance and serum aminotransferase activities in Japanese men.
Diabetes Mellitus
Glycemic control and raised serum alanine aminotransferase activity in treated diabetes mellitus.
Diabetes Mellitus
Hepatic safety profile and glycemic control of pioglitazone in more than 20,000 patients with type 2 diabetes mellitus: postmarketing surveillance study in Japan.
Diabetes Mellitus
Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta-analysis of the risk factors.
Diabetes Mellitus
Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease.
Diabetes Mellitus
Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Diabetes Mellitus
Hepatic subcapsular steatosis as a complication associated with intraperitoneal insulin treatment in diabetic peritoneal dialysis patients.
Diabetes Mellitus
Hepatitis C Testing and Liver Fibrosis Predictors in the Birth Cohort of a Primary Care Practice.
Diabetes Mellitus
Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma.
Diabetes Mellitus
High-dose intravenous methylprednisolone therapy for patients with Diamond-Blackfan anemia refractory to conventional doses of prednisone.
Diabetes Mellitus
Higher levels of alanine aminotransferase within the reference range predict unhealthy metabolic phenotypes of obesity in normoglycemic first-degree relatives of patients with type 2 diabetes mellitus.
Diabetes Mellitus
Histological Remission during Corticosteroid Therapy of Overlapping Nonalcoholic Steatohepatitis and Autoimmune Hepatitis: Case Report and Literature Review.
Diabetes Mellitus
Hypoadiponectinemia and its Association with Liver Fibrosis in Morbidly Obese Patients.
Diabetes Mellitus
Independent effect of alanine transaminase on the incidence of type 2 diabetes mellitus, stratified by age and gender: A secondary analysis based on a large cohort study in China.
Diabetes Mellitus
Kidney Function Following Left Ventricular Assist Device Implantation: An Observational Cohort Study.
Diabetes Mellitus
Large-scale population analysis reveals an extremely low threshold for "non-healthy" alanine aminotransferase that predicts diabetes mellitus.
Diabetes Mellitus
Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus.
Diabetes Mellitus
Liver Biomarkers and Lipid Profiles in Mexican and Mexican-American 10- to 14-Year-Old Adolescents at Risk for Type 2 Diabetes.
Diabetes Mellitus
Long-term obestatin treatment of mice type 2 diabetes increases insulin sensitivity and improves liver function.
Diabetes Mellitus
Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus.
Diabetes Mellitus
Phytochemical analysis and antidiabetic potential of Elaeagnus umbellata (Thunb.) in streptozotocin-induced diabetic rats: pharmacological and computational approach.
Diabetes Mellitus
Prediction of new onset of diabetes mellitus during a 10-year period by using a combination of levels of alanine aminotransferase and ?-glutamyl transferase.
Diabetes Mellitus
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Diabetes Mellitus
Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study.
Diabetes Mellitus
Prevalence and risk factors of nonalcoholic fatty liver disease in breast cancer patients.
Diabetes Mellitus
Prognostic significance of low serum cholesterol after cardiothoracic surgery.
Diabetes Mellitus
Quantitative MRI of fatty liver disease in a large pediatric cohort: correlation between liver fat fraction, stiffness, volume, and patient-specific factors.
Diabetes Mellitus
Red blood cell distribution width as a predictor of long-term mortality in patients with carbon monoxide poisoning.
Diabetes Mellitus
Relationship between the alanine aminotransferase levels and Type 2 diabetes mellitus in the general Chinese population.
Diabetes Mellitus
Risk factors for aneurysmal subarachnoid hemorrhage in patients in Izumo City, Japan.
Diabetes Mellitus
Risk factors for non-invasive/invasive-ventilatory support in patients with COVID-19 pneumonia: a retrospective study within a multidisciplinary approach.
Diabetes Mellitus
Risk factors for primary intracerebral hemorrhage in patients in Izumo City, Japan.
Diabetes Mellitus
Role of insulin resistance and adipocytokines on serum alanine aminotransferase in obese patients with type 2 diabetes mellitus.
Diabetes Mellitus
Self-reported faster eating associated with higher ALT activity in middle-aged, apparently healthy Japanese women.
Diabetes Mellitus
Serum alanine aminotransferase predicts interventricular septum thickness and left ventricular mass in patients with nonalcoholic fatty liver disease.
Diabetes Mellitus
Serum lactate levels are associated with serum alanine aminotransferase and total bilirubin levels in patients with type 2 diabetes mellitus: A cross-sectional study.
Diabetes Mellitus
Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore.
Diabetes Mellitus
Study on Alanine Aminotransferase in Patients of Type 2 Diabetes Mellitus.
Diabetes Mellitus
Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.
Diabetes Mellitus
The -11377C > G adiponectin gene polymorphism alters the adiponectin concentration and the susceptibility to type 2 diabetes in Thais.
Diabetes Mellitus
The association of gamma-glutamyl transferase and alanine aminotransferase with type 2 diabetes mellitus incidence in middle-aged Japanese men: 12-year follow-up.
Diabetes Mellitus
The Changing Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Turkey in the Last Decade.
Diabetes Mellitus
The effects of ipragliflozin on the liver-to-spleen attenuation ratio as assessed by computed tomography and on alanine transaminase levels in Japanese patients with type 2 diabetes mellitus.
Diabetes Mellitus
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases.
Diabetes Mellitus
The prevalence of undetectable vaccine-induced immunity against hepatitis B virus in US adults at high risk for infection.
Diabetes Mellitus
The role of elevated alanine aminotransferase (ALT), FasL and atherogenic dyslipidemia in type II diabetes mellitus.
Diabetes Mellitus
The upper normal limit of serum alanine aminotransferase in Golestan Province, northeast Iran.
Diabetes Mellitus
TOTAL BODY ADIPOSITY, TRIGLYCERIDES, AND LEG FAT ARE INDEPENDENT RISK FACTORS FOR DIABETIC PERIPHERAL NEUROPATHY IN CHINESE PATIENTS WITH TYPE 2 DIABETES MELLITUS.
Diabetes Mellitus
Urine uric acid excretion is associated with nonalcoholic fatty liver disease in patients with type 2 diabetes.
Diabetes Mellitus
Use of a predictive equation for diagnosis of acute gangrenous cholecystitis.
Diabetes Mellitus
Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population.
Diabetes Mellitus
[Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
Diabetes Mellitus
[Creatine kinase and aspartate and alanine transaminase activity in the myocardium and blood serum of albino rats in experimental streptozotocin diabetes mellitus. Effect of (-)-epicatechin]
Diabetes Mellitus
[The effect of diabetes and cholelithiasis on the course and consequences of acute viral hepatitis type B]
Diabetes Mellitus
[Value of determining serum enzyme activity during the exercise test in evaluating the functional condition of patients with ischemic heart disease and concomitant diabetes mellitus]
Diabetes Mellitus, Experimental
Influence of alloxan diabetes and insulin treatment on the activity of alanine aminotransferase in rat brain regions, liver and heart.
Diabetes Mellitus, Experimental
[Creatine kinase and aspartate and alanine transaminase activity in the myocardium and blood serum of albino rats in experimental streptozotocin diabetes mellitus. Effect of (-)-epicatechin]
Diabetes Mellitus, Type 1
Abnormal liver function tests in patients with Type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies.
Diabetes Mellitus, Type 1
Factors associated with elevated serum alanine aminotransferase in patients with type 1 diabetes mellitus.
Diabetes Mellitus, Type 1
Hepatic changes in adenine nucleotide levels and adenosine 3'-monophosphate forming enzyme in streptozotocin-induced diabetic mice.
Diabetes Mellitus, Type 1
Nonalcoholic Fatty Liver Disease Markers Are Associated with Insulin Resistance in Type 1 Diabetes.
Diabetes Mellitus, Type 1
On elevated alanine aminotransferase in type 1 diabetes mellitus.
Diabetes Mellitus, Type 2
A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients.
Diabetes Mellitus, Type 2
A modified Mediterranean diet is associated with the greatest reduction in alanine aminotransferase levels in obese type 2 diabetes patients: results of a quasi-randomised controlled trial.
Diabetes Mellitus, Type 2
A novel alternatively spliced transcript of cytosolic alanine aminotransferase gene associated with enhanced gluconeogenesis in liver of Sparus aurata.
Diabetes Mellitus, Type 2
A Randomized, Controlled Study of Once Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes.
Diabetes Mellitus, Type 2
Alanine aminotransferase and mortality in patients with type 2 diabetes (ZODIAC-38).
Diabetes Mellitus, Type 2
Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
Diabetes Mellitus, Type 2
Alanine aminotransferase is associated with an adverse nocturnal blood glucose profile in individuals with normal glucose regulation.
Diabetes Mellitus, Type 2
Alanine aminotransferase is associated with atherothrombotic risk factors in a British South Asian population.
Diabetes Mellitus, Type 2
Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.
Diabetes Mellitus, Type 2
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Diabetes Mellitus, Type 2
Application of Machine Learning Methods to Predict Non-Alcoholic Steatohepatitis (NASH) in Non-Alcoholic Fatty Liver (NAFL) Patients.
Diabetes Mellitus, Type 2
Association of gamma-glutamyltransferase with incidence of type 2 diabetes in Japan.
Diabetes Mellitus, Type 2
Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
Diabetes Mellitus, Type 2
Association of serum liver enzyme Alanine Aminotransferase (ALT) in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
Biochemical characteristics and risk factors in non-alcoholic fatty liver.
Diabetes Mellitus, Type 2
Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
Diabetes Mellitus, Type 2
Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients.
Diabetes Mellitus, Type 2
Complex association of serum alanine aminotransferase with the risk of future cardiovascular disease in type 2 diabetes.
Diabetes Mellitus, Type 2
Correlation between polymorphism of FTO gene and type 2 diabetes mellitus in Uygur people from northwest China.
Diabetes Mellitus, Type 2
Curcumin anti-diabetic effect mainly correlates with its anti-apoptotic actions and PI3K/Akt signal pathway regulation in the liver.
Diabetes Mellitus, Type 2
Decreased Quality of Life Is Significantly Associated With Body Composition in Patients With Nonalcoholic Fatty Liver Disease.
Diabetes Mellitus, Type 2
Differing clinical phenotype for higher alanine-aminotransferase (ALT) compared with high-risk NAFLD fibrosis score in type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography.
Diabetes Mellitus, Type 2
Discordant Effects on Central Obesity, Hepatic Insulin Resistance, and Alanine Aminotransferase of Low-dose Metformin and Thiazolidinedione Combination Therapy in Patients with Impaired Glucose Tolerance.
Diabetes Mellitus, Type 2
Dyslipidaemia is common among patients with type 2 diabetes: a cross-sectional study at Tema Port Clinic.
Diabetes Mellitus, Type 2
Effect of Dapagliflozin on Alanine Aminotransferase Improvement in Type 2 Diabetes Mellitus with Non-alcoholic Fatty Liver Disease.
Diabetes Mellitus, Type 2
Effect of pituitary surgery in patients with acromegaly on adiponectin serum concentrations and alanine aminotransferase activity.
Diabetes Mellitus, Type 2
Effects of Bardoxolone Methyl on Hepatic Enzymes in Patients with Type 2 Diabetes Mellitus and Stage 4 CKD.
Diabetes Mellitus, Type 2
Effects of Sodium Glucose Co-transporter 2 Inhibitors on Serum Alanine Aminotransferase Values in Type 2 Diabetes Patients: A Multi-Institutional Cohort Study.
Diabetes Mellitus, Type 2
Elevated alanine aminotransferase is associated with metabolic syndrome but not consistently associated with impaired fasting glucose or type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Elevated alanine aminotransferase levels are associated with impaired fasting glucose and type 2 diabetes in obese women.
Diabetes Mellitus, Type 2
Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.
Diabetes Mellitus, Type 2
Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: the bogalusa heart study.
Diabetes Mellitus, Type 2
Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Elevation of Alanine Transaminase and Markers of Liver Fibrosis After a Mixed Meal Challenge in Individuals with Type 2 Diabetes.
Diabetes Mellitus, Type 2
Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.
Diabetes Mellitus, Type 2
Evolution of 29 Anthropometric, Nutritional, and Cardiometabolic Parameters Among Morbidly Obese Adolescents 2 Years Post Sleeve Gastrectomy.
Diabetes Mellitus, Type 2
Factors associated with elevated serum alanine aminotransferase in patients with type 1 diabetes mellitus.
Diabetes Mellitus, Type 2
Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trials.
Diabetes Mellitus, Type 2
Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
Diabetes Mellitus, Type 2
Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance.
Diabetes Mellitus, Type 2
Glucose intolerance and serum aminotransferase activities in Japanese men.
Diabetes Mellitus, Type 2
Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study (Data from an Epidemiological Study on the Insulin Resistance syndrome).
Diabetes Mellitus, Type 2
Hepatitis C infection and type 2 diabetes in American-Indian women.
Diabetes Mellitus, Type 2
High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.
Diabetes Mellitus, Type 2
High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests.
Diabetes Mellitus, Type 2
Higher levels of alanine aminotransferase within the reference range predict unhealthy metabolic phenotypes of obesity in normoglycemic first-degree relatives of patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Hypoadiponectinemia and its Association with Liver Fibrosis in Morbidly Obese Patients.
Diabetes Mellitus, Type 2
Impact of increasing alanine aminotransferase levels within normal range on incident diabetes.
Diabetes Mellitus, Type 2
Increased alanine aminotransferase level and future risk of type 2 diabetes and impaired fasting glucose among the employees in a university hospital in Thailand.
Diabetes Mellitus, Type 2
Independent effect of alanine transaminase on the incidence of type 2 diabetes mellitus, stratified by age and gender: A secondary analysis based on a large cohort study in China.
Diabetes Mellitus, Type 2
INTERMITTENT INTENSIVE INSULIN THERAPY FOR TYPE 2 DIABETES: EFFECTS ON HYPOGLYCEMIA, WEIGHT GAIN, AND QUALITY OF LIFE OVER 2 YEARS.
Diabetes Mellitus, Type 2
Inverse linear associations between liver aminotransferases and incident cardiovascular disease risk: The PREVEND study.
Diabetes Mellitus, Type 2
Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Liver Biomarkers and Lipid Profiles in Mexican and Mexican-American 10- to 14-Year-Old Adolescents at Risk for Type 2 Diabetes.
Diabetes Mellitus, Type 2
Liver enzymes compared with alcohol consumption in predicting the risk of type 2 diabetes: the Kansai Healthcare Study.
Diabetes Mellitus, Type 2
Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 Adults.
Diabetes Mellitus, Type 2
Long-term obestatin treatment of mice type 2 diabetes increases insulin sensitivity and improves liver function.
Diabetes Mellitus, Type 2
Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
Diabetes Mellitus, Type 2
Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor.
Diabetes Mellitus, Type 2
Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus.
Diabetes Mellitus, Type 2
Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study.
Diabetes Mellitus, Type 2
Natural History of Elevated Alanine Aminotransferase (ALT) Levels in Youth with Type 2 Diabetes (T2D).
Diabetes Mellitus, Type 2
No independent association of alanine aminotransferase with risk of future type 2 diabetes in the Hoorn study.
Diabetes Mellitus, Type 2
Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases.
Diabetes Mellitus, Type 2
Opposite associations between alanine aminotransferase and ?-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
Diabetes Mellitus, Type 2
Paraoxonase-2 variants potentially influence insulin resistance, beta-cell function, and their interrelationships with alanine aminotransferase in type 2 diabetes.
Diabetes Mellitus, Type 2
Phytochemical analysis and antidiabetic potential of Elaeagnus umbellata (Thunb.) in streptozotocin-induced diabetic rats: pharmacological and computational approach.
Diabetes Mellitus, Type 2
Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.
Diabetes Mellitus, Type 2
Plasma Levels of Alanine Aminotransferase in the First Trimester Identify High Risk Chinese Women for Gestational Diabetes.
Diabetes Mellitus, Type 2
Population-Level Prediction of Type 2 Diabetes From Claims Data and Analysis of Risk Factors.
Diabetes Mellitus, Type 2
Postprandial Antihyperglycemic And Antioxidant Activities of Acalypha indica Linn Stem Extract: An In-vivo Study.
Diabetes Mellitus, Type 2
Predictive Factors for Differentiating Pancreatic Cancer-Associated Diabetes Mellitus from Common Type 2 Diabetes Mellitus for the Early Detection of Pancreatic Cancer.
Diabetes Mellitus, Type 2
Prevalence and risk factors of nonalcoholic fatty liver disease in breast cancer patients.
Diabetes Mellitus, Type 2
Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes.
Diabetes Mellitus, Type 2
Probable NAFLD, by ALT levels, and diabetes among Filipino-American women.
Diabetes Mellitus, Type 2
Raised alanine transaminase and decreased adiponectin are features of the metabolic syndrome in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
Relationship between insulin resistance, inflammation and liver cell apoptosis in patients with severe obesity.
Diabetes Mellitus, Type 2
Relationship between the alanine aminotransferase levels and Type 2 diabetes mellitus in the general Chinese population.
Diabetes Mellitus, Type 2
Risk Factors for Medication-Induced Diabetes and Type 2 Diabetes.
Diabetes Mellitus, Type 2
Role of insulin resistance and adipocytokines on serum alanine aminotransferase in obese patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Safety and effectiveness of rosiglitazone in type 2 diabetes patients with nonalcoholic Fatty liver disease.
Diabetes Mellitus, Type 2
Screening for liver fibrosis by using FibroScan(®) and FibroTest in patients with diabetes.
Diabetes Mellitus, Type 2
Self-reported faster eating associated with higher ALT activity in middle-aged, apparently healthy Japanese women.
Diabetes Mellitus, Type 2
Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor.
Diabetes Mellitus, Type 2
Serum adiponectin levels and enzyme markers of liver dysfunction in diabetic and non-diabetic Caribbean subjects.
Diabetes Mellitus, Type 2
Serum alanine aminotransferase is associated with serum adiponectin, C-reactive protein and apolipoprotein B in young healthy men.
Diabetes Mellitus, Type 2
Serum alanine aminotransferase predicts interventricular septum thickness and left ventricular mass in patients with nonalcoholic fatty liver disease.
Diabetes Mellitus, Type 2
Serum Alanine Transaminase as a Predictor of Type 2 Diabetes Incidence: The Yuport Prospective Cohort Study.
Diabetes Mellitus, Type 2
Serum alanine transaminase levels predict type 2 diabetes risk among a middle-aged and elderly Chinese population.
Diabetes Mellitus, Type 2
Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men.
Diabetes Mellitus, Type 2
Serum lactate levels are associated with serum alanine aminotransferase and total bilirubin levels in patients with type 2 diabetes mellitus: A cross-sectional study.
Diabetes Mellitus, Type 2
Sex influenced association of directly measured insulin sensitivity and serum transaminase levels: Why alanine aminotransferase only predicts cardiovascular risk in men?
Diabetes Mellitus, Type 2
SGLT2 inhibitors and incretin agents: Associations with alanine aminotransferase activity in type 2 diabetes.
Diabetes Mellitus, Type 2
Sonographic Features of the Liver Among Females with Type 2 Diabetes.
Diabetes Mellitus, Type 2
Study on Alanine Aminotransferase in Patients of Type 2 Diabetes Mellitus.
Diabetes Mellitus, Type 2
The -11377C > G adiponectin gene polymorphism alters the adiponectin concentration and the susceptibility to type 2 diabetes in Thais.
Diabetes Mellitus, Type 2
The association of gamma-glutamyl transferase and alanine aminotransferase with type 2 diabetes mellitus incidence in middle-aged Japanese men: 12-year follow-up.
Diabetes Mellitus, Type 2
The association of Plasma free amino acids with liver enzymes in type 2 diabetes patients.
Diabetes Mellitus, Type 2
The effects of ipragliflozin on the liver-to-spleen attenuation ratio as assessed by computed tomography and on alanine transaminase levels in Japanese patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes.
Diabetes Mellitus, Type 2
The UGT1A1*28 gene variant predicts long-term mortality in patients undergoing coronary angiography.
Diabetes Mellitus, Type 2
Thiazolidinediones versus metformin on improving abnormal liver enzymes in patients with type 2 diabetes mellitus: a meta-analysis.
Diabetes Mellitus, Type 2
Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort.
Diabetes Mellitus, Type 2
TOTAL BODY ADIPOSITY, TRIGLYCERIDES, AND LEG FAT ARE INDEPENDENT RISK FACTORS FOR DIABETIC PERIPHERAL NEUROPATHY IN CHINESE PATIENTS WITH TYPE 2 DIABETES MELLITUS.
Diabetes Mellitus, Type 2
Trajectories of metabolic risk factors and biochemical markers prior to the onset of type 2 diabetes: the population-based longitudinal Doetinchem study.
Diabetes Mellitus, Type 2
Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase.
Diabetes Mellitus, Type 2
Urine uric acid excretion is associated with nonalcoholic fatty liver disease in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
[Associated risk factors of fatty liver in the patients with type 2 diabetes mellitus]
Diabetes Mellitus, Type 2
[Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
Diabetes Mellitus, Type 2
[Study on prevalence and risk factors of fatty liver of patients with type 2 diabetes]
Diabetes, Gestational
Analysis on the outcomes of hepatitis B virus perinatal vertical transmission: nested case-control study.
Diabetes, Gestational
Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia.
Diabetes, Gestational
Gamma-glutamyltransferase, alanine transaminase and aspartate transaminase levels and the diagnosis of gestational diabetes mellitus.
Diabetes, Gestational
Higher level of GGT during mid-pregnancy is associated with increased risk of gestational diabetes mellitus.
Diabetes, Gestational
Implications of abnormal liver function in pregnancy and non-alcoholic fatty liver disease.
Diabetes, Gestational
Influences of pregravid liver enzyme levels on the development of gestational diabetes mellitus.
Diabetes, Gestational
Plasma Levels of Alanine Aminotransferase in the First Trimester Identify High Risk Chinese Women for Gestational Diabetes.
Diabetes, Gestational
Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses.
Diabetes, Gestational
The Association of Alanine Aminotransferase in Early Pregnancy with Gestational Diabetes.
Diabetes, Gestational
The association of early unexplained elevated alanine aminotransferase with large-for-gestational-age birthweight.
Diabetes, Gestational
The association of plasma levels of liver enzymes and risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis of observational studies.
Diabetic Foot
In patients with diabetic foot, improved left ventricular functions are detected by strain echocardiography after the diabetic foot treatment: A cross-sectional study.
Diabetic Ketoacidosis
[Serum enzyme alterations during diabetic ketoacidosis. Prospective study of the behaviour of AP, AsAT, AIAT, and GGPT in 24 cases (author's transl)]
Diabetic Nephropathies
The Association of Aspartate Aminotransferase/Alanine Aminotransferase Ratio with Diabetic Nephropathy in Patients with Type 2 Diabetes.
Diffuse Cerebral Sclerosis of Schilder
Suppression of elevated alanine aminotransferase activity in liver disease by vigabatrin.
Digestive System Diseases
A correlative study on serum cholylglycine levels in hepatobiliary disease.
Digestive System Diseases
Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality.
Digestive System Diseases
Evaluation of diagnostic tests using relative operating characteristic (ROC) curves and the differential positive rate. An example using the total serum bile acid concentration and the alanine aminotransferase activity in the diagnosis of canine hepatobiliary diseases.
Digestive System Diseases
Evaluation of fasting and postprandial total serum bile acid concentration in dogs with hepatobiliary disorders.
Digestive System Diseases
Glycemic control and raised serum alanine aminotransferase activity in treated diabetes mellitus.
Diphtheria
Human liver chimeric mouse model based on diphtheria toxin-induced liver injury.
Disseminated Intravascular Coagulation
New onset acute promyelocytic Leukemia during pregnancy: report of 2 cases.
Disseminated Intravascular Coagulation
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Down Syndrome
Serum alpha fetoprotein in 714 mentally retarded carriers of hepatitis B surface antigen.
Drug Hypersensitivity
[Diagnostic value of leukocytic alteration test (in vitro) for drug-induced allergy in a therapist's practice]
Drug-Related Side Effects and Adverse Reactions
Circulating MicroRNAs in Drug Safety Assessment for Hepatic and Cardiovascular Toxicity: The Latest Biomarker Frontier?
Drug-Related Side Effects and Adverse Reactions
Effect of ipragliflozin on liver function in Japanese type 2 diabetes mellitus patients: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM).
Drug-Related Side Effects and Adverse Reactions
Effect of methyl jasmonate and 3-bromopyruvate combination therapy on mice bearing the 4 T1 breast cancer cell line.
Drug-Related Side Effects and Adverse Reactions
Efficacy and safety of two doses of pemetrexed supplemented with folic acid and vitamin B12 in previously treated patients with non-small cell lung cancer.
Drug-Related Side Effects and Adverse Reactions
Improvement in medication compliance and glycemic control with voglibose oral disintegrating tablet.
Drug-Related Side Effects and Adverse Reactions
Increased alanine transaminase activity associated with tetracycline administration in a cat.
Drug-Related Side Effects and Adverse Reactions
Randomized controlled trial comparing the efficacy of daily and every other day atorvastatin therapy and its correlation with serum hydroxymethylglutaryl-CoA reductase enzyme levels in naïve dyslipidemic patients.
Drug-Related Side Effects and Adverse Reactions
Safety and Efficacy of Avaren-Fc Lectibody Targeting HCV High-Mannose Glycans in a Human Liver Chimeric Mouse Model.
Drug-Related Side Effects and Adverse Reactions
Safety and efficacy of intravenous N-acetylcysteine for acetaminophen overdose: analysis of the Hunter Area Toxicology Service (HATS) database.
Drug-Related Side Effects and Adverse Reactions
Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer.
Drug-Related Side Effects and Adverse Reactions
Sapropterin is safe and effective in patients less than 4-years-old with BH4-responsive phenylalanine hydrolase deficiency.
Drug-Related Side Effects and Adverse Reactions
ST09, A Novel Curcumin Derivative, Blocks Cell Migration by Inhibiting Matrix Metalloproteases in Breast Cancer Cells and Inhibits Tumor Progression in EAC Mouse Tumor Models.
Drug-Related Side Effects and Adverse Reactions
Systemic osteoprotective effects of Epimedii Folium and Ligustri Lucidi Fructus in senile osteoporosis rats by promoting the osteoblastogenesis and osteoclastogenesis based on MLP-ANN model.
Drug-Related Side Effects and Adverse Reactions
[Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population].
Drug-Related Side Effects and Adverse Reactions
[Results of a post-marketing surveillance of meropenem administered over 2 g/day for serious infectious diseases].
Drug-Related Side Effects and Adverse Reactions
[Results of a post-marketing surveillance of meropenem for children].
Drug-Related Side Effects and Adverse Reactions
[Results of a post-marketing surveillance of meropenem for febrile neutropenia].
Duodenal Ulcer
[Non-proteolytic enzymes of human gastric and duodenal mucosa in peptic ulcer]
Dysarthria
Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.
Dysentery
[Serum creatine phosphokinase, GOT, and GPT activity in different types of infectious diseases in monkeys]
Dysgeusia
A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors.
Dysgeusia
First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer.
Dysgeusia
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial.
Dysgeusia
The European Medicines Agency review of pazopanib for the treatment of advanced renal cell carcinoma: summary of the scientific assessment of the Committee for Medicinal Products for Human Use.
Dyslipidemias
Abnormality of risk factors for atherosclerotic disease among young Japanese aged 19-39 years old: an evaluation of health checkup data.
Dyslipidemias
Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease.
Dyslipidemias
Combined effects of hepatitis B virus infection and elevated alanine aminotransferase levels on dyslipidemia.
Dyslipidemias
Cross-sectional study of the prevalence and risk factors of metabolic syndrome in a rural population of the Qianjiang area.
Dyslipidemias
Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.
Dyslipidemias
Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease.
Dyslipidemias
Evaluation of various biomarkers as potential mediators of the association between ?5 desaturase, ?6 desaturase, and stearoyl-CoA desaturase activity and incident type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study.
Dyslipidemias
Exposure to famine in early life and non-alcoholic fatty liver disease in adulthood.
Dyslipidemias
Hepatotoxicity of Statins as Determined by Serum Alanine Aminotransferase in a Pediatric Cohort With Dyslipidemia.
Dyslipidemias
Hypoceruloplasminemia: an unusual biochemical finding in a girl with Hashimoto's thyroiditis and severe hypothyroidism.
Dyslipidemias
Inhibition of CCL19 benefits non?alcoholic fatty liver disease by inhibiting TLR4/NF??B?p65 signaling.
Dyslipidemias
Insulin protects against hepatocyte ultrastructural damage induced by type 1 diabetes mellitus in rats.
Dyslipidemias
New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence.
Dyslipidemias
OUTPATIENT ANALYTIC ASSESSMENT OF ANOREXIA NERVOSA - THE IMPORTANCE OF VENOUS BLOOD GASES.
Dyslipidemias
Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
Dyslipidemias
Protective effect of oligomeric proanthocyanidins against alcohol-induced liver steatosis and injury in mice.
Dyslipidemias
The association of obstructive sleep apnea with dyslipidemia in Korean children and adolescents: a single-center, cross-sectional study.
Dyslipidemias
The Changing Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Turkey in the Last Decade.
Dyslipidemias
The effect of tomato juice supplementation on biomarkers and gene expression related to lipid metabolism in rats with induced hepatic steatosis.
Dyslipidemias
The role of elevated alanine aminotransferase (ALT), FasL and atherogenic dyslipidemia in type II diabetes mellitus.
Dyslipidemias
The UGT1A1*28 gene variant predicts long-term mortality in patients undergoing coronary angiography.
Dyslipidemias
Triterpenoids Extracted From Antrodia cinnamomea Mycelia Attenuate Acute Alcohol-Induced Liver Injury in C57BL/6 Mice via Suppression Inflammatory Response.
Dyspnea
Clinical and immunological features of severe and moderate coronavirus disease 2019.
Dyspnea
Clinical Benefits and Safety of FMS-Like Tyrosine Kinase 3 Inhibitors in Various Treatment Stages of Acute Myeloid Leukemia: A Systematic Review, Meta-Analysis, and Network Meta-Analysis.
Dyspnea
Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
Dyspnea
Clinical features and prognostic factors of intensive and non-intensive 1014 COVID-19 patients: an experience cohort from Alahsa, Saudi Arabia.
Dyspnea
Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses.
Dyspnea
Estimating Risk of Mechanical Ventilation and Mortality Among Adult COVID-19 patients Admitted to Mass General Brigham: The VICE and DICE Scores.
Dyspnea
Exacerbation of allopurinol-induced drug reaction with eosinophilia and systemic symptoms by teicoplanin: A case report.
Dyspnea
IL-6 and IL-10 Levels, Rather Than Viral Load and Neutralizing Antibody Titers, Determine the Fate of Patients With Severe Fever With Thrombocytopenia Syndrome Virus Infection in South Korea.
Dyspnea
Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.
Dyspnea
Osimertinib for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLC: Tolerability and Diagnostic Methods From an Expanded Access Program.
Dyspnea
Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in Patients with Refractory Solid Tumors.
Dyspnea
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity.
Dyspnea
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
Dyspnea
Prognostic factors associated with death from visceral leishmaniasis: a case-control study in Brazil.
Dyspnea
Risk factors associated with acute respiratory distress syndrome in COVID-19 patients outside Wuhan: A double-center retrospective cohort study of 197 cases in Hunan, China.
Dyspnea
Risk factors for the critical illness in SARS-CoV-2 infection: a multicenter retrospective cohort study.
Dyspnea
The chest radiographic scoring system in initial diagnosis of COVID-19: Is a radiologist needed?
Dyspnea
The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation.
Dyspnea
Tolerability of Switch to Macitentan from Bosentan in Pulmonary Arterial Hypertension.
Dyspnea
U.S. Food and Drug Administration Approval Summary: Atezolizumab for Metastatic Non-Small Cell Lung Cancer.
Dyspnea
[Clinical characteristics and GAA gene mutation in children with glycogen storage disease type II: an analysis of 3 cases].
Dystonia
The correlation of dystonia severity and serum transaminases in a child with a brain injury.
Echinococcosis
[Evaluation of the diagnostic efficiency of three anti-Echinococcus antibody-based assays for the serodiagnosis of echinococcosis].
Eclampsia
Alanine Aminotransferase and Total Bilirubin Concentration in Preeclampsia and Eclampsia.
Eclampsia
Maternal serum uric acid level and maternal and neonatal complications in preeclamptic women: A cross-sectional study.
Eclampsia
Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes.
Eclampsia
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Eczema
[Problem of the behavior of glutamic acid-pyruvic acid transaminase in the blood and vesicular skin serum in eczema and bullous dermatoses.]
Embolism
Bone marrow mesenchymal stem cells transfer in patients with ST-segment elevation myocardial infarction: single-blind, multicenter, randomized controlled trial.
Embolism
First study of the safety, tolerability, and pharmacokinetics of CP-724,714 in patients with advanced malignant solid HER2-expressing tumors.
Encephalitis
Genetic polymorphism of CCL2-2510 and susceptibility to enterovirus 71 encephalitis in a Chinese population.
End Stage Liver Disease
Predictors of fifty days in-hospital mortality in patients with culture negative neutrocytic ascites.
End Stage Liver Disease
Profiling Neutrophil-to-Lymphocyte Ratio Changes in Response to Nucleoside Analog Therapy for Chronic Hepatitis B Infection.
Endocarditis
Prognostic significance of low serum cholesterol after cardiothoracic surgery.
Endometriosis
[Clinical effect evaluation of acupuncture combined with medication for prevention of endometriosis recurrence after surgery].
Endometritis
Relationships among some serum enzymes, negative energy balance parameters, parity and postparturient clinical (endo)metritis in Holstein Friesian cows - Short communication.
Endotoxemia
Augmenter of liver regeneration (ALR) is a novel biomarker of hepatocellular stress/inflammation: in vitro, in vivo and in silico studies.
Endotoxemia
Effect of rebamipide on liver damage and increased tumor necrosis factor in a rat model of endotoxin shock.
Endotoxemia
Effects of thrombin inhibition with melagatran on renal hemodynamics and function and liver integrity during early endotoxemia.
Endotoxemia
GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat.
Endotoxemia
Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice.
Endotoxemia
Inhibition of 3-Hydroxy-3-Methyl-Glutaryl-Coenzyme A Reductase Reduces Leukocyte Recruitment and Hepatocyte Apoptosis in Endotoxin-Induced Liver Injury.
Endotoxemia
Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia.
Endotoxemia
Lysophosphatidic acid reduces the organ injury caused by endotoxemia-a role for G-protein-coupled receptors and peroxisome proliferator-activated receptor-gamma.
Endotoxemia
Peroxisome proliferator-activated receptor-gamma antagonists GW9662 and T0070907 reduce the protective effects of lipopolysaccharide preconditioning against organ failure caused by endotoxemia*
Endotoxemia
Protective role of supplement with foreign Bifidobacterium and Lactobacillus in experimental hepatic ischemia-reperfusion injury.
Endotoxemia
Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton.
Endotoxemia
Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin.
Endotoxemia
Role of preprotachykinin-A gene products on multiple organ injury in LPS-induced endotoxemia.
Endotoxemia
Ultralow doses of dextromethorphan protect mice from endotoxin-induced sepsis-like hepatotoxicity.
Eosinophilia
Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Probably Induced by a Lamotrigine-Ginseng Drug Interaction.
Eosinophilia
Efficacious and safe dose of praziquantel for the successful treatment of feline reservoir hosts with opisthorchiasis.
Eosinophilia
Etiopathological and hematobiochemical profiles in goats with gastrointestinal disorders.
Eosinophilia
Experimentally induced canine toxocariasis: laboratory examinations and pathologic changes, with emphasis on the gastrointestinal tract.
Eosinophilia
Fatal hepatic sarcocystosis in a puppy with eosinophilia and eosinophilic peritoneal effusion.
Eosinophilia
Imipenem-cilastatin in pediatric patients: an overview of safety and efficacy in studies conducted in the United States.
Eosinophilia
Increased type 2 innate lymphoid cells in patients with drug reaction with eosinophilia and systemic symptom.
Eosinophilia
[Biliary ascariasis after cholecystectomy and papillotomy in a non-endemic area]
Epilepsy
Effect of ketogenic diet on nucleotide hydrolysis and hepatic enzymes in blood serum of rats in a lithium-pilocarpine-induced status epilepticus.
Epilepsy
Effects of l-carnitine supplementation in patients with childhood-onset epilepsy prescribed valproate.
Epilepsy
Evidence for both in vivo and in vitro interaction between vigabatrin and alanine transaminase.
Epistaxis
Safety and efficacy of the addition of pertuzumab to T-DM1 ± taxane in patients with HER2-positive, locally advanced or metastatic breast cancer: a pooled analysis.
Epstein-Barr Virus Infections
Diagnostic Time Lag of Pediatric Haemophagocytic Lymphohistiocytosis and Patient Characteristics: A Retrospective Cohort Study.
Epstein-Barr Virus Infections
Serum leucine aminopeptidase for monitoring viral infections with plasmacytoid reaction.
Erectile Dysfunction
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Erythema
A case of incomplete Kawasaki disease with extremely high serum ferritin and interleukin-18 levels.
Erythema
Clinical factors that affect blood gases in non-smoking women with chronic liver disease.
Erythema
Exacerbation of allopurinol-induced drug reaction with eosinophilia and systemic symptoms by teicoplanin: A case report.
Erythema
Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine Group.
Erythema
Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes.
Erythema
[Clinical presentation of Ixodes tick-borne borreliosis caused by Borrelia miyamotoi in the context of an immune response to the pathogen].
Erythema
[Subacute and subchronic percutaneous tolerance testing (28-day and 90-day test) of epicutaneously applied dis-infectants as demonstrated by the example of peroxyethanoic acid (author's transl)]
Erythema Multiforme
Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
Escherichia coli Infections
Urinary tract infections in infants: comparison between those with conjugated vs unconjugated hyperbilirubinaemia.
Esophageal and Gastric Varices
Effect of entecavir in the treatment of patients with hepatitis B virus-related compensated and decompensated cirrhosis.
Esophageal Neoplasms
The independent effects of cigarette smoking, alcohol consumption, and serum aspartate aminotransferase on the alanine aminotransferase ratio in korean men for the risk for esophageal cancer.
Essential Hypertension
Effect of folic acid intervention on ALT concentration in hypertensives without known hepatic disease: a randomized, double-blind, controlled trial.
Exanthema
72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension.
Exanthema
A case of incomplete Kawasaki disease with extremely high serum ferritin and interleukin-18 levels.
Exanthema
A Multicenter Study of Docetaxel at a Dose of 100 mg/m2 in Japanese Patients with Advanced or Recurrent Breast Cancer.
Exanthema
A Phase 1 Clinical Study of Temsirolimus (CCI-779) in Japanese Patients with Advanced Solid Tumors.
Exanthema
A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B(12) in Japanese patients with solid tumours.
Exanthema
A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma.
Exanthema
A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer.
Exanthema
Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study.
Exanthema
Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies.
Exanthema
Adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in cancer patients: A systematic review and meta-analysis.
Exanthema
Appetite Loss as an Adverse Effect During Treatment with EGFR-TKIs in Elderly Patients with Non-small Cell Lung Cancer.
Exanthema
Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.
Exanthema
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.
Exanthema
Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial.
Exanthema
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.
Exanthema
Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial.
Exanthema
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Exanthema
Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non-Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study.
Exanthema
Clinical aspects of splenomegaly as a possible predictive factor of coronary artery changes in Kawasaki disease.
Exanthema
Clinical evaluation of combination of cefmetazole and piperacillin in the treatment of infections in patients with acute leukemia.
Exanthema
Clinical Manifestations and Predictors of Thrombocytopenia in Hospitalized Adults with Dengue Fever.
Exanthema
Clinical outcomes in elderly patients administered gefitinib as first-line treatment in epidermal growth factor receptor-mutated non-small-cell lung cancer: retrospective analysis in a Nagano Lung Cancer Research Group study.
Exanthema
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study.
Exanthema
Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan.
Exanthema
Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system.
Exanthema
Development, Production, and Postmarketing Surveillance of Hepatitis A Vaccines in China.
Exanthema
E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma: A phase I study.
Exanthema
Efficacies and adverse reactions of modified vitamin supplement programs before pemetrexed chemotherapy as a second-line treatment against epidermal growth factor receptor (EGFR) mutant wild-type lung adenocarcinoma.
Exanthema
Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial.
Exanthema
Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease.
Exanthema
Epidemiological and clinical analysis of the outbreak of dengue fever in Zhangshu City, Jiangxi Province, in 2019.
Exanthema
Exacerbation of allopurinol-induced drug reaction with eosinophilia and systemic symptoms by teicoplanin: A case report.
Exanthema
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer.
Exanthema
Fever after a stay in the tropics: diagnostic predictors of the leading tropical conditions.
Exanthema
First-in-Human Phase I Study of AC0010, a Mutant-Selective EGFR Inhibitor in Non-Small Cell Lung Cancer: Safety, Efficacy, and Potential Mechanism of Resistance.
Exanthema
First-line gefitinib treatment in elderly patients (aged ?75 years) with non-small cell lung cancer harboring EGFR mutations.
Exanthema
Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase 3, Randomized, Open-label, Multi-center FESTnd Study.
Exanthema
Gefitinib as First-line Treatment in Elderly Epidermal Growth Factor Receptor-mutated Patients With Advanced Lung Adenocarcinoma: Results of a Nagano Lung Cancer Research Group Study.
Exanthema
Icotinib versus Cisplatin Plus Docetaxel as Adjuvant Chemotherapy in Patients with Stage II (N1+) Non-Small Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study.
Exanthema
Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial.
Exanthema
Imipenem and cilastatin in acute osteomyelitis and suppurative arthritis. Therapy in infants and children.
Exanthema
Immune-related adverse events with PD-1 versus PD-L1 inhibitors: a meta-analysis of 8730 patients from clinical trials.
Exanthema
Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients.
Exanthema
Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs.
Exanthema
Increased type 2 innate lymphoid cells in patients with drug reaction with eosinophilia and systemic symptom.
Exanthema
Infection dynamics of sylvatic dengue virus in a natural primate host, the African Green Monkey.
Exanthema
Laboratory-acquired dengue virus infection by needlestick injury: a case report, South Korea, 2014.
Exanthema
Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
Exanthema
Mild Isoniazid-Induced Liver Injury in Humans Is Associated with an Increase in Th17 Cells and T Cells Producing IL-10.
Exanthema
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial.
Exanthema
One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency.
Exanthema
Overview of tigecycline efficacy and safety in the treatment of complicated skin and skin structure infections - a European perspective.
Exanthema
Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4{Delta}30-4995 in healthy adult volunteers.
Exanthema
Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma.
Exanthema
Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer.
Exanthema
Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitor.
Exanthema
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
Exanthema
Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma.
Exanthema
Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy.
Exanthema
Phase II study of imatinib mesylate in patients with prostate cancer with evidence of biochemical relapse after definitive radical retropubic prostatectomy or radiotherapy.
Exanthema
Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma.
Exanthema
Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma.
Exanthema
Prevalence and clinical differentiation of dengue fever in children in northern India.
Exanthema
Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L.
Exanthema
Risk Factors of Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease: A Meta-Analysis of Case-Control Studies.
Exanthema
Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients.
Exanthema
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study.
Exanthema
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.
Exanthema
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial.
Exanthema
Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES.
Exanthema
Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
Exanthema
Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam.
Exanthema
Safety and Tolerability of Bismuthyl Ecabet Suspension, a Novel Anti-Ulcer Agent, following Single and Multiple Oral Dose Administration in Healthy Chinese Subjects.
Exanthema
Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials.
Exanthema
Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma.
Exanthema
Safety of PD-1/PD-L1 Inhibitors Combined With Palliative Radiotherapy and Anti-Angiogenic Therapy in Advanced Hepatocellular Carcinoma.
Exanthema
Safety, pharmacokinetics, and preliminary efficacy of the PARP inhibitor talazoparib in Japanese patients with advanced solid tumors: phase 1 study.
Exanthema
The difference in clinical characteristics between acute Q fever and scrub typhus in southern Taiwan.
Exanthema
The identification of risk factors for infectious patients with acute fever and formulation of activation criteria to alert outpatient clinic doctors.
Exanthema
Treatment-related adverse effects with TKIs in patients with advanced or radioiodine refractory differentiated thyroid carcinoma: a systematic review and meta-analysis.
Exanthema
Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor-mutant lung cancers and brain metastases.
Exanthema
[Analysis of the efficacy and safety of gefitinib in the treatment of recurrent advanced non-small cell lung cancer in an expanded access program (EAP)]
Exfoliation Syndrome
Serum Uric Acid, Alanine Aminotransferase, Hemoglobin and Red Blood Cell Count Levels in Pseudoexfoliation Syndrome.
Factor VII Deficiency
Description of breed ancestry and genetic health traits in arctic sled dog breeds.
Fascioliasis
Seroepidemiology of human fascioliasis and its relationship with anti-Fasciola IgG and liver enzymes as biomarkers of pathogenicity.
Fatty Liver
A common haplotype of carnitine palmitoyltransferase 1b is associated with the metabolic syndrome.
Fatty Liver
A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.
Fatty Liver
A higher flavonoid intake is associated with less likelihood of nonalcoholic fatty liver disease: results from a multiethnic study.
Fatty Liver
A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease.
Fatty Liver
A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients.
Fatty Liver
A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis.
Fatty Liver
A preliminary study of apparent diffusion coefficient in chemotherapy-induced liver damage.
Fatty Liver
Absence of increased liver-related inflammatory markers in type 1 diabetes with metabolic syndrome: a nested case-control study from Brazil.
Fatty Liver
Adenovirus?mediated overexpression of bone morphogenetic protein?9 promotes methionine choline deficiency?induced non?alcoholic steatohepatitis in non?obese mice.
Fatty Liver
Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice.
Fatty Liver
Advanced hepatic fibrosis and cirrhosis due to nonalcoholic fatty liver disease in Sri Lankan children: a preliminary report.
Fatty Liver
Adverse impact of egg consumption on fatty liver is partially explained by cardiometabolic risk factors: A population-based study.
Fatty Liver
Adverse signaling of scavenger receptor class B1 and PGC1s in alcoholic hepatosteatosis and steatohepatitis and protection by betaine in rat.
Fatty Liver
Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
Fatty Liver
Alanine aminotransferase elevation not associated with fatty liver is frequently seen in obese Japanese women.
Fatty Liver
Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat.
Fatty Liver
Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.
Fatty Liver
Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth.
Fatty Liver
Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer's disease and myocardial infarction.
Fatty Liver
Alleviation of diabetic complications by ginsenoside Rg3-enriched red ginseng extract in western diet-fed LDL-/- mice.
Fatty Liver
Alleviation of ischemia/reperfusion injury in ob/ob mice by inhibiting UCP-2 expression in fatty liver.
Fatty Liver
ALT Trends through Childhood and Adolescence Associated with Hepatic Steatosis at 24 Years: A Population-Based UK Cohort Study.
Fatty Liver
An early fish oil-enriched diet reverses biochemical, liver and adipose tissue alterations in male offspring from maternal protein restriction in mice.
Fatty Liver
Angiopoietin-like protein 4 improves glucose tolerance and insulin resistance but induces liver steatosis in high-fat-diet mice.
Fatty Liver
Anti-hepatitis C virus seropositivity is not associated with metabolic syndrome irrespective of age, gender and fibrosis.
Fatty Liver
Assessment of NAFLD cases and its correlation to BMI and metabolic syndrome in healthy blood donors in Kerman.
Fatty Liver
Association between continuous positive airway pressure and serum aminotransferases in patients with obstructive sleep apnea.
Fatty Liver
Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
Fatty Liver
Association between environmental exposure to cadmium and risk of suspected non-alcoholic fatty liver disease.
Fatty Liver
Association between eosinophil count and cholelithiasis among a population with Clonorchis sinensis infection in Foshan City, China.
Fatty Liver
Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals.
Fatty Liver
Association between Hepatitis B Virus Infection and Metabolic Syndrome in Southwest China: A Cross-sectional Study.
Fatty Liver
Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease.
Fatty Liver
Association between Markers of Fatty Liver Disease and Impaired Glucose Regulation in Men and Women from the General Population: The KORA-F4-Study.
Fatty Liver
Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes.
Fatty Liver
Association Between Severity of Obstructive Sleep Apnea and Blood Markers of Liver Injury.
Fatty Liver
Association of fatty liver with increased ratio of visceral to subcutaneous adipose tissue in obese men.
Fatty Liver
Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
Fatty Liver
Association of the I148M/PNPLA3 (rs738409) polymorphism with premature coronary artery disease, fatty liver, and insulin resistance in type 2 diabetic patients and healthy controls. The GEA study.
Fatty Liver
Association of the I148M/PNPLA3 variant with elevated alanine transaminase levels in normal-weight and overweight/obese Mexican children.
Fatty Liver
Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
Fatty Liver
Associations between arterial structure and function and serum levels of liver enzymes in obese adolescents.
Fatty Liver
Betulin attenuated liver damage by prevention of hepatic mitochondrial dysfunction in rats with alcoholic steatohepatitis.
Fatty Liver
Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men.
Fatty Liver
Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease.
Fatty Liver
Can hepatokines be regarded as novel non-invasive serum biomarkers of intrahepatic lipid content in obese children?
Fatty Liver
Cardiorespiratory fitness, waist circumference and liver enzyme levels in European adolescents: The HELENA cross-sectional study.
Fatty Liver
Carotid Intima-media thickness in childhood and adolescent obesity relations to abdominal obesity, high triglyceride level and insulin resistance.
Fatty Liver
Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression.
Fatty Liver
Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.
Fatty Liver
Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
Fatty Liver
Chronic effects of celecoxib, a cyclooxygenase-2 inhibitor, cause enhanced alcohol-induced liver steatosis in rats.
Fatty Liver
Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese.
Fatty Liver
Clinical characteristics of patients under 40 years old with early-onset hyperuricaemia: a retrospective monocentric study in China.
Fatty Liver
Clinical features and risk factors of patients with fatty liver in Guangzhou area.
Fatty Liver
Clinical significance of fatty liver disease induced by tamoxifen and toremifene in breast cancer patients.
Fatty Liver
Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferase values.
Fatty Liver
Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
Fatty Liver
Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males.
Fatty Liver
Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe(-/-) mice.
Fatty Liver
Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels.
Fatty Liver
Comparing Outcomes of Two Types of Bariatric Surgery in an Adolescent Obese Population: Roux-en-Y Gastric Bypass vs. Sleeve Gastrectomy.
Fatty Liver
Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescents.
Fatty Liver
Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease.
Fatty Liver
Comprehensive characterization of metabolic, inflammatory and fibrotic changes in a mouse model of diet-derived nonalcoholic steatohepatitis.
Fatty Liver
Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease.
Fatty Liver
Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.
Fatty Liver
Development of a hepatocellular carcinoma in a chronic hepatitis C patient 18 years after achieving a sustained virological response to interferon therapy: case report and literature review.
Fatty Liver
Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance.
Fatty Liver
Diagnostic performance of fibroscan and computed tomography in 322 normal alanine aminotransferase non-obese non-alcoholic fatty liver disease patients diagnosed by ultrasound.
Fatty Liver
Dietary soya protein concentrate enriched with isoflavones reduced fatty liver, increased hepatic fatty acid oxidation and decreased the hepatic mRNA level of VLDL receptor in obese Zucker rats.
Fatty Liver
Discordant Effects on Central Obesity, Hepatic Insulin Resistance, and Alanine Aminotransferase of Low-dose Metformin and Thiazolidinedione Combination Therapy in Patients with Impaired Glucose Tolerance.
Fatty Liver
Disrupted ER-to-Golgi Trafficking Underlies Anti-HIV Drugs and Alcohol-Induced Cellular Stress and Hepatic Injury.
Fatty Liver
Do high ferritin levels confer lower cardiovascular risk in men with Type 2 diabetes?
Fatty Liver
Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial.
Fatty Liver
Dose-response association of the ZJU index and fatty liver disease risk: A large cohort in China.
Fatty Liver
Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
Fatty Liver
Early menarche is associated with insulin-resistance and non-alcoholic fatty liver disease in adolescents with obesity.
Fatty Liver
Early-onset metabolic syndrome in prepubertal obese children and the possible role of alanine aminotransferase as marker of metabolic syndrome.
Fatty Liver
Eating Fast and Until Full Is Associated with Elevated Alanine Aminotransferase Activity in Japanese Schoolchildren: A Cross-Sectional Study.
Fatty Liver
Effect of body weight and lifestyle changes on long-term course of nonalcoholic fatty liver disease in Koreans.
Fatty Liver
Effect of Dapagliflozin on Alanine Aminotransferase Improvement in Type 2 Diabetes Mellitus with Non-alcoholic Fatty Liver Disease.
Fatty Liver
Effect of dietary epigallocatechin-3-gallate on cytochrome P450 2E1-dependent alcoholic liver damage: enhancement of fatty acid oxidation.
Fatty Liver
Effect of hepatic function on the EC50 of midazolam and the BIS50 at the time of loss of consciousness.
Fatty Liver
Effect of ipragliflozin on liver function in Japanese type 2 diabetes mellitus patients: a subgroup analysis of the STELLA-LONG TERM study (3-month interim results).
Fatty Liver
Effect of ipragliflozin on liver function in Japanese type 2 diabetes mellitus patients: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM).
Fatty Liver
Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model.
Fatty Liver
Effect of livergol on the improvement of fatty liver in patients with cancer undergoing irinotecan- and oxaliplatin-based chemotherapy regimen.
Fatty Liver
Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis.
Fatty Liver
Effect of Nigella sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Fatty Liver
Effect of pituitary surgery in patients with acromegaly on adiponectin serum concentrations and alanine aminotransferase activity.
Fatty Liver
Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms.
Fatty Liver
Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial.
Fatty Liver
Effect of Weight Loss Medications on Hepatic Steatosis and Steatohepatitis: A Systematic Review.
Fatty Liver
Effects of anthropometric and metabolic parameters on transaminase levels and liver stiffness in patients with non-alcohol fatty liver disease.
Fatty Liver
Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
Fatty Liver
Effects of epicatechin gallate (ECG) on fetal bovine serum (FBS)-induced steatosis in human liver cell line L02 and 2,2?-azobis (2-amidinopropane) (AAPH)-induced oxidative stress in human erythrocytes
Fatty Liver
Effects of intragastric balloon placement in metabolic dysfunction-associated fatty liver disease: A systematic review and meta-analysis.
Fatty Liver
Effects of Liraglutide and Vitamin E in Fructose-Induced Metabolic Syndrome in Rats.
Fatty Liver
Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia.
Fatty Liver
Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease.
Fatty Liver
Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.
Fatty Liver
Effects of vitamin E on chronic hepatitis C genotype 3: a randomized, double-blind, placebo-controlled study.
Fatty Liver
Efficacy and effectiveness of liver screening program to detect fatty liver in the periodic health check-ups.
Fatty Liver
Efficacy of bariatric surgery in improving metabolic outcomes in patients with diabetes. A 24-month follow-up study from a single center in the UAE.
Fatty Liver
Efficacy of herbomineral compounds and pathya (Ayurvedic dietary regime and physical exercise) in the management of Yak?t Roga (Non-alcoholic fatty liver disease).
Fatty Liver
Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
Fatty Liver
Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease.
Fatty Liver
Elevated alanine aminotransferase and low aspartate aminotransferase/alanine aminotransferase ratio are associated with chronic kidney disease among middle-aged women: a cross-sectional study.
Fatty Liver
Elevated alanine aminotransferase independently predicts new onset of depression in employees undergoing health screening examinations.
Fatty Liver
Elevated Alt and Ast in an Asymptomatic Person: What the primary care doctor should do?
Fatty Liver
Elevated levels of alanine transaminase and triglycerides within normal limits are associated with fatty liver.
Fatty Liver
Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
Fatty Liver
Endothelial dysfunction in nonalcoholic steatohepatitis with low cardiac disease risk.
Fatty Liver
Establishment of a mouse model of enalapril-induced liver injury and investigation of the pathogenesis.
Fatty Liver
Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice.
Fatty Liver
Evaluation of neck circumference as an easy and reliable predictor for non-alcoholic fatty liver disease.
Fatty Liver
Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography.
Fatty Liver
Evaluation of various biomarkers as potential mediators of the association between ?5 desaturase, ?6 desaturase, and stearoyl-CoA desaturase activity and incident type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study.
Fatty Liver
Exercise training attenuates hepatic inflammation, fibrosis and macrophage infiltration during diet induced-obesity in mice.
Fatty Liver
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.
Fatty Liver
Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
Fatty Liver
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals.
Fatty Liver
Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults.
Fatty Liver
Fatty liver--based identification of two distinct hypertriglyceridemic subgroups in familial combined hyperlipidemia.
Fatty Liver
Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia.
Fatty Liver
Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study.
Fatty Liver
Gamma-glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community-based cross-sectional study.
Fatty Liver
Generalized likelihood ratio concept and logistic regression analysis for multiple diagnostic categories.
Fatty Liver
Glucomannan or Glucomannan Plus Spirulina-Enriched Squid-Surimi Diets Reduce Histological Damage to Liver and Heart in Zucker fa/fa Rats Fed a Cholesterol-Enriched and Non-Cholesterol-Enriched Atherogenic Diet.
Fatty Liver
Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance.
Fatty Liver
Grape seed extract to improve liver function in patients with nonalcoholic fatty liver change.
Fatty Liver
Green tea extract protects against hepatic NF?B activation along the gut-liver axis in diet-induced obese mice with nonalcoholic steatohepatitis by reducing endotoxin and TLR4/MyD88 signaling.
Fatty Liver
Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease.
Fatty Liver
Hepatic functional and pathological changes of type 1 diabetic mice in growing and maturation time.
Fatty Liver
Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
Fatty Liver
Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
Fatty Liver
Hepatocyte-Specific Deletion of TIPARP, a Negative Regulator of the Aryl Hydrocarbon Receptor, Is Sufficient to Increase Sensitivity to Dioxin-Induced Wasting Syndrome.
Fatty Liver
Heritability and genetic loci of fatty liver in familial combined hyperlipidemia.
Fatty Liver
High alanine aminotransferase level as a predictor for the incidence of macrovascular disease in type 2 diabetic patients with fatty liver disease.
Fatty Liver
Higher adherence to plant-based diets are associated with lower likelihood of fatty liver.
Fatty Liver
Higher Fetuin-A Level Is Associated with Coexistence of Elevated Alanine Aminotransferase and the Metabolic Syndrome in the General Population.
Fatty Liver
Ideal cardiovascular health associated with fatty liver: Results from a multi-ethnic survey.
Fatty Liver
Ideal cardiovascular health predicts lower risk of abnormal liver enzymes levels in the Chilean National Health Survey (2009-2010).
Fatty Liver
IL-32: A new proinflammatory cytokine involved in HCV-related liver inflammation and fibrosis.
Fatty Liver
Impact of Fasting Lipid Profile on Chronic Kidney Disease Patients Having Fatty Liver Disease.
Fatty Liver
Impact of fatty liver disease and metabolic syndrome on incident type 2 diabetes; a population based cohort study.
Fatty Liver
Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation.
Fatty Liver
Impact of lifestyle and cardiovascular risk factors on early atherosclerosis in a large cohort of healthy adolescents: The Early Vascular Ageing (EVA)-Tyrol Study.
Fatty Liver
Impact of myosteatosis on skeletal muscle volume loss in patients with chronic liver disease.
Fatty Liver
Impaired hepatic autophagic activity in dairy cows with severe fatty liver is associated with inflammation and reduced liver function.
Fatty Liver
Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial.
Fatty Liver
Incidences and Determinants of Functional Cure during Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.
Fatty Liver
Increased hepatic expression is a major determinant of serum alanine aminotransferase elevation in mice with nonalcoholic steatohepatitis.
Fatty Liver
Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Fatty Liver
Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process.
Fatty Liver
Influence of light alcohol consumption on lifestyle-related diseases: a predictor of fatty liver with liver enzyme elevation in Japanese females with metabolic syndrome.
Fatty Liver
Inhibition of aldose reductase ameliorates diet-induced nonalcoholic steatohepatitis in mice via modulating the phosphorylation of hepatic peroxisome proliferator-activated receptor ?.
Fatty Liver
Inhibition of Triggering Receptor Expressed on Myeloid Cells 1 Ameliorates Inflammation and Macrophage and Neutrophil Activation in Alcoholic Liver Disease in Mice.
Fatty Liver
Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.
Fatty Liver
Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients.
Fatty Liver
Integrative proteomic and lipidomic analysis of Kaili Sour Soup-mediated attenuation of high-fat diet-induced nonalcoholic fatty liver disease in a rat model.
Fatty Liver
Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment.
Fatty Liver
Interleukin-10 to tumor necrosis factor-alpha ratio is a predictive biomarker in nonalcoholic fatty liver disease: interleukin-10 to tumor necrosis factor-alpha ratio in steatohepatitis.
Fatty Liver
Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3.
Fatty Liver
Intestinal gas and liver steatosis: a casual association? A prospective multicentre assessment.
Fatty Liver
Intrahepatic fat, abdominal adipose tissues, and metabolic state: magnetic resonance imaging study.
Fatty Liver
Inverse Association between Serum 25-hydroxyvitamin D Levels and Risk of Suspected Non-Alcoholic Fatty Liver Disease in Obese Population.
Fatty Liver
Investigation of the effects of chlorella vulgaris supplementation in patients with non-alcoholic Fatty liver disease: a randomized clinical trial.
Fatty Liver
Joint associations of serum uric acid and ALT with NAFLD in elderly men and women: a Chinese cross-sectional study.
Fatty Liver
Kefir improves fatty liver syndrome by inhibiting the lipogenesis pathway in leptin-deficient ob/ob knockout mice.
Fatty Liver
Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway.
Fatty Liver
Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fatty Liver
Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury.
Fatty Liver
Leptin Receptors Are Not Required for Roux-en-Y Gastric Bypass Surgery to Normalize Energy and Glucose Homeostasis in Rats.
Fatty Liver
Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers.
Fatty Liver
Lipoprotein lipase activator NO-1886 improves fatty liver caused by high-fat feeding in streptozotocin-induced diabetic rats.
Fatty Liver
Liver acoustic radiation force impulse (ARFI) in childhood obesity: comparison and correlation with biochemical markers.
Fatty Liver
Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.
Fatty Liver
Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction.
Fatty Liver
Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure.
Fatty Liver
Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease.
Fatty Liver
Long-term dietary potential renal acid load during adolescence is prospectively associated with indices of nonalcoholic fatty liver disease in young women.
Fatty Liver
Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years.
Fatty Liver
Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men.
Fatty Liver
Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
Fatty Liver
Low vitamin D levels are associated with increased risk for fatty liver disease among non-obese adults.
Fatty Liver
Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture.
Fatty Liver
Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment.
Fatty Liver
Marginal iron deficiency enhances liver triglyceride accumulation in rats fed a high-sucrose diet.
Fatty Liver
Mean arterial pressure and arterial stiffness in Japanese population: a secondary analysis based on a cross-sectional study.
Fatty Liver
Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
Fatty Liver
Metabolically healthy but obese individuals: relationship with hepatic enzymes.
Fatty Liver
Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease.
Fatty Liver
MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease.
Fatty Liver
Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet.
Fatty Liver
Most overweight and obese Indian children have nonalcoholic fatty liver disease.
Fatty Liver
Murine alanine aminotransferase: cDNA cloning, functional expression, and differential gene regulation in mouse fatty liver.
Fatty Liver
Mutagenic safety and fatty liver improvement of nanonized black soybeans in senescence-accelerated prone-8 mice.
Fatty Liver
New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence.
Fatty Liver
Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis.
Fatty Liver
Non-Alcoholic Fatty Liver Disease and Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia.
Fatty Liver
Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese.
Fatty Liver
Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort.
Fatty Liver
Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status.
Fatty Liver
Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010-2015.
Fatty Liver
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial.
Fatty Liver
Novel GLP-1 Analog Supaglutide Reduces HFD-Induced Obesity Associated with Increased Ucp-1 in White Adipose Tissue in Mice.
Fatty Liver
Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.
Fatty Liver
Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2.
Fatty Liver
Optimal cut-off value of alanine aminotransferase level to precisely estimate the presence of fatty liver in patients with poorly controlled type 2 diabetes.
Fatty Liver
Orexin-A represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling.
Fatty Liver
Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant.
Fatty Liver
Perceived dietary salt intake and the risk of primary liver cancer: a population-based prospective study.
Fatty Liver
Performance and Utility of Transient Elastography and Non-Invasive Markers of Liver Fiibrosis in Patients with Autoimmune Hepatitis: A Single Centre Experience.
Fatty Liver
Phenotypic Differences Between Polygenic and Monogenic Hypobetalipoproteinemia.
Fatty Liver
Phosphatidylcholine transfer protein/StarD2 promotes microvesicular steatosis and liver injury in murine experimental steatohepatitis.
Fatty Liver
Plasma interleukin-18/interleukin-18 binding protein ratio in Chinese with NAFLD.
Fatty Liver
Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study.
Fatty Liver
Polydatin supplementation ameliorates diet-induced development of insulin resistance and hepatic steatosis in rats.
Fatty Liver
Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
Fatty Liver
Predictive value of elevated alanine aminotransferase for in-hospital mortality in patients with acute myocardial infarction.
Fatty Liver
Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) Study.
Fatty Liver
Predictive Values of Serum Uric Acid and Alanine-aminotransferase for Fatty Liver Index in Montenegrin Population.
Fatty Liver
Preliminary evidence for obesity-associated insulin resistance in adolescents without elevations of inflammatory cytokines.
Fatty Liver
Presence of the metabolic syndrome in obese adolescents predicts impaired glucose tolerance and nonalcoholic fatty liver disease.
Fatty Liver
Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
Fatty Liver
Prevalence and risk factors of elevated alanine aminotransferase among Korean adolescents: 2001-2014.
Fatty Liver
Prevalence of increased transaminases and its association with sex, age, and metabolic parameters in children and adolescents with obesity - a nationwide cross-sectional cohort study.
Fatty Liver
Prevention of alterations in intestinal permeability is involved in zinc inhibition of acute ethanol-induced liver damage in mice.
Fatty Liver
Preventive Effects of Total Flavonoid C-Glycosides from Abrus mollis on Nonalcoholic Fatty Liver Disease through Activating the PPAR? Signaling Pathway.
Fatty Liver
Probiotic Therapy in Patients with Nonalcoholic Steatohepatitis in Zagazig University Hospitals.
Fatty Liver
Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
Fatty Liver
Prospective study of gestational diabetes and fatty liver scores 9 to 16?years after pregnancy.
Fatty Liver
Protective effect of oligomeric proanthocyanidins against alcohol-induced liver steatosis and injury in mice.
Fatty Liver
Protocatechuic acid exhibits hepatoprotective, vasculoprotective, antioxidant and insulin-like effects in dexamethasone-induced insulin-resistant rats.
Fatty Liver
Puerarin ameliorates experimental alcoholic liver injury by inhibition of endotoxin gut leakage, Kupffer cell activation, and endotoxin receptors expression.
Fatty Liver
Quantitative Profiling of Oxylipin Reveals the Mechanism of Pien-Tze-Huang on Alcoholic Liver Disease.
Fatty Liver
Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis.
Fatty Liver
Red blood cell distribution width as a non-invasive marker for the assessment of inflammation in non-alcoholic steatohepatitis.
Fatty Liver
Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat.
Fatty Liver
Relationship between body mass index and alanine aminotransferase concentration in non-diabetic Korean adults.
Fatty Liver
Relationship between fatty liver, alanine aminotransferase, HBsAg and hepatitis C virus.
Fatty Liver
Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
Fatty Liver
Relationship of visceral adipose tissue with surrogate insulin resistance and liver markers in individuals with metabolic syndrome chronic complications.
Fatty Liver
Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.
Fatty Liver
Resistant Maltodextrin Ameliorates Altered Hepatic Lipid Homeostasis via Activation of AMP-Activated Protein Kinase in a High-Fat Diet-Fed Rat Model.
Fatty Liver
Retinol binding protein-4 as a serum biomarker of intrahepatic lipid content in obese children - preliminary report.
Fatty Liver
Revision of serum ALT upper limits of normal facilitates assessment of mild liver injury in obese children with non-alcoholic fatty liver disease.
Fatty Liver
Ritonavir and Lopinavir Suppress RCE1 and CAAX Rab Proteins Sensitizing the Liver to Organelle Stress and Injury.
Fatty Liver
Role of Probiotics in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-analysis.
Fatty Liver
Role of Soluble Adiponectin Receptor 2 in Non-Alcoholic Fatty Liver Disease in Children.
Fatty Liver
Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
Fatty Liver
Safety and effectiveness of rosiglitazone in type 2 diabetes patients with nonalcoholic Fatty liver disease.
Fatty Liver
Screening of Family Members of Nonalcoholic Fatty Liver Disease Patients can Detect Undiagnosed Nonalcoholic Fatty Liver Disease Among Them: Is There a Genetic Link?
Fatty Liver
Serum alanine aminotransferase concentration as a predictive factor for the development or regression of fatty liver.
Fatty Liver
Serum alanine aminotransferase independently correlates with intrahepatic triglyceride contents in obese subjects.
Fatty Liver
Serum alanine aminotransferase predicts the histological course of non-alcoholic steatohepatitis in Japanese patients.
Fatty Liver
Serum alanine aminotransferase to aspartate aminotransferase ratio and degree of fatty liver in morbidly obese patients.
Fatty Liver
Serum Alanine Transaminase Total Bilirubin Concentrations Predict CYP3A Activity as Measured by Midazolam and 1'-Hydroxylation.
Fatty Liver
Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis.
Fatty Liver
Serum testosterone and non-alcoholic fatty liver disease in men and women in the US.
Fatty Liver
Serum vascular endothelial cadherin and thrombomodulin are markers of non-alcoholic fatty liver disease in children.
Fatty Liver
Severity of ultrasonographic liver steatosis and metabolic syndrome in Korean men and women.
Fatty Liver
Sex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathway.
Fatty Liver
Short-Term Soy Protein Isolate Feeding Prevents Liver Steatosis and Reduces Serum ALT and AST Levels in Obese Female Zucker Rats.
Fatty Liver
Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.
Fatty Liver
Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
Fatty Liver
Simple Resistance Exercise for 24 Weeks Decreases Alanine Aminotransferase Levels in Patients with Non-Alcoholic Fatty Liver Disease.
Fatty Liver
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
Fatty Liver
Sleeve Gastrectomy Is Associated with a Greater Reduction in Plasma Liver Enzymes Than Bypass Surgeries-A Registry-Based Two-Year Follow-Up Analysis.
Fatty Liver
Small Intestinal Length Associates with Serum Triglycerides Before and After LRYGB.
Fatty Liver
Sonographic Measurement of Mesenteric Fat Predicts Presence of Fatty Liver among Subjects with Polycystic Ovary Syndrome.
Fatty Liver
Spontaneous development of hepatocellular carcinomas in the FLS mice with hereditary fatty liver.
Fatty Liver
Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
Fatty Liver
Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts.
Fatty Liver
Targeting n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease.
Fatty Liver
Test validity of periodic liver function tests in a population of Japanese male bank employees.
Fatty Liver
The add-on effects of Gynostemma pentaphyllum on nonalcoholic fatty liver disease.
Fatty Liver
The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels.
Fatty Liver
The association of lipid metabolism and non-alcoholic fatty liver disease in children with obesity.
Fatty Liver
The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
Fatty Liver
The association of vitamin D deficiency with non-alcoholic fatty liver disease.
Fatty Liver
The change in prevalence of suspected non-alcoholic fatty liver disease in Korean adolescents from 2001 to 2017.
Fatty Liver
The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.
Fatty Liver
The Effect of Green Tea Extract Supplementation on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease.
Fatty Liver
The Effect of Low Glycemic Index and Glycemic Load Diets on Hepatic Fat Mass, Insulin Resistance, and Blood Lipid Panels in Individuals with Nonalcoholic Fatty Liver Disease.
Fatty Liver
The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial.
Fatty Liver
The Effects of Melatonin in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial.
Fatty Liver
The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial.
Fatty Liver
The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial.
Fatty Liver
The efficacy of saxagliptin in T2DM patients with non-alcoholic fatty liver disease: preliminary data.
Fatty Liver
The ERLIN1-CHUK-CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart Study.
Fatty Liver
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases.
Fatty Liver
The glycated albumin to glycated haemoglobin ratio increases along with the fibrosis stage in non-alcoholic steatohepatitis.
Fatty Liver
The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD).
Fatty Liver
The prevalence and correlates of T-wave inversion in lead III in non-obese men.
Fatty Liver
The relationship between severity of liver steatosis and metabolic parameters in a sample of Iranian adults.
Fatty Liver
Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice.
Fatty Liver
TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children.
Fatty Liver
Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus.
Fatty Liver
Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: A pilot trial.
Fatty Liver
Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents.
Fatty Liver
Triglycerides and alanine aminotransferase as screening markers for suspected fatty liver disease in obese children and adolescents.
Fatty Liver
Ultrasound measurement of pediatric visceral fat thickness: correlations with metabolic and liver profiles.
Fatty Liver
Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review.
Fatty Liver
Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males.
Fatty Liver
Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.
Fatty Liver
Visceral fat predominance is associated with non-alcoholic fatty liver disease in Japanese women with metabolic syndrome.
Fatty Liver
Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis.
Fatty Liver
[Assessment of high sensitivity C-reactive protein (HS-CRP) as a marker of liver inflammation in patients with metabolic syndrome]
Fatty Liver
[Associated risk factors of fatty liver in the patients with type 2 diabetes mellitus]
Fatty Liver
[Clinical significance of the measurement of serum cytokeratin-18 in patients with non-alcoholic steatohepatitis].
Fatty Liver
[Fat distribution and its relationship with genetic polymorphism in patients with nonalcoholic liver disease].
Fatty Liver
[Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?]
Fatty Liver
[Metabolic syndrome: jumble syndrome of obesity or specific entity? Which treatment: diet or polypill?]
Fatty Liver
[Nutritional status and energy metabolism characteristics in patients with nonalcoholic fatty liver disease].
Fatty Liver
[Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population].
Fatty Liver
[Relationship of fatty liver with HBV infection, hyperlipidemia and abnormal alanine aminotransferase]
Fatty Liver
Most overweight and obese Indian children have nonalcoholic fatty liver disease.
Fatty Liver, Alcoholic
Alanine aminotransferase elevation in obese infants and children: a marker of early onset non alcoholic Fatty liver disease.
Fatty Liver, Alcoholic
Effect of baicalin on toll-like receptor 4-mediated ischemia/reperfusion inflammatory responses in alcoholic fatty liver condition.
Fatty Liver, Alcoholic
Hepatic gamma-glutamyltransferase activity in alcoholic fatty liver: comparison with other liver enzymes in man and rats.
Fatty Liver, Alcoholic
Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates alcoholic liver disease in ethanol-containing diet-fed C57BL/6N mice.
Fatty Liver, Alcoholic
Protective effect of apocynin in an established alcoholic steatohepatitis rat model.
Fatty Liver, Alcoholic
Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review.
Fatty Liver, Alcoholic
[Non alcoholic steatohepatitis: a multifactorial, frequent, paucysymptomatic liver disease with a fibrotic outcome]
Febrile Neutropenia
Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study.
Febrile Neutropenia
Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients.
Febrile Neutropenia
Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours.
Febrile Neutropenia
Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan.
Febrile Neutropenia
Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer.
Febrile Neutropenia
Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer.
Febrile Neutropenia
Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065).
Febrile Neutropenia
Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer.
Febrile Neutropenia
Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison.
Febrile Neutropenia
Side effects of CDK4/6 inhibitors in the treatment of HR+/HER2- advanced breast cancer: a systematic review and meta-analysis of randomized controlled trials.
Febrile Neutropenia
Trabectedin for the treatment of advanced metastatic Soft Tissue Sarcoma.
Febrile Neutropenia
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
Febrile Neutropenia
Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial.
Fetal Death
Factors influencing occurrence of postpartum haemorrhage in pregnant women with hepatitis E infection and deranged coagulation profile.
Fetal Growth Retardation
Analysis on the outcomes of hepatitis B virus perinatal vertical transmission: nested case-control study.
Fetal Growth Retardation
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Fibrosarcoma
Bacopa monniera Linn. extract modulates antioxidant and marker enzyme status in fibrosarcoma bearing rats.
Focal Nodular Hyperplasia
Large-scale screening of circulating microRNAs in individuals with HIV-1 mono-infections reveals specific liver damage signatures.
Foot Ulcer
Screening for liver fibrosis by using FibroScan(®) and FibroTest in patients with diabetes.
fumarate hydratase deficiency
Combined metabolomic and correlation networks analyses reveal fumarase insufficiency altered amino acid metabolism.
Galactosemias
Clinical significance of plasma galactose and erythrocyte galactose-1-phosphate measurements in transferase-deficient galactosemia and in individuals with below-normal transferase activity.
Gallstones
Free fatty acids and triglyceride change in the gallbladder bile of gallstone patients with pancreaticobiliary reflux.
Gallstones
Predictability of clinicobiochemical scoring systems for early identification of severe gallstone-associated pancreatitis.
Gallstones
Risk factors for pegylated liposomal doxorubicin-induced moderate to severe hand-foot syndrome in breast cancer patients: assessment of baseline clinical parameters.
Gallstones
Use of amylase and alanine transaminase to predict acute gallstone pancreatitis in a population with high HIV prevalence.
Gallstones
When is pancreatitis considered to be of biliary origin and what are the implications for management?
Gallstones
[Is routine intra-operative cholangiography in laparoscopic cholecystectomy truly unnecessary?]
Gallstones
[Value of laboratory tests and echography in the diagnosis of biliary disease in the initial phase of acute pancreatitis]
Gangliosidoses, GM2
A possible biomarker of neurocytolysis in infantile gangliosidoses: aspartate transaminase.
Gastroenteritis
Cooperative activity of cytotoxic chemotherapy with antiangiogenic thrombospondin-I peptides, ABT-526 in pet dogs with relapsed lymphoma.
Gastroesophageal Reflux
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Gastroesophageal Reflux
Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial.
Gastroesophageal Reflux
Population-Level Prediction of Type 2 Diabetes From Claims Data and Analysis of Risk Factors.
Gastrointestinal Diseases
Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study.
Gastrointestinal Diseases
Simultaneous monitoring of pazopanib and its metabolites by UPLC-MS/MS.
Gilbert Disease
Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert's syndrome.
Gilbert Disease
Lapatinib-Induced Liver Injury Characterized by Class II HLA and Gilbert's Syndrome Genotypes.
Gingivitis
[Analysis of enzyme activity and the level of malondialdehyde in the saliva of children with gingivitis]
Glucose Intolerance
Alanine-aminotransferase levels predict impaired glucose tolerance in a worksite population.
Glucose Intolerance
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Glucose Intolerance
Angiotensin-(1-7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism.
Glucose Intolerance
Anti-diabetic effects of pentamethylquercetin in neonatally streptozotocin-induced diabetic rats.
Glucose Intolerance
Association between Markers of Fatty Liver Disease and Impaired Glucose Regulation in Men and Women from the General Population: The KORA-F4-Study.
Glucose Intolerance
Combining Fasting Plasma Glucose with Gamma-glutamyl Transferase Improves the Sensitivity to Predict Incident Diabetes in Asian Indian Men with Impaired Glucose Tolerance.
Glucose Intolerance
Di(2-ethylhexyl)phthalate exposure exacerbates metabolic disorders in diet-induced obese mice.
Glucose Intolerance
Discordant Effects on Central Obesity, Hepatic Insulin Resistance, and Alanine Aminotransferase of Low-dose Metformin and Thiazolidinedione Combination Therapy in Patients with Impaired Glucose Tolerance.
Glucose Intolerance
Glucose intolerance and serum aminotransferase activities in Japanese men.
Glucose Intolerance
Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population.
Glucose Intolerance
Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status.
Glucose Intolerance
Parkin deficiency accentuates chronic alcohol intake-induced tissue injury and autophagy defects in brain, liver and skeletal muscle.
Glucose Intolerance
Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
Glucose Intolerance
Reference ranges of HOMA-IR in normal-weight and obese young Caucasians.
Glucose Intolerance
Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
Glucose Intolerance
Sildenafil augments fetal weight and placental adiponectin in gestational testosterone-induced glucose intolerant rats.
Glucose Intolerance
Sodium acetate prevents nicotine-induced cardiorenal dysmetabolism through uric acid/creatine kinase-dependent pathway.
Glucose Intolerance
The association of early unexplained elevated alanine aminotransferase with large-for-gestational-age birthweight.
Glucose Intolerance
The C57BL/6J Niemann-Pick C1 mouse model with decreased gene dosage has impaired glucose tolerance independent of body weight.
Glucose Intolerance
The prevalence of abnormal liver enzymes and metabolic syndrome in obese adolescent females with polycystic ovary syndrome.
Glucose Intolerance
Visceral fat predominance is associated with non-alcoholic fatty liver disease in Japanese women with metabolic syndrome.
Glycogen Storage Disease
Glycogen debranching enzyme deficiency: long-term study of serum enzyme activities and clinical features.
Glycogen Storage Disease
[Determination of blood level of muscle enzymes in glycogenoses with liver involvement: a diagnostic criterion]
Glycogen Storage Disease Type II
A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatment.
Glycogen Storage Disease Type III
Glycogen debranching enzyme deficiency: long-term study of serum enzyme activities and clinical features.
Glycosuria
[The influence of alcohol drinking on medical care expenditures among National Health Insurance beneficiaries]
Graft vs Host Disease
Hepatitis B associated liver failure following bone marrow transplantation.
Graft vs Host Disease
Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation.
Graft vs Host Disease
Serum 5'nucleotidase and alkaline phosphatase--highly predictive liver function tests for the diagnosis of graft-versus-host disease in bone marrow transplant recipients.
Graft vs Host Disease
The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group.
Granuloma
A boswellic acid-containing extract attenuates hepatic granuloma in C57BL/6 mice infected with Schistosoma japonicum.
Granuloma
A single dose of the antineoplastics hydroxyurea or cisplatin has praziquantel-like effects on Schistosoma mansoni worms and host mouse liver.
Granuloma
ApoE deficiency promotes hepatic pathology by aggravating Th17/Treg imbalance in murine schistosomiasis japonica.
Granuloma
B1 cells protect against Schistosoma japonicum-induced liver inflammation and fibrosis by controlling monocyte infiltration.
Granuloma
Dexamethasone treatment improves morphological and hematological parameters in chronic experimental schistosomiasis.
Granuloma
Silymarin reduces profibrogenic cytokines and reverses hepatic fibrosis in chronic murine schistosomiasis.
Graves Disease
Primary biliary cirrhosis associated with Graves' disease in a male patient.
Graves Disease
Serial changes in liver function tests in patients with thyrotoxicosis induced by graves' disease and painless thyroiditis.
Graves Disease
SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Guillain-Barre Syndrome
Guillain-Barré syndrome and serum activities of gamma-glutamyltransferase and glutamic-pyruvic transaminase.
Hallucinations
Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile.
Hallucinations
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
Hand-Foot Syndrome
Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATG.
Hand-Foot Syndrome
Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trial.
Hand-Foot Syndrome
Efficacy and safety assessment of S-1-based regimens comparing to intravenous fluorouracil-based ones in Asian patients with metastatic colorectal carcinoma: A system review and meta-analysis.
Hand-Foot Syndrome
First-Line Pazopanib Treatment in Metastatic Renal Cell Carcinoma: Real-World Data From a Single Chinese Center.
Hand-Foot Syndrome
Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison.
Hand-Foot Syndrome
Treatment-related adverse effects with TKIs in patients with advanced or radioiodine refractory differentiated thyroid carcinoma: a systematic review and meta-analysis.
Hand-Foot Syndrome
[Capecitabine combined with cisplatin as first-line therapy in Chinese patients with advanced gastric carcinoma-a phase II clinical study]
Head and Neck Neoplasms
Prognostic and diagnostic value of serum pseudocholinesterase, serum aspartate transaminase, and serum alinine transaminase in malignancies treated by radiotherapy.
Hearing Loss
Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system.
Hearing Loss
Hearing impairment and hypoxia ischaemic encephalopathy: Incidence and associated factors.
Heart Arrest
An Open-Label, Dose-Escalating Phase I Study of Elsamitrucin (SPI 28090) in Treatment of Malignant Solid Tumors in Dogs.
Heart Arrest
Estimating the Number of Organ Donors in Australian Hospitals--Implications for Monitoring Organ Donation Practices.
Heart Arrest
Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters.
Heart Arrest
Possible Predictive Factors for In-hospital Cardiac Arrest in Patients with Cancer: A Retrospective Single Center Study.
Heart Defects, Congenital
Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion.
Heart Diseases
Estimating the Number of Organ Donors in Australian Hospitals--Implications for Monitoring Organ Donation Practices.
Heart Diseases
Interferon-alpha treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children.
Heart Diseases
Mendelian randomization estimates of alanine aminotransferase with cardiovascular disease: Guangzhou Biobank Cohort study.
Heart Diseases
Risk factors for aneurysmal subarachnoid hemorrhage in patients in Izumo City, Japan.
Heart Diseases
Risk factors for primary intracerebral hemorrhage in patients in Izumo City, Japan.
Heart Diseases
The Correlation Between Low Serum T3 Levels and All-Cause and Cardiovascular Mortality in Peritoneal Dialysis Patients.
Heart Failure
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Heart Failure
An Open-Label, Dose-Escalating Phase I Study of Elsamitrucin (SPI 28090) in Treatment of Malignant Solid Tumors in Dogs.
Heart Failure
Aspartate aminotransferase to alanine aminotransferase ratio is associated with frailty and mortality in older patients with heart failure.
Heart Failure
Association of plasma selenium concentrations with total IGF-1 among older community-dwelling adults: The InCHIANTI study.
Heart Failure
Association of TSH Elevation with All-Cause Mortality in Elderly Patients with Chronic Kidney Disease.
Heart Failure
Clinical and biochemical characteristics of infants with prolonged neonatal jaundice.
Heart Failure
Comparison of One-Year Survival After Acute Coronary Syndrome in Patients ?75 Years of Age With Versus Without Living With Spouse.
Heart Failure
Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong.
Heart Failure
Fibrosis-4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction.
Heart Failure
Human herpesvirus 6-related fulminant myocarditis and hepatitis in an immunocompetent adult with fatal outcome.
Heart Failure
Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients.
Heart Failure
Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction.
Heart Failure
Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.
Heart Failure
Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics.
Heart Failure
Physical activity with alanine aminotransferase and gamma-glutamyltransferase among congestive heart failure patients.
Heart Failure
Relation of Aspartate Aminotransferase to Alanine Aminotransferase Ratio to Nutritional Status and Prognosis in Patients With Acute Heart Failure.
Heart Failure
Relationship between uric acid levels and cardiometabolic findings in a large cohort of ?-thalassemia major patients.
Heart Failure
Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device.
Heart Failure
[Acute hepatic ischemia and cardiogenic shock in patients with dilated cardiomyopathy]
Heart Failure
[SERUM GLUTAMIC-EXALACETIC AND GLUTAMIC-PYRUVIC TRANSAMINASE ACTIVITY IN CONGESTIVE HEART FAILURE.]
HELLP Syndrome
A case of massive hepatic infarction in severe preeclampsia as part of the HELLP syndrome.
HELLP Syndrome
Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP)
HELLP Syndrome
Apoptosis, proliferation and Fas ligand expression in placental trophoblast from pregnancies complicated by HELLP syndrome or pre-eclampsia.
HELLP Syndrome
HELLP syndrome is associated with an increased inflammatory response, which may be inhibited by administration of prednisolone.
HELLP Syndrome
Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome.
HELLP Syndrome
Maternal serum uric acid level and maternal and neonatal complications in preeclamptic women: A cross-sectional study.
HELLP Syndrome
Obstetric implications of antepartum corticosteroid therapy for HELLP syndrome.
HELLP Syndrome
Prognostic Factors of the Efficacy of High-dose Corticosteroid Therapy in Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome During Pregnancy: A Meta-analysis.
HELLP Syndrome
[Ethnic predisposition of the severity of HELLP syndrome. Retrospective study of 12 cases including 5 during post-partum]
HELLP Syndrome
[Risk factors analysis of reversible posterior leukoencephalopathy syndrome in pre-eclampsia or eclampsia gravida].
HELLP Syndrome
[Severe precocious pre-eclampsia : how to manage the feto-maternal conflict of interest]
Hemangioma
Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Hematemesis
Case report on alimentary tract hemorrhage and liver injury after therapy with oseltamivir: A case report.
Hematologic Diseases
Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation.
Hematologic Diseases
The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group.
Hematologic Neoplasms
Serum concentration and localization in tumor cells of proteasomes in patients with hematologic malignancy and their pathophysiologic significance.
Hematologic Neoplasms
Venocclusive disease of the liver after allogeneic bone marrow transplantation in man.
Hematuria
Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial).
Hematuria
Relationship between genotypes and clinical manifestation, pathology, and cccDNA in Chinese children with hepatitis B virus-associated glomerulonephritis.
Hematuria
The Predictors for Positive Yield Abdominal Computed Tomography in Pediatric Abdominal Trauma.
Hematuria
Urinalysis and Clinical Correlations in Patients with P. vivax or P. falciparum Malaria from Colombia.
Hematuria
Validation of a Prediction Rule for the Identification of Children With Intra-abdominal Injuries After Blunt Torso Trauma.
Hematuria
[Clinical and pathological differences between children with various genotypes of hepatitis B virus-associated glomerulonephritis].
Hemochromatosis
Hemochromatosis discovered through blood donor screening for alanine aminotransferase.
Hemochromatosis
Porphyria cutanea tarda: effects and risk factors for hepatotoxicity from high-dose chloroquine treatment.
Hemochromatosis
Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase.
Hemochromatosis
[Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population].
Hemoglobinuria
Venous malformations with severe localized intravascular coagulopathy treated with microwave ablation.
Hemophilia A
Anti-inflammatory/regulatory cytokine microenvironment mediated by IL-4 and IL-10 coordinates the immune response in hemophilia A patients infected chronically with hepatitis C virus.
Hemophilia A
Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates.
Hemophilia A
Idiopathic CD4+ T-lymphocytopenia in HIV seronegative men with hemophilia and sex partners of HIV seropositive men. Multicenter Hemophilia Cohort Study.
Hemorrhagic Disorders
Occurrence of abscesses during treatment with pazopanib in metastatic renal cancer: a case report.
Hemorrhagic Fever with Renal Syndrome
Co-circulation of multiple hemorrhagic fever diseases with distinct clinical characteristics in Dandong, China.
Hemorrhagic Fever with Renal Syndrome
[A study on virus localization and microcirculation in the liver in patients with epidemic hemorrhagic fever]
Hemorrhagic Fever, Crimean
Predictors of Crimean-Congo hemorrhagic fever in the Emergency Department.
Hepatic Encephalopathy
Acute liver failure in two dogs following ingestion of cheese tree (Glochidion ferdinandi) roots.
Hepatic Encephalopathy
Clinical observation on the treatment of chronic severe hepatitis B by retention enema with Huchang Jiedu Decoction.
Hepatic Encephalopathy
Complement factor 3 among children with hepatitis A: Assessment of bilirubin levels.
Hepatic Encephalopathy
Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis.
Hepatic Encephalopathy
Effect of L-carnitine on liver enzymes and biochemical factors in hepatic encephalopathy: A systematic review and meta-analysis.
Hepatic Encephalopathy
Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom.
Hepatic Encephalopathy
Factors influencing occurrence of postpartum haemorrhage in pregnant women with hepatitis E infection and deranged coagulation profile.
Hepatic Encephalopathy
Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure.
Hepatic Encephalopathy
Plasma Interleukin-10: A Likely Predictive Marker for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.
Hepatic Encephalopathy
Predicting 90-day mortality at admission and 7 days post-admission among patients with hepatitis B virus-related acute-on-chronic liver failure.
Hepatic Encephalopathy
Predictors of fifty days in-hospital mortality in patients with culture negative neutrocytic ascites.
Hepatic Encephalopathy
Prognostic factors for chronic severe hepatitis and construction of a prognostic model.
Hepatic Encephalopathy
Prognostic factors for fatal outcomes prior to receiving liver transplantation in patients with non-acetaminophen-related fulminant hepatic failure.
Hepatic Encephalopathy
Severe desflurane hepatotoxicity after colon surgery in an elderly patient.
Hepatic Encephalopathy
Treatment of fulminant hepatic failure with intravenous prostaglandin E1.
Hepatic Encephalopathy
Variceal bleeding has increased mortality compared to nonvariceal bleeding only in males.
Hepatic Encephalopathy
[Effect of Acupuncture at Thirteen Evil Acupoints on Liver Function, and the Contents of Blood Ammonia and ?-endorphin in Patients with Hepatic Encephalopathy].
Hepatic Encephalopathy
[Multivariate analysis of hepatic encephalopathy occurrence in patients with liver failure].
Hepatic Infarction
Preoperative Coil Embolization in Patients With a Replaced Hepatic Artery Scheduled for Pancreatectomy With Splanchnic Artery Resection Helps to Prevent Ischemic Organ Injury.
Hepatic Insufficiency
A prospective and comparative cohort study on efficacy and drug resistance during long-term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis.
Hepatic Insufficiency
Initial experience with the use of tris-acryl gelatin microspheres for transcatheter arterial embolization for enlarged polycystic liver.
Hepatic Insufficiency
[Use of a new drug, lomefloxacin (maxaquin), from the fluoroquinolone group in the treatment of patients with wound infection]
Hepatitis
4,4'-Methylenedianiline-Induced Hepatotoxicity Is Modified by N-Acetyltransferase 2 (NAT2) Acetylator Polymorphism in the Rat.
Hepatitis
?-glutamyl transpeptidase in men and alanine aminotransferase in women are the most suitable parameters among liver function tests for the prediction of metabolic syndrome in nonviral hepatitis and nonfatty liver in the elderly.
Hepatitis
A case of primary biliary cholangitis overlapping with type 2 autoimmune hepatitis.
Hepatitis
A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.
Hepatitis
A detection method for point mutation in the precore region of human hepatitis B virus (HBV)-DNA using mutation-site-specific assay.
Hepatitis
A microtiter plate assay for measurement of serum alanine aminotransferase in blood donors.
Hepatitis
A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis.
Hepatitis
A personalized approach to optimize hepatitis B treatment in treatment-naive patients.
Hepatitis
A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis.
Hepatitis
A randomized trial of Chinese herbal medicines for the treatment of symptomatic hepatitis C.
Hepatitis
A randomized, controlled trial of weekly administration of lymphoblastoid interferon in patients with chronic hepatitis C.
Hepatitis
A review of donor alanine aminotransferase testing. Implications for the blood donor and practitioner.
Hepatitis
A study of primary- and re-infection with hepatitis C virus in blood transfusion recipients.
Hepatitis
A unique seroepidemiologic situation for hepatitis B markers in Guadeloupe. Results of a prospective study in blood donors.
Hepatitis
Abnormal alanine aminotransferase level in blood units from donors in Montreal does not indicate high risk of transmitting hepatitis.
Hepatitis
Acute exacerbation of hepatitis C in hepatocellular carcinoma patients receiving chemotherapy.
Hepatitis
Acute hepatitis B virus window-period blood donations detected by individual-donation nucleic acid testing: a report on the first two cases found and interdicted in Spain.
Hepatitis
Acute pseudohepatitis in a chronic substance abuser secondary to occult seat belt injury.
Hepatitis
Acute Q fever in southern Taiwan: atypical manifestations of hyperbilirubinemia and prolonged fever.
Hepatitis
Acute viral hepatitis increases liver stiffness values measured by transient elastography.
Hepatitis
Adenosine deaminase and guanosine deaminase activities in sera of patients with viral hepatitis.
Hepatitis
Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice.
Hepatitis
Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.
Hepatitis
Alanine aminotransferase deficiency in a hepatitis B surface antigen positive patient presenting with acute hepatitis.
Hepatitis
Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance.
Hepatitis
Amantadine therapy in renal transplant patients with hepatitis C virus infection.
Hepatitis
An antigen detected frequently in human sera with elevated levels of alanine aminotransferase: a potential marker for non-A, non-B hepatitis.
Hepatitis
An antigen/antibody system specific for an epidemic non-A, non-B hepatitis in patients of a cardiovascular surgical unit.
Hepatitis
Anti-hepatitis C virus (HCV) screening at a Canadian Red Cross center: significance of a positive c100 HCV enzyme-linked immunosorbent assay.
Hepatitis
Antibodies to core antigen of hepatitis B virus in patients on renal replacement therapy: association with demographic, clinical and laboratory data.
Hepatitis
Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis non-A, non-B in recipients.
Hepatitis
Antibodies to hepatitis C virus in prospectively followed patients with posttransfusion hepatitis.
Hepatitis
Antibodies to hepatitis E virus among several populations in Greece: increased prevalence in an hemodialysis unit.
Hepatitis
Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
Hepatitis
Antibodies to single stranded DNA: a diagnostic aid in chronic hepatitis B virus infections.
Hepatitis
Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients.
Hepatitis
Application of kushenin on patients with chronic hepatitis C after renal transplantation.
Hepatitis
Are laboratory parameter (biomarker) values similar to the healthy volunteer reference range in all patient populations?
Hepatitis
Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease.
Hepatitis
Association between liver copper concentration and subclinical hepatitis in Doberman Pinschers.
Hepatitis
Association between serum liver enzymes and all-cause mortality: The Japan Public Health Center-based Prospective Study.
Hepatitis
Association of elevated vitamin B12 with oncohematological diseases in a cohort of 79,524 patients from Latvia.
Hepatitis
Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients.
Hepatitis
Biomarkers of Inflammation and Coagulation Are Associated With Mortality and Hepatitis Flares in Persons Coinfected With HIV and Hepatitis Viruses.
Hepatitis
Blood-borne non-A, non-B hepatitis: lack of infectivity of feces from chimpanzees infected with a strain producing cytoplasmic tubular alterations.
Hepatitis
Case of autoimmune hepatitis with markedly enlarged hepatoduodenal ligament lymph nodes.
Hepatitis
CD49a promotes T-cell-mediated hepatitis by driving T helper 1 cytokine and interleukin-17 production.
Hepatitis
cDNA microarray analysis of autoimmune hepatitis, primary biliary cirrhosis and consecutive disease manifestation.
Hepatitis
Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study.
Hepatitis
Changing patterns of acute viral hepatitis at a major urban referral center in Egypt.
Hepatitis
Characteristics and prediction of hepatitis B e-antigen negative hepatitis following seroconversion in patients with chronic hepatitis B.
Hepatitis
Characteristics of hepatitis viruses among Egyptian children with acute hepatitis.
Hepatitis
Characterization of risk factors and efficacy of medical management of immune-related hepatotoxicity in real-world patients with metastatic melanoma treated with immune checkpoint inhibitors.
Hepatitis
Chronic hepatitis C in elderly patients: Clinical, histolocical and virolocical features.
Hepatitis
Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.
Hepatitis
Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years.
Hepatitis
Circulating intercellular adhesion molecule-1 in chronic liver disease and hepatocellular carcinoma.
Hepatitis
Circulating levels and liver tissue distribution of intercellular adhesion molecule-1 during beta-interferon therapy of hepatitis C virus-associated chronic active liver disease.
Hepatitis
Clearance of argininosuccinate synthetase from the circulation in acute liver disease.
Hepatitis
Clinical and biochemical characteristics of infants with prolonged neonatal jaundice.
Hepatitis
Clinical and histological features of cytomegalovirus hepatitis in previously healthy adults.
Hepatitis
Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin.
Hepatitis
Clinical characteristics and outcome of toxicity from Amanita mushroom poisoning.
Hepatitis
Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity.
Hepatitis
Clinical evaluation of four cases of acute viral hepatitis complicated by pure red cell aplasia.
Hepatitis
Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver diseases.
Hepatitis
Clinical expression of 'silent' hepatitis B virus infection in a patient with visceral leishmaniasis.
Hepatitis
Clinical features and molecular characterization of hepatitis A virus outbreak in a child care center in Thailand.
Hepatitis
Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States.
Hepatitis
Clinical manifestations and quantitative analysis of virus load in Taiwanese children with Epstein-Barr virus-associated infectious mononucleosis.
Hepatitis
Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence.
Hepatitis
Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
Hepatitis
Clinical significance of elevated alanine aminotransferase in blood donors: a follow-up study.
Hepatitis
Clinical usefulness and performance of acoustic radiation force impulse in patients with chronic hepatitis B.
Hepatitis
Clinicopathologic features and genotyping of patients with chronic HBV infection in the Upper Egypt.
Hepatitis
Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B.
Hepatitis
Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma--results of 152 resected cases.
Hepatitis
Community-acquired non-A, non-B hepatitis: clinical characteristics and chronicity.
Hepatitis
Comparable Ten-Year Outcome in Hemodialysis Patients with Hepatitis C Virus and Hepatitis B Virus Coinfection and Single Hepatitis B Virus Infection.
Hepatitis
Comparative study of C-Reactive Protein and other biochemical parameters in patients with hepatitis B and malaria in Calabar, Nigeria.
Hepatitis
Comparing the Clinical Features and Outcomes of Acute Hepatitis E Viral Infections with Those of Acute Hepatitis A, B, and C Infections in Korea.
Hepatitis
Correlation between electroencephalographic and biochemical indices in acute hepatic encephalopathy in rats.
Hepatitis
Correlation of hepatitis C RNA and serum alanine aminotransferase in hepatitis B and C seronegative healthy blood donors.
Hepatitis
Correlation of viral RNA, alanine aminotransferase, and histopathology in hepatitis C virus-associated hepatitis.
Hepatitis
Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment.
Hepatitis
Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study.
Hepatitis
Decrease in reported posttransfusion hepatitis. Contributions of donor screening for alanine aminotransferase and antibodies to hepatitis B core antigen and changes in the general population.
Hepatitis
Density analysis of hepatitis C virus particle population in the circulation of infected hosts: implications for virus neutralization or persistence.
Hepatitis
Detection and viral nucleotide sequence analysis of transfusion-transmitted virus infection in acute fulminant and non-fulminant hepatitis.
Hepatitis
Detection of 2',5' oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stage.
Hepatitis
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
Hepatitis
Detection of Genotype 4 Swine Hepatitis E Virus in Systemic Tissues in Cross-Species Infected Rabbits.
Hepatitis
Detection of HBV core promoter and precore mutations helps distinguish flares of chronic hepatitis from acute hepatitis B.
Hepatitis
Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase.
Hepatitis
Determination of alanine aminotransferase in blood donor screening--evidence of its usefulness in the prevention of post-transfusion hepatitis.
Hepatitis
Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.
Hepatitis
Development of a primary tamarin hepatocyte culture system for GB virus-B: a surrogate model for hepatitis C virus.
Hepatitis
Development of hepatotoxicity in HIV patients switching at least one protease inhibitor.
Hepatitis
Developmental consequences of children born from mothers with telbivudine treatment during late pregnancy: A prospective study with 3-year follow-up.
Hepatitis
Dietary choline and folate relationships with serum hepatic inflammatory injury markers in Taiwanese adults.
Hepatitis
Differential effects of dietary casein and soybean protein isolate on lipopolysaccharide-induced hepatitis in D-galactosamine-sensitized rats.
Hepatitis
Diffuse pattern of transient hepatic attenuation differences in viral hepatitis: a sign of acute hepatic injury in patients without cirrhosis.
Hepatitis
Dipterocarpus tuberculatus Roxb. Ethanol Extract Has Anti-Inflammatory and Hepatoprotective Effects In Vitro and In Vivo by Targeting the IRAK1/AP-1 Pathway.
Hepatitis
Dissociation of alanine aminotransferase values in acute hepatitis A patients with and without past experience to the hepatitis B virus.
Hepatitis
Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients.
Hepatitis
Do serum ALAT values reflect the inflammatory activity in the liver of patients with chronic viral hepatitis?
Hepatitis
Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?
Hepatitis
Dolutegravir with tenofovir disoproxil fumarate - emtricitabine as HIV post-exposure prophylaxis in gay and bisexual men.
Hepatitis
Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes.
Hepatitis
Donor serum alanine aminotransferase activity and the risk of transfusion-associated hepatitis.
Hepatitis
Double-blind, placebo-controlled pilot trial of anthocyanin-rich purple sweet potato beverage on serum hepatic biomarker levels in healthy Caucasians with borderline hepatitis.
Hepatitis
Drug-induced hepatitis following use of octreotide for long-term treatment of congenital hyperinsulinism.
Hepatitis
Dynamic relationship between infantile hepatitis syndrome and cytomegalovirus infection.
Hepatitis
Early appearance and biphasic kinetics of IgG antibody against hepatitis C virus protein C100-3.
Hepatitis
Early Onset Immune-Related Adverse Event to Identify Pseudo-Progression in a Patient With Ovarian Cancer Treated With Nivolumab: A Case Report and Review of the Literature.
Hepatitis
Early syphilitic hepatitis concomitant with nephrotic syndrome followed by acute kidney injury.
Hepatitis
Effect of amodiaquine, a histamine N-methyltransferase inhibitor, on, Propionibacterium acnes and lipopolysaccharide-induced hepatitis in mice.
Hepatitis
Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis.
Hepatitis
Effect of the nitric oxide donor and the nitric oxide synthase inhibitor on the liver of rats with chronic hepatitis induced by dimethylnitrosamine.
Hepatitis
Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma.
Hepatitis
Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(-) donors.
Hepatitis
Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients.
Hepatitis
Efficacy of a selective histamine H2 receptor agonist, dimaprit, in experimental models of endotoxin shock and hepatitis in mice.
Hepatitis
Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B.
Hepatitis
Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis.
Hepatitis
Eight new glycosides with hepatoprotective activity isolated from the aerial parts of Morinda parvifolia.
Hepatitis
Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia.
Hepatitis
Elevated alanine aminotransferase levels in HIV-infected persons without hepatitis B or C virus coinfection.
Hepatitis
Elevated Alt and Ast in an Asymptomatic Person: What the primary care doctor should do?
Hepatitis
Elevated perioperative transaminase level predicts intrahepatic recurrence in hepatitis B-related hepatocellular carcinoma after curative hepatectomy.
Hepatitis
Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States.
Hepatitis
Elevated serum transaminase values during therapy for acute lymphoblastic leukemia correlate with prior blood transfusions.
Hepatitis
Emodin protects against concanavalin A-induced hepatitis in mice through inhibiting activation of the p38 MAPK-NF-?B signaling pathway.
Hepatitis
Endoscopic sonographic evaluation of the thickened gallbladder wall in patients with acute hepatitis.
Hepatitis
Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis.
Hepatitis
Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
Hepatitis
Epidemiological and virological characteristics of symptomatic acute hepatitis E in Greater Cairo, Egypt.
Hepatitis
Epidemiological, clinical and laboratory characteristics of acute Q fever in an endemic area in Israel, 2006-2016.
Hepatitis
Epidemiology and outcomes of marked elevations of alanine aminotransferase >1000 IU/L in an Australian cohort.
Hepatitis
Erlotinib-induced hepatitis complicated by fatal lactic acidosis in an elderly man with lung cancer.
Hepatitis
Evaluation of hepatocyte-derived microRNA-122 for diagnosis of acute and chronic hepatitis of dogs.
Hepatitis
Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis.
Hepatitis
Exacerbation of acetaminophen hepatotoxicity by thalidomide and protection by nicotinic acid amide.
Hepatitis
Excessive accumulation of hepatic copper in LEC rats aged 80 days without hepatitis and 130 days with hepatitis.
Hepatitis
Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease.
Hepatitis
Expression of infectious viral particles by primary chimpanzee hepatocytes isolated during the acute phase of non-A, non-B hepatitis.
Hepatitis
Expression of oxidative stress-related molecules in circulating leukocytes and urine in patients with chronic viral hepatitis.
Hepatitis
Factors predictive of liver cirrhosis in patients with chronic hepatitis B: a multivariate analysis in a longitudinal study.
Hepatitis
Fermented Castanea crenata Inner Shell Extract Increases Fat Metabolism and Decreases Obesity in High-Fat Diet-Induced Obese Mice.
Hepatitis
Follow-up of mild alanine aminotransferase elevation identifies hidden hepatitis C in primary care.
Hepatitis
Frequency and characteristics of post-transfusion hepatitis in Greece with emphasis on hepatitis C: comparing second- and third-generation assays.
Hepatitis
Frequent detection of hepatitis A viral RNA in serum during the early convalescent phase of acute hepatitis A.
Hepatitis
G Protein-Coupled Receptor 39 Agonist Improves Concanavalin A-Induced Hepatitis in Mice.
Hepatitis
Gamma-glutamyltransferase as a potential surrogate marker for detection of the non-A, non-B carrier state.
Hepatitis
Gender Impacts on the Disease Severity of Overt Acute Hepatitis A: Different from Overt Acute Hepatitis B.
Hepatitis
Gene expressions of c-met and hepatocyte growth factor in chronic liver disease and hepatocellular carcinoma.
Hepatitis
Generalized likelihood ratio concept and logistic regression analysis for multiple diagnostic categories.
Hepatitis
Genetic and physicochemical analyses of a novel ferret hepatitis E virus, and clinical signs of infection after birth.
Hepatitis
Genetic polymorphisms of regulatory T cell-related genes modulate systemic inflammation induced by viral hepatitis.
Hepatitis
Ghrelin reduces liver impairment in a model of concanavalin A-induced acute hepatitis in mice.
Hepatitis
Glycogen Hepatopathy: A Reversible yet Relapsing Cause of Hepatitis in Type 1 Diabetics.
Hepatitis
Glycyrrhizin alleviates Con A-induced hepatitis by differentially regulating the production of IL-17 and IL-25.
Hepatitis
Graphical analysis of laboratory data in the differential diagnosis of cholestasis: a computer-assisted prospective study.
Hepatitis
HCFC-123-induced toxic hepatitis and death at a Korean fire extinguisher manufacturing facility: a case series.
Hepatitis
Hepatic changes in adenine nucleotide levels and adenosine 3'-monophosphate forming enzyme in streptozotocin-induced diabetic mice.
Hepatitis
Hepatitis activity should be considered a confounder of liver stiffness measured with MR elastography.
Hepatitis
Hepatitis B Evaluation and Linkage to Care for Newly Arrived Refugees: A Multisite Quality Improvement Initiative.
Hepatitis
Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.
Hepatitis
Hepatitis B virus in the State of Alagoas, Brazil: genotypes characterization and mutations of the precore and basal core promoter regions.
Hepatitis
Hepatitis B Virus Infection in Pregnancy: An Update on Evidence-Based Management.
Hepatitis
Hepatitis B Virus Infection in Pregnancy: Immunological Response, Natural Course and Pregnancy Outcomes.
Hepatitis
Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival.
Hepatitis
Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition.
Hepatitis
Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report.
Hepatitis
Hepatitis B-like infection in a Pacific white-sided dolphin (Lagenorhynchus obliquidens).
Hepatitis
Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients.
Hepatitis
Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C.
Hepatitis
Hepatitis C virus infection in health care workers referred to a hepatitis clinic.
Hepatitis
Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study.
Hepatitis
Hepatitis C virus transfusion-transmitted infection in Brazilian cardiac surgery patients.
Hepatitis
Hepatitis C virus: prevalence and routes of infection among blood donors of West Mexico.
Hepatitis
Hepatitis Flare During Immunotherapy in Patients With Current or Past Hepatitis B Virus Infection.
Hepatitis
Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy.
Hepatitis
Hepatitis Flares Are Associated With Better Outcomes Than No Flare in Patients With Decompensated Cirrhosis and Chronic Hepatitis B Virus Infection.
Hepatitis
Hepatitis G virus infection in a high-risk subgroup of hospitalized dental patients.
Hepatitis
Hepatitis in patients receiving intraarterial chemotherapy for metastatic colorectal carcinoma.
Hepatitis
Hepatitis temporally associated with an herbal supplement containing artemisinin - Washington, 2008.
Hepatitis
Hepatocyte dysfunction and hepatic encephalopathy in Plasmodium falciparum malaria.
Hepatitis
Hepatoprotective activity of Tridax procumbens against d-galactosamine/lipopolysaccharide-induced hepatitis in rats.
Hepatitis
Hepatoprotective properties of Crepis rueppellii and Anisotes trisulcus: two traditional medicinal plants of Yemen.
Hepatitis
Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection.
Hepatitis
Hepatotoxicity during Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living with HIV with Severe Immunosuppression: a Secondary Analysis of a Multi-country Open-label Randomized Controlled Clinical Trial.
Hepatitis
High aspartate to alanine aminotransferase ratio is an indicator of cirrhosis and poor outcome in patients with primary sclerosing cholangitis.
Hepatitis
High levels of immunoglobulin A anti-tissue transglutaminase antibodies at diagnosis are a predictive factor for celiac hepatitis.
Hepatitis
High prevalence, low pathogenicity of hepatitis G virus in kidney transplant recipients.
Hepatitis
Higher levels of alanine aminotransferase within the reference range predict unhealthy metabolic phenotypes of obesity in normoglycemic first-degree relatives of patients with type 2 diabetes mellitus.
Hepatitis
Histological improvement of chronic hepatitis B, and non-A, non-B with interferon treatment: application of a numerical scoring system for evaluating sequential morphologic changes.
Hepatitis
Histopathologic and biochemical liver test abnormalities in chronic asymptomatic or oligosymptomatic alcoholics: a review.
Hepatitis
Histopathological features of liver and its relation to serum transaminase levels in 91 cases of anti-HBe-positive chronic hepatitis B.
Hepatitis
Immunologic status of hemophilia patients treated with cryoprecipitate or lyophilized concentrate.
Hepatitis
Immunological changes in different patient populations with chronic hepatitis C virus infection.
Hepatitis
Impact of different sofosbuvir based treatment regimens on the biochemical profile of chronic hepatitis C genotype 4 patients.
Hepatitis
Impact of MELD score and cardiopulmonary bypass duration on post-operative hypoxic hepatitis in patients with liver cirrhosis undergoing open heart surgery.
Hepatitis
Impaired function of dendritic cells circulating in patients infected with hepatitis C virus who have persistently normal alanine aminotransferase levels.
Hepatitis
In subjects with antibody to hepatitis C virus a high serum level of interleukin-2 soluble receptor suggests activity of liver disease.
Hepatitis
Inactivation of hepatitis B and non-A, non-B viruses by combined use of Tween 80, beta-propiolactone, and ultraviolet irradiation.
Hepatitis
Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt.
Hepatitis
Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
Hepatitis
Increased AST and GGT activity as marker of RT-PCR inhibition in RNA extracts from peripheral blood.
Hepatitis
Increased hepatic expression is a major determinant of serum alanine aminotransferase elevation in mice with nonalcoholic steatohepatitis.
Hepatitis
Increased serum levels of macrophage inflammatory protein-3alpha in chronic viral hepatitis: prognostic importance of macrophage inflammatory protein-3alpha during interferon therapy in chronic hepatitis C.
Hepatitis
Indoleamine-2,3-dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B.
Hepatitis
Inducible nitric oxide synthase (iNOS) expression in liver and splenic T lymphocyte rise are associated with liver histological damage during experimental hepatitis A virus (HAV) infection in Callithrix jacchus.
Hepatitis
Infectious disease testing for blood transfusions. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions.
Hepatitis
Intake of purple sweet potato beverage affects on serum hepatic biomarker levels of healthy adult men with borderline hepatitis.
Hepatitis
Interferon treatment in patients with chronic hepatitis C with normal alanine-aminotransferase activity.
Hepatitis
Interferon-alpha treatment of children with chronic hepatitis D virus infection: the Greek experience.
Hepatitis
Is the response to recombinant alpha interferon related to the presence of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis?
Hepatitis
Lactoferrin dampens high-fructose corn syrup-induced hepatic manifestations of the metabolic syndrome in a murine model.
Hepatitis
Lactoferrin protects against development of hepatitis caused by sensitization of Kupffer cells by lipopolysaccharide.
Hepatitis
Large dosage of chishao in formulae for cholestatic hepatitis: a systematic review and meta-analysis.
Hepatitis
Large dose means significant effect--dose and effect relationship of Chi-Dan-Tui-Huang decoction on alpha-naphthylisothiocyanate-induced cholestatic hepatitis in rats.
Hepatitis
Less Severe but Prolonged Course of Acute Hepatitis A in HIV-positive Patients than HIV-negative Patients During an Outbreak: A Multicenter Observational Study.
Hepatitis
Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes.
Hepatitis
Liver Enzymes Abnormalities among Highly Active Antiretroviral Therapy Experienced and HAART Naïve HIV-1 Infected Patients at Debre Tabor Hospital, North West Ethiopia: A Comparative Cross-Sectional Study.
Hepatitis
Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review.
Hepatitis
Liver resections performed under prolonged portal triad occlusion in patients with active chronic liver diseases.
Hepatitis
Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma.
Hepatitis
Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.
Hepatitis
Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety.
Hepatitis
Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross-disease cohort study.
Hepatitis
Low serum level of hepatitis B core-related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapy.
Hepatitis
Lower Levels of Transaminases but Higher Levels of Serum Creatinine in Patients with Acute Hepatitis E in Comparison to Patients with Hepatitis A.
Hepatitis
Mass spectrometry-based plasma peptide profiling of acute exacerbation in HBeAg-positive chronic hepatitis B.
Hepatitis
Measurement of alanine aminotransferase (ALT) levels in Zimbabwean donor serum--a possible indicator of non-A, non-B hepatitis.
Hepatitis
Metformin Modulates T Cell Function and Alleviates Liver Injury Through Bioenergetic Regulation in Viral Hepatitis.
Hepatitis
Modifications in the serum concentrations of prolyl hydroxylase in patients with chronic hepatitis B during and after interferon therapy.
Hepatitis
Molecular detection of transfusion transmitted virus coinfection with some hepatotropic viruses.
Hepatitis
Monophasic and polyphasic pattern of alanine aminotransferase in acute non-A, non-B hepatitis. Clinical and prognostic implications.
Hepatitis
Multivariate analysis of an enzymic profile for the differential diagnosis of viral hepatitis.
Hepatitis
NFkappaB decoy delivery using dendritic poly(l-lysine) for treatment of endotoxin-induced hepatitis in mice.
Hepatitis
Non-A, non-B hepatitis in chimpanzees: interference with acute hepatitis A virus and chronic hepatitis B virus infections.
Hepatitis
Non-B hepatitis in Japanese recipients of blood transfusions: clinical and serologic studies after the introduction of laboratory screening of donor blood for hepatitis B surface antigen.
Hepatitis
Non-response to Previous Interferon Therapy and Cirrhosis Are Risk Factors for Predicting Breakthrough during Lamivudine Therapy in Patients with Chronic Hepatitis B.
Hepatitis
Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B.
Hepatitis
Nuclear HBcAg and histology activity index as independent predictors of the expression of singly spliced HBV-RNA.
Hepatitis
Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus.
Hepatitis
Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study.
Hepatitis
Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation.
Hepatitis
Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population.
Hepatitis
Persistently normal alanine transaminase levels in chronic C hepatitis: what does it tell us?
Hepatitis
Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases.
Hepatitis
Plasma isocitrate dehydrogenase as a marker of centrilobular hepatic necrosis in patients with hyperthyroidism.
Hepatitis
Plasma kallikrein clearance by the liver of chronic carbon tetrachloride-treated rats.
Hepatitis
Plasmatic vitamin C in nontreated hepatitis C patients is negatively associated with aspartate aminotransferase.
Hepatitis
Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan.
Hepatitis
Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
Hepatitis
Post transfusion hepatitis: comparison between homologous and autologous blood transfusion.
Hepatitis
Post-transfusion hepatitis after open-heart surgery in Finland--a prospective study.
Hepatitis
Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood.
Hepatitis
Post-transfusion non-A, non-B hepatitis: significance of raised ALT and anti-HBc in blood donors.
Hepatitis
Preablation neutrophil-to-lymphocyte ratio as an independent prognostic factor in locally advanced hepatocellular carcinoma patients following radiofrequency ablation.
Hepatitis
Predicting Liver Fibrosis in the Hepatitis C Population: Concordance Analysis Between Noninvasive Scoring Systems and Percutaneous Liver Biopsy.
Hepatitis
Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group.
Hepatitis
Prevalence and heterogeneity of serum DNA polymerase activity in patients with non-A, non-B hepatitis and HBsAg-negative blood donors with elevated SGPT.
Hepatitis
Prevalence and Prognostic Value of Abnormal Liver Test Results in Critically Ill Children and the Impact of Delaying Parenteral Nutrition.
Hepatitis
Prevalence of hepatitis B virus (HBV) markers and human immunodeficiency virus (HIV) in employees of a blood transfusion centre.
Hepatitis
Prevalence of hepatitis C infection in a large urban hospital-based sample of individuals with spinal cord injury.
Hepatitis
Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Hepatitis
Prevalence of Overlap of Primary Biliary Cirrhosis-Autoimmnune Hepatitis Overlap Syndrome.
Hepatitis
Prevalence of serum antibodies against lymphocytic choriomeningitis virus in selected populations from two U.S. cities.
Hepatitis
Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice.
Hepatitis
Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection.
Hepatitis
Prolonged treatment with interferon in patients with histologically mild chronic hepatitis C: a decision analysis.
Hepatitis
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.
Hepatitis
Prophylactic Use of Entecavir for Lymphoma Patients With Past Hepatitis B Virus Infection: A Randomized Controlled Trial.
Hepatitis
Protective effects of soyasapogenol A on liver injury mediated by immune response in a concanavalin A-induced hepatitis model.
Hepatitis
Protective Mechanism Of Lignans From Phyllanthus Amarus Against Galactosamine/ Lipopolysaccharide-Induced Hepatitis: An In-Vivo And In-Silico Studies.
Hepatitis
Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C.
Hepatitis
Redefining the alanine aminotransferase upper limit of normal improves the prediction of metabolic syndrome risk.
Hepatitis
Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis.
Hepatitis
Reducing the incidence of non-A, non-B post-transfusion hepatitis by testing donor blood for alanine aminotransferase: economic considerations.
Hepatitis
Relation between donor transaminase and recipient hepatitis non-A, non-B in Sweden.
Hepatitis
Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies.
Hepatitis
Relations between oxidative stress, hepatocyte growth factor, and liver disease in hemodialysis patients.
Hepatitis
Relationship between fatty liver, alanine aminotransferase, HBsAg and hepatitis C virus.
Hepatitis
Relationship between the serum alanine aminotransferase level at the end of interferon treatment and histologic changes in wild-type and precore mutant hepatitis B virus infections.
Hepatitis
Replication of hepatitis B virus with corticosteroid therapy in hepatitis B virus related membranous nephropathy.
Hepatitis
Rescue of in vivo FAS-induced apoptosis of hepatocytes by corticosteroids either associated with alcohol consumption by mice or provided exogenously.
Hepatitis
Response to interferon alpha therapy is influenced by the iron content of the liver.
Hepatitis
Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance.
Hepatitis
Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C.
Hepatitis
Risk Assessment of Hepatocellular Carcinoma in General Population by Liver Stiffness in Combination with Controlled Attenuation Parameter using Transient Elastography: A Cross Sectional Study.
Hepatitis
Risk factors associated with hepatitis B or C markers or elevated alanine aminotransferase level among blood donors on a tropical island: the Guadeloupe experience.
Hepatitis
Risk factors for hepatitis C virus infection among blood donors in Beijing and implications for improving the pretesting donor screening process.
Hepatitis
Roles of the genetic polymorphisms of alcohol-metabolizing enzymes on the immunology in high-risk drinkers.
Hepatitis
Rosuvastatin Use Implicated in the Drug Reaction with Eosinophilia and Systemic Symptoms.
Hepatitis
Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a case-control study.
Hepatitis
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.
Hepatitis
Safety of Monitoring Viral and Liver Function Markers in Patients With Prior Resolved Hepatitis B Infection After Kidney Transplantation.
Hepatitis
Salmonella hepatitis: analysis of 27 cases and comparison with acute viral hepatitis.
Hepatitis
Selective CB1 cannabinoid receptor antagonist, SR141716A, attenuates liver injury induced by Concanavalin A.
Hepatitis
Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection.
Hepatitis
Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study.
Hepatitis
Serologic and virologic profiles of hepatitis C infection in renal transplant candidates. New England Organ Bank Hepatitis C Study Group.
Hepatitis
Seroprevalence of hepatitis delta virus infection among subjects with underlying hepatic diseases in Chennai, southern India.
Hepatitis
Seroprevalence of hepatitis E virus immunoglobulin G and M antibodies in adults: a hospital-based study.
Hepatitis
Serum alanine aminotransferase (ALT) assay and incidence of posttransfusion non-A,non-B hepatitis.
Hepatitis
Serum alanine aminotransferase level alone may not accurately represent necro-inflammation in patients with acute hepatitis.
Hepatitis
Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study.
Hepatitis
Serum bile acids and alanine aminotransferase concentrations. Comparison of efficacy as indirect means of identifying carriers of non-A, non-B hepatitis agents and of onset, severity, and duration of posttransfusion non-A, non-B hepatitis in recipients.
Hepatitis
Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men.
Hepatitis
Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.
Hepatitis
Serum glycoproteins in the liver diseases. V. Desialylated glycoproteins in chronic hepatitis.
Hepatitis
Serum hepatitis B surface antigen levels help predict disease progression in patients with low HBV loads.
Hepatitis
Serum hepatocyte growth factor is associated with viral hepatitis, cardiovascular disease, erythropoietin treatment, and type of heparin in haemodialysis patients.
Hepatitis
Serum Immunoglobulin G Levels Predict Biochemical and Histological Remission of Autoimmune Hepatitis Type 1: A Single-Center Experience and Literature Review.
Hepatitis
Serum levels of alpha-interferon and gamma-interferon in patients with acute and chronic viral hepatitis.
Hepatitis
Serum levels of soluble Tac peptide in acute and chronic hepatitis B virus infection.
Hepatitis
Severe de novo Hepatitis B Recovered from Late-Onset Liver Insufficiency with Prolonged Ascites and Hypoalbuminemia due to Hepatitis B Virus Genotype Bj with Precore Mutation.
Hepatitis
Severe hepatitis arising from ipilimumab administration, following melanoma treatment with nivolumab.
Hepatitis
Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey.
Hepatitis
Should donor blood be screened for elevated alanine aminotransferase levels? A cost-effectiveness analysis.
Hepatitis
Significance of alanine aminotransferase testing in diagnosis of acute and chronic HBV infection.
Hepatitis
Significance of viral load, core promoter/precore mutations and specific sequences of polymerase gene in HBV-infected patients on 3-year lamivudine treatment.
Hepatitis
Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore.
Hepatitis
Simultaneous acute hepatitis B virus and hepatitis C virus infection leading to fulminant hepatitis and subsequent chronic hepatitis C.
Hepatitis
Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.
Hepatitis
Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients.
Hepatitis
Stem cells from human exfoliated deciduous teeth ameliorate concanavalin A-induced autoimmune hepatitis by protecting hepatocytes from apoptosis.
Hepatitis
Strategies for detection of transfusion-transmitted viruses eluding identification by conventional serologic tests. II. Detection of host DNA in human plasmas with elevated alanine aminotransferase.
Hepatitis
Studies on 5-lipoxygenase inhibitors. I. Synthesis and 5-lipoxygenase-inhibitory activity of novel hydroxamic acid derivatives.
Hepatitis
Studies on the active principles of Schisandra sphenanthera Rehd. et Wils. The structures of schisantherin A, B, C, D, E, and the related compounds.
Hepatitis
Study on Evaluation of Alanine Aminotransferase (ALT) as Surrogate Marker in Hepatitis Virus Test.
Hepatitis
Studying the association of microRNA-210 level with chronic hepatitis B progression.
Hepatitis
Surrogate testing for non-A, non-B hepatitis in Queensland, Australia: an ALT microtitre tray method for screening blood donors.
Hepatitis
Swine hepatitis E virus in rural southern China: genetic characterization and experimental infection in rhesus monkeys (Macaca mulatta).
Hepatitis
Synthesis and biological evaluation of (1,2,4)triazole[4,3-a]pyridine derivatives as potential therapeutic agents for concanavalin A-induced hepatitis.
Hepatitis
T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?
Hepatitis
Telbivudine treatment of hepatitis B virus-infected pregnant women at different gestational stages for the prevention of mother-to-child transmission: Outcomes of telbivudine treatment during pregnancy.
Hepatitis
The clinical chemistry of chimpanzees: II. Gamma glutamyl transferase levels in hepatitis studies.
Hepatitis
The clinical features and outcomes of acute liver failure associated with dengue infection in adults: a case series.
Hepatitis
The correlations of surrogate markers with anti-hepatitis C virus and other disease markers.
Hepatitis
The E3 ubiquitin ligase MuRF2 attenuates LPS-induced macrophage activation by inhibiting production of inflammatory cytokines and migration.
Hepatitis
The frequency of blood-born viral infections in a population of multitransfused Brazilian patients.
Hepatitis
The Impact of Hypoxic Hepatitis on Clinical Outcomes after Extracorporeal Cardiopulmonary Resuscitation.
Hepatitis
The impact of screening a heterogeneous donor population for alanine aminotransferase and hepatitis B core antibody. Experience at a large southern California hospital.
Hepatitis
The incidence of GB virus C / hepatitis G virus infection in Brazilian patients who received blood transfusion during cardiac surgery.
Hepatitis
The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
Hepatitis
The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.
Hepatitis
The lack of transmission of NANB/C hepatitis between acute and chronically infected patients and their heterosexual partners.
Hepatitis
The mushroom Agaricus blazei Murill extract normalizes liver function in patients with chronic hepatitis B.
Hepatitis
The persistence and significance of elevated alanine aminotransferase levels in blood donors.
Hepatitis
The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection.
Hepatitis
The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus-positive hemophilic men undergoing HCV "seroreversion".
Hepatitis
The relationship between urinary genistein levels and serum alanine aminotransferase levels in adults in the USA: National Health and Nutrition Examination Survey 1999-2010.
Hepatitis
Treatment of acetaminophen-induced hepatitis and fulminant hepatic failure with extracorporeal sorbent-based devices.
Hepatitis
Treatment of chronic hepatitis B and C with alpha interferon in a renal transplant patient.
Hepatitis
Treatment rate and factors related to interferon-based treatment initiation for chronic hepatitis C in South Korea.
Hepatitis
Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States.
Hepatitis
UNC93B1 mediates innate inflammation and antiviral defense in the liver during acute murine cytomegalovirus infection.
Hepatitis
Unusually high alanine aminotransferase to aspartate aminotransferase ratio in a patient with cyproterone-induced icteric hepatitis.
Hepatitis
Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review.
Hepatitis
Use of a table-top analyzer for predonation screening for alanine aminotransferase--a cost-effective approach?
Hepatitis
Use of the hemagglutinating virus of Japan (HVJ)-liposome method for analysis of infiltrating lymphocytes induced by hepatitis B virus gene expression in liver tissue.
Hepatitis
Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
Hepatitis
Vigna nakashimae extract prevents hepatic steatosis in obese mice fed high-fat diets.
Hepatitis
Viral hepatitis: enzyme assays and serologic procedures in the study of an epidemic.
Hepatitis
Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels.
Hepatitis
What technique should be used for routine detection and quantification of HBV DNA in clinical samples?
Hepatitis
Y-40138, a multiple cytokine production modulator, protects against D-galactosamine and lipopolysaccharide-induced hepatitis.
Hepatitis
[Activity of alanine aminotransferase in women of child-bearing age, ill with viral hepatitis]
Hepatitis
[Activity of the marker liver enzymes under the conditions of toxic hepatitis and alimentary deprivation of protein].
Hepatitis
[An analysis of the clinical characteristics of patients with chronic hepatitis B superinfected with acute hepatitis E]
Hepatitis
[An epidemiological study on hepatitis C among the plasmapheretic donors in two villages with a 5-year history of plasma donation]
Hepatitis
[Anti-HCV in patients without risk factors for hepatitis C. Prospective study in 200 patients]
Hepatitis
[AspAT and AlAT aminotransferase activity following virus hepatitis and chronic hepatitis in outpatient practice]
Hepatitis
[Change of hepatitis B surface antigen in serum from patients with chronic hepatitis B]
Hepatitis
[Chronic HCV hepatitis with normal level of alanine transaminase: interferon therapy of active observation?]
Hepatitis
[Clinical significance of serum levels of human hepatocyte growth factor in patients with acute viral hepatitis]
Hepatitis
[Combined therapy with recombinant alfa-2 and gamma interferons in patients with chronic hepatitis delta virus infection]
Hepatitis
[Comparison on efficacy in treating liver fibrosis of chronic hepatitis B between Astragalus Polygonum anti-fibrosis decoction and jinshuibao capsule]
Hepatitis
[Evaluation of a quantitative HBV-DNA PCR assay in lamivudine treated hepatitis B-infected patients]
Hepatitis
[Experimental models of hepatitis A in macaques using viral strains isolated from man and monkeys]
Hepatitis
[Gene mutation pattern of Gilbert's syndrome combined with viral hepatitis and its relationship with the exploration of clinical data].
Hepatitis
[Immunological indices of viral hepatitis patients and the prognosis for the time periods of aspartate and alanine transaminase normalization]
Hepatitis
[Incidence and risk factors for hepatitis A in the province of Guadalajara (Spain)]
Hepatitis
[Occurrence of non-A, non-B post-transfusion hepatitis in heart surgery. Prospective study on the value of the determination of serum alanine aminotransferase and detection of anti-HBc antibodies in blood donors]
Hepatitis
[On the atypical behavior of serum glutamate-pyruvate transaminase in the acute stage of viral hepatitis]
Hepatitis
[Optimal spectrophotometric methods for the determination of serum glutamic-oxalacetic and glutamic-pyruvic transaminase activity in the diagnosis of icetrigenous hepatitis]
Hepatitis
[Oxyphenisatin, a laxative responsible for chronic hepatitis and cirrhosis, still marketed in France (author's transl)]
Hepatitis
[Preliminary results of interferon alpha-2a and lamivudine combination therapy regimen in children with chronic hepatitis B]
Hepatitis
[Prevalence of hepatitis A, B, C and E virus markers among patients with elevated levels of Alanine aminotransferase and Aspartate aminotransferase in Phnom Penh (Cambodia) and Nha Trang (Central Vietnam)]
Hepatitis
[Prevalence of high ALAT and serologic markers of hepatitis B virus in blood donors incriminated in non-A, non-B posttransfusion hepatitis]
Hepatitis
[Prognostic value of monoamine oxidase (MAO) in the serum in correlation to the activity of AspAt and AlAt in viral hepatitis]
Hepatitis
[Role of ALAT level in preventing post-transfusional hepatitis. Prospective study of 1,180 blood donors in Tunisia]
Hepatitis
[Role of the hemobiologist in the detection and prevention of post-transfusional hepatitis]
Hepatitis
[SERUM GLUTAMIC-PYRUVIC TRANSAMINASE AS A FUNCTIONAL TEST IN EPIDEMIC HEPATITIS.]
Hepatitis
[Serum levels of B7-H3 and IFN-? in patients with hepatitis B and clinical implications].
Hepatitis
[Serum type IV collagen and laminin in patients with chronic hepatitis and its clinical significance]
Hepatitis
[Significance of alanine aminotransferase and reduction of post-transfusion non-A, non-B hepatitis]
Hepatitis
[Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
Hepatitis
[The bile cholate-cholesterol coefficient for assessing the causes of a protracted convalescence in patients with viral hepatitis]
Hepatitis
[The combined treatment with prednisolone and recombinant alpha 2-interferon of patients with chronic hepatitis B: the factors influencing the immune response]
Hepatitis
[The determination of alpha fetoprotein using radioimmunologic and immunoenzyme methods of analysis and its relation to the level of alanine aminotransferase in children with viral hepatitis]
Hepatitis
[The relationships of pyridoxal phosphate to the activity of pyruvate-glutamate transaminase (GPT). 1. Results in epidemic hepatitis.]
Hepatitis
[The sensitivity of rhesus and cynomolgus macaques to the human hepatitis A virus]
Hepatitis
[Value of serum determination of glutamic-pyruvic transaminase in viral hepatitis.]
Hepatitis A
A comparative study of hepatitis caused by scrub typhus and viral hepatitis A in South Korea.
Hepatitis A
A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.
Hepatitis A
A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children.
Hepatitis A
Atypical clinical manifestations of hepatitis a among children aged 1-16 years in South-Eastern Region of Turkey.
Hepatitis A
Blood levels of leukotrienes (LTC4, D4, E4, B4) and synthesis of leukotriene B4 by peripheral leukocytes in children with acute A and B hepatitis.
Hepatitis A
Can ultrasonographic findings of perihepatic lymphadenopathy promote investigations to detect possible presence of virus C infection in non-symptomatic subjects?
Hepatitis A
Case report: hepatitis in a child infected with SARS-CoV-2 presenting toll-like receptor 7 Gln11Leu single nucleotide polymorphism.
Hepatitis A
Chronic hepatitis B, nonalcoholic steatohepatitis and physical fitness of military males: CHIEF study.
Hepatitis A
Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine.
Hepatitis A
Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
Hepatitis A
Clinical, epidemiological and prognostic aspects of hepatitis "non-A, non-B"--a comparison with hepatitis A and B.
Hepatitis A
Community-acquired non-A, non-B hepatitis: clinical characteristics and chronicity.
Hepatitis A
Detection of 2',5' oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stage.
Hepatitis A
Dissociation of alanine aminotransferase values in acute hepatitis A patients with and without past experience to the hepatitis B virus.
Hepatitis A
Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial.
Hepatitis A
Frequent detection of hepatitis A viral RNA in serum during the early convalescent phase of acute hepatitis A.
Hepatitis A
Fulminant hepatic failure and paracetamol overuse with therapeutic intent in febrile children.
Hepatitis A
High and persistent excretion of hepatitis A virus in immunocompetent patients.
Hepatitis A
Iminosugar glucosidase inhibitors reduce hepatic inflammation in HAV-infected Ifnar1-/- mice.
Hepatitis A
Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell cultures.
Hepatitis A
Protracted alanine aminotransferase levels in tamarins infected with hepatitis A virus.
Hepatitis A
Serum alanine aminotransferase levels and prevalence of hepatitis A, B, and delta in outpatients.
Hepatitis A
Short report: elevated levels of alanine aminotransferase and hepatitis A in the context of a pediatric malaria vaccine trial in a village in Mali.
Hepatitis A
Sustained alanine aminotransferase increase during hepatitis A due to concomitant lymphogranuloma venereum infection in an HIV-1 positive patient.
Hepatitis A
The development of hepatitis C antibody shortly after acute icteric non-A non-B hepatitis.
Hepatitis A
TT viral infection through blood transfusion: retrospective investigation on patients in a prospective study of post-transfusion hepatitis.
Hepatitis A
Viral safety of a pasteurized, monoclonal antibody-purified factor VIII concentrate in previously untreated haemophilia A patients.
Hepatitis A
Virological course of hepatitis A virus as determined by real time RT-PCR: Correlation with biochemical, immunological and genotypic profiles.
Hepatitis A
[Combined therapy with recombinant alfa-2 and gamma interferons in patients with chronic hepatitis delta virus infection]
Hepatitis A
[Current concepts of the role of the thymol test in the laboratory diagnosis of viral hepatitis A]
Hepatitis A
[Experimental model of hepatitis A in rhesus monkeys (Macaca mulatta) infected with human hepatitis A virus]
Hepatitis A
[Prevalence of hepatitis A, B, C and E virus markers among patients with elevated levels of Alanine aminotransferase and Aspartate aminotransferase in Phnom Penh (Cambodia) and Nha Trang (Central Vietnam)]
Hepatitis A
[Significance of alanine aminotransferase and reduction of post-transfusion non-A, non-B hepatitis]
Hepatitis A
[The blood level of cobalamin as an indicator of the functional status of the liver in jaundice of different etiologies]
Hepatitis A
[The diagnostic value of determining serum fructose-1-phosphate aldolase and alanine aminotransferase activity in patients with infectious hepatitis in the foci]
Hepatitis A
[The sensitivity of rhesus and cynomolgus macaques to the human hepatitis A virus]
Hepatitis B
3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China.
Hepatitis B
3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence.
Hepatitis B
A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates.
Hepatitis B
A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis B.
Hepatitis B
A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997-1999.
Hepatitis B
A comparison of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive patients: a prospective cohort study in China.
Hepatitis B
A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B: long term follow up.
Hepatitis B
A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B.
Hepatitis B
A high seroprevalence of human herpesvirus type 8 already present in patients with chronic hepatitis before the development of cirrhosis.
Hepatitis B
A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.
Hepatitis B
A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B.
Hepatitis B
A Multicenter Study of the Antiviral Efficacy of Entecavir Monotherapy Compared to Lamivudine Monotherapy in Children with Nucleos(t)ide-naïve Chronic Hepatitis B.
Hepatitis B
A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels.
Hepatitis B
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.
Hepatitis B
A pilot study of long-term weekly interferon-beta administration for chronic hepatitis B.
Hepatitis B
A practical guide to the use of interferons in the management of hepatitis virus infections.
Hepatitis B
A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period.
Hepatitis B
A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation.
Hepatitis B
A prospective study of post-transfusion non-A, non-B (type C) hepatitis following cardiovascular surgery in Taiwan.
Hepatitis B
A randomized controlled trial of kurorinone versus interferon-alpha2a treatment in patients with chronic hepatitis B.
Hepatitis B
A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.
Hepatitis B
A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
Hepatitis B
A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B: First-stage results at week 48.
Hepatitis B
A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naïve chronic hepatitis B patients.
Hepatitis B
A review of recent events related to surrogate testing of blood to prevent non-A, non-B posttransfusion hepatitis.
Hepatitis B
A review of the natural history of chronic hepatitis B in the era of transient elastography.
Hepatitis B
A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update.
Hepatitis B
Absence of seroconversion to hepatitis B and C among blood donors with elevated alanine aminotransferase.
Hepatitis B
Accuracy of body mass index in detecting an elevated alanine aminotransferase level in adolescents.
Hepatitis B
Accuracy of International Guidelines for Identifying Significant Fibrosis in Hepatitis B e Antigen-Negative Patients With Chronic Hepatitis.
Hepatitis B
Acquirement and disappearance of HBsAg and anti-HCV in an aged population: a follow-up study in an endemic township.
Hepatitis B
Active and inactive replication of hepatitis B virus deoxyribonucleic acid in chronic liver disease.
Hepatitis B
Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients.
Hepatitis B
Acute hepatitis B in the era of immunisation: pitfalls in the identification of high risk patients.
Hepatitis B
Acute hepatitis B virus infection with delayed appearance of hepatitis B core antibody in an immunocompromised patient: a case report.
Hepatitis B
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.
Hepatitis B
Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg chronic hepatitis B patients: A 4-year study.
Hepatitis B
Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine.
Hepatitis B
Adherence to Chronic Hepatitis B Treatment Guideline Recommendations for Laboratory Monitoring of Patients Who Are Not Receiving Antiviral Treatment.
Hepatitis B
Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase.
Hepatitis B
Alanine aminotransferase deficiency in a hepatitis B surface antigen positive patient presenting with acute hepatitis.
Hepatitis B
Alanine Aminotransferase Influencing Performances of Routine Available Tests Detecting Hepatitis B Related Cirrhosis.
Hepatitis B
Alanine aminotransferase is more sensitive to the decrease in hepatitis B virus-DNA load than other liver markers in chronic hepatitis B patients.
Hepatitis B
Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance.
Hepatitis B
Alanine aminotransferase, gamma-glutamyltransferase, antibodies to hepatitis B core antigen and antibodies to hepatitis C virus in blood donor screening. A prospective study in Finland.
Hepatitis B
Alternative Therapies for Chronic Hepatitis B Patients With Partial Virological Response to Standard Entecavir Monotherapy.
Hepatitis B
An antigen detected frequently in human sera with elevated levels of alanine aminotransferase: a potential marker for non-A, non-B hepatitis.
Hepatitis B
An Immuno-Clinic score model for evaluating T cell immunity and predicting early antiviral therapy effectiveness in chronic hepatitis B.
Hepatitis B
Analysis of baseline hepatitis B virus DNA levels in chronic hepatitis B patients with non-hematological malignancies prior to the initiation of cancer chemotherapy.
Hepatitis B
Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis.
Hepatitis B
Analysis of hepatitis B precore region in serum and liver of chronic hepatitis B virus carriers.
Hepatitis B
Analysis of serum hepatitis B virus RNA levels in a multiethnic cohort of pregnant chronic hepatitis B carriers.
Hepatitis B
Analysis of the hepatitis B virus precore and ORF-X sequences in patients with antibody to hepatitis B e antigen with and without normal ALT levels.
Hepatitis B
Anti-Hepatitis B Virus Activity and Mechanisms of Recombinant Human Serum Albumin-Interferon-alpha-2b Fusion Protein in vitro and in vivo.
Hepatitis B
Anti-Hepatitis B Virus Activity of Esculetin from Microsorium fortunei In Vitro and In Vivo.
Hepatitis B
Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing.
Hepatitis B
Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis non-A, non-B in recipients.
Hepatitis B
Antibodies to hepatitis E virus among several populations in Greece: increased prevalence in an hemodialysis unit.
Hepatitis B
Antiviral activity and safety of LB80380 in hepatitis B e antigen-positive chronic hepatitis B patients with lamivudine-resistant disease.
Hepatitis B
Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference.
Hepatitis B
Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
Hepatitis B
Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study.
Hepatitis B
Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta-analysis.
Hepatitis B
Apoptosis observed in peripheral T lymphocytes from patients with chronic hepatitis B.
Hepatitis B
Are alanine aminotransferase, hepatitis B virus DNA or IgM antibody to hepatitis B core antigen serum levels predictors of histological grading in chronic hepatitis B?
Hepatitis B
Are serum quantitative hepatitis b surface antigen levels, liver histopathology and viral loads related in chronic hepatitis b-infected patients?
Hepatitis B
Ascitic form of sporadic acute viral hepatitis in children: a distinct entity for recognition.
Hepatitis B
Aspartate aminotransferase-to-platelet ratio index predicts prognosis of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization.
Hepatitis B
Assessment of Liver Fibrosis Using Real-time Shear-wave Elastography for Patients with Hepatitis B e Antigen-negative Chronic Hepatitis B and Alanine Transaminase <2 Times the Upper Limit of Normal.
Hepatitis B
Association between clinical features and YMDD mutations in patients with chronic hepatitis B following lamivudine therapy.
Hepatitis B
Association between gallbladder stones and chronic hepatitis C: ultrasonographic survey in a hepatitis C and B hyperendemic township in Taiwan.
Hepatitis B
Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection.
Hepatitis B
Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B.
Hepatitis B
Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.
Hepatitis B
Association of anti-HBc and liver inflammation in HBeAg-negative chronic hepatitis B virus-infected patients with normal ALT and detectable HBV DNA.
Hepatitis B
Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels.
Hepatitis B
Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B.
Hepatitis B
Association of Reduced Renal Function with Hepatitis B Virus Infection and Elevated Alanine Aminotransferase.
Hepatitis B
Baseline HBsAg levels associated with HBsAg loss in HBeAg-negative chronic hepatitis B infection with persistently normal alanine aminotransferase.
Hepatitis B
Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase Level.
Hepatitis B
Baseline serum miR-125b levels predict virologic response to nucleos(t)ide analogue treatment in patients with HBeAg-positive chronic hepatitis B.
Hepatitis B
Blockade of neutrophil elastase attenuates severe liver injury in hepatitis B transgenic mice.
Hepatitis B
Blood donation and transfusion practices: the 1990 American Association of Blood Banks Institutional Membership Questionnaire.
Hepatitis B
Blood folate levels and risk of liver damage and hepatocellular carcinoma in a prospective high-risk cohort.
Hepatitis B
Body mass index is a good predictor of an elevated alanine transaminase level in the general population: hints from the Dionysos study.
Hepatitis B
Cadaveric renal transplantation in hepatitis B antigen-positive recipients using hepatitis B antigen-positive donor organs with lamivudine treatment.
Hepatitis B
Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
Hepatitis B
Case report: dramatic response to lamivudine therapy following corticosteroid priming in chronic hepatitis B.
Hepatitis B
Change in Serum Hepatitis B Surface Antigen Level and Its Clinical Significance in Treatment-naïve, Hepatitis B e Antigen-positive Patients Receiving Entecavir.
Hepatitis B
Changes in lymphocyte single strand breakage and liver function of workers exposed to vinyl chloride monomer.
Hepatitis B
Changes in Mitochondrial Toxicity in Peripheral Blood Mononuclear Cells During Four-Year Administration of Entecavir Monotherapy in Chinese Patients with Chronic Hepatitis B.
Hepatitis B
Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular Carcinoma.
Hepatitis B
Changes to the migratory inhibitory factor, IL-17, and IL-10 levels in serum from chronic hepatitis B patients and clinical significance following Baraclude(®) treatment.
Hepatitis B
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study.
Hepatitis B
Characteristics and prediction of hepatitis B e-antigen negative hepatitis following seroconversion in patients with chronic hepatitis B.
Hepatitis B
Characteristics of a population volunteering for human immunodeficiency virus immunization. NIAID AIDS Clinical Trials Network.
Hepatitis B
Characteristics of hepatocellular carcinoma in hemodialysis patients in hepatitis B endemic area.
Hepatitis B
Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome.
Hepatitis B
Chronic hepatitis B with flare due to co-infection of hepatitis delta virus during lamivudine therapy.
Hepatitis B
Chronic Hepatitis Is Common and Often Untreated Among Children with Hepatitis B Infection in the United States and Canada.
Hepatitis B
Cimicifuga foetida L. plus adefovir effectively inhibits the replication of hepatitis B virus in patients with chronic hepatitis B.
Hepatitis B
Circulating tumor cells are associated with poor outcomes in early-stage hepatocellular carcinoma: a prospective study.
Hepatitis B
Clinical and histological characteristics of chronic hepatitis B with negative hepatitis B e-antigen.
Hepatitis B
Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B.
Hepatitis B
Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine.
Hepatitis B
Clinical Characteristics of Hepatitis B Virus Patients After Switching to Tenofovir Alafenamide Fumarate: A Retrospective Observational Study.
Hepatitis B
Clinical course after stopping lamivudine in chronic hepatitis B patients with lamivudine-resistant mutants.
Hepatitis B
Clinical efficacy and safety in telbivudine- or tenofovir-treated hepatitis B e antigen-positive pregnant women.
Hepatitis B
Clinical features of chronic hepatitis B patients with YMDD mutation after lamivudine therapy.
Hepatitis B
Clinical implications of serum hepatitis B virus RNA quantitation in untreated chronic hepatitis B virus-infected patients.
Hepatitis B
Clinical importance of serum hepatitis B surface antigen levels in chronic hepatitis B.
Hepatitis B
Clinical outcomes of hepatitis B virus (HBV) genotypes B and C in Japanese patients with chronic HBV infection.
Hepatitis B
Clinical outcomes of low-dose leflunomide for rheumatoid arthritis complicated with Hepatitis B virus carriage and safety observation.
Hepatitis B
Clinical relapse after cessation of tenofovir therapy in HBeAg-negative patients.
Hepatitis B
Clinical response to long-term tenofovir monotherapy in Korean chronic hepatitis B patients.
Hepatitis B
Clinical significance of enlarged perihepatic lymph nodes in chronic hepatitis B.
Hepatitis B
Clinical significance of low molecular weight (7-8S) immunoglobulin M antibody to hepatitis B core antigen in chronic hepatitis B virus infections.
Hepatitis B
Clinical significance of low or negative titer of antibody to hepatitis B core antigen during the course of chronic hepatitis B virus infection in adolescents.
Hepatitis B
Clinical significance of TT virus infection in children with chronic hepatitis B.
Hepatitis B
Clinical, epidemiological and prognostic aspects of hepatitis "non-A, non-B"--a comparison with hepatitis A and B.
Hepatitis B
Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.
Hepatitis B
Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
Hepatitis B
Combination of Entecavir or Tenofovir with Pegylated Interferon-? for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy.
Hepatitis B
Combination of Entecavir/Peginterferon Alfa-2a in Children With Hepatitis B e Antigen-Positive Immune Tolerant Chronic Hepatitis B Virus Infection.
Hepatitis B
Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B.
Hepatitis B
Combination of quantitative hepatitis B core antibody (qHBcAb) and aspartate aminotransferase (AST) can accurately diagnose immune tolerance of chronic hepatitis B virus infection based on liver biopsy.
Hepatitis B
Combined effects of hepatitis B virus infection and elevated alanine aminotransferase levels on dyslipidemia.
Hepatitis B
Combined pre-S deletion and core promoter mutations related to hepatocellular carcinoma: A nested case-control study in China.
Hepatitis B
Community-acquired non-A, non-B hepatitis: clinical characteristics and chronicity.
Hepatitis B
Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants.
Hepatitis B
Comparing the Efficacy and Safety of Treating Chronic Hepatitis B Infection during Pregnancy with Lamivudine, Telbivudine, and Tenofovir: A Meta-analysis.
Hepatitis B
Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels.
Hepatitis B
Comparison of clinical, virologic and pathologic features in patients with acute hepatitis B and C.
Hepatitis B
Comparison of four markers of hepatic fibrosis and hepatic function indices in patients with liver cirrhosis and hepatoma.
Hepatitis B
Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America.
Hepatitis B
Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection.
Hepatitis B
Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients.
Hepatitis B
Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice.
Hepatitis B
Comparison of the Efficacy of Tenofovir Versus Tenofovir plus Entecavir in the Treatment of Chronic Hepatitis B in Patients With Poor Efficacy of Entecavir: A Systematic Review and Meta-analysis.
Hepatitis B
Comparison of the on-treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis.
Hepatitis B
Complementary laboratory indices for predicting the disease status of patients with hepatitis B virus infection.
Hepatitis B
Complete Remission of Nephrotic Syndrome of Hepatitis B Virus-associated Membranous Glomerulopathy After Lamivudine Monotherapy.
Hepatitis B
Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.
Hepatitis B
Concomitant food intake does not affect the efficacy of entecavir in chronic hepatitis B patients with virological response: a randomized, multicenter, noninferiority trial.
Hepatitis B
Consistently normal CD4+, CD8+ levels in haemophilic boys only treated with a virally safe factor VIII concentrate (BPL 8Y)
Hepatitis B
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial.
Hepatitis B
Correlation between clinical indication for treatment and liver histology in HBeAg-negative chronic hepatitis B: a novel role of alpha-fetoprotein.
Hepatitis B
Correlation between serum levels of alanine aminotransferase and ferritin in male blood donors with antibody to hepatitis C virus.
Hepatitis B
Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients.
Hepatitis B
Correlation of hepatitis C RNA and serum alanine aminotransferase in hepatitis B and C seronegative healthy blood donors.
Hepatitis B
Correlation of TLR1-10 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure.
Hepatitis B
Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment.
Hepatitis B
Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B.
Hepatitis B
Could Complement C4 be an Alternative to Biopsy for Chronic Hepatitis B Histopathologic Findings?
Hepatitis B
Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study.
Hepatitis B
Decrease in reported posttransfusion hepatitis. Contributions of donor screening for alanine aminotransferase and antibodies to hepatitis B core antigen and changes in the general population.
Hepatitis B
Decreased liver stiffness by transient elastography indicates lower incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
Hepatitis B
Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
Hepatitis B
Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance.
Hepatitis B
Defining hepatocellular chimerism in a liver failure patient bridged with hepatocyte infusion.
Hepatitis B
Deletions in the hepatitis B virus core gene may influence the clinical outcome in hepatitis B e antigen-positive asymptomatic healthy carriers.
Hepatitis B
Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study.
Hepatitis B
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
Hepatitis B
Detection of HBV core promoter and precore mutations helps distinguish flares of chronic hepatitis from acute hepatitis B.
Hepatitis B
Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen.
Hepatitis B
Detection of hepatitis B virus DNA in the liver and serum of patients with hepatitis B surface antigen and hepatitis C virus antibody negative chronic liver disease.
Hepatitis B
Detection of SENV Virus in Healthy, Hepatitis B- and Hepatitis C-Infected Individuals in Yazd Province, Iran.
Hepatitis B
Development and validation of a model for hepatitis B e antigen seroconversion in entecavir-treated patients with chronic hepatitis B.
Hepatitis B
Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa.
Hepatitis B
Developmental consequences of children born from mothers with telbivudine treatment during late pregnancy: A prospective study with 3-year follow-up.
Hepatitis B
Diabetes and prediabetes in patients with hepatitis B residing in North America.
Hepatitis B
Diagnostic Dilemma for Low Viremia with Significant Fibrosis; is Hepatitis B Virus DNA Threshold Level a Good Indicator for Predicting Liver Damage?
Hepatitis B
Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
Hepatitis B
Diagnostic value of the ?-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma.
Hepatitis B
Different models of HBeAg seroconversion predicated by on-treatment ALT and HBV DNA profiles.
Hepatitis B
Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis.
Hepatitis B
Dissociation of alanine aminotransferase values in acute hepatitis A patients with and without past experience to the hepatitis B virus.
Hepatitis B
Distinct disease features in chimpanzees infected with a precore HBV mutant associated with acute liver failure in humans.
Hepatitis B
Do Liver IL-12 Levels Predict Sustained Response to IFN-alpha Therapy in Children With Chronic Hepatitis B?
Hepatitis B
Do serum ALAT values reflect the inflammatory activity in the liver of patients with chronic viral hepatitis?
Hepatitis B
Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes.
Hepatitis B
Double point mutation in the core promoter region of hepatitis B virus (HBV) genotype C may be related to liver deterioration in patients with chronic HBV infection.
Hepatitis B
Double-blinded placebo-controlled study of Phyllanthus urinaris for the treatment of chronic hepatitis B.
Hepatitis B
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase.
Hepatitis B
Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation.
Hepatitis B
Durability of serologic response after lamivudine treatment of chronic hepatitis B.
Hepatitis B
Duration and efficacy of immune response to hepatitis B vaccine in high-risk Chinese adolescents.
Hepatitis B
Dynamic changes of HBV DNA in serum and peripheral blood mononuclear cells of chronic hepatitis patients after lamivudine treatment.
Hepatitis B
Dynamic prediction of liver cirrhosis risk in chronic hepatitis B patients using longitudinal clinical data.
Hepatitis B
Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.
Hepatitis B
Early experiences from one of the first treatment programs for chronic hepatitis B in sub-Saharan Africa.
Hepatitis B
Early initiation of antiviral therapy contributes to a rapid and significant loss of serum HBsAg in infantile-onset hepatitis B.
Hepatitis B
Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels.
Hepatitis B
Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation.
Hepatitis B
Early viral kinetics of telbivudine and entecavir: results of a 12-week randomized exploratory study with patients with HBeAg-positive chronic hepatitis B.
Hepatitis B
Economic evaluation of lamivudine compared with interferon-alpha in the treatment of chronic hepatitis B in the United States.
Hepatitis B
Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection.
Hepatitis B
Effect of FibroScan test in antiviral therapy for HBV-infected patients with ALT <2 upper limit of normal.
Hepatitis B
Effect of nucleoside analog-interferon sequential therapy on patients with acute exacerbation of chronic hepatitis B.
Hepatitis B
Effect of switching from treatment with nucleos(t)ide analogs to pegylated interferon ?-2a on virological and serological responses in chronic hepatitis B patients.
Hepatitis B
Effect of Telbivudine Versus Other Nucleos(t)ide Analogs on HBeAg Seroconversion and Other Outcomes in Patients with Chronic Hepatitis B: A Network Meta-Analysis.
Hepatitis B
Effectiveness and long-term outcome of lamivudine therapy for acute hepatitis B.
Hepatitis B
Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine.
Hepatitis B
Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy.
Hepatitis B
Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma.
Hepatitis B
Effects of Entecavir on Hepatitis B Virus Covalently Closed Circular DNA in Hepatitis B e Antigen-Positive Patients with Hepatitis B.
Hepatitis B
Effects of entecavir on peripheral blood lymphocyte profiles in chronic hepatitis B patients with suboptimal responses to adefovir.
Hepatitis B
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.
Hepatitis B
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection.
Hepatitis B
Effects of hepatitis B virus infection, alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase on prediabetes and diabetes mellitus: A cohort study.
Hepatitis B
Effects of recombinant alpha interferon on chronic active hepatitis B: preliminary results.
Hepatitis B
Effects of Tenofovir Disoproxil Fumarate in Hepatitis B e Antigen-Positive Patients With Normal Levels of Alanine Aminotransferase and High Levels of Hepatitis B Virus DNA.
Hepatitis B
Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B.
Hepatitis B
Efficacy and Safety of Entecavir 0. 5 mg in Treating Naive Chronic Hepatitis B Virus Patients in Egypt: Five Years of Real Life Experience.
Hepatitis B
Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China.
Hepatitis B
Efficacy and safety of tenofovir disoproxil fumarate rescue therapy for chronic hepatitis B patients who failed other nucleos(t)ide analogs.
Hepatitis B
Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study.
Hepatitis B
Efficacy Comparison of Tenofovir and Entecavir in HBeAg-Positive Chronic Hepatitis B Patients with High HBV DNA.
Hepatitis B
Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients.
Hepatitis B
Efficacy of combined interferon alpha and long-term lamivudine therapy in children with chronic hepatitis B.
Hepatitis B
Efficacy of consensus interferon in treatment of HbeAg-positive chronic hepatitis B: a multicentre, randomized controlled trial.
Hepatitis B
Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
Hepatitis B
Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.
Hepatitis B
Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?
Hepatitis B
Efficacy of long-term treatment with tenofovir in Chinese nucleos(t)ide-naïve chronic hepatitis B patients regardless of baseline viral load.
Hepatitis B
Efficacy of prolonged interferon-alpha treatment in chronic hepatitis B patients with HBeAb: comparison between 6 and 12 months of therapy.
Hepatitis B
Efficacy of sequential use of telbivudine in hepatitis B e antigen-positive chronic hepatitis B patients with partial responses to pegylated interferon: a pilot study.
Hepatitis B
Efficacy of telbivudine in HBeAg-positive chronic hepatitis B patients with high baseline ALT levels.
Hepatitis B
Eight genotypes (A-H) of hepatitis B virus infecting patients from San Francisco and their demographic, clinical, and virological characteristics.
Hepatitis B
Elevated alanine aminotransferase levels in HIV-infected persons without hepatitis B or C virus coinfection.
Hepatitis B
Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: Virological breakthrough is also dependent on adherence to medication.
Hepatitis B
End-stage liver disease: Prevalence, risk factors and clinical characteristics in a cohort of HIV-HCV coinfected Han Chinese.
Hepatitis B
Entecavir is Safe and Effective in Long Term for the Treatment of Hepatitis B in Immunocompromised Children.
Hepatitis B
Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks.
Hepatitis B
Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.
Hepatitis B
Entecavir to Telbivudine Switch Therapy in Entecavir-Treated Patients with Undetectable Hepatitis B Viral DNA.
Hepatitis B
Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.
Hepatitis B
Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection.
Hepatitis B
Epidemiological features of chronic hepatitis C infection caused by remunerated blood donors: A nearly 27-year period survey.
Hepatitis B
Epidemiological, clinical and biological characteristics of acute non-A, non-B hepatitis with and without hepatitis C virus infection.
Hepatitis B
Epidemiology and clinical significance of chronic hepatitis-related viruses infection in hemodialysis patients from Taiwan.
Hepatitis B
Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors.
Hepatitis B
Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia.
Hepatitis B
Estimation of Hepatitis B Virus, Hepatitis C Virus, and Different Clinical Parameters in the Thalassemic Population of Capital Twin Cities of Pakistan.
Hepatitis B
Ethnicity, socioeconomic status, transfusions and risk of hepatitis B and hepatitis C infection.
Hepatitis B
Evaluation of a confidential method of excluding blood donors exposed to human immunodeficiency virus: studies on hepatitis and cytomegalovirus markers.
Hepatitis B
Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levels.
Hepatitis B
Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography.
Hepatitis B
Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT???2 ULN: A retrospective cohort study.
Hepatitis B
Evaluation of elevated alanine aminotransferase and hepatitis B virus DNA in healthy seronegative blood donors.
Hepatitis B
Evaluation of hepatitis B viraemia levels in patients with HBeAg-negative chronic hepatitis B virus infection.
Hepatitis B
Evaluation of liver biopsy in Egyptian HBeAg-negative chronic hepatitis B patients at initial presentation: implications for therapy.
Hepatitis B
Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.
Hepatitis B
Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Cooperative Study Group.
Hepatitis B
Expression pattern of serum cytokines in hepatitis B virus infected patients with persistently normal alanine aminotransferase levels.
Hepatitis B
Extended lamivudine consolidation therapy in hepatitis B e antigen-positive chronic hepatitis B patients improves sustained hepatitis B e antigen seroconversion.
Hepatitis B
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.
Hepatitis B
Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase.
Hepatitis B
Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection.
Hepatitis B
Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine.
Hepatitis B
Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function.
Hepatitis B
Factors predictive of significant hepatic fibrosis in adults with chronic hepatitis B and normal serum ALT.
Hepatitis B
Factors related to post-treatment relapse in chronic hepatitis B patients who lost HBeAg after lamivudine therapy.
Hepatitis B
FibroScan, aspartate aminotransferase and alanine aminotransferase ratio (AAR), aspartate aminotransferase to platelet ratio index (APRI), fibrosis index based on the 4 factor (FIB-4), and their combinations in the assessment of liver fibrosis in patients with hepatitis B.
Hepatitis B
Field tested milliliter-scale blood filtration device for point-of-care applications.
Hepatitis B
Five-year Follow-up of Chronic Hepatitis B Patients Immunized by Nasal Route with the Therapeutic Vaccine HeberNasvac.
Hepatitis B
Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis.
Hepatitis B
Four years of lamivudine treatment in Chinese patients with chronic hepatitis B.
Hepatitis B
Four-year Outcomes After Cessation of Tenofovir in Immune-tolerant Chronic Hepatitis B Patients.
Hepatitis B
Frequency and characteristics of post-transfusion hepatitis in Greece with emphasis on hepatitis C: comparing second- and third-generation assays.
Hepatitis B
Frequency of hepatitis G virus infection among HIV positive subjects with parenteral and sexual exposure.
Hepatitis B
Fulminant hepatic failure and paracetamol overuse with therapeutic intent in febrile children.
Hepatitis B
Future aspects of therapy for hepatitis B virus infection: value of surrogate markers, innovative therapy, and global collaboration.
Hepatitis B
Genetic polymorphisms of interleukin-1-beta in association with sustained response to anti-viral treatment in chronic hepatitis B in Chinese.
Hepatitis B
Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline.
Hepatitis B
Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
Hepatitis B
Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis B.
Hepatitis B
HBeAg-negative chronic hepatitis patients should be monitored more strictly: a cross-sectional retrospective study on antiviral treatment-naïve patients.
Hepatitis B
HBsAg loss is not an ideal indicator for discontinuing treatment of HBeAg-negative chronic hepatitis B: a case report.
Hepatitis B
HBV DNA level to predict liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication.
Hepatitis B
HBV genotype C is independently associated with cirrhosis in community-based population.
Hepatitis B
Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
Hepatitis B
Hepatic Histology in Treatment-naïve Children With Chronic Hepatitis B Infection Living in the United States and Canada.
Hepatitis B
Hepatic necroinflammation and severe liver fibrosis in patients with chronic hepatitis B with undetectable HBV DNA and persistently normal alanine aminotransferase.
Hepatitis B
Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.
Hepatitis B
Hepatitis B core antibody and liver stiffness measurements predict HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients with minimally elevated alanine aminotransferase (ALT) levels.
Hepatitis B
Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL.
Hepatitis B
Hepatitis B e antigen-positive and high levels of alanine aminotransferase are associated with prevalence of metabolic syndrome in chronic HBV patients.
Hepatitis B
Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management.
Hepatitis B
Hepatitis B patients exhibiting mild alanine aminotransferase elevation: A comparative analysis of treatment with and without Bicyclol tablets.
Hepatitis B
Hepatitis B surface antigen loss and sustained viral suppression in Asian chronic hepatitis B patients: A community-based real-world study.
Hepatitis B
Hepatitis B Surface Antigen Seroconversion by Interferon-?2b Combined with Granulocyte-Macrophage Colony-Stimulating Factor and Hepatitis B Vaccine: A Case Report.
Hepatitis B
Hepatitis B surface antigen, core-related antigen and HBV RNA: Predicting clinical relapse after NA therapy discontinuation.
Hepatitis B
Hepatitis B surface antigen, hepatitis C virus antibody, body mass index, and alcohol drinking among workers with elevated serum alanine aminotransferase.
Hepatitis B
Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention.
Hepatitis B
Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels.
Hepatitis B
Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study.
Hepatitis B
Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection.
Hepatitis B
Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection.
Hepatitis B
Hepatitis B virus DNA in the serum of Sardinian blood donors negative for the hepatitis B surface antigen.
Hepatitis B
Hepatitis B Virus DNA Level Predicts Hepatic Decompensation in Patients With Acute Exacerbation of Chronic Hepatitis B.
Hepatitis B
Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.
Hepatitis B
Hepatitis B Virus Genotype C Is Associated With More Severe Liver Fibrosis Than Genotype B.
Hepatitis B
Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey.
Hepatitis B
Hepatitis B virus genotypes in southwest Iran: Molecular, serological and clinical outcomes.
Hepatitis B
Hepatitis B virus genotypes, precore mutations, and basal core promoter mutations in HBV-infected Chinese patients with persistently normal alanine aminotransferase and low serum HBV-DNA levels.
Hepatitis B
Hepatitis B virus in the State of Alagoas, Brazil: genotypes characterization and mutations of the precore and basal core promoter regions.
Hepatitis B
Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase.
Hepatitis B
Hepatitis B virus of genotype C persistence after recovery from acute hepatitis B virus infection in Japan.
Hepatitis B
Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection.
Hepatitis B
Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report.
Hepatitis B
Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences.
Hepatitis B
Hepatitis B virus viral dynamics: effects of drug dose and baseline alanine aminotransferase.
Hepatitis B
Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
Hepatitis B
Hepatitis C tested prevalence and comorbidities among veterans in the US Northwest.
Hepatitis B
Hepatitis C virus genotypes among patients with lichen planus in the Kingdom of Saudi Arabia.
Hepatitis B
Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
Hepatitis B
Hepatitis D virus (delta agent) superinfection in an endemic area of hepatitis B infection: immunopathologic and serologic findings.
Hepatitis B
Hepatitis delta virus and GBV-C infection in two neighboring hepatitis B virus and hepatitis C virus-endemic villages in Taiwan.
Hepatitis B
Hepatitis G virus infection in a high-risk subgroup of hospitalized dental patients.
Hepatitis B
Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
Hepatitis B
High Human Immunodeficiency Virus (HIV) Viral Load and Coinfection with Viral Hepatitis Are Associated with Liver Enzyme Abnormalities among HIV Seropositive Patients on Antiretroviral Therapy in the Lake Victoria Zone, Tanzania.
Hepatitis B
High Level of Hepatitis B Core-related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
Hepatitis B
High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients with Low HBV Load.
Hepatitis B
High prevalence of hepatitis G virus infection in multiply transfused children with thalassaemia.
Hepatitis B
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
Hepatitis B
High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patients.
Hepatitis B
High Rates of Viral Suppression After Long-term Entecavir Treatment of Asian Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B.
Hepatitis B
Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B.
Hepatitis B
Higher efficacy of pegylated interferon-?2b add-on therapy in hepatitis B envelope antigen-positive chronic hepatitis B patients on tenofovir monotherapy.
Hepatitis B
Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
Hepatitis B
Histologic activity of childhood chronic hepatitis B related to viremia levels, genotypes, mutations, and epidemiologic factors.
Hepatitis B
Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis and Systematic Review.
Hepatitis B
Histological disease in Asian-Americans with chronic hepatitis B, high hepatitis B virus DNA, and normal alanine aminotransferase levels.
Hepatitis B
How can we make decision for patients with chronic hepatitis B according to hepatitis B virus (HBV) DNA level?
Hepatitis B
Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus.
Hepatitis B
Identification of serum cytokine profiles associated with HBeAg seroconversion following antiviral treatment interruption.
Hepatitis B
Identifying Patient and Provider-specific Gaps in Care Among Patients With Hepatitis B.
Hepatitis B
Idiopathic CD4+ T-lymphocytopenia in HIV seronegative men with hemophilia and sex partners of HIV seropositive men. Multicenter Hemophilia Cohort Study.
Hepatitis B
IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
Hepatitis B
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
Hepatitis B
Impact of precore and core promoter mutations on hepatic histology in patients with chronic hepatitis B.
Hepatitis B
Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission.
Hepatitis B
Impact of weight reduction program on serum alanine aminotransferase activity and immunologic response in obese hepatitis B patients.
Hepatitis B
Inactivation of hepatitis B and non-A, non-B viruses by combined use of Tween 80, beta-propiolactone, and ultraviolet irradiation.
Hepatitis B
Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan.
Hepatitis B
Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
Hepatitis B
Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus.
Hepatitis B
Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values.
Hepatitis B
Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
Hepatitis B
Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients.
Hepatitis B
Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.
Hepatitis B
Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
Hepatitis B
Indoleamine-2,3-dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B.
Hepatitis B
Infection with hepatitis G virus and its strain variant, the GB agent (GBV-C), among blood donors in Japan.
Hepatitis B
Infective, chronic carriers of hepatitis C virus among blood donors with no history of clinical hepatitis.
Hepatitis B
Influence of Alanine Transaminase Levels on Alpha-Fetoprotein for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Infection.
Hepatitis B
Influence of hepatitis delta virus superinfection on the clearance of hepatitis B virus (HBV) markers in HBV carriers in Japan.
Hepatitis B
Influence of serum HBV DNA load on recurrence of hepatocellular carcinoma after treatment with percutaneous radiofrequency ablation.
Hepatitis B
Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare Settings.
Hepatitis B
Inhibitory effect of total saponins isolated from Taraphochlamys affinis on duck hepatitis B virus replication.
Hepatitis B
Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
Hepatitis B
Initial uptake, time to treatment, and real-world effectiveness of all-oral direct-acting antivirals for hepatitis C virus infection in the United States: A retrospective cohort analysis.
Hepatitis B
Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
Hepatitis B
Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
Hepatitis B
Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B.
Hepatitis B
Interferon therapy of Turkish patients with chronic hepatitis B virus infection.
Hepatitis B
Interferon treatment of chronic active hepatitis B: effect of a six month treatment regimen.
Hepatitis B
Interferon-alpha treatment in children and young adults with chronic hepatitis B: a long-term follow-up study in Taiwan.
Hepatitis B
Interferon-alpha treatment of children with chronic hepatitis D virus infection: the Greek experience.
Hepatitis B
Interferon-alpha treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children.
Hepatitis B
Interferon-Alpha-2a and Zinc Combination Therapy in Children with Chronic Hepatitis B Infection.
Hepatitis B
Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis.
Hepatitis B
Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease.
Hepatitis B
Investigation of transfusion transmitted viruses in cases clinically suspected of posttransfusion hepatitis with undetermined ethiology.
Hepatitis B
IP-10 Expression in Patients with Chronic HBV Infection and Its Ability to Predict the Decrease in HBsAg Levels after Treatment with Entecavir.
Hepatitis B
Is correction for protein concentration appropriate for protein adduct dosimetry? Hypothesis and clues from an aflatoxin B1-exposed population.
Hepatitis B
Is Serum Angiotensin-Converting Enzyme Level Useful For Determining Necroinflammatory Activity In Chronic Hepatitis B Infection?
Hepatitis B
Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?
Hepatitis B
Ischemic stroke in liver cirrhosis: epidemiology, risk factors, and in-hospital outcomes.
Hepatitis B
Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders.
Hepatitis B
Lamivudine and interferon-alpha combination treatment of childhood patients with chronic hepatitis B infection.
Hepatitis B
Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B.
Hepatitis B
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis.
Hepatitis B
Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: a preliminary study.
Hepatitis B
Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study.
Hepatitis B
Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients.
Hepatitis B
Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis B virus-related liver disease.
Hepatitis B
Leukopenia and thrombocytopenia in hemodialysis patients with hepatitis B or C virus infection and non-hemodialysis patients with hepatitis cirrhosis.
Hepatitis B
Level of Hepatitis B Virus DNA in Inactive Carriers With Persistently Normal Levels of Alanine Aminotransferase.
Hepatitis B
Liquid biopsy for non-invasive assessment of liver injury in hepatitis B patients.
Hepatitis B
Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status.
Hepatitis B
Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation.
Hepatitis B
Liver fibrosis and iron levels during long-term deferiprone treatment of thalassemia major patients.
Hepatitis B
Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B - a prospective cohort study with paired transient elastography examination.
Hepatitis B
Liver histology of children with chronic hepatitis treated with interferon-alpha alone or in combination with lamivudine.
Hepatitis B
Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.
Hepatitis B
Long-term efficacy and safety of peginterferon in the treatment of children with HBeAg-positive chronic hepatitis B.
Hepatitis B
Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan.
Hepatitis B
Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.
Hepatitis B
Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection.
Hepatitis B
Long-term evolution of chronic hepatitis B in children with antibody to hepatitis B e antigen.
Hepatitis B
Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
Hepatitis B
Long-term follow-up of a randomized trial of interferon therapy for chronic hepatitis B in a predominantly homosexual male population.
Hepatitis B
Long-term follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses.
Hepatitis B
Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
Hepatitis B
Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine.
Hepatitis B
Long-term follow-up study of Chinese patients with YMDD mutations: significance of hepatitis B virus genotypes and characteristics of biochemical flares.
Hepatitis B
Long-term lamivudine for chronic hepatitis B and cirrhosis: A real-life cohort study.
Hepatitis B
Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B.
Hepatitis B
Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety.
Hepatitis B
Long-term Nucleos(t)ides Analogues for Chronic Hepatitis B Improve Liver and Spleen Size: A Noninvasive Sonographic Study.
Hepatitis B
Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.
Hepatitis B
Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood.
Hepatitis B
Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan.
Hepatitis B
Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.
Hepatitis B
Long-term outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments.
Hepatitis B
Long-term outcomes of add-on adefovir dipivoxil therapy to ongoing lamivudine in patients with lamivudine-resistant chronic hepatitis B.
Hepatitis B
Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901.
Hepatitis B
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.
Hepatitis B
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.
Hepatitis B
Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men.
Hepatitis B
Long-term trends and geographic variations in the survival of patients with hepatocellular carcinoma: Analysis of 11 312 patients in Taiwan.
Hepatitis B
Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevation.
Hepatitis B
Loss of intrahepatic HBsAg expression predicts sustained response to peginterferon and is reflected by pronounced serum HBsAg decline.
Hepatitis B
Low-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment response.
Hepatitis B
Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers.
Hepatitis B
Lower plasma adiponectin is correlated to higher alanine aminotransferase independent of metabolic factors and hepatitis B virus carrier status.
Hepatitis B
Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend.
Hepatitis B
Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study.
Hepatitis B
Management of individuals with chronic hepatitis B virus infection and persistent normal or mildly elevated aminotransferase levels.
Hepatitis B
Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations.
Hepatitis B
Mathematical modeling of cytotoxic lymphocyte-mediated immune response to hepatitis B virus infection.
Hepatitis B
Matrix metalloproteinases 2 and 9 correlate with alanine aminotransferase and hepatitis C virus in blood donors.
Hepatitis B
Models for predicting hepatitis B e antigen seroconversion in response to interferon-? in chronic hepatitis B patients.
Hepatitis B
Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine aminotransferase.
Hepatitis B
Molecular characterization of hepatitis B virus basal core promoter and precore region of isolates from chronic hepatitis B patients.
Hepatitis B
Molecular detection of transfusion transmitted virus coinfection with some hepatotropic viruses.
Hepatitis B
Monitoring of HBe antigen and alanine aminotransferase levels in hepatitis B virus DNA positive patients.
Hepatitis B
Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B.
Hepatitis B
Motor development delay in offspring is associated with prenatal telbivudine exposure.
Hepatitis B
Multicenter evaluation of a semiautomated, standardized assay for detection of hepatitis B virus DNA in blood donations.
Hepatitis B
Multicenter study of lamivudine therapy for hepatitis B after liver transplantation.Lamivudine Transplant Group.
Hepatitis B
Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma.
Hepatitis B
Natural history and clinical management of chronic hepatitis B virus infection in children.
Hepatitis B
Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years' follow-up in northern Greece.
Hepatitis B
Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels.
Hepatitis B
Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase.
Hepatitis B
Naturally occurring deletions/insertions in HBV core promoter tend to decrease in hepatitis B e antigen-positive chronic hepatitis B patients during antiviral therapy.
Hepatitis B
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B.
Hepatitis B
NICE guidelines and a treatment algorithm for the management of chronic hepatitis B: a review of 12 years experience in west London.
Hepatitis B
No evidence for association between cutaneous lichen planus and hepatitis B and C virus infection in south Poland - a case-control study.
Hepatitis B
Nonalcoholic Fatty Liver Disease is Underrecognized in the Primary Care Setting.
Hepatitis B
Nucleoside Analog-treated Chronic Hepatitis B Patients showed Reduced Expression of PECAM-1 Gene in Peripheral Blood Mononuclear Cells in Bangladesh.
Hepatitis B
Nucleoside analogs assisted with Chinese compound prescription in treating hepatic fibrosis of chronic hepatitis B patients: A protocol of systematic review and meta-analysis.
Hepatitis B
Nutritional status of children with chronic hepatitis B in a population with low socioeconomic status.
Hepatitis B
Obesity and diabetic hyperglycemia were associated with serum alanine aminotransferase activity in patients with hepatitis B infection.
Hepatitis B
Occult HBV infection in continuous ambulatory peritoneal dialysis and hemodialysis patients.
Hepatitis B
Occult hepatitis B virus among the patients with abnormal alanine transaminase.
Hepatitis B
Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
Hepatitis B
Occult hepatitis B virus infection in a Kenyan cohort of HIV infected anti-retroviral therapy naïve adults.
Hepatitis B
Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study.
Hepatitis B
Occupational coke oven emissions exposure and risk of abnormal liver function: modifications of body mass index and hepatitis virus infection.
Hepatitis B
Oedema of gallbladder wall: correlation with chronic hepatitis B on MR imaging.
Hepatitis B
Off-Treatment Hepatitis B Virus (HBV) DNA Levels and the Prediction of Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B: A Prospective Stop Study.
Hepatitis B
On-treatment quantitative hepatitis B e antigen predicted response to nucleos(t)ide analogues in chronic hepatitis B.
Hepatitis B
One year of Lamivudine therapy for portuguese patients with chronic hepatitis B.
Hepatitis B
Oral oxymatrine preparation for chronic hepatitis B: A systematic review of randomized controlled trials.
Hepatitis B
Patient management and clinical decision making in HBV--aims of therapy and what we can achieve.
Hepatitis B
PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody.
Hepatitis B
Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial.
Hepatitis B
Peginterferon Alfa-2a (40KD) Plus Lamivudine or Entecavir in Children With Immune-Tolerant Chronic Hepatitis B.
Hepatitis B
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.
Hepatitis B
Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.
Hepatitis B
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.
Hepatitis B
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta.
Hepatitis B
Persistence of hepatitis B virus DNA after reduction of viral replication in serum and liver.
Hepatitis B
Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B.
Hepatitis B
Pilot interferon-beta trial in children with chronic hepatitis B who had previously not responded to interferon-alpha therapy.
Hepatitis B
Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients.
Hepatitis B
Plasma miR-146a predicts serological conversion of hepatitis B e-antigen (HBeAg) in chronic hepatitis B patients treated with nucleotide analogs.
Hepatitis B
Poor Adherence to Guidelines for Treatment of Chronic Hepatitis B Virus Infection at Primary Care and Referral Practices.
Hepatitis B
Post-transfusion non-A, non-B hepatitis: significance of raised ALT and anti-HBc in blood donors.
Hepatitis B
Potential impact of long-term nucleoside therapy on the mortality and morbidity of active chronic hepatitis B.
Hepatitis B
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.
Hepatitis B
Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B.
Hepatitis B
Prediction and Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) and Identification of Its Associated Factors Using the Classification Tree Method.
Hepatitis B
Prediction model for sustained hepatitis B e antigen seroconversion to peginterferon alfa-2a in chronic hepatitis B.
Hepatitis B
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE).
Hepatitis B
Predictive Effect of Serial Serum Alanine Aminotransferase Levels on Spontaneous HBeAg Seroconversion in Chronic Genotypes B and C HBV infected Children.
Hepatitis B
Predictive Factors for Differentiating Pancreatic Cancer-Associated Diabetes Mellitus from Common Type 2 Diabetes Mellitus for the Early Detection of Pancreatic Cancer.
Hepatitis B
Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B.
Hepatitis B
Predictive markers for hepatitis C antibody ELISA specificity in Australian blood donors.
Hepatitis B
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Hepatitis B
Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
Hepatitis B
Predictive value of intrahepatic hepatitis B virus covalently closed circular DNA and total DNA in patients with acute hepatitis B and patients with chronic hepatitis B receiving anti?viral treatment.
Hepatitis B
Predictive value of plasmacytoid dendritic cells and Toll-like receptor-9 regarding the treatment efficacy of interferon-? in HBeAg-positive chronic hepatitis B patients.
Hepatitis B
Predictive value of serum ALT and T-cell receptor beta variable chain for HBeAg seroconversion in chronic hepatitis B patients during tenofovir treatment.
Hepatitis B
Predictive value of serum Golgi protein 73 for prominent hepatic necroinflammation in chronic HBV infection.
Hepatitis B
Predictors associated with treatment initiation and switch in a real-world chronic hepatitis B population from five European countries.
Hepatitis B
Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis.
Hepatitis B
Prednisolone priming enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B.
Hepatitis B
Prepregnancy liver enzyme levels and risk of preeclampsia in a subsequent pregnancy: A population-based cohort study.
Hepatitis B
Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study.
Hepatitis B
Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group.
Hepatitis B
Pretreatment Hepatitis B Viral Load Predicts Long-term Hepatitis B Response after Anti-hepatitis C Therapy in Hepatitis B/C Dual-infected Patients.
Hepatitis B
Prevalence and clinical significance of SEN virus infection among volunteer blood donors in southern Taiwan.
Hepatitis B
Prevalence and heterogeneity of serum DNA polymerase activity in patients with non-A, non-B hepatitis and HBsAg-negative blood donors with elevated SGPT.
Hepatitis B
Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia.
Hepatitis B
Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China.
Hepatitis B
Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.
Hepatitis B
Prevalence of antibodies to hepatitis C virus after blood transfusion in heart surgery.
Hepatitis B
Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients.
Hepatitis B
Prevalence of antibodies to hepatitis C virus in transfused children with cancer.
Hepatitis B
Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
Hepatitis B
Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
Hepatitis B
Prevalence of hepatitis B and hepatitis C in an orthopaedics and traumatology ward.
Hepatitis B
Prevalence of Occult Hepatitis C Virus Infection among Blood Donors in Jiangsu, China.
Hepatitis B
Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre.
Hepatitis B
Prevalence, infectivity, and risk factor analysis of hepatitis C virus infection in prostitutes.
Hepatitis B
Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
Hepatitis B
Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study.
Hepatitis B
Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals.
Hepatitis B
Prognostic factors of the short-term outcomes of patients with hepatitis B virus-associated acute-on-chronic liver failure.
Hepatitis B
Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection.
Hepatitis B
Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
Hepatitis B
Prognostic values of fluctuations in serum levels of alanine transaminase in inactive carrier state of HBV infection.
Hepatitis B
Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study.
Hepatitis B
Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients.
Hepatitis B
Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs.
Hepatitis B
Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus.
Hepatitis B
Quantification of intrahepatic total hepatitis B virus DNA in chronic hepatitis B patients and its relationship with liver histology.
Hepatitis B
Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection.
Hepatitis B
Quantitative intrahepatic HBV cccDNA correlates with histological liver inflammation in chronic hepatitis B virus infection.
Hepatitis B
Randomized, controlled trial of natural interferon-alpha therapy for e-antigen-positive chronic hepatitis B patients.
Hepatitis B
Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.
Hepatitis B
Rapid determination of serological cytokine biomarkers for hepatitis B virus-related hepatocellular carcinoma using antibody microarrays.
Hepatitis B
Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferase.
Hepatitis B
Reactivation of viral replication after liver resection in patients infected with hepatitis B virus.
Hepatitis B
Real-world single-center experience with entecavir and tenofovir disoproxil fumarate in treatment-naïve and experienced patients with chronic hepatitis B.
Hepatitis B
Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine.
Hepatitis B
Recombinant immunoblot assays for hepatitis C in human immunodeficiency virus type 1-infected US Navy personnel.
Hepatitis B
Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis.
Hepatitis B
Regulatory T-Cell Responses in Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogs Compared with Healthy Subjects and Untreated Infected Individuals.
Hepatitis B
Relation between serum quantitative HBsAg, ALT and HBV DNA levels in HBeAg negative chronic HBV infection.
Hepatitis B
Relationship between fatty liver, alanine aminotransferase, HBsAg and hepatitis C virus.
Hepatitis B
Relationship Between Hepatic Steatosis and the Elevation of Aminotransferases in HBV-Infected Patients With HBe-Antigen Negativity and a Low Viral Load.
Hepatitis B
Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
Hepatitis B
Relationship between the serum alanine aminotransferase level at the end of interferon treatment and histologic changes in wild-type and precore mutant hepatitis B virus infections.
Hepatitis B
Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir.
Hepatitis B
Retreatment decision for hepatitis B flare in HBeAg negative Chronic Hepatitis B.
Hepatitis B
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients.
Hepatitis B
Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients.
Hepatitis B
Risk factors associated with hepatitis B or C markers or elevated alanine aminotransferase level among blood donors on a tropical island: the Guadeloupe experience.
Hepatitis B
Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004.
Hepatitis B
Risk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine. Prometheus Study Group.
Hepatitis B
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
Hepatitis B
Risk factors for liver disease among adults of Mexican descent in the United States and Mexico.
Hepatitis B
Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI.
Hepatitis B
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
Hepatitis B
Risk of hepatocellular carcinoma in cirrhotic hepatitis B virus patients during nucleoside/nucleotide analog therapy.
Hepatitis B
Risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Hepatitis B
Risk of Severe Acute Exacerbation of Chronic HBV Infection Cancer Patients Who Underwent Chemotherapy and Did Not Receive Anti-Viral Prophylaxis.
Hepatitis B
Risk score system for the prediction of hepatocellular carcinoma in patients with type 2 diabetes: Taiwan Diabetes Study.
Hepatitis B
Role of CD44 in CTL-induced acute liver injury in hepatitis B virus transgenic mice.
Hepatitis B
Role of monokine induced by interferon-? in liver injury induced by hepatitis B virus in mice.
Hepatitis B
Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase levels.
Hepatitis B
Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia B.
Hepatitis B
Safety of Monitoring Viral and Liver Function Markers in Patients With Prior Resolved Hepatitis B Infection After Kidney Transplantation.
Hepatitis B
Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
Hepatitis B
Screening and evaluation of chronic and occult Hepatitis B in chemo - radiotherapy patients with cancer.
Hepatitis B
Screening for tuberculosis and hepatitis B prior to the initiation of anti-tumor necrosis therapy.
Hepatitis B
Screening of hepatitis C virus genotypes in urticaria patients in saudi arabia.
Hepatitis B
SEN virus infection among patients on maintenance hemodialysis in southern Taiwan.
Hepatitis B
SEN virus infection in children in Taiwan: transmission route and role in blood transfusion and liver diseases.
Hepatitis B
Sequential changes of serum aminotransferase levels in patients with severe acute respiratory syndrome.
Hepatitis B
Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.
Hepatitis B
Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B.
Hepatitis B
Sequential treatment with lamivudine and interferon-alpha monotherapies in hepatitis B e antigen-negative Chinese patients and its suppression of lamivudine-resistant mutations.
Hepatitis B
Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion.
Hepatitis B
Serological Patterns and Molecular Characterization of Occult Hepatitis B Virus Infection among Blood Donors.
Hepatitis B
Seroprevalence of hepatitis B virus co-infection among HIV-1-positive patients in North-Central Nigeria: The urgent need for surveillance.
Hepatitis B
Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B.
Hepatitis B
Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: is sustained clearance of HBV DNA dependent on levels of pretreatment viremia?
Hepatitis B
Serum alanine aminotransferase level in relation to hepatitis B and C virus infections among blood donors.
Hepatitis B
Serum alanine aminotransferase levels among volunteer blood donors: effect of sex, alcohol intake and obesity.
Hepatitis B
Serum alanine aminotransferase levels and prevalence of hepatitis A, B, and delta in outpatients.
Hepatitis B
Serum alanine aminotransferase levels in relation to hepatitis B and C virus infections among drug abusers in an area hyperendemic for hepatitis B.
Hepatitis B
Serum alanine aminotransferase measurement as a guide to selective testing for hepatitis C during medical checkup.
Hepatitis B
Serum alanine transaminase levels in hospital personnel and effect before and after hepatitis B vaccination.
Hepatitis B
Serum alpha fetoprotein in 714 mentally retarded carriers of hepatitis B surface antigen.
Hepatitis B
Serum beta2-microglobulin levels in hepatitis B e antigen-negative chronic hepatitis B patients under long term lamivudine monotherapy: relationship with virological breakthrough.
Hepatitis B
Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients.
Hepatitis B
Serum Gamma-Glutamyltransferase and Ferritin are Related to Insulin Resistance: A Population-Based Study.
Hepatitis B
Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase.
Hepatitis B
Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
Hepatitis B
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load.
Hepatitis B
Serum hepatitis B surface antigen levels predict insignificant fibrosis and non-cirrhosis in hepatitis B e antigen positive patients with normal or mildly elevated alanine transaminase levels.
Hepatitis B
Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues.
Hepatitis B
Serum hepatitis B virus ribonucleic acid and its influencing factors in chronic hepatitis B.
Hepatitis B
Serum Interleukin-37 Concentrations and HBeAg Seroconversion in Chronic HBV Patients During Telbivudine Treatment.
Hepatitis B
Serum levels of soluble Tac peptide in acute and chronic hepatitis B virus infection.
Hepatitis B
Serum M2BPGi level is a novel predictive biomarker for the responses to pegylated interferon-? treatment in HBeAg-positive chronic hepatitis B patients.
Hepatitis B
Serum Metabolomics Reveals ?-Glutamyl Dipeptides as Biomarkers for Discrimination among Different Forms of Liver Disease.
Hepatitis B
Serum zinc as a factor predicting response to interferon-alpha2b therapy in children with chronic hepatitis B.
Hepatitis B
Serum zinc status in chronic hepatitis B and its relationship to liver histology and treatment results.
Hepatitis B
Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels.
Hepatitis B
Sex difference in chronic hepatitis B virus infection: studies of serum HBeAg and alanine aminotransferase levels in 10,431 asymptomatic Chinese HBsAg carriers.
Hepatitis B
Sex differences in relation to serum hepatitis B e antigen and alanine aminotransferase levels among asymptomatic hepatitis B surface antigen carriers.
Hepatitis B
Sex disparity in viral load, inflammation and liver damage in transgenic mice carrying full hepatitis B virus genome with the W4P mutation in the preS1 region.
Hepatitis B
Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients: A Community-Based Study in a Hepatitis B/Hepatitis C Virus Hyperendemic Area.
Hepatitis B
Short-term overlap lamivudine treatment with adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B.
Hepatitis B
Significance of anti-hbc in the absence of other hepatitis B markers in a college-aged population.
Hepatitis B
Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus.
Hepatitis B
Significance of sublobular hepatic necrosis in the progression of chronic hepatitis C.
Hepatitis B
Significant Hepatic Fibrosis Among Treatment-Naive Chronic Hepatitis B Virus With Increased Hepatitis B Virus DNA and Normal Alanine Aminotransferase.
Hepatitis B
Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.
Hepatitis B
Simultaneous acute hepatitis B virus and hepatitis C virus infection leading to fulminant hepatitis and subsequent chronic hepatitis C.
Hepatitis B
Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression.
Hepatitis B
Smoking and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase.
Hepatitis B
Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis.
Hepatitis B
Stability of Chronic Hepatitis-Related Parameters in Serum Samples After Long-Term Storage.
Hepatitis B
Statistical models for predicting response to interferon-alpha and spontaneous seroconversion in children with chronic hepatitis B.
Hepatitis B
Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
Hepatitis B
Study on Evaluation of Alanine Aminotransferase (ALT) as Surrogate Marker in Hepatitis Virus Test.
Hepatitis B
Successful treatment of hepatitis B virus infection with Lamivudine after heart transplantation.
Hepatitis B
Sustained hepatitis B e antigen seroconversion in patients with chronic hepatitis B after adefovir dipivoxil treatment: analysis of precore and basal core promoter mutants.
Hepatitis B
Sustained immune control in HBeAg-positive patients who switched from entecavir therapy to pegylated interferon-?2a: 1-year follow-up of the OSST study.
Hepatitis B
Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.
Hepatitis B
Synergistic effect of hepatitis virus infection and occupational exposures to vinyl chloride monomer and ethylene dichloride on serum aminotransferase activity.
Hepatitis B
Systematic review with meta-analysis: Change in liver stiffness during anti-viral therapy in patients with hepatitis B.
Hepatitis B
Telbivudine plus adefovir therapy for chronic hepatitis B patients with virological breakthrough or genotypic resistance to telbivudine.
Hepatitis B
Telbivudine Prevents Vertical Transmission from HBeAg-Positive Women With Chronic Hepatitis B.
Hepatitis B
Tenofovir alafenamide fumarate therapy in subjects with positive HBV-DNA and normal levels of alanine transaminase: a study protocol for a randomised controlled trial.
Hepatitis B
Tenofovir alafenamide in the treatment of chronic hepatitis B virus infection: rationale and clinical trial evidence.
Hepatitis B
Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.
Hepatitis B
Tenofovir decrease hepatocellular carcinoma recurrence in chronic hepatitis B patients after liver resection.
Hepatitis B
Tenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B.
Hepatitis B
Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks.
Hepatitis B
Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis.
Hepatitis B
Tenofovir monotherapy versus tenofovir plus entecavir combination therapy in HBeAg-positive chronic hepatitis patients with partial virological response to entecavir.
Hepatitis B
The aetiology of chronic hepatitis in Italy: results from a multicentre national study.
Hepatitis B
The correlations of surrogate markers with anti-hepatitis C virus and other disease markers.
Hepatitis B
The curative effect of adefovir dipivoxil treating HBeAg negative chronic hepatitis B and treating HBeAg positive chronic hepatitis B combining interferon ?-2b.
Hepatitis B
The Defective Allele of Aldehyde Dehydrogenase 2 Gene is Associated with Favorable Postoperative Prognosis in Hepatocellular Carcinoma.
Hepatitis B
The different effects of adefovir dipivoxil and telbivudine on the prognosis of hepatitis b virus-related hepatocellular carcinoma patients after curative resection.
Hepatitis B
The duration of lamivudine therapy for chronic hepatitis B: cessation vs. continuation of treatment after HBeAg seroconversion.
Hepatitis B
The effectiveness of lamivudine treatment in cirrhotic patients with HBV precore mutations: a prospective, open-label study.
Hepatitis B
The effects of cytokines on spontaneous hepatitis B surface antigen seroconversion in chronic hepatitis B virus infection.
Hepatitis B
The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus.
Hepatitis B
The frequency and skewed T-cell receptor beta-chain variable patterns of peripheral CD4(+)CD25(+) regulatory T-cells are associated with hepatitis B e antigen seroconversion of chronic hepatitis B patients during antiviral treatment.
Hepatitis B
The impact of screening a heterogeneous donor population for alanine aminotransferase and hepatitis B core antibody. Experience at a large southern California hospital.
Hepatitis B
The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
Hepatitis B
The lack of effect of therapeutic vaccination with a pre-S2/S HBV vaccine in the immune tolerant phase of chronic HBV infection.
Hepatitis B
The long-term effect of treatment with interferon-alpha 2a in chronic hepatitis B. The Long-Term Follow-up Investigator Group. The European Study Group on Viral Hepatitis (EUROHEP). Executive Team on Anti-Viral Treatment.
Hepatitis B
The long-term effects of anti-TNF-? agents on patients with chronic viral hepatitis C and B infections.
Hepatitis B
The mushroom Agaricus blazei Murill extract normalizes liver function in patients with chronic hepatitis B.
Hepatitis B
The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points.
Hepatitis B
The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine.
Hepatitis B
The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B.
Hepatitis B
The prevalence and clinical correlates of elevated ALT levels in an urban Chinatown community.
Hepatitis B
The Prevalence and Presumed Etiology of Elevated Aminotransferase Levels in a Pacific Northwest Tribal Community.
Hepatitis B
The relationship between visfatin, liver inflammation, and acute phase reactants in chronic viral hepatitis B.
Hepatitis B
The relationship of hepatitis antibodies and elevated liver enzymes with impaired fasting glucose and undiagnosed diabetes.
Hepatitis B
The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
Hepatitis B
The risk of hepatocellular carcinoma among chronic hepatitis B virus-infected patients outside current treatment criteria.
Hepatitis B
The risky body mass index ranges for significant hepatitis B viral load: A campus-based study.
Hepatitis B
The role of HBeAg seroconversion in acute exacerbation of liver disease with termination of hepatitis B and D virus infection in a chronic hepatitis D patient during alpha-interferon therapy.
Hepatitis B
The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group.
Hepatitis B
The role of pre-core hepatitis B virus mutants on the long-term outcome of chronic hepatitis B virus hepatitis. A longitudinal study.
Hepatitis B
The Roles of Fibrosis Index Based on Four Factors and Aspartate Transaminase-to-Platelet Ratio Index Scoring Systems as an Alternative to Transient Elastography Liver Stiffness in Liver Fibrosis Staging in Human Immunodeficiency Virus and Hepatitis C Virus Co-Infected Patients.
Hepatitis B
The roles of GSTM1 and GSTT1 null genotypes and other predictors in anti-tuberculosis drug-induced liver injury.
Hepatitis B
The serum interleukin-26 level is a potential biomarker for chronical hepatitis B.
Hepatitis B
The use of a recombinant immunoblot assay in the interpretation of anti-hepatitis C virus reactivity among prospectively followed patients, implicated donors, and random donors.
Hepatitis B
The use of deferoxamine infusions to enhance the response rate to interferon-alpha treatment of chronic viral hepatitis B.
Hepatitis B
The Use of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase.
Hepatitis B
Therapeutic efficacy of sequential and simultaneous treatments with interferon-alpha and lamivudine in children with chronic hepatitis B.
Hepatitis B
Three Years of Continuous Entecavir Therapy in Treatment-Naïve Chronic Hepatitis B Patients: VIRAL Suppression, Viral Resistance, and Clinical Safety.
Hepatitis B
Three-year efficacy and safety of tenofovir in nucleos(t)ide analog-naïve and -experienced chronic hepatitis B patients.
Hepatitis B
TNF-?/IFN-? profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
Hepatitis B
Transfusion-transmitted virus infection in hemodialysis patients in Arar, Saudi Arabia: Prevalence, predictors and genotyping.
Hepatitis B
Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis.
Hepatitis B
Treatment Eligibility of Patients With Chronic Hepatitis B Initially Ineligible for Therapy.
Hepatitis B
Treatment of chronic hepatitis B and C with alpha interferon in a renal transplant patient.
Hepatitis B
Treatment of chronic hepatitis B in Asia-Pacific countries: is the Asia-Pacific consensus statement being followed?
Hepatitis B
Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice.
Hepatitis B
Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States.
Hepatitis B
Triiodothyronine level and triiodothyronine/thyroxine ratio in HBeAg-positive chronic hepatitis patients treated with prednisolone withdrawal.
Hepatitis B
Twelve-month interferon-alpha therapy induces a similar sustained response in anti-HBe-positive and HBeAg-positive chronic hepatitis B patients.
Hepatitis B
Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial.
Hepatitis B
Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.
Hepatitis B
Unidentified virus-like particles are detected in plasmas with elevated ALT levels: are they significant of etiological agent(s) of non-B, non-C hepatitis?
Hepatitis B
Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B.
Hepatitis B
Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review.
Hepatitis B
Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients.
Hepatitis B
Vertical transmission of hepatitis B virus despite maternal lamivudine therapy.
Hepatitis B
Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B.
Hepatitis B
Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels.
Hepatitis B
Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.
Hepatitis B
Virological, serological and biochemical outcomes through 3 years of entecavir treatment in nucleoside-naive Chinese chronic hepatitis B patients.
Hepatitis B
Virus and transaminase levels determine the emergence of drug resistance during long-term lamivudine therapy in chronic hepatitis B.
Hepatitis B
What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis?
Hepatitis B
Zidovudine plus interferon alfa-2b treatment in patients with HIV and chronic active viral hepatitis.
Hepatitis B
[A case of hepatitis B virus/human immunodeficiency virus coinfection in a patient who achived hepatitis B surface antigen seroclearance after interferon therapy followed by antiretroviral therapy without developing immune reconstitution inflammatory syndrome].
Hepatitis B
[A clinical study of adefovir dipivoxil, made in China, for treatment of hepatitis B e antigen-positive patients with chronic hepatitis B]
Hepatitis B
[A randomized controlled trial on 240-week monotherapy with entecavir or adefovir in patients with chronic hepatitis B and cirrhosis].
Hepatitis B
[Activity of alanine aminotransferase in women of child-bearing age, ill with viral hepatitis]
Hepatitis B
[Anti-HCV in patients without risk factors for hepatitis C. Prospective study in 200 patients]
Hepatitis B
[Change of hepatitis B surface antigen in serum from patients with chronic hepatitis B]
Hepatitis B
[Changes in synthesis of nitric oxide, blood levels of ACTH and cortisol in viral hepatitis B]
Hepatitis B
[Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment]
Hepatitis B
[Community-based hepatocellular carcinoma screening in seven townships in Taiwan]
Hepatitis B
[Comparative study of the prevalence of hepatitis B virus infection and human immunodeficiency virus type 1 infection in the prison population between 1985 and 1992]
Hepatitis B
[Compare the effect of combined therapy between telbivudine plus adefovir dipivoxil and lamivudine plus adefovir dipivoxil corresponding to renal function in patients with hepatitis B virus infection].
Hepatitis B
[Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B]
Hepatitis B
[Dynamic changes and clinical significance of HBcAg18-27 specific cytotoxic T lymphocytes in acute hepatitis B patients.]
Hepatitis B
[Efficacy of 48-week tenofovir disoproxil fumarate therapy in patients who were unresponsive to nucleoside-analogue treatments].
Hepatitis B
[Efficacy of combination antiviral therapy following childbirth in pregnant HBV carriers receiving telbivudine for prevention of mother-to-child transmission].
Hepatitis B
[Elevation of some serum liver enzymes in coke oven workers and the possible relationship with exposure to polycyclic aromatic hydrocarbons]
Hepatitis B
[Evaluation of a quantitative HBV-DNA PCR assay in lamivudine treated hepatitis B-infected patients]
Hepatitis B
[Expression of interferon-alpha receptor in liver tissues in patients with chronic hepatitis B and its clinical significance.]
Hepatitis B
[Hepatitis B core antigen expression pattern predicts response to lamivudine therapy in patients with chronic hepatitis B]
Hepatitis B
[Hepatitis B virus genotypes and alanine aminotransferase levels in HBeAg negative patients with chronic hepatitis B and liver cirrhosis]
Hepatitis B
[Intrahepatic hepatitis B virus covalently closed circular DNA correlation with serum HBV DNA, serum HBsAg, alanine aminotransferase and age].
Hepatitis B
[Long term study of the treatment with recombinant alfa 2b interferon in chronic active hepatitis due to B virus in children and adolescents]
Hepatitis B
[Markers of viral hepatitis B and D and levels of alanine aminotransferase in military blood donors: a profile of 30,000 blood donations in 1989]
Hepatitis B
[Nested casejcontrol study on the influence factors of perinatal stage transmission of hepatitis B virus]
Hepatitis B
[New German and American guidelines for therapy of hepatitis B. discrepancies and similarities]
Hepatitis B
[Phenotypic and functional features of NK and NKT cells in chronic hepatitis B].
Hepatitis B
[Prevalence of high ALAT and serologic markers of hepatitis B virus in blood donors incriminated in non-A, non-B posttransfusion hepatitis]
Hepatitis B
[Prevention of post-transfusion hepatitis in Guadeloupe: results after application of new measures for detecting blood donors potentially at risk]
Hepatitis B
[Relation of serological markers of hepatitis B virus and alanine transaminase to hepatic tissue pathology in patients with chronic hepatitis B]
Hepatitis B
[Relationship of fatty liver with HBV infection, hyperlipidemia and abnormal alanine aminotransferase]
Hepatitis B
[Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
Hepatitis B
[Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal].
Hepatitis B
[The effect of telbivudine on peripheral blood CD4+CD25+ regulatory T cells and its significance in patients with chronic hepatitis B]
Hepatitis B
[The follow-up of serum aminotransferase levels and investigation of hepatitis B virus load in inactive HBsAg carriers]
Hepatitis B
Epidemiologic trends in HBV infections at a reference centre in Turkey: an 11-year retrospective analysis.
Hepatitis B, Chronic
3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China.
Hepatitis B, Chronic
A controlled trial of interferon with or without prednisone priming for chronic hepatitis B.
Hepatitis B, Chronic
A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.
Hepatitis B, Chronic
A Mechanistic Assessment of the Discordance between Normal Serum Alanine Aminotransferase Levels and Altered Liver Histology in Chronic Hepatitis B.
Hepatitis B, Chronic
A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase ?2upper limit of normal.
Hepatitis B, Chronic
A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
Hepatitis B, Chronic
A new model for predicting liver cirrhosis in chronic hepatitis B virus carriers with low serum alanine transaminase activity.
Hepatitis B, Chronic
A non-invasive model for predicting liver fibrosis in HBeAg-positive patients with normal or slightly elevated alanine aminotransferase.
Hepatitis B, Chronic
A Non-invasive Model for Predicting Liver Inflammation in Chronic Hepatitis B Patients With Normal Serum Alanine Aminotransferase Levels.
Hepatitis B, Chronic
A noninvasive model to predict liver histology for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase
Hepatitis B, Chronic
A noninvasive model to predict liver histology in HBeAg-positive chronic hepatitis B with alanine aminotransferase ?2upper limit of normal.
Hepatitis B, Chronic
A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels.
Hepatitis B, Chronic
A novel diagnostic algorithm to predict significant liver inflammation in chronic hepatitis B virus infection patients with detectable HBV DNA and persistently normal alanine transaminase.
Hepatitis B, Chronic
A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels.
Hepatitis B, Chronic
A promising non-invasive index for predicting liver inflammation in chronic hepatitis B patients with alanine aminotransferase ?2 upper limit of normal.
Hepatitis B, Chronic
A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.
Hepatitis B, Chronic
A randomized, double-blind, controlled trial of natural interferon-beta therapy for e-antigen-negative chronic hepatitis B patients with abnormal transaminase levels.
Hepatitis B, Chronic
A review of the natural history of chronic hepatitis B in the era of transient elastography.
Hepatitis B, Chronic
A Scoring System for Predicting Significant Fibrosis in Chronic Hepatitis B Patients With Normal or Mildly Elevated Alanine Aminotransferase Levels.
Hepatitis B, Chronic
A simple algorithm for non-invasive diagnosis of significant liver histological changes in patients with CHB and normal or mildly elevated alanine transaminase levels.
Hepatitis B, Chronic
Abnormal IL-10 levels were related to alanine aminotransferase abnormalities during postpartum in HBeAg positive women with chronic hepatitis B.
Hepatitis B, Chronic
Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C.
Hepatitis B, Chronic
Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients.
Hepatitis B, Chronic
Acute exacerbation during interferon alfa treatment of chronic hepatitis B: frequency and relation to serum beta-2 microglobulin levels.
Hepatitis B, Chronic
Acute ischemic injury due to a giant intrahepatic hematoma: A complication of percutaneous liver biopsy.
Hepatitis B, Chronic
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.
Hepatitis B, Chronic
Adherence to Chronic Hepatitis B Treatment Guideline Recommendations for Laboratory Monitoring of Patients Who Are Not Receiving Antiviral Treatment.
Hepatitis B, Chronic
Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase.
Hepatitis B, Chronic
Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferase.
Hepatitis B, Chronic
Alanine aminotransferase is more sensitive to the decrease in hepatitis B virus-DNA load than other liver markers in chronic hepatitis B patients.
Hepatitis B, Chronic
Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.
Hepatitis B, Chronic
alpha-Galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial.
Hepatitis B, Chronic
ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B.
Hepatitis B, Chronic
ALT Flare Predicts Hepatocellular Carcinoma Among Antiviral Treated Patients With Chronic Hepatitis B: A Cross-Country Cohort Study.
Hepatitis B, Chronic
Alterations of the Gut Microbiome in Chronic Hepatitis B Virus Infection Associated with Alanine Aminotransferase Level.
Hepatitis B, Chronic
An association study of functional polymorphic genes IRF-1, IFNGR-1, and IFN-? with disease progression, aspartate aminotransferase, alanine aminotransferase, and viral load in chronic hepatitis B and C.
Hepatitis B, Chronic
Anti-viral effect in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase.
Hepatitis B, Chronic
Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference.
Hepatitis B, Chronic
Antiviral therapy for chronic hepatitis B: are we doing any good to patients?
Hepatitis B, Chronic
Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study.
Hepatitis B, Chronic
Applicability of liver stiffness measurement based nomograms to the assessments of hepatitis B related significant fibrosis and cirrhosis.
Hepatitis B, Chronic
Are alanine aminotransferase, hepatitis B virus DNA or IgM antibody to hepatitis B core antigen serum levels predictors of histological grading in chronic hepatitis B?
Hepatitis B, Chronic
Are serum quantitative hepatitis b surface antigen levels, liver histopathology and viral loads related in chronic hepatitis b-infected patients?
Hepatitis B, Chronic
Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study.
Hepatitis B, Chronic
Assessment of Clinical Utility of Low and High Normal Alanine Aminotransferase Values in Patients with Chronic Hepatitis B Virus Infection in Bangladesh.
Hepatitis B, Chronic
Assessment of Liver Fibrosis Using Real-time Shear-wave Elastography for Patients with Hepatitis B e Antigen-negative Chronic Hepatitis B and Alanine Transaminase <2 Times the Upper Limit of Normal.
Hepatitis B, Chronic
Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection.
Hepatitis B, Chronic
Association of anti-HBc and liver inflammation in HBeAg-negative chronic hepatitis B virus-infected patients with normal ALT and detectable HBV DNA.
Hepatitis B, Chronic
Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels.
Hepatitis B, Chronic
Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B.
Hepatitis B, Chronic
Baseline HBsAg levels associated with HBsAg loss in HBeAg-negative chronic hepatitis B infection with persistently normal alanine aminotransferase.
Hepatitis B, Chronic
Beneficial effects of 'lamivudine pulse' therapy in HBeAg-positive patients with normal ALT*.
Hepatitis B, Chronic
Beneficial therapeutic effect of Chinese herbal Bushen formula on CHB patients with mildly elevated alanine aminotransferase by down-regulating CD4+CD25+T cells.
Hepatitis B, Chronic
beta-Hexosaminidase level in serum from patients with viral hepatitis as a measure of reticuloendothelial function.
Hepatitis B, Chronic
Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
Hepatitis B, Chronic
Changes in serum alanine aminotransferase levels in telbivudine versus lamivudine treatment for chronic hepatitis B: A meta-analysis.
Hepatitis B, Chronic
Changes of serum sPD-1 levels in HBeAg-positive chronic hepatitis B patients with
entecavir treatment and correlation with curative effect
Hepatitis B, Chronic
Changes to the migratory inhibitory factor, IL-17, and IL-10 levels in serum from chronic hepatitis B patients and clinical significance following Baraclude(®) treatment.
Hepatitis B, Chronic
Characteristics of chronic hepatitis B patients who underwent liver biopsies.
Hepatitis B, Chronic
Characterization of T cell immunity in chronic hepatitis B virus-infected mothers with postpartum alanine transaminase flare.
Hepatitis B, Chronic
Clinical and histopathological features of chronic hepatitis B virus infected patients with high HBV-DNA viral load and normal alanine aminotransferase level: A multicentre-based study in China.
Hepatitis B, Chronic
Clinical features of treatment-naive patients with hepatitis B virus infection: A community-based survey from high- and intermediate-hepatitis B endemicity regions in Southeast China.
Hepatitis B, Chronic
Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.
Hepatitis B, Chronic
Clinical Non-invasive Model to Predict Liver Inflammation in Chronic Hepatitis B With Alanine Aminotransferase ? 2 Upper Limit of Normal.
Hepatitis B, Chronic
Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normal.
Hepatitis B, Chronic
Clinical Presentation and Disease Phases of Chronic Hepatitis B Using Conventional Versus Modified ALT Criteria in Asian Americans.
Hepatitis B, Chronic
Clinical significance of enlarged perihepatic lymph nodes in chronic hepatitis B.
Hepatitis B, Chronic
Clinical significance of low or negative titer of antibody to hepatitis B core antigen during the course of chronic hepatitis B virus infection in adolescents.
Hepatitis B, Chronic
Clinical significance of TT virus infection in children with chronic hepatitis B.
Hepatitis B, Chronic
Clinical trial results and treatment resistance with lamivudine in hepatitis B.
Hepatitis B, Chronic
Comparative study of C-reactive protein in chronic hepatitis B and chronic hepatitis C.
Hepatitis B, Chronic
Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels.
Hepatitis B, Chronic
Comparison of acoustic radiation force impulse imaging and transient elastography for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B.
Hepatitis B, Chronic
Comparison of antiviral effect of lamivudine with interferon-alpha2a versus -alpha2b in children with chronic hepatitis B infection.
Hepatitis B, Chronic
Comparison of clinical outcome between patients continuing and discontinuing lamivudine therapy after biochemical breakthrough of YMDD mutants.
Hepatitis B, Chronic
Comparison of FIB-4 and APRI in Chinese HBV-infected patients with persistently normal ALT and mildly elevated ALT.
Hepatitis B, Chronic
Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America.
Hepatitis B, Chronic
Comparison of histologic characteristics of Chinese chronic hepatitis B patients with persistently normal or mildly elevated ALT.
Hepatitis B, Chronic
Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection.
Hepatitis B, Chronic
Complementary laboratory indices for predicting the disease status of patients with hepatitis B virus infection.
Hepatitis B, Chronic
Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment.
Hepatitis B, Chronic
Declining diagnostic accuracy of non-invasive fibrosis tests is associated with elevated alanine aminotransferase in chronic hepatitis B.
Hepatitis B, Chronic
Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
Hepatitis B, Chronic
Detection of HBV core promoter and precore mutations helps distinguish flares of chronic hepatitis from acute hepatitis B.
Hepatitis B, Chronic
Development and Validation of a Model to Predict Advanced Fibrosis in Chronic Hepatitis B Virus-Infected Patients with High Viral Load and Normal or Minimally Raised ALT.
Hepatitis B, Chronic
Development and Validation of a Novel Model to Predict Liver Histopathology in Patients with Chronic Hepatitis B.
Hepatitis B, Chronic
Diagnostic accuracy of liver stiffness measurement in chronic hepatitis B patients with normal or mildly elevated alanine transaminase levels.
Hepatitis B, Chronic
Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
Hepatitis B, Chronic
Different models of HBeAg seroconversion predicated by on-treatment ALT and HBV DNA profiles.
Hepatitis B, Chronic
Double-blinded placebo-controlled study of Phyllanthus urinaris for the treatment of chronic hepatitis B.
Hepatitis B, Chronic
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase.
Hepatitis B, Chronic
Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients.
Hepatitis B, Chronic
Earlier Alanine Aminotransferase Normalization During Antiviral Treatment Is Independently Associated With Lower Risk of Hepatocellular Carcinoma in Chronic Hepatitis B.
Hepatitis B, Chronic
Early viral kinetics of telbivudine and entecavir: results of a 12-week randomized exploratory study with patients with HBeAg-positive chronic hepatitis B.
Hepatitis B, Chronic
Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.
Hepatitis B, Chronic
Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis.
Hepatitis B, Chronic
Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study.
Hepatitis B, Chronic
Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load.
Hepatitis B, Chronic
Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients.
Hepatitis B, Chronic
Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
Hepatitis B, Chronic
Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study.
Hepatitis B, Chronic
Efficacy of lamivudine or entecavir on acute exacerbation of chronic hepatitis B.
Hepatitis B, Chronic
Efficacy of short-term dexamethasone therapy in acute-on-chronic pre-liver failure.
Hepatitis B, Chronic
Efficacy of telbivudine in HBeAg-positive chronic hepatitis B patients with high baseline ALT levels.
Hepatitis B, Chronic
Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: Virological breakthrough is also dependent on adherence to medication.
Hepatitis B, Chronic
Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks.
Hepatitis B, Chronic
Entecavir versus lamivudine for HBeAg positive and negative chronic hepatitis B.
Hepatitis B, Chronic
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.
Hepatitis B, Chronic
Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levels.
Hepatitis B, Chronic
Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography.
Hepatitis B, Chronic
Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT???2 ULN: A retrospective cohort study.
Hepatitis B, Chronic
Evaluation of hepatitis B viraemia levels in patients with HBeAg-negative chronic hepatitis B virus infection.
Hepatitis B, Chronic
Evaluation of liver biopsy in Egyptian HBeAg-negative chronic hepatitis B patients at initial presentation: implications for therapy.
Hepatitis B, Chronic
Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.
Hepatitis B, Chronic
Evaluation of the need for treatment on 72 subjects with anti-HBe positive chronic hepatitis B.
Hepatitis B, Chronic
Expression of CXC chemokine IP-10 in patients with chronic hepatitis B.
Hepatitis B, Chronic
Expression of MicroRNA-155 is Downregulated in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B Patients.
Hepatitis B, Chronic
Expression of transforming growth factor-alpha mRNA in livers of patients with chronic viral hepatitis and hepatocellular carcinoma.
Hepatitis B, Chronic
Expression pattern of serum cytokines in hepatitis B virus infected patients with persistently normal alanine aminotransferase levels.
Hepatitis B, Chronic
Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy.
Hepatitis B, Chronic
Factors predictive of significant hepatic fibrosis in adults with chronic hepatitis B and normal serum ALT.
Hepatitis B, Chronic
Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B.
Hepatitis B, Chronic
Fibrosis progression rates between chronic hepatitis B and C patients with elevated alanine aminotransferase levels.
Hepatitis B, Chronic
Four years of lamivudine treatment in Chinese patients with chronic hepatitis B.
Hepatitis B, Chronic
Future aspects of therapy for hepatitis B virus infection: value of surrogate markers, innovative therapy, and global collaboration.
Hepatitis B, Chronic
Halting the natural history of hepatitis B viral infection: a paradigm shift.
Hepatitis B, Chronic
Hepatic necroinflammation and severe liver fibrosis in patients with chronic hepatitis B with undetectable HBV DNA and persistently normal alanine aminotransferase.
Hepatitis B, Chronic
Hepatitis B core antibody and liver stiffness measurements predict HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients with minimally elevated alanine aminotransferase (ALT) levels.
Hepatitis B, Chronic
Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management.
Hepatitis B, Chronic
Hepatitis B patients exhibiting mild alanine aminotransferase elevation: A comparative analysis of treatment with and without Bicyclol tablets.
Hepatitis B, Chronic
Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.
Hepatitis B, Chronic
Hepatitis B virus (HBV)-specific T-cell responses to recombinant HBV core protein in patients with normal liver function and co-infected with chronic HBV and human immunodeficiency virus 1 (HIV-1).
Hepatitis B, Chronic
Hepatitis B virus in the State of Alagoas, Brazil: genotypes characterization and mutations of the precore and basal core promoter regions.
Hepatitis B, Chronic
Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes.
Hepatitis B, Chronic
Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report.
Hepatitis B, Chronic
Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy.
Hepatitis B, Chronic
Hepatitis Flares Are Associated With Better Outcomes Than No Flare in Patients With Decompensated Cirrhosis and Chronic Hepatitis B Virus Infection.
Hepatitis B, Chronic
Hepatocyte growth factor (HGF) in patients with hepatitis B and meningitis.
Hepatitis B, Chronic
Hepatotoxicity following nevirapine-containing regimens in HIV-1-infected individuals.
Hepatitis B, Chronic
High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.
Hepatitis B, Chronic
High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation.
Hepatitis B, Chronic
High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B.
Hepatitis B, Chronic
Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B.
Hepatitis B, Chronic
Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
Hepatitis B, Chronic
Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis and Systematic Review.
Hepatitis B, Chronic
Histologic Disease in Chinese Chronic Hepatitis B Patients With Low Viral Loads and Persistently Normal Alanine Aminotransferase Levels.
Hepatitis B, Chronic
Histologic Evidence of Active Liver Injury in Chronic Hepatitis B Patients With Normal Range or Minimally Elevated Alanine Aminotransferase Levels.
Hepatitis B, Chronic
Histological disease in Asian-Americans with chronic hepatitis B, high hepatitis B virus DNA, and normal alanine aminotransferase levels.
Hepatitis B, Chronic
Histological improvement of chronic hepatitis B, and non-A, non-B with interferon treatment: application of a numerical scoring system for evaluating sequential morphologic changes.
Hepatitis B, Chronic
Histological improvement of long-term antiviral therapy in chronic hepatitis B patients with persistently normal alanine aminotransferase levels.
Hepatitis B, Chronic
Histopathological features of liver and its relation to serum transaminase levels in 91 cases of anti-HBe-positive chronic hepatitis B.
Hepatitis B, Chronic
Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission.
Hepatitis B, Chronic
How Can We Enhance the Performance of Liver Stiffness Measurement Using FibroScan in Diagnosing Liver Cirrhosis in Patients With Chronic Hepatitis B?
Hepatitis B, Chronic
Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus.
Hepatitis B, Chronic
Impact of liver biopsy on the decision to treat patients with chronic hepatitis B genotype D virus infection.
Hepatitis B, Chronic
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
Hepatitis B, Chronic
Impact of mild to moderate elevations of alanine aminotransferase on liver stiffness measurement in chronic hepatitis B patients during antiviral therapy.
Hepatitis B, Chronic
Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy.
Hepatitis B, Chronic
Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values.
Hepatitis B, Chronic
Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients.
Hepatitis B, Chronic
Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes.
Hepatitis B, Chronic
Influence of Genotype 3 Hepatitis C Coinfection on Liver Enzyme Elevation in HIV-1-Positive Patients After Commencement of a New Highly Active Antiretroviral Regimen: Results From the EPOKA-MASTER Cohort.
Hepatitis B, Chronic
Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare Settings.
Hepatitis B, Chronic
Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis.
Hepatitis B, Chronic
Is alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign?
Hepatitis B, Chronic
Lamivudine treatment in patients with chronic hepatitis B and cirrhosis.
Hepatitis B, Chronic
Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B.
Hepatitis B, Chronic
Lingmao Formula Combined with Entecavir for HBeAg-Positive Chronic Hepatitis B Patients with Mildly Elevated Alanine Aminotransferase: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Hepatitis B, Chronic
Liver transient elastography (Fibroscan): a place in the management algorithms of chronic viral hepatitis.
Hepatitis B, Chronic
Long-term evolution of chronic hepatitis B in children with antibody to hepatitis B e antigen.
Hepatitis B, Chronic
Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B.
Hepatitis B, Chronic
Long-term Nucleos(t)ides Analogues for Chronic Hepatitis B Improve Liver and Spleen Size: A Noninvasive Sonographic Study.
Hepatitis B, Chronic
Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.
Hepatitis B, Chronic
Longitudinal Change of Body Mass Index Is Associated With Alanine Aminotransferase Elevation After Complete Viral Suppression in Chronic Hepatitis B Patients.
Hepatitis B, Chronic
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B*
Hepatitis B, Chronic
Low level wild-type and pre-core mutant hepatitis B viruses and HBeAg negative reactivation of chronic hepatitis B.
Hepatitis B, Chronic
Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers.
Hepatitis B, Chronic
Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis.
Hepatitis B, Chronic
Management of hepatitis B: Pakistan Society for the Study of Liver Diseases (PSSLD) practice guidelines.
Hepatitis B, Chronic
Mass spectrometry-based plasma peptide profiling of acute exacerbation in HBeAg-positive chronic hepatitis B.
Hepatitis B, Chronic
Microwave treatment of serum facilitates detection of hepatitis B virus DNA by the polymerase chain reaction. Results of a study in anti-HBe positive chronic hepatitis B.
Hepatitis B, Chronic
Mild-to-Moderate Elevation of Alanine Aminotransferase Increases Liver Stiffness Measurement by Transient Elastography in Patients With Chronic Hepatitis B.
Hepatitis B, Chronic
Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase.
Hepatitis B, Chronic
Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patients.
Hepatitis B, Chronic
Noninvasive measurement of liver fibrosis by transient elastography and influencing factors in patients with chronic hepatitis B-A single center retrospective study of 466 patients.
Hepatitis B, Chronic
Nutritional therapy of chronic hepatitis by whey protein (non-heated).
Hepatitis B, Chronic
Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial.
Hepatitis B, Chronic
PD-1 expression on CTL may be related to more severe liver damage in CHB patients with HBV genotype C than in those with genotype B infection.
Hepatitis B, Chronic
Peripartum cytokine flares in a multiethnic cohort of chronic hepatitis B carriers does not correlate with hepatitis B virus suppression or increased risk of liver disease.
Hepatitis B, Chronic
Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients.
Hepatitis B, Chronic
Plasma Interleukin-10: A Likely Predictive Marker for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.
Hepatitis B, Chronic
Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT.
Hepatitis B, Chronic
Potential impact of long-term nucleoside therapy on the mortality and morbidity of active chronic hepatitis B.
Hepatitis B, Chronic
Pre-existing Liver Diseases and On-Admission Liver-Related Laboratory Tests in COVID-19: A Prognostic Accuracy Meta-Analysis With Systematic Review.
Hepatitis B, Chronic
Predictive Effect of Serial Serum Alanine Aminotransferase Levels on Spontaneous HBeAg Seroconversion in Chronic Genotypes B and C HBV infected Children.
Hepatitis B, Chronic
Predictors for advanced liver fibrosis in chronic hepatitis B virus infection with persistently normal or mildly elevated alanine aminotransferase.
Hepatitis B, Chronic
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B.
Hepatitis B, Chronic
Predictors of liver histological changes and a sustained virological response to peginterferon among chronic hepatitis B e antigen-positive patients with normal or minimally elevated alanine aminotransferase levels.
Hepatitis B, Chronic
PREDICTORS OF TREATMENT REQUIREMENT IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS WITH PERSISTENTLY NORMAL ALT AND HIGH SERUM HBV-DNA LEVELS.
Hepatitis B, Chronic
Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group.
Hepatitis B, Chronic
Prevalence of precore-defective mutant of hepatitis B virus in HBV carriers.
Hepatitis B, Chronic
Profile of HBV polymerase gene mutations during entecavir treatment in patients with chronic hepatitis B.
Hepatitis B, Chronic
Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.
Hepatitis B, Chronic
Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B.
Hepatitis B, Chronic
Relationships between transient elastography values and liver fibrosis in chronic liver disease patients with normal or mildly abnormal aminotransferase levels.
Hepatitis B, Chronic
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients.
Hepatitis B, Chronic
Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT.
Hepatitis B, Chronic
Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.
Hepatitis B, Chronic
Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase levels.
Hepatitis B, Chronic
Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B.
Hepatitis B, Chronic
Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: is sustained clearance of HBV DNA dependent on levels of pretreatment viremia?
Hepatitis B, Chronic
Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad.
Hepatitis B, Chronic
Serum alanine aminotransferase level and liver-related mortality in patients with chronic hepatitis B: A large national cohort study.
Hepatitis B, Chronic
Serum alanine transaminase level is a good predictor of response to interferon alfa therapy for chronic hepatitis B in human immunodeficiency virus-infected patients.
Hepatitis B, Chronic
Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
Hepatitis B, Chronic
Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease.
Hepatitis B, Chronic
Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase.
Hepatitis B, Chronic
Serum hepatitis B surface antigen levels predict insignificant fibrosis and non-cirrhosis in hepatitis B e antigen positive patients with normal or mildly elevated alanine transaminase levels.
Hepatitis B, Chronic
Serum levels of interleukin-12 in various clinical states with hepatitis B virus infection.
Hepatitis B, Chronic
Serum liver fibrosis markers discriminate significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase.
Hepatitis B, Chronic
Serum Metabolomics Reveals ?-Glutamyl Dipeptides as Biomarkers for Discrimination among Different Forms of Liver Disease.
Hepatitis B, Chronic
Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase.
Hepatitis B, Chronic
Serum Monocyte Chemoattractant Protein-1 Predicts Liver Inflammation of Patients with Chronic Hepatitis B.
Hepatitis B, Chronic
Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels.
Hepatitis B, Chronic
Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease.
Hepatitis B, Chronic
Sex difference in chronic hepatitis B virus infection: studies of serum HBeAg and alanine aminotransferase levels in 10,431 asymptomatic Chinese HBsAg carriers.
Hepatitis B, Chronic
Shear wave elastography for liver fibrosis in chronic hepatitis B: Adapting the cut-offs to alanine aminotransferase levels improves accuracy.
Hepatitis B, Chronic
Significant Hepatic Fibrosis Among Treatment-Naive Chronic Hepatitis B Virus With Increased Hepatitis B Virus DNA and Normal Alanine Aminotransferase.
Hepatitis B, Chronic
Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.
Hepatitis B, Chronic
Significant histological changes and satisfying antiviral efficacy in chronic hepatitis B virus infection patients with normal alanine aminotransferase. Antiviral therapy decision in chronic HBV patients with normal ALT.
Hepatitis B, Chronic
Significant histopathology in Chinese chronic hepatitis B patients with persistently high-normal alanine aminotransferase.
Hepatitis B, Chronic
Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels.
Hepatitis B, Chronic
Soluble E-cadherin as a serum biomarker in patients with HBV-related liver diseases.
Hepatitis B, Chronic
Spleen thickness can predict significant liver pathology in patients with chronic hepatitis B with persistently normal alanine aminotransferase or minimally raised alanine aminotransferase: a retrospective study.
Hepatitis B, Chronic
Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.
Hepatitis B, Chronic
Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ? 40 IU/L and significant hepatic fibrosis.
Hepatitis B, Chronic
Telbivudine Prevents Vertical Transmission from HBeAg-Positive Women With Chronic Hepatitis B.
Hepatitis B, Chronic
Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission.
Hepatitis B, Chronic
Tenofovir Alafenamide Attenuates Effects of Diabetes and Body Mass on Serum Alanine Aminotransferase Activities in Patients With Chronic Hepatitis B.
Hepatitis B, Chronic
The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial.
Hepatitis B, Chronic
The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase.
Hepatitis B, Chronic
The independent predictors of significant liver histological changes in chronic hepatitis B virus infection patients with persistently high-normal or low-normal alanine transaminase levels.
Hepatitis B, Chronic
The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points.
Hepatitis B, Chronic
The role of the non-invasive serum marker FibroTest-ActiTest in the prediction of histological stage of fibrosis and activity in children with naïve chronic hepatitis B infection.
Hepatitis B, Chronic
The serum interleukin-26 level is a potential biomarker for chronical hepatitis B.
Hepatitis B, Chronic
The Study of Clinical and Biochemical Parameters in Assessing the Response to the Antiviral Therapy in the Chronic Viral Hepatitis B.
Hepatitis B, Chronic
Three Years of Continuous Entecavir Therapy in Treatment-Naïve Chronic Hepatitis B Patients: VIRAL Suppression, Viral Resistance, and Clinical Safety.
Hepatitis B, Chronic
Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study.
Hepatitis B, Chronic
Treatment of chronic hepatitis B in Asia-Pacific countries: is the Asia-Pacific consensus statement being followed?
Hepatitis B, Chronic
Treatment of HBeAg-negative chronic hepatitis B with pegylated interferon.
Hepatitis B, Chronic
Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States.
Hepatitis B, Chronic
Two patterns of alanine aminotransferase increase to predict long-term viral response in chronic hepatitis B patients: virus- or host-induced?
Hepatitis B, Chronic
Viral and host factors related with histopathologyc activity in patients with chronic hepatitis B and moderate or intermittently elevated alanine aminotransferase levels.
Hepatitis B, Chronic
[Accuracy of FibroScan for the diagnosis of liver fibrosis influenced by serum alanine aminotransferase levels in patients with chronic hepatitis B].
Hepatitis B, Chronic
[Association of baseline alanine aminotransferase levels with therapeutic effects of entecavir and interferon-? in patients with chronic hepatitis B].
Hepatitis B, Chronic
[Association of liver histopathology and clinical features among patients with chronic hepatitis B virus infection].
Hepatitis B, Chronic
[Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
Hepatitis B, Chronic
[Direct more attention to chronic hepatitis B patients with normal serum alanine aminotransferase levels.]
Hepatitis B, Chronic
[Expression of chemokine monokine induced by interferon-gama in patients with chronic hepatitis B]
Hepatitis B, Chronic
[Hepatic stetaosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads]
Hepatitis B, Chronic
[Hepatitis B virus genotypes and alanine aminotransferase levels in HBeAg negative patients with chronic hepatitis B and liver cirrhosis]
Hepatitis B, Chronic
[Histological changes in the livers of chronic hepatitis B patients with persistently normal serum alanine transaminase levels]
Hepatitis B, Chronic
[Investigation of the relationship between serum nitric oxide levels, HBV-DNA and ALT levels in chronic hepatitis B patients]
Hepatitis B, Chronic
[Pathological study of liver biopsy from 156 patients clinically diagnosed with mild chronic hepatitis B based on current guideline]
Hepatitis B, Chronic
[Relation of serological markers of hepatitis B virus and alanine transaminase to hepatic tissue pathology in patients with chronic hepatitis B]
Hepatitis B, Chronic
[Relationship between HBV DNA serum level and acute exacerbation of the disease in chronic hepatitis B patients]
Hepatitis B, Chronic
[The comparison of liver inflammation and fibrosis between chronic HBV and HCV infection].
Hepatitis B, Chronic
[The correlation between the spontaneous clearance of HBV DNA and the levels of Alanine Aminotransferase in chronic hepatitis B].
Hepatitis B, Chronic
[The therapeutic effects of pegasys in chronic hepatitis B patients with low-level ALT].
Hepatitis C
A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus.
Hepatitis C
A case of intrahepatic cholangiocarcinoma detected after successful interferon therapy for chronic hepatitis C.
Hepatitis C
A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997-1999.
Hepatitis C
A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase.
Hepatitis C
A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT.
Hepatitis C
A double-blind controlled trial of recombinant interferon-alpha 2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels. Nephrologists' Group for the Study of HCV infection.
Hepatitis C
A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Hepatitis Study Group of the Association of Italian Hemophilia Centers.
Hepatitis C
A physician with a positive hepatitis C virus RNA test after a needlestick injury.
Hepatitis C
A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C.
Hepatitis C
A pilot study of daily subcutaneous interleukin-10 in patients with chronic hepatitis C infection.
Hepatitis C
A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.
Hepatitis C
A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C.
Hepatitis C
A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use.
Hepatitis C
A search for hepatitis C virus polymerase chain reaction-positive but seronegative subjects among blood donors with elevated alanine aminotransferase.
Hepatitis C
A short induction regimen of interferon-alpha is not effective for treatment of relapse in chronic hepatitis C: a randomized trial. For the multicentre GER-CYT-01 group.
Hepatitis C
Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in haemodialysis patients.
Hepatitis C
Abnormal serum porphyrin levels in patients with the acquired immunodeficiency syndrome with or without hepatitis C virus infection.
Hepatitis C
Accuracy of body mass index in detecting an elevated alanine aminotransferase level in adolescents.
Hepatitis C
Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C.
Hepatitis C
Acute Hepatitis C in an HIV-Infected patient: A Case Report and Review of Literature.
Hepatitis C
Acute hepatitis C treatment in advanced renal failure using 8 weeks of pan-genotypic daclatasvir and reduced-dose sofosbuvir.
Hepatitis C
Advanced Hepatic Fibrosis and Steatosis Are Associated With Persistent Alanine Aminotransferase Elevation in Chronic Hepatitis C Patients Negative for Hepatitis C Virus RNA During Pegylated Interferon Plus Ribavirin Therapy.
Hepatitis C
After successful hepatitis C virus antiviral therapy: It looks that normal alanine aminotransferase level is not the normal.
Hepatitis C
Age-related comparison of the profiles of patients with hepatocellular carcinoma.
Hepatitis C
Alanine aminotransferase flare-up in hepatitis C virus carriers with persistently normal alanine aminotransferase levels in a hyperendemic area of Japan.
Hepatitis C
Alanine aminotransferase level as a predictor of hepatitis C virus-associated hepatocellular carcinoma incidence in a community-based population in Japan.
Hepatitis C
Alanine aminotransferase normalization at week 8 predicts viral response during hepatitis C treatment.
Hepatitis C
Alanine aminotransferase, gamma-glutamyltransferase, antibodies to hepatitis B core antigen and antibodies to hepatitis C virus in blood donor screening. A prospective study in Finland.
Hepatitis C
Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection.
Hepatitis C
Alanine transaminase levels in the year before pregnancy predict the risk of hepatitis C virus vertical transmission.
Hepatitis C
Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels.
Hepatitis C
Analysis of ELISA hepatitis C virus-positive blood donors population by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA.
Hepatitis C
Analyzing predictors of graft survival in patients undergoing liver transplantation with donors aged 70 years and over.
Hepatitis C
Anticarcinogenic impact of interferon on patients with chronic hepatitis C: a large-scale long-term study in a single center.
Hepatitis C
Are hepatitis G virus and TT virus involved in cryptogenic chronic liver disease?
Hepatitis C
Assessment and proposal of a new combination of screening criteria for hepatitis C in France.
Hepatitis C
Assessment of liver histology in patients with hepatitis C and normal transaminase levels.
Hepatitis C
Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C.
Hepatitis C
Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis.
Hepatitis C
Association of Interferon Alpha Receptor 1 with sustained virological response in hepatitis C and B co-infected patients.
Hepatitis C
Beta interferon therapy for chronic hepatitis C in patients with haemophilia and other haemorrhagic disorders.
Hepatitis C
Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
Hepatitis C
Biochemical response to interferon therapy correlates with interferon sensitivity-determining region in hepatitis C virus genotype 1b infection.
Hepatitis C
Body mass index is a good predictor of an elevated alanine transaminase level in the general population: hints from the Dionysos study.
Hepatitis C
Case report: Occurrence of hepatocellular carcinoma 4.5 years after successful treatment with virus clearance for chronic hepatitis C.
Hepatitis C
Changes in serum hepatic fibrosis markers in biochemical responders to interferon therapy for chronic hepatitis C.
Hepatitis C
Characteristics of hepatocellular carcinoma in hemodialysis patients in hepatitis B endemic area.
Hepatitis C
Characterization of anti-hepatitis C virus-positive sera not genotyped by restriction fragment length polymorphism or serology.
Hepatitis C
Chemical aspects of coumarin compounds for the prevention of hepatocellular carcinomas.
Hepatitis C
Chronic hepatitis C and interferon alfa therapy: predictors of long term response.
Hepatitis C
Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.
Hepatitis C
Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children.
Hepatitis C
Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon. The Consensus Interferon Study Group.
Hepatitis C
Chronic hepatitis C with normal or abnormal aminotransferase levels: is it the same entity?
Hepatitis C
Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy.
Hepatitis C
Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation.
Hepatitis C
Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis.
Hepatitis C
Clinical characteristics of patients with chronic hepatitis C showing biochemical remission, without hepatitis C virus eradication, as a result of interferon therapy. The Osaka Liver Disease Study Group.
Hepatitis C
Clinical features of hepatitis C virus carriers with persistently normal alanine aminotransferase levels.
Hepatitis C
Clinical impact of normal alanine aminotransferase on direct-acting antiviral outcome in patients with chronic hepatitis C virus infection.
Hepatitis C
Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence.
Hepatitis C
Clinical significance of activity of ALT enzyme in patients with hepatitis C virus.
Hepatitis C
Clinical significance of hepatitis G virus infection in patients on long-term haemodialysis.
Hepatitis C
Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C.
Hepatitis C
Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels.
Hepatitis C
Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.
Hepatitis C
Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma--results of 152 resected cases.
Hepatitis C
Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis.
Hepatitis C
Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma.
Hepatitis C
Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C.
Hepatitis C
Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial.
Hepatitis C
Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study.
Hepatitis C
Comparative effects of different doses of ribavirin plus interferon-alpha2b for therapy of chronic hepatitis C: results of a controlled, randomized trial.
Hepatitis C
Comparison among Different Types, Dosages and Duration of Interferon Therapy in Chronic Hepatitis C.
Hepatitis C
Comparison of clinical, virologic and pathologic features in patients with acute hepatitis B and C.
Hepatitis C
Comparison of hepatitis C virus testing strategies: birth cohort versus elevated alanine aminotransferase levels.
Hepatitis C
Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation.
Hepatitis C
Comparison of the sensitivity of nested PCR in the 5' non-coding and the NS5 regions of the HCV genome.
Hepatitis C
Comparison of three different immunoassays and PCR for the detection of hepatitis C virus infection in pregnant women in Taiwan.
Hepatitis C
Comparison of thrice weekly vs daily human leucocyte interferon-alpha therapy for chronic hepatitis C. TVVH Study Group.
Hepatitis C
Consistently normal CD4+, CD8+ levels in haemophilic boys only treated with a virally safe factor VIII concentrate (BPL 8Y)
Hepatitis C
Correlation between serum HCV RNA and aminotransferase levels in patients with chronic HCV infection.
Hepatitis C
Correlation between serum levels of alanine aminotransferase and ferritin in male blood donors with antibody to hepatitis C virus.
Hepatitis C
Correlation between the serum level of hepatitis C virus RNA and disease activities in acute and chronic hepatitis C.
Hepatitis C
Correlation of biological serum markers with the degree of hepatic fibrosis and necroinflammatory activity in hepatitis C and schistosomiasis patients.
Hepatitis C
Correlation of hepatitis C RNA and serum alanine aminotransferase in hepatitis B and C seronegative healthy blood donors.
Hepatitis C
Correlation of plasma hepatitis C virus RNA levels with serum alanine aminotransferase in non-A, non-B chronic liver disease.
Hepatitis C
Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin.
Hepatitis C
Correlation of viral RNA, alanine aminotransferase, and histopathology in hepatitis C virus-associated hepatitis.
Hepatitis C
Costs and cost-effectiveness of different follow-up schedules for detection of occupational hepatitis C virus infection.
Hepatitis C
De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.
Hepatitis C
Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
Hepatitis C
Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study.
Hepatitis C
Detection and quantitation of serum HCV-RNA by branched DNA amplification in anti-HCV positive blood donors.
Hepatitis C
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
Hepatitis C
Detection of hepatitis B virus DNA in the liver and serum of patients with hepatitis B surface antigen and hepatitis C virus antibody negative chronic liver disease.
Hepatitis C
Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.
Hepatitis C
Detection of Hepatitis C virus RNA in peripheral blood mononuclear cells of patients with abnormal alanine transaminase in Ahvaz.
Hepatitis C
Detection of the hepatitis C virus genome in acute and chronic experimental infection in chimpanzees.
Hepatitis C
Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities.
Hepatitis C
Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase.
Hepatitis C
Determinants of serum ALT normalization after phlebotomy in patients with chronic hepatitis C infection.
Hepatitis C
Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
Hepatitis C
Development of a TT virus DNA quantification system using real-time detection PCR.
Hepatitis C
Development of multicentric hepatocellular carcinoma after completion of interferon therapy.
Hepatitis C
Development of well-differentiated hepatocellular carcinoma in large adenomatous hyperplasia after long-term follow-up: a case report.
Hepatitis C
Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests.
Hepatitis C
Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
Hepatitis C
Difference in serum complement component C4a levels between hepatitis C virus carriers with persistently normal alanine aminotransferase levels or chronic hepatitis C.
Hepatitis C
Different hepatitis C virus (HCV) RNA load profiles following seroconversion among injecting drug users without correlation with HCV genotype and serum alanine aminotransferase levels.
Hepatitis C
Disappearance of hepatitis C virus RNA in plasma during interferon alpha-2B treatment in hemophilia patients.
Hepatitis C
Discordance between serum alanine aminotransferase (ALT) and virologic response to IFN-alpha2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers.
Hepatitis C
Dissociation of serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus and treated with antiretroviral drugs.
Hepatitis C
Do serum ALAT values reflect the inflammatory activity in the liver of patients with chronic viral hepatitis?
Hepatitis C
Does a rapid decline in the hematological and biochemical parameters induced by interferon and ribavirin combination therapy for the hepatitis C virus predict a sustained viral response?
Hepatitis C
Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes.
Hepatitis C
Durability of serological remission in chronic hepatitis C treated with interferon-alpha-2B.
Hepatitis C
Early increased ficolin-2 concentrations are associated with severity of liver inflammation and efficacy of anti-viral therapy in chronic hepatitis C patients.
Hepatitis C
Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT.
Hepatitis C
Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.
Hepatitis C
Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C.
Hepatitis C
Effect of caffeine-containing beverage consumption on serum alanine aminotransferase levels in patients with chronic hepatitis C virus infection: a hospital-based cohort study.
Hepatitis C
Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection.
Hepatitis C
Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users.
Hepatitis C
Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.
Hepatitis C
Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study.
Hepatitis C
Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C.
Hepatitis C
Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C.
Hepatitis C
Effectiveness of interferon treatment for patients with chronic hepatitis C virus infection and normal aminotransferase levels.
Hepatitis C
Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees.
Hepatitis C
Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C.
Hepatitis C
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C.
Hepatitis C
Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection.
Hepatitis C
Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy.
Hepatitis C
Efficacy of interferon retreatment on interferon-resistant patients with chronic hepatitis C.
Hepatitis C
Efficacy of interferon treatment for patients with chronic hepatitis C: comparison of response in cirrhotics, fibrotics, or nonfibrotics.
Hepatitis C
Efficacy of long-term dietary restriction of total calories, fat, iron, and protein in patients with chronic hepatitis C virus.
Hepatitis C
Efficacy of longterm interferon treatment in chronic liver disease evaluated by sensitive polymerase chain reaction assay for hepatitis C virus RNA.
Hepatitis C
Elevated alanine aminotransferase (ALT) in blood donors: an assessment of the main associated conditions and its relationship to the development of hepatitis C.
Hepatitis C
Elevated serum alanine aminotransferase levels in blood donors: the contribution of hepatitis C virus.
Hepatitis C
Elevated serum soluble Fas levels in the various stages of hepatitis C virus-induced liver disease.
Hepatitis C
Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse.
Hepatitis C
End-stage renal disease and hepatitis C infection: comparison of alanine aminotransferase levels and liver histology in patients with and without renal damage.
Hepatitis C
Epidemiological aspects of hepatitis C virus infection among renal transplant recipients in Central Brazil.
Hepatitis C
Epidemiological, clinical and biological characteristics of acute non-A, non-B hepatitis with and without hepatitis C virus infection.
Hepatitis C
Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia.
Hepatitis C
Estimating the Time to Diagnosis and the Chance of Spontaneous Clearance During Acute Hepatitis C in Human Immunodeficiency Virus-Infected Individuals.
Hepatitis C
Evaluation of serum alanine transaminase as a surrogate for hepatitis C virus screening.
Hepatitis C
Evaluation of serum hyaluronic acid level and hyaluronidase activity in acute and chronic hepatitis C.
Hepatitis C
Evaluation of twice-daily administration of interferon-beta for chronic hepatitis C.
Hepatitis C
Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively.
Hepatitis C
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals.
Hepatitis C
Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels.
Hepatitis C
Fish to meat intake ratio and cooking oils are associated with hepatitis C virus carriers with persistently normal alanine aminotransferase levels.
Hepatitis C
Follow-up of mild alanine aminotransferase elevation identifies hidden hepatitis C in primary care.
Hepatitis C
Frequency and characteristics of post-transfusion hepatitis in Greece with emphasis on hepatitis C: comparing second- and third-generation assays.
Hepatitis C
Frequency of hepatitis C viral RNA in anti-hepatitis C virus non- reactive blood donors with normal alanine aminotransferase.
Hepatitis C
Frequency of hepatitis C viral RNA in anti-hepatitis C virus non- reactive blood donors with raised alanine aminotransferase.
Hepatitis C
Frequency of hepatitis C virus antibodies and elevated serum alanine transaminase levels in Ghanaian blood donors.
Hepatitis C
Frequency of hepatitis G virus infection among HIV positive subjects with parenteral and sexual exposure.
Hepatitis C
Gender-Related Risk Factors Improve Mortality Predictive Ability of VACS Index Among HIV-Infected Women.
Hepatitis C
Genetic analysis of serum alanine transaminase activity in normal and hepatitis C virus-infected chimpanzees: an application of research-oriented genetic management.
Hepatitis C
Genetic variants associated with serum alanine aminotransferase levels among patients with hepatitis C virus infection: A genome-wide association study.
Hepatitis C
Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C.
Hepatitis C
Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers.
Hepatitis C
HBV genotype C is independently associated with cirrhosis in community-based population.
Hepatitis C
Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection.
Hepatitis C
Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin.
Hepatitis C
Hepatitis B Evaluation and Linkage to Care for Newly Arrived Refugees: A Multisite Quality Improvement Initiative.
Hepatitis C
Hepatitis B surface antigen, hepatitis C virus antibody, body mass index, and alcohol drinking among workers with elevated serum alanine aminotransferase.
Hepatitis C
Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention.
Hepatitis C
Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group.
Hepatitis C
Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels.
Hepatitis C
Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C.
Hepatitis C
Hepatitis C viremia in German blood donors: serum alanine aminotransferase is not a valid marker for screening.
Hepatitis C
Hepatitis C virus (HCV)-specific in vitro antibody secretion by peripheral blood lymphocytes: correlation with progression of disease and HCV RNA in HCV antibody-positive patients.
Hepatitis C
Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease.
Hepatitis C
Hepatitis C virus and GB virus C/hepatitis G virus viremia in Swedish blood donors with different alanine aminotransferase levels.
Hepatitis C
Hepatitis C virus antibody in multiply transfused Chinese with thalassaemia major.
Hepatitis C
Hepatitis C Virus Clearance by Direct-acting Antiviral Results in Rapid Resolution of Hepatocytic Injury as Indicated by Both Alanine Aminotransferase and Aspartate Aminotransferase Normalization.
Hepatitis C
Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town.
Hepatitis C
Hepatitis C virus infection in a resident elderly population: a 10-year follow-up study.
Hepatitis C
Hepatitis C virus infection in pregnant women: detection by different anti-HCV immunoassays and serum HCV-RNA.
Hepatitis C
Hepatitis C virus RNA and hepatitis C virus antibody in the serum of patients with abnormal liver function.
Hepatitis C
Hepatitis C virus screening and clinical monitoring of biomarkers in patients undergoing hemodialysis.
Hepatitis C
Hepatitis C virus-infected patients with a persistently normal alanine aminotransferase: do they exist and is this really a group with mild disease?
Hepatitis C
Hepatitis C virus: prevalence and routes of infection among blood donors of West Mexico.
Hepatitis C
Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and nonviral chronic liver disease.
Hepatitis C
Hepatitis G virus infection in a high-risk subgroup of hospitalized dental patients.
Hepatitis C
Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels.
Hepatitis C
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy.
Hepatitis C
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.
Hepatitis C
High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.
Hepatitis C
High dosage alpha-interferon for treatment of children and young adults with chronic hepatitis C disease.
Hepatitis C
High Human Immunodeficiency Virus (HIV) Viral Load and Coinfection with Viral Hepatitis Are Associated with Liver Enzyme Abnormalities among HIV Seropositive Patients on Antiretroviral Therapy in the Lake Victoria Zone, Tanzania.
Hepatitis C
High prevalence of hepatitis G virus infection in multiply transfused children with thalassaemia.
Hepatitis C
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
Hepatitis C
High prevalence, low pathogenicity of hepatitis G virus in kidney transplant recipients.
Hepatitis C
High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study.
Hepatitis C
High serum alanine aminotransferase levels for the first three successive years can predict very high incidence of hepatocellular carcinoma in patients with Child Stage A HCV-associated liver cirrhosis.
Hepatitis C
Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC).
Hepatitis C
Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels.
Hepatitis C
How soon can a virological sustained response be determined after withdrawal of interferon therapy in chronic hepatitis C? Tokyo-Chiba Hepatitis Research Group.
Hepatitis C
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts.
Hepatitis C
Hypervariable region 1 quasispecies in hepatitis C virus genotypes 1b and 3 infected patients with normal and abnormal alanine aminotransferase levels.
Hepatitis C
Identifying hepatitis C virus: endemic areas and estimating the viral antibody prevalence based on the prevalence of ALT elevation.
Hepatitis C
Idiopathic CD4+ T-lymphocytopenia in HIV seronegative men with hemophilia and sex partners of HIV seropositive men. Multicenter Hemophilia Cohort Study.
Hepatitis C
IFN-alpha2b monotherapy in patients with chronic hepatitis C and persistently normal or near normal aminotransferase activity: a randomized, controlled study.
Hepatitis C
IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C.
Hepatitis C
IL-28B polymorphisms and treatment response in hepatitis C virus patients with persistently normal alanine aminotransferase.
Hepatitis C
Immunolocalisation of interferon-alpha in hepatitis C patients and its correlation with response to interferon-alpha therapy.
Hepatitis C
Immunosuppressive effect of chenodeoxycholic acid on natural killer cell activity in patients with biliary atresia and hepatitis C virus-related liver cirrhosis.
Hepatitis C
Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission.
Hepatitis C
Impaired function of dendritic cells circulating in patients infected with hepatitis C virus who have persistently normal alanine aminotransferase levels.
Hepatitis C
Improved detection of hepatitis C virus RNA by reverse transcription and polymerase chain reaction.
Hepatitis C
Improvement of alanine aminotransferase by administration of suplatast tosilate plus ursodeoxycholic acid in patients with resistance to ursodeoxycholic acid monotherapy on hepatitis C virus-related chronic liver disease.
Hepatitis C
Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study.
Hepatitis C
Incidence of hepatitis C in patients with chronic elevations of aminotransferases.
Hepatitis C
Incidence of hepatocellular carcinoma after interferon therapy in patients with chronic hepatitis C.
Hepatitis C
Incidence of hepatocellular carcinoma in chronic hepatitis C after interferon therapy.
Hepatitis C
Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels.
Hepatitis C
Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
Hepatitis C
Increased frequency of IFN-gamma-producing peripheral CD8+ T cells with memory-phenotype in patients with chronic hepatitis C.
Hepatitis C
Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels.
Hepatitis C
Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flares.
Hepatitis C
Induction of antinuclear antibody after interferon therapy in patients with type-C chronic hepatitis: its relation to the efficacy of therapy.
Hepatitis C
Infection with hepatitis G virus and its strain variant, the GB agent (GBV-C), among blood donors in Japan.
Hepatitis C
Infectious disease testing for blood transfusions. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions.
Hepatitis C
Infective, chronic carriers of hepatitis C virus among blood donors with no history of clinical hepatitis.
Hepatitis C
Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3.4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a.
Hepatitis C
Influence of hepatitis C virus (HCV) genotype, HCV RNA load, and alanine aminotransferase level on reduction of HCV RNA after a single administration of interferon-alpha.
Hepatitis C
Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus.
Hepatitis C
Inhibition of hepatocellular carcinoma by PegIFN?-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study.
Hepatitis C
Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo.
Hepatitis C
Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study.
Hepatitis C
Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group.
Hepatitis C
Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study.
Hepatitis C
Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial.
Hepatitis C
Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: a comparison with genotype 1.
Hepatitis C
Interferon retreatment of nonresponders with HCV-RNA-positive chronic hepatitis C.
Hepatitis C
Interferon sensitivity-determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection.
Hepatitis C
Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
Hepatitis C
Interferon-alpha 2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: a prospective and randomised trial.
Hepatitis C
Interferon-alpha plus amantadine in chronic hepatitis C resistant to interferon alone: a pilot randomized study.
Hepatitis C
Interferon-alpha plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers.
Hepatitis C
Interferon-based hepatitis C antiviral treatment outcomes may be predicted by alanine aminotransferase levels.
Hepatitis C
Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption.
Hepatitis C
Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial.
Hepatitis C
Investigation of transfusion transmitted viruses in cases clinically suspected of posttransfusion hepatitis with undetermined ethiology.
Hepatitis C
Is alanine aminotransferase a good marker of histologic hepatic damage in renal transplant patients with hepatitis C virus infection?
Hepatitis C
Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
Hepatitis C
Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Hepatitis C
Is the response to recombinant alpha interferon related to the presence of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis?
Hepatitis C
Lack of association between serum leptin levels and hepatic steatosis, fibrosis or response to antiviral therapy in Korean chronic hepatitis C patients.
Hepatitis C
Lack of higher frequency of the chemokine receptor 5-delta32/delta32 genotype in hepatitis C.
Hepatitis C
Limited utility of alanine aminotransferase screening of hepatitis C antibody-screened blood donors.
Hepatitis C
Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
Hepatitis C
Liver biopsy in hepatitis C virus carriers with normal alanine aminotransferase levels.
Hepatitis C
Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C.
Hepatitis C
Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection.
Hepatitis C
Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation.
Hepatitis C
Liver fibrosis and iron levels during long-term deferiprone treatment of thalassemia major patients.
Hepatitis C
Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase.
Hepatitis C
Liver fibrosis in HIV-positive patients with hepatitis C virus: role of persistently normal alanine aminotransferase levels.
Hepatitis C
Liver fibrosis progression in HIV/hepatitis C virus coinfected patients with normal aminotransferases levels.
Hepatitis C
Long term survey of hepatitis C virus infection in hemodialysis units in Fukuoka, Japan.
Hepatitis C
Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C.
Hepatitis C
Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.
Hepatitis C
Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels.
Hepatitis C
Long-term follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses.
Hepatitis C
Long-term follow-up of patients with hepatitis C with a normal alanine aminotransferase.
Hepatitis C
Long-term follow-up of sustained responders to interferon therapy, in patients with chronic hepatitis C.
Hepatitis C
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
Hepatitis C
Long-term monitoring of platelet count, as a non-invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy.
Hepatitis C
Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevation.
Hepatitis C
Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
Hepatitis C
Low prevalence of hepatitis C virus and infrequent perinatal or spouse infections in pregnant women in Taiwan.
Hepatitis C
Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels.
Hepatitis C
Matrix metalloproteinases 2 and 9 correlate with alanine aminotransferase and hepatitis C virus in blood donors.
Hepatitis C
MicroRNA profiles in serum samples from patients with stable cirrhosis and miRNA-21 as a predictor of transplant-free survival.
Hepatitis C
Modified range of alanine aminotransferase is insufficient for screening of hepatitis C virus infection in hemodialysis patients.
Hepatitis C
Molecular analysis and patterns of ALT and hepatitis C virus seroconversion in haemodialysis patients with acute hepatitis.
Hepatitis C
Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection.
Hepatitis C
New infection with heterotypic hepatitis C virus in a patient with long-term hepatitis C virus eradication.
Hepatitis C
Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy.
Hepatitis C
Non-invasive assessment of fibrosis using color Doppler ultrasound in patients with hepatitis C virus in the Amazon rainforest, Brazil.
Hepatitis C
Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment.
Hepatitis C
Nonalcoholic Fatty Liver Disease and Risk of Diabetes: A Prospective Study in China.
Hepatitis C
Nonalcoholic Fatty Liver Disease is Underrecognized in the Primary Care Setting.
Hepatitis C
Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study.
Hepatitis C
Occult Hepatitis B Virus Infection in HIV-Infected Patients with Isolated Hepatitis B Core Antibody.
Hepatitis C
On alanine aminotransferase, hepatitis C virus, and reverse transcription-polymerase chain reaction.
Hepatitis C
Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.
Hepatitis C
Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation.
Hepatitis C
Outcomes of Controlled Donation After Cardiac Death Compared With Donation After Brain Death in Liver Transplantation: A Systematic Review and Meta-analysis.
Hepatitis C
Parenterally transmitted non-A, non-B hepatitis: virus-specific antibody response patterns in hepatitis C virus-infected chimpanzees.
Hepatitis C
Peginterferon alfa-2b treatment for patients affected by acute hepatitis C: presentation of six case reports.
Hepatitis C
Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.
Hepatitis C
PNPLA3 polymorphisms are associated with raised alanine aminotransferase levels in hepatitis C virus genotype 3.
Hepatitis C
Polyneuropathy with demyelinating features in mixed cryoglobulinemia with hepatitis C virus infection.
Hepatitis C
Post-partum acute exacerbation of chronic hepatitis in a hepatitis C-carrier mother.
Hepatitis C
Posthepatectomy hepatitis shortens tumor-free intervals in hepatitis C virus-associated hepatocellular carcinoma patients.
Hepatitis C
Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin.
Hepatitis C
Predicting the prevalence of antibody to hepatitis C virus (HCV) in a community by the prevalence of elevated levels of alanine aminotransferase: a method to identify areas endemic for HCV.
Hepatitis C
Prediction of a favorable clinical course in hepatitis C virus carriers with persistently normal serum alanine aminotransferase levels: A long-term follow-up study.
Hepatitis C
Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin.
Hepatitis C
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Hepatitis C
Predictors of Pegylated Interferon Alpha and Ribavirin Efficacy and Long-Term Assessment of Relapse in Patients With Chronic Hepatitis C: A One-Center Experience From China.
Hepatitis C
Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon-alpha.
Hepatitis C
Prevalence and genomic variability of transfusion transmitted virus in Italian cryptogenic chronic liver disease and healthy blood donors.
Hepatitis C
Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.
Hepatitis C
Prevalence of antibodies to hepatitis C virus (anti-HCV) in different populations in Taiwan.
Hepatitis C
Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients.
Hepatitis C
Prevalence of hepatic abnormalities in a cohort of Egyptian children with type 1 diabetes mellitus.
Hepatitis C
Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
Hepatitis C
Prevalence of hepatitis C infection in a large urban hospital-based sample of individuals with spinal cord injury.
Hepatitis C
Prevalence of hepatitis C virus antibodies in Italian blood donors. The Italian Cooperative Group.
Hepatitis C
Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre.
Hepatitis C
Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
Hepatitis C
Prognostic impact of postoperative low platelet count after liver transplantation.
Hepatitis C
Prolonged treatment of chronic C hepatitis by means of medium-high doses of recombinant alpha-2b interferon: an open study to evaluate response and long-term relapse.
Hepatitis C
Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies.
Hepatitis C
Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.
Hepatitis C
Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus.
Hepatitis C
Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C.
Hepatitis C
Randomized controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor for the treatment of chronic hepatitis c.
Hepatitis C
Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferase.
Hepatitis C
Re-treatment with interferon-beta of patients with chronic hepatitis C virus infection.
Hepatitis C
Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: do they alter their decision with time?
Hepatitis C
Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis.
Hepatitis C
Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis C.
Hepatitis C
Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis.
Hepatitis C
Relation between incidence of hepatic carcinogenesis and integration value of alanine aminotransferase in patients with hepatitis C virus infection.
Hepatitis C
Relation between serum hepatitis C virus-RNA levels and efficacy of interferon-beta therapy.
Hepatitis C
Relationship between biochemical and virological responses to interferon therapy in chronic hepatitis C infection. Consensus Interferon Study Group.
Hepatitis C
Relationship between fatty liver, alanine aminotransferase, HBsAg and hepatitis C virus.
Hepatitis C
Relationship between serum alanine aminotransferase levels and liver histology in chronic hepatitis C-infected patients.
Hepatitis C
Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
Hepatitis C
Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC.
Hepatitis C
Relationship of TT virus infection with prevalence of hepatitis C virus infection and elevated alanine aminotransferase levels.
Hepatitis C
Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan.
Hepatitis C
Relationships between serum asunaprevir concentration and alanine aminotransferase elevation during daclatasvir plus asunaprevir for chronic HCV genotype 1b infection.
Hepatitis C
Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus.
Hepatitis C
Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity.
Hepatitis C
Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation.
Hepatitis C
Risk factors associated with hepatitis B or C markers or elevated alanine aminotransferase level among blood donors on a tropical island: the Guadeloupe experience.
Hepatitis C
Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004.
Hepatitis C
Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin.
Hepatitis C
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
Hepatitis C
Risk factors for liver disease among adults of Mexican descent in the United States and Mexico.
Hepatitis C
Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI.
Hepatitis C
Risk factors for relapse in chronic hepatitis C patients who have achieved end of treatment response.
Hepatitis C
Risk factors for remaining liver injury in patients with virological elimination of chronic hepatitis C.
Hepatitis C
Risk of alanine aminotransferase flare-up among asymptomatic hepatitis C virus RNA carriers: a 10-year follow-up study.
Hepatitis C
Risk of hepatitis C virus infection in a population exposed to biological materials.
Hepatitis C
Risk score system for the prediction of hepatocellular carcinoma in patients with type 2 diabetes: Taiwan Diabetes Study.
Hepatitis C
Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
Hepatitis C
SEN virus infection among patients on maintenance hemodialysis in southern Taiwan.
Hepatitis C
Sequences in the NS5A protein of hepatitis C virus and the serum alanine aminotransferase response to interferon therapy in Japanese patients.
Hepatitis C
Sequential interferon-alpha and beta treatment in patients with chronic hepatitis C.
Hepatitis C
SERIAL CHANGES OF LIVER FUNCTION TESTS BEFORE AND DURING METHIMAZOLE TREATMENT IN THYROTOXIC PATIENTS.
Hepatitis C
Serial quantitative analysis of serum hepatitis C virus RNA level in patients with acute and chronic hepatitis C.
Hepatitis C
Serological markers of autoimmunity in renal transplant patients with chronic hepatitis C.
Hepatitis C
Serological Patterns and Molecular Characterization of Occult Hepatitis B Virus Infection among Blood Donors.
Hepatitis C
Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis.
Hepatitis C
Serum alanine aminotransferase level in relation to hepatitis B and C virus infections among blood donors.
Hepatitis C
Serum alanine aminotransferase levels and survival after hepatectomy in patients with hepatocellular carcinoma and hepatitis C virus-associated liver cirrhosis.
Hepatitis C
Serum alanine aminotransferase levels and the detection of hepatitis C virus (HCV) in chronic HCV infections.
Hepatitis C
Serum alanine aminotransferase levels, hematocrit rate and body weight correlations before and after hemodialysis session.
Hepatitis C
Serum alanine aminotransferase measurement as a guide to selective testing for hepatitis C during medical checkup.
Hepatitis C
Serum hepatitis C virus (HCV) RNA: a reliable tool for evaluating HCV-related liver disease in anti-HCV-positive blood donors with persistently normal alanine aminotransferase values.
Hepatitis C
Serum Interleukin-37 Concentrations and HBeAg Seroconversion in Chronic HBV Patients During Telbivudine Treatment.
Hepatitis C
Serum Metabolomics Reveals ?-Glutamyl Dipeptides as Biomarkers for Discrimination among Different Forms of Liver Disease.
Hepatitis C
Severity and correlates of liver disease in hepatitis C virus-infected injection drug users.
Hepatitis C
Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients: A Community-Based Study in a Hepatitis B/Hepatitis C Virus Hyperendemic Area.
Hepatitis C
Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C.
Hepatitis C
Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus.
Hepatitis C
Significance of hepatitis C virus coinfection with persistently normal alanine aminotransferase levels in HIV-1-infected patients.
Hepatitis C
Significance of Serum Alpha-Glutathione S-Transferase Assessment in Hepatitis C Patients with Different Alanine Aminotransferase Patterns.
Hepatitis C
Significance of sublobular hepatic necrosis in the progression of chronic hepatitis C.
Hepatitis C
Six-way decomposition of causal effects: Unifying mediation and mechanistic interaction.
Hepatitis C
Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity.
Hepatitis C
Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression.
Hepatitis C
Stability of Chronic Hepatitis-Related Parameters in Serum Samples After Long-Term Storage.
Hepatitis C
Study on the relationship between insulin growth factor 1 and liver fibrosis in patients with chronic hepatitis C with type 2 diabetes mellitus.
Hepatitis C
Subjects positive for hepatitis C virus RNA with normal aminotransferase levels, a "trompe l'oeil" clinical picture?
Hepatitis C
Sustained low alanine aminotransferase levels can predict the survival for 10 years without hepatocellular carcinoma development in patients with hepatitis C virus-associated liver cirrhosis of child stage A.
Hepatitis C
Sustained response to interferon-ribavirin combination therapy predicted by a model of hepatitis C virus dynamics using both HCV RNA and alanine aminotransferase.
Hepatitis C
Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels.
Hepatitis C
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study.
Hepatitis C
Tenofovir-based antiretroviral therapy in ?HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database.
Hepatitis C
The antibody response to hepatitis B virus vaccination is negatively influenced by the hepatitis C virus viral load in patients with chronic hepatitis C: a case-control study.
Hepatitis C
The effect of antioxidant supplementation on hepatitis C viral load, transaminases and oxidative status: a randomized trial among chronic hepatitis C virus-infected patients.
Hepatitis C
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
Hepatitis C
The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group.
Hepatitis C
The impact of liver steatosis on early and sustained treatment response in chronic hepatitis C patients.
Hepatitis C
The impact of past alcohol use on treatment response rates in patients with chronic hepatitis C.
Hepatitis C
The lack of transmission of NANB/C hepatitis between acute and chronically infected patients and their heterosexual partners.
Hepatitis C
The Prevalence and Presumed Etiology of Elevated Aminotransferase Levels in a Pacific Northwest Tribal Community.
Hepatitis C
The prevalence of undetectable vaccine-induced immunity against hepatitis B virus in US adults at high risk for infection.
Hepatitis C
The response of hepatitis C virus and TT virus to high dose and long duration interferon-alpha therapy in naïve chronic hepatitis C patients.
Hepatitis C
The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group.
Hepatitis C
Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
Hepatitis C
Time course of serum hepatitis C virus-RNA during chronic hepatitis C treatment accurately predicts the type of response.
Hepatitis C
Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial.
Hepatitis C
Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response.
Hepatitis C
Treatment of chronic hepatitis B and C with alpha interferon in a renal transplant patient.
Hepatitis C
Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
Hepatitis C
Treatment of chronic hepatitis C with interferon alfa-n3: a multicenter, randomized, open-label trial.
Hepatitis C
Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric study.
Hepatitis C
Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group.
Hepatitis C
Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment.
Hepatitis C
Type C chronic hepatitis with the discovery of a small hepatocellular carcinoma 7 years after successful interferon therapy.
Hepatitis C
Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.
Hepatitis C
Unidentified virus-like particles are detected in plasmas with elevated ALT levels: are they significant of etiological agent(s) of non-B, non-C hepatitis?
Hepatitis C
Updated thresholds for alanine aminotransferase do not exclude significant histological disease in chronic hepatitis C.
Hepatitis C
Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review.
Hepatitis C
Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Hepatitis C
Use of polymerase chain reaction for early detection and management of hepatitis C virus infection after needlestick injury.
Hepatitis C
Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients.
Hepatitis C
Using the prevalence of an elevated serum alanine aminotransferase level for identifying communities with a high prevalence of hepatitis C virus infection.
Hepatitis C
Utility of the FIB-4 Index for hepatocarcinogenesis in hepatitis C virus carriers with normal alanine aminotransferase levels.
Hepatitis C
Validation of the Hepatocellular Carcinoma Early detection Screening (HES) algorithm in a Cohort of Veterans with Cirrhosis.
Hepatitis C
Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.
Hepatitis C
Viral clearance in HCV viraemic patients with normal alanine aminotransferase after combination therapy: a controlled, open-labelled study.
Hepatitis C
Viral markers and use of factor products among Finnish patients with bleeding disorders.
Hepatitis C
Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group.
Hepatitis C
Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.
Hepatitis C
[Anti-HCV in patients without risk factors for hepatitis C. Prospective study in 200 patients]
Hepatitis C
[Autoimmune hemolytic anemia presenting during treatment of chronic hepatitis C with interferon alpha]
Hepatitis C
[Community-based hepatocellular carcinoma screening in seven townships in Taiwan]
Hepatitis C
[Contribution of liver biopsy and serology of hepatitis C virus to the diagnosis of a moderate and prolonged elevation of aminotransferases]
Hepatitis C
[Dynamic changes in PD-1, TLR3, and TLR4 surface expression on peripheral blood mononuclear cells in chronic hepatitis C patients undergoing peg-IFNalpha-2a plus ribavirin combination therapy].
Hepatitis C
[Epidemiology of chronic hepatitis C virus in patients infected by human immunodeficiency virus. Study of 767 patients]
Hepatitis C
[Identification of the cutoff value for serum alanine aminotransferase in hepatitis C screening of patients with chronic renal failure on hemodialysis]
Hepatitis C
[Investigation of the relationship between hepatitis c virus (HCV) genotypes with HCV-RNA and alanine aminotransferase levels in chronic hepatitis c patients]
Hepatitis C
[Prevalence of hepatitis C infection in patients with type 2 diabetes mellitus]
Hepatitis C
[Short-term curative effect of ribavirin combination therapy with pegylated interferon alfa-2a vs. interferon alfa-2a in patients with chronic hepatitis C].
Hepatitis C, Chronic
"Hepatitic flare", asthenia, peripheral polyneuropathy and diffuse liver steatosis in a hepatitis C virus asymptomatic chronic carrier.
Hepatitis C, Chronic
A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels.
Hepatitis C, Chronic
A comparison of genotype and markers of disease severity of chronic hepatitis C in patients with and without end-stage renal disease.
Hepatitis C, Chronic
A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Hepatitis C, Chronic
A health economic model to assess the cost-effectiveness of pegylated interferon alpha-2a and ribavirin in patients with moderate chronic hepatitis C and persistently normal alanine aminotransferase levels.
Hepatitis C, Chronic
A novel IgM class autoantibody to a hepatocyte-related 190 kDa molecule in patients with type 1 autoimmune hepatitis.
Hepatitis C, Chronic
A pilot study of daily subcutaneous interleukin-10 in patients with chronic hepatitis C infection.
Hepatitis C, Chronic
A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan.
Hepatitis C, Chronic
Absolute quantification of serum microRNA-122 and its correlation with liver inflammation grade and serum alanine aminotransferase in chronic hepatitis C patients.
Hepatitis C, Chronic
Active disease in chronic hepatitis C patients with normal alanine aminotransferase.
Hepatitis C, Chronic
Advanced Hepatic Fibrosis and Steatosis Are Associated With Persistent Alanine Aminotransferase Elevation in Chronic Hepatitis C Patients Negative for Hepatitis C Virus RNA During Pegylated Interferon Plus Ribavirin Therapy.
Hepatitis C, Chronic
Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.
Hepatitis C, Chronic
Alanine aminotransferase and HCV-RNA responses following interferon therapy of HCV-RNA positive chronic hepatitis.
Hepatitis C, Chronic
Alanine aminotransferase and spleno-portal dynamics affect spleen stiffness measured by point shear-wave elastography in patients with chronic hepatitis C in the absence of significant liver fibrosis.
Hepatitis C, Chronic
Alanine aminotransferase level as a predictor of hepatitis C virus-associated hepatocellular carcinoma incidence in a community-based population in Japan.
Hepatitis C, Chronic
Alanine aminotransferase normalization at week 8 predicts viral response during hepatitis C treatment.
Hepatitis C, Chronic
Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels.
Hepatitis C, Chronic
alpha-Glutathione S-transferase levels in chronic hepatitis C infection and the effect of alpha-interferon therapy.
Hepatitis C, Chronic
An assessment of the clinical utility of serum ALT and AST in chronic hepatitis C.
Hepatitis C, Chronic
Analysis of the core region of HCV genome isolated from patients with chronic hepatitis C during intervals of normal ALT concentration.
Hepatitis C, Chronic
Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
Hepatitis C, Chronic
Appropriate interferon-alpha therapy for chronic hepatitis C: an assessment by quantitative changes in serum hepatitis C virus-RNA.
Hepatitis C, Chronic
Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?
Hepatitis C, Chronic
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index.
Hepatitis C, Chronic
Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C.
Hepatitis C, Chronic
Association of response to combined interferon alpha-2b and ribavirin therapy in patients of chronic hepatitis c with serum alanine aminotransferase levels and severity of the disease on liver biopsy.
Hepatitis C, Chronic
Baseline high viral load and unfavorable patterns of alanine aminotransferase change predict virological relapse in patients with chronic hepatitis C genotype 1 or 2 obtaining rapid virological response during antiviral therapy.
Hepatitis C, Chronic
Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response?
Hepatitis C, Chronic
Can Peg-IFN alpha-2a plus ribavirin be used to treat patients with chronic hepatitis C and normal alanine aminotransferase levels?
Hepatitis C, Chronic
Case report: Alanine aminotransferase deficiency detected in a patient with chronic hepatitis C.
Hepatitis C, Chronic
Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C.
Hepatitis C, Chronic
Characterization of elevated alanine aminotransferase levels during pegylated-interferon ?-2b plus ribavirin treatment for chronic hepatitis C.
Hepatitis C, Chronic
Chronic hepatitis C and interferon alpha: conventional and cumulative meta-analyses of randomized controlled trials.
Hepatitis C, Chronic
Chronic hepatitis C in different populations: similar patterns of alanine aminotransferase alteration characterize similar clinical subgroups.
Hepatitis C, Chronic
Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.
Hepatitis C, Chronic
Chronic hepatitis C in patients with persistently normal alanine transaminase levels.
Hepatitis C, Chronic
Chronic hepatitis C in the Hispanic/Latino population living in the United States: a literature review.
Hepatitis C, Chronic
Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon. The Consensus Interferon Study Group.
Hepatitis C, Chronic
Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy.
Hepatitis C, Chronic
Clinical and virological characteristics of untreated patients with chronic hepatitis C who develop serum alanine aminotransferase flare-up.
Hepatitis C, Chronic
Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapy.
Hepatitis C, Chronic
Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States.
Hepatitis C, Chronic
Clinical impact of normal alanine aminotransferase on direct-acting antiviral outcome in patients with chronic hepatitis C virus infection.
Hepatitis C, Chronic
Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
Hepatitis C, Chronic
Clinical significance of alanine aminotransferase levels and the effect of ursodeoxycholic acid in hemodialysis patients with chronic hepatitis C.
Hepatitis C, Chronic
Clinical significance of ultrasonographic imaging of the common hepatic arterial lymph node (No. 8 LN) in chronic liver diseases.
Hepatitis C, Chronic
Clinical study of cryoglobulinaemia in Chinese patients with chronic hepatitis C.
Hepatitis C, Chronic
Clinical trial results of peginterferons in combination with ribavirin.
Hepatitis C, Chronic
Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor - a randomized placebo-controlled study in patients with chronic hepatitis C.
Hepatitis C, Chronic
Cold activation of complement in sera from patients with persistent hepatitis C virus infection on interferon therapy.
Hepatitis C, Chronic
Comparative study of C-reactive protein in chronic hepatitis B and chronic hepatitis C.
Hepatitis C, Chronic
Comparison between serum alpha-glutathione S-transferase and aminotransaminases in detecting cytolysis in hepatitis C-infected children.
Hepatitis C, Chronic
Comparison of high initial and fixed-dose regimens of interferon-alpha2a in chronic hepatitis C: a randomized controlled trial. French Multicenter Interferon Study Group.
Hepatitis C, Chronic
Comparison of thrice weekly vs daily human leucocyte interferon-alpha therapy for chronic hepatitis C. TVVH Study Group.
Hepatitis C, Chronic
Controlled trial with interferon alfa 2-b in chronic hepatitis C patients.
Hepatitis C, Chronic
Correlation between relative number of circulating low-density hepatitis C virus particles and disease activity in patients with chronic hepatitis C.
Hepatitis C, Chronic
Correlation between serum HCV RNA and aminotransferase levels in patients with chronic HCV infection.
Hepatitis C, Chronic
Correlation between the serum level of hepatitis C virus RNA and disease activities in acute and chronic hepatitis C.
Hepatitis C, Chronic
Correlation of biochemical response to interferon alfa with histological improvement in hepatitis C: a meta-analysis of diagnostic test characteristics.
Hepatitis C, Chronic
Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.
Hepatitis C, Chronic
Correlation of serum alanine aminotransferase and aspartate aminotransferase levels to liver histology in chronic hepatitis C.
Hepatitis C, Chronic
Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin.
Hepatitis C, Chronic
Correlation of serum leptin levels with anthropometric and metabolic parameters and biochemical liver function in Chinese patients with chronic hepatitis C virus infection.
Hepatitis C, Chronic
Daily interferon monotherapy for chronic hepatitis C in patients with normal or near-normal serum alanine transaminase levels: a comparison of two protocols.
Hepatitis C, Chronic
Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C.
Hepatitis C, Chronic
Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.
Hepatitis C, Chronic
Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levels.
Hepatitis C, Chronic
Difference in serum complement component C4a levels between hepatitis C virus carriers with persistently normal alanine aminotransferase levels or chronic hepatitis C.
Hepatitis C, Chronic
Discordance between serum alanine aminotransferase (ALT) and virologic response to IFN-alpha2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers.
Hepatitis C, Chronic
Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels.
Hepatitis C, Chronic
Disease stage of chronic hepatitis C assessed by both peritoneoscopic and histologic findings and its relationship with response to interferon therapy.
Hepatitis C, Chronic
Distribution of hepatitis C virus infection in liver biopsies from children and adults with chronic hepatitis C.
Hepatitis C, Chronic
Does previous hepatitis A infection affect the clinicopathological status of chronic hepatitis C?
Hepatitis C, Chronic
Does the control of alanine aminotransferase levels lead to a regression of liver fibrosis in chronic hepatitis C patients?
Hepatitis C, Chronic
Dynamic decision analysis to determine optimal treatment duration in chronic hepatitis C.
Hepatitis C, Chronic
Dysfunction of Immune Systems and Host Genetic Factors in Hepatitis C Virus Infection with Persistent Normal ALT.
Hepatitis C, Chronic
Early and accurate prediction of Peg-IFNs/ribavirin therapy outcome in the individual patient with chronic hepatitis C by modeling the dynamics of the infected cells.
Hepatitis C, Chronic
Effect of caffeine-containing beverage consumption on serum alanine aminotransferase levels in patients with chronic hepatitis C virus infection: a hospital-based cohort study.
Hepatitis C, Chronic
Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial.
Hepatitis C, Chronic
Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis.
Hepatitis C, Chronic
Effects of 1-year interferon-alpha 2a treatment in patients with chronic hepatitis C and persistently normal transaminase activity.
Hepatitis C, Chronic
Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: an individually controlled cohort study.
Hepatitis C, Chronic
Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C.
Hepatitis C, Chronic
Efficacy and safety of addition of minor bloodletting (petit phlebotomy) in hepatitis C virus-infected patients receiving regular glycyrrhizin injections.
Hepatitis C, Chronic
Efficacy of a glycyrrhizin suppository for the treatment of chronic hepatitis C: a pilot study.
Hepatitis C, Chronic
Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy.
Hepatitis C, Chronic
Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control study.
Hepatitis C, Chronic
Elevated serum ALT levels during pegylated interferon monotherapy may be caused by hepatic iron overload.
Hepatitis C, Chronic
Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis.
Hepatitis C, Chronic
Elevated serum soluble Fas levels in the various stages of hepatitis C virus-induced liver disease.
Hepatitis C, Chronic
Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse.
Hepatitis C, Chronic
Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis.
Hepatitis C, Chronic
Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C.
Hepatitis C, Chronic
Evaluation of Interleukin-18 as a Non Invasive Marker of Liver Fibrosis among Chronic Hepatitis C Virus Patients.
Hepatitis C, Chronic
Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group.
Hepatitis C, Chronic
Factors predictive of the response to interferon in patients with chronic hepatitis C.
Hepatitis C, Chronic
Factors predisposing to the occurrence of cryoglobulinemia in two cohorts of Egyptian and Japanese patients with chronic hepatitis C infection: ethnic and genotypic influence.
Hepatitis C, Chronic
Female patients in fertile age with chronic hepatitis C, easy genotype, and persistently normal transaminases have a 100% chance to reach a sustained virological response.
Hepatitis C, Chronic
Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.
Hepatitis C, Chronic
HCV-RNA assay in peripheral blood mononuclear cells in relation to IFN therapy.
Hepatitis C, Chronic
Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes.
Hepatitis C, Chronic
Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels.
Hepatitis C, Chronic
Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years.
Hepatitis C, Chronic
Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment.
Hepatitis C, Chronic
Hepatocyte-protective and anti-oxidant effects of rifampicin on human chronic hepatitis C and murine acute hepatocyte disorder.
Hepatitis C, Chronic
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
Hepatitis C, Chronic
Histological and clinical characteristics of patients with chronic hepatitis C and persistently normal alanine aminotransferase levels.
Hepatitis C, Chronic
Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels.
Hepatitis C, Chronic
How soon can a virological sustained response be determined after withdrawal of interferon therapy in chronic hepatitis C? Tokyo-Chiba Hepatitis Research Group.
Hepatitis C, Chronic
Hypervariable region 1 quasispecies in hepatitis C virus genotypes 1b and 3 infected patients with normal and abnormal alanine aminotransferase levels.
Hepatitis C, Chronic
IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C.
Hepatitis C, Chronic
Immunological changes in different patient populations with chronic hepatitis C virus infection.
Hepatitis C, Chronic
Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France.
Hepatitis C, Chronic
Incidence and predictors for abnormal liver function during direct-acting antiviral agents in chronic hepatitis C patients.
Hepatitis C, Chronic
Incidence of hepatocellular carcinoma in chronic hepatitis C after interferon therapy.
Hepatitis C, Chronic
Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines.
Hepatitis C, Chronic
Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels.
Hepatitis C, Chronic
Increased AST and GGT activity as marker of RT-PCR inhibition in RNA extracts from peripheral blood.
Hepatitis C, Chronic
Influence of age, sex, and degree of liver fibrosis on the association between serum alanine aminotransferase levels and liver inflammation in patients with chronic hepatitis C.
Hepatitis C, Chronic
Influence of viral load and alanine aminotransferase on viral genetic heterogeneity in patients with chronic hepatitis C virus infection.
Hepatitis C, Chronic
Initial results with recombinant interferon alfa-2b in patients with chronic hepatitis C: the United States experience.
Hepatitis C, Chronic
Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity.
Hepatitis C, Chronic
Interferon retreatment of nonresponders with HCV-RNA-positive chronic hepatitis C.
Hepatitis C, Chronic
Interferon treatment in patients with chronic hepatitis C with normal alanine-aminotransferase activity.
Hepatitis C, Chronic
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study.
Hepatitis C, Chronic
Interferon-alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients with persistently normal aminotransferase levels.
Hepatitis C, Chronic
Interleukin (IL) 1beta and IL-10 gene polymorphism in chronic hepatitis C patients with normal or elevated alanine aminotransferase levels.
Hepatitis C, Chronic
Interleukin 6 and 12, alanine aminotransferase activity, and HCV viral load in children with chronic hepatitis C treated with interferon and ribavirin.
Hepatitis C, Chronic
Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest).
Hepatitis C, Chronic
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors.
Hepatitis C, Chronic
Intrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels.
Hepatitis C, Chronic
Intrahepatic mRNA expression of interferon-inducible antiviral genes in liver diseases: dsRNA-dependent protein kinase overexpression and RNase L inhibitor suppression in chronic hepatitis C.
Hepatitis C, Chronic
Is delayed normalization of alanine aminotransferase a poor prognostic predictor in chronic hepatitis C patients treated with a combined interferon and ribavirin therapy?
Hepatitis C, Chronic
Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Hepatitis C, Chronic
Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C.
Hepatitis C, Chronic
Lack of clinical and histological progression of chronic hepatitis C in individuals with true persistently normal ALT: the result of a 17-year follow-up.
Hepatitis C, Chronic
Lack of higher frequency of the chemokine receptor 5-delta32/delta32 genotype in hepatitis C.
Hepatitis C, Chronic
Late disappearance of hepatitis C virus RNA from peripheral blood mononuclear cells in patients with chronic hepatitis C in sustained response after alpha-interferon therapy.
Hepatitis C, Chronic
Levels of Alanine Aminotransferase Confound Use of Transient Elastography to Diagnose Fibrosis in Patients With Chronic Hepatitis C Virus Infection.
Hepatitis C, Chronic
Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
Hepatitis C, Chronic
Liver biopsy in the evaluation of patients with chronic hepatitis C who have repeatedly normal or near-normal serum alanine aminotransferase levels.
Hepatitis C, Chronic
Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels.
Hepatitis C, Chronic
Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
Hepatitis C, Chronic
Liver histology and alanine aminotransferase levels in children and adults with chronic hepatitis C infection.
Hepatitis C, Chronic
Liver tissue expression of CD80 and CD95 antigens in chronic hepatitis C: relationship with biological and histological disease activities.
Hepatitis C, Chronic
Long-term clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patients with non-response or relapse to interferon.
Hepatitis C, Chronic
Long-term efficacy of recombinant interferon alpha 2a in the treatment of chronic hepatitis C: a randomized prospective study comparing two dose schedules in Chinese patients.
Hepatitis C, Chronic
Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center.
Hepatitis C, Chronic
Long-term follow-up of sustained responders to interferon therapy, in patients with chronic hepatitis C.
Hepatitis C, Chronic
Long-term histological outcome in patients with chronic hepatitis C treated repeatedly with interferon alpha-2b without sustained response.
Hepatitis C, Chronic
Long-term histological prognosis and serum fibrosis markers in chronic hepatitis C patients treated with interferon.
Hepatitis C, Chronic
Long-Term Persistent GBV-B Infection and Development of a Chronic and Progressive Hepatitis C-Like Disease in Marmosets.
Hepatitis C, Chronic
Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C.
Hepatitis C, Chronic
Long-term prognosis of chronic hepatitis C after treatment with interferon alpha 2b and characterization of incomplete responders.
Hepatitis C, Chronic
Long-term responders without eradication of hepatitis C virus after interferon therapy: characterization of clinical profiles and incidence of hepatocellular carcinoma.
Hepatitis C, Chronic
Long-term titrated recombinant interferon-alpha 2a in chronic hepatitis C: a randomized controlled trial.
Hepatitis C, Chronic
Magnitude of activity in chronic hepatitis C is influenced by apoptosis of T cells responsible for hepatitis C virus.
Hepatitis C, Chronic
Metabolic Changes in Chronic Hepatitis C Patients who Carry IFNL4-?G and Achieve Sustained Virologic Response with Direct-Acting Antiviral Therapy.
Hepatitis C, Chronic
Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C.
Hepatitis C, Chronic
Metabolic profiles in patients with chronic hepatitis C: a case-control study.
Hepatitis C, Chronic
Multicenter evaluation of a semiautomated, standardized assay for detection of hepatitis B virus DNA in blood donations.
Hepatitis C, Chronic
Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C.
Hepatitis C, Chronic
Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.
Hepatitis C, Chronic
Pattern of histological findings in chronic hepatitis C with alanine transaminase levels below twice the normal value.
Hepatitis C, Chronic
PEG-IFNalpha/RBV combination therapy for chronic hepatitis C patients increases serum ferritin level while it improves sustained viral response rate.
Hepatitis C, Chronic
Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels.
Hepatitis C, Chronic
Peginterferon alfa-2a is associated with elevations in alanine aminotransferase at the end of treatment in chronic hepatitis C patients with sustained virologic response.
Hepatitis C, Chronic
Peginterferon-based therapy for chronic hepatitis C virus infection in patients with normal alanine aminotransferase levels.
Hepatitis C, Chronic
Pegylated interferon ?-2b plus ribavirin for Japanese chronic hepatitis C patients with normal alanine aminotransferase.
Hepatitis C, Chronic
Pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C virus genotype 4 infection in patients with normal serum ALT.
Hepatitis C, Chronic
Periportal Stellate Cells in Subjects with Chronic Hepatitis C with a Varied Serum Alanine Aminotransferase Level.
Hepatitis C, Chronic
Persistently normal alanine transaminase levels in chronic C hepatitis: what does it tell us?
Hepatitis C, Chronic
Plasma sphingolipids as potential indicators of hepatic necroinflammation in patients with chronic hepatitis C and normal alanine aminotransferase level.
Hepatitis C, Chronic
Predicting Liver Fibrosis in the Hepatitis C Population: Concordance Analysis Between Noninvasive Scoring Systems and Percutaneous Liver Biopsy.
Hepatitis C, Chronic
Prediction of significant fibrosis in chronic hepatitis C patients with normal ALT.
Hepatitis C, Chronic
Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study.
Hepatitis C, Chronic
Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon-alpha.
Hepatitis C, Chronic
Preliminary results of ozone therapy as a possible treatment for patients with chronic hepatitis C.
Hepatitis C, Chronic
Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
Hepatitis C, Chronic
Psychosocial stress, personality, and the severity of chronic hepatitis C.
Hepatitis C, Chronic
Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.
Hepatitis C, Chronic
Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. The TriVeneto Viral Hepatitis Group.
Hepatitis C, Chronic
Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients.
Hepatitis C, Chronic
Re-evaluation of the serum alanine aminotransferase upper normal limit in chronic hepatitis C patients.
Hepatitis C, Chronic
Recurrent myocardial ischaemia during combination antiviral therapy in a patient with chronic hepatitis C and normal aminotransferase levels.
Hepatitis C, Chronic
Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies.
Hepatitis C, Chronic
Relationship between five-year histological outcome and serial changes in serum alanine aminotransferase in patients with biochemical and virological relapse after interferon treatment for chronic hepatitis C.
Hepatitis C, Chronic
Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan.
Hepatitis C, Chronic
Response to interferon therapy: influence of human leucocyte antigen alleles in patients with chronic hepatitis C.
Hepatitis C, Chronic
Results of the multicenter natural interferon-alpha treatment for chronic hepatitis C: correlation between total dose, administration periods and efficacy of therapy. Keio Natural IFN-alpha study group.
Hepatitis C, Chronic
Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity.
Hepatitis C, Chronic
SEN virus infection in children in Taiwan: transmission route and role in blood transfusion and liver diseases.
Hepatitis C, Chronic
Serological markers of autoimmunity in renal transplant patients with chronic hepatitis C.
Hepatitis C, Chronic
Serum alanine aminotransferase has limited predictive value for liver disease in chronic hepatitis C.
Hepatitis C, Chronic
Serum alanine aminotransferase level and response to interferon-ribavirin combination therapy in patients with chronic hepatitis C.
Hepatitis C, Chronic
Serum alpha-fetoprotein levels in patients with chronic hepatitis C. Relationships with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB-1 scores.
Hepatitis C, Chronic
Serum aminotransferase levels and histological disease in chronic hepatitis C.
Hepatitis C, Chronic
Serum aspartate but not alanine aminotransferase levels help to predict the histological features of chronic hepatitis C viral infections in adults.
Hepatitis C, Chronic
Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
Hepatitis C, Chronic
Serum concentration of TNF-alpha and IL-1 beta in patients with chronic hepatitis C treated with interferon alpha--a preliminary report.
Hepatitis C, Chronic
Serum Metabolomics Reveals ?-Glutamyl Dipeptides as Biomarkers for Discrimination among Different Forms of Liver Disease.
Hepatitis C, Chronic
Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C.
Hepatitis C, Chronic
Should patients with chronic hepatitis C who have normal ALT levels be treated?
Hepatitis C, Chronic
Significance of hepatitis C virus coinfection with persistently normal alanine aminotransferase levels in HIV-1-infected patients.
Hepatitis C, Chronic
Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C.
Hepatitis C, Chronic
Soluble Markers of Immune Activation Differentially Normalize and Selectively Associate with Improvement in AST, ALT, Albumin, and Transient Elastography During IFN-Free HCV Therapy.
Hepatitis C, Chronic
Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity.
Hepatitis C, Chronic
Strenuous physical labor is important as a cause of elevated alanine aminotransferase levels in Japanese patients with chronic hepatitis C viremia.
Hepatitis C, Chronic
Sustained virologic response is associated with improved health-related quality of life in relapsed chronic hepatitis C patients.
Hepatitis C, Chronic
Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels.
Hepatitis C, Chronic
The association between the genetic polymorphism of HLA-DQA1, DQB1, and DRB1 and serum alanine aminotransferase levels in chronic hepatitis C in the Chinese population.
Hepatitis C, Chronic
The effect of alanine aminotransferase dynamics on predicting sustained virological response in chronic hepatitis C virus infection.
Hepatitis C, Chronic
The fluctuations of viral load and serum alanine aminotransferase levels in chronic hepatitis C.
Hepatitis C, Chronic
The long term efficacy of glycyrrhizin in chronic hepatitis C patients.
Hepatitis C, Chronic
The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy.
Hepatitis C, Chronic
The response of hepatitis C virus and TT virus to high dose and long duration interferon-alpha therapy in naïve chronic hepatitis C patients.
Hepatitis C, Chronic
The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C.
Hepatitis C, Chronic
Time course of serum hepatitis C virus-RNA during chronic hepatitis C treatment accurately predicts the type of response.
Hepatitis C, Chronic
Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon alpha-2a (40 kDa) plus ribavirin: Impact on health-related quality of life.
Hepatitis C, Chronic
Treatment of patients with hepatitis C and normal serum aminotransferase levels.
Hepatitis C, Chronic
Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group.
Hepatitis C, Chronic
Updated thresholds for alanine aminotransferase do not exclude significant histological disease in chronic hepatitis C.
Hepatitis C, Chronic
Utility of alpha-glutathione S-transferase assessment in chronic hepatitis C patients with near normal alanine aminotransferase levels.
Hepatitis C, Chronic
Vertical transmission of hepatitis C virus (HCV) detected by HCV-RNA analysis.
Hepatitis C, Chronic
Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C.
Hepatitis C, Chronic
Viral clearance in HCV viraemic patients with normal alanine aminotransferase after combination therapy: a controlled, open-labelled study.
Hepatitis C, Chronic
Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels.
Hepatitis C, Chronic
Virological Rather Than Host Factors Are Associated With Transaminase Levels Among HIV/HCV-Coinfected Patients.
Hepatitis C, Chronic
Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group.
Hepatitis C, Chronic
[Amantadine-HCL in the treatment of chronic hepatitis C in non-responders to alpha-interferon. Effect on ALT serum levels and viral load]
Hepatitis C, Chronic
[CLINICAL AND PHARMACOECONOMIC RESULTS OF THE USAGE OF VARIOUS HIV REVERSE TRANSCRIPTASE INHIBITORS IN THE SCHEMES OF ANTIRETROVIRAL THERAPY OF PATIENT RECEIVING THERAPY FOR THE CHRONIC HEPATITIS C VIRUS].
Hepatitis C, Chronic
[Effect of iron depletion on long-term response to interferon in patients with chronic hepatitis C with increased plasma iron without accumulation of liver iron]
Hepatitis C, Chronic
[Immune status of patients with different outcomes of acute hepatitis C]
Hepatitis C, Chronic
[Investigation of the relationship between hepatitis c virus (HCV) genotypes with HCV-RNA and alanine aminotransferase levels in chronic hepatitis c patients]
Hepatitis C, Chronic
[Non-invasive fibrosis assessment in chronic hepatitis C: aspartate-aminotransferase to platelet ratio index (APRI) and transient elastography (FibroScan)].
Hepatitis C, Chronic
[The comparison of liver inflammation and fibrosis between chronic HBV and HCV infection].
Hepatitis C, Chronic
[Therapy with interferon alfa and ribavirin in patients with chronic hepatitis C and normal levels of alanine aminotransferase]
Hepatitis D
A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis.
Hepatitis D
HBV genotype C is independently associated with cirrhosis in community-based population.
Hepatitis D
Hepatitis D virus (delta agent) superinfection in an endemic area of hepatitis B infection: immunopathologic and serologic findings.
Hepatitis D
Interferon-alpha treatment of children with chronic hepatitis D virus infection: the Greek experience.
Hepatitis D
Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study.
Hepatitis D
Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.
Hepatitis D
Serum alanine aminotransferase levels and prevalence of hepatitis A, B, and delta in outpatients.
Hepatitis D
The role of HBeAg seroconversion in acute exacerbation of liver disease with termination of hepatitis B and D virus infection in a chronic hepatitis D patient during alpha-interferon therapy.
Hepatitis E
A nationwide survey for hepatitis E virus prevalence in Japanese blood donors with elevated alanine aminotransferase.
Hepatitis E
Epidemiological and virological characteristics of symptomatic acute hepatitis E in Greater Cairo, Egypt.
Hepatitis E
Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK/French study.
Hepatitis E
Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland.
Hepatitis E
Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys.
Hepatitis E
Liver dysfunction in pregnancy: an important cause of maternal and perinatal morbidity and mortality in Pakistan.
Hepatitis E
Ongoing subclinical infection of hepatitis E virus among blood donors with an elevated alanine aminotransferase level in Japan.
Hepatitis E
Prevalence of antibodies to hepatitis E virus among Japanese blood donors: identification of three blood donors infected with a genotype 3 hepatitis E virus.
Hepatitis E
Significance of Anti-Nuclear Antibodies and Cryoglobulins in Patients with Acute and Chronic HEV Infection.
Hepatitis E
Temporal profile of HEV RNA concentration in blood and stool from patients with acute uncomplicated hepatitis E in a region with genotype 1 predominance.
Hepatitis E
The association of elevated alanine aminotransferase levels with hepatitis E virus infections among blood donors in China.
Hepatitis E
Unchanged high prevalence of antibodies to hepatitis E virus (HEV) and HEV RNA among blood donors with an elevated alanine aminotransferase level in Japan during 1991-2006.
Hepatitis E
Unexpected elevated alanine aminotransferase, aspartate aminotransferase levels and hepatitis E virus infection among persons who work with pigs in accra, Ghana.
Hepatitis, Alcoholic
Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival.
Hepatitis, Alcoholic
The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
Hepatitis, Alcoholic
Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review.
Hepatitis, Autoimmune
Acute toxic hepatitis induced by a herbal medicine : Anchusa Boraginaceae.
Hepatitis, Autoimmune
Clinical and histopathological features of immunoglobulin G4-associated autoimmune hepatitis in children.
Hepatitis, Autoimmune
Deletion of the C6orf120 gene with unknown function ameliorates autoimmune hepatitis induced by concanavalin A.
Hepatitis, Autoimmune
Graft histology characteristics in long-term survivors of pediatric liver transplantation.
Hepatitis, Autoimmune
Hypothyroidism and Levothyroxine-responsive Liver Dysfunction in a Patient with Ring Chromosome 18 Syndrome.
Hepatitis, Autoimmune
Hypothyroidism and Levothyroxine-Responsive Liver Dysfunction in a Patient with Ring Chromosome 18 Syndrome.
Hepatitis, Autoimmune
Long-term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country.
Hepatitis, Autoimmune
Overlap syndrome between autoimmune hepatitis and primary sclerosing cholangitis in two cases.
Hepatitis, Autoimmune
Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis.
Hepatitis, Autoimmune
Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis.
Hepatitis, Autoimmune
Priming of CD4(+) T cells by liver sinusoidal endothelial cells induces CD25(low) forkhead box protein 3(-) regulatory T cells suppressing autoimmune hepatitis.
Hepatitis, Autoimmune
Rapid-onset primary biliary cirrhosis resembling drug-induced liver injury.
Hepatitis, Autoimmune
Recurrence of autoimmune hepatitis after liver transplantation without elevation of alanine aminotransferase.
Hepatitis, Autoimmune
Risk factors associated with relapse of type 1 autoimmune hepatitis in Japan.
Hepatitis, Autoimmune
Serum Immunoglobulin G Levels Predict Biochemical and Histological Remission of Autoimmune Hepatitis Type 1: A Single-Center Experience and Literature Review.
Hepatitis, Autoimmune
Synthesis and biological evaluation of (1,2,4)triazole[4,3-a]pyridine derivatives as potential therapeutic agents for concanavalin A-induced hepatitis.
Hepatitis, Autoimmune
Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus.
Hepatitis, Autoimmune
Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review.
Hepatitis, Autoimmune
Well-controlled autoimmune hepatitis treatment withdrawal may be safely accomplished without liver-biopsy guidance.
Hepatitis, Autoimmune
[Elevated alanine aminotransferase in a four-year-old as an early sign of autoimmune hepatitis.]
Hepatitis, Autoimmune
[Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population].
Hepatitis, Chronic
"Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country.
Hepatitis, Chronic
A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Hepatitis, Chronic
A high seroprevalence of human herpesvirus type 8 already present in patients with chronic hepatitis before the development of cirrhosis.
Hepatitis, Chronic
A personalized approach to optimize hepatitis B treatment in treatment-naive patients.
Hepatitis, Chronic
A practical guide to the use of interferons in the management of hepatitis virus infections.
Hepatitis, Chronic
A prospective and comparative cohort study on efficacy and drug resistance during long-term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis.
Hepatitis, Chronic
A randomized controlled trial of thymopentin therapy in patients with chronic hepatitis B.
Hepatitis, Chronic
A randomized, controlled trial of weekly administration of lymphoblastoid interferon in patients with chronic hepatitis C.
Hepatitis, Chronic
Alanine aminotransferase and HCV-RNA responses following interferon therapy of HCV-RNA positive chronic hepatitis.
Hepatitis, Chronic
Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders.
Hepatitis, Chronic
Amantadine therapy in renal transplant patients with hepatitis C virus infection.
Hepatitis, Chronic
Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
Hepatitis, Chronic
Antibodies to single stranded DNA: a diagnostic aid in chronic hepatitis B virus infections.
Hepatitis, Chronic
Are alanine aminotransferase, hepatitis B virus DNA or IgM antibody to hepatitis B core antigen serum levels predictors of histological grading in chronic hepatitis B?
Hepatitis, Chronic
Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease.
Hepatitis, Chronic
Biochemical and serological characteristics of children with membranous nephropathy due to hepatitis B virus infection: correlation with hepatitis B e antigen, hepatitis B DNA and hepatitis D.
Hepatitis, Chronic
Cadmium excretion predicting hospital mortality and illness severity of critically ill medical patients.
Hepatitis, Chronic
Characteristics of hepatitis B X antigen, antibodies to X antigen, and antibodies to the viral polymerase during hepatitis B virus infection.
Hepatitis, Chronic
Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome.
Hepatitis, Chronic
Chronic hepatitis C in elderly patients: Clinical, histolocical and virolocical features.
Hepatitis, Chronic
Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.
Hepatitis, Chronic
Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation.
Hepatitis, Chronic
Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin.
Hepatitis, Chronic
Clinicopathologic features and genotyping of patients with chronic HBV infection in the Upper Egypt.
Hepatitis, Chronic
Co-infections with hepatitis G and TT virus in patients with chronic hepatitis C in Hungary.
Hepatitis, Chronic
Comparison of antiviral effect of lamivudine with interferon-alpha2a versus -alpha2b in children with chronic hepatitis B infection.
Hepatitis, Chronic
Comparison of high initial and fixed-dose regimens of interferon-alpha2a in chronic hepatitis C: a randomized controlled trial. French Multicenter Interferon Study Group.
Hepatitis, Chronic
Congenital absence of portal vein with multiple hyperplastic nodular lesions in the liver.
Hepatitis, Chronic
Cyclosporin A-mediated cholestasis in patients with chronic hepatitis after heart transplantation.
Hepatitis, Chronic
Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.
Hepatitis, Chronic
Dietary amino acid taurine ameliorates liver injury in chronic hepatitis patients.
Hepatitis, Chronic
Diffuse pattern of transient hepatic attenuation differences in viral hepatitis: a sign of acute hepatic injury in patients without cirrhosis.
Hepatitis, Chronic
Effect of glycyrrhizin on lysis of hepatocyte membranes induced by anti-liver cell membrane antibody.
Hepatitis, Chronic
Efficacy and tolerability of diphenyl-dimethyldicarboxylate plus garlic oil in patients with chronic hepatitis.
Hepatitis, Chronic
Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients.
Hepatitis, Chronic
Elevated serum soluble Fas levels in the various stages of hepatitis C virus-induced liver disease.
Hepatitis, Chronic
Epidemiology and natural history of hepatitis C infections in liver transplant recipients.
Hepatitis, Chronic
Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors.
Hepatitis, Chronic
Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C.
Hepatitis, Chronic
Gene expressions of c-met and hepatocyte growth factor in chronic liver disease and hepatocellular carcinoma.
Hepatitis, Chronic
Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C.
Hepatitis, Chronic
Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection.
Hepatitis, Chronic
Hepatitis B virus genotypes and clinical manifestation among hepatitis B carriers in Thailand.
Hepatitis, Chronic
Hepatitis B virus in the State of Alagoas, Brazil: genotypes characterization and mutations of the precore and basal core promoter regions.
Hepatitis, Chronic
Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease.
Hepatitis, Chronic
Hepatitis C virus infection in health care workers referred to a hepatitis clinic.
Hepatitis, Chronic
Hepatitis D virus (delta agent) superinfection in an endemic area of hepatitis B infection: immunopathologic and serologic findings.
Hepatitis, Chronic
Hepatitis G virus infection in hemodialysis patients and its relationship with hepatitis C virus infection.
Hepatitis, Chronic
How to distinguish normal liver from chronic hepatitis in anti-HCV positive individuals with normal alanine aminotransferase levels.
Hepatitis, Chronic
In subjects with antibody to hepatitis C virus a high serum level of interleukin-2 soluble receptor suggests activity of liver disease.
Hepatitis, Chronic
Infection by an unenveloped DNA virus associated with non-A to -G hepatitis in Japanese blood donors with or without elevated ALT levels.
Hepatitis, Chronic
Infection with Toxoplasma gondii can promote chronic liver diseases in HIV-infected individuals.
Hepatitis, Chronic
Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare Settings.
Hepatitis, Chronic
Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity.
Hepatitis, Chronic
Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study.
Hepatitis, Chronic
Interferon therapy as chemoprevention of hepatocarcinogenesis in patients with chronic hepatitis C.
Hepatitis, Chronic
Interferon treatment of chronic active hepatitis B: effect of a six month treatment regimen.
Hepatitis, Chronic
Interferon-alpha treatment of chronic hepatitis C virus infection in children.
Hepatitis, Chronic
L-carnitine decreases severity and type of fatigue induced by interferon-alpha in the treatment of patients with hepatitis C.
Hepatitis, Chronic
Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis B virus-related liver disease.
Hepatitis, Chronic
Liver resections performed under prolonged portal triad occlusion in patients with active chronic liver diseases.
Hepatitis, Chronic
Long term follow-up and patterns of response of ALT in patients with chronic hepatitis NANB/C treated with recombinant interferon-alpha.
Hepatitis, Chronic
Long-term observation of acute-onset autoimmune hepatitis presenting clinically and radiologically as acute hepatitis.
Hepatitis, Chronic
Loss of immunogenecity of liver dendritic cells from mouse with chronic hepatitis.
Hepatitis, Chronic
Multivariate analysis of an enzymic profile for the differential diagnosis of viral hepatitis.
Hepatitis, Chronic
Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
Hepatitis, Chronic
Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin.
Hepatitis, Chronic
Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population.
Hepatitis, Chronic
Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
Hepatitis, Chronic
Prolonged treatment of chronic C hepatitis by means of medium-high doses of recombinant alpha-2b interferon: an open study to evaluate response and long-term relapse.
Hepatitis, Chronic
Randomized trial of prolonged interferon retreatment for chronic hepatitis C patients with HCV-genotype 1b and high virus load.
Hepatitis, Chronic
Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis.
Hepatitis, Chronic
Reactivation of hepatitis B virus during interferon-free therapy with daclatasvir and asunaprevir in patient with hepatitis B virus/hepatitis C virus co-infection.
Hepatitis, Chronic
Recombinant interferon alfa-2b treatment in chronic non-A, non-B/type C hepatitis.
Hepatitis, Chronic
Recombinant interferon-alfa therapy in children with chronic hepatitis C.
Hepatitis, Chronic
Relationship between serum alanine aminotransferase levels and liver histology in chronic hepatitis C-infected patients.
Hepatitis, Chronic
Retreatment decision for hepatitis B flare in HBeAg negative Chronic Hepatitis B.
Hepatitis, Chronic
Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection.
Hepatitis, Chronic
Serum aminotransferase levels and histological disease in chronic hepatitis C.
Hepatitis, Chronic
Serum hepatitis B virus DNA levels differentiating inactive carriers from patients with chronic hepatitis B.
Hepatitis, Chronic
Serum levels of macrophage colony stimulating factor (M-CSF) in liver disease.
Hepatitis, Chronic
Serum neopterin levels in children with hepatitis-B-related chronic liver disease and its relationship to disease severity.
Hepatitis, Chronic
Significance of Anti-Nuclear Antibodies and Cryoglobulins in Patients with Acute and Chronic HEV Infection.
Hepatitis, Chronic
Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis.
Hepatitis, Chronic
Telbivudine therapy for chronic hepatitis B: a journey to identify super-responders and to optimize treatment using the roadmap model.
Hepatitis, Chronic
The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders.
Hepatitis, Chronic
The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus-positive hemophilic men undergoing HCV "seroreversion".
Hepatitis, Chronic
The risk of hepatocellular carcinoma among chronic hepatitis B virus-infected patients outside current treatment criteria.
Hepatitis, Chronic
Treatment of chronic hepatitis B and C with alpha interferon in a renal transplant patient.
Hepatitis, Chronic
Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States.
Hepatitis, Chronic
Triiodothyronine level and triiodothyronine/thyroxine ratio in HBeAg-positive chronic hepatitis patients treated with prednisolone withdrawal.
Hepatitis, Chronic
Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review.
Hepatitis, Chronic
Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
Hepatitis, Chronic
What technique should be used for routine detection and quantification of HBV DNA in clinical samples?
Hepatitis, Chronic
[Accuracy of FibroScan for the diagnosis of liver fibrosis influenced by serum alanine aminotransferase levels in patients with chronic hepatitis B].
Hepatitis, Chronic
[AspAT and AlAT aminotransferase activity following virus hepatitis and chronic hepatitis in outpatient practice]
Hepatitis, Chronic
[Association of baseline alanine aminotransferase levels with therapeutic effects of entecavir and interferon-? in patients with chronic hepatitis B].
Hepatitis, Chronic
[Change of hepatitis B surface antigen in serum from patients with chronic hepatitis B]
Hepatitis, Chronic
[Optimal antiviral therapy of chronic hepatitis caused by hepatitis C virus]
Hepatitis, Chronic
[Serum type IV collagen and laminin in patients with chronic hepatitis and its clinical significance]
Hepatitis, Chronic
[The anti-HCV assay in viral hepatitis and hepatoma and the relationship between HCV infection and blood transfusion]
Hepatitis, Chronic
[The blood level of cobalamin as an indicator of the functional status of the liver in jaundice of different etiologies]
Hepatitis, Chronic
[The correlation between the spontaneous clearance of HBV DNA and the levels of Alanine Aminotransferase in chronic hepatitis B].
Hepatitis, Chronic
[Treatment of chronic hepatitis with interferon in children with kidney diseases]
Hepatolenticular Degeneration
Alanine Aminotransferase as the First Test Parameter for Wilson's Disease.
Hepatolenticular Degeneration
Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure.
Hepatolenticular Degeneration
Fulminant Wilson's disease in children: appraisal of a critical diagnosis.
Hepatolenticular Degeneration
Hypoceruloplasminemia: an unusual biochemical finding in a girl with Hashimoto's thyroiditis and severe hypothyroidism.
Hepatolenticular Degeneration
Isolated persistent elevation of alanine transaminase for early diagnosis of pre-symptomatic Wilson's disease in Chinese children.
Hepatomegaly
A case of glycogenic hepatopathy developed in a patient with new-onset fulminant type 1 diabetes: the role of image modalities in diagnosing hepatic glycogen deposition including gradient-dual-echo MRI.
Hepatomegaly
A clinical and biochemical profile of biopsy-proven non-alcoholic Fatty liver disease subjects.
Hepatomegaly
A comparative study between Wuweizi seed and its post-ethanol extraction residue in normal and hypercholesterolemic mice.
Hepatomegaly
Ameliorative Potential of Tamarindus indica on High Fat Diet Induced Nonalcoholic Fatty Liver Disease in Rats.
Hepatomegaly
Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients.
Hepatomegaly
Clinical and Laboratory Profile of Persons Living with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Histoplasmosis from a Colombian Hospital.
Hepatomegaly
Co-option of PPAR? in the regulation of lipogenesis and fatty acid oxidation in CLA-induced hepatic steatosis.
Hepatomegaly
Coinfection with HIV and hepatitis C virus in 229 children and young adults living in Europe.
Hepatomegaly
Dexamethasone treatment improves morphological and hematological parameters in chronic experimental schistosomiasis.
Hepatomegaly
Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?
Hepatomegaly
Estimation of Hepatitis B Virus, Hepatitis C Virus, and Different Clinical Parameters in the Thalassemic Population of Capital Twin Cities of Pakistan.
Hepatomegaly
Eugenol Reduces LDL Cholesterol and Hepatic Steatosis in Hypercholesterolemic Rats by Modulating TRPV1 Receptor.
Hepatomegaly
Fanconi-Bickel syndrome in an infant with cytomegalovirus infection: A case report and review of the literature.
Hepatomegaly
Glycine N-methyltransferase-/- mice develop chronic hepatitis and glycogen storage disease in the liver.
Hepatomegaly
Glycogen Hepatopathy: A Reversible yet Relapsing Cause of Hepatitis in Type 1 Diabetics.
Hepatomegaly
Hepatitis associated with low-dose venlafaxine for postmenopausal vasomotor symptoms.
Hepatomegaly
Hepatotoxic Effects of Hexafluoropropylene Oxide Trimer Acid (HFPO-TA), A Novel Perfluorooctanoic Acid (PFOA) Alternative, on Mice.
Hepatomegaly
Hypocholesterolemic effect of ?-caryophyllene in rats fed cholesterol and fat enriched diet.
Hepatomegaly
Less Severe but Prolonged Course of Acute Hepatitis A in HIV-positive Patients than HIV-negative Patients During an Outbreak: A Multicenter Observational Study.
Hepatomegaly
Liver manifestations in a cohort of 39 patients with congenital disorders of glycosylation: pin-pointing the characteristics of liver injury and proposing recommendations for follow-up.
Hepatomegaly
Nonobstructive neonatal cholestasis: clinical outcome and scoring of the histopathological changes in liver biopsies.
Hepatomegaly
Pharmacological ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice.
Hepatomegaly
PHKA2 mutation spectrum in Korean patients with glycogen storage disease type IX: prevalence of deletion mutations.
Hepatomegaly
Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats.
Hepatomegaly
Prevalence of hepatic abnormalities in a cohort of Egyptian children with type 1 diabetes mellitus.
Hepatomegaly
Relationship between genotypes and clinical manifestation, pathology, and cccDNA in Chinese children with hepatitis B virus-associated glomerulonephritis.
Hepatomegaly
Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease.
Hepatomegaly
Serological evidence of infection with rodent-borne hepatitis E virus HEV-C1 or antigenically related virus in humans.
Hepatomegaly
Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry.
Hepatomegaly
The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
Hepatomegaly
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice.
Hepatomegaly
The natural history of liver glycogenosis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients.
Hepatomegaly
The Significance of Prolonged and Saddleback Fever in Hospitalised Adult Dengue.
Hepatomegaly
Three broad modalities in the natural history of vertically acquired hepatitis C virus infection.
Hepatomegaly
Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus.
Hepatomegaly
Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
Hepatomegaly
Ultrasonography as a non-invasive tool for detection of nonalcoholic fatty liver disease in overweight/obese Egyptian children.
Hepatomegaly
[Analysis of five cases of hepatitis associated aplastic anemia presenting with hemophagocytic lymphohistiocytosis at onset].
Hepatomegaly
[Primary biliary liver cirrhosis in patients treated at Szczecin hospitals in 1978-1988]
Hepatomegaly
[Successful treatment of chronic active hepatitis with high-dose intravenous immunoglobulins in agammaglobulinemia]
Hepatopulmonary Syndrome
Chronic liver disease is universal in children with biliary atresia living with native liver.
Hepatorenal Syndrome
Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
Hepatorenal Syndrome
[Clinical study on hepatitis D virus-positive patients died from severe hepatitis B]
Herpes Simplex
Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG Mice.
Herpes Simplex
[Specific features of a change in some blood biochemical indicators in virus urogenital infections].
Herpesviridae Infections
Analysis and simulation of an Adefovir anti-hepatitis B virus infection therapy immune model with alanine aminotransferase.
Herpesviridae Infections
Relationship between the serum alanine aminotransferase level at the end of interferon treatment and histologic changes in wild-type and precore mutant hepatitis B virus infections.
Hirsutism
Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess.
Hirsutism
Insulin-like growth factor 1, liver enzymes, and insulin resistance in patients with PCOS and hirsutism.
Histoplasmosis
AST to ALT Ratio is elevated in disseminated histoplasmosis as compared to localized pulmonary disease and other endemic mycoses.
Histoplasmosis
Hepatic Failure in a Patient Receiving Itraconazole for Pulmonary Histoplasmosis-Case Report and Literature Review.
HIV Infections
Abnormal serum porphyrin levels in patients with the acquired immunodeficiency syndrome with or without hepatitis C virus infection.
HIV Infections
Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection.
HIV Infections
Hepatitis C Screening in an Underserved U.S. Cohort of Reproductive Age Women.
HIV Infections
Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting.
HIV Infections
Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.
HIV Infections
LIMITED ELEVATIONS IN ANTITUBERCULOSIS DRUG-INDUCED SERUM ALANINE AMINOTRANSFERASE (ALT) LEVELS IN A COHORT OF NIGERIANS ON TREATMENT FOR PULMONARY TUBERCULOSIS AND HIV INFECTION IN YENAGOA.
HIV Infections
Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.
HIV Infections
Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.
HIV Infections
Prevalence of hepatitis C virus infection according to the year of birth: identification of risk groups.
HIV Infections
The association of the platelet count and the peripheral CD8+ cell count in Japanese HIV-infected hemophiliacs.
HIV Infections
Virus safety of solvent/detergent-treated antihaemophilic factor concentrate.
HIV Seropositivity
The prevalence and interaction of human immunodeficiency virus and hepatitis B virus infections in Israeli hemophiliacs.
Hoarseness
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas.
Hodgkin Disease
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Huntington Disease
Increased alanine aminotransferase activity in the Huntington's disease putamen.
Hydronephrosis
Prognostic-factors-based risk-stratification model for invasive urothelial carcinoma of the urinary bladder in Taiwan.
Hymenolepiasis
[The activity of acetyl COA hydrolase (AACo) and aminotransferases AspAT and AlAt in the course of experimental hymenolepiasis]
Hypercalcemia
Epidemiology of massive hepatocellular carcinoma in dogs: A 4-year retrospective study.
Hypercholesterolemia
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors.
Hypercholesterolemia
Acute intoxication of deltamethrin in monosex Nile tilapia, Oreochromis niloticus with special reference to the clinical, biochemical and haematological effects.
Hypercholesterolemia
Anemia, myopathy, and pansteatitis in vitamin E-deficient captive marmosets (Callithrix spp.).
Hypercholesterolemia
Diverse cardiovascular responses to aortic constriction in normotensive Sprague-Dawley versus spontaneously hypertensive rats.
Hypercholesterolemia
Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage).
Hypercholesterolemia
Everolimus with reduced-dose cyclosporine in de novo renal transplant recipients: Philippine experience.
Hypercholesterolemia
Experimental toxic liver damage and hepatic plasma clearance of 99mTc-mebrofenin (iminodiacetate derivative). II. Recovery from the acute, CCl4-induced liver damage.
Hypercholesterolemia
Gugulipid causes hypercholesterolemia leading to endothelial dysfunction, increased atherosclerosis, and premature death by ischemic heart disease in male mice.
Hypercholesterolemia
How should we manage patients with non-alcoholic fatty liver disease in 2007?
Hypercholesterolemia
Isolated hypercholesterolemia leads to steatosis in the liver without affecting the pancreas.
Hypercholesterolemia
Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases.
Hypercholesterolemia
Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience.
Hypercholesterolemia
Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers.
Hypercholesterolemia
Protective role of phytosterol esters in combating oxidative hepatocellular injury in hypercholesterolemic rats.
Hypercholesterolemia
The Clinical Investigation of Disparity of Nonalcoholic Fatty Liver Disease in a Chinese Occupational Population in Taipei, Taiwan: Experience at a Teaching Hospital.
Hypercholesterolemia
The influence of fluoride ions upon selected enzymes of protein metabolism in blood plasma of rabbits with hypercholesterolemia.
Hypercholesterolemia
Tipranavir: a new option for the treatment of drug-resistant HIV infection.
Hyperemesis Gravidarum
Liver enzyme elevation induced by hyperemesis gravidarum: aetiology, diagnosis and treatment.
Hyperferritinemia
Association of Nonimmune Hydrops Fetalis With Familial Hemophagocytic Lymphohistiocytosis in Identical Twin Neonates With Perforin His222Arg (c665A>G) Mutation.
Hyperferritinemia
Different Clinical Presentation of 3 Children With Familial Hemophagocytic Lymphohistiocytosis With 2 Novel Mutations.
Hyperferritinemia
Ferritin level is associated with metabolic syndrome and elevated alanine aminotransferase in children and adolescents.
Hyperferritinemia
Macrophage activation syndrome as a complication of juvenile rheumatoid arthritis.
Hyperferritinemia
Potential Predictors of Poor Prognosis among Severe COVID-19 Patients: A Single-Center Study.
Hypergammaglobulinemia
Telbivudine on IgG-associated hypergammaglobulinemia and TGF-?1 hyperactivity in hepatitis B virus-related liver cirrhosis.
Hypergammaglobulinemia
The prevalence and interaction of human immunodeficiency virus and hepatitis B virus infections in Israeli hemophiliacs.
Hyperglycemia
A Phase 1 Clinical Study of Temsirolimus (CCI-779) in Japanese Patients with Advanced Solid Tumors.
Hyperglycemia
A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors.
Hyperglycemia
A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer.
Hyperglycemia
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
Hyperglycemia
A retrospective evaluation of eastern coral snake envenomation and antivenom administration in cats: 30 cases (2012-2019).
Hyperglycemia
ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study.
Hyperglycemia
An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma.
Hyperglycemia
Beneficial effects of N-acetylcysteine on hepatic oxidative stress in streptozotocin-induced diabetic rats.
Hyperglycemia
Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2.
Hyperglycemia
Diverse cardiovascular responses to aortic constriction in normotensive Sprague-Dawley versus spontaneously hypertensive rats.
Hyperglycemia
Dose-ranging antiemetic evaluation of the serotonin antagonist RG 12915 in patients receiving anticancer chemotherapy.
Hyperglycemia
Effect of oral vanadyl sulfate treatment on serum enzymes and lipids of streptozotocin-diabetic young rats.
Hyperglycemia
Encapsulation of 16-Hydroxycleroda-3,13-Dine-16,15-Olide in Mesoporous Silica Nanoparticles as a Natural Dipeptidyl Peptidase-4 Inhibitor Potentiated Hypoglycemia in Diabetic Mice.
Hyperglycemia
Exposure to deltamethrin induces oxidative stress and decreases of energy reserve in tissues of the Neotropical fruit-eating bat Artibeus lituratus.
Hyperglycemia
FDA Approval: Alectinib for the Treatment of Metastatic ALK-Positive Non-Small Cell Lung Cancer Following Crizotinib.
Hyperglycemia
Hepatic changes in adenine nucleotide levels and adenosine 3'-monophosphate forming enzyme in streptozotocin-induced diabetic mice.
Hyperglycemia
Hepatic lesions induced by feeding Western diets to Zucker fatty rats, an insulin-resistant model.
Hyperglycemia
Immunomodulatory and protective properties of tacrolimus in experimental scorpion envenomation.
Hyperglycemia
Lentinus edodes Exposure before and after Fetus Implantation: Materno-Fetal Development in Rats with Gestational Diabetes Mellitus.
Hyperglycemia
Malignant Hyperthermia in Bariatric Surgery: A Case Study With Clinical, Pathophysiological, Biochemical and Biophysical Correlations.
Hyperglycemia
Mesenchymal stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow-derived cells.
Hyperglycemia
Obesity and diabetic hyperglycemia were associated with serum alanine aminotransferase activity in patients with hepatitis B infection.
Hyperglycemia
Outcomes and Adverse Effects With Peramivir for the Treatment of Influenza H1N1 in Critically Ill Pediatric Patients.
Hyperglycemia
Phase I Study of the Pan-PI3K Inhibitor Buparlisib in Adult Chinese Patients with Advanced Solid Tumors.
Hyperglycemia
Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy.
Hyperglycemia
Postprandial Antihyperglycemic And Antioxidant Activities of Acalypha indica Linn Stem Extract: An In-vivo Study.
Hyperglycemia
Presumed Choline Chloride Toxicosis in Cats With Positive Ethylene Glycol Tests After Consuming a Recalled Cat Food.
Hyperglycemia
Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
Hyperglycemia
Regulation mechanism of oxidative stress induced by high glucose through PI3K/Akt/Nrf2 pathway in juvenile blunt snout bream (Megalobrama amblycephala).
Hyperglycemia
Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging and Treatment Management of Neuroendocrine Tumors.
Hyperglycemia
Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES.
Hyperglycemia
Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection.
Hyperglycemia
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Hyperglycemia
Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma - systematic review and meta-analysis.
Hyperhomocysteinemia
Association of serum VLDL level with hyperhomocysteinemia in hypertensive patients: A cross-sectional study.
Hyperhomocysteinemia
Corrective effects of hepatotoxicity by hepatic Dyrk1a gene delivery in mice with intermediate hyperhomocysteinemia.
Hyperhomocysteinemia
Differences in betaine-homocysteine methyltransferase expression, endoplasmic reticulum stress response, and liver injury between alcohol-fed mice and rats.
Hyperinsulinism
A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology.
Hyperinsulinism
Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.
Hyperinsulinism
Hepatic lesions induced by feeding Western diets to Zucker fatty rats, an insulin-resistant model.
Hyperinsulinism
Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations.
Hyperinsulinism
Impaired FAD-glycerophosphate dehydrogenase activity in islet and liver homogenates of fa/fa rats.
Hyperinsulinism
Insulin-like growth factor 1, liver enzymes, and insulin resistance in patients with PCOS and hirsutism.
Hyperinsulinism
Mesenchymal stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow-derived cells.
Hyperkalemia
Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
Hyperkalemia
Lethal peracute rhabdomyolysis associated with stress and general anesthesia in three dystrophin-deficient cats.
Hyperkalemia
Malignant Hyperthermia in Bariatric Surgery: A Case Study With Clinical, Pathophysiological, Biochemical and Biophysical Correlations.
Hyperkalemia
Toxoplasma gondii inclusions in peripheral blood leukocytes of a red-necked wallaby (Macropus rufogriseus).
Hyperlactatemia
A retrospective evaluation of eastern coral snake envenomation and antivenom administration in cats: 30 cases (2012-2019).
Hyperlactatemia
Gallbladder and Liver Lobe Torsion in a Young Cat Presented with Hemoabdomen.
Hyperlactatemia
Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens.
Hyperlipidemias
A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients.
Hyperlipidemias
A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology.
Hyperlipidemias
Associations between liver enzymes, psychopathological and clinical features in eating disorders.
Hyperlipidemias
Clinical features in coronavirus disease 2019 (COVID-19) patients with early clearance and prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA.
Hyperlipidemias
Creatine Alleviates Doxorubicin-Induced Liver Damage by Inhibiting Liver Fibrosis, Inflammation, Oxidative Stress, and Cellular Senescence.
Hyperlipidemias
Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils.
Hyperlipidemias
Effect of Hypericum perforatum Aqueous Extracts on Serum Lipids, Aminotransferases, and Lipid Peroxidation in Hyperlipidemic Rats.
Hyperlipidemias
Effect of naringenin in Qianggu capsule on population pharmacokinetics in Chinese women with primary osteoporosis.
Hyperlipidemias
Establishment and Application of Early Risk Stratification Method for Acute Abdominal Pain in Adults.
Hyperlipidemias
Hepatic lesions induced by feeding Western diets to Zucker fatty rats, an insulin-resistant model.
Hyperlipidemias
Hyperlipidemia and Nonalcoholic Steatohepatitis Predispose to Hepatocellular Carcinoma Development Without Cirrhosis.
Hyperlipidemias
Improvement in the Oral Bioavailability and Efficacy of New Ezetimibe Formulations-Comparative Study of a Solid Dispersion and Different Micellar Systems.
Hyperlipidemias
Mesenchymal stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow-derived cells.
Hyperlipidemias
Pharmacological activity of deep-sea water: examination of hyperlipemia prevention and medical treatment effect.
Hyperlipidemias
Serum levels of pigment epithelium-derived factor (PEDF) are independently associated with procollagen III N-terminal peptide levels in patients with nonalcoholic fatty liver disease.
Hyperlipidemias
Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.
Hyperlipidemias
Sex differences in metabolic morbidities: influenced by diet or exercise habits?
Hyperlipidemias
Successful rescue of antepartum eclampsia in a Chinese patient: Case report.
Hyperlipidemias
Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies).
Hyperlipidemias
Usefulness of admission gamma-glutamyltransferase level for predicting new-onset heart failure in patients with acute coronary syndrome with left ventricular systolic dysfunction.
Hyperlipidemias
[Fatty hepatosis. Non-alcoholic steatohepatitis (evolution of the knowledge about clinico-morphological features, prognosis, treatment)]
Hyperlipidemias
[Relationship of fatty liver with HBV infection, hyperlipidemia and abnormal alanine aminotransferase]
Hyperlipoproteinemias
[Moniside (isosorbide-5-mononitrate)--the effect on some changes in a hyperlipoproteinemia mode in rats]
Hypernatremia
Hypoglycemia and seizures associated with canine primary hepatic neuroendocrine carcinoma.
Hypernatremia
Malignant Hyperthermia in Bariatric Surgery: A Case Study With Clinical, Pathophysiological, Biochemical and Biophysical Correlations.
Hypernatremia
Severe hypernatremia in deceased liver donors does not impact early transplant outcome.
Hyperoxaluria, Primary
Crystal structure of the S187F variant of human liver alanine: aminotransferase associated with primary hyperoxaluria type I and its functional implications.
Hyperoxaluria, Primary
gene2drug: a Computational Tool for Pathway-based Rational Drug Repositioning.
Hyperphosphatemia
Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
Hyperphosphatemia
Lethal peracute rhabdomyolysis associated with stress and general anesthesia in three dystrophin-deficient cats.
Hyperphosphatemia
Renal transitional cell carcinoma and choristoma in a degu (Octodon degus).
Hyperphosphatemia
Toxoplasma gondii inclusions in peripheral blood leukocytes of a red-necked wallaby (Macropus rufogriseus).
Hyperpigmentation
Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial.
Hypersensitivity
A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors.
Hypersensitivity
A prospective observational study of a novel 2-phase infusion protocol for the administration of acetylcysteine in paracetamol poisoning.
Hypersensitivity
Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
Hypersensitivity
Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes.
Hypersensitivity
Elevation of alanine transaminase and gallbladder wall abnormalities as biomarkers of anaphylaxis in canine hypersensitivity patients.
Hypersensitivity
Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry.
Hypersensitivity
Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): an exploratory, open-label, phase 2 study.
Hypersensitivity
Phase 1 study of the ATR inhibitor berzosertib in combination with cisplatin in patients with advanced solid tumours.
Hypersensitivity
Predictive criteria of severe cases in COVID-19 patients of early stage: A retrospective observational study.
Hypersensitivity
Safety and efficacy of cetuximab combined with chemotherapy in Chinese patients with advanced non-small cell lung cancer.
Hypersensitivity
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
Hypersplenism
Hypersplenism is correlated with increased risk of hepatocellular carcinoma in patients with post-hepatitis cirrhosis.
Hypersplenism
Laparoscopic Splenectomy for the Elderly Liver Cirrhotic Patients With Hypersplenism: A Retrospective Comparable Study.
Hypertension
A clinical and biochemical profile of biopsy-proven non-alcoholic Fatty liver disease subjects.
Hypertension
A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients.
Hypertension
A phase I dose-escalation study of ZD6474 in Japanese patients with solid, malignant tumors.
Hypertension
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas.
Hypertension
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer.
Hypertension
A single-nucleotide polymorphism in the interleukin-1 receptor-associated protein gene is associated with impaired glucose regulation and type 2 diabetes in a case-controlled study.
Hypertension
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.
Hypertension
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Hypertension
An observational study on the relationship between serum uric acid and hypertension in a Northern Chinese population aged 45 to 59 years.
Hypertension
Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706).
Hypertension
Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trial.
Hypertension
Association between Alcohol Intake and Hemoglobin A1c in the Korean Adults: The 2011-2013 Korea National Health and Nutrition Examination Survey.
Hypertension
Association between aldehyde dehydrogenase 2 gene rs671 G>A polymorphism and alcoholic liver cirrhosis in southern Chinese Hakka population.
Hypertension
Association between resting heart rate and arterial stiffness in Korean adults.
Hypertension
Association between serum ?-glutamyltransferase and chronic kidney disease in urban Han Chinese: a prospective cohort study.
Hypertension
Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes.
Hypertension
Association of Lactate Dehydrogenase with In-Hospital Mortality in Patients with Acute Aortic Dissection: A Retrospective Observational Study.
Hypertension
Association of TSH Elevation with All-Cause Mortality in Elderly Patients with Chronic Kidney Disease.
Hypertension
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial.
Hypertension
Bi-directional and temporal relationship between elevated alanine aminotransferase and hypertension in a longitudinal study of Chinese adults.
Hypertension
BMI and health risks of health checkup clients at the Preventive Medicine Clinic, King Chulalongkorn Memorial Hospital.
Hypertension
Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Hypertension
Cardioprotective and antihypertensive effects of Enicostemma littorale Blume extract in fructose-fed rats.
Hypertension
Cediranib (AZD2171) in Patients With Advanced Hepatocellular Carcinoma: A Phase II North Central Cancer Treatment Group Clinical Trial.
Hypertension
Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
Hypertension
Clinical characteristics of patients under 40 years old with early-onset hyperuricaemia: a retrospective monocentric study in China.
Hypertension
Clinical features in coronavirus disease 2019 (COVID-19) patients with early clearance and prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA.
Hypertension
Clinical outcome in elderly Chinese patients with primary hepatocellular carcinoma treated with percutaneous microwave coagulation therapy (PMCT): A Strobe-compliant observational study.
Hypertension
Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
Hypertension
Combination nivolumab and bevacizumab for metastatic myxofibrosarcoma: A case report and review of the literature.
Hypertension
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study.
Hypertension
Concurrent Incidental Presentation of Primary Retroperitoneal Follicular Lymphoma With Acute Pancreatitis.
Hypertension
Cystatin C, COVID-19 severity and mortality: a systematic review and meta-analysis.
Hypertension
Dabrafenib plus trametinib in patients with previously untreated BRAF(V600E)-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial.
Hypertension
Dallas Steatosis Index Identifies Patients With Nonalcoholic Fatty Liver Disease.
Hypertension
Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C.
Hypertension
Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong.
Hypertension
Diabetes based on 2-h plasma glucose among those classified as having prediabetes based on fasting plasma glucose or A1c.
Hypertension
Disease Severity Affects Ventricular Repolarization Parameters in Patients With COVID-19.
Hypertension
Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?
Hypertension
Efficacy and safety of fluvastatin in hypertensive patients. An analysis of a clinical trial database.
Hypertension
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study.
Hypertension
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study.
Hypertension
Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients.
Hypertension
Epidemiology, Risk Factors, and In-Hospital Mortality of Venous Thromboembolism in Liver Cirrhosis: A Single-Center Retrospective Observational Study.
Hypertension
Establishment and Application of Early Risk Stratification Method for Acute Abdominal Pain in Adults.
Hypertension
Exposure to famine in early life and non-alcoholic fatty liver disease in adulthood.
Hypertension
First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer.
Hypertension
First-Line Pazopanib Treatment in Metastatic Renal Cell Carcinoma: Real-World Data From a Single Chinese Center.
Hypertension
Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies.
Hypertension
Gastrointestinal bleeding in patients admitted to cardiology: risk factors and a new risk score.
Hypertension
Gender difference on the relationship between hyperuricemia and nonalcoholic fatty liver disease among Chinese: An observational study.
Hypertension
Gender differences in the association of hypertension with gamma-glutamyltransferase and alanine aminotransferase levels in Chinese adults in Qingdao, China.
Hypertension
Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
Hypertension
High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery.
Hypertension
Hypertension is an important predictor of recurrent colorectal adenoma after screening colonoscopy with adenoma polypectomy.
Hypertension
Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study.
Hypertension
Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients.
Hypertension
Incidence and risk factors for progression from prehypertension to hypertension: a 12-year Korean Cohort Study.
Hypertension
Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance.
Hypertension
Induction of transient proteinuria, hematuria, and glucosuria by ethanol consumption in Japanese alcoholics.
Hypertension
Ischemic stroke in liver cirrhosis: epidemiology, risk factors, and in-hospital outcomes.
Hypertension
Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population.
Hypertension
Metabolic correlates of subcutaneous and visceral abdominal fat measured by ultrasonography: a comparison with waist circumference.
Hypertension
Modulatory effect of sesamol on DOCA-salt-induced oxidative stress in uninephrectomized hypertensive rats.
Hypertension
Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial.
Hypertension
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial.
Hypertension
Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase.
Hypertension
Nonalcoholic fatty liver disease is associated with coronary artery calcification.
Hypertension
Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.
Hypertension
Occurrence of abscesses during treatment with pazopanib in metastatic renal cancer: a case report.
Hypertension
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.
Hypertension
Outcomes and Adverse Effects With Peramivir for the Treatment of Influenza H1N1 in Critically Ill Pediatric Patients.
Hypertension
Overweight Is Highly Prevalent In Children with Type 1 Diabetes And Associates with Cardiometabolic Risk.
Hypertension
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.
Hypertension
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial.
Hypertension
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial.
Hypertension
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.
Hypertension
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial.
Hypertension
Perceived dietary salt intake and the risk of primary liver cancer: a population-based prospective study.
Hypertension
Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas.
Hypertension
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy.
Hypertension
Phase II study of lenvatinib for metastatic colorectal cancer refractory to standard chemotherapy: the LEMON study (NCCH1503).
Hypertension
Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease.
Hypertension
Predicting the risk of postoperative acute kidney injury: development and assessment of a novel predictive nomogram.
Hypertension
Prediction of the Presence of Insulin Resistance using General Health Checkup Data in Japanese Employees with Metabolic Risk Factors.
Hypertension
Predictors of Carotid Intima-Media Thickness Progression in Adolescents-The EVA-Tyrol Study.
Hypertension
Predictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study.
Hypertension
Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial.
Hypertension
Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker.
Hypertension
Prepregnancy liver enzyme levels and risk of preeclampsia in a subsequent pregnancy: A population-based cohort study.
Hypertension
Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
Hypertension
Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity.
Hypertension
Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience.
Hypertension
Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
Hypertension
Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B.
Hypertension
Prevalence and risk factors of nonalcoholic fatty liver disease in breast cancer patients.
Hypertension
Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
Hypertension
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.
Hypertension
Recurrence of insulin resistant metabolic syndrome following liver transplantation.
Hypertension
Red blood cell distribution width as a predictor of long-term mortality in patients with carbon monoxide poisoning.
Hypertension
Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial.
Hypertension
Relationship between area under the concentration versus time curve of cyclosporin A, creatinine clearance, hematocrit value, and other clinical factors in Japanese renal transplant patients.
Hypertension
Relationship between genotypes and clinical manifestation, pathology, and cccDNA in Chinese children with hepatitis B virus-associated glomerulonephritis.
Hypertension
Relationship between parental hypertension and cardiometabolic risk factors in adolescents.
Hypertension
Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma.
Hypertension
Reverse Engineering and Evaluation of Prediction Models for Progression to Type 2 Diabetes: An Application of Machine Learning Using Electronic Health Records.
Hypertension
Risk factors and characteristics associated with nonalcoholic fatty liver disease in patients with ischemic colitis.
Hypertension
Risk factors for aneurysmal subarachnoid hemorrhage in patients in Izumo City, Japan.
Hypertension
Risk factors for primary intracerebral hemorrhage in patients in Izumo City, Japan.
Hypertension
Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study.
Hypertension
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.
Hypertension
Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial.
Hypertension
Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men.
Hypertension
Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Hypertension
Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in patients with type 2 diabetes.
Hypertension
Serum triglyceride level and hypertension are highly associated with the recovery of COVID-19 patients.
Hypertension
Sex differences in metabolic morbidities: influenced by diet or exercise habits?
Hypertension
Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients: A Community-Based Study in a Hepatitis B/Hepatitis C Virus Hyperendemic Area.
Hypertension
Short-term laboratory and related safety outcomes for the multiple sclerosis oral disease-modifying therapies: an observational study.
Hypertension
Simvastatin-induced myopathy, the role of interaction with diltiazem and genetic predisposition.
Hypertension
Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
Hypertension
Surufatinib in Advanced Well-Differentiated Neuroendocrine Tumors: A Multicenter, Single-Arm, Open-Label, Phase Ib/II Trial.
Hypertension
The Association Between Self-Reported Sleep Quality and Overweight in A Chinese Population.
Hypertension
The association between serum alanine aminotransferase and hypertension: A national based cross-sectional analysis among over 21 million Chinese adults.
Hypertension
The Associations between Liver Enzymes and Cardiovascular Risk Factors in Adults with Mild Dyslipidemia.
Hypertension
The Changing Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Turkey in the Last Decade.
Hypertension
The Clinical Investigation of Disparity of Nonalcoholic Fatty Liver Disease in a Chinese Occupational Population in Taipei, Taiwan: Experience at a Teaching Hospital.
Hypertension
The European Medicines Agency review of pazopanib for the treatment of advanced renal cell carcinoma: summary of the scientific assessment of the Committee for Medicinal Products for Human Use.
Hypertension
The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation.
Hypertension
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Hypertension
The paradox of the role of resistin in early-onset obesity hypertension: A comparative study among four Chinese adult subgroups.
Hypertension
The polymorphism -863C/A in tumour necrosis factor-{alpha} gene contributes an independent association to gout.
Hypertension
The risk factors of adverse pregnancy outcome for pre-pregnancy couples in Hunan, China: A cross-sectional study based on population.
Hypertension
Transient elastography assessed hepatic steatosis and fibrosis are associated with body composition in the United States.
Hypertension
Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia.
Hypertension
Usefulness of admission gamma-glutamyltransferase level for predicting new-onset heart failure in patients with acute coronary syndrome with left ventricular systolic dysfunction.
Hypertension
Vatalanib in malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B (CALGB 30107).
Hypertension
Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population.
Hypertension
[Association between gamma-glutamyltransferase and hypertension incidence in rural prehypertensive adults]
Hypertension
[Evaluation of fetal condition in pregnancy complicated by hypertension--biochemical assessment of amniotic fluid. II. Enzymes]
Hypertension
[Metabolic syndrome: jumble syndrome of obesity or specific entity? Which treatment: diet or polypill?]
Hypertension
[Predictors of the development of hypertension: ten-year follow-up study in a community]
Hypertension
[Risk factors analysis of reversible posterior leukoencephalopathy syndrome in pre-eclampsia or eclampsia gravida].
Hypertension
[The relationship between non-alcoholic fatty liver disease and metabolic syndrome in patients with latent autoimmune diabetes in adults].
Hypertension, Portal
Characteristics of Liver Disease in 100 Individuals With Joubert Syndrome Prospectively Evaluated at a Single Center.
Hypertension, Portal
Chronic liver disease is universal in children with biliary atresia living with native liver.
Hypertension, Portal
Effectiveness of direct-acting antiviral drugs against hepatitis C virus: predictive factors of response to the treatment.
Hypertension, Portal
Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats.
Hypertension, Portal
Factors predicting advanced hepatic fibrosis in patients with postcholecystectomy bile duct strictures.
Hypertension, Portal
Involvement of heat shock protein 47 in Schistosoma japonicum-induced hepatic fibrosis in mice.
Hypertension, Portal
Machine Learning for the Prediction of Red Blood Cell Transfusion in Patients During or After Liver Transplantation Surgery.
Hypertension, Portal
Noncirrhotic Portal Hypertension in HIV-Infected Patients: A Case Control Evaluation and Review of the Literature.
Hypertension, Portal
Noninvasive Assessment of Portal Hypertension Using Spectral Computed Tomography.
Hypertension, Portal
Oxidative-stress-related changes in the livers of bile-duct-ligated rats.
Hypertension, Pregnancy-Induced
From Pruritus to Cholestasis: Building a Statistical Model and Online Application to Predict a Diagnosis Prior to Bile Acid Determination.
Hypertension, Pulmonary
Prognostic significance of low serum cholesterol after cardiothoracic surgery.
Hyperthyroidism
A clinical retrospective analysis of factors associated with apathetic hyperthyroidism.
Hyperthyroidism
Abnormal Liver Blood Tests in Patients with Hyperthyroidism: Systematic Review and Meta-Analysis.
Hyperthyroidism
Alleviation of enhanced oxidative stress and oxygen consumption of L-thyroxine induced hyperthyroid rat liver mitochondria by vitamin E and curcumin.
Hyperthyroidism
Elevated Serum Fibroblast Growth Factor 21 Levels in Patients With Hyperthyroidism.
Hyperthyroidism
Graves' hyperthyroidism accompanied with acute hepatitis B virus infection: an extrahepatic manifestation?
Hyperthyroidism
Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study.
Hyperthyroidism
Hepatoprotective effect of satureja khuzestanica essential oil and vitamin e in experimental hyperthyroid rats: evidence for role of antioxidant effect.
Hyperthyroidism
Independent Association of Serum Fibroblast Growth Factor 21 Levels With Impaired Liver Enzymes in Hyperthyroid Patients.
Hyperthyroidism
Omega-3 fatty acids decreases oxidative stress, tumor necrosis factor-alpha, and interleukin-1 beta in hyperthyroidism-induced hepatic dysfunction rat model.
Hyperthyroidism
Paradoxical effects of perturbation of intracellular levels of glutathione on halothane-induced hepatotoxicity in hyperthyroid rats.
Hyperthyroidism
Plasma isocitrate dehydrogenase as a marker of centrilobular hepatic necrosis in patients with hyperthyroidism.
Hyperthyroidism
Thyroid enlargement and its relationship to clinicopathological parameters and T(4) status in suspected hyperthyroid cats().
Hypertriglyceridemia
A Phase 1 Clinical Study of Temsirolimus (CCI-779) in Japanese Patients with Advanced Solid Tumors.
Hypertriglyceridemia
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors.
Hypertriglyceridemia
Association between obesity, hypertriglyceridemia and low hepatitis B viral load.
Hypertriglyceridemia
Cardioprotective and antihypertensive effects of Enicostemma littorale Blume extract in fructose-fed rats.
Hypertriglyceridemia
Clinical analysis and long-term treatment monitoring of 3 patients with glycogen storage disease type Ib.
Hypertriglyceridemia
Diagnostic Time Lag of Pediatric Haemophagocytic Lymphohistiocytosis and Patient Characteristics: A Retrospective Cohort Study.
Hypertriglyceridemia
Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients.
Hypertriglyceridemia
Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study.
Hypertriglyceridemia
Macrophage activation syndrome as a complication of juvenile rheumatoid arthritis.
Hypertriglyceridemia
Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy.
Hypertriglyceridemia
Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases.
Hypertriglyceridemia
Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study.
Hypertriglyceridemia
Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas.
Hypertriglyceridemia
Prevalence of Suspected Nonalcoholic Fatty Liver Disease In Lean Adolescents In The United States.
Hypertriglyceridemia
Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers.
Hypertriglyceridemia
Surufatinib in Advanced Well-Differentiated Neuroendocrine Tumors: A Multicenter, Single-Arm, Open-Label, Phase Ib/II Trial.
Hypertriglyceridemia
The Clinical Investigation of Disparity of Nonalcoholic Fatty Liver Disease in a Chinese Occupational Population in Taipei, Taiwan: Experience at a Teaching Hospital.
Hypertriglyceridemia
What is the appropriate strategy for diagnosing NAFLD using ultrasonography in obese children?
Hypertriglyceridemia
[The comparative characteristic of short-term and long-term ethanol effects on the rat organism state]
Hypertrophy, Left Ventricular
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Hypesthesia
[Warming needling combined with Zhuyu Tongluo Xuebi decoction for arteriosclerosis obliterans with stasis].
Hypoalbuminemia
A Multicenter Study of Docetaxel at a Dose of 100 mg/m2 in Japanese Patients with Advanced or Recurrent Breast Cancer.
Hypoalbuminemia
Abnormal Liver Function Tests Were Associated With Adverse Clinical Outcomes: An Observational Cohort Study of 2,912 Patients With COVID-19.
Hypoalbuminemia
Accidental fatal aflatoxicosis due to contaminated commercial diet in 50 dogs.
Hypoalbuminemia
Acute intoxication of deltamethrin in monosex Nile tilapia, Oreochromis niloticus with special reference to the clinical, biochemical and haematological effects.
Hypoalbuminemia
An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma.
Hypoalbuminemia
Anemia, myopathy, and pansteatitis in vitamin E-deficient captive marmosets (Callithrix spp.).
Hypoalbuminemia
Association of Nonimmune Hydrops Fetalis With Familial Hemophagocytic Lymphohistiocytosis in Identical Twin Neonates With Perforin His222Arg (c665A>G) Mutation.
Hypoalbuminemia
Chronic Canine Ehrlichiosis (Ehrlichia canis): A Retrospective Study of 19 Natural Cases.
Hypoalbuminemia
Clinical and immunological features of severe and moderate coronavirus disease 2019.
Hypoalbuminemia
Clinical Implication of Performance Status in Patients with Hepatocellular Carcinoma Complicating with Cirrhosis.
Hypoalbuminemia
Clinical manifestations of dengue hemorrhagic fever in Puerto Rico, 1990-1991. Puerto Rico Association of Epidemiologists.
Hypoalbuminemia
Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function.
Hypoalbuminemia
Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
Hypoalbuminemia
Demographic and clinical characteristics of dogs with centroblastic lymphoma.
Hypoalbuminemia
E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma: A phase I study.
Hypoalbuminemia
Evaluation of heart rate variability and behavior of electrocardiographic parameters in dogs affected by chronic Monocytic Ehrlichiosis.
Hypoalbuminemia
Evaluation of Risk Factors and Follow-Up Criteria for Severity of Snakebite in Children.
Hypoalbuminemia
Experimentally induced canine toxocariasis: laboratory examinations and pathologic changes, with emphasis on the gastrointestinal tract.
Hypoalbuminemia
Gallbladder and Liver Lobe Torsion in a Young Cat Presented with Hemoabdomen.
Hypoalbuminemia
Haemato-biochemical characterization of fasciolosis in Gir cattle and Jaffrabadi buffaloes.
Hypoalbuminemia
Infection with Sin Nombre hantavirus: clinical presentation and outcome in children and adolescents.
Hypoalbuminemia
Is there any difference in pyogenic liver abscess caused by Streptococcus milleri and Klebsiella spp?: Retrospective analysis over a 10-year period in a regional hospital.
Hypoalbuminemia
Laboratory findings in patients with avian-origin influenza A (H7N9) virus infections.
Hypoalbuminemia
Liver Function Testing Is Not Useful in the Diagnosis of Sarcoidosis in Patients Presenting with Uveitis.
Hypoalbuminemia
Liver impairment after portacaval shunt in the rat: The loss of protective role of mast cells?
Hypoalbuminemia
Liver synthesis function in chronic asymptomatic or oligosymptomatic alcoholics: correlation with other liver tests.
Hypoalbuminemia
Longdan Xiegan Tang attenuates liver injury and hepatic insulin resistance by regulating the angiotensin-converting enzyme 2/Ang (1-7)/Mas axis-mediated anti-inflammatory pathway in rats.
Hypoalbuminemia
Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease.
Hypoalbuminemia
Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization--single-center experience.
Hypoalbuminemia
Pathology of Experimental Aerosol Zaire Ebolavirus Infection in Rhesus Macaques.
Hypoalbuminemia
Prognostic factors for survival after surgical palliation of malignant pleural effusion.
Hypoalbuminemia
Renal transitional cell carcinoma and choristoma in a degu (Octodon degus).
Hypoalbuminemia
Risk Factors of Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease: A Meta-Analysis of Case-Control Studies.
Hypoalbuminemia
Scrub typhus in children in a teaching hospital in eastern Taiwan, 2000-2005.
Hypoalbuminemia
Severe de novo Hepatitis B Recovered from Late-Onset Liver Insufficiency with Prolonged Ascites and Hypoalbuminemia due to Hepatitis B Virus Genotype Bj with Precore Mutation.
Hypoalbuminemia
Strangles in Arabian horses in Egypt: Clinical, epidemiological, hematological, and biochemical aspects.
Hypoalbuminemia
The autophagy marker LC3 strongly predicts immediate mortality after surgical resection for hepatocellular carcinoma.
Hypoalbuminemia
The First Study Evaluating the Safety of Pre-Surgery Administration of Metformin in Patients with Colorectal and other Gastrointestinal Cancers and Effect on Cancer Stem Cells.
Hypoalbuminemia
Toxoplasma gondii inclusions in peripheral blood leukocytes of a red-necked wallaby (Macropus rufogriseus).
Hypoalbuminemia
Toxoplasma gondii-like organisms in skin aspirates from a cat with disseminated protozoal infection.
Hypoalbuminemia
[Clinical analysis of pregnancy in second and third trimesters complicated severe acute respiratory syndrome]
Hypobetalipoproteinemias
Phenotypic Differences Between Polygenic and Monogenic Hypobetalipoproteinemia.
Hypocalcemia
Addition of Zoledronate to Chemotherapy in Patients with Osteosarcoma Treated with Limb-Sparing Surgery: A Phase III Clinical Trial.
Hypocalcemia
Evaluation of Risk Factors and Follow-Up Criteria for Severity of Snakebite in Children.
Hypocalcemia
FDA Approval: Alectinib for the Treatment of Metastatic ALK-Positive Non-Small Cell Lung Cancer Following Crizotinib.
Hypocalcemia
Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
Hypocalcemia
Laboratory findings in patients with avian-origin influenza A (H7N9) virus infections.
Hypocalcemia
Lethal peracute rhabdomyolysis associated with stress and general anesthesia in three dystrophin-deficient cats.
Hypocalcemia
Malignant Hyperthermia in Bariatric Surgery: A Case Study With Clinical, Pathophysiological, Biochemical and Biophysical Correlations.
Hypocalcemia
Prospective study of Chikungunya virus acute infection in the Island of La Réunion during the 2005-2006 outbreak.
Hypocalcemia
Treatment-related adverse effects with TKIs in patients with advanced or radioiodine refractory differentiated thyroid carcinoma: a systematic review and meta-analysis.
Hypoglycemia
16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.
Hypoglycemia
A Randomized, Controlled Study of Once Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes.
Hypoglycemia
Acute intoxication of deltamethrin in monosex Nile tilapia, Oreochromis niloticus with special reference to the clinical, biochemical and haematological effects.
Hypoglycemia
Adverse event profile of tigecycline: data mining of the public version of the U.S. Food and Drug Administration adverse event reporting system.
Hypoglycemia
Anorexia nervosa with severe liver dysfunction and subsequent critical complications.
Hypoglycemia
Effect of duck hepatitis A virus genotype 3 infection on glucose metabolism of Pekin ducklings and underlying mechanism.
Hypoglycemia
Hypoglycemia and seizures associated with canine primary hepatic neuroendocrine carcinoma.
Hypoglycemia
Hypoglycemic Toxins and Enteroviruses as Causes of Outbreaks of Acute Encephalitis-Like Syndrome in Children, Bac Giang Province, Northern Vietnam.
Hypoglycemia
Insulin-like growth factor-I prevents lethal acute liver failure induced by D-galactosamine and lipopolysaccharide in rats.
Hypoglycemia
Long-term Efficacy and Safety of Sitagliptin in Elderly Patients with Type 2 Diabetes Mellitus.
Hypoglycemia
OUTPATIENT ANALYTIC ASSESSMENT OF ANOREXIA NERVOSA - THE IMPORTANCE OF VENOUS BLOOD GASES.
Hypoglycemia
Physical examination, serum biochemical, and coagulation abnormalities, treatments, and outcomes for dogs with toxicosis from ?-amanitin-containing mushrooms: 59 cases (2006-2019).
Hypoglycemia
Plasma enzymic changes in insulin-induced hypoglycemia in experimental rabbits.
Hypogonadism
The application value of serum 25(OH)D3, uric acid, triglyceride, and homeostasis model assessment of insulin resistance in male patients with hyperuricemia combined with hypogonadism.
Hypogonadism
[Metabolic syndrome: jumble syndrome of obesity or specific entity? Which treatment: diet or polypill?]
Hypokalemia
A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.
Hypokalemia
A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer.
Hypokalemia
A retrospective evaluation of eastern coral snake envenomation and antivenom administration in cats: 30 cases (2012-2019).
Hypokalemia
Aldosterone-, corticosterone- and cortisol-secreting adrenocortical carcinoma in a dog: case report.
Hypokalemia
E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma: A phase I study.
Hypokalemia
Effect of Caspofungin vs Fluconazole Prophylaxis on Invasive Fungal Disease Among Children and Young Adults With Acute Myeloid Leukemia: A Randomized Clinical Trial.
Hypokalemia
Laboratory findings in patients with avian-origin influenza A (H7N9) virus infections.
Hypokalemia
Weekly 24 h infusion of aviscumine (rViscumin): a phase I study in patients with solid tumours.
Hypokalemia
[Clinical characteristics of the patients with dengue fever seen from 2002 to 2006 in Guangzhou]
Hypokinesia
[Effect of clinostatic and anti-orthostatic hypokinesia on serum enzyme activity]
Hypokinesia
[Several indicators of protein and nucleic acid metabolism in lymphoid organs of rats exposed to hypokinesia and vitamin B1 deficiency]
Hyponatremia
A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.
Hyponatremia
A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma.
Hyponatremia
An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma.
Hyponatremia
An outbreak of Legionnaires' disease associated with a circulating bathwater system at a public bathhouse. II: radiological findings of pneumonia.
Hyponatremia
Association of Nonimmune Hydrops Fetalis With Familial Hemophagocytic Lymphohistiocytosis in Identical Twin Neonates With Perforin His222Arg (c665A>G) Mutation.
Hyponatremia
Clinical and laboratory associations of severity in a Sri Lankan cohort of patients with serologically confirmed leptospirosis: a prospective study.
Hyponatremia
Clinical characteristics of hemophagocytic lymphohistiocytosis related to kawasaki disease.
Hyponatremia
Clinical Implication of Performance Status in Patients with Hepatocellular Carcinoma Complicating with Cirrhosis.
Hyponatremia
Comparison of Clinical Symptoms and Cardiac Lesions in Children with Typical and Atypical Kawasaki Disease.
Hyponatremia
Dengue virus infection in travellers returning to Berlin, Germany: clinical, laboratory, and diagnostic aspects.
Hyponatremia
E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma: A phase I study.
Hyponatremia
Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma.
Hyponatremia
Epidemiological evaluation of Mediterranean spotted fever in children of the Karak province in south Jordan.
Hyponatremia
Erythema multiforme major and disseminated intravascular coagulation in a dog following application of a d-limonene-based insecticidal dip.
Hyponatremia
Incidence and factors predictive of acute renal failure in patients with advanced liver cirrhosis.
Hyponatremia
Laboratory findings in patients with avian-origin influenza A (H7N9) virus infections.
Hyponatremia
Strangles in Arabian horses in Egypt: Clinical, epidemiological, hematological, and biochemical aspects.
Hyponatremia
Toxoplasma gondii-like organisms in skin aspirates from a cat with disseminated protozoal infection.
Hyponatremia
U.S. Food and Drug Administration Approval Summary: Atezolizumab for Metastatic Non-Small Cell Lung Cancer.
Hyponatremia
Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients.
Hypophosphatemia
A Phase 1 Clinical Study of Temsirolimus (CCI-779) in Japanese Patients with Advanced Solid Tumors.
Hypophosphatemia
A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma.
Hypophosphatemia
Addition of Zoledronate to Chemotherapy in Patients with Osteosarcoma Treated with Limb-Sparing Surgery: A Phase III Clinical Trial.
Hypophosphatemia
Benefit-Risk Summary of Crizotinib for the Treatment of Patients With ROS1 Alteration-Positive, Metastatic Non-Small Cell Lung Cancer.
Hypophosphatemia
Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase 3, Randomized, Open-label, Multi-center FESTnd Study.
Hypophosphatemia
Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies.
Hypophosphatemia
Phase ib of sorafenib in combination with everolimus in patients with advanced solid tumors, selected on the basis of molecular targets.
Hypophosphatemia
Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial.
Hypophysitis
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.
Hypophysitis
Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial.
Hypopituitarism
Immune-related adverse events following administration of anti-cytotoxic T-lymphocyte-associated protein-4 drugs: a comprehensive systematic review and meta-analysis.
Hypoproteinemia
Acute intoxication of deltamethrin in monosex Nile tilapia, Oreochromis niloticus with special reference to the clinical, biochemical and haematological effects.
Hypoproteinemia
Anemia, myopathy, and pansteatitis in vitamin E-deficient captive marmosets (Callithrix spp.).
Hypoproteinemia
Chemopreventive and hepatoprotective effects of embelin on N-nitrosodiethylamine and carbon tetrachloride induced preneoplasia and toxicity in rat liver.
Hypoproteinemia
Deferoxamine Attenuates Lipid Peroxidation, Blocks Interleukin-6 Production, Ameliorates Sepsis Inflammatory Response Syndrome, and Confers Renoprotection After Acute Hepatic Ischemia in Pigs.
Hypoproteinemia
Demographic and clinical characteristics of dogs with centroblastic lymphoma.
Hypoproteinemia
Erythema multiforme major and disseminated intravascular coagulation in a dog following application of a d-limonene-based insecticidal dip.
Hypoproteinemia
Evaluation of Risk Factors and Follow-Up Criteria for Severity of Snakebite in Children.
Hypoproteinemia
Gallbladder and Liver Lobe Torsion in a Young Cat Presented with Hemoabdomen.
Hypoproteinemia
Haemato-biochemical characterization of fasciolosis in Gir cattle and Jaffrabadi buffaloes.
Hypoproteinemia
Laboratory findings in patients with avian-origin influenza A (H7N9) virus infections.
Hypoproteinemia
Renal transitional cell carcinoma and choristoma in a degu (Octodon degus).
Hypoproteinemia
[Dynamics of biochemical indices of dog blood serum at high altitudes and on return to low altitude]
Hypotension
Clinical manifestations, microbiology and prognosis of 42 patients with necrotizing fasciitis.
Hypotension
Clinical presentation and prognostic factors in sodium monofluoroacetate intoxication.
Hypotension
Deferoxamine Attenuates Lipid Peroxidation, Blocks Interleukin-6 Production, Ameliorates Sepsis Inflammatory Response Syndrome, and Confers Renoprotection After Acute Hepatic Ischemia in Pigs.
Hypotension
Effects of 15-deoxy-Delta12,14-prostaglandin-J2 during hyperdynamic porcine endotoxemia.
Hypotension
Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats.
Hypotension
Escherichia coli-induced lung and liver dysfunction in dogs: effects of flunixin meglumine treatment.
Hypotension
Human umbilical cord blood-derived CD34+ cells cause attenuation of multiorgan dysfunction during experimental heatstroke.
Hypotension
Hyperbaric oxygen improves survival in heatstroke rats by reducing multiorgan dysfunction and brain oxidative stress.
Hypotension
Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters.
Hypotension
Percutaneous Biventricular Mechanical Heart Support in Cardiogenic Shock: A Nursing Case Report.
Hypotension
Predicting duration of mechanical ventilation in patients with carbon monoxide poisoning: a retrospective study.
Hypotension
Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials.
Hypotension
The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation.
Hypotension
Therapeutic effects of melatonin on heatstroke-induced multiple organ dysfunction syndrome in rats.
Hypotension
[Relationship between changes of increased amylase or lipase levels and pancreas injury in critically ill children].
Hypotension, Orthostatic
The safety of healthy volunteers in First-in-Man trials - an analysis of studies conducted at the Bayer in-house ward from 2000 to 2005.
Hypothyroidism
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Non-Pancreatic Neuroendocrine Tumors.
Hypothyroidism
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial.
Hypothyroidism
Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.
Hypothyroidism
Elevated irisin and alanine aminotransferase levels in hypothyroidism: role of oxidative stress?
Hypothyroidism
Immune-related adverse events following administration of anti-cytotoxic T-lymphocyte-associated protein-4 drugs: a comprehensive systematic review and meta-analysis.
Hypothyroidism
Longitudinal study of the effects of chronic hypothyroidism on skeletal muscle in dogs.
Hypothyroidism
Occurrence of abscesses during treatment with pazopanib in metastatic renal cancer: a case report.
Hypothyroidism
Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma.
Hypothyroidism
Safety and efficacy of nivolumab in Japanese patients with malignant melanoma: An interim analysis of a postmarketing surveillance.
Hypothyroidism
Therapeutic effects of acupuncture with MOK, a polyherbal medicine, on PTU-induced hypothyroidism in rats.
Ichthyosis
Description of breed ancestry and genetic health traits in arctic sled dog breeds.
Immune Reconstitution Inflammatory Syndrome
Antibody and markers of T-cell activation illuminate the pathogenesis of HCV immune restoration disease in HIV/HCV co-infected patients commencing ART.
Immune Reconstitution Inflammatory Syndrome
Hepatitis virus immune restoration disease of the liver.
Immune Reconstitution Inflammatory Syndrome
Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy.
Immune Reconstitution Inflammatory Syndrome
Periportal CD4+ Cell Infiltration Increases in HIV/Hepatitis C Virus-Coinfected Patients Commencing ART, Whereas CD8+ Cells Clear From the Liver.
Immune System Diseases
Predictors of oedema type in reversible posterior leukoencephalopathy syndrome with preeclampsia or eclampsia.
Infections
A Biosimilarity Study Between QX001S and Ustekinumab in Healthy Chinese Male Subjects.
Infections
A comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-TNF antibody, in phase 3 clinical trials.
Infections
A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT.
Infections
A controlled human malaria infection model enabling evaluation of transmission-blocking interventions.
Infections
A Mechanistic Assessment of the Discordance between Normal Serum Alanine Aminotransferase Levels and Altered Liver Histology in Chronic Hepatitis B.
Infections
A novel diagnostic algorithm to predict significant liver inflammation in chronic hepatitis B virus infection patients with detectable HBV DNA and persistently normal alanine transaminase.
Infections
A pathogenic role of IL-12 in blood-stage murine malaria lethal strain Plasmodium berghei NK65 infection.
Infections
A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B(12) in Japanese patients with solid tumours.
Infections
A practical guide to the use of interferons in the management of hepatitis virus infections.
Infections
A prospective study of transfusion-transmitted virus transmission by blood transfusion.
Infections
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer.
Infections
A rapid chemokine response of MIP-1alpha, MIP-1beta and RANTES is associated with a sustained virological response in the treatment of chronic hepatitis C.
Infections
A Scoring System for Predicting Significant Fibrosis in Chronic Hepatitis B Patients With Normal or Mildly Elevated Alanine Aminotransferase Levels.
Infections
A study of primary- and re-infection with hepatitis C virus in blood transfusion recipients.
Infections
Accuracy of body mass index in detecting an elevated alanine aminotransferase level in adolescents.
Infections
Acute hepatitis B virus infection with delayed appearance of hepatitis B core antibody in an immunocompromised patient: a case report.
Infections
Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection.
Infections
Acute murine cytomegalovirus infection: a model for determining antiviral activity against CMV induced hepatitis.
Infections
Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferase.
Infections
Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C.
Infections
Alanine aminotransferase level as a predictor of hepatitis C virus-associated hepatocellular carcinoma incidence in a community-based population in Japan.
Infections
Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection.
Infections
All-oral daclatasvir plus asunaprevir for chronic HCV genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study.
Infections
Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus.
Infections
alpha-Galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial.
Infections
alpha-Glutathione S-transferase levels in chronic hepatitis C infection and the effect of alpha-interferon therapy.
Infections
Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses.
Infections
An Hepatitis C Virus (HCV)/HIV Co-Infected Patient who Developed Severe Hepatitis during Chronic HCV Infection: Sustained Viral Response with Simeprevir Plus Peginterferon-Alpha and Ribavirin.
Infections
Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus.
Infections
Analysis on the outcomes of hepatitis B virus perinatal vertical transmission: nested case-control study.
Infections
Anti-inflammatory/regulatory cytokine microenvironment mediated by IL-4 and IL-10 coordinates the immune response in hemophilia A patients infected chronically with hepatitis C virus.
Infections
Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing.
Infections
Anticoccidial Effect of Herbal Powder "Shi Ying Zi" in Chickens Infected with Eimeria tenella.
Infections
Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and Consensus.
Infections
Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study.
Infections
Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta-analysis.
Infections
Appropriate interferon-alpha therapy for chronic hepatitis C: an assessment by quantitative changes in serum hepatitis C virus-RNA.
Infections
Are serum quantitative hepatitis b surface antigen levels, liver histopathology and viral loads related in chronic hepatitis b-infected patients?
Infections
Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource-limited settings.
Infections
Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?
Infections
Assessment of liver histology in patients with hepatitis C and normal transaminase levels.
Infections
Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C.
Infections
Association between eosinophil count and cholelithiasis among a population with Clonorchis sinensis infection in Foshan City, China.
Infections
Association between hepatitis B/C viral infection, chronic kidney disease and insulin resistance in individuals undergoing general health screening.
Infections
Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.
Infections
Association between visceral obesity and hepatitis C infection stratified by gender: a cross-sectional study in Taiwan.
Infections
Association of elevated vitamin B12 with oncohematological diseases in a cohort of 79,524 patients from Latvia.
Infections
Association of genetic polymorphism of low-density lipoprotein receptor with chronic viral hepatitis C infection in Han Chinese.
Infections
Association of genotypes with viral load and biochemical markers in HCV-infected Sindhi patients.
Infections
Association of Human Leucocyte Antigen Class I (HLA-A and HLA-B) With Chronic Hepatitis C Virus Infection in Egyptian Patients.
Infections
Association of miRNA-122-binding site polymorphism at the interleukin-1 ? gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Infections
Baseline HBsAg levels associated with HBsAg loss in HBeAg-negative chronic hepatitis B infection with persistently normal alanine aminotransferase.
Infections
Beneficial effects of 'lamivudine pulse' therapy in HBeAg-positive patients with normal ALT*.
Infections
Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Infections
Biochemical and histopathological alterations in Biomphalaria glabrata due to co-infection by Angiostrongylus cantonensis and Echinostoma paraensei.
Infections
Biochemical changes after subchronic and chronic interaction of Schistosoma mansoni infection in Swiss albino mice with two specific compounds.
Infections
Biochemical profile of Biomphalaria glabrata (Mollusca: Gastropoda) after infection by Echinostoma paraensei (Trematoda: Echinostomatidae).
Infections
Bioprotective potential of bacteriocinogenic Enterococcus gallinarum strains isolated from some Nigerian fermented foods, and of their bacteriocins.
Infections
Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice.
Infections
Blood levels of leukotrienes (LTC4, D4, E4, B4) and synthesis of leukotriene B4 by peripheral leukocytes in children with acute A and B hepatitis.
Infections
Bone Marrow-Derived Mesenchymal Stem Cells Attenuate Immune-Mediated Liver Injury and Compromise Virus Control During Acute Hepatitis B Virus Infection in Mice.
Infections
Central venous pressure during the post-anhepatic phase is not associated with early postoperative outcomes following orthotopic liver transplantation.
Infections
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study.
Infections
Changing patterns of acute viral hepatitis at a major urban referral center in Egypt.
Infections
Chemopreventive effect of methanolic extract of Azadirachta indica on experimental Trypanosoma brucei induced oxidative stress in dogs.
Infections
Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA.
Infections
Chronic hepatitis B, nonalcoholic steatohepatitis and physical fitness of military males: CHIEF study.
Infections
Chronic hepatitis C with normal or abnormal aminotransferase levels: is it the same entity?
Infections
Chronic hepatitis E virus infection after living donor liver transplantation via blood transfusion: a case report.
Infections
Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy.
Infections
Circulating soluble Fas levels in patients with hepatitis C virus infection and interferon therapy.
Infections
Clinical and biochemical characteristics of infants with prolonged neonatal jaundice.
Infections
Clinical and histopathological features of chronic hepatitis B virus infected patients with high HBV-DNA viral load and normal alanine aminotransferase level: A multicentre-based study in China.
Infections
Clinical and molecular virological differences between fulminant hepatic failures following acute and chronic infection with hepatitis B virus.
Infections
Clinical and virological characteristics of untreated patients with chronic hepatitis C who develop serum alanine aminotransferase flare-up.
Infections
Clinical approach to the patient with chronic hepatitis C infection and normal aminotransferases.
Infections
Clinical characteristics and outcome of morbidly obese bariatric patients with concurrent hepatitis B viral infection.
Infections
Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States.
Infections
Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon.
Infections
Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection.
Infections
Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence.
Infections
Clinical outcomes of hepatitis B virus (HBV) genotypes B and C in Japanese patients with chronic HBV infection.
Infections
Clinical significance of hepatitis G virus infection in patients on long-term haemodialysis.
Infections
Clinical significance of SEN virus infection in patients on maintenance haemodialysis.
Infections
Clinical significance of T.T. virus infection in maintenance hemodialysis patients of an endemic area for hepatitis C infection.
Infections
Clinical spectrum and histopathologic features of chronic hepatitis C infection in children.
Infections
Clinical symptoms and laboratory findings supporting early diagnosis of Crimean-Congo hemorrhagic fever in Iran.
Infections
Clinical, epidemiological and prognostic aspects of hepatitis "non-A, non-B"--a comparison with hepatitis A and B.
Infections
Clinicopathologic features and genotyping of patients with chronic HBV infection in the Upper Egypt.
Infections
Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.
Infections
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study.
Infections
Combined effects of hepatitis B virus infection and elevated alanine aminotransferase levels on dyslipidemia.
Infections
Community-acquired non-A, non-B hepatitis: clinical characteristics and chronicity.
Infections
Comparative efficacy assessment of pentamidine isethionate and diminazene aceturate in the chemotherapy of Trypanosoma brucei brucei infection in dogs.
Infections
Comparative study between occult hepatitis C virus infection and chronic hepatitis C.
Infections
Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels.
Infections
Comparison between serum alpha-glutathione S-transferase and aminotransaminases in detecting cytolysis in hepatitis C-infected children.
Infections
Comparison of antiviral effect of lamivudine with interferon-alpha2a versus -alpha2b in children with chronic hepatitis B infection.
Infections
Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation.
Infections
Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.
Infections
Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients.
Infections
Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels.
Infections
Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19.
Infections
Complexity of the HVR-1 quasispecies and disease activity in patients with hepatitis C.
Infections
Correction to: Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase.
Infections
Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin.
Infections
Correlation of Severity of COVID-19 Disease With Gastrointestinal Manifestations and Liver Injury - A North Brooklyn Community Hospital Experience: A Retrospective Cohort Study.
Infections
Correlation of viral RNA, alanine aminotransferase, and histopathology in hepatitis C virus-associated hepatitis.
Infections
Course of viral hepatitis B and combined B and C hepatitis in children treated for neoplastic diseases.
Infections
Cross-challenge studies in rhesus monkeys employing different Indian isolates of hepatitis E virus.
Infections
Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection.
Infections
Current care of hepatitis C-positive patients by primary care physicians in an integrated delivery system.
Infections
Current practice patterns of primary care physicians in the management of patients with hepatitis C.
Infections
Current practices of screening for incident hepatitis C virus (HCV) infection among HIV-infected, HCV-uninfected individuals in primary care.
Infections
Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.
Infections
Cytomegalovirus and legionella species as the cause of liver enzyme elevations in haemodialysis patients.
Infections
Decrease in reported posttransfusion hepatitis. Contributions of donor screening for alanine aminotransferase and antibodies to hepatitis B core antigen and changes in the general population.
Infections
Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C.
Infections
Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV.
Infections
Deletions in the hepatitis B virus core gene may influence the clinical outcome in hepatitis B e antigen-positive asymptomatic healthy carriers.
Infections
Detection and transmission in chimpanzees of hepatitis B virus-related agents formerly designated "non-A, non-B" hepatitis.
Infections
Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope.
Infections
Detection of host immune responses in acute phase sera of spontaneous resolution versus persistent hepatitis C virus infection.
Infections
Determinants of serum ALT normalization after phlebotomy in patients with chronic hepatitis C infection.
Infections
Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
Infections
Development of a Novel Simple Model to Predict Mortality in Patients With Systemic Lupus Erythematosus Admitted to the Intensive Care Unit.
Infections
Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa.
Infections
Dexamethasone treatment improves morphological and hematological parameters in chronic experimental schistosomiasis.
Infections
Diabetes mellitus and hepatocellular carcinoma: comparison of Chinese patients with and without HBV-related cirrhosis.
Infections
Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan.
Infections
Diagnostic Challenges and Clinical Characteristics of Hepatitis E Virus-Associated Guillain-Barré Syndrome.
Infections
Diagnostic value of anti-hepatitis C virus (HCV) core immunoglobulin M in recurrence of HCV infection after orthotopic liver transplantation.
Infections
Different hepatitis C virus (HCV) RNA load profiles following seroconversion among injecting drug users without correlation with HCV genotype and serum alanine aminotransferase levels.
Infections
Discordance between serum alanine aminotransferase (ALT) and virologic response to IFN-alpha2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers.
Infections
Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi®.
Infections
Dissociation of serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus and treated with antiretroviral drugs.
Infections
Distribution of hepatitis C virus infection in liver biopsies from children and adults with chronic hepatitis C.
Infections
Durable response but prolonged cytopenia after cladribine treatment in relapsed patients with indolent non-Hodgkin's lymphomas: results of a Japanese phase II study.
Infections
Dynamic relationship between infantile hepatitis syndrome and cytomegalovirus infection.
Infections
Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease.
Infections
Early virological response in children with chronic hepatitis C treated with pegylated interferon and ribavirin.
Infections
Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection.
Infections
Effect of duck hepatitis A virus genotype 3 infection on glucose metabolism of Pekin ducklings and underlying mechanism.
Infections
Effect of Ficus sycomorus and Azadirachta indica extracts on liver state of mice infected with Schistosoma mansoni.
Infections
Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users.
Infections
Effect of sodium stibogluconate on hepatic mixed function oxidase system and marker enzymes of golden hamsters during Leishmania donovani infection.
Infections
Effectiveness and safety of iguratimod treatment in patients with active rheumatoid arthritis in Chinese: A nationwide, prospective real-world study.
Infections
Effectiveness of interferon treatment for patients with chronic hepatitis C virus infection and normal aminotransferase levels.
Infections
Effects of continuous use of probiotics before liver transplantation: A randomized, double-blind, placebo-controlled trial.
Infections
Effects of infection by larvae of Angiostrongylus cantonensis (Nematoda, Metastrongylidae) on the metabolism of the experimental intermediate host Biomphalaria glabrata.
Infections
Efficacy and safety of boric acid as a preventive treatment against Saprolegnia infection in Nile tilapia (Oreochromis niloticus).
Infections
Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients.
Infections
Efficacy of fosfomycin in the prevention of postoperative infection following transurethral resection of bladder tumor during periods of limited cefazolin, cefotiam, and cefmetazole supply.
Infections
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study.
Infections
Elevated alanine aminotransferase levels in HIV-infected persons without hepatitis B or C virus coinfection.
Infections
Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.
Infections
Elevation of Alanine Aminotransferase Activity Occurs after Activation of the Cell-Death Signaling Initiated by Pattern-Recognition Receptors ?but before Activation of Cytolytic Effectors in NK or CD8+ T Cells in the Liver During Acute HCV Infection.
Infections
ELISA and some biochemical tests of heterophyidae infection in laboratory animals.
Infections
End-stage renal disease and hepatitis C infection: comparison of alanine aminotransferase levels and liver histology in patients with and without renal damage.
Infections
Enhancement of hepatitis virus immunoassay outcome predictions in imbalanced routine pathology data by data balancing and feature selection before the application of support vector machines.
Infections
Epidemiological, clinical and biological characteristics of acute non-A, non-B hepatitis with and without hepatitis C virus infection.
Infections
ESTIMATION OF IMMUNOLOGICAL AND BIOCHEMICAL PARAMETERS IN HEPATITIS B POSITIVE PATIENTS.
Infections
Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C- a retrospective study.
Infections
Evaluation of clinically asymptomatic high risk infants with congenital cytomegalovirus infection.
Infections
Evaluation of hepatitis B viraemia levels in patients with HBeAg-negative chronic hepatitis B virus infection.
Infections
Evaluation of serum chemistry values associated with avian malaria infections in African black-footed penguins (Spheniscus demersus).
Infections
Evolution of a Cell Culture-Derived Genotype 1a Hepatitis C Virus (H77S.2) during Persistent Infection with Chronic Hepatitis in a Chimpanzee.
Infections
Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively.
Infections
Experimental paratuberculosis (Johne's disease)--studies on biochemical parameters in cattle.
Infections
Experimental salmonellosis in guinea-pigs: haematological and biochemical studies.
Infections
Experimental transmission of the delta virus to a hepatitis B chronic carrier chimpanzee with the development of persistent delta carriage.
Infections
Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection.
Infections
Factors associated with acute renal failure in falciparum malaria infected patients.
Infections
Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection.
Infections
Factors predictive of significant hepatic fibrosis in adults with chronic hepatitis B and normal serum ALT.
Infections
Fever after a stay in the tropics: diagnostic predictors of the leading tropical conditions.
Infections
Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B.
Infections
Frequency and characteristics of post-transfusion hepatitis in Greece with emphasis on hepatitis C: comparing second- and third-generation assays.
Infections
G-to-A Hypermutation in Hepatitis B Virus (HBV) and Clinical Course of Patients with Chronic HBV Infection.
Infections
GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.
Infections
GB virus C/hepatitis G virus infection in patients on continuous ambulatory peritoneal dialysis.
Infections
GB virus-C/hepatitis G virus infection in a hepatitis C virus endemic village: prevalence in residents with low educational attainment and frequent recovery in females.
Infections
Genetic and physicochemical analyses of a novel ferret hepatitis E virus, and clinical signs of infection after birth.
Infections
Genetic Variants in TNFSF4 and TNFSF8 Are Associated With the Risk of HCV Infection Among Chinese High-Risk Population.
Infections
Genotyping of occult hepatitis B virus infection in Egyptian hemodialysis patients without hepatitis C virus infection.
Infections
Glutamate pyruvate transaminase as an indicator of infection with Plasmodium falciparum.
Infections
HBV superinfection in HCV chronic carriers: a disease that is frequently severe but associated with the eradication of HCV.
Infections
HBV/A and HBV/C genotype predominance among patients with chronic hepatitis B virus infection in Cebu City, Philippines.
Infections
HCV carriers with normal alanine aminotransferase levels: healthy persons or severely ill patients? Dealing with an everyday clinical problem.
Infections
Helicobacter hepaticus infection induces chronic hepatitis and fibrosis in male BALB/c mice via the activation of NF-?B, Stat3, and MAPK signaling pathways.
Infections
Helicobacter pylori infection as a risk factor for serum bilirubin change and less favourable lipid profiles: a hospital-based health examination survey.
Infections
Hematologic, plasma biochemical, and other indicators of the health of Tasmanian platypuses (Ornithorhynchus anatinus): predictors of mucormycosis.
Infections
Hepatic Arterial Infusion Chemotherapy with Modified FOLFOX as an Alternative Treatment Option in Advanced Hepatocellular Carcinoma Patients with Failed or Unsuitability for Transarterial Chemoembolization.
Infections
Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase II, single-arm, prospective study.
Infections
Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin.
Infections
Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.
Infections
Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis.
Infections
Hepatitis B core antibody and liver stiffness measurements predict HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients with minimally elevated alanine aminotransferase (ALT) levels.
Infections
Hepatitis B core-related antigen (HBcrAg): an alternative to HBV DNA to assess treatment eligibility in Africa.
Infections
Hepatitis B Evaluation and Linkage to Care for Newly Arrived Refugees: A Multisite Quality Improvement Initiative.
Infections
Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management.
Infections
Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
Infections
Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection.
Infections
Hepatitis B virus DNA in the serum of Sardinian blood donors negative for the hepatitis B surface antigen.
Infections
Hepatitis B Virus Genotype C Is Associated With More Severe Liver Fibrosis Than Genotype B.
Infections
Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey.
Infections
Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.
Infections
Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity.
Infections
Hepatitis B Virus Reactivation in the Setting of Immunosuppressive Drug Therapy.
Infections
Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report.
Infections
Hepatitis B virus-specific effector CD8+ T cells are an important determinant of disease prognosis: A meta-analysis.
Infections
Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients.
Infections
Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group.
Infections
Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels.
Infections
Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C.
Infections
Hepatitis C viral infection in thalassemic children: clinical and molecular studies.
Infections
Hepatitis C virus (HCV) infection as a risk factor for spontaneous intracerebral hemorrhage: hospital based case-control study.
Infections
Hepatitis C Virus Clearance by Direct-acting Antiviral Results in Rapid Resolution of Hepatocytic Injury as Indicated by Both Alanine Aminotransferase and Aspartate Aminotransferase Normalization.
Infections
Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment.
Infections
Hepatitis C virus genotypes and clinical features in hepatitis C virus-related mixed cryoglobulinemia.
Infections
Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications.
Infections
Hepatitis C virus infection in health care workers referred to a hepatitis clinic.
Infections
Hepatitis C virus infection in pregnant women: detection by different anti-HCV immunoassays and serum HCV-RNA.
Infections
Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees.
Infections
Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection.
Infections
Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo.
Infections
Hepatitis d virus isolates with low replication and epithelial-mesenchymal transition-inducing activity are associated with disease remission.
Infections
Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK/French study.
Infections
Hepatitis E virus is an infrequent but potentially serious infection in allogeneic hematopoietic stem cell transplant recipients.
Infections
Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland.
Infections
Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy.
Infections
Hepatitis Flares Are Associated With Better Outcomes Than No Flare in Patients With Decompensated Cirrhosis and Chronic Hepatitis B Virus Infection.
Infections
Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and nonviral chronic liver disease.
Infections
Hepatitis G virus infection in hemodialysis patients and its relationship with hepatitis C virus infection.
Infections
Hepatotoxicity following nevirapine-containing regimens in HIV-1-infected individuals.
Infections
High dissemination and hepatotoxicity in rats infected with Candida albicans after stress exposure: potential sensitization to liver damage.
Infections
High prevalence of GB virus C/hepatitis G virus infection among the Jewish population in Uzbekistan.
Infections
High prevalence, low pathogenicity of hepatitis G virus in kidney transplant recipients.
Infections
High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments.
Infections
Histological and clinical characteristics of patients with chronic hepatitis C and persistently normal alanine aminotransferase levels.
Infections
Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels.
Infections
Histopathological features of hepatitis C in renal transplant candidates [see comment]
Infections
Histopathological features of liver and its relation to serum transaminase levels in 91 cases of anti-HBe-positive chronic hepatitis B.
Infections
How can we make decision for patients with chronic hepatitis B according to hepatitis B virus (HBV) DNA level?
Infections
How to distinguish normal liver from chronic hepatitis in anti-HCV positive individuals with normal alanine aminotransferase levels.
Infections
How to manage HBeAg-negative chronic HBV infection with normal alanine aminotransferase levels in clinical practice?
Infections
IL-22 Protects Against Liver Pathology and Lethality of an Experimental Blood-Stage Malaria Infection.
Infections
Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure.
Infections
Immunological changes in different patient populations with chronic hepatitis C virus infection.
Infections
Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients.
Infections
Impact of Human Immunodeficiency Virus Coinfection on the Progression of Mother-to-child Transmitted Hepatitis C Virus Infection.
Infections
Impaired lipopolysaccharide-induced interleukin-1-beta production in patients with anti-hepatitis C virus antibody-positive chronic liver disease.
Infections
Implementing evidenced-based practice guidelines for the management of chronic hepatitis B virus infection.
Infections
Importance of recall and follow-up screening for chronic hepatitis C in children receiving blood products prior to 1990 in Japan.
Infections
Improvement of alanine aminotransferase by administration of suplatast tosilate plus ursodeoxycholic acid in patients with resistance to ursodeoxycholic acid monotherapy on hepatitis C virus-related chronic liver disease.
Infections
Inactivation of hepatitis B and non-A, non-B viruses by combined use of Tween 80, beta-propiolactone, and ultraviolet irradiation.
Infections
Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines.
Infections
Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels.
Infections
Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values.
Infections
Incidence, patterns, risk factors, and histopathological findings of liver injury in coronavirus disease 2019 (COVID-19): a scoping review.
Infections
Incidence, transmission, and clinical significance of hepatitis G virus infection in hemodialysis patients.
Infections
Increased levels of circulating IL-10 in persons recovered from hepatitis C virus (HCV) infection compared with persons with active HCV infection.
Infections
Inducible nitric oxide synthase (iNOS) expression in liver and splenic T lymphocyte rise are associated with liver histological damage during experimental hepatitis A virus (HAV) infection in Callithrix jacchus.
Infections
Infection with hepatitis G virus and its strain variant, the GB agent (GBV-C), among blood donors in Japan.
Infections
Infectious disease testing for blood transfusions. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions.
Infections
Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys.
Infections
Influence of age and autoimmunity on liver disease in HCV-associated type II mixed cryoglobulinemia.
Infections
Influence of Alanine Transaminase Levels on Alpha-Fetoprotein for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Infection.
Infections
Inhibitory Effect of Sestrin 2 on Hepatic Stellate Cell Activation and Liver Fibrosis.
Infections
Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection.
Infections
Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption.
Infections
Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
Infections
Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
Infections
Is there any difference in anesthetic management of different post-OLT stage patients undergoing nontransplant organ surgery?
Infections
Isolation of an in vitro transmissible agent with reverse transcriptase activity from a blood donor with a borderline-positive HIV-1 serology for more than five years.
Infections
Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease.
Infections
Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area.
Infections
Lack of persistent hepatitis E virus infection as a cause for unexplained transaminase elevation in renal transplant recipients in India.
Infections
Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis B virus-related liver disease.
Infections
Liquid biopsy for non-invasive assessment of liver injury in hepatitis B patients.
Infections
Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study.
Infections
Liver histology and alanine aminotransferase levels in children and adults with chronic hepatitis C infection.
Infections
Liver histology and HBV DNA levels in chronically HBV infected patients with persistently normal alanine aminotransferase.
Infections
Liver inflammation is a risk factor for prediabetes in at-risk latinos with and without hepatitis C infection.
Infections
Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of retrospective studies.
Infections
Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases.
Infections
Liver tissue expression of CD80 and CD95 antigens in chronic hepatitis C: relationship with biological and histological disease activities.
Infections
Logistic regression analysis of risk factors for upper gastrointestinal bleeding induced by PCI in combination with double antiplatelet therapy for STEMI patients.
Infections
Long term survey of hepatitis C virus infection in hemodialysis units in Fukuoka, Japan.
Infections
Long-Term Follow-up of Children With Postnatal Immunoprophylaxis Failure Who Were Infected With Hepatitis B Virus Surface Antigen Gene Mutant.
Infections
Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease.
Infections
Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years.
Infections
Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.
Infections
Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men.
Infections
Longitudinal analysis of hepatitis C virus infection and genetic drift of the hypervariable region.
Infections
Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevation.
Infections
Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.
Infections
Low prevalence of hepatitis C virus and infrequent perinatal or spouse infections in pregnant women in Taiwan.
Infections
Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
Infections
Lower Expression of MicroRNA-155 Contributes to Dysfunction of Natural Killer Cells in Patients with Chronic Hepatitis B.
Infections
Lymphocytic mitochondrial DNA deletions, biochemical folate status and hepatocellular carcinoma susceptibility in a case-control study.
Infections
Meta-analysis of factors associated with sustained viral response in patients on hemodialysis treated with standard or pegylated interferon for hepatitis C infection.
Infections
Modifications enzymatiques sanguines chez la canette mularde (Catrina moschata x Anas platyrhynchos) lors d'infection experimentale par Eimeria mulardi.
Infections
Molecular analysis and patterns of ALT and hepatitis C virus seroconversion in haemodialysis patients with acute hepatitis.
Infections
Molecular characterization and histo-physiological alterations induced by concurrent helminthosis in the liver of urban commensal rodents in Punjab, India.
Infections
Molecular detection of transfusion transmitted virus coinfection with some hepatotropic viruses.
Infections
Mother-to-Child Transmission of Hepatitis C Virus (HCV) Among HIV/HCV-Coinfected Women.
Infections
Multicenter evaluation of the COBAS AMPLICOR HCV assay, an integrated PCR system for rapid detection of hepatitis C virus RNA in the diagnostic laboratory.
Infections
Multicombination Approach Suppresses Listeria monocytogenes-Induced Septicemia-Associated Acute Hepatic Failure: The Role of iRhom2 Signaling.
Infections
Mutations in ISDR of NS5A gene influence interferon efficacy in Chinese patients with chronic hepatitis C virus genotype 1b infection.
Infections
Natural cocoa ingestion reduced liver damage in mice infected with Plasmodium berghei (NK65).
Infections
Natural course of chronic hepatitis B is characterized by changing patterns of programmed death type-1 of CD8-positive T cells.
Infections
Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years' follow-up in northern Greece.
Infections
Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
Infections
Natural history of the TT virus infection through follow-up of TTV DNA-positive multiple-transfused patients.
Infections
Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase.
Infections
Non-invasive assessment of fibrosis using color Doppler ultrasound in patients with hepatitis C virus in the Amazon rainforest, Brazil.
Infections
Nutritional status of children with chronic hepatitis B in a population with low socioeconomic status.
Infections
Obesity and diabetic hyperglycemia were associated with serum alanine aminotransferase activity in patients with hepatitis B infection.
Infections
Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
Infections
Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen.
Infections
Occult hepatitis B virus infection in HIV-infected patients: Evaluation of biochemical, virological and molecular parameters.
Infections
Occurrence and clinical characteristics of occult hepatitis C virus infection in hemodialysis units at Ismailia, Egypt.
Infections
Omega-3 fatty acid improves the clinical outcome of hepatectomized patients with hepatitis B virus (HBV)-associated hepatocellular carcinoma.
Infections
On the persistence of human serum resistance and isoenzyme patterns of Trypanozoon in experimentally infected pigs.
Infections
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial.
Infections
Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
Infections
Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.
Infections
Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection.
Infections
Oxidative Modifications of Rat Liver Cell Components During Fasciola hepatica Infection.
Infections
Pathogenic molecular mechanisms in an animal model of fulminant hepatic failure: rabbit hemorrhagic viral disease.
Infections
Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.
Infections
Pathology of Experimental Aerosol Zaire Ebolavirus Infection in Rhesus Macaques.
Infections
Pegylated interferon ?-2b plus ribavirin for Japanese chronic hepatitis C patients with normal alanine aminotransferase.
Infections
Percutaneous liver biopsy: retrospective study over 15 years comparing 287 inpatients with 428 outpatients.
Infections
Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: results of the National Hepatitis Screening Survey. National Hepatitis Surveillance Group.
Infections
Perihepatic lymph node enlargement observed at a general health examination: A cross-sectional study.
Infections
Perihepatic lymphadenopathy in chronic hepatitis C: a complementary diagnostic element?
Infections
Persistently normal alanine transaminase levels in chronic C hepatitis: what does it tell us?
Infections
Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors.
Infections
Phase II study of a combination regimen of gefitinib and pemetrexed as first-line treatment in patients with advanced non-small cell lung cancer harboring a sensitive EGFR mutation.
Infections
Physiological alterations in Bradybaena similaris (Stylommatophora: Bradybaenidae) induced by the entomopathogenic nematode Heterorhabditis indica (Rhabditida: Heterorhabditidae) strain LPP1.
Infections
Plasma glutathione concentration in patients with chronic hepatitis C virus infection.
Infections
Poor efficacy of preemptive amoxicillin clavulanate for preventing secondary infection from Bothrops snakebites in the Brazilian Amazon: A randomized controlled clinical trial.
Infections
Population Pharmacokinetics of Diethylcarbamazine in Patients with Lymphatic Filariasis and Healthy Individuals.
Infections
Potential impact of long-term nucleoside therapy on the mortality and morbidity of active chronic hepatitis B.
Infections
Pre-existing Liver Diseases and On-Admission Liver-Related Laboratory Tests in COVID-19: A Prognostic Accuracy Meta-Analysis With Systematic Review.
Infections
Predicting Liver Fibrosis in the Hepatitis C Population: Concordance Analysis Between Noninvasive Scoring Systems and Percutaneous Liver Biopsy.
Infections
Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men.
Infections
Predictive Factors for Differentiating Pancreatic Cancer-Associated Diabetes Mellitus from Common Type 2 Diabetes Mellitus for the Early Detection of Pancreatic Cancer.
Infections
Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study.
Infections
Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
Infections
Predictors for advanced liver fibrosis in chronic hepatitis B virus infection with persistently normal or mildly elevated alanine aminotransferase.
Infections
Prednisone withdrawal followed by interferon alpha for treatment of chronic hepatitis C infection: results of a randomized controlled trial.
Infections
Preoperative Chemoradiation With Irinotecan and Capecitabine in Patients With Locally Advanced Resectable Rectal Cancer: Long-Term Results of a Phase II Study.
Infections
Presence and significance of TT virus in Danish patients on maintenance hemodialysis.
Infections
Prevalence and genotype of hepatitis G virus in Chinese professional blood donors and hepatitis patients.
Infections
Prevalence and manifestations of hepatitis C seropositivity in children in an endemic area.
Infections
Prevalence and predictors of anemia in patients with HIV infection at the initiation of combined antiretroviral therapy in Xinjiang, China.
Infections
Prevalence and Risk Factors for Significant Liver Fibrosis in Patients with HIV Infection.
Infections
Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia.
Infections
Prevalence and risk of hepatitis E virus infection in the HIV population of Nepal.
Infections
Prevalence of antibodies to hepatitis E virus among Japanese blood donors: identification of three blood donors infected with a genotype 3 hepatitis E virus.
Infections
Prevalence of GB virus C/hepatitis G virus RNA and anti-E2 glycoprotein antibodies in homosexual men with HIV coinfection.
Infections
Prevalence of HBsAg/HBeAg amongst 1 936 801 couples preparing for pregnancy in rural China: An observational study.
Infections
Prevalence of hepatitis G virus in hepatitis C virus (HCV)-infected patients and in HCV-contaminated intravenous immunoglobulin products.
Infections
Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre.
Infections
Prevalence of torque viruses in HIV-infected and non-HIV-infected Nigerian subjects: analysis of near-full-length genome sequences.
Infections
Prevalence of TT virus in serum and peripheral mononuclear cells from a CAPD population.
Infections
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection.
Infections
Prognostic factors associated with death from visceral leishmaniasis: a case-control study in Brazil.
Infections
Prognostic factors for chronic severe hepatitis and construction of a prognostic model.
Infections
Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection.
Infections
Prognostic values of fluctuations in serum levels of alanine transaminase in inactive carrier state of HBV infection.
Infections
Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study.
Infections
Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.
Infections
Prospective Evaluation of FibroScan for the Diagnosis of Hepatic Fibrosis Compared with Liver Biopsy/AST Platelet Ratio Index and FIB-4 in Patients with Chronic HBV Infection.
Infections
Prospective follow-up of patients with acute hepatitis C virus infection in Brazil.
Infections
Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies.
Infections
Protection against Klebsiella pneumoniae Using Lithium Chloride in an Intragastric Infection Model.
Infections
Protective effect of berberine chloride on Plasmodium chabaudi-induced hepatic tissue injury in mice.
Infections
Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection.
Infections
Randomized Clinical Trial on the Effect of Bardoxolone Methyl on GFR in Diabetic Kidney Disease Patients (TSUBAKI Study).
Infections
Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infection.
Infections
Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: do they alter their decision with time?
Infections
Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate.
Infections
Referral for chronic hepatitis C treatment from a drug dependency treatment setting.
Infections
Relation between serum quantitative HBsAg, ALT and HBV DNA levels in HBeAg negative chronic HBV infection.
Infections
Relationship between biochemical and virological responses to interferon therapy in chronic hepatitis C infection. Consensus Interferon Study Group.
Infections
Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B.
Infections
Relationship between serum alanine aminotransferase levels and liver histology in chronic hepatitis C-infected patients.
Infections
Relationship between the serum alanine aminotransferase level at the end of interferon treatment and histologic changes in wild-type and precore mutant hepatitis B virus infections.
Infections
Relationships between hepatitis B infection status and liver dysfunction after chemotherapy of lung cancer patients in mainland China.
Infections
Relationships between serum asunaprevir concentration and alanine aminotransferase elevation during daclatasvir plus asunaprevir for chronic HCV genotype 1b infection.
Infections
Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-Term Follow-Up.
Infections
Resolution of hepatitis E virus infection in CD8+ T cell-depleted rhesus macaques.
Infections
Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study.
Infections
Resveratrol attenuates methylglyoxal-induced mitochondrial dysfunction and apoptosis by Sestrin2 induction.
Infections
Retrospective analyses of dogs found serologically positive for Ehrlichia canis in Cebu, Philippines from 2003 to 2014.
Infections
Rhesus monkeys infected with hepatitis E virus (HEV) from the former USSR are immune to subsequent challenge with an Indian strain of HEV.
Infections
Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004.
Infections
Risk factors for hepatitis C virus infection among blood donors in Beijing and implications for improving the pretesting donor screening process.
Infections
Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin.
Infections
Risk factors for liver disease among adults of Mexican descent in the United States and Mexico.
Infections
Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.
Infections
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial.
Infections
Safety and efficacy of fish oil-enriched parenteral nutrition regimen on postoperative patients undergoing major abdominal surgery: a meta-analysis of randomized controlled trials.
Infections
Safety and Efficacy of Infliximab in Severe Alcoholic Hepatitis: A Systematic Review.
Infections
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project.
Infections
Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials.
Infections
Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis B virus infection: a retrospective cohort study.
Infections
Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trial.
Infections
Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial.
Infections
Schistosomatium douthitti: biochemical and morphological effects of an experimental infection in mice.
Infections
SEN and hepatitis virus infections in nontransfused children and pediatric thalassemia patients with multiple transfusions in Taiwan.
Infections
SEN virus infection in children in Taiwan: transmission route and role in blood transfusion and liver diseases.
Infections
SEN virus infection in Egyptian patients undergoing maintenance hemodialysis: prevalence and clinical importance.
Infections
SEN virus prevalence among non-B and non-C hepatitis patients with high liver function tests in the south of Turkey.
Infections
Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion.
Infections
Serial quantitative analysis of serum hepatitis C virus RNA level in patients with acute and chronic hepatitis C.
Infections
Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion.
Infections
Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with ?-thalassemia major.
Infections
Seroprevalence and incidence of hepatitis E virus infection in German blood donors.
Infections
Seroprevalence of hepatitis delta virus infection among subjects with underlying hepatic diseases in Chennai, southern India.
Infections
Serotype-specific differences in the laboratory parameters among hospitalized children with dengue and genetic diversity of dengue viruses circulating in Tamil Nadu, India during 2017.
Infections
Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad.
Infections
Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis.
Infections
Serum alanine aminotransferase level in relation to hepatitis B and C virus infections among blood donors.
Infections
Serum alanine aminotransferase levels among volunteer blood donors: effect of sex, alcohol intake and obesity.
Infections
Serum alanine aminotransferase levels and the detection of hepatitis C virus (HCV) in chronic HCV infections.
Infections
Serum alanine aminotransferase levels in relation to hepatitis B and C virus infections among drug abusers in an area hyperendemic for hepatitis B.
Infections
Serum alanine aminotransferase measurement as a guide to selective testing for hepatitis C during medical checkup.
Infections
Serum glutamyl transferase and other liver function tests in Opisthorchis viverrini infection.
Infections
Serum levels of aspartate transaminase, alanine transaminase and worm burden in mice infected with Ancylostoma caninum larvae.
Infections
Serum levels of hepatitis C virus RNA in infants and children with chronic hepatitis C.
Infections
Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4.
Infections
Serum miRNAs Predicting Sustained HBs Antigen Reduction 48 Weeks after Pegylated Interferon Therapy in HBe Antigen-Negative Patients.
Infections
Serum soluble interleukin-2 receptor levels in patients with chronic hepatitis B virus infection and its relation with anti-HBc.
Infections
Severe transaminitis after interferon-ribavirin therapy in HIV/HCV-coinfected patients: influence of a sustained HCV response.
Infections
Sex differences in relation to serum hepatitis B e antigen and alanine aminotransferase levels among asymptomatic hepatitis B surface antigen carriers.
Infections
Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients: A Community-Based Study in a Hepatitis B/Hepatitis C Virus Hyperendemic Area.
Infections
Shear wave elastography for liver fibrosis in chronic hepatitis B: Adapting the cut-offs to alanine aminotransferase levels improves accuracy.
Infections
Significance of alanine aminotransferase testing in diagnosis of acute and chronic HBV infection.
Infections
Significance of Anti-Nuclear Antibodies and Cryoglobulins in Patients with Acute and Chronic HEV Infection.
Infections
Significance of hepatitis C virus coinfection with persistently normal alanine aminotransferase levels in HIV-1-infected patients.
Infections
Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay.
Infections
Significant histological changes and satisfying antiviral efficacy in chronic hepatitis B virus infection patients with normal alanine aminotransferase. Antiviral therapy decision in chronic HBV patients with normal ALT.
Infections
Simultaneously acute hepatitis B virus and C virus coinfection and subsequent chronic hepatitis C.
Infections
Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C.
Infections
Soluble Markers of Immune Activation Differentially Normalize and Selectively Associate with Improvement in AST, ALT, Albumin, and Transient Elastography During IFN-Free HCV Therapy.
Infections
Spontaneous Clearance After Relapse Following Direct-Acting Antiviral Treatment for Chronic HCV Infection.
Infections
Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.
Infections
Study of Gefitinib and Pemetrexed as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation.
Infections
Study on the function of circulating plasmacytoid dendritic cells in the immunoactive phase of patients with chronic genotype B and C HBV infection.
Infections
Sustained alanine aminotransferase increase during hepatitis A due to concomitant lymphogranuloma venereum infection in an HIV-1 positive patient.
Infections
Sustained Virological Response after 8-Week Treatment of Simeprevir with Peginterferon ?-2a plus Ribavirin in a Japanese Female with Hepatitis C Virus Genotype 1b and IL28B Minor Genotype.
Infections
Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3.
Infections
Symptomatic elevation creatine kinase following treatment of rheumatoid arthritis with baricitinib.
Infections
Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity.
Infections
Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE.
Infections
Targeted HCV core antigen monitoring among HIV-positive men who have sex with men is cost-saving.
Infections
Tenofovir alafenamide in the treatment of chronic hepatitis B virus infection: rationale and clinical trial evidence.
Infections
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.
Infections
The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses.
Infections
The association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females.
Infections
The Clinical and Imaging Characteristics Associated With Neurological Sequelae of Pediatric Patients With Acute Necrotizing Encephalopathy.
Infections
The Clinical Presentation of Chronic Hepatitis B Virus (HBV) Infection in Asian Americans: A Single Center Retrospective Study.
Infections
The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.
Infections
The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection: use of clinical features and a rapid direct fluorescent antigen test.
Infections
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
Infections
The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Infections
The identification of risk factors for infectious patients with acute fever and formulation of activation criteria to alert outpatient clinic doctors.
Infections
The identify role and molecular mechanism of the MALAT1/hsa-mir-20b-5p/TXNIP axis in liver inflammation caused by CHB in patients with chronic HBV infection complicated with NAFLD.
Infections
The impact of Aeromonas salmonicida infection on innate immune parameters of Atlantic salmon (Salmo salar L).
Infections
The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
Infections
The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation.
Infections
The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed hemophiliacs.
Infections
The natural history of hepatitis C infection acquired through injection drug use: meta-analysis and meta-regression.
Infections
The prevalence and clinical correlates of elevated ALT levels in an urban Chinatown community.
Infections
The roles of GSTM1 and GSTT1 null genotypes and other predictors in anti-tuberculosis drug-induced liver injury.
Infections
The roles of intrahepatic Valpha14(+) NK1.1(+) T cells for liver injury induced by Salmonella infection in mice.
Infections
The spontaneous clearance of hepatitis E virus (HEV) and emergence of HEV antibodies in a transfusion-transmitted chronic hepatitis E case after completion of chemotherapy for acute myeloid leukemia.
Infections
The TcI and TcII Trypanosoma cruzi experimental infections induce distinct immune responses and cardiac fibrosis in dogs.
Infections
Thiol-disulphide balance and total oxidant-antioxidant status in patients with chronic hepatitis C.
Infections
TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A Virions.
Infections
TNF-?/IFN-? profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
Infections
Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis.
Infections
Toll-like receptor 2 contributes to liver injury by Salmonella infection through Fas ligand expression on NKT cells in mice.
Infections
Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study.
Infections
Trajectories of hepatic and coagulation dysfunctions related to a rapidly fatal outcome among hospitalized patients with dengue fever in Tainan, 2015.
Infections
Transfusion-transmitted virus infection in hemodialysis patients in Arar, Saudi Arabia: Prevalence, predictors and genotyping.
Infections
Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response.
Infections
Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes.
Infections
Ultrastructural alterations in hepatocytes and sinus endothelia in experimental non-A, non-B hepatitis in chimpanzees with and without immunoglobulin prophylaxis.
Infections
UNC93B1 mediates innate inflammation and antiviral defense in the liver during acute murine cytomegalovirus infection.
Infections
Unchanged high prevalence of antibodies to hepatitis E virus (HEV) and HEV RNA among blood donors with an elevated alanine aminotransferase level in Japan during 1991-2006.
Infections
Unexpected elevated alanine aminotransferase, aspartate aminotransferase levels and hepatitis E virus infection among persons who work with pigs in accra, Ghana.
Infections
Unfavorable prognosis of patients with acute liver injury due to drug-induced liver injury and acute exacerbation of hepatitis B virus infection.
Infections
Urinary tract infections in infants: comparison between those with conjugated vs unconjugated hyperbilirubinaemia.
Infections
Using the prevalence of an elevated serum alanine aminotransferase level for identifying communities with a high prevalence of hepatitis C virus infection.
Infections
Variation in adenovirus transgene expression between BALB/c and C57BL/6 mice is associated with differences in interleukin-12 and gamma interferon production and NK cell activation.
Infections
Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial.
Infections
Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C.
Infections
Viral clearance in HCV viraemic patients with normal alanine aminotransferase after combination therapy: a controlled, open-labelled study.
Infections
Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study.
Infections
Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion.
Infections
Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.
Infections
Virological Rather Than Host Factors Are Associated With Transaminase Levels Among HIV/HCV-Coinfected Patients.
Infections
Virological responses of pegylated interferon alpha-2a treatment in hemodialysis patients infected with hepatitis C.
Infections
Virulent and attenuated strains of duck hepatitis A virus elicit discordant innate immune responses in vivo.
Infections
Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group.
Infections
Which patients with chronic hepatitis B are more likely to relapse after interferon alpha-induced hepatitis B e antigen loss in Korea?
Infections
Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.
Infections
[A trial of a cultured inactivated vaccine against hepatitis A on Saguinus mystax tamarins]
Infections
[Alanine aminotransferase and aspartate aminotransferase activity in cultured chicken fibroblasts in the process of growing and after infection by vaccinia virus]
Infections
[Alteration of enzyme activities in serum of Eimeria stiedai infected rabbits (author's transl)]
Infections
[Analysis of risk factors and prognosis of cirrhosis combined with bacterial pneumonia].
Infections
[Analysis of risk factors of Budd-Chiari syndrome complicated with hepatocellular carcinoma].
Infections
[Anti-HCV in patients without risk factors for hepatitis C. Prospective study in 200 patients]
Infections
[Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection]
Infections
[Assessment of the PCR-Southern blot technique for the analysis of viremia in patients with acute hepatitis A]
Infections
[Clinical application and exploration on mechanism of action of Cordyceps sinesis mycella prepration for renal transplantation recipients]
Infections
[Development of an infection in monkeys as a result of their sequential natural and experimental exposure to the hepatitis A virus]
Infections
[Diagnostic significance of antibody detection to various hepatitis C virus antigens in patients with acute and chronic HCV-infection]
Infections
[Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
Infections
[Effect of an experimental infestation with Cysticercus ovis on serum enzyme activity in lambs]
Infections
[Epstein-Barr virus and cytomegalovirus primary infections: A comparative study in 52 immunocompetent adults.]
Infections
[Hepatitis caused by tick-borne meningoencephalitis virus (TBEV)--a rare clinical manifestation outside the central nervous system involvement]
Infections
[Investigation of the relationship between hepatitis c virus (HCV) genotypes with HCV-RNA and alanine aminotransferase levels in chronic hepatitis c patients]
Infections
[Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients]
Infections
[Multivariate analysis of hepatic encephalopathy occurrence in patients with liver failure].
Infections
[Personalized treatment of viral hepatitis of the present and the future : Hepatitis B, C, delta, and E].
Infections
[Prevalence and significance of ant-HCV-antibodies in ambulatory patients with raised transaminases]
Infections
[Primary evaluation of anti-HEV diagnostic reagent by experimental infection animal model with hepatitis E virus]
Infections
[Prospective study of effect of recombinant human growth hormone on nutritional status and immune function in early postoperative stage of liver transplantation]
Infections
[Relationship among pathological changes in liver tissues and level of serum ALT, virology of patients with chronic HBV infection]
Infections
[Relationship of fatty liver with HBV infection, hyperlipidemia and abnormal alanine aminotransferase]
Infections
[Screening for post-transfusion hepatitis C-importance of enrollment and recall of blood transfusion recipients]
Infections
[Serum creatine phosphokinase, GOT, and GPT activity in different types of infectious diseases in monkeys]
Infections
[Study of disease burden of chronic hepatitis B and C patients in Shanghai based on Bronfenbrenner' s ecological systems theory: a community-based survey].
Infections
[The activity of acetyl COA hydrolase (AACo) and aminotransferases AspAT and AlAt in the course of experimental hymenolepiasis]
Infections
[The behavior of serum "liver enzyme" activity in children with chronic renal failure, hemodialysis and kidney transplantation]
Infections
[The clinical analysis of fulminant Wilson's disease in patients with hepatitis B virus infection: a report of 13 cases].
Infections
[The comparison of liver inflammation and fibrosis between chronic HBV and HCV infection].
Infections
[The modelling of hepatitis A and of enterally transmitted non-A, non-B hepatitis (hepatitis E) in Saguinus mystax tamarins]
Infections
[The sensitivity of rhesus and cynomolgus macaques to the human hepatitis A virus]
Infections
[The significance of TT virus detection in persons with elevated alanine aminotransferase during routine medical check up and patients with liver diseases]
Infections
[Treatment outcome of latent tuberculosis infection in persons with fibrotic pulmonary lesions].
Infertility, Female
Abnormal aminotransferase activity in women with polycystic ovary syndrome.
Inflammatory Bowel Diseases
Dextran sulfate sodium inhibits alanine synthesis in caco-2 cells.
Inflammatory Bowel Diseases
Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study.
Inflammatory Bowel Diseases
Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits.
Influenza, Human
Case report: hepatitis in a child infected with SARS-CoV-2 presenting toll-like receptor 7 Gln11Leu single nucleotide polymorphism.
Influenza, Human
Clinical features and risk factors for severe influenza in children: A study from multiple hospitals in Shanghai.
Influenza, Human
Coronavirus Disease 2019 versus Influenza A in Children: An Observational Control Study in China.
Influenza, Human
Dietary supplementation of Aspergillus oryzae meal and its effect on performance, carcass characteristics, blood variables, and immunity of broiler chickens.
Influenza, Human
Liver involvement during influenza infection: perspective on the 2009 influenza pandemic.
Influenza, Human
Risk stratification of hospitalized COVID-19 patients through comparative studies of laboratory results with influenza.
Influenza, Human
[The clinical and pathological characteristics of histiocytic necrotizing lymphadenitis: analysis of 52 cases]
Insulin Resistance
A 12-week aerobic exercise program without energy restriction improves intrahepatic fat, liver function and atherosclerosis-related factors.
Insulin Resistance
A better parameter in predicting insulin resistance: obesity plus elevated alanine aminotransferase.
Insulin Resistance
A comparison of associations of alanine aminotransferase and gamma-glutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes.
Insulin Resistance
A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.
Insulin Resistance
A Low ?-6 to ?-3 PUFA Ratio (n-6:n-3 PUFA) Diet to Treat Fatty Liver Disease in Obese Youth.
Insulin Resistance
A Nomogram for Predicting Non-Alcoholic Fatty Liver Disease in Obese Children.
Insulin Resistance
A novel alternatively spliced transcript of cytosolic alanine aminotransferase gene associated with enhanced gluconeogenesis in liver of Sparus aurata.
Insulin Resistance
A Preliminary Study on the Effect of Psyllium Husk Ethanolic Extract on Hyperlipidemia, Hyperglycemia, and Oxidative Stress Induced by Triton X-100 Injection in Rats.
Insulin Resistance
A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease.
Insulin Resistance
Abdominal obesity: causal factor or simply a symptom of obesity-related health risk.
Insulin Resistance
Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease.
Insulin Resistance
Abnormal Serum Alanine Aminotransferase Levels are Associated with Impaired Insulin Sensitivity in Young Women With Polycystic Ovary Syndrome.
Insulin Resistance
Acanthosis Nigricans as a Clinical Predictor of Insulin Resistance in Obese Children.
Insulin Resistance
Alanine aminotransferase and ?-glutamyltransferase as markers for elevated insulin resistance-associated metabolic abnormalities in obese Japanese men younger than 30 years of age.
Insulin Resistance
Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study.
Insulin Resistance
Alanine aminotransferase is associated with metabolic syndrome independently of insulin resistance.
Insulin Resistance
Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat.
Insulin Resistance
Alanine aminotransferase levels predict insulin resistance in HIV lipodystrophy.
Insulin Resistance
Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth.
Insulin Resistance
Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis.
Insulin Resistance
Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis.
Insulin Resistance
Angiotensin-(1-7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism.
Insulin Resistance
Anti-diabetic effects of pentamethylquercetin in neonatally streptozotocin-induced diabetic rats.
Insulin Resistance
Appendicular muscle mass and fasting triglycerides predict serum liver aminotransferases in young female collegiate athletes.
Insulin Resistance
Assessment of atherosclerosis in obese adolescents: Positive correlation of mean platelet volume and carotid intima media thickness.
Insulin Resistance
Association between aspartate aminotransferase-to-alanine aminotransferase ratio and insulin resistance among US adults.
Insulin Resistance
Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study.
Insulin Resistance
Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes.
Insulin Resistance
Association of Alanine Aminotransferase Levels (ALT) with the Hepatic Insulin Resistance Index (HIRI): a cross-sectional study.
Insulin Resistance
Association of Apolipoprotein C3 Levels and Hepatic Steatosis: A Follow-Up Study.
Insulin Resistance
Association of insulin resistance with serum ferritin and aminotransferases-iron hypothesis.
Insulin Resistance
Association of serum alanine aminotransferase and ?-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease.
Insulin Resistance
Association of sleep duration and insulin resistance in Taiwanese vegetarians.
Insulin Resistance
Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes.
Insulin Resistance
Associations Between Body Fat, Muscle Mass, and Nonalcoholic Fatty Liver Disease: A Population-Based Study.
Insulin Resistance
Associations Between Serum Uric Acid Levels and Cardiometabolic Risk, Renal ?njury in Obese and Overweight Children
Insulin Resistance
Associations between sitting time and non-alcoholic fatty liver diseases in Chinese male workers: a cross-sectional study.
Insulin Resistance
Associations between weight change and biomarkers of cardiometabolic risk in South Asians: secondary analyses of the PODOSA trial.
Insulin Resistance
Associations of adiponectin with metabolic and vascular risk parameters in the British Regional Heart Study reveal stronger links to insulin resistance-related than to coronory heart disease risk-related parameters.
Insulin Resistance
Associations of Insulin Resistance and Glycemia With Liver Enzymes in Hispanic/Latino Youths: Results From the Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth).
Insulin Resistance
Bariatric surgery improves metabolic and nonalcoholic fatty liver disease markers in metabolically healthy patients with morbid obesity at 5 years.
Insulin Resistance
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
Insulin Resistance
Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats.
Insulin Resistance
Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease.
Insulin Resistance
Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression.
Insulin Resistance
Change in obesity-related metabolic abnormalities associated with body mass index improvement through life-style intervention: A meta-regression.
Insulin Resistance
Changes in Liver Enzymes and Metabolic Profile in Adolescents with Fatty Liver following Exercise Interventions.
Insulin Resistance
Changes of the Fatty Acid Profile in Erythrocyte Membranes of Patients following 6-Month Dietary Intervention Aimed at the Regression of Nonalcoholic Fatty Liver Disease (NAFLD).
Insulin Resistance
Changes Over Time in Hepatic Markers Predict Changes in Insulin Sensitivity, ?-Cell Function, and Glycemia.
Insulin Resistance
Chemerin/CMKLR1 ameliorates nonalcoholic steatohepatitis by promoting autophagy and alleviating oxidative stress through the JAK2-STAT3 pathway.
Insulin Resistance
Chronic inflammation in polycystic ovary syndrome: A case-control study using multiple markers.
Insulin Resistance
Circulating ALT Levels in Healthy Volunteers Over Life-Span: Assessing Aging Paradox and Nutritional Implications.
Insulin Resistance
Circulating Resistin Is Associated with Plasma Glucagon-Like Peptide-1 in Cirrhotic Patients with Hepatitis C Virus Genotype-4 Infection.
Insulin Resistance
Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome.
Insulin Resistance
Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.
Insulin Resistance
Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients.
Insulin Resistance
Clinical trial: Pilot study of metformin for the treatment of nonalcoholic steatohepatitis.
Insulin Resistance
Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males.
Insulin Resistance
Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-? as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH).
Insulin Resistance
Consumption of guava may have beneficial effects in type 2 diabetes: A bioactive perspective.
Insulin Resistance
Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease.
Insulin Resistance
Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus.
Insulin Resistance
Cystatin C, cardiometabolic risk, and body composition in severely obese children.
Insulin Resistance
Decreased retinol binding protein 4 concentrations are associated with cholesterol gallstone disease.
Insulin Resistance
Determinants of hepatic insulin clearance - Results from a Mendelian Randomization study.
Insulin Resistance
Development and Internal Validation of Fatty Liver Prediction Models in Obese Children and Adolescents.
Insulin Resistance
Di(2-ethylhexyl)phthalate exposure exacerbates metabolic disorders in diet-induced obese mice.
Insulin Resistance
Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy.
Insulin Resistance
Dietary cocoa ameliorates obesity-related inflammation in high fat-fed mice.
Insulin Resistance
Dietary fatty acid oxidation is decreased in non-alcoholic fatty liver disease: A palmitate breath test study.
Insulin Resistance
Dietary fructose intake in obese children and adolescents: relation to procollagen type III N-terminal peptide (P3NP) and non-alcoholic fatty liver disease.
Insulin Resistance
Dietary sugars and cardiometabolic risk factors: a network meta-analysis on isocaloric substitution interventions.
Insulin Resistance
Different surgical approaches in laparoscopic sleeve gastrectomy and their influence on metabolic syndrome: A retrospective study.
Insulin Resistance
Discordant Effects on Central Obesity, Hepatic Insulin Resistance, and Alanine Aminotransferase of Low-dose Metformin and Thiazolidinedione Combination Therapy in Patients with Impaired Glucose Tolerance.
Insulin Resistance
Discriminatory value of alanine aminotransferase for diabetes prediction: the Insulin Resistance Atherosclerosis Study.
Insulin Resistance
Docosahexaenoic acid for the treatment of fatty liver: Randomised controlled trial in children.
Insulin Resistance
Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial.
Insulin Resistance
Early Pregnancy Biochemical Predictors of Gestational Diabetes Mellitus.
Insulin Resistance
Early-onset metabolic syndrome in prepubertal obese children and the possible role of alanine aminotransferase as marker of metabolic syndrome.
Insulin Resistance
Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease.
Insulin Resistance
Effect of betaine treatment on the regression of existing hepatic triglyceride accumulation and oxidative stress in rats fed on high fructose diet.
Insulin Resistance
Effect of deferoxamine therapy on insulin resistance in end-stage renal disease patients with iron overload.
Insulin Resistance
Effect of Ginger Powder Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.
Insulin Resistance
Effect of Miricorilant, a Selective Glucocorticoid Receptor Modulator, on Olanzapine-Associated Weight Gain in Healthy Subjects: A Proof-of-Concept Study.
Insulin Resistance
Effect of pituitary surgery in patients with acromegaly on adiponectin serum concentrations and alanine aminotransferase activity.
Insulin Resistance
Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial.
Insulin Resistance
Effect of simulated microgravity on the antidiabetic properties of wheatgrass (Triticum aestivum) in streptozotocin-induced diabetic rats.
Insulin Resistance
Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial.
Insulin Resistance
Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial.
Insulin Resistance
Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease.
Insulin Resistance
Effect of Weight Reduction on Histological Activity and Fibrosis of Lean Nonalcoholic Steatohepatitis Patient.
Insulin Resistance
Effects of Chinese Medicinal Formula BNG-1 on Phosphodiesterase 3B Expression, Hepatic Steatosis, and Insulin Resistance in High Fat Diet-induced NAFLD Mice.
Insulin Resistance
Effects of Dietary Intervention on Gut Microbiota and Metabolic-Nutritional Profile of Outpatients with Non-Alcoholic Steatohepatitis: a Randomized Clinical Trial.
Insulin Resistance
Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial.
Insulin Resistance
Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development.
Insulin Resistance
Effects of lacto-ovo-vegetarian diet vs. standard-weight-loss diet on obese and overweight adults with non-alcoholic fatty liver disease: a randomised clinical trial.
Insulin Resistance
Effects of the Combination of Evogliptin and Leucine on Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed Mice.
Insulin Resistance
Efficacy of Intragastric Balloons in the Markers of Metabolic Dysfunction-associated Fatty Liver Disease: Results from Meta-analyses.
Insulin Resistance
Efficacy of orlistat in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Insulin Resistance
Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease.
Insulin Resistance
Elevated alanine aminotransferase and low aspartate aminotransferase/alanine aminotransferase ratio are associated with chronic kidney disease among middle-aged women: a cross-sectional study.
Insulin Resistance
Elevated Alanine Aminotransferase in Current National Football League Players: Correlation with Cardiometabolic Syndrome Markers, Obesity, and Insulin Resistance.
Insulin Resistance
Elevated haemoglobin A1c but not fasting plasma glucose conveys risk of chronic kidney disease in non-diabetic individuals.
Insulin Resistance
Elevated Hemoglobin Level Is Associated With Advanced Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease.
Insulin Resistance
Elevated vaspin and leptin levels are associated with obesity in prepubertal Korean children.
Insulin Resistance
Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
Insulin Resistance
Empagliflozin decreases remnant-like particle cholesterol in type 2 diabetes patients with insulin resistance.
Insulin Resistance
Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Insulin Resistance
Evaluation of clinical, endocrine and metabolic findings in obese children with and without hepatosteatosis.
Insulin Resistance
Evaluation of Plasma Trace Elements in Different Stages of Nonalcoholic Fatty Liver Disease.
Insulin Resistance
Evaluation of the hypoglycaemic and antioxidant effects of submerged Ganoderma lucidum cultures in type 2 diabetic rats.
Insulin Resistance
Evaluation of tissue metal and trace element content in a rat model of non-alcoholic fatty liver disease using ICP-DRC-MS.
Insulin Resistance
Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids.
Insulin Resistance
Evolution of ferritin levels in hepatitis C patients treated with antivirals.
Insulin Resistance
Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease.
Insulin Resistance
Factors associated with elevated serum alanine aminotransferase in patients with type 1 diabetes mellitus.
Insulin Resistance
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study.
Insulin Resistance
Fatness, fitness, and cardiometabolic risk factors in middle-aged white men.
Insulin Resistance
Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population.
Insulin Resistance
Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
Insulin Resistance
Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy.
Insulin Resistance
Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
Insulin Resistance
Genome-Wide Association Study of Liver Fat: The Multiethnic Cohort Adiposity Phenotype Study.
Insulin Resistance
Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.
Insulin Resistance
Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
Insulin Resistance
GPR40 deficiency is associated with hepatic FAT/CD36 upregulation, steatosis, inflammation, and cell injury in C57BL/6 mice.
Insulin Resistance
Habitually Higher Dietary Glycemic Index During Puberty Is Prospectively Related to Increased Risk Markers of Type 2 Diabetes in Younger Adulthood.
Insulin Resistance
Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.
Insulin Resistance
Hepatic steatosis and thyroid function tests in overweight and obese children.
Insulin Resistance
Hepatocyte-Specific Loss of PPAR? Protects Mice From NASH and Increases the Therapeutic Effects of Rosiglitazone in the Liver.
Insulin Resistance
High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.
Insulin Resistance
High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population.
Insulin Resistance
Hyperglycosylated ferritin in sera of HIV-1-infected patients treated with highly active antiretroviral therapy.
Insulin Resistance
Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations.
Insulin Resistance
I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
Insulin Resistance
ICP-DRC-MS analysis of serum essential and toxic element levels in postmenopausal prediabetic women in relation to glycemic control markers.
Insulin Resistance
Impact of a low-carbohydrate and high-fiber diet on nonalcoholic fatty liver disease.
Insulin Resistance
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.
Insulin Resistance
Increased plasma isoprostane is associated with visceral fat, high molecular weight adiponectin, and metabolic complications in obese children.
Insulin Resistance
Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance.
Insulin Resistance
Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress.
Insulin Resistance
Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect?
Insulin Resistance
Influence of Dietary Chitosan Feeding Duration on Glucose and Lipid Metabolism in a Diabetic Rat Model.
Insulin Resistance
Influence of insulin resistance and adipocytokines on elevated serum alanine aminotransferase in obese patients.
Insulin Resistance
Influence of insulin resistance in obese patients on elevated serum alanine aminotransferase.
Insulin Resistance
Insulin Resistance and ? Cell Function in Patients with ?-Thalassemia Major.
Insulin Resistance
Insulin sensitizers for the treatment of non-alcoholic fatty liver disease.
Insulin Resistance
Integrative proteomic and lipidomic analysis of Kaili Sour Soup-mediated attenuation of high-fat diet-induced nonalcoholic fatty liver disease in a rat model.
Insulin Resistance
Intrahepatic fat, abdominal adipose tissues, and metabolic state: magnetic resonance imaging study.
Insulin Resistance
Inverse Relationship between Hepatic Steatosis and Alanine Aminotransferase with Sex Hormone-Binding Globulin in Men.
Insulin Resistance
Investigation of the effects of chlorella vulgaris supplementation in patients with non-alcoholic Fatty liver disease: a randomized clinical trial.
Insulin Resistance
Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease.
Insulin Resistance
Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis.
Insulin Resistance
Lipopolysaccharide-binding protein plasma levels as a biomarker of obesity-related insulin resistance in adolescents.
Insulin Resistance
Liraglutide modulates gut microbiome and attenuates nonalcoholic fatty liver in db/db mice.
Insulin Resistance
Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus.
Insulin Resistance
Liver alterations in anorexia nervosa are not caused by insulin resistance.
Insulin Resistance
Liver enzyme and adipocytokine profiles are synergistically associated with insulin resistance: the J-SHIPP study.
Insulin Resistance
Liver Enzymes Correlate With Metabolic Syndrome, Inflammation, and Endothelial Dysfunction in Prepubertal Children With Obesity.
Insulin Resistance
Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding.
Insulin Resistance
Long-chain polyunsaturated fatty acids and extensively hydrolyzed casein-induced browning in a Ucp-1 reporter mouse model of obesity.
Insulin Resistance
Long-term empagliflozin therapy improves levels of hepatic fibrosis marker in patients with non-alcoholic fatty liver disease complicated by type 2 diabetes mellitus.
Insulin Resistance
Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men.
Insulin Resistance
Low normal thyroid function attenuates serum alanine aminotransferase elevations in the context of metabolic syndrome and insulin resistance in white people.
Insulin Resistance
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease.
Insulin Resistance
Lycium ruthenicum extract alleviates high-fat diet-induced nonalcoholic fatty liver disease via enhancing the AMPK signaling pathway.
Insulin Resistance
Machine Learning Approaches to Identify Factors Associated with Women's Vasomotor Symptoms Using General Hospital Data.
Insulin Resistance
Mammalian target of the rapamycin pathway is involved in non-alcoholic fatty liver disease.
Insulin Resistance
Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children.
Insulin Resistance
Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor.
Insulin Resistance
Metabolically healthy overweight adolescents: definition and components.
Insulin Resistance
Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial.
Insulin Resistance
Models Predictive of Metabolic Syndrome Components in Obese Pediatric Patients.
Insulin Resistance
Motivational support programme to enhance health and well-being and promote weight loss in overweight and obese adolescents: A randomized controlled trial in Turkey.
Insulin Resistance
MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease.
Insulin Resistance
Multicomponent Exercise Training Combined with Nutritional Counselling Improves Physical Function, Biochemical and Anthropometric Profiles in Obese Children: A Pilot Study.
Insulin Resistance
Multiple biomarkers and their relative contributions to identifying metabolic syndrome.
Insulin Resistance
Muscadine grape products intake, diet and blood constituents of non-diabetic and type 2 diabetic subjects.
Insulin Resistance
New botanical drug, HL tablet, reduces hepatic fat as measured by magnetic resonance spectroscopy in patients with nonalcoholic fatty liver disease: A placebo-controlled, randomized, phase II trial.
Insulin Resistance
New factors of cardiometabolic risk in severely obese children: influence of pubertal status.
Insulin Resistance
NLRP3 deficiency did not attenuate NASH development under high fat calorie diet plus high fructose and glucose in drinking water.
Insulin Resistance
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension.
Insulin Resistance
Non-invasive prediction of non-alcoholic steatohepatitis in Japanese patients with morbid obesity by artificial intelligence using rule extraction technology.
Insulin Resistance
Non-invasive Tests Do Not Accurately Differentiate Non-alcoholic Steatohepatitis From Simple Steatosis: A Systematic Review and Meta-Analysis.
Insulin Resistance
Nonalcoholic Fatty Liver Disease Markers Are Associated with Insulin Resistance in Type 1 Diabetes.
Insulin Resistance
Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.
Insulin Resistance
Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens.
Insulin Resistance
Normal serum alanine aminotransferase activity in uncomplicated obesity.
Insulin Resistance
Novel laboratory index, based on fasting blood parameters, accurately reflects insulin sensitivity.
Insulin Resistance
Obesity, insulin resistance, and the risk of an elevated alanine aminotransferase activity in the Korean adolescent population.
Insulin Resistance
Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials.
Insulin Resistance
Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease.
Insulin Resistance
Osteocalcin, glucose metabolism, lipid profile and chronic low-grade inflammation in middle-aged and elderly Chinese.
Insulin Resistance
Paraoxonase-2 variants potentially influence insulin resistance, beta-cell function, and their interrelationships with alanine aminotransferase in type 2 diabetes.
Insulin Resistance
PEDIATRIC VISCERAL ADIPOSITY INDEX ADAPTATION CORRELATES WITH HOMA-IR, MATSUDA, AND TRANSAMINASES.
Insulin Resistance
Persistent organic pollutants and non-alcoholic fatty liver disease in morbidly obese patients: a cohort study.
Insulin Resistance
Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats.
Insulin Resistance
Plasma complement C3 levels are associated with insulin secretion independently of adiposity measures in non-diabetic individuals.
Insulin Resistance
Plasma Xanthine Oxidoreductase Activity as a Novel Biomarker of Metabolic Disorders in a General Population.
Insulin Resistance
Plasma Zonulin Levels as a Non-Invasive Biomarker of Intestinal Permeability in Women with Gestational Diabetes Mellitus.
Insulin Resistance
Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet.
Insulin Resistance
Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus.
Insulin Resistance
Potential impact of joint association of alanine aminotransferase and gamma- glutamyltransferase on insulin resistance in Japan: the Toranomon Hospital Health Management Center Study 19 (TOPICS 19).
Insulin Resistance
Potential role of liver enzymes levels as predictor markers of glucose metabolism disorders in Tunisian population.
Insulin Resistance
Predictors of hepatic steatosis in HBeAg-negative chronic hepatitis B patients and their diagnostic values in hepatic fibrosis.
Insulin Resistance
Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain.
Insulin Resistance
Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity.
Insulin Resistance
Prevalence and risk factors of steatosis and advanced fibrosis using transient elastography in the United States' adolescent population.
Insulin Resistance
Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
Insulin Resistance
Prevalence of Optimal Metabolic Health in U.S. Adolescents, NHANES 2007-2016.
Insulin Resistance
Prevalence of Suspected Nonalcoholic Fatty Liver Disease In Lean Adolescents In The United States.
Insulin Resistance
Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome.
Insulin Resistance
Protective effect of probiotics in patients with non-alcoholic fatty liver disease.
Insulin Resistance
Reduced Growth Hormone Secretion is Associated with Nonalcoholic Fatty Liver Disease in Obese Children.
Insulin Resistance
Relationship Between Immune Parameters and Non-alcoholic Fatty Liver Disease in Obese Children.
Insulin Resistance
Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
Insulin Resistance
Relationship between insulin resistance and serum levels of adiponectin and resistin with childhood obesity.
Insulin Resistance
Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients.
Insulin Resistance
Relationship of liver enzymes to insulin sensitivity and intra-abdominal fat.
Insulin Resistance
Relationship of visceral adipose tissue with surrogate insulin resistance and liver markers in individuals with metabolic syndrome chronic complications.
Insulin Resistance
Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
Insulin Resistance
Risk factors for incident type 2 diabetes in individuals with a BMI of <27 kg/m2: the role of gamma-glutamyltransferase. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).
Insulin Resistance
RLA8 - A new and highly effective quadruple PPARs-?/?/? and GPR40 agonist to reverse nonalcoholic steatohepatitis and fibrosis.
Insulin Resistance
Role of insulin resistance and adipocytokines on serum alanine aminotransferase in obese patients with type 2 diabetes mellitus.
Insulin Resistance
Role of Probiotics in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-analysis.
Insulin Resistance
Role of urinary NGAL and KIM-1 as biomarkers of early kidney injury in obese prepubertal children.
Insulin Resistance
Salidroside and Curcumin Formula Prevents Liver Injury in Nonalcoholic Fatty Liver Disease in Rats.
Insulin Resistance
Saskatoon berry powder reduces hepatic steatosis and insulin resistance in high fat-high sucrose diet-induced obese mice.
Insulin Resistance
Serologic predictors of nonalcoholic steatohepatitis in population undergoing bariatric surgery.
Insulin Resistance
Serum adiponectin levels and enzyme markers of liver dysfunction in diabetic and non-diabetic Caribbean subjects.
Insulin Resistance
Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children.
Insulin Resistance
Serum alanine aminotransferase/aspartate aminotransferase ratio is one of the best markers of insulin resistance in the Chinese population.
Insulin Resistance
Serum betatrophin concentrations are significantly increased in overweight but not in obese or type 2 diabetic individuals.
Insulin Resistance
Serum creatinine levels and risk of nonalcohol fatty liver disease in a middle-aged and older Chinese population: A cross-sectional analysis.
Insulin Resistance
Serum ferritin levels are associated with carotid atherosclerosis in Chinese postmenopausal women: the Shanghai Changfeng Study.
Insulin Resistance
Serum ferritin levels are associated with insulin resistance in Chinese men and post-menopausal women: the Shanghai Changfeng study.
Insulin Resistance
Serum gamma-glutamyl transpeptidase is a determinant of insulin resistance independently of adiposity in Pima Indian children.
Insulin Resistance
Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C.
Insulin Resistance
Serum Osteocalcin Levels in Children With Nonalcoholic Fatty Liver Disease.
Insulin Resistance
Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in patients with type 2 diabetes.
Insulin Resistance
Serum Soluble Receptor for AGE (sRAGE) Levels Are Associated With Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease.
Insulin Resistance
Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children.
Insulin Resistance
Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men.
Insulin Resistance
Several mutations in the melanocortin 4 receptor gene are associated with obesity in Chinese children and adolescents.
Insulin Resistance
Severe nonalcoholic steatohepatitis and type 2 diabetes: liver histology after weight loss therapy in a randomized clinical trial.
Insulin Resistance
Severity of HCV-induced liver damage alters glucose homeostasis in noncirrhotic patients with chronic HCV infection.
Insulin Resistance
Sex influenced association of directly measured insulin sensitivity and serum transaminase levels: Why alanine aminotransferase only predicts cardiovascular risk in men?
Insulin Resistance
Silymarin preconditioning protected insulin resistant rats from liver ischemia-reperfusion injury: role of endogenous H2S.
Insulin Resistance
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
Insulin Resistance
Sleep Duration and Media Time Have a Major Impact on Insulin Resistance and Metabolic Risk Factors in Obese Children and Adolescents.
Insulin Resistance
Sodium acetate prevents nicotine-induced cardiorenal dysmetabolism through uric acid/creatine kinase-dependent pathway.
Insulin Resistance
Swimming, but not vitamin E, ameliorates prothrombotic state and hypofibrinolysis in a rat model of nonalcoholic fatty liver disease.
Insulin Resistance
Targeting n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease.
Insulin Resistance
The -11377C > G adiponectin gene polymorphism alters the adiponectin concentration and the susceptibility to type 2 diabetes in Thais.
Insulin Resistance
The 1975 type Japanese diet improves the gut microbial flora and inhibits visceral fat accumulation in mice.
Insulin Resistance
The add-on effects of Gynostemma pentaphyllum on nonalcoholic fatty liver disease.
Insulin Resistance
The application value of serum 25(OH)D3, uric acid, triglyceride, and homeostasis model assessment of insulin resistance in male patients with hyperuricemia combined with hypogonadism.
Insulin Resistance
The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
Insulin Resistance
The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the Insulin Resistance Atherosclerosis Study.
Insulin Resistance
The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
Insulin Resistance
The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease.
Insulin Resistance
The C57BL/6J Niemann-Pick C1 mouse model with decreased gene dosage has impaired glucose tolerance independent of body weight.
Insulin Resistance
The changes of serum glypican4 in obese patients with different glucose metabolism status.
Insulin Resistance
The cross-sectional association between insulin resistance and circulating complement C3 is partly explained by plasma alanine aminotransferase, independent of central obesity and general inflammation (the CODAM study).
Insulin Resistance
The Effect of Low Glycemic Index and Glycemic Load Diets on Hepatic Fat Mass, Insulin Resistance, and Blood Lipid Panels in Individuals with Nonalcoholic Fatty Liver Disease.
Insulin Resistance
The Effect of the Mediterranean Diet on Metabolic Health: A Systematic Review and Meta-Analysis of Controlled Trials in Adults.
Insulin Resistance
The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Insulin Resistance
The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial.
Insulin Resistance
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis.
Insulin Resistance
The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid.
Insulin Resistance
The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial.
Insulin Resistance
The efficacy of saxagliptin in T2DM patients with non-alcoholic fatty liver disease: preliminary data.
Insulin Resistance
The evaluation of carotid intima-media thickness and mean platelet volume values and correlation with cardiac functions in obese children.
Insulin Resistance
The Expression of PNPLA3 Polymorphism could be the Key for Severe Liver Disease in NAFLD in Hispanic Population.
Insulin Resistance
The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies.
Insulin Resistance
The independent predictors of NASH and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, ALT and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment.
Insulin Resistance
The Relationship between Prebiotic Supplementation and Anthropometric and Biochemical Parameters in Patients with NAFLD-A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Insulin Resistance
The relationships of leptin, adiponectin levels and paraoxonase activity with metabolic and cardiovascular risk factors in females treated with psychiatric drugs.
Insulin Resistance
The risky body mass index ranges for significant hepatitis B viral load: A campus-based study.
Insulin Resistance
The role of thiazolidinediones in non-alcoholic steatohepatitis - A systematic review and meta analysis.
Insulin Resistance
The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes.
Insulin Resistance
The Symptoms of Gastroesophageal Reflux Disease Correlate with High Body Mass Index, the Aspartate Aminotransferase/Alanine Aminotransferase Ratio and Insulin Resistance in Japanese Patients with Non-alcoholic Fatty Liver Disease.
Insulin Resistance
The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression.
Insulin Resistance
Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study.
Insulin Resistance
Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
Insulin Resistance
Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects.
Insulin Resistance
TOTAL BODY ADIPOSITY, TRIGLYCERIDES, AND LEG FAT ARE INDEPENDENT RISK FACTORS FOR DIABETIC PERIPHERAL NEUROPATHY IN CHINESE PATIENTS WITH TYPE 2 DIABETES MELLITUS.
Insulin Resistance
Trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet.
Insulin Resistance
Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats.
Insulin Resistance
Truncal-to-leg fat ratio and cardiometabolic disease risk factors in US adolescents: NHANES 2003-2006.
Insulin Resistance
Upper Normal Alanine Aminotransferase Range and Insulin Resistance in Korean Adolescents: Korean National Health and Nutrition Examination Survey, 2009-2010.
Insulin Resistance
Usefulness of Triglyceride to High-Density Lipoprotein Ratio and Alanine Aminotransferase for Predicting Insulin Resistance and Metabolic Syndrome in the Japanese Population.
Insulin Resistance
Utility of MR proton density fat fraction and its correlation with ultrasonography and biochemical markers in nonalcoholic fatty liver disease in overweight adolescents.
Insulin Resistance
Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.
Insulin Resistance
Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Insulin Resistance
Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial.
Insulin Resistance
Weight-adjusted lean body mass and calf circumference are protective against obesity-associated insulin resistance and metabolic abnormalities.
Insulin Resistance
White sweet potato ameliorates hyperglycemia and regenerates pancreatic islets in diabetic mice.
Insulin Resistance
Yogurt improves insulin resistance and liver fat in obese women with nonalcoholic fatty liver disease and metabolic syndrome: a randomized controlled trial.
Insulin Resistance
Zonulin level, a marker of intestinal permeability, is increased in association with liver enzymes in young adolescents.
Insulin Resistance
[A virological response study of serum leptin level and insulin resistance on the antivirus effect in patients with chronic hepatitis C]
Insulin Resistance
[Assessment of relationship of lipid and carbon profile indicators with vitamin D supply in children depending on body mass index].
Insulin Resistance
[Correlations of serum alanine aminotransferase and insulin resistance, pancreatic B-cell function].
Insulin Resistance
[Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial].
Insulin Resistance
[Effects of Yiqi Sanju Formula on non-alcoholic fatty liver disease: a randomized controlled trial]
Insulin Resistance
[Metabolic syndrome: jumble syndrome of obesity or specific entity? Which treatment: diet or polypill?]
Insulin Resistance
[Pharmacological mechanism of Semen Litchi on antagonizing insulin resistance in rats with type 2 diabetes]
Insulin Resistance
[Waist circumference as a marker for screening nonalcoholic fatty liver disease in obese adolescents].
Intellectual Disability
Novel compound heterozygous mutations in GPT2 linked to microcephaly, and intellectual developmental disability with or without spastic paraplegia.
Intellectual Disability
Serum glutamic-oxaloacetic transaminase (GOT) and glutamic-pyruvic transaminase (GPT) levels in children and adolescents with intellectual disabilities.
Intestinal Diseases
[Alanine aminotransferase (ALT), aspartate aminotransferase (AST), glutamate dehydrogenase (GLDH), alkaline phosphatase (AP) and gamma-glutamyltransferase (GGP) in intestinal diseases of dogs]
Intestinal Obstruction
Efficacy and safety of Seprafilm for preventing intestinal obstruction after gastrointestinal neoplasms surgery: a systematic review and meta-analysis.
Intestinal Pseudo-Obstruction
Incidence and Risk Factors of Gastrointestinal and Hepatobiliary Complications after Spinal Fusion Surgery: a Retrospective Cohort Study.
Intraabdominal Infections
Efficacy and safety of Seprafilm for preventing intestinal obstruction after gastrointestinal neoplasms surgery: a systematic review and meta-analysis.
Intraabdominal Infections
Laparoscopic versus open surgery in the treatment of hepatic hemangioma: A meta-analysis.
Intracranial Hemorrhages
Development of a Novel Simple Model to Predict Mortality in Patients With Systemic Lupus Erythematosus Admitted to the Intensive Care Unit.
Intracranial Hemorrhages
Extremely Low Serum Alanine Transaminase Level Is Associated with All-Cause Mortality in the Elderly after Intracranial Hemorrhage.
Intracranial Hemorrhages
New onset acute promyelocytic Leukemia during pregnancy: report of 2 cases.
Intracranial Hypertension
Human umbilical cord blood-derived CD34+ cells cause attenuation of multiorgan dysfunction during experimental heatstroke.
Intracranial Hypertension
Hyperbaric oxygen improves survival in heatstroke rats by reducing multiorgan dysfunction and brain oxidative stress.
Intracranial Hypertension
[Relationship between changes of increased amylase or lipase levels and pancreas injury in critically ill children].
Invasive Fungal Infections
AST to ALT Ratio is elevated in disseminated histoplasmosis as compared to localized pulmonary disease and other endemic mycoses.
Iron Deficiencies
Marginal iron deficiency enhances liver triglyceride accumulation in rats fed a high-sucrose diet.
Iron Overload
3D Multi-Echo Dixon technique for simultaneous assessment of liver steatosis and iron overload in patients with chronic liver diseases: a feasibility study.
Iron Overload
Bamboo Stems (Phyllostachys nigra variety henosis) Containing Polyphenol Mixtures Activate Nrf2 and Attenuate Phenylhydrazine-Induced Oxidative Stress and Liver Injury.
Iron Overload
Effect of bioactive tannoid principles of Emblica officinalis on iron-induced hepatic toxicity in rats.
Iron Overload
Moderate-intensity aerobic training reduces cardiac damage attributable to experimental iron overload in rats.
Iron Overload
Relationship between liver iron concentration determined by R2-MRI, serum ferritin, and liver enzymes in patients with thalassemia intermedia.
Iron Overload
Toxicity associated with iron overload found in hemochromatosis: possible mechanism in a rat model.
Iron Overload
Vitamin C protective role for alcoholic liver disease in mice through regulating iron metabolism.
Irritable Bowel Syndrome
Irritable Bowel Syndrome May Be Associated with Elevated Alanine Aminotransferase and Metabolic Syndrome.
Irritable Bowel Syndrome
Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture.
Ischemic Stroke
Aspartate transaminase/alanine transaminase (De Ritis ratio) predicts survival in major burn patients.
Ischemic Stroke
AST to ALT ratio and risk of hemorrhagic transformation in patients with acute ischemic stroke.
Ischemic Stroke
Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels.
Ischemic Stroke
Does Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predict Acute Kidney Injury After Cardiac Surgery?
Ischemic Stroke
Implication of liver enzymes on incident cardiovascular diseases and mortality: A nationwide population-based cohort study.
Ischemic Stroke
Ischemic stroke in liver cirrhosis: epidemiology, risk factors, and in-hospital outcomes.
Ischemic Stroke
Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort.
Ischemic Stroke
Significantly Reduced Alanine Aminotransferase Level Increases All-Cause Mortality Rate in the Elderly after Ischemic Stroke.
Joint Diseases
Deferiprone or Deferoxamine vs. Combination Therapyin Patients with beta-Thalassemia Major: A Case Studyin Taiwan.
Joint Diseases
[STUDY OF GLUTAMIC-OXALOACETIC TRANSAMINASE, GLUTAMIC-PYRUVIC TRANSAMINASE AND ALDOLASE IN THE SYNOVIA OF PATIENTS WITH POST-TRAUMATIC ARTHROPATHY.]
Keloid
Effects of intralesional injection of triamcinolone on glucose-6-phosphate dehydrogenase and alanine aminotransferase activity in keloids.
Keratitis, Herpetic
[Use of tear enzyme assay to predict recurrent herpetic keratitis in children]
Ketosis
Effects of OP 2507, a stable analogue of prostaglandin I2, on carbon tetrachloride-induced liver damage in starved rats.
Ketosis
Increased sinusoidal efflux of reduced and oxidized glutathione in rats with endotoxin/D-galactosamine hepatitis.
Ketosis
Ketosis in buffalo (Bubalus bubalis): clinical findings and the associated oxidative stress level.
Ketosis
Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients.
Kidney Diseases
Cross-sectional study of the prevalence and risk factors of metabolic syndrome in a rural population of the Qianjiang area.
Kidney Diseases
Prevalence of TT virus in serum and peripheral mononuclear cells from a CAPD population.
Kidney Failure, Chronic
A comparison of genotype and markers of disease severity of chronic hepatitis C in patients with and without end-stage renal disease.
Kidney Failure, Chronic
Assessment of factors affecting mortality in geriatric patients with warfarin overdose.
Kidney Failure, Chronic
Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation.
Kidney Failure, Chronic
Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis.
Kidney Failure, Chronic
Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function.
Kidney Failure, Chronic
End-stage renal disease and hepatitis C infection: comparison of alanine aminotransferase levels and liver histology in patients with and without renal damage.
Kidney Failure, Chronic
Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention.
Kidney Failure, Chronic
Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting.
Kidney Failure, Chronic
Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal.
Kidney Failure, Chronic
Is hepatitis C more aggressive in renal transplant patients than in patients with end-stage renal disease?
Kidney Failure, Chronic
Serum alanine aminotransferase levels, hematocrit rate and body weight correlations before and after hemodialysis session.
Kidney Failure, Chronic
Similar HCV viral load levels and genotype distribution among end-stage renal disease patients on hemodialysis and HCV-infected patients with normal renal function.
Kidney Failure, Chronic
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
Kidney Failure, Chronic
[Identification of the cutoff value for serum alanine aminotransferase in hepatitis C screening of patients with chronic renal failure on hemodialysis]
Lassa Fever
Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study.
Latent Tuberculosis
[Treatment outcome of latent tuberculosis infection in persons with fibrotic pulmonary lesions].
Leishmaniasis, Visceral
Alteration of Clinical Chemistry Parameters Among Visceral Leishmaniasis Patients in Western Tigrai, Ethiopia, 2018/2019: A Comparative Cross-Sectional Study.
Leishmaniasis, Visceral
Leishmaniasis in Brazil. XXII: Characterization of Leishmania from man, dogs and the sandfly Lutzomyia longipalpis (Lutz & Neiva, 1912) isolated during an outbreak of visceral leishmaniasis in Santarém, Pará State.
Leishmaniasis, Visceral
[The identification of Leishmania isolates obtained from patients and dogs with visceral leishmaniasis in the Turkmen SSR]
Leptospirosis
Biomechanical and biochemical investigation of erythrocytes in late stage human leptospirosis.
Lethargy
A longitudinal observational study in two cats naturally-infected with hepadnavirus.
Lethargy
Hepatitis B-like infection in a Pacific white-sided dolphin (Lagenorhynchus obliquidens).
Lethargy
Potential drug-drug interactions in pediatric patients admitted to intensive care unit of Khyber Teaching Hospital, Peshawar, Pakistan: A cross-sectional study.
Lethargy
Retrospective study of 46 cases of feline haemobartonellosis in Israel and their relationships with FeLV and FIV infections.
Lethargy
Subchronic toxicity and toxicokinetics of LZB, a new proton pump inhibitor, after 13-week repeated oral administration in dogs.
Leukemia
Enzyme activities of NADPH-forming metabolic pathways in normal and leukemic leukocytes.
Leukemia
The important role of ADAM8 in the progression of hepatocellular carcinoma induced by diethylnitrosamine in mice.
Leukemia
[Effect of combined administration of Angelica polysaccharide and cytarabine on liver of human leukemia NOD/SCID mouse model].
Leukemia, B-Cell
The important role of ADAM8 in the progression of hepatocellular carcinoma induced by diethylnitrosamine in mice.
Leukemia, Myeloid, Acute
Enzyme activities of NADPH-forming metabolic pathways in normal and leukemic leukocytes.
Leukemia, Myeloid, Acute
New onset acute promyelocytic Leukemia during pregnancy: report of 2 cases.
Leukemia, Myeloid, Acute
[The Influence of Glutamic Pyruvate Transaminase 2 to Biological Characteristics of Acute Myeloid Leukemia Cell HL-60].
Leukemia, Promyelocytic, Acute
New onset acute promyelocytic Leukemia during pregnancy: report of 2 cases.
Leukemia, T-Cell
Isolation of an in vitro transmissible agent with reverse transcriptase activity from a blood donor with a borderline-positive HIV-1 serology for more than five years.
Leukocytosis
A retrospective evaluation of eastern coral snake envenomation and antivenom administration in cats: 30 cases (2012-2019).
Leukocytosis
Canine hepatic neuroendocrine carcinoma: an immunohistochemical and electron microscopic study.
Leukocytosis
Clinical manifestations, laboratory findings, treatment and outcome of acute organophosphate or carbamate intoxication in 102 dogs: A retrospective study.
Leukocytosis
Clinical, morphological, and molecular characterization of an undetermined Babesia species in a maned wolf (Chrysocyon brachyurus).
Leukocytosis
Community-Acquired Methicillin-Resistant Staphylococcus Aureus Hepatic Liver Abscess.
Leukocytosis
Comparative Toxicological Effects of Biologically and Chemically Synthesized Copper Oxide Nanoparticles on Mice.
Leukocytosis
Deferoxamine Attenuates Lipid Peroxidation, Blocks Interleukin-6 Production, Ameliorates Sepsis Inflammatory Response Syndrome, and Confers Renoprotection After Acute Hepatic Ischemia in Pigs.
Leukocytosis
Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Probably Induced by a Lamotrigine-Ginseng Drug Interaction.
Leukocytosis
Erythema multiforme major and disseminated intravascular coagulation in a dog following application of a d-limonene-based insecticidal dip.
Leukocytosis
Experimentally induced canine toxocariasis: laboratory examinations and pathologic changes, with emphasis on the gastrointestinal tract.
Leukocytosis
First case of erysipelas in a free-ranging bottlenose dolphin (Tursiops truncatus) stranded in the Mediterranean Sea.
Leukocytosis
Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
Leukocytosis
Hepatitis B-like infection in a Pacific white-sided dolphin (Lagenorhynchus obliquidens).
Leukocytosis
Is there any difference in pyogenic liver abscess caused by Streptococcus milleri and Klebsiella spp?: Retrospective analysis over a 10-year period in a regional hospital.
Leukocytosis
Latrodectus bites in northern Dalmatia, Croatia: clinical, laboratory, epidemiological, and therapeutical aspects.
Leukocytosis
Potential Hepatotoxicity of Efavirenz and Saquinavir/Ritonavir Coadministration in Healthy Volunteers.
Leukocytosis
Pyogenic Liver Abscess and Sepsis Caused by Streptococcus constellatus in the Immunocompetent Host.
Leukocytosis
Revisiting clinico-epidemiological pattern of human rickettsial infections in the central region of Sri Lanka: a hospital based descriptive study.
Leukocytosis
Risk factors for the critical illness in SARS-CoV-2 infection: a multicenter retrospective cohort study.
Leukocytosis
Sequential assessment of clinical and laboratory parameters in patients with hemorrhagic fever with renal syndrome.
Leukocytosis
Successful treatment of glucocorticoid and cyclosporine refractory adult-onset Still's disease complicated with hemophagocytic syndrome with plasma exchange therapy and tocilizumab : a case report.
Leukocytosis
The difference in clinical characteristics between acute Q fever and scrub typhus in southern Taiwan.
Leukocytosis
The Infectious Tale of Aerococcal Aortic Endocarditis: Cardiac Pacing in Acute Aortic Insufficiency With Complete Heart Block as a Bridge to Aortic Valve Replacement.
Leukocytosis
Treatment of mandibular osteomyelitis in two red-necked wallabies (Macropus rufogriseus) by means of intensive long-term parenteral drug administration and serial computed tomographic monitoring.
Leukocytosis
[Treatment of chronic hepatitis with interferon in children with kidney diseases]
Leukopenia
A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignancies.
Leukopenia
A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC).
Leukopenia
A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.
Leukopenia
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers.
Leukopenia
A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma.
Leukopenia
A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma.
Leukopenia
A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Leukopenia
An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma.
Leukopenia
Association of ABCC2 with levels and toxicity of methotrexate in Malaysian Childhood Acute Lymphoblastic Leukemia (ALL).
Leukopenia
Baseline laboratory test abnormalities are common in early arthritis but rarely contraindicate methotrexate: Study of three cohorts (ESPOIR, VErA, and Brittany).
Leukopenia
Candidatus Rickettsia tarasevichiae Infection in Eastern Central China: A Case Series.
Leukopenia
Clinical and laboratory findings of a sandfly fever Turkey Virus outbreak in Ankara.
Leukopenia
Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting.
Leukopenia
Clinical profiles and factors associated with mortality in adults with yellow fever admitted to an intensive care unit in Minas Gerais, Brazil.
Leukopenia
Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in Wave Five: Clinical and virological findings.
Leukopenia
Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1.
Leukopenia
Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients.
Leukopenia
Cytokines storm in COVID-19 with dengue co-infection in pregnancy: Fatal maternal and fetal outcome.
Leukopenia
Efficacies and adverse reactions of modified vitamin supplement programs before pemetrexed chemotherapy as a second-line treatment against epidermal growth factor receptor (EGFR) mutant wild-type lung adenocarcinoma.
Leukopenia
Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma.
Leukopenia
Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
Leukopenia
Feasibility and pharmacokinetics of combined therapy with S-1 and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic or recurrent breast cancer.
Leukopenia
Fever after a stay in the tropics: diagnostic predictors of the leading tropical conditions.
Leukopenia
Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase II, single-arm, prospective study.
Leukopenia
Integrated safety summary of phase II and III studies comparing oral nemonoxacin and levofloxacin in community-acquired pneumonia.
Leukopenia
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial.
Leukopenia
Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization--single-center experience.
Leukopenia
Occurrence of abscesses during treatment with pazopanib in metastatic renal cancer: a case report.
Leukopenia
Pharmacokinetics and tolerability of human mouse chimeric anti-CD22 monoclonal antibody in Chinese patients with CD22-positive non-Hodgkin lymphoma.
Leukopenia
Phase 2 Study of Adjuvant Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.
Leukopenia
Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas.
Leukopenia
Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma.
Leukopenia
Phase II study of imatinib mesylate in patients with prostate cancer with evidence of biochemical relapse after definitive radical retropubic prostatectomy or radiotherapy.
Leukopenia
Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065).
Leukopenia
Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study.
Leukopenia
Preoperative Chemoradiation With Irinotecan and Capecitabine in Patients With Locally Advanced Resectable Rectal Cancer: Long-Term Results of a Phase II Study.
Leukopenia
Prospective study of Chikungunya virus acute infection in the Island of La Réunion during the 2005-2006 outbreak.
Leukopenia
Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison.
Leukopenia
Severe Fever with Thrombocytopenia Syndrome Accompanied by Invasive Pulmonary Aspergillosis: An Autopsy Case.
Leukopenia
Severe fever with thrombocytopenia syndrome with myocardial dysfunction and encephalopathy: A case report.
Leukopenia
Severely Disseminated Kaposi Sarcoma after ABO-Incompatible Kidney Transplantation Treated Successfully with Paclitaxel and Gemcitabine Combined with Hemodialysis.
Leukopenia
Side effects of CDK4/6 inhibitors in the treatment of HR+/HER2- advanced breast cancer: a systematic review and meta-analysis of randomized controlled trials.
Leukopenia
Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3.
Leukopenia
The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation.
Leukopenia
The role of the methylenetetrahydrofolate reductase 677 and 1298 polymorphisms in Cretan children with acute lymphoblastic leukemia.
Leukopenia
The Significance of Prolonged and Saddleback Fever in Hospitalised Adult Dengue.
Leukopenia
Toxicological interactions of Cassia senna and Nerium oleander in the diet of rats.
Leukopenia
Trypanosoma evansi infection in a German shepherd dog - Apparent successful treatment using serial low dose of diminazene aceturate.
Leukopenia
[Clinical characteristics of the patients with dengue fever seen from 2002 to 2006 in Guangzhou]
Leukostasis
Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence.
Lichen Planus
Oral lichen planus and chronic liver disease: a clinical and morphometric study of the oral lesions in relation to transaminase elevation.
Lipid Metabolism Disorders
Puerarin attenuates cadmium-induced hepatic lipid metabolism disorder by inhibiting oxidative stress and inflammation in mice.
Lipid Metabolism Disorders
Scutellarin Reduce the Homocysteine Level and Alleviate Liver Injury in Type 2 Diabetes Model.
Lipid Metabolism Disorders
Spontaneous nonalcoholic fatty liver disease and ER stress in Sidt2 deficiency mice.
Lipid Metabolism Disorders
The ameliorative effect of Lactobacillus plantarum Y44 oral administration on inflammation and lipid metabolism in obese mice fed with a high fat diet.
Lipidoses
Measurement of serum bile acids concentrations for diagnosis of hepatobiliary disease in cats.
Lipodystrophy
Alanine aminotransferase levels predict insulin resistance in HIV lipodystrophy.
Lipodystrophy, Congenital Generalized
Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy.
Liver Cirrhosis
13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
Liver Cirrhosis
25-OH-vitamin D deficiency identifies poor tumor response in hepatocellular carcinoma treated with transarterial chemoembolization.
Liver Cirrhosis
3D Multi-Echo Dixon technique for simultaneous assessment of liver steatosis and iron overload in patients with chronic liver diseases: a feasibility study.
Liver Cirrhosis
A different detection method reveals a new role of alanine aminotransferase as an indicator of liver fibrosis.
Liver Cirrhosis
A new model for predicting liver cirrhosis in chronic hepatitis B virus carriers with low serum alanine transaminase activity.
Liver Cirrhosis
A non-invasive model for predicting liver fibrosis in HBeAg-positive patients with normal or slightly elevated alanine aminotransferase.
Liver Cirrhosis
A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels.
Liver Cirrhosis
A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B.
Liver Cirrhosis
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis.
Liver Cirrhosis
A review of the natural history of chronic hepatitis B in the era of transient elastography.
Liver Cirrhosis
Abundance of immunologically active alanine aminotransferase in sera of liver cirrhosis and hepatocellular carcinoma patients.
Liver Cirrhosis
Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice.
Liver Cirrhosis
Alanine aminotransferase and spleno-portal dynamics affect spleen stiffness measured by point shear-wave elastography in patients with chronic hepatitis C in the absence of significant liver fibrosis.
Liver Cirrhosis
Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.
Liver Cirrhosis
American ancestry is a risk factor for suspected non-alcoholic fatty liver disease in Hispanic/Latino adults.
Liver Cirrhosis
Amygdalin inhibits TGF?1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl4-induced hepatic fibrosis in rats in vivo.
Liver Cirrhosis
An Hepatitis C Virus (HCV)/HIV Co-Infected Patient who Developed Severe Hepatitis during Chronic HCV Infection: Sustained Viral Response with Simeprevir Plus Peginterferon-Alpha and Ribavirin.
Liver Cirrhosis
Angelica Polysaccharide Antagonizes 5-FU-Induced Oxidative Stress Injury to Reduce Apoptosis in the Liver Through Nrf2 Pathway.
Liver Cirrhosis
Angelica sinensis polysaccharide attenuates CCl4-induced liver fibrosis via the IL-22/STAT3 pathway.
Liver Cirrhosis
Anti-fibrotic effects of the anthocyanins isolated from the purple-fleshed sweet potato on hepatic fibrosis induced by dimethylnitrosamine administration in rats.
Liver Cirrhosis
Antifibrotic activity of anisodamine in vivo is associated with changed intrahepatic levels of matrix metalloproteinase-2 and its inhibitor tissue inhibitors of metalloproteinases-2 and transforming growth factor beta1 in rats with carbon tetrachloride-induced liver injury.
Liver Cirrhosis
Antifibrotic activity of hesperidin against dimethylnitrosamine-induced liver fibrosis in rats.
Liver Cirrhosis
Antifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K/AKT/mTOR/p70S6K1 signaling pathways.
Liver Cirrhosis
Antioxidant and hepatoprotective effects of extract of ginkgo biloba in rats of non-alcoholic steatohepatitis.
Liver Cirrhosis
Antioxidant effects of kimchi supplemented with black raspberry during fermentation protect against liver cirrhosis-induced oxidative stress in rats.
Liver Cirrhosis
Antiviral activity, dose-response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial.
Liver Cirrhosis
Applicability of liver stiffness measurement based nomograms to the assessments of hepatitis B related significant fibrosis and cirrhosis.
Liver Cirrhosis
APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology.
Liver Cirrhosis
Artificial MicroRNA-Mediated Tgfbr2 and Pdgfrb Co-Silencing Ameliorates Carbon Tetrachloride-Induced Hepatic Fibrosis in Mice.
Liver Cirrhosis
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index.
Liver Cirrhosis
Assessment of Liver Fibrosis Using Real-time Shear-wave Elastography for Patients with Hepatitis B e Antigen-negative Chronic Hepatitis B and Alanine Transaminase <2 Times the Upper Limit of Normal.
Liver Cirrhosis
Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B.
Liver Cirrhosis
Association Between Severity of Obstructive Sleep Apnea and Blood Markers of Liver Injury.
Liver Cirrhosis
Association of miRNA-122-binding site polymorphism at the interleukin-1 ? gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Liver Cirrhosis
Association of serum interferon-?3 levels with hepatocarcinogenesis in chronic hepatitis C patients treated with direct-acting antiviral agents.
Liver Cirrhosis
Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis.
Liver Cirrhosis
Branched chain amino acids supplementation modulates TGF-?1/Smad signaling pathway and interleukins in CCl4 -induced liver fibrosis.
Liver Cirrhosis
Case-control study on prednisolone combined with ursodeoxycholic acid and azathioprine in pure primary biliary cirrhosis with high levels of immunoglobulin G and transaminases: efficacy and safety analysis.
Liver Cirrhosis
Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
Liver Cirrhosis
Changes in seroprevalence of hepatitis B surface antigen and epidemiologic characteristics in the Republic of Korea, 1998-2013.
Liver Cirrhosis
Characteristics of hepatitis C viral genome associated with disease progression.
Liver Cirrhosis
Characteristics of patients with chronic hepatitis-B virus infection in an urban hospital.
Liver Cirrhosis
Chronic hepatitis C in elderly patients: Clinical, histolocical and virolocical features.
Liver Cirrhosis
Chronic hepatitis C in the Hispanic/Latino population living in the United States: a literature review.
Liver Cirrhosis
Chronic restraint stress reduces carbon tetrachloride-induced liver fibrosis.
Liver Cirrhosis
Clinical features of treatment-naive patients with hepatitis B virus infection: A community-based survey from high- and intermediate-hepatitis B endemicity regions in Southeast China.
Liver Cirrhosis
Clinical implication of serum Wisteria floribunda Agglutinin-Positive Mac-2-binding protein in treatment naïve chronic hepatitis B.
Liver Cirrhosis
Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.
Liver Cirrhosis
Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
Liver Cirrhosis
Clinical significance of serum hyaluronan in patients with chronic viral liver disease.
Liver Cirrhosis
Clinical significance of serum wisteria floribunda agglutinin-positive Mac-2-binding protein level in non-alcoholic steatohepatitis.
Liver Cirrhosis
Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma.
Liver Cirrhosis
Comparative Analysis of Noninvasive Models to Predict Early Liver Fibrosis in Hepatitis B e Antigen-negative Chronic Hepatitis B.
Liver Cirrhosis
Comparative assessment of liver fibrosis in patients with HIV/chronic hepatitis C co-infection in different ethnic groups.
Liver Cirrhosis
Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels.
Liver Cirrhosis
Comparison of acoustic radiation force impulse imaging and transient elastography for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B.
Liver Cirrhosis
Comparison of four markers of hepatic fibrosis and hepatic function indices in patients with liver cirrhosis and hepatoma.
Liver Cirrhosis
Comparison of long-term survival and immediate postoperative liver function after laparoscopic and open distal gastrectomy for early gastric cancer patients with liver cirrhosis.
Liver Cirrhosis
Comparison of the on-treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis.
Liver Cirrhosis
Comprehensive characterization of serum clinical chemistry parameters and the identification of urinary superoxide dismutase in a carbon tetrachloride-induced model of hepatic fibrosis in the female Hanover Wistar rat.
Liver Cirrhosis
Correlation analysis between four serum biomarkers of liver fibrosis and liver function in infants with cholestasis.
Liver Cirrhosis
Correlation between serum cytokeratin 19 fragment and tissue polypeptide antigen levels in patients with non-malignant diseases.
Liver Cirrhosis
Correlation of liver function with intestinal flora, vitamin deficiency and IL-17A in patients with liver cirrhosis.
Liver Cirrhosis
Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients.
Liver Cirrhosis
Data mining reveals complex interactions of risk factors and clinical feature profiling associated with the staging of non-hepatitis B virus/non-hepatitis C virus-related hepatocellular carcinoma.
Liver Cirrhosis
Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.
Liver Cirrhosis
Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance.
Liver Cirrhosis
Depression rather than liver impairment reduces quality of life in patients with hepatitis C.
Liver Cirrhosis
Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C.
Liver Cirrhosis
Development of experimental fibrotic liver diseases animal model by Carbon Tetracholoride.
Liver Cirrhosis
Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan.
Liver Cirrhosis
Diagnostic Accuracy of 2-D Shear Wave Elastography for the Non-Invasive Staging of Liver Fibrosis in Patients with Elevated Alanine Aminotransferase Levels.
Liver Cirrhosis
Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes.
Liver Cirrhosis
Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect.
Liver Cirrhosis
Does the control of alanine aminotransferase levels lead to a regression of liver fibrosis in chronic hepatitis C patients?
Liver Cirrhosis
Dynamic Changes in Liver Stiffness Measured by Transient Elastography Predict Clinical Outcomes Among Patients With Chronic Hepatitis B.
Liver Cirrhosis
Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV Patients.
Liver Cirrhosis
Eating quickly is associated with a low aspartate aminotransferase to alanine aminotransferase ratio in middle-aged adults: a large-scale cross-sectional survey in Japan.
Liver Cirrhosis
Effect of acupuncture combined with Shenqi Yigan Decoction on liver function and T cell subsets in patients with HBV-induced liver fibrosis.
Liver Cirrhosis
Effect of previous interferon-based therapy on recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma.
Liver Cirrhosis
Effect of Sho-saiko-to extract on hepatic inflammation and fibrosis in dimethylnitrosamine induced liver injury rats.
Liver Cirrhosis
Effectiveness of direct-acting antiviral drugs against hepatitis C virus: predictive factors of response to the treatment.
Liver Cirrhosis
Effects of bicyclol on dimethylnitrosamine-induced liver fibrosis in mice and its mechanism of action.
Liver Cirrhosis
Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGF?-1) and SMADs Pathway in a Mouse Model of Cirrhosis.
Liver Cirrhosis
Effects of Fructus Piperis Longi extract on fibrotic liver of gamma-irradiated rats.
Liver Cirrhosis
Effects of Vitamin D Supplementation on Serum 25-Hydroxyvitamin D Concentrations in Cirrhotic Patients: A Randomized Controlled Trial.
Liver Cirrhosis
Effects of Yinchenhao decoction on self-regulation of renin-angiotensin system by targeting angiotensin converting enzyme 2 in bile duct-ligated rat liver.
Liver Cirrhosis
Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study.
Liver Cirrhosis
Efficacy of orlistat in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Liver Cirrhosis
Elevated Alt and Ast in an Asymptomatic Person: What the primary care doctor should do?
Liver Cirrhosis
Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population-Based Study of Mexican Americans.
Liver Cirrhosis
Elevation of Alanine Transaminase and Markers of Liver Fibrosis After a Mixed Meal Challenge in Individuals with Type 2 Diabetes.
Liver Cirrhosis
Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis.
Liver Cirrhosis
Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography.
Liver Cirrhosis
Evaluation of hepatic and kidney dysfunction among newly diagnosed HIV patients with viral hepatitis infection in Cape Coast, Ghana.
Liver Cirrhosis
Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection.
Liver Cirrhosis
External validation of Liaoning score for predicting esophageal varices in liver cirrhosis: a Chinese multicenter cross-sectional study.
Liver Cirrhosis
Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B.
Liver Cirrhosis
FibroScan, aspartate aminotransferase and alanine aminotransferase ratio (AAR), aspartate aminotransferase to platelet ratio index (APRI), fibrosis index based on the 4 factor (FIB-4), and their combinations in the assessment of liver fibrosis in patients with hepatitis B.
Liver Cirrhosis
Fibrosis Progression in Paired Liver Biopsies from HIV/HCV-Coinfected Patients without Prior Treatment of Hepatitis C.
Liver Cirrhosis
Fibrosis-4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction.
Liver Cirrhosis
First Case in Kazakhstan of Successful Therapy With 2 Consecutive Direct-Acting Antiviral Regimens in a Patient with Hepatitis C Virus-Induced Decompensated Liver Cirrhosis on a Liver Transplant Wait List.
Liver Cirrhosis
Five Fibrosis Biomarkers Together with Serum Ferritin Level to Diagnose Liver Fibrosis and Cirrhosis.
Liver Cirrhosis
Flavanones from Sedum sarmentosum Bunge Alleviate CCl4-Induced Liver Fibrosis in Rats by Targeting TGF-?1/T?R/Smad Pathway In Turn Inhibiting Epithelial Mesenchymal Transition.
Liver Cirrhosis
Future aspects of therapy for hepatitis B virus infection: value of surrogate markers, innovative therapy, and global collaboration.
Liver Cirrhosis
Galectin-9 in autoimmune hepatitis: Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis.
Liver Cirrhosis
Genistein attenuates D-GalN induced liver fibrosis/chronic liver damage in rats by blocking the TGF-?/Smad signaling pathways.
Liver Cirrhosis
Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
Liver Cirrhosis
GRHL2 induces liver fibrosis and intestinal mucosal barrier dysfunction in non-alcoholic fatty liver disease via microRNA-200 and the MAPK pathway.
Liver Cirrhosis
H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule.
Liver Cirrhosis
HBV DNA level to predict liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication.
Liver Cirrhosis
Hepatic Fibrosis, Inflammation, and Steatosis: Influence on the MR Viscoelastic and Diffusion Parameters in Patients with Chronic Liver Disease.
Liver Cirrhosis
Hepatic flares promote rapid decline of serum hepatitis B surface antigen (HBsAg) in patients with HBsAg seroclearance: A long-term follow-up study.
Liver Cirrhosis
Hepatic necroinflammation and severe liver fibrosis in patients with chronic hepatitis B with undetectable HBV DNA and persistently normal alanine aminotransferase.
Liver Cirrhosis
Hepatitis activity should be considered a confounder of liver stiffness measured with MR elastography.
Liver Cirrhosis
Hepatitis B surface antigen-negative, but HBV DNA-positive patients in Bangladesh.
Liver Cirrhosis
Hepatitis B virus genotypes and clinical manifestation among hepatitis B carriers in Thailand.
Liver Cirrhosis
Hepatoprotective effects of loach (Misgurnus anguillicaudatus) lyophilized powder on dimethylnitrosamine-induced liver fibrosis in rats.
Liver Cirrhosis
High aspartate to alanine aminotransferase ratio is an indicator of cirrhosis and poor outcome in patients with primary sclerosing cholangitis.
Liver Cirrhosis
High association of T1858-G1896 precore mutations with impaired base pairing and high hepatitis B virus DNA levels in HBeAg-negative chronically infected patients.
Liver Cirrhosis
High percentage atypical hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs.
Liver Cirrhosis
High serum alanine aminotransferase levels for the first three successive years can predict very high incidence of hepatocellular carcinoma in patients with Child Stage A HCV-associated liver cirrhosis.
Liver Cirrhosis
High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis.
Liver Cirrhosis
Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Hepatic Stellate Cell Activation and Liver Fibrosis by Upregulating MicroRNA-455-3p through Suppression of p21-Activated Kinase-2.
Liver Cirrhosis
IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats.
Liver Cirrhosis
IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus.
Liver Cirrhosis
IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
Liver Cirrhosis
Immune Regulation of Intrahepatic Regulatory T Cells in Fibrotic Livers of Mice.
Liver Cirrhosis
Immunosuppressive effect of chenodeoxycholic acid on natural killer cell activity in patients with biliary atresia and hepatitis C virus-related liver cirrhosis.
Liver Cirrhosis
Impact of mild to moderate elevations of alanine aminotransferase on liver stiffness measurement in chronic hepatitis B patients during antiviral therapy.
Liver Cirrhosis
Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.
Liver Cirrhosis
Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C.
Liver Cirrhosis
Indoleamine 2,3-dioxygenase 1 deficiency attenuates CCl4-induced fibrosis through Th17 cells down-regulation and tryptophan 2,3-dioxygenase compensation.
Liver Cirrhosis
Influence of age, sex, and degree of liver fibrosis on the association between serum alanine aminotransferase levels and liver inflammation in patients with chronic hepatitis C.
Liver Cirrhosis
Influence of serum HBV DNA load on recurrence of hepatocellular carcinoma after treatment with percutaneous radiofrequency ablation.
Liver Cirrhosis
Insulin resistance/beta-cell function and serum ferritin level in non-diabetic patients with hepatitis C virus infection.
Liver Cirrhosis
Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-beta1 expression in pig serum-induced rat liver fibrosis in vivo.
Liver Cirrhosis
Interleukin 28B rs12979860 (CT/TT) genotype is associated with milder hepatic damage in the natural evolution of HCV/HIV coinfection.
Liver Cirrhosis
Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo.
Liver Cirrhosis
Investigation of the hepatoprotective effect of Corydalis saxicola Bunting on carbon tetrachloride-induced liver fibrosis in rats by 1H-NMR-based metabonomics and network pharmacology approaches.
Liver Cirrhosis
Laparoscopic Splenectomy for the Elderly Liver Cirrhotic Patients With Hypersplenism: A Retrospective Comparable Study.
Liver Cirrhosis
Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
Liver Cirrhosis
Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation.
Liver Cirrhosis
Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase.
Liver Cirrhosis
Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease.
Liver Cirrhosis
Liver fibrosis in HIV-positive patients with hepatitis C virus: role of persistently normal alanine aminotransferase levels.
Liver Cirrhosis
Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
Liver Cirrhosis
Liver Fibrosis Regression Measured by Transient Elastography in Human Immunodeficiency Virus (HIV)-Hepatitis B Virus (HBV)-Coinfected Individuals on Long-Term HBV-Active Combination Antiretroviral Therapy.
Liver Cirrhosis
Liver manifestations in a cohort of 39 patients with congenital disorders of glycosylation: pin-pointing the characteristics of liver injury and proposing recommendations for follow-up.
Liver Cirrhosis
Liver resections performed under prolonged portal triad occlusion in patients with active chronic liver diseases.
Liver Cirrhosis
Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
Liver Cirrhosis
Liver Stiffness Measurement and Biochemical Markers in Senegalese Chronic Hepatitis B Patients with Normal ALT and High Viral Load.
Liver Cirrhosis
Liver Stiffness Measurement in Combination With Noninvasive Markers for the Improved Diagnosis of B-viral Liver Cirrhosis.
Liver Cirrhosis
LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in obese adults with modest hypertriglyceridemia.
Liver Cirrhosis
Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease.
Liver Cirrhosis
Long-term Nucleos(t)ides Analogues for Chronic Hepatitis B Improve Liver and Spleen Size: A Noninvasive Sonographic Study.
Liver Cirrhosis
Loss of NLRP3 Function Alleviates Murine Hepatic Graft-versus-Host Disease.
Liver Cirrhosis
Lowering the upper limit of serum alanine aminotransferase levels may reveal significant liver disease in the elderly.
Liver Cirrhosis
Meta-analysis of factors associated with sustained viral response in patients on hemodialysis treated with standard or pegylated interferon for hepatitis C infection.
Liver Cirrhosis
Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis.
Liver Cirrhosis
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis.
Liver Cirrhosis
MicroRNA-10a Impairs Liver Metabolism in Hepatitis C Virus-Related Cirrhosis Through Deregulation of the Circadian Clock Gene Brain and Muscle Aryl Hydrocarbon Receptor Nuclear Translocator-Like 1.
Liver Cirrhosis
Moderate-intensity aerobic training reduces cardiac damage attributable to experimental iron overload in rats.
Liver Cirrhosis
Multipotent cells from the human third molar: feasibility of cell-based therapy for liver disease.
Liver Cirrhosis
Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C--a study of 527 patients at one establishment.
Liver Cirrhosis
Neoagarooligosaccharide Protects against Hepatic Fibrosis via Inhibition of TGF-?/Smad Signaling Pathway.
Liver Cirrhosis
New prolyl 4-hydroxylase inhibitor reduces procollagen gene expression and enzyme-altered lesions in rat liver cirrhosis.
Liver Cirrhosis
Nutrient intake in Italian obese patients: Relationships with insulin resistance and markers of non-alcoholic fatty liver disease.
Liver Cirrhosis
Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/?-catenin signaling pathway, c-Myc and cyclin D1.
Liver Cirrhosis
Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation.
Liver Cirrhosis
Percutaneous liver biopsy: retrospective study over 15 years comparing 287 inpatients with 428 outpatients.
Liver Cirrhosis
Performance of fibrosis prediction scores in paediatric non-alcoholic fatty liver disease.
Liver Cirrhosis
Phylogenetic, Virological, and Clinical Characteristics of Genotype C Hepatitis B Virus with TCC at Codon 15 of the Precore Region.
Liver Cirrhosis
Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity.
Liver Cirrhosis
Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
Liver Cirrhosis
Polymorphism of OAS-1 determines liver fibrosis progression in hepatitis C by reduced ability to inhibit viral replication.
Liver Cirrhosis
Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet.
Liver Cirrhosis
Predictors for advanced liver fibrosis in chronic hepatitis B virus infection with persistently normal or mildly elevated alanine aminotransferase.
Liver Cirrhosis
Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
Liver Cirrhosis
Preparation and evaluation of PEGylated asiatic acid nanostructured lipid carriers on anti-fibrosis effects.
Liver Cirrhosis
Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B.
Liver Cirrhosis
Progression of liver fibrosis among injection drug users with chronic hepatitis C.
Liver Cirrhosis
Progressive liver functional impairment is associated with an increase in AST/ALT ratio.
Liver Cirrhosis
Protective Effects of Amarogentin against Carbon Tetrachloride-Induced Liver Fibrosis in Mice.
Liver Cirrhosis
Psychological Disorders and Quality of Life Among Patients With Chronic Viral Hepatitis: A Single-Center Cross-Sectional Study With Pair-Matched Healthy Controls.
Liver Cirrhosis
Recurrence of Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy.
Liver Cirrhosis
Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients.
Liver Cirrhosis
Red blood cell distribution width levels correlate with liver fibrosis and inflammation: a noninvasive serum marker panel to predict the severity of fibrosis and inflammation in patients with hepatitis B.
Liver Cirrhosis
Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis.
Liver Cirrhosis
Relationship of ?-fetoprotein levels and development of hepatocellular carcinoma in hepatitis C patients with liver cirrhosis.
Liver Cirrhosis
Remote development of hepatocellular carcinoma in patients with liver cirrhosis type B serologically cured for HBs antigenemia with long-standing normalization of ALT values.
Liver Cirrhosis
Retrospective analysis of hepatitis B virus chronic infection in 247 patients: clinical stages, response to treatment and poor prognostic factors.
Liver Cirrhosis
Rho-kinase inhibitor prevents hepatocyte damage in acute liver injury induced by carbon tetrachloride in rats.
Liver Cirrhosis
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
Liver Cirrhosis
Risk score system for the prediction of hepatocellular carcinoma in patients with type 2 diabetes: Taiwan Diabetes Study.
Liver Cirrhosis
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
Liver Cirrhosis
Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes.
Liver Cirrhosis
Serum alanine aminotransferase levels and survival after hepatectomy in patients with hepatocellular carcinoma and hepatitis C virus-associated liver cirrhosis.
Liver Cirrhosis
Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients.
Liver Cirrhosis
Serum hepatitis B surface antigen levels predict insignificant fibrosis and non-cirrhosis in hepatitis B e antigen positive patients with normal or mildly elevated alanine transaminase levels.
Liver Cirrhosis
Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients.
Liver Cirrhosis
Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection.
Liver Cirrhosis
Serum levels of soluble interferon Alfa/Beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C.
Liver Cirrhosis
Serum liver fibrosis markers discriminate significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase.
Liver Cirrhosis
Serum vitamin D? does not correlate with liver fibrosis in chronic hepatitis C.
Liver Cirrhosis
Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in chronic hepatitis C patients.
Liver Cirrhosis
Shear wave elastography for liver fibrosis in chronic hepatitis B: Adapting the cut-offs to alanine aminotransferase levels improves accuracy.
Liver Cirrhosis
Significance of prior hepatitis B virus infection in the development of hepatocellular carcinoma in patients with chronic hepatitis C.
Liver Cirrhosis
Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.
Liver Cirrhosis
Suppression of elevated alanine aminotransferase activity in liver disease by vigabatrin.
Liver Cirrhosis
Sustained low alanine aminotransferase levels can predict the survival for 10 years without hepatocellular carcinoma development in patients with hepatitis C virus-associated liver cirrhosis of child stage A.
Liver Cirrhosis
Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome.
Liver Cirrhosis
Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-?1/Smads signaling pathway modulation.
Liver Cirrhosis
Synergistic antifibrotic effect of verapamil and interferon-gamma in rats: partially based on enhanced verapamil oral bioavailability.
Liver Cirrhosis
Taiwanese Green Propolis and Propolin G Protect the Liver from the Pathogenesis of Fibrosis via Eliminating TGF-?-Induced Smad2/3 Phosphorylation.
Liver Cirrhosis
The Author's Response: Anti-Viral Therapy for Compensated Liver Cirrhosis Patients with Normal Alanine Aminotransferase.
Liver Cirrhosis
The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma.
Liver Cirrhosis
The combination of 5 serum markers compared to FibroScan to predict significant liver fibrosis in patients with chronic hepatitis B virus.
Liver Cirrhosis
The current state of chronic dialysis treatment in Japan (as of December 31, 2000).
Liver Cirrhosis
The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Liver Cirrhosis
The independent predictors of NASH and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, ALT and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment.
Liver Cirrhosis
The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders.
Liver Cirrhosis
The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease.
Liver Cirrhosis
The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C.
Liver Cirrhosis
The Utility of the "NAFLD Fibrosis Score" in Morbidly Obese Subjects with NAFLD.
Liver Cirrhosis
Time-related changes in full-length hepatitis C virus sequences and hepatitis activity.
Liver Cirrhosis
TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice.
Liver Cirrhosis
Traditional Chinese medicine Bao Gan Ning increase phosphorylation of CREB in liver fibrosis in vivo and in vitro.
Liver Cirrhosis
Transjugular liver biopsy and hepatic venous pressure gradient measurement in patients with and without liver cirrhosis.
Liver Cirrhosis
Transplantation of basic fibroblast growth factor-pretreated adipose tissue-derived stromal cells enhances regression of liver fibrosis in mice.
Liver Cirrhosis
Treatment of pig serum-induced rat liver fibrosis with Boschniakia rossica, oxymatrine and interferon-alpha.
Liver Cirrhosis
Treatment rate and factors related to interferon-based treatment initiation for chronic hepatitis C in South Korea.
Liver Cirrhosis
Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis.
Liver Cirrhosis
Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Liver Cirrhosis
Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
Liver Cirrhosis
Utility of the FIB-4 Index for hepatocarcinogenesis in hepatitis C virus carriers with normal alanine aminotransferase levels.
Liver Cirrhosis
Variant in CD209 promoter is associated with severity of liver disease in chronic hepatitis C virus infection.
Liver Cirrhosis
Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis.
Liver Cirrhosis
Viral clearance in HCV viraemic patients with normal alanine aminotransferase after combination therapy: a controlled, open-labelled study.
Liver Cirrhosis
Yu Jin Pulvis inhibits carbon tetrachloride-induced liver fibrosis by blocking the MAPK and PI3K/Akt signaling pathways.
Liver Cirrhosis
[Accuracy of FibroScan for the diagnosis of liver fibrosis influenced by serum alanine aminotransferase levels in patients with chronic hepatitis B].
Liver Cirrhosis
[Analysis of clinical features and prognosis in patients with primary Sjögren's syndrome and autoimmune liver disease].
Liver Cirrhosis
[Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection]
Liver Cirrhosis
[Clinical study on treatment of liver fibrosis by different dosages of Salvia injection]
Liver Cirrhosis
[Community-based hepatocellular carcinoma screening in seven townships in Taiwan]
Liver Cirrhosis
[Effect of targeted inhibition of hypoxia-inducible factor-1? by 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole on the progression of non-alcoholic fatty liver disease in rats].
Liver Cirrhosis
[Effects of Hemerocallis citrine baroni flavonids on CCl4-induced liver fibrosis of rats].
Liver Cirrhosis
[Hepatitis B virus genotypes and alanine aminotransferase levels in HBeAg negative patients with chronic hepatitis B and liver cirrhosis]
Liver Cirrhosis
[Multivariate analysis of hepatic encephalopathy occurrence in patients with liver failure].
Liver Cirrhosis
[Relationship between hepatitis B surface antigen, HBV DNA quantity and liver fibrosis severity].
Liver Cirrhosis
[The effect of hydrocortisone on the activity of blood plasma and liver tissue enzymes. II. The changes of -glucuronidase ( -GR) and alanine aminotransferase (AlAT) activities in experimental liver cirrhosis and in biliary obstruction in rats]
Liver Cirrhosis
[The therapeutic effects of interleukin 10 gene-modified bone marrow-derived dendritic cells in a murine model of liver fibrosis].
Liver Cirrhosis
[TRANSPLANTATION OF HUMAN AMNIOTIC EPITHELIAL CELLS IN TREATMENT OF HEPATIC FIBROSIS IN IMMUNE RATS].
Liver Cirrhosis
[Treatment of chronic hepatitis C in human immunodeficiency virus infected patients]
Liver Cirrhosis
[Treatment of chronic hepatitis C in human immunodeficiency virus infected patients].
Liver Cirrhosis
[Ultrasonic scores combined with blood indexes for screening and predicting compensated liver cirrhosis in chronic hepatitis B patients]
Liver Cirrhosis, Alcoholic
Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians.
Liver Cirrhosis, Alcoholic
Serum Concentration of Fluoride in Patients with Alcoholic Liver Cirrhosis from the Lublin Region in Eastern Poland.
Liver Cirrhosis, Biliary
Autoantibody against 70 kD heat shock protein in patients with autoimmune liver diseases.
Liver Cirrhosis, Biliary
Clinical characteristics of antimitochondrial antibody-positive patients at a safety net health care system in Arizona.
Liver Cirrhosis, Biliary
Computer-guided randomized concentration-controlled trials of tacrolimus in autoimmunity: multiple sclerosis and primary biliary cirrhosis.
Liver Cirrhosis, Biliary
Consumption of dietary supplements in a liver transplant population.
Liver Cirrhosis, Biliary
High aspartate to alanine aminotransferase ratio is an indicator of cirrhosis and poor outcome in patients with primary sclerosing cholangitis.
Liver Cirrhosis, Biliary
Predictive Value of Aspartate Aminotransferase to Alanine Aminotransferase Ratio for Hepatic Fibrosis and Clinical Adverse Outcomes in Patients With Primary Biliary Cirrhosis.
Liver Cirrhosis, Biliary
Real-World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis.
Liver Cirrhosis, Experimental
[The effect of hydrocortisone on the activity of blood plasma and liver tissue enzymes. II. The changes of -glucuronidase ( -GR) and alanine aminotransferase (AlAT) activities in experimental liver cirrhosis and in biliary obstruction in rats]
Liver Diseases
"Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country.
Liver Diseases
(13)C-aminopyrine demethylation is decreased in cirrhotic patients with normal biochemical markers.
Liver Diseases
3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China.
Liver Diseases
A 10-year-old boy with dyspnea and hypoxia: abernathy malformation masquerading as pulmonary arteriovenous fistula.
Liver Diseases
A case of glycogenic hepatopathy developed in a patient with new-onset fulminant type 1 diabetes: the role of image modalities in diagnosing hepatic glycogen deposition including gradient-dual-echo MRI.
Liver Diseases
A case of severe acute hepatitis C and delayed antibody production due to rituximab therapy.
Liver Diseases
A comparison of associations of alanine aminotransferase and gamma-glutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes.
Liver Diseases
A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT.
Liver Diseases
A Follow-Up Study on the Renal Protective Efficacy of Telbivudine for Hepatitis B Virus-Infected Taiwanese Patients After Living Donor Liver Transplant.
Liver Diseases
A Multiple Logistic Regression Model Based on Gamma-Glutamyl Transferase as a Biomarker for Early Prediction of Drug-Induced Liver Injury in Vietnamese Patients.
Liver Diseases
A prospective study on the causes of notably raised alanine aminotransferase (ALT).
Liver Diseases
A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation.
Liver Diseases
A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid.
Liver Diseases
A replication study of genome-wide CNV association for hepatic biomarkers identifies nine genes associated with liver function.
Liver Diseases
A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients.
Liver Diseases
A study about immunomodulatory effect and efficacy and prognosis of human umbilical cord mesenchymal stem cells in patients with chronic hepatitis B-induced decompensated liver cirrhosis.
Liver Diseases
A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and ?-glutamyl transferase.
Liver Diseases
Abnormal Serum Alanine Aminotransferase Levels are Associated with Impaired Insulin Sensitivity in Young Women With Polycystic Ovary Syndrome.
Liver Diseases
Abnormality of risk factors for atherosclerotic disease among young Japanese aged 19-39 years old: an evaluation of health checkup data.
Liver Diseases
Active and inactive replication of hepatitis B virus deoxyribonucleic acid in chronic liver disease.
Liver Diseases
Acute liver dysfunction after modified Fontan operation for complex cardiac lesions. Analysis of the contributing factors and its relation to the early prognosis.
Liver Diseases
Acute liver failure and death predictors in patients with dengue-induced severe hepatitis.
Liver Diseases
Adaptation of methods for glutamate dehydrogenase and alcohol dehydrogenase activities to a centrifugal analyser: assessment of their clinical use in anoxic states of the liver.
Liver Diseases
Adequate Intake levels of choline are sufficient for preventing elevations in serum markers of liver dysfunction in Mexican American men but are not optimal for minimizing plasma total homocysteine increases after a methionine load.
Liver Diseases
Alanine aminopeptidase in serum: automated optimized assay, and effects of age, sex, smoking, and alcohol consumption in a selected population.
Liver Diseases
Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
Liver Diseases
Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease: A Secondary Analysis Using TONIC Trial Data.
Liver Diseases
Alanine aminotransferase as an independent predictor of incident nonalcoholic fatty liver disease.
Liver Diseases
Alanine aminotransferase elevation in obese infants and children: a marker of early onset non alcoholic Fatty liver disease.
Liver Diseases
Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.
Liver Diseases
Alanine aminotransferase, gamma-glutamyltransferase (GGT) and all-cause mortality: results from a population-based Danish twins study alanine aminotransferase, GGT and mortality in elderly twins.
Liver Diseases
Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth.
Liver Diseases
Alcoholism, hepatitis B and C viral infections, and impaired liver function among Taiwanese aboriginal groups.
Liver Diseases
ALT Course, Serum HBV DNA and Liver Stiffness Measurement for Therapeutic Decision in HBeAg-Negative Chronic Hepatitis B.
Liver Diseases
ALT Trends through Childhood and Adolescence Associated with Hepatic Steatosis at 24 Years: A Population-Based UK Cohort Study.
Liver Diseases
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Liver Diseases
Aminotransferase upper reference limits and the prevalence of elevated aminotransferases in the Korean adolescent population.
Liver Diseases
Analysis of copy number variation in 8,842 Korean individuals reveals 39 genes associated with hepatic biomarkers AST and ALT.
Liver Diseases
Analyzing predictors of graft survival in patients undergoing liver transplantation with donors aged 70 years and over.
Liver Diseases
Anorexia nervosa with severe liver dysfunction and subsequent critical complications.
Liver Diseases
Are hepatitis G virus and TT virus involved in cryptogenic chronic liver disease?
Liver Diseases
Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?
Liver Diseases
Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014.
Liver Diseases
Ascitic form of sporadic acute viral hepatitis in children: a distinct entity for recognition.
Liver Diseases
Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease.
Liver Diseases
Assessment of increased serum aminotransferases in a managed Atlantic bottlenose dolphin (Tursiops truncatus) population.
Liver Diseases
Assessment of NAFLD cases and its correlation to BMI and metabolic syndrome in healthy blood donors in Kerman.
Liver Diseases
Association between alanine aminotransferase within the normal range and all-cause and cause-specific mortality: A nationwide cohort study.
Liver Diseases
Association between aspartate aminotransferase-to-alanine aminotransferase ratio and insulin resistance among US adults.
Liver Diseases
Association between eosinophil count and cholelithiasis among a population with Clonorchis sinensis infection in Foshan City, China.
Liver Diseases
Association Between High-Normal Levels of Alanine Aminotransferase and Risk Factors for Atherogenesis.
Liver Diseases
Association between Markers of Fatty Liver Disease and Impaired Glucose Regulation in Men and Women from the General Population: The KORA-F4-Study.
Liver Diseases
Association Between Severity of Obstructive Sleep Apnea and Blood Markers of Liver Injury.
Liver Diseases
Association of Alanine Aminotransferase and Periodontitis: A Cross-Sectional Analysis-NHANES 2009-2012.
Liver Diseases
Association of elevated alanine aminotransferase with BMI and diabetes in older veteran outpatients.
Liver Diseases
Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex-related analysis.
Liver Diseases
Association of MBOAT7 gene variant with plasma ALT levels in children: the PANIC study.
Liver Diseases
Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits.
Liver Diseases
Association of response to combined interferon alpha-2b and ribavirin therapy in patients of chronic hepatitis c with serum alanine aminotransferase levels and severity of the disease on liver biopsy.
Liver Diseases
Association of serum alanine aminotransferase and ?-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease.
Liver Diseases
Association of the I148M/PNPLA3 variant with elevated alanine transaminase levels in normal-weight and overweight/obese Mexican children.
Liver Diseases
Associations of Liver Disease with Alcohol Use among People Living with HIV and the Role of Hepatitis C: The New Orleans Alcohol Use in HIV Study.
Liver Diseases
AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
Liver Diseases
Attitudes and barriers to the use of DCD livers: Comparison of a U.S. transplant center survey to the United Network for Organ Sharing data.
Liver Diseases
Autoantibody against 70 kD heat shock protein in patients with autoimmune liver diseases.
Liver Diseases
Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes.
Liver Diseases
Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients.
Liver Diseases
Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers.
Liver Diseases
Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease.
Liver Diseases
Burden of Future Liver Abnormalities in Patients With Intrahepatic Cholestasis of Pregnancy.
Liver Diseases
Can hepatokines be regarded as novel non-invasive serum biomarkers of intrahepatic lipid content in obese children?
Liver Diseases
Carbohydrate 19-9 antigen is not a marker of liver disease in patients with cystic fibrosis.
Liver Diseases
Case of idiopathic portal hypertension complicated with autoimmune hepatitis.
Liver Diseases
Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression.
Liver Diseases
Change in ALT levels after administration of HMG-CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practice.
Liver Diseases
Characteristics of chronic hepatitis B patients who underwent liver biopsies.
Liver Diseases
Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort.
Liver Diseases
Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal miR-122-5p.
Liver Diseases
Chronic cryptogenic hepatitis in childhood is unrelated to hepatitis G virus.
Liver Diseases
Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.
Liver Diseases
Chronic hepatitis infected with hepatitis GB virus type C/hepatitis G virus presenting as non-alcoholic steatohepatitis.
Liver Diseases
Chronic liver disease is universal in children with biliary atresia living with native liver.
Liver Diseases
Circulating ALT Levels in Healthy Volunteers Over Life-Span: Assessing Aging Paradox and Nutritional Implications.
Liver Diseases
Circulating levels and liver tissue distribution of intercellular adhesion molecule-1 during beta-interferon therapy of hepatitis C virus-associated chronic active liver disease.
Liver Diseases
Clinical and Esophagoenteroduodenoscopy Findings in Pediatric Patients with Severe Obesity Evaluated Prior to Bariatric Surgery.
Liver Diseases
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
Liver Diseases
Clinical characteristics of antimitochondrial antibody-positive patients at a safety net health care system in Arizona.
Liver Diseases
Clinical features of liver disturbance in rheumatoid diseases: clinicopathological study with special reference to the cause of liver disturbance.
Liver Diseases
Clinical laboratory tests and five-year incidence of major depressive disorder: a prospective cohort study of 433,890 participants from the UK Biobank.
Liver Diseases
Clinical Management of Nonalcoholic Steatohepatitis (NASH) With the Use of Thiazolidinediones and the Additive Effect of Thiazolidinediones and a GLP-1 Agonist: Case Series.
Liver Diseases
Clinical outcomes in a prospective study of community-acquired hepatitis C virus infection in Northern Norway.
Liver Diseases
Clinical performance of stem cell therapy in patients with acute-on-chronic liver failure: a systematic review and meta-analysis.
Liver Diseases
Clinical Presentation and Gene Expression of Acute Alcohol-Induced Microvesicular Steatosis Mimicking Alcoholic Hepatitis.
Liver Diseases
Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease.
Liver Diseases
Clinical significance of serum alanine aminotransferase and lifestyle intervention in children with nonalcoholic fatty liver disease.
Liver Diseases
Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
Liver Diseases
Clinical usefulness of serum tripeptide aminopeptidase activity in diagnosing liver diseases.
Liver Diseases
Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients.
Liver Diseases
Clinical, virological and histological implications of GB virus-C/hepatitis G virus infection in patients with chronic hepatitis C virus infection: a multicentre study based on 671 patients.
Liver Diseases
Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.
Liver Diseases
Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males.
Liver Diseases
Coffee: good, bad, or just fun? A critical review of coffee's effects on liver enzymes.
Liver Diseases
Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe(-/-) mice.
Liver Diseases
COMBINATION OF MOLECULAR ADSORBENT RECIRCULATING SYSTEM AND RADIOIODINE FOR THE TREATMENT OF CONCURRENT HYPERTHYROIDISM AND SEVERE LIVER DYSFUNCTION: A RETROSPECTIVE COHORT STUDY.
Liver Diseases
Combinative analysis of factors influence serum alanine aminotransferase activity in adult male population from southern China.
Liver Diseases
Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels.
Liver Diseases
Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescents.
Liver Diseases
Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease.
Liver Diseases
Comparison of FIB-4 and APRI in Chinese HBV-infected patients with persistently normal ALT and mildly elevated ALT.
Liver Diseases
Comparison of histologic characteristics of Chinese chronic hepatitis B patients with persistently normal or mildly elevated ALT.
Liver Diseases
Comparison of the combined marker ggt-cdt and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers.
Liver Diseases
Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea.
Liver Diseases
Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease.
Liver Diseases
Correlation between Helicobacter pylori Infection and Metabolic Abnormality in General Population: A Cross-Sectional Study.
Liver Diseases
Correlation between serum alanine aminotransferase activity and age: an inverted U curve pattern.
Liver Diseases
Correlation between serum enzymes and serum unsaturated vitamin B12 binding proteins in primary liver carcinoma.
Liver Diseases
Correlation of plasma hepatitis C virus RNA levels with serum alanine aminotransferase in non-A, non-B chronic liver disease.
Liver Diseases
Cytokine response to human liver ischemia-reperfusion injury during hepatectomy: marker of injury or surgical stress?
Liver Diseases
Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update.
Liver Diseases
Detection of hepatitis B virus DNA in the liver and serum of patients with hepatitis B surface antigen and hepatitis C virus antibody negative chronic liver disease.
Liver Diseases
Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase.
Liver Diseases
Determinants of Serum Alpha-Fetoprotein Levels in Hepatitis C-Infected Patients.
Liver Diseases
Determination of alanine aminotransferase with an electrochemical nano ir-C biosensor for the screening of liver diseases.
Liver Diseases
Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong.
Liver Diseases
Development of risk scoring system for stratifying population for hepatocellular-carcinoma screening.
Liver Diseases
Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma.
Liver Diseases
Diagnosis of bile duct hepatocellular carcinoma thrombus without obvious intrahepatic mass.
Liver Diseases
Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy.
Liver Diseases
Diagnostic performance of fibroscan and computed tomography in 322 normal alanine aminotransferase non-obese non-alcoholic fatty liver disease patients diagnosed by ultrasound.
Liver Diseases
Diet as moderator in the association of adiposity with inflammatory biomarkers among adolescents in the HELENA study.
Liver Diseases
Dietary cocoa ameliorates obesity-related inflammation in high fat-fed mice.
Liver Diseases
Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome.
Liver Diseases
Differential but infrequent alterations of hepatic enzyme levels and thyroid hormone levels by anticonvulsant drugs.
Liver Diseases
Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities.
Liver Diseases
Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography.
Liver Diseases
Diurnal variation of serum alanine transaminase activity in chronic liver disease.
Liver Diseases
Does Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predict Acute Kidney Injury After Cardiac Surgery?
Liver Diseases
Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.
Liver Diseases
Dose-response association of the ZJU index and fatty liver disease risk: A large cohort in China.
Liver Diseases
Early outcomes of implanting larger-sized grafts in deceased donor liver transplantation.
Liver Diseases
Early-onset metabolic syndrome in prepubertal obese children and the possible role of alanine aminotransferase as marker of metabolic syndrome.
Liver Diseases
Eating Fast and Until Full Is Associated with Elevated Alanine Aminotransferase Activity in Japanese Schoolchildren: A Cross-Sectional Study.
Liver Diseases
Eating quickly is associated with a low aspartate aminotransferase to alanine aminotransferase ratio in middle-aged adults: a large-scale cross-sectional survey in Japan.
Liver Diseases
Effect of Dapagliflozin on Alanine Aminotransferase Improvement in Type 2 Diabetes Mellitus with Non-alcoholic Fatty Liver Disease.
Liver Diseases
Effect of pituitary surgery in patients with acromegaly on adiponectin serum concentrations and alanine aminotransferase activity.
Liver Diseases
Effect of rebamipide on liver damage and increased tumor necrosis factor in a rat model of endotoxin shock.
Liver Diseases
Effect of ribavirin and amantadine on early hepatitis C virus RNA rebound and clearance in serum during daily high-dose interferon.
Liver Diseases
Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis.
Liver Diseases
Effect of some anti-cancer drugs and combined chemotherapy on the pharmacokinetics of antipyrine in the rat.
Liver Diseases
Effect of ursodeoxycholic acid therapy on hepatic function in children with intrahepatic cholestatic liver disease.
Liver Diseases
Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis.
Liver Diseases
Effectiveness of direct-acting antiviral drugs against hepatitis C virus: predictive factors of response to the treatment.
Liver Diseases
Effects of continuous use of probiotics before liver transplantation: A randomized, double-blind, placebo-controlled trial.
Liver Diseases
Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
Liver Diseases
Effects of epicatechin gallate (ECG) on fetal bovine serum (FBS)-induced steatosis in human liver cell line L02 and 2,2?-azobis (2-amidinopropane) (AAPH)-induced oxidative stress in human erythrocytes
Liver Diseases
Effects of intragastric balloon placement in metabolic dysfunction-associated fatty liver disease: A systematic review and meta-analysis.
Liver Diseases
Effects of Phytosterol Supplementation on Serum Levels of Lipid Profiles, Liver Enzymes, Inflammatory Markers, Adiponectin, and Leptin in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Liver Diseases
Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.
Liver Diseases
Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C.
Liver Diseases
Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily.
Liver Diseases
Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis.
Liver Diseases
Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
Liver Diseases
Efficacy of herbomineral compounds and pathya (Ayurvedic dietary regime and physical exercise) in the management of Yak?t Roga (Non-alcoholic fatty liver disease).
Liver Diseases
Efficacy, Safety, and Predictors of Direct-acting antivirals in Hepatitis C Virus Patients with Heterogeneous Liver Diseases.
Liver Diseases
Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease.
Liver Diseases
Elevated alanine aminotransferase and low aspartate aminotransferase/alanine aminotransferase ratio are associated with chronic kidney disease among middle-aged women: a cross-sectional study.
Liver Diseases
Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia.
Liver Diseases
Elevated alanine aminotransferase independently predicts new onset of depression in employees undergoing health screening examinations.
Liver Diseases
Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: the bogalusa heart study.
Liver Diseases
Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States.
Liver Diseases
Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes mellitus.
Liver Diseases
Elevated serum transaminases in patients with acute coronary syndromes: Do we need a revision of exclusion criteria for clinical trials?
Liver Diseases
Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
Liver Diseases
Eltrombopag-induced liver dysfunction during the treatment of immune thrombocytopenia and its risk factors.
Liver Diseases
Endotoxin Metabolism Reflects Hepatic Functional Reserve in End-Stage Liver Disease.
Liver Diseases
Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology.
Liver Diseases
Estimation of Upper Limit of Normal for Serum Alanine Transaminase in Healthy South Indian Population.
Liver Diseases
Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom.
Liver Diseases
Evaluation of blood donors with elevated serum alanine aminotransferase levels.
Liver Diseases
Evaluation of liver biopsy in Egyptian HBeAg-negative chronic hepatitis B patients at initial presentation: implications for therapy.
Liver Diseases
Evaluation of Non-invasive Fibrosis Markers in Predicting Esophageal Variceal Bleeding.
Liver Diseases
Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography.
Liver Diseases
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.
Liver Diseases
Exploring the efficacy and safety of polyene phosphatidylcholine for treatment of drug-induced liver injury using the Roussel Uclaf causality assessment method: a propensity score matching comparison.
Liver Diseases
Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection.
Liver Diseases
Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
Liver Diseases
Factors associated with long-term survival after liver transplantation: A retrospective cohort study.
Liver Diseases
Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity.
Liver Diseases
Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection.
Liver Diseases
Forsythia suspensa extract attenuates lipopolysaccharide-induced inflammatory liver injury in rats via promoting antioxidant defense mechanisms.
Liver Diseases
GB virus C/hepatitis G virus infection among patients with hepatocellular carcinoma in the inshore area of the Yangtze River, China.
Liver Diseases
Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
Liver Diseases
Glucagon-producing pancreatic endocrine tumors in two dogs with superficial necrolytic dermatitis.
Liver Diseases
Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance.
Liver Diseases
Grade 4 epistaxis in a woman with metastatic breast cancer treated with bevacizumab: a case report.
Liver Diseases
Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease.
Liver Diseases
GWAS of serum ALT and AST reveals an association of SLC30A10 Thr95Ile with hypermanganesemia symptoms.
Liver Diseases
Halting the natural history of hepatitis B viral infection: a paradigm shift.
Liver Diseases
Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis.
Liver Diseases
Hazardous environmental factors enhance impairment of liver function in HBV and HCV hepatitis.
Liver Diseases
HBV reactivation in allogeneic stem cell transplant recipients: Risk factors, outcome, and role of hepatitis B virus mutations.
Liver Diseases
HCV viraemia is more important than genotype as a predictor of response to interferon in Sicily (southern Italy).
Liver Diseases
Healthy Range of Serum Alanine Aminotransferase and its Predictive Power for Cardiovascular Risk in Children and Adolescents.
Liver Diseases
Heat Shock Protein 70 Expression is Increased in the Liver of Neonatal Intrauterine Growth Retardation Piglets.
Liver Diseases
Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
Liver Diseases
Hepatic arterial resistance index--an indicator of diffuse liver disease in children treated with bone marrow transplantation.
Liver Diseases
Hepatic functional and pathological changes of type 1 diabetic mice in growing and maturation time.
Liver Diseases
Hepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the longitudinal assessment of bariatric surgery (LABS) study.
Liver Diseases
Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis.
Liver Diseases
Hepatitis B core-related antigen (HBcrAg): an alternative to HBV DNA to assess treatment eligibility in Africa.
Liver Diseases
Hepatitis B genotypes: relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia.
Liver Diseases
Hepatitis B surface antigen, hepatitis C virus antibody, body mass index, and alcohol drinking among workers with elevated serum alanine aminotransferase.
Liver Diseases
Hepatitis B virus (HBV) X gene mutations and their association with liver disease progression in HBV-infected patients.
Liver Diseases
Hepatitis B virus DNA in the serum of Sardinian blood donors negative for the hepatitis B surface antigen.
Liver Diseases
Hepatitis B virus genotypes and clinical manifestation among hepatitis B carriers in Thailand.
Liver Diseases
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.
Liver Diseases
Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease.
Liver Diseases
Hepatitis C virus infection in children treated for acute lymphoblastic leukemia.
Liver Diseases
Hepatoprotective and immunomodulatory effects of copper-nicotinate complex against fatty liver in rat model.
Liver Diseases
Hepatoprotective effect of sodium hydrosulfide on hepatic encephalopathy in rats.
Liver Diseases
Herbal Traditional Chinese Medicine and suspected liver injury: A prospective study.
Liver Diseases
High alanine aminotransferase level as a predictor for the incidence of macrovascular disease in type 2 diabetic patients with fatty liver disease.
Liver Diseases
High prevalence and phylogenetic analysis of TT-virus infection in Mongolia.
Liver Diseases
High prevalence of antibodies to hepatitis C virus in three haemodialysis centres in south-western Poland.
Liver Diseases
High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity.
Liver Diseases
High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests.
Liver Diseases
High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.
Liver Diseases
High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patients.
Liver Diseases
High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase-Lowering Effect of a HSD17B13 Variant.
Liver Diseases
High-Fat Diet Promotes Macrophage-Mediated Hepatic Inflammation and Aggravates Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice.
Liver Diseases
Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease.
Liver Diseases
Higher Fetuin-A Level Is Associated with Coexistence of Elevated Alanine Aminotransferase and the Metabolic Syndrome in the General Population.
Liver Diseases
Histologic activity of childhood chronic hepatitis B related to viremia levels, genotypes, mutations, and epidemiologic factors.
Liver Diseases
Histologic Evidence of Active Liver Injury in Chronic Hepatitis B Patients With Normal Range or Minimally Elevated Alanine Aminotransferase Levels.
Liver Diseases
Histological abnormalities in children with nonalcoholic Fatty liver disease and normal or mildly elevated alanine aminotransferase levels.
Liver Diseases
Histological and clinical characteristics of patients with chronic hepatitis C and persistently normal alanine aminotransferase levels.
Liver Diseases
HMGB1-associated necroptosis and Kupffer cells M1 polarization underlies remote liver injury induced by intestinal ischemia/reperfusion in rats.
Liver Diseases
Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation.
Liver Diseases
Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations.
Liver Diseases
Hyperlipidemia and Nonalcoholic Steatohepatitis Predispose to Hepatocellular Carcinoma Development Without Cirrhosis.
Liver Diseases
Hypertension is an important predictor of recurrent colorectal adenoma after screening colonoscopy with adenoma polypectomy.
Liver Diseases
Hypolipidemic, Hepatoprotective and Renoprotective Effects of Cydonia Oblonga Mill. Fruit in Streptozotocin-Induced Diabetic Rats.
Liver Diseases
Idiopathic CD4+ T-lymphocytopenia in HIV seronegative men with hemophilia and sex partners of HIV seropositive men. Multicenter Hemophilia Cohort Study.
Liver Diseases
IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection.
Liver Diseases
Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation.
Liver Diseases
Impact of Human Immunodeficiency Virus Coinfection on the Progression of Mother-to-child Transmitted Hepatitis C Virus Infection.
Liver Diseases
Impact of lifestyle and cardiovascular risk factors on early atherosclerosis in a large cohort of healthy adolescents: The Early Vascular Ageing (EVA)-Tyrol Study.
Liver Diseases
Impact of metabolic syndrome on elevated serum alanine aminotransferase levels in the Japanese population.
Liver Diseases
Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.
Liver Diseases
Impaired function of dendritic cells circulating in patients infected with hepatitis C virus who have persistently normal alanine aminotransferase levels.
Liver Diseases
Improved parenchymal liver enhancement with extended delay on Gd-EOB-DTPA-enhanced MRI in patients with parenchymal liver disease: associated clinical and imaging factors.
Liver Diseases
Improvement of alanine aminotransferase by administration of suplatast tosilate plus ursodeoxycholic acid in patients with resistance to ursodeoxycholic acid monotherapy on hepatitis C virus-related chronic liver disease.
Liver Diseases
In Vivo Carbon-13 Dynamic MRS and MRSI of Normal and Fasted Rat Liver with Hyperpolarized (13)C-Pyruvate.
Liver Diseases
Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial.
Liver Diseases
Incidence of side effects during therapy with different types of alpha interferon: a randomised controlled trial comparing recombinant alpha 2b versus leukocyte interferon in the therapy of naive patients with chronic hepatitis C.
Liver Diseases
Increased cystatin C serum concentrations in patients with hepatic diseases of various severities.
Liver Diseases
Increased hepatic expression is a major determinant of serum alanine aminotransferase elevation in mice with nonalcoholic steatohepatitis.
Liver Diseases
Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Liver Diseases
Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic.
Liver Diseases
Independent Association of Physical Activity with Nonalcoholic Fatty Liver Disease and Alanine Aminotransferase Levels.
Liver Diseases
Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus.
Liver Diseases
Influence of thyroid dysfunction on liver lipid peroxidation and antioxidant status in experimental rats.
Liver Diseases
Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.
Liver Diseases
Interaction and joint effect of ALT and chronic liver disease on liver cancer in type 2 diabetes patients.
Liver Diseases
Interferon-alpha treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children.
Liver Diseases
Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest).
Liver Diseases
Intra-individual variation of analytes in serum from patients with chronic liver diseases.
Liver Diseases
Intrahepatic Cholestasis of Pregnancy: A Review of Diagnosis and Management.
Liver Diseases
Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo.
Liver Diseases
Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States.
Liver Diseases
Inverse relationship between fasting direct bilirubin and metabolic syndrome in Korean adults.
Liver Diseases
Investigation of the effects of chlorella vulgaris supplementation in patients with non-alcoholic Fatty liver disease: a randomized clinical trial.
Liver Diseases
Involvement of transporter associated with antigen processing 2 (TAP2) gene polymorphisms in hepatitis C virus infection.
Liver Diseases
Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease?
Liver Diseases
Isolated presence of antibody to hepatitis B core antigen in dialysis patients: occurrence of subclinical hepatitis?
Liver Diseases
Joint associations of serum uric acid and ALT with NAFLD in elderly men and women: a Chinese cross-sectional study.
Liver Diseases
Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis.
Liver Diseases
Lifestyle and the development of increased serum gamma-glutamyltransferase in middle-aged Japanese men.
Liver Diseases
Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers.
Liver Diseases
Linoleic Acid-Derived Oxylipins Differentiate Early Stage Alcoholic Hepatitis From Mild Alcohol-Associated Liver Injury.
Liver Diseases
Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus.
Liver Diseases
Liver Biomarkers and Lipid Profiles in Mexican and Mexican-American 10- to 14-Year-Old Adolescents at Risk for Type 2 Diabetes.
Liver Diseases
Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis.
Liver Diseases
Liver dysfunction associated with artificial nutrition in critically ill patients.
Liver Diseases
Liver Dysfunction Associated With In-Hospital Mortality in Adult Extracorporeal Membrane Oxygenation Support.
Liver Diseases
Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy.
Liver Diseases
Liver dysfunction in anti-melanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis.
Liver Diseases
Liver dysfunction is associated with poor prognosis in patients after immune checkpoint inhibitor therapy.
Liver Diseases
Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis.
Liver Diseases
Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.
Liver Diseases
Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study.
Liver Diseases
Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.
Liver Diseases
Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction.
Liver Diseases
Liver function recovery of COVID-19 patients after discharge, a follow-up study.
Liver Diseases
Liver function tests and mortality in a cohort of life insurance applicants.
Liver Diseases
Liver histology and alanine aminotransferase levels in children and adults with chronic hepatitis C infection.
Liver Diseases
Liver histopathology and liver and serum alanine aminotransferase and alkaline phosphatase activities in epileptic dogs receiving phenobarbital.
Liver Diseases
Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.
Liver Diseases
Liver iron influences the response to interferon alpha therapy in chronic hepatitis C.
Liver Diseases
Liver manifestations in a cohort of 39 patients with congenital disorders of glycosylation: pin-pointing the characteristics of liver injury and proposing recommendations for follow-up.
Liver Diseases
Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.
Liver Diseases
Liver Maximum Capacity: A Novel Test to Accurately Diagnose Different Stages of Liver Fibrosis.
Liver Diseases
Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial.
Liver Diseases
Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure.
Liver Diseases
Liver Test Results Do Not Identify Liver Disease in Adults With ?(1)-Antitrypsin Deficiency.
Liver Diseases
Living donor liver transplantation for acute liver failure in pediatric patients caused by the ingestion of fireworks containing yellow phosphorus.
Liver Diseases
Long term survey of hepatitis C virus infection in hemodialysis units in Fukuoka, Japan.
Liver Diseases
Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years.
Liver Diseases
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B*
Liver Diseases
Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
Liver Diseases
Low vitamin D levels are associated with increased risk for fatty liver disease among non-obese adults.
Liver Diseases
Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial.
Liver Diseases
Lowering the upper limit of serum alanine aminotransferase levels may reveal significant liver disease in the elderly.
Liver Diseases
Management of Chronic Hepatitis B: An Overview of Practice Guidelines for Primary Care Providers.
Liver Diseases
Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment.
Liver Diseases
Marginal iron deficiency enhances liver triglyceride accumulation in rats fed a high-sucrose diet.
Liver Diseases
Measurement of Spleen Stiffness with Acoustic Radiation Force Impulse Imaging Predicts Mortality and Hepatic Decompensation in Patients with Liver Cirrhosis.
Liver Diseases
Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
Liver Diseases
Methionine enkephalin is increased in plasma in acute liver disease and is present in bile and urine.
Liver Diseases
MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease.
Liver Diseases
MicroRNA profiles in serum samples from patients with stable cirrhosis and miRNA-21 as a predictor of transplant-free survival.
Liver Diseases
Milk thistle for the treatment of liver disease: a systematic review and meta-analysis.
Liver Diseases
Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life.
Liver Diseases
Multiparametric Magnetic Resonance Imaging, Autoimmune Hepatitis, and Prediction of Disease Activity.
Liver Diseases
Multivariate analysis of an enzymic profile for the differential diagnosis of viral hepatitis.
Liver Diseases
Myostatin deficiency not only prevents muscle wasting but also improves survival in septic mice.
Liver Diseases
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Liver Diseases
New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence.
Liver Diseases
Non-Alcoholic Fatty Liver Disease and Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia.
Liver Diseases
Non-F HBV/HDV-3 coinfection is associated with severe liver disease in Western Brazilian Amazon.
Liver Diseases
Nonalcoholic Fatty Liver Disease and Risk of Diabetes: A Prospective Study in China.
Liver Diseases
Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status.
Liver Diseases
Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase.
Liver Diseases
Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in U.S. adults.
Liver Diseases
Nonfasted Liver Stiffness Correlates with Liver Disease Parameters and Portal Hypertension in Pediatric Cholestatic Liver Disease.
Liver Diseases
Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels.
Liver Diseases
Normal limit for serum alanine aminotransferase level and distribution of metabolic factors in old population of kalaleh, iran.
Liver Diseases
Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B.
Liver Diseases
Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010-2015.
Liver Diseases
Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study.
Liver Diseases
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial.
Liver Diseases
Nutritional status of children with chronic hepatitis B in a population with low socioeconomic status.
Liver Diseases
Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents.
Liver Diseases
Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen.
Liver Diseases
Orexin-A represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling.
Liver Diseases
Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.
Liver Diseases
Pattern of histological findings in chronic hepatitis C with alanine transaminase levels below twice the normal value.
Liver Diseases
PEDIATRIC VISCERAL ADIPOSITY INDEX ADAPTATION CORRELATES WITH HOMA-IR, MATSUDA, AND TRANSAMINASES.
Liver Diseases
Percutaneous liver biopsy: retrospective study over 15 years comparing 287 inpatients with 428 outpatients.
Liver Diseases
Performance and Utility of Transient Elastography and Non-Invasive Markers of Liver Fiibrosis in Patients with Autoimmune Hepatitis: A Single Centre Experience.
Liver Diseases
Performance of Risk-Based and Birth-Cohort Strategies for Identifying Hepatitis C Virus Infection Among People Entering Prison, Wisconsin, 2014.
Liver Diseases
Persistence of circulating HBsAg/IgM complexes in acute viral hepatitis, type B: an early marker of chronic evolution.
Liver Diseases
Persistent alanine aminotransferase elevations in children with parenteral nutrition-associated liver disease.
Liver Diseases
Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study.
Liver Diseases
Persistent organic pollutants and liver dysfunction biomarkers in a population-based human sample of men and women.
Liver Diseases
Persistently normal alanine transaminase levels in chronic C hepatitis: what does it tell us?
Liver Diseases
Pharmacokinetics of rocuronium during the three stages of liver transplantation.
Liver Diseases
Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases.
Liver Diseases
Physiological adaptations to fasting in an actively wintering canid, the Arctic blue fox (Alopex lagopus).
Liver Diseases
Plasma interleukin-18/interleukin-18 binding protein ratio in Chinese with NAFLD.
Liver Diseases
Poor prognosis of liver transplantation for acute liver failure with acute pancreatitis: Two case reports.
Liver Diseases
Population-Level Prediction of Type 2 Diabetes From Claims Data and Analysis of Risk Factors.
Liver Diseases
Potential conditions causing impairment of selective hepatobiliary enhancement of gadobenate dimeglumine-enhanced delayed magnetic resonance imaging.
Liver Diseases
Practical approach in hepatitis B e antigen-negative individuals to identify treatment candidates.
Liver Diseases
Pre-existing Liver Diseases and On-Admission Liver-Related Laboratory Tests in COVID-19: A Prognostic Accuracy Meta-Analysis With Systematic Review.
Liver Diseases
Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score.
Liver Diseases
Predicting utility of a model for end stage liver disease in alcoholic liver disease.
Liver Diseases
Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
Liver Diseases
Predictive value of elevated alanine aminotransferase for in-hospital mortality in patients with acute myocardial infarction.
Liver Diseases
Predictive Values of Serum Uric Acid and Alanine-aminotransferase for Fatty Liver Index in Montenegrin Population.
Liver Diseases
Predictive values of various liver function tests with respect to the diagnosis of liver disease.
Liver Diseases
Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients.
Liver Diseases
Predictors of fifty days in-hospital mortality in patients with culture negative neutrocytic ascites.
Liver Diseases
Predictors of GBV-C infection among patients referred for renal transplantation.
Liver Diseases
Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese Children.
Liver Diseases
Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
Liver Diseases
Prevalence and Impact of Reformed and De Novo Anti-HLA Donor-Specific Antibodies in Liver Transplantation.
Liver Diseases
Prevalence and risk factors of elevated alanine aminotransferase among Korean adolescents: 2001-2014.
Liver Diseases
Prevalence and Risk Factors of Elevated Liver Enzymes in Japanese Women With Polycystic Ovary Syndrome.
Liver Diseases
Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population.
Liver Diseases
Prevalence of amiodarone-related hepatotoxicity in 720 Chinese patients with or without baseline liver dysfunction.
Liver Diseases
Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.
Liver Diseases
Prevalence of Elevated Alanine Aminotransferase by Diagnostic Criterion, Age, and Gender among Adolescents.
Liver Diseases
Prevalence of increased transaminases and its association with sex, age, and metabolic parameters in children and adolescents with obesity - a nationwide cross-sectional cohort study.
Liver Diseases
Prevalence, Risk Factors and In-hospital Outcomes of QTc Interval Prolongation in Liver Cirrhosis.
Liver Diseases
Pro-C5, a marker of true type V collagen formation and fibrillation, correlates with portal hypertension in patients with alcoholic cirrhosis.
Liver Diseases
Probing alanine transaminase catalysis with hyperpolarized (13)CD(3)-pyruvate.
Liver Diseases
Profiling Neutrophil-to-Lymphocyte Ratio Changes in Response to Nucleoside Analog Therapy for Chronic Hepatitis B Infection.
Liver Diseases
Prognostic Significance of End-Stage Liver Diseases, Respiratory Tract Infection, and Chronic Kidney Diseases in Symptomatic Acute Hepatitis E.
Liver Diseases
Prospective association of liver function biomarkers with development of hepatobiliary cancers.
Liver Diseases
Protective effect of aminoguanidine against lipopolysaccharide-induced hepatotoxicity and liver dysfunction in rat.
Liver Diseases
Protective effects of extracts of Schisandra chinensis stems against acetaminophen-induced hepatotoxicity via regulation of MAPK and caspase-3 signaling pathways.
Liver Diseases
Protective effects of paclitaxel on thioacetamide-induced liver fibrosis in a rat model.
Liver Diseases
Protein Tyrosine Phosphatase Nonreceptor Type 2 Expression Does Not Correlate with Viral Load or Response to Direct-Acting Antiviral Therapy in Hepatitis C Virus Infections-Infected Patients.
Liver Diseases
Quantitation of alcohol dehydrogenase in human tissue and serum by an enzyme-linked immunosorbent assay (ELISA).
Liver Diseases
Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience.
Liver Diseases
Recovery from liver dysfunction after adult isolated intestinal transplantation without liver grafting.
Liver Diseases
Reduction in risk of hepatitis transmission by heat-treatment of a human Factor VIII concentrate.
Liver Diseases
Reference Intervals of Fibrosis Index Based on Four Indicators in Healthy Elderly Chinese.
Liver Diseases
Relation between alanine aminotransferase concentrations and visceral fat accumulation among nondiabetic overweight Korean women.
Liver Diseases
Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease.
Liver Diseases
Relationship between body mass index and alanine aminotransferase concentration in non-diabetic Korean adults.
Liver Diseases
Relationship Between Hepatic Steatosis and the Elevation of Aminotransferases in HBV-Infected Patients With HBe-Antigen Negativity and a Low Viral Load.
Liver Diseases
Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B.
Liver Diseases
Relationship of liver enzymes to insulin sensitivity and intra-abdominal fat.
Liver Diseases
Relationships Between Alanine Aminotransferase, Serum Triglycerides, Body Mass Index and Nonalcoholic Fatty Liver Disease in an Outpatient Pediatric Clinic Population.
Liver Diseases
Relationships between hepatitis B infection status and liver dysfunction after chemotherapy of lung cancer patients in mainland China.
Liver Diseases
Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus.
Liver Diseases
Restriction of calorie and iron intake results in reduction of visceral fat and serum alanine aminotransferase and ferritin levels in patients with chronic liver disease.
Liver Diseases
Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection.
Liver Diseases
Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity.
Liver Diseases
Revision of serum ALT upper limits of normal facilitates assessment of mild liver injury in obese children with non-alcoholic fatty liver disease.
Liver Diseases
Risk Assessment of Hepatocellular Carcinoma in General Population by Liver Stiffness in Combination with Controlled Attenuation Parameter using Transient Elastography: A Cross Sectional Study.
Liver Diseases
Risk factors for Acetaminophen-induced liver injury: A Single-center study from Japan.
Liver Diseases
Risk factors for aneurysmal subarachnoid hemorrhage in patients in Izumo City, Japan.
Liver Diseases
Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004.
Liver Diseases
Risk factors for primary intracerebral hemorrhage in patients in Izumo City, Japan.
Liver Diseases
Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile.
Liver Diseases
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
Liver Diseases
Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer.
Liver Diseases
SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease.
Liver Diseases
SARS-CoV nucleocapsid protein interacts with cellular pyruvate kinase protein and inhibits its activity.
Liver Diseases
SCO-792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice.
Liver Diseases
Screening for elevated risk of liver disease in preschool children (aged 2-5?years) being seen for obesity management.
Liver Diseases
Sensitivity and Specificity of Plasma ALT, ALP, and Bile Acids for Hepatitis in Labrador Retrievers.
Liver Diseases
Serologic and virologic profiles of hepatitis C infection in renal transplant candidates. New England Organ Bank Hepatitis C Study Group.
Liver Diseases
Seroprevalence of hepatitis delta virus infection among subjects with underlying hepatic diseases in Chennai, southern India.
Liver Diseases
Serum alanine aminotransferase has limited predictive value for liver disease in chronic hepatitis C.
Liver Diseases
Serum alanine aminotransferase independently correlates with intrahepatic triglyceride contents in obese subjects.
Liver Diseases
Serum alanine aminotransferase predicts interventricular septum thickness and left ventricular mass in patients with nonalcoholic fatty liver disease.
Liver Diseases
Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014.
Liver Diseases
Serum Alanine Transaminase Is an Inadequate Nonalcoholic Fatty Liver Screening Test in Adolescents: Results From the National Health and Nutrition Examination Survey 2017-2018.
Liver Diseases
Serum Alanine Transaminase Total Bilirubin Concentrations Predict CYP3A Activity as Measured by Midazolam and 1'-Hydroxylation.
Liver Diseases
Serum aminotransferase activity and mortality risk in a United States community.
Liver Diseases
Serum beta2-microglobulin levels in hepatitis B e antigen-negative chronic hepatitis B patients under long term lamivudine monotherapy: relationship with virological breakthrough.
Liver Diseases
Serum concentration and localization in tumor cells of proteasomes in patients with hematologic malignancy and their pathophysiologic significance.
Liver Diseases
Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels.
Liver Diseases
Serum glycated albumin levels, but not glycated hemoglobin, is low in relation to glycemia in non-diabetic men with nonalcoholic fatty liver disease with high alanine aminotransferase levels.
Liver Diseases
Serum hepatitis C virus (HCV) RNA: a reliable tool for evaluating HCV-related liver disease in anti-HCV-positive blood donors with persistently normal alanine aminotransferase values.
Liver Diseases
Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4.
Liver Diseases
Serum molybdenum concentration in healthy Japanese adults determined by inductively coupled plasma-mass spectrometry.
Liver Diseases
Serum soluble CD40 is associated with liver injury in patients with chronic hepatitis B.
Liver Diseases
Serum testosterone and non-alcoholic fatty liver disease in men and women in the US.
Liver Diseases
Serum thymosin beta4 levels in patients with hepatitis B virus-related liver failure.
Liver Diseases
Serum vascular endothelial cadherin and thrombomodulin are markers of non-alcoholic fatty liver disease in children.
Liver Diseases
Sex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathway.
Liver Diseases
SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob-/- mice.
Liver Diseases
Short-term monotherapy with IDX184, a liver-targeted nucleotide polymerase inhibitor, in patients with chronic hepatitis C virus infection.
Liver Diseases
Significance of sublobular hepatic necrosis in the progression of chronic hepatitis C.
Liver Diseases
Significant effects of late evening snack on liver functions in patients with liver cirrhosis: A meta-analysis of randomized controlled trials.
Liver Diseases
Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue.
Liver Diseases
Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore.
Liver Diseases
Simple Resistance Exercise for 24 Weeks Decreases Alanine Aminotransferase Levels in Patients with Non-Alcoholic Fatty Liver Disease.
Liver Diseases
Sinapic acid ameliorates D-galactosamine/lipopolysaccharide-induced fulminant hepatitis in rats: Role of nuclear factor erythroid-related factor 2/heme oxygenase-1 pathways.
Liver Diseases
Single and simultaneous effects of acrylamide and ethanol on bone microstructure of mice after one remodeling cycle.
Liver Diseases
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
Liver Diseases
Sleeve Gastrectomy Is Associated with a Greater Reduction in Plasma Liver Enzymes Than Bypass Surgeries-A Registry-Based Two-Year Follow-Up Analysis.
Liver Diseases
Soy diet for nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials.
Liver Diseases
Spontaneous reactivation of hepatitis B virus replication in HBsAg carriers who seroconverted from HBeAg to anti-HBe.
Liver Diseases
Studies on anti-LP-1 and anti-Tamm-Horsfall glycoprotein in chronic liver disease using ADCC assay against antigen-coated target cells.
Liver Diseases
Study of serum argininosuccinate lyase determination for diagnosis of liver diseases.
Liver Diseases
Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts.
Liver Diseases
Superinfection of TT virus and hepatitis C virus among chronic haemodialysis patients.
Liver Diseases
Supplementation of antioxidants prevents oxidative stress during a deep saturation dive.
Liver Diseases
Suppression of elevated alanine aminotransferase activity in liver disease by vigabatrin.
Liver Diseases
Survival effects of physical activity on mortality among persons with liver disease.
Liver Diseases
The alanine aminotransferase to triglycerides ratio as a marker to identify nonalcoholic fatty liver disease.
Liver Diseases
The apoenzyme of aspartate aminotransferase and alanine aminotransferase in the serum of healthy persons and patients suffering from liver diseases.
Liver Diseases
The association between dietary lifestyles and hepatocellular injury in Japanese workers.
Liver Diseases
The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
Liver Diseases
The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels.
Liver Diseases
The association of early unexplained elevated alanine aminotransferase with large-for-gestational-age birthweight.
Liver Diseases
The association of lipid metabolism and non-alcoholic fatty liver disease in children with obesity.
Liver Diseases
The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
Liver Diseases
The association of non-alcoholic fatty liver disease with lung function: A survey design analysis using propensity score.
Liver Diseases
The association of obstructive sleep apnea with dyslipidemia in Korean children and adolescents: a single-center, cross-sectional study.
Liver Diseases
The association of vitamin D deficiency with non-alcoholic fatty liver disease.
Liver Diseases
The change in prevalence of suspected non-alcoholic fatty liver disease in Korean adolescents from 2001 to 2017.
Liver Diseases
The effect of early virological response in health-related quality of life in HCV-infected patients.
Liver Diseases
The effect of metformin on aminotransferase levels, metabolic parameters and body mass index in nonalcoholic fatty liver disease patients: a meta-analysis.
Liver Diseases
The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-on-chronic liver failure.
Liver Diseases
The effect of the spanish ketogenic mediterranean diet on nonalcoholic Fatty liver disease: a pilot study.
Liver Diseases
The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group.
Liver Diseases
The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.
Liver Diseases
The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis.
Liver Diseases
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
Liver Diseases
The glycated albumin to glycated haemoglobin ratio increases along with the fibrosis stage in non-alcoholic steatohepatitis.
Liver Diseases
The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD).
Liver Diseases
The lipid accumulation product is highly related to serum alanine aminotransferase level in male adults.
Liver Diseases
The mechanism of release of hepatic enzymes in various liver diseases. II. Altered activity ratios of GOT to GPT in serum and liver of patients with liver diseases.
Liver Diseases
The mechanism of the release of hepatic enzymes in various liver diseases. 1. Alterations in cytoplasmic and mitochondrial enzyme activities in serum.
Liver Diseases
The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders.
Liver Diseases
The prevalence and correlates of T-wave inversion in lead III in non-obese men.
Liver Diseases
The relationship between 25-hydroxyvitamin D concentration and liver enzymes in overweight or obese adults: Cross-sectional and interventional outcomes.
Liver Diseases
The Relationship Between Serum Uric Acid Levels and The Major Risk Factors for The Development of Non-Alcoholic Fatty Liver Disease.
Liver Diseases
The Relative Risk of Immune-Related Liver Dysfunction of PD-1/PD-L1 Inhibitors Versus Chemotherapy in Solid Tumors: A Meta-Analysis of Randomized Controlled Trials.
Liver Diseases
The role of bilio-pancreatic limb in nonalcoholic steatohepatitis improvement after duodenal-jejunal bypass in rats.
Liver Diseases
The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Liver Diseases
The roles of ATF3 in liver dysfunction and the regulation of phosphoenolpyruvate carboxykinase gene expression.
Liver Diseases
The selective PPAR-delta agonist seladelpar reduces ethanol-induced liver disease by restoring gut barrier function and bile acid homeostasis in mice.
Liver Diseases
The Serum Gamma Glutamyl Transpeptidase - A Non invasive Diagnostic Bio Marker of Chronic Anicteric Non Alcoholic Liver Diseases.
Liver Diseases
The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects.
Liver Diseases
The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
Liver Diseases
The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment.
Liver Diseases
Therapeutic effect and safety of stem cell therapy for chronic liver disease: a systematic review and meta-analysis of randomized controlled trials.
Liver Diseases
Therapeutic Effects of Plasmapheresis on Acute Exacerbations of Chronic Hepatitis B Infection.
Liver Diseases
There's More under the Nonalcoholic Fatty Liver Disease Umbrella Than an Elevated Alanine Aminotransferase Level.
Liver Diseases
Tissue Hypoperfusion, Hypercoagulopathy, and Kidney and Liver Dysfunction after Ingestion of a Naphazoline-Containing Antiseptic.
Liver Diseases
Trace and non-trace elements in blood cells of bottlenose dolphins (Tursiops truncatus): variations with values from liver function indicators.
Liver Diseases
TRANSIENT ELASTOGRAPHIC EVALUATION IN ADULT SUBJECTS WITHOUT OVERT LIVER DISEASE: INFLUENCE OF ALANINE AMINOTRANSFERASE LEVELS.
Liver Diseases
Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus.
Liver Diseases
Transplantation of autologous mesenchymal stem cells for end-stage liver cirrhosis: a meta-analysis based on seven controlled trials.
Liver Diseases
Triglycerides and alanine aminotransferase as screening markers for suspected fatty liver disease in obese children and adolescents.
Liver Diseases
Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation in Hepatitis B Virus Related Acute-on-Chronic Liver Failure Treated with Plasma Exchange and Entecavir: a 24-Month Prospective Study.
Liver Diseases
Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).
Liver Diseases
Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects.
Liver Diseases
Upper limit of normal serum alanine aminotransferase levels in Japanese subjects.
Liver Diseases
Upper limits of normal for alanine aminotransferase activity in the United States population.
Liver Diseases
Upper limits of normal for serum alanine aminotransferase levels in chinese han population.
Liver Diseases
Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease.
Liver Diseases
Upper Reference Limits for Aminotransferase Activities and the Prevalence of Elevated Aminotransferase Activities in a Korean Population.
Liver Diseases
Urinary assays for desmosine and hydroxylysylpyridinoline in the detection of cirrhosis.
Liver Diseases
Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review.
Liver Diseases
Use of Lactulose to Treat Hyperammonemia in ICU Patients Without Chronic Liver Disease or Significant Hepatocellular Injury.
Liver Diseases
Utility of ALT Concentration in Men and Women with Nonalcoholic Fatty Liver Disease: Cohort Study.
Liver Diseases
Variant in CD209 promoter is associated with severity of liver disease in chronic hepatitis C virus infection.
Liver Diseases
Variceal bleeding has increased mortality compared to nonvariceal bleeding only in males.
Liver Diseases
Venocclusive disease of the liver after allogeneic bone marrow transplantation in man.
Liver Diseases
Viral clearance in HCV viraemic patients with normal alanine aminotransferase after combination therapy: a controlled, open-labelled study.
Liver Diseases
Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis.
Liver Diseases
Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury.
Liver Diseases
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.
Liver Diseases
Yield of diagnostic tests in obese children with an elevated alanine aminotransferase.
Liver Diseases
Zinc finger protein Zbtb20 is essential for postnatal survival and glucose homeostasis.
Liver Diseases
[Alanine aminotransferase normalization with antiviral therapies in hepatitis B].
Liver Diseases
[Amantadine-HCL in the treatment of chronic hepatitis C in non-responders to alpha-interferon. Effect on ALT serum levels and viral load]
Liver Diseases
[Anti-HCV in patients without risk factors for hepatitis C. Prospective study in 200 patients]
Liver Diseases
[Application and efficacy of adefovir dipivoxil in hepatitis B virus-associated chronic liver diseases]
Liver Diseases
[Assessment of high sensitivity C-reactive protein (HS-CRP) as a marker of liver inflammation in patients with metabolic syndrome]
Liver Diseases
[Behavior of ornithine-carbamoyl transferase, glutamic-oxaloacetic transaminase and glutamic-pyruvic transaminase in the serum in non-infectious acute liver diseases]
Liver Diseases
[Children can present with liver disease without elevation of liver-specific enzymes].
Liver Diseases
[Chronic liver disease increases with damage to intestinal barrier function].
Liver Diseases
[Clinical immunological features and interferon therapy in chronic hepatitis C]
Liver Diseases
[Correlation analysis between ICG-R15 and modified Scheuer score in liver tissues of patients with hepatitis B e antigen-positive/negative chronic hepatitis B].
Liver Diseases
[Correlation between interleukin-6 single nucleotide polymorphism and the occurrence and prognosis of hepatitis B virus-associated acute-on-chronic liver failure].
Liver Diseases
[Fat distribution and its relationship with genetic polymorphism in patients with nonalcoholic liver disease].
Liver Diseases
[New reference interval for ALAT does not identify subclinical liver disease. Lower limit than the proposed should be used for medical considerations!]
Liver Diseases
[On the influence of surgery on the biliary system, especially in liver diseases, on the serum level of the enzymes sorbitol dehydrogenase, glutamic-pyruvic transaminase, lactate dehydrogenase and glutamic dehydrogenase.]
Liver Diseases
[Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population].
Liver Diseases
[Prevalence of hepatitis A, B, C and E virus markers among patients with elevated levels of Alanine aminotransferase and Aspartate aminotransferase in Phnom Penh (Cambodia) and Nha Trang (Central Vietnam)]
Liver Diseases
[Prevalence of non-alcoholic fatty liver disease in a population with elevated transaminases and level of accuracy of the diagnosis in Primary Care].
Liver Diseases
[Results of annual health examination for the aged provided by the law that are predictive of increased mortality risk]
Liver Diseases
[Serum levels of alanine aminotransferase in Chilean population: analysis of results of the national health survey 2009-2010].
Liver Diseases
[The efficacy of hepatotropic agent Remaxol in oncological patients with postoperative liver dysfunction].
Liver Diseases
[The relationship between serum adiponectin level and serum alanine aminotransferase elevation in korean male with nonalcoholic fatty liver disease]
Liver Diseases
[The Sellek-Frade copper acetate test and glutamic-oxalacetic and glutamic-pyruvic transaminase activity in the sera of children with liver disease.]
Liver Diseases
[The significance of TT virus detection in persons with elevated alanine aminotransferase during routine medical check up and patients with liver diseases]
Liver Diseases
[Value of the determination of serum glutamic-oxalacetic transaminase and serum glutamic-pyruvic transaminase in the diagnosis of myocardial infarct and liver disease.]
Liver Diseases, Alcoholic
AMPK protects against alcohol-induced liver injury through UQCRC2 to up-regulate mitophagy.
Liver Diseases, Alcoholic
Expansion of Granulocytic, Myeloid-Derived Suppressor Cells in Response to Ethanol-Induced Acute Liver Damage.
Liver Diseases, Alcoholic
Hepatocyte and nuclear areas and fatty infiltration of the liver in chronic alcoholic liver disease.
Liver Diseases, Alcoholic
High aspartate to alanine aminotransferase ratio is an indicator of cirrhosis and poor outcome in patients with primary sclerosing cholangitis.
Liver Diseases, Alcoholic
IgA against gut-derived endotoxins: does it contribute to suppression of hepatic inflammation in alcohol-induced liver disease?
Liver Diseases, Alcoholic
Increased Prevalence of Obesity and Metabolic Syndrome in Patients with Alcoholic Fatty Liver Disease.
Liver Diseases, Alcoholic
Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic.
Liver Diseases, Alcoholic
Inverse relationship between fasting direct bilirubin and metabolic syndrome in Korean adults.
Liver Diseases, Alcoholic
Motion - all patients with NASH need to have a liver biopsy: arguments for the motion.
Liver Diseases, Alcoholic
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Liver Diseases, Alcoholic
Prevalence and heterogeneity of serum DNA polymerase activity in patients with non-A, non-B hepatitis and HBsAg-negative blood donors with elevated SGPT.
Liver Diseases, Alcoholic
Secondary metabolites of petri-dish cultured Antrodia camphorata and their hepatoprotective activities against alcohol-induced liver injury in mice.
Liver Diseases, Alcoholic
Serum aspartate aminotransferase to alanine aminotransferase ratio in human and experimental alcoholic liver disease: relationship to histologic changes.
Liver Diseases, Alcoholic
Serum level of ornithine carbamoyltransferase is influenced by the state of Kupffer cells.
Liver Diseases, Alcoholic
The ratio of aspartate aminotransferase to alanine aminotransferase (AST/ALT): the correlation of value with underlying severity of alcoholic liver disease.
Liver Diseases, Alcoholic
The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
Liver Failure
A mouse model of subacute liver failure with ascites induced by step-wise increased doses of (-)-epigallocatechin-3-gallate.
Liver Failure
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B.
Liver Failure
A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma.
Liver Failure
Adverse event profile of tigecycline: data mining of the public version of the U.S. Food and Drug Administration adverse event reporting system.
Liver Failure
Allogeneic bone marrow transplantation from HBsAg+ donors: a multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Liver Failure
Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference.
Liver Failure
ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
Liver Failure
Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
Liver Failure
Effects of intraperitoneal injection of magnetic graphene oxide on the improvement of acute liver injury induced by CCl4.
Liver Failure
Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis.
Liver Failure
Evolution of the hepatitis B virus gene during chronic infection in seven patients.
Liver Failure
HBV reactivation in allogeneic stem cell transplant recipients: Risk factors, outcome, and role of hepatitis B virus mutations.
Liver Failure
Hepatic failure leads to lethality of chlordecone-amplified hepatotoxicity of carbon tetrachloride.
Liver Failure
Hepatitis A-induced diabetes mellitus, acute renal failure, and liver failure.
Liver Failure
Hepatitis B Virus Reactivation in the Setting of Immunosuppressive Drug Therapy.
Liver Failure
Herpes simplex virus hepatitis in pregnancy: a clinicopathologic study of three cases.
Liver Failure
Macrophage populations and apoptotic cells in the liver before spontaneous hepatitis in Long-Evans Cinnamon (LEC) rats.
Liver Failure
Occurrence and management of hepatitis B virus reactivation following kidney transplantation.
Liver Failure
Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events.
Liver Failure
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
Liver Failure
Protective effects of oxymatrine against lipopolysaccharide/D?galactosamine?induced acute liver failure through oxidative damage, via activation of Nrf2/HO?1 and modulation of inflammatory TLR4?signaling pathways.
Liver Failure
Recommendation to Exclude Bile-Duct-Cannulated Rats with Hyperbilirubinemia for Proper Conduct of Biliary Drug Excretion Studies.
Liver Failure
Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals.
Liver Failure
Restriction of non-opioid analgesics sold over-the-counter in Denmark: A national study of impact on poisonings.
Liver Failure
Role of recombinant human erythropoietin against mitomycin C-induced cardiac, hepatic and renal dysfunction in Wistar rats.
Liver Failure
Silica Magnetic Graphene Oxide Improves the Effects of Stem Cell-Conditioned Medium on Acute Liver Failure.
Liver Failure
The protective effect of recombinant human erythropoietin against cisplatin-induced renal and hepatic dysfunctions in Wistar rats.
Liver Failure
Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children.
Liver Failure
Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
Liver Failure
[Hepatitis caused by tick-borne meningoencephalitis virus (TBEV)--a rare clinical manifestation outside the central nervous system involvement]
Liver Failure
[Race of experimental animals and development of renal failure in animal model of hepatorenal syndrome]
Liver Failure
[Two steps liver resection with right portal vein ligation for two giant hemangiomas of the left and right lobes]
Liver Failure, Acute
A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents.
Liver Failure, Acute
A rare case of Reye's syndrome induced by influenza A virus with use of ibuprofen in an adult.
Liver Failure, Acute
Acute Hepatitis C in an HIV-Infected patient: A Case Report and Review of Literature.
Liver Failure, Acute
Acute liver failure in an antimitochondrial antibody-positive 63-year-old man.
Liver Failure, Acute
Acute lymphoblastic leukemia in an adolescent presenting with acute hepatic failure: A case report.
Liver Failure, Acute
Acute respiratory failure in adult patients with dengue virus infection.
Liver Failure, Acute
Berberine protects acute liver failure in mice through inhibiting inflammation and mitochondria-dependent apoptosis.
Liver Failure, Acute
Characteristics and Outcomes of Acetaminophen Overdose and Hepatotoxicity in Thailand.
Liver Failure, Acute
Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure.
Liver Failure, Acute
Crizotinib-induced acute fatal liver failure in an Asian ALK-positive lung adenocarcinoma patient with liver metastasis: A case report.
Liver Failure, Acute
Effects of intraperitoneal injection of magnetic graphene oxide on the improvement of acute liver injury induced by CCl4.
Liver Failure, Acute
Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom.
Liver Failure, Acute
Fulminant hepatic failure caused by ecarazine hydrochloride (a hydralazine derivative).
Liver Failure, Acute
Fulminant Wilson's disease in children: appraisal of a critical diagnosis.
Liver Failure, Acute
Genotype-confirmed alanine aminotransferase deficiency in a Chinese patient with acute liver failure: a potential diagnostic pitfall.
Liver Failure, Acute
Hepatic Failure in a Patient Receiving Itraconazole for Pulmonary Histoplasmosis-Case Report and Literature Review.
Liver Failure, Acute
Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury.
Liver Failure, Acute
Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure.
Liver Failure, Acute
Licochalcone A Upregulates Nrf2 Antioxidant Pathway and Thereby Alleviates Acetaminophen-Induced Hepatotoxicity.
Liver Failure, Acute
Network pharmacology based investigation into the bioactive compounds and molecular mechanisms of Schisandrae Chinensis Fructus against drug-induced liver injury.
Liver Failure, Acute
Pre-existing Liver Diseases and On-Admission Liver-Related Laboratory Tests in COVID-19: A Prognostic Accuracy Meta-Analysis With Systematic Review.
Liver Failure, Acute
Prognostic factors for fatal outcomes prior to receiving liver transplantation in patients with non-acetaminophen-related fulminant hepatic failure.
Liver Failure, Acute
Salvianolic Acid C against Acetaminophen-Induced Acute Liver Injury by Attenuating Inflammation, Oxidative Stress, and Apoptosis through Inhibition of the Keap1/Nrf2/HO-1 Signaling.
Liver Failure, Acute
Severe de novo Hepatitis B Recovered from Late-Onset Liver Insufficiency with Prolonged Ascites and Hypoalbuminemia due to Hepatitis B Virus Genotype Bj with Precore Mutation.
Liver Failure, Acute
Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection.
Liver Failure, Acute
Transplantation of human thioredoxin gene-modified hepatocytes for treatment of acute liver failure in rat model.
Liver Failure, Acute
[Fulminant liver failure after administration of the herbal antidepressant Kava-Kava]
Liver Neoplasms
25-OH-vitamin D deficiency identifies poor tumor response in hepatocellular carcinoma treated with transarterial chemoembolization.
Liver Neoplasms
A novel scoring model for predicting mortality risk in patients with cirrhosis and hepatorenal syndrome.
Liver Neoplasms
A Predictive Formula for Portal Venous Pressure Prior to Liver Resection Using Directly Measured Values.
Liver Neoplasms
Aspartate aminotransferase-to-platelet ratio index predicts prognosis of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization.
Liver Neoplasms
Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization.
Liver Neoplasms
Changes in seroprevalence of hepatitis B surface antigen and epidemiologic characteristics in the Republic of Korea, 1998-2013.
Liver Neoplasms
Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy.
Liver Neoplasms
Dietary Broccoli Lessens Development of Fatty Liver and Liver Cancer in Mice Given Diethylnitrosamine and Fed a Western or Control Diet.
Liver Neoplasms
Fine Particle Pollution, Alanine Transaminase, and Liver Cancer: A Taiwanese Prospective Cohort Study (REVEAL-HBV).
Liver Neoplasms
Fufang Banmao Capsule, a Traditional Chinese Medicinal Formulation, Enhances the Survival of Patients with Hepatocellular Carcinoma and Vp3-4 Portal Vein Tumor Thrombosis Undergoing Supportive Treatment.
Liver Neoplasms
High Levels of TRIM14 Are Associated with Poor Prognosis in Hepatocellular Carcinoma.
Liver Neoplasms
Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy.
Liver Neoplasms
Potential chemoprevention of diethylnitrosamine-initiated and 2-acetylaminofluorene-promoted hepatocarcinogenesis by zerumbone from the rhizomes of the subtropical ginger (Zingiber zerumbet).
Liver Neoplasms
Potential chemoprevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by polyphenolics from Acacia nilotica bark.
Liver Neoplasms
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Liver Neoplasms
Preoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma.
Liver Neoplasms
Prognostic association of demographic and clinical factors with the change rates of symptoms and depression among patients with hepatocellular carcinoma.
Liver Neoplasms
RE: Fine Particle Pollution, Alanine Transaminase, and Liver Cancer: A Taiwanese Prospective Cohort Study (REVEAL-HBV).
Liver Neoplasms
Relationship Between Serum Tumor-related Markers and Dietary Intakes in Korean Healthy Adults.
Liver Neoplasms
Total cholesterol, alanine aminotransferase and the risk of primary liver cancer: A population-based prospective study.
Lung Diseases, Interstitial
Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing.
Lung Diseases, Interstitial
Induction of interstitial pneumonitis during interferon treatment for chronic hepatitis C.
Lung Diseases, Interstitial
Questions and Answers on Smoking in Patients With Diffuse ILD. Use of PICO Methodology.
Lung Injury
HAT inhibitor, garcinol, exacerbates lipopolysaccharide?induced inflammation in vitro and in vivo.
Lung Injury
Ischemia and reperfusion increases susceptibility to ventilator-induced lung injury in rats.
Lung Injury
Kupffer cell phagocytosis blockade decreases morbidity in endotoxemic rats with obstructive jaundice.
Lung Injury
[Organ-protective effect of continuous renal replacement therapy in a patient with severe polymyositis and dermatomyositis].
Lung Neoplasms
Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing.
Lung Neoplasms
Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits.
Lung Neoplasms
Levels of serum bilirubin in small cell lung cancer and non-small cell lung cancer patients.
Lung Neoplasms
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ?50%: real-world data.
Lung Neoplasms
Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer.
Lupus Erythematosus, Systemic
Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine.
Lupus Erythematosus, Systemic
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Lymphadenopathy
Adult Kawasaki's disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels.
Lymphadenopathy
Clinical aspects of splenomegaly as a possible predictive factor of coronary artery changes in Kawasaki disease.
Lymphadenopathy
Evaluation of predictor variables of diagnostic [18F] FDG-PET/CT in fever of unknown origin.
Lymphadenopathy
Hepato-splenic lymphoma: a rare entity mimicking acute hepatitis: a case report.
Lymphadenopathy
The difference in clinical characteristics between acute Q fever and scrub typhus in southern Taiwan.
Lymphatic Metastasis
miR-942 promotes proliferation and metastasis of hepatocellular carcinoma cells by inhibiting RRM2B.
Lymphatic Metastasis
Prognostic-factors-based risk-stratification model for invasive urothelial carcinoma of the urinary bladder in Taiwan.
Lymphocytosis
Clinical and histological features of cytomegalovirus hepatitis in previously healthy adults.
Lymphocytosis
Clinical characteristics and laboratory findings in Danish children hospitalized with primary Epstein-Barr virus infection.
Lymphocytosis
Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection.
Lymphocytosis
Epstein-Barr virus-associated infectious mononucleosis and risk factor analysis for complications in hospitalized children.
Lymphocytosis
Serologic and molecular evaluation of Leishmania infantum in cats from Central Spain.
Lymphocytosis
The Indian langur: preliminary report of a new nonhuman primate host for visceral leishmaniasis.
Lymphocytosis
[Behavior of some leukocytic enzymes (glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, alkaline phosphatases) in subjects of pediatric age with absolute lymphocytosis and neutrophilia.]
Lymphocytosis
[Epstein-Barr virus and cytomegalovirus primary infections: A comparative study in 52 immunocompetent adults.]
Lymphogranuloma Venereum
Sustained alanine aminotransferase increase during hepatitis A due to concomitant lymphogranuloma venereum infection in an HIV-1 positive patient.
Lymphoma
Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity.
Lymphoma
Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing.
Lymphoma
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ?50%: real-world data.
Lymphoma
Protective efficacy of thymoquinone or ebselen separately against arsenic-induced hepatotoxicity in rat.
Lymphoma, B-Cell
Protection afforded by pre- or post-treatment with 4-phenylbutyrate against liver injury induced by acetaminophen overdose in mice.
Lymphoma, Non-Hodgkin
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C.
Lymphoma, Non-Hodgkin
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Lymphopenia
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers.
Lymphopenia
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.
Lymphopenia
An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma.
Lymphopenia
Candidatus Rickettsia tarasevichiae Infection in Eastern Central China: A Case Series.
Lymphopenia
Children hospitalized with severe acute respiratory syndrome-related illness in Toronto.
Lymphopenia
Clinical and immunological characteristics of human infections with H5N6 avian influenza virus.
Lymphopenia
Clinical and immunological features of severe and moderate coronavirus disease 2019.
Lymphopenia
Clinical and laboratory features in the early stage of severe acute respiratory syndrome.
Lymphopenia
Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever.
Lymphopenia
Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta-analysis.
Lymphopenia
Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses.
Lymphopenia
Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in Wave Five: Clinical and virological findings.
Lymphopenia
Dose-escalation study of tabalumab with bortezomib and dexamethasone in Japanese patients with multiple myeloma.
Lymphopenia
E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma: A phase I study.
Lymphopenia
Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) in China: an integrated data analysis.
Lymphopenia
Gastrointestinal Infection is the Risk Factor for COVID-19 Inpatients with Assisted Ventilation.
Lymphopenia
Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation.
Lymphopenia
Hypoglycemia and seizures associated with canine primary hepatic neuroendocrine carcinoma.
Lymphopenia
Molecular evidence and hematological alterations associated with the occurrence of coronavirus in domestic dogs in Pakistan.
Lymphopenia
Pandemic 2009 influenza A (H1N1)-associated deaths among children in China: A retrospective analysis.
Lymphopenia
Pathology of Experimental Aerosol Zaire Ebolavirus Infection in Rhesus Macaques.
Lymphopenia
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
Lymphopenia
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
Lymphopenia
Predictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study.
Lymphopenia
Profiling of dihydroorotate dehydrogenase, p38, and JAK inhibitors in the rat adjuvant-induced arthritis model: a translational study.
Lymphopenia
Restoration of immunity and reactivation of hepatitis B virus after immunosuppressive therapy in a patient with severe aplastic anaemia.
Lymphopenia
Risk factors for the critical illness in SARS-CoV-2 infection: a multicenter retrospective cohort study.
Lymphopenia
Severe acute respiratory distress syndrome (SARS): a critical care perspective.
Lymphopenia
Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong.
Lymphopenia
Short-term laboratory and related safety outcomes for the multiple sclerosis oral disease-modifying therapies: an observational study.
Lymphopenia
Systemic influenza virus H5N1 infection in cats after gastrointestinal exposure.
Lymphopenia
Toxoplasma gondii-like organisms in skin aspirates from a cat with disseminated protozoal infection.
Lymphopenia
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.
Lymphopenia
Utility of Laboratory Test Result Monitoring in Patients Taking Oral Terbinafine or Griseofulvin for Dermatophyte Infections.
Lymphopenia
[Clinical presentation of Ixodes tick-borne borreliosis caused by Borrelia miyamotoi in the context of an immune response to the pathogen].
Macrophage Activation Syndrome
Macrophage activation syndrome as a complication of juvenile rheumatoid arthritis.
Malaria
A controlled human malaria infection model enabling evaluation of transmission-blocking interventions.
Malaria
Clinical and laboratory findings in acute malaria caused by various plasmodium species.
Malaria
Comparative study of C-Reactive Protein and other biochemical parameters in patients with hepatitis B and malaria in Calabar, Nigeria.
Malaria
Does Malaria Co-Infection Alter the Clinical Course in Children Infected with Dengue? Analysis from 623 Indian Children Admitted with Dengue Infection.
Malaria
Factors associated with acute renal failure in falciparum malaria infected patients.
Malaria
Fever after a stay in the tropics: diagnostic predictors of the leading tropical conditions.
Malaria
Glutamate pyruvate transaminase as an indicator of infection with Plasmodium falciparum.
Malaria
Prevalence and laboratory analysis of malaria and dengue co-infection: a systematic review and meta-analysis.
Malaria
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
Malaria
Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial.
Malaria
Short report: elevated levels of alanine aminotransferase and hepatitis A in the context of a pediatric malaria vaccine trial in a village in Mali.
Malaria
[Association between blood test parameters and intensity of Plasmodium falciparum infections in imported falciparum malaria cases in Tianjin City from 2015 to 2019].
Malaria, Avian
Evaluation of serum chemistry values associated with avian malaria infections in African black-footed penguins (Spheniscus demersus).
Malnutrition
Assessment of leptin-to-adiponectin ratio in prediction of insulin resistance and nutrition status in a geriatric female population.
Malnutrition
Effects of nutrition restriction of fat- and lean-line broiler breeder hens during the laying period on offspring performance, blood biochemical parameters, and hormone levels.
Malnutrition
Nutritional status of children with chronic hepatitis B in a population with low socioeconomic status.
Malnutrition
Prognostic factors associated with death from visceral leishmaniasis: a case-control study in Brazil.
Malnutrition
Relation of Aspartate Aminotransferase to Alanine Aminotransferase Ratio to Nutritional Status and Prognosis in Patients With Acute Heart Failure.
Malnutrition
Serum aspartate and alanine aminotransferase activities in protein energy malnutrition.
Massive Hepatic Necrosis
1,8-cineole protects against liver failure in an in-vivo murine model of endotoxemic shock.
Massive Hepatic Necrosis
16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.
Massive Hepatic Necrosis
A new amphiphilic derivative, N-{[4-(lactobionamido)methyl]benzylidene}-1,1-dimethyl-2-(octylsulfanyl)ethylamine N-oxide, has a protective effect against copper-induced fulminant hepatitis in Long-Evans Cinnamon rats at an extremely low concentration compared with its original form alpha-phenyl-N-(tert-butyl) nitrone.
Massive Hepatic Necrosis
A novel prostaglandin E receptor subtype agonist, 0N0-4819, attenuates acute experimental liver injury in rats.
Massive Hepatic Necrosis
Antioxidative and hepatoprotective activities of the ethyl acetate fraction separated from the fruit of Livistona chinensis.
Massive Hepatic Necrosis
Beneficial effect of Cyclosporin A on acute hepatic injury induced by galactosamine and lipopolysaccharide in rats.
Massive Hepatic Necrosis
Complementary laboratory indices for predicting the disease status of patients with hepatitis B virus infection.
Massive Hepatic Necrosis
Detection and viral nucleotide sequence analysis of transfusion-transmitted virus infection in acute fulminant and non-fulminant hepatitis.
Massive Hepatic Necrosis
Fulminant hepatitis following crizotinib administration for ALK-positive non-small-cell lung carcinoma.
Massive Hepatic Necrosis
Hepatitis B Virus Reactivation in the Setting of Immunosuppressive Drug Therapy.
Massive Hepatic Necrosis
Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.
Massive Hepatic Necrosis
Potential use of fucose-appended dendrimer/?-cyclodextrin conjugates as NF-?B decoy carriers for the treatment of lipopolysaccharide-induced fulminant hepatitis in mice.
Massive Hepatic Necrosis
Prevalence, implication, and viral nucleotide sequence analysis of GB virus-C/hepatitis G virus infection in acute fulminant and nonfulminant hepatitis.
Massive Hepatic Necrosis
[Effects of green tea extract on galactosamine-induced hepatic injury in rats]
Mastitis
Clinicobiochemical investigations of gangrenous mastitis in does: immunological responses and oxidative stress biomarkers.
Mastocytoma
Antitumor activity of a novel nucleotide derivative, 5'-(1,2-dipalmitoyl-sn-glycero-3-phospho)-5-fluorouridine (TJ14026) on murine tumors.
Measles
Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group.
Megacolon
Toxicity studies on one-year treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate.
Melanoma
Reduction of liver metastasis of intraocular melanoma by interferon-beta gene transfer.
Melanoma
Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer.
Melanoma
Unique O-methoxyethyl ribose-DNA chimeric oligonucleotide induces an atypical melanoma differentiation-associated gene 5-dependent induction of type I interferon response.
Meningitis
Does antimicrobial usage before meningitis lead to a higher risk of adult postsurgical Acinetobacter baumannii meningitis than that of Enterobacteriaceae meningitis?
Meningoencephalitis
[Glutamic-pyruvic transaminase and glutamic-oxaloacetic transaminase in the cerebrospinal fluid in children with tuberculous encephalomeningitis]
Metabolic Diseases
Accumulation of visceral fat is positively associated with serum ALT and ?-GTP activities in healthy and preclinical middle-aged Japanese men.
Metabolic Diseases
Diagnostic performance of individual characteristics and anthropometric measurements in detecting elevated serum alanine aminotransferase among children and adolescents.
Metabolic Diseases
Self-rated Subjective Health Status Is Strongly Associated with Sociodemographic Factors, Lifestyle, Nutrient Intakes, and Biochemical Indices, but Not Smoking Status: KNHANES 2007-2012.
Metabolic Syndrome
?-glutamyl transpeptidase in men and alanine aminotransferase in women are the most suitable parameters among liver function tests for the prediction of metabolic syndrome in nonviral hepatitis and nonfatty liver in the elderly.
Metabolic Syndrome
A better parameter in predicting insulin resistance: obesity plus elevated alanine aminotransferase.
Metabolic Syndrome
A longitudinal genetic study of uric Acid and liver enzymes in adolescent twins.
Metabolic Syndrome
A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients.
Metabolic Syndrome
Absence of increased liver-related inflammatory markers in type 1 diabetes with metabolic syndrome: a nested case-control study from Brazil.
Metabolic Syndrome
Alanine aminotransferase and gamma-glutamyl transferase are associated with the metabolic syndrome but not with angiographically determined coronary atherosclerosis.
Metabolic Syndrome
Alanine aminotransferase and metabolic syndrome in adolescents: the Korean National Health and Nutrition Examination Survey Study.
Metabolic Syndrome
Alanine aminotransferase and risk of the metabolic syndrome: a linear dose-response relationship.
Metabolic Syndrome
Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn Study.
Metabolic Syndrome
Alanine Aminotransferase and Total Bilirubin Are Synergistically Associated with Metabolic Syndrome Among Middle-Aged and Elderly Japanese Women.
Metabolic Syndrome
Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
Metabolic Syndrome
Alanine aminotransferase is associated with metabolic syndrome independently of insulin resistance.
Metabolic Syndrome
Alanine aminotransferase within reference range is associated with metabolic syndrome in middle-aged and elderly Chinese men and women.
Metabolic Syndrome
Alanine aminotransferase, metabolic syndrome, and cardiovascular disease: a missing link?
Metabolic Syndrome
Aldehyde dehydrogenase 2 and beta3-adrenergic receptor gene polymorphisms: their association with elevated liver enzymes and metabolic syndrome.
Metabolic Syndrome
Aminotransferase activity in morbid and uncomplicated obesity: predictive role of fasting insulin.
Metabolic Syndrome
Aminotransferase levels as a prospective predictor for the development of metabolic syndrome in patients with schizophrenia.
Metabolic Syndrome
Anti-hepatitis C virus seropositivity is not associated with metabolic syndrome irrespective of age, gender and fibrosis.
Metabolic Syndrome
Anti-Obesity and Anti-Adipogenic Effects of Chitosan Oligosaccharide (GO2KA1) in SD Rats and in 3T3-L1 Preadipocytes Models.
Metabolic Syndrome
Assessment of NAFLD cases and its correlation to BMI and metabolic syndrome in healthy blood donors in Kerman.
Metabolic Syndrome
Association among serum ferritin, alanine aminotransferase levels, and metabolic syndrome in Korean postmenopausal women.
Metabolic Syndrome
Association between abnormal liver function and risk factors for metabolic syndrome among freshmen.
Metabolic Syndrome
Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study.
Metabolic Syndrome
Association between hemoglobin glycation index and cardiometabolic risk factors in Korean pediatric nondiabetic population.
Metabolic Syndrome
Association between Serum Liver Enzymes and Metabolic Syndrome in Korean Adults.
Metabolic Syndrome
Association between Serum Uric Acid and Elevated Alanine Aminotransferase in the General Population.
Metabolic Syndrome
Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes.
Metabolic Syndrome
Association of Alanine Aminotransferase and Periodontitis: A Cross-Sectional Analysis-NHANES 2009-2012.
Metabolic Syndrome
Association of Cardiometabolic Risk Factors and Hepatic Enzymes in a National Sample of Iranian Children and Adolescents: The CASPIAN-III Study.
Metabolic Syndrome
Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex-related analysis.
Metabolic Syndrome
Association of liver enzymes with metabolic syndrome and carotid atherosclerosis in young adults. The Cardiovascular Risk in Young Finns Study.
Metabolic Syndrome
Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children.
Metabolic Syndrome
Association of serum alanine aminotransferase and ?-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease.
Metabolic Syndrome
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
Metabolic Syndrome
Bone Marrow Fat Measured by a Chemical Shift-Encoded Sequence (IDEAL-IQ) in Patients With and Without Metabolic Syndrome.
Metabolic Syndrome
Bright liver and alanine aminotransferase are associated with metabolic syndrome in adults.
Metabolic Syndrome
Butyrylcholinesterase: association with the metabolic syndrome and identification of 2 gene loci affecting activity.
Metabolic Syndrome
Care for Adolescents With Polycystic Ovary Syndrome: Development and Prescribing Patterns of a Multidisciplinary Clinic.
Metabolic Syndrome
Change of components of the metabolic syndrome in a workers' health checkup after five years--relation with elevated liver enzymes, gene polymorphisms for ALDH 2, beta3-AR and lifestyle.
Metabolic Syndrome
Characterization of a new animal model of metabolic syndrome: the DahlS.Z-Lepr(fa)/Lepr(fa) rat.
Metabolic Syndrome
Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-? as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH).
Metabolic Syndrome
Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescents.
Metabolic Syndrome
Comparison of alanine aminotransferase, white blood cell count, and uric acid in their association with metabolic syndrome: a study of Korean adults.
Metabolic Syndrome
Comparison of hepatic enzymes between Japanese men with and without metabolic syndrome.
Metabolic Syndrome
Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease.
Metabolic Syndrome
Contribution of Visceral Fat Accumulation and Adiponectin to the Clustering of Metabolic Abnormalities in a Japanese Population.
Metabolic Syndrome
Correlation between normal range of serum alanine aminotransferase level and metabolic syndrome: A community-based study.
Metabolic Syndrome
Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study.
Metabolic Syndrome
Dietary cholesterol induces hepatic inflammation and blunts mitochondrial function in the liver of high-fat-fed mice.
Metabolic Syndrome
Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome.
Metabolic Syndrome
Dose-Response Relationship between Alanine Aminotransferase Levels within the Reference Interval and Metabolic Syndrome in Chinese Adults.
Metabolic Syndrome
Early-onset metabolic syndrome in prepubertal obese children and the possible role of alanine aminotransferase as marker of metabolic syndrome.
Metabolic Syndrome
Eating Fast and Until Full Is Associated with Elevated Alanine Aminotransferase Activity in Japanese Schoolchildren: A Cross-Sectional Study.
Metabolic Syndrome
Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial.
Metabolic Syndrome
Elevated Alanine Aminotransferase in Current National Football League Players: Correlation with Cardiometabolic Syndrome Markers, Obesity, and Insulin Resistance.
Metabolic Syndrome
Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia.
Metabolic Syndrome
Elevated alanine aminotransferase is associated with metabolic syndrome but not consistently associated with impaired fasting glucose or type 2 diabetes mellitus.
Metabolic Syndrome
Elevated alanine aminotransferase is strongly associated with incident metabolic syndrome: a meta-analysis of prospective studies.
Metabolic Syndrome
Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.
Metabolic Syndrome
Elevated Liver Enzymes in Metabolic Syndrome Are Associated With Coronary Stenosis in a Tunisian Population.
Metabolic Syndrome
Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: the bogalusa heart study.
Metabolic Syndrome
Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome.
Metabolic Syndrome
Erratum: Measurement of the Combined Levels of Serum Uric Acid and Alanine Aminotransferase and the Risk of Metabolic Syndrome in a Population Aged 60 Years or More in Northeastern China.
Metabolic Syndrome
Ethnic and Sex Differences in the Association Between Metabolic Syndrome and Suspected Nonalcoholic Fatty Liver Disease in a Nationally Representative Sample of US Adolescents.
Metabolic Syndrome
Exercise training and calorie restriction influence the metabolic parameters in ovariectomized female rats.
Metabolic Syndrome
Factors associated with elevated serum alanine aminotransferase in patients with type 1 diabetes mellitus.
Metabolic Syndrome
Factors Associated with Insulin Resistance in Patients with Chronic HCV Genotype 1 Infection without Obesity or Type 2 Diabetes.
Metabolic Syndrome
Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity.
Metabolic Syndrome
Ferritin level is associated with metabolic syndrome and elevated alanine aminotransferase in children and adolescents.
Metabolic Syndrome
gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men.
Metabolic Syndrome
General Lack of Correlations between Age and Signs of the Metabolic Syndrome in Subjects with Non-diabetic Fasting Glucose Values.
Metabolic Syndrome
Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.
Metabolic Syndrome
Hepatic steatosis in patients with schizophrenia: a clinical cross-sectional study.
Metabolic Syndrome
Hepatitis B e antigen-positive and high levels of alanine aminotransferase are associated with prevalence of metabolic syndrome in chronic HBV patients.
Metabolic Syndrome
High serum alanine aminotransferase is associated with the risk of colorectal adenoma in Korean men.
Metabolic Syndrome
Higher Fetuin-A Level Is Associated with Coexistence of Elevated Alanine Aminotransferase and the Metabolic Syndrome in the General Population.
Metabolic Syndrome
Higher waist-to-height ratio and waist circumference are predictive of metabolic syndrome and elevated serum alanine aminotransferase in adolescents and young adults in mainland China.
Metabolic Syndrome
Hypertension is an important predictor of recurrent colorectal adenoma after screening colonoscopy with adenoma polypectomy.
Metabolic Syndrome
Impact of elevated aspartate and alanine aminotransferase on metabolic syndrome and its components among adult people living in Ningxia, China.
Metabolic Syndrome
Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity.
Metabolic Syndrome
Impact of metabolic syndrome on elevated serum alanine aminotransferase levels in the Japanese population.
Metabolic Syndrome
Increased serum ferritin concentrations and liver enzyme activities in patients with metabolic syndrome.
Metabolic Syndrome
Incremental Predictive Value of Serum AST-to-ALT Ratio for Incident Metabolic Syndrome: The ARIRANG Study.
Metabolic Syndrome
Independent and supra-additive effects of alcohol consumption, cigarette smoking, and metabolic syndrome on the elevation of serum liver enzyme levels.
Metabolic Syndrome
Irritable Bowel Syndrome May Be Associated with Elevated Alanine Aminotransferase and Metabolic Syndrome.
Metabolic Syndrome
Lack of Associations between Elevated Serum Uric Acid and Components of Metabolic Syndrome Such as Hypertension, Dyslipidemia, and T2DM in Overweight and Obese Chinese Adults.
Metabolic Syndrome
Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus.
Metabolic Syndrome
Liver Function Test Changes in Centrally Obese Youth with Metabolic Syndrome in a Serbian Population.
Metabolic Syndrome
Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.
Metabolic Syndrome
Longitudinal Changes in Liver Aminotransferases Predict Metabolic Syndrome in Chinese Patients with Nonviral Hepatitis.
Metabolic Syndrome
Low normal thyroid function attenuates serum alanine aminotransferase elevations in the context of metabolic syndrome and insulin resistance in white people.
Metabolic Syndrome
Measurement of the Combined Levels of Serum Uric Acid and Alanine Aminotransferase and the Risk of Metabolic Syndrome in a Population Aged 60 Years or More in Northeastern China.
Metabolic Syndrome
Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population.
Metabolic Syndrome
Metabolic Syndrome and Serum Liver Enzymes in the General Chinese Population.
Metabolic Syndrome
Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus.
Metabolic Syndrome
Metabolic syndrome predicts the incidence of hepatic steatosis in Koreans.
Metabolic Syndrome
Metabolically healthy overweight adolescents: definition and components.
Metabolic Syndrome
Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study.
Metabolic Syndrome
Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese.
Metabolic Syndrome
Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.
Metabolic Syndrome
Normal limit for serum alanine aminotransferase level and distribution of metabolic factors in old population of kalaleh, iran.
Metabolic Syndrome
Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease in children: A systematic review and meta-analysis of randomized controlled trials.
Metabolic Syndrome
Overweight Is Highly Prevalent In Children with Type 1 Diabetes And Associates with Cardiometabolic Risk.
Metabolic Syndrome
Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study.
Metabolic Syndrome
Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders.
Metabolic Syndrome
Prediction of coronary atherosclerotic disease with liver transaminase level.
Metabolic Syndrome
Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker.
Metabolic Syndrome
Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
Metabolic Syndrome
Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain.
Metabolic Syndrome
Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
Metabolic Syndrome
Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B.
Metabolic Syndrome
Prevalence of elevated alanine transaminase (ALT) in Australia and its relationship to metabolic risk factors: a cross sectional study of 9,447 people.
Metabolic Syndrome
Prevalence of metabolic syndrome and risks of abnormal serum alanine aminotransferase in Hispanics: a population-based study.
Metabolic Syndrome
Prevalence of metabolic syndrome increases with the increase in blood levels of gamma glutamyltransferase and alanine aminotransferase in Japanese men and women.
Metabolic Syndrome
Raised alanine transaminase and decreased adiponectin are features of the metabolic syndrome in patients with type 2 diabetes.
Metabolic Syndrome
Redefining the alanine aminotransferase upper limit of normal improves the prediction of metabolic syndrome risk.
Metabolic Syndrome
Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents.
Metabolic Syndrome
Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease.
Metabolic Syndrome
Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B.
Metabolic Syndrome
Relationships Among C-Reactive Protein, Alanine Aminotransferase, and Metabolic Syndrome in Apparently Healthy Chinese Subjects.
Metabolic Syndrome
Relationships between alanine aminotransferase levels, abnormal liver echogenicity, and metabolic syndrome.
Metabolic Syndrome
Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004.
Metabolic Syndrome
Risk factors for liver disease among adults of Mexican descent in the United States and Mexico.
Metabolic Syndrome
Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses.
Metabolic Syndrome
Risk of developing pre-diabetes or diabetes over time in a cohort of Mexican health workers.
Metabolic Syndrome
Risk of metabolic syndrome in participants within the normal range of alanine aminotransferase: A population-based nationwide study.
Metabolic Syndrome
Saskatoon Berry Amelanchier alnifolia Regulates Glucose Metabolism and Improves Cardiovascular and Liver Signs of Diet-Induced Metabolic Syndrome in Rats.
Metabolic Syndrome
Screening for liver fibrosis by using FibroScan(®) and FibroTest in patients with diabetes.
Metabolic Syndrome
Serum Alanine Aminotransferase and Its Association with Metabolic Syndrome in Children: The Bogalusa Heart Study.
Metabolic Syndrome
Serum Alanine Aminotransferase Is Associated with Metabolic Syndrome and 10-year Risk of Cardiovascular Disease.
Metabolic Syndrome
Serum alanine aminotransferase predicts interventricular septum thickness and left ventricular mass in patients with nonalcoholic fatty liver disease.
Metabolic Syndrome
Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014.
Metabolic Syndrome
Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population.
Metabolic Syndrome
Serum cytokeratin 18 level is associated with dietary intake and serum triglycerides level in hemodialysis patients.
Metabolic Syndrome
Serum ferritin levels are associated with metabolic syndrome in postmenopausal women but not in premenopausal women.
Metabolic Syndrome
Serum gamma-glutamyl transferase activity predicts future development of metabolic syndrome defined by 2 different criteria.
Metabolic Syndrome
Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men.
Metabolic Syndrome
Sex-Specific Association between Metabolic Abnormalities and Elevated Alanine Aminotransferase Levels in a Military Cohort: The CHIEF Study.
Metabolic Syndrome
Shift work aggravates metabolic syndrome development among early-middle-aged males with elevated ALT.
Metabolic Syndrome
Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis.
Metabolic Syndrome
The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
Metabolic Syndrome
The Association between Metabolic Syndrome and Elevated Alanine Aminotransferase Levels in an Indigenous Population in Northern Taiwan: A Community-Based and Cross-Sectional Study.
Metabolic Syndrome
The Association between Metabolic Syndrome and Related Factors among the Community-Dwelling Indigenous Population in Taiwan.
Metabolic Syndrome
The association between normal alanine aminotransferase levels and the metabolic syndrome: 2005 Korean National Health and Nutrition Examination Survey.
Metabolic Syndrome
The association between the metabolic syndrome and alanine amino transferase is mediated by insulin resistance via related metabolic intermediates (the Cohort on Diabetes and Atherosclerosis Maastricht study).
Metabolic Syndrome
The association of elevated alanine aminotransferase and the metabolic syndrome in an overweight and obese pediatric population of multi-ethnic origin.
Metabolic Syndrome
The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome.
Metabolic Syndrome
The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
Metabolic Syndrome
The grade of nonalcoholic fatty liver disease is an independent risk factor for gallstone disease: An observational Study.
Metabolic Syndrome
The independent predictors of NASH and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, ALT and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment.
Metabolic Syndrome
The lipid accumulation product is highly related to serum alanine aminotransferase level in male adults.
Metabolic Syndrome
The longitudinal increments of serum alanine aminotransferase increased the incidence risk of metabolic syndrome: A large cohort population in China.
Metabolic Syndrome
The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia.
Metabolic Syndrome
The Relationship Between Aspartate Aminotransferase To Alanine Aminotransferase Ratio And Metabolic Syndrome In Adolescents In Northeast China.
Metabolic Syndrome
The relationship of alanine aminotransferase to metabolic syndrome in a Korean population.
Metabolic Syndrome
The relationship of serum alanine aminotransferase normal-range levels to arterial stiffness and metabolic syndrome in non-drinkers and drinkers: a Chinese community-based analysis.
Metabolic Syndrome
Treating Obstructive Sleep Apnea and Chronic Intermittent Hypoxia Improves the Severity of Nonalcoholic Fatty Liver Disease in Children.
Metabolic Syndrome
Type 1 Diabetes and Non-Alcoholic Fatty Liver Disease: When Should We Be Concerned? A Nationwide Study in Brazil.
Metabolic Syndrome
Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).
Metabolic Syndrome
Usefulness of GPT for diagnosis of metabolic syndrome in obese Japanese children.
Metabolic Syndrome
Usefulness of Triglyceride to High-Density Lipoprotein Ratio and Alanine Aminotransferase for Predicting Insulin Resistance and Metabolic Syndrome in the Japanese Population.
Metabolic Syndrome
Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C.
Metabolic Syndrome
Which Liver Enzymes Are Better Indicators of Metabolic Syndrome in Adolescents: The Fifth Korea National Health and Nutrition Examination Survey, 2010.
Metabolic Syndrome
Xuefu Zhuyu decoction for nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis.
Metabolic Syndrome
[Association between occupational stress and aminotransferase activity in patients with metabolic syndrome].
Metabolic Syndrome
[Association of metabolic syndrome markers with abnormal alanine aminotransferase levels in healthy children].
Methemoglobinemia
Accidental oral poisoning caused by RDX (cyclonite): a report of 5 cases.
Microcephaly
Novel compound heterozygous mutations in GPT2 linked to microcephaly, and intellectual developmental disability with or without spastic paraplegia.
Mitral Valve Insufficiency
Usefulness of admission gamma-glutamyltransferase level for predicting new-onset heart failure in patients with acute coronary syndrome with left ventricular systolic dysfunction.
Mucocutaneous Lymph Node Syndrome
Association between left ventricular ejection fraction and Kawasaki disease shock syndrome.
Mucocutaneous Lymph Node Syndrome
Case-control study of giant coronary aneurysms due to Kawasaki disease.
Mucocutaneous Lymph Node Syndrome
Clinical aspects of splenomegaly as a possible predictive factor of coronary artery changes in Kawasaki disease.
Mucocutaneous Lymph Node Syndrome
Implications of hepatic dysfunction in Kawasaki disease: Time-related changes in aspartate aminotransferase, alanine aminotransferase, total bilirubin, and C-reactive protein levels.
Mucocutaneous Lymph Node Syndrome
Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases.
Mucocutaneous Lymph Node Syndrome
Serum alanine aminotransferase concentrations in patients with Kawasaki disease.
Mucocutaneous Lymph Node Syndrome
The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection: use of clinical features and a rapid direct fluorescent antigen test.
Mucositis
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group.
Mucositis
A phase I dose-escalation study of the polyamine analog PG-11047 in patients with advanced solid tumors.
Mucositis
Adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in cancer patients: A systematic review and meta-analysis.
Mucositis
Lower glomerular filtration rate predicts increased hepatic and mucosal toxicity in myeloma patients treated with high-dose melphalan.
Mucositis
Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial.
Mucositis
Trabectedin plus pegylated liposomal doxorubicin: retrospective analysis in heavily pretreated platinum-sensitive ovarian cancer.
Mucositis
[Clinical study on combination of homoharringtonine, Ara-C and idarubicin induction for treatment of newly diagnosed acute myeloid leukemia patients].
Multiple Sclerosis
Effects of fingolimod treatments on alanine transaminase and aspartate transaminase levels in patients with multiple sclerosis.
Multiple Sclerosis
Liver test abnormalities in multiple sclerosis: findings from placebo-treated patients.
Multiple Sclerosis
[Studies of alanine and aspartate transaminases, lactate dehydrogenase and phosphocreatine kinase levels in the cerebrospinal fluid and serum in multiple sclerosis]
Muscle Cramp
Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation Study.
Muscle Hypotonia
[Clinical characteristics and GAA gene mutation in children with glycogen storage disease type II: an analysis of 3 cases].
Muscle Weakness
Acute, subchronic and chronic 2,4-dichlorophenoxyacetic acid (2,4-D) intoxication in rats.
Muscle Weakness
Correlation between tests of muscle involvement and clinical muscle weakness in polymyositis and dermatomyositis.
Muscle Weakness
Evaluation of topically applied enilconazole for the treatment of dermatophytosis in a Persian cattery.
Muscle Weakness
Palmar erythema and palmar papules as predictors for dermatomyositis-related acute/subacute interstitial lung disease: a retrospective study.
Muscle Weakness
Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies.
Muscular Atrophy
Exercise interrupts ongoing glucocorticoid-induced muscle atrophy and glutamine synthetase induction.
Muscular Atrophy
Liver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes.
Muscular Atrophy
[Changes in lactate dehydrogenase, glutamate-cxaloacetate transaminase and glutamate-pyruvate transaminase in several muscular atrophies. I. Changes following tenotomy]
Muscular Diseases
Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
Muscular Diseases
Effect of rosuvastatin 5-20mg on triglycerides and other lipid parameters in Japanese patients with hypertriglyceridemia.
Muscular Diseases
Exertional myopathy in whooping cranes (Grus americana) with prognostic guidelines.
Muscular Diseases
Increased serum alanine aminotransferase activity associated with muscle necrosis in the dog.
Muscular Diseases
The correlation of dystonia severity and serum transaminases in a child with a brain injury.
Muscular Diseases
TREATMENT OF SUSPECTED EXERTIONAL MYOPATHY USING DANTROLENE IN A COYOTE ( CANIS LATRANS).
Muscular Dystrophies
Increased serum alanine aminotransferase activity associated with muscle necrosis in the dog.
Muscular Dystrophies
[Elevation of alanine aminotransferase concentration in the serum: one of the symptoms of muscular dystrophy]
Muscular Dystrophies
[On the behavior of some serum enzymatic activities in subjects with progressive muscular dystrophy treated with nucleotide and nucleoside substances. II. Malate dehydrogenase, glutamic oxalacetic transaminase and glutamic-pyruvic transaminase activity]
Muscular Dystrophy, Duchenne
Effects of Bisphosphonates on Osteoporosis Induced by Duchenne Muscular Dystrophy: A Prospective Study.
Muscular Dystrophy, Duchenne
Erythrocyte enzyme allotypes in the X-linked recessive disorders, Duchenne muscular dystrophy and haemophilia-A hemizygotes and heterozygotes.
Muscular Dystrophy, Duchenne
RENAL, HEPATIC AND IMMUNE FUNCTION INDICES IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY.
Musculoskeletal Pain
U.S. Food and Drug Administration Approval Summary: Atezolizumab for Metastatic Non-Small Cell Lung Cancer.
Myalgia
A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.
Myalgia
Clinical and laboratory associations of severity in a Sri Lankan cohort of patients with serologically confirmed leptospirosis: a prospective study.
Myalgia
Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma.
Myalgia
Comparative efficacy and safety of statin and fibrate monotherapy: A systematic review and meta-analysis of head-to-head randomized controlled trials.
Myalgia
Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.
Myalgia
Differences in clinical and laboratory characteristics and disease severity between children and adults with dengue virus infection in Taiwan, 2002.
Myalgia
Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia.
Myalgia
Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment.
Myalgia
Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response study.
Myalgia
Epidemiological and clinical analysis of the outbreak of dengue fever in Zhangshu City, Jiangxi Province, in 2019.
Myalgia
Laboratory-acquired dengue virus infection by needlestick injury: a case report, South Korea, 2014.
Myalgia
Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumors.
Myalgia
Phase II Study of Plitidepsin 3-Hour Infusion Every 2 Weeks in Patients With Unresectable Advanced Medullary Thyroid Carcinoma.
Myalgia
Predictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study.
Myalgia
Revisiting clinico-epidemiological pattern of human rickettsial infections in the central region of Sri Lanka: a hospital based descriptive study.
Myalgia
Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trials.
Myalgia
The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation.
Myalgia
The importance of overweight in COVID-19: A retrospective analysis in a single center of Wuhan, China.
Myalgia
U.S. Food and Drug Administration Approval: peginterferon-alfa-2b for the adjuvant treatment of patients with melanoma.
Myalgia
Use of Cold-Water Immersion to Reduce Muscle Damage and Delayed-Onset Muscle Soreness and Preserve Muscle Power in Jiu-Jitsu Athletes.
Myalgia
Variability in serum creatine kinase response after eccentric exercise of the elbow flexors.
Mycoses
AST to ALT Ratio is elevated in disseminated histoplasmosis as compared to localized pulmonary disease and other endemic mycoses.
Myocardial Infarction
Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer's disease and myocardial infarction.
Myocardial Infarction
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Myocardial Infarction
Association between ALT level and the rate of cardio/cerebrovascular events in HIV-positive individuals: The D: A: D Study.
Myocardial Infarction
Beneficial effects of triple drug combination of pioglitazone with glibenclamide and metformin in type 2 diabetes mellitus patients on insulin therapy.
Myocardial Infarction
Cardioprotective effect of mangiferin on isoproterenol induced myocardial infarction in rats.
Myocardial Infarction
Cardioprotective effect of rosuvastatin against isoproterenol-induced myocardial infarction injury in rats.
Myocardial Infarction
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study.
Myocardial Infarction
Creatine kinase B-subunit activity in human serum. II. Evaluation of s-ck b-subunit activity in the diagnosis of acute myocardial infarction.
Myocardial Infarction
De-Ritis Ratio Improves Long-Term Risk Prediction after Acute Myocardial Infarction.
Myocardial Infarction
Does Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predict Acute Kidney Injury After Cardiac Surgery?
Myocardial Infarction
Efficacy of gold nanoparticles against isoproterenol induced acute myocardial infarction in adult male albino rats.
Myocardial Infarction
Elevated Alt and Ast in an Asymptomatic Person: What the primary care doctor should do?
Myocardial Infarction
Greater than expected alanine aminotransferase activities in plasma and in hearts of patients with acute myocardial infarction.
Myocardial Infarction
Implication of liver enzymes on incident cardiovascular diseases and mortality: A nationwide population-based cohort study.
Myocardial Infarction
Mitochondrial and cytoplasmic isoenzymes of aspartate aminotransferase in sera of patients after myocardial infarction.
Myocardial Infarction
Plasma pyridoxal 5'-phosphate concentrations in relation to apo-aminotransferase levels in normal, uraemic, and post-myocardial infarct sera.
Myocardial Infarction
Postoperative course of serum aminotransferases after total hip arthroplasty.
Myocardial Infarction
Predictive value of elevated alanine aminotransferase for in-hospital mortality in patients with acute myocardial infarction.
Myocardial Infarction
Serum adenylate kinase activity in the early phase of acute myocardial infarction.
Myocardial Infarction
Serum transaminase determined in the emergency room predicts outcomes in patients with acute ST-segment elevation myocardial infarction who undergo primary percutaneous coronary intervention.
Myocardial Infarction
Systemic short-term fibrinolysis with high-dose streptokinase in acute myocardial infarction: time course of biochemical parameters.
Myocardial Infarction
Trace elements in serum from Pakistani patients with acute and chronic ischemic heart disease and hypertension.
Myocardial Infarction
Vectorcardiography in the diagnosis of postoperative myocardial infarction.
Myocardial Infarction
[Activity of certain enzymes (AspAT, AlaAT, nonspecific ChE, CytO, LDH) and LDH isoenzymes in the serum, myocardium and liver in experimental myocardial infarct]
Myocardial Infarction
[Behavior of glutamic-pyruvic transaminase during the clinical course of acute myocardial infarct]
Myocardial Infarction
[Biological profile in acute coronary insufficiency: study of blood myoglobin, enzymes and inflammatory proteins]
Myocardial Infarction
[Enzyme diagnosis of liver dysfunction in acute myocardial infarct and its complications]
Myocardial Infarction
[Increase of liver enzymes during treatment of myocardial infarct using intravenous nitro-derivatives]
Myocardial Infarction
[Plasma myoglobin level as a course criterium in patients with acute myocardial infarct]
Myocardial Infarction
[Value of the determination of serum glutamic-oxalacetic transaminase and serum glutamic-pyruvic transaminase in the diagnosis of myocardial infarct and liver disease.]
Myocardial Ischemia
Alanine transaminase has opposite associations with death from diabetes and ischemic heart disease in NHANES III.
Myocardial Ischemia
Aspartate aminotransferase and alanine aminotransferase serum activities in neonatal transient myocardial ischemia.
Myocardial Ischemia
Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong.
Myocardial Ischemia
Effects of Xinnaoning combined with trimetazidine on the levels of CK and its isoenzymes, AST, ALT and LDH in patients with myocardial ischemia.
Myocardial Ischemia
Gugulipid causes hypercholesterolemia leading to endothelial dysfunction, increased atherosclerosis, and premature death by ischemic heart disease in male mice.
Myocardial Ischemia
Joint Effect of Hepatic Steatosis and Alanine Aminotransferase Within the Normal Range on Incident Ischemic Heart Disease: A Prospective Study in Koreans.
Myocardial Ischemia
Prevalence of Atrial Fibrillation and Relation to Echocardiographic Parameters in a Healthy Asymptomatic Rural Korean Population.
Myocarditis
Slam haplotype 2 promotes NKT but suppresses V?4(+) T-cell activation in coxsackievirus b3 infection leading to increased liver damage but reduced myocarditis.
Myoglobinuria
Review of exertional rhabdomyolysis and a case in a rhesus monkey (Macaca mulatta).
Myoglobinuria
Spasmodic Muscle Cramps and Weakness as Presenting Symptoms in Wilson Disease.
Myoglobinuria
TREATMENT OF SUSPECTED EXERTIONAL MYOPATHY USING DANTROLENE IN A COYOTE ( CANIS LATRANS).
Myositis
Correlation of PMN elastase and PMN elastase-to-neutrophil ratio with disease activity in patients with myositis.
Myositis
Daily and intermittent rosuvastatin 5?mg therapy in statin intolerant patients: an observational study.
Myositis
RENAL, HEPATIC AND IMMUNE FUNCTION INDICES IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY.
Myositis
Serum alanine aminotransferase elevations correlate with serum creatine phosphokinase levels in myositis.
Myositis
Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.
Myotoxicity
Phase I and pharmacokinetics study of crotoxin (cytotoxic PLA(2), NSC-624244) in patients with advanced cancer.
Nasal Obstruction
Clinical manifestations and laboratory results of 61 children with infectious mononucleosis.
Nasopharyngitis
72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension.
Nasopharyngitis
Efficacy and Safety of Evinacumab for the Treatment of Hypercholesterolemia: A Meta-Analysis.
Nasopharyngitis
The safety of healthy volunteers in First-in-Man trials - an analysis of studies conducted at the Bayer in-house ward from 2000 to 2005.
Neoplasm Metastasis
A primary extraskeletal osteogenic sarcoma arising in the spleen of a dog.
Neoplasm Metastasis
Addition of Zoledronate to Chemotherapy in Patients with Osteosarcoma Treated with Limb-Sparing Surgery: A Phase III Clinical Trial.
Neoplasm Metastasis
Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Neoplasm Metastasis
B30-MDP, a synthetic muramyl dipeptide derivative for tumour vaccination to enhance antitumour immunity and antimetastatic effect in mice.
Neoplasm Metastasis
Clinical presentation, natural history and prognostic factors in advanced malignant melanoma.
Neoplasm Metastasis
Compensatory upregulation of aldo-keto reductase 1B10 to protect hepatocytes against oxidative stress during hepatocarcinogenesis.
Neoplasm Metastasis
Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma.
Neoplasm Metastasis
Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma.
Neoplasm Metastasis
Hepatic Metastases is Associated with Poor Efficacy of Erlotinib as 2nd/3rd Line Therapy in Patients with Lung Adenocarcinoma.
Neoplasm Metastasis
Insulin-like growth factor-I, interleukin-1 alpha and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes.
Neoplasm Metastasis
Leucine amino peptidase a better indicator of carcinoma of liver, biliary tract and pancreas.
Neoplasm Metastasis
Liver dysfunction is associated with poor prognosis in patients after immune checkpoint inhibitor therapy.
Neoplasm Metastasis
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis.
Neoplasm Metastasis
Outcome of postoperative radiation therapy for cholangiocarcinoma and analysis of dose-volume histogram of remnant liver.
Neoplasm Metastasis
Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
Neoplasm Metastasis
Plasma endoxifen and 4-hydroxytamoxifen levels in CYP2D6(C100T) carrying breast cancer patients and association with serum cholesterol.
Neoplasm Metastasis
Population pharmacokinetics meta-analysis of plitidepsin (Aplidin((R))) in cancer subjects.
Neoplasm Metastasis
Population pharmacokinetics of kahalalide F in advanced cancer patients.
Neoplasm Metastasis
Population pharmacokinetics of PM00104 (Zalypsis(®)) in cancer patients.
Neoplasm Metastasis
Predictors of distant metastasis on exploration in patients with potentially resectable pancreatic cancer.
Neoplasm Metastasis
Pretreatment serum C-reactive protein level predicts poor prognosis in patients with hepatocellular carcinoma.
Neoplasm Metastasis
Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort.
Neoplasm Metastasis
Prognostic-factors-based risk-stratification model for invasive urothelial carcinoma of the urinary bladder in Taiwan.
Neoplasm Metastasis
Reduction of liver metastasis of intraocular melanoma by interferon-beta gene transfer.
Neoplasm Metastasis
Serological diagnostic factors for liver metastasis in patients with colorectal cancer.
Neoplasm Metastasis
Subclinical involvement of the liver is associated with prognosis in treatment naïve cancer patients.
Neoplasm Metastasis
Transcatheter arterial embolization treatment in patients with hepatocellular carcinoma and risk of pulmonary metastasis.
Neoplasms
1,8-cineole protects against liver failure in an in-vivo murine model of endotoxemic shock.
Neoplasms
1-Deoxynojirimycin Alleviates Liver Injury and Improves Hepatic Glucose Metabolism in db/db Mice.
Neoplasms
18Beta-glycyrrhetinic acid ameliorates acute Propionibacterium acnes-induced liver injury through inhibition of macrophage inflammatory protein-1alpha.
Neoplasms
20(R)-ginsenoside Rg3, a rare saponin from red ginseng, ameliorates acetaminophen-induced hepatotoxicity by suppressing PI3K/AKT pathway-mediated inflammation and apoptosis.
Neoplasms
3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence.
Neoplasms
5'-Methylthioadenosine Attenuates Ischemia Reperfusion Injury After Liver Transplantation in Rats.
Neoplasms
5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice.
Neoplasms
?(8) -Tetrahydrocannabivarin protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress and inflammatory response involving CB(2) receptors.
Neoplasms
?-Imidazolyl-alkyl derivatives as new preclinical drug candidates for treating non-alcoholic steatohepatitis.
Neoplasms
?-Mangostin suppresses NLRP3 inflammasome activation via promoting autophagy in LPS-stimulated murine macrophages and protects against CLP-induced sepsis in mice.
Neoplasms
A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus.
Neoplasms
A combination of levosimendan and N-Acetylcysteine shows significant favorable efficacy on experimental liver ischemia/reperfusion injury.
Neoplasms
A comparison of the effects of thymoquinone, silymarin and N-acetylcysteine in an experimental hepatotoxicity.
Neoplasms
A diterpenoid acanthoic acid from Acanthopanax koreanum protects against D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
Neoplasms
A Diterpenoid, 14-Deoxy-11, 12-Didehydroandrographolide, in Andrographis paniculata Reduces Steatohepatitis and Liver Injury in Mice Fed a High-Fat and High-Cholesterol Diet.
Neoplasms
A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia.
Neoplasms
A Japanese herbal medicine, Sho-saiko-to, prevents gut ischemia/reperfusion-induced hepatic microvascular dysfunction in rats.
Neoplasms
A medicinal and edible formula YH0618 ameliorates the toxicity induced by Doxorubicin via regulating the expression of Bax/Bcl-2 and FOXO4.
Neoplasms
A newly designed biliary brachytherapy drainage catheter for patients with malignant biliary obstruction: A pilot study.
Neoplasms
A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis.
Neoplasms
A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablation.
Neoplasms
A protein from Cajanus indicus Spreng protects liver and kidney against mercuric chloride-induced oxidative stress.
Neoplasms
A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide.
Neoplasms
A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
Neoplasms
A voluntary oral ethanol-feeding rat model associated with necroinflammatory liver injury.
Neoplasms
A1 adenosine receptor knockout mice exhibit increased mortality, renal dysfunction, and hepatic injury in murine septic peritonitis.
Neoplasms
Abdominal obesity: causal factor or simply a symptom of obesity-related health risk.
Neoplasms
Abrogating GPT2 in triple-negative breast cancer inhibits tumor growth and promotes autophagy.
Neoplasms
Acacia ferruginea inhibits cyclophosphamide-induced immunosuppression and urotoxicity by modulating cytokines in mice.
Neoplasms
Acacia ferruginea inhibits tumor progression by regulating inflammatory mediators-(TNF-a, iNOS, COX-2, IL-1?, IL-6, IFN-?, IL-2, GM-CSF) and pro-angiogenic growth factor- VEGF.
Neoplasms
Activated protein C improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat lipopolysaccharide model.
Neoplasms
Activity of tumor necrosis factor-? blocked by phytoglycoprotein (38 kDa) at initiation stage in N-nitrosodiethylamine-induced ICR mice.
Neoplasms
Ad5/48 hexon oncolytic virus expressing sTGF?RIIFc produces reduced hepatic and systemic toxicities and inhibits prostate cancer bone metastases.
Neoplasms
Adiponectin deficiency exacerbates lipopolysaccharide/D-galactosamine-induced liver injury in mice.
Neoplasms
Administration of human inter-alpha-inhibitors maintains hemodynamic stability and improves survival during sepsis.
Neoplasms
Administration of PPAR?/? agonist reduces copper-induced liver damage in mice: possible implications in clinical practice.
Neoplasms
Adrenomedullin and its binding protein attenuate the proinflammatory response after hemorrhage.
Neoplasms
Adverse signaling of scavenger receptor class B1 and PGC1s in alcoholic hepatosteatosis and steatohepatitis and protection by betaine in rat.
Neoplasms
Agomelatine: an antidepressant with new potent hepatoprotective effects on paracetamol-induced liver damage in rats.
Neoplasms
Aldose reductase is involved in the development of murine diet-induced nonalcoholic steatohepatitis.
Neoplasms
Allantoin improves methionine-choline deficient diet-induced nonalcoholic steatohepatitis in mice through involvement in endoplasmic reticulum stress and hepatocytes apoptosis-related genes expressions.
Neoplasms
Allele increasing susceptibility to human breast cancer may be linked to the glutamate-pyruvate transaminase locus.
Neoplasms
Alleviation of Hepatic Ischemia Reperfusion Injury by Oleanolic Acid Pretreating via Reducing HMGB1 Release and Inhibiting Apoptosis and Autophagy.
Neoplasms
Alleviation of ischemia/reperfusion injury in ob/ob mice by inhibiting UCP-2 expression in fatty liver.
Neoplasms
Alleviation of remote lung injury following liver ischemia/reperfusion: Possible protective role of vildagliptin.
Neoplasms
Allylpyrocatechol, isolated from betel leaf ameliorates thyrotoxicosis in rats by altering thyroid peroxidase and thyrotropin receptors.
Neoplasms
Alterations of biliary biochemical constituents and cytokines in infantile hepatitis syndrome.
Neoplasms
Altered methylation and expression of ER-associated degradation factors in long-term alcohol and constitutive ER stress-induced murine hepatic tumors.
Neoplasms
Amelioration of tamoxifen-induced liver injury in rats by grape seed extract, black seed extract and curcumin.
Neoplasms
Ameliorative effect of septilin, an ayurvedic preparation against gamma-irradiation-induced oxidative stress and tissue injury in rats.
Neoplasms
Aminotransferase activities and involution of the thymus in rats bearing AH 130 tumors.
Neoplasms
An antioxidative nutrient-rich enteral diet attenuates lethal activity and oxidative stress induced by lipopolysaccharide in mice.
Neoplasms
An application of a genetic algorithm in conjunction with other data mining methods for estimating outcome after hospitalization in cancer patients.
Neoplasms
An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice.
Neoplasms
An early fish oil-enriched diet reverses biochemical, liver and adipose tissue alterations in male offspring from maternal protein restriction in mice.
Neoplasms
An evaluation of the protective role of vitamin C in reactive oxygen species-induced hepatotoxicity due to hexavalent chromium in vitro and in vivo.
Neoplasms
An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins.
Neoplasms
ANGIOTENSIN CONVERTING ENZYME INHIBITORS IMPROVE HEPATIC STEATOSIS BY MODULATING EXPRESSION OF TUMOR NECROSIS FACTOR-Alpha, INTERLEUKIN-6 AND ADIPONECTIN RECEPTOR-2 IN RATS WITH TYPE 2 DIABETES.
Neoplasms
Anionic polymer-coated lipoplex for safe gene delivery into tumor by systemic injection.
Neoplasms
Antagonism by salvianolic acid B of lipopolysaccharide-induced disseminated intravascular coagulation in rabbits.
Neoplasms
Anti-apoptotic and antioxidant effect of leptin on CCl(4)-induced acute liver injury in rats.
Neoplasms
Anti-Inflammatory and Antioxidant Effect of Eucommia ulmoides Polysaccharide in Hepatic Ischemia-Reperfusion Injury by Regulating ROS and the TLR-4-NF-?B Pathway.
Neoplasms
Anti-Inflammatory and Hepatoprotective Effects of Ganoderma lucidum Polysaccharides against Carbon Tetrachloride-Induced Liver Injury in Kunming Mice.
Neoplasms
Anti-inflammatory and nephroprotective activity of Juglans mollis against renal ischemia-reperfusion damage in a Wistar rat model.
Neoplasms
Anti-oxidant and anti-inflammatory effects of hydrogen-rich water alleviate ethanol-induced fatty liver in mice.
Neoplasms
Anti?apoptotic effects of human placental hydrolysate against hepatocyte toxicity in vivo and in vitro.
Neoplasms
Anticancer activity of Acacia nilotica (L.) Wild. Ex. Delile subsp. indica against Dalton's ascitic lymphoma induced solid and ascitic tumor model.
Neoplasms
Anticancer potency of the milk extract of Semecarpus anacardium Linn. nuts against aflatoxin B1 mediated hepatocellular carcinoma bearing Wistar rats with reference to tumour marker enzymes.
Neoplasms
Antihepatitis C virus status in hepatocellular carcinoma and the influence on clinicopathological findings and operative results.
Neoplasms
Antioxidant Capacity-Related Preventive Effects of Shoumei (Slightly Fermented Camellia sinensis) Polyphenols against Hepatic Injury.
Neoplasms
Antioxidant, antiapoptotic, antigenotoxic, and hepatic ameliorative effects of L-carnitine and selenium on cadmium-induced hepatotoxicity and alterations in liver cell structure in male mice.
Neoplasms
Antioxidative and hepatoprotective activities of the ethyl acetate fraction separated from the fruit of Livistona chinensis.
Neoplasms
Antithrombin reduces reperfusion-induced liver injury in mice by enhancing sensory neuron activation.
Neoplasms
Antitumor activity of hyaluronic acid-selenium nanoparticles in Heps tumor mice models.
Neoplasms
Antitumor effect and mechanism of action of a tumor-targeting recombinant human tumor necrosis factor-? fusion protein mediated by urokinase.
Neoplasms
Antitumor Effects and Mechanism of n-butanol Fraction from Aril of Torreya grandis in H22 Mice.
Neoplasms
Antitumoral and antioxidant effects of a hydroalcoholic extract of cat's claw (Uncaria tomentosa) (Willd. Ex Roem. & Schult) in an in vivo carcinosarcoma model.
Neoplasms
Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-?B pathway.
Neoplasms
Ascorbate promotes carbon tetrachloride-induced hepatic injury in senescence marker protein 30-deficient mice by enhancing inflammation.
Neoplasms
Asiatic Acid Exhibits Anti-inflammatory and Antioxidant Activities against Lipopolysaccharide and d-Galactosamine-Induced Fulminant Hepatic Failure.
Neoplasms
Aspartate aminotransferase-to-platelet ratio index predicts prognosis of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization.
Neoplasms
Assessment of the protective and therapeutic effect of melatonin against thioacetamide-induced acute liver damage.
Neoplasms
Association between age and overall survival of patients with hepatocellular carcinoma after hepatic resection.
Neoplasms
Association between tumor necrosis factor inhibitor (TNFi) therapy and changes in C-reactive protein (CRP), blood pressure, and alanine aminotransferase (ALT) among patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis.
Neoplasms
Association of 5-methylcytosine and 5-hydroxymethylcytosine with mitochondrial DNA content and clinical and biochemical parameters in hepatocellular carcinoma.
Neoplasms
Association of TSH Elevation with All-Cause Mortality in Elderly Patients with Chronic Kidney Disease.
Neoplasms
Atractylodin ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via the suppression of inflammation and oxidative stress.
Neoplasms
Augmentation of hepatoprotective potential of Aegle marmelos in combination with piperine in carbon tetrachloride model in wistar rats.
Neoplasms
B30-MDP, a synthetic muramyl dipeptide derivative for tumour vaccination to enhance antitumour immunity and antimetastatic effect in mice.
Neoplasms
Bacopa monniera Linn. extract modulates antioxidant and marker enzyme status in fibrosarcoma bearing rats.
Neoplasms
Baicalein inhibits nuclear factor-?B and apoptosis via c-FLIP and MAPK in d-GalN/LPS induced acute liver failure in murine models.
Neoplasms
Barley Sprouts Extract Attenuates Alcoholic Fatty Liver Injury in Mice by Reducing Inflammatory Response.
Neoplasms
Basic fibroblast growth factor reduces the gut and liver morphologic and functional injuries after ischemia and reperfusion.
Neoplasms
Beraprost sodium preconditioning prevents inflammation, apoptosis, and autophagy during hepatic ischemia-reperfusion injury in mice via the P38 and JNK pathways.
Neoplasms
Beraprost sodium, a prostacyclin (PGI) analogue, ameliorates concanavalin A-induced liver injury in mice.
Neoplasms
Beta-sitosterol and its derivatives repress lipopolysaccharide/d-galactosamine-induced acute hepatic injury by inhibiting the oxidation and inflammation in mice.
Neoplasms
Bioactive Phytochemicals of Leaf Essential Oils of Cinnamomum osmophloeum Prevent Lipopolysaccharide/d-Galactosamine (LPS/d-GalN)-Induced Acute Hepatitis in Mice.
Neoplasms
Biochemical and biophysical study of chemopreventive and chemotherapeutic anti-tumor potential of some Egyptian plant extracts.
Neoplasms
Biochemical investigation of human exposure to aflatoxin M1 and its association with risk factors of diabetes mellitus.
Neoplasms
Bletilla striata polysaccharide has a protective effect on intestinal epithelial barrier disruption in TAA-induced cirrhotic rats.
Neoplasms
Bone marrow mononuclear cells boosts anti-cytogentical aberration effect of N-acetylcysteine and ?-lipoic acid in rat's liver and bone marrow: implication of oxidative and inflammatory pathways.
Neoplasms
Bracteanolide A abrogates oxidative stress-induced cellular damage and protects against hepatic ischemia and reperfusion injury in rats.
Neoplasms
Calotropis procera latex affords protection against carbon tetrachloride induced hepatotoxicity in rats.
Neoplasms
Cancer chemoprevention by oleaster (Elaeagnus angustifoli L.) fruit extract in a model of hepatocellular carcinoma induced by diethylnitrosamine in rats.
Neoplasms
Cancer history and other personal factors affect quality of life in patients with hepatitis C.
Neoplasms
Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats.
Neoplasms
Carbon Monoxide-Releasing Molecule-3 Alleviates Kupffer Cell Pyroptosis Induced by Hemorrhagic Shock and Resuscitation via sGC-cGMP Signal Pathway.
Neoplasms
Cardiac and hepatic role of r-AtHSP70: basal effects and protection against ischemic and sepsis conditions.
Neoplasms
Carnosic acid impedes cell growth and enhances anticancer effects of carmustine and lomustine in melanoma.
Neoplasms
Carvacrol Protects against Hepatic Steatosis in Mice Fed a High-Fat Diet by Enhancing SIRT1-AMPK Signaling.
Neoplasms
Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats.
Neoplasms
Chemerin/CMKLR1 ameliorates nonalcoholic steatohepatitis by promoting autophagy and alleviating oxidative stress through the JAK2-STAT3 pathway.
Neoplasms
Chemomodulatory effects of Azadirachta indica on the hepatic status of skin tumor bearing mice.
Neoplasms
Chemoprevention and cytotoxic effect of Bauhinia variegata against N-nitrosodiethylamine induced liver tumors and human cancer cell lines.
Neoplasms
Chemoprevention of N-nitrosodiethylamine induced phenobarbitol promoted liver tumors in rat by extract of Indigofera aspalathoides.
Neoplasms
Chronic effects of celecoxib, a cyclooxygenase-2 inhibitor, cause enhanced alcohol-induced liver steatosis in rats.
Neoplasms
Chronological expression of PAR isoforms in acute liver injury and its amelioration by PAR2 blockade in a rat model of sepsis.
Neoplasms
Cinnamon extract supplementation improves inflammation and oxidative stress induced by acrylamide: An experimental animal study.
Neoplasms
Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study.
Neoplasms
Clinical Implication of Performance Status in Patients with Hepatocellular Carcinoma Complicating with Cirrhosis.
Neoplasms
Clinical outcome in elderly Chinese patients with primary hepatocellular carcinoma treated with percutaneous microwave coagulation therapy (PMCT): A Strobe-compliant observational study.
Neoplasms
Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
Neoplasms
Co-administration of prostaglandin E1 with somatostatin attenuates acute liver damage after massive hepatectomy in rats via inhibition of inflammatory responses, apoptosis and endoplasmic reticulum stress.
Neoplasms
Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins.
Neoplasms
Combination of Sodium Selenite and Doxorubicin Prodrug Ac-Phe-Lys-PABC-ADM Affects Gastric Cancer Cell Apoptosis in Xenografted Mice.
Neoplasms
Combination therapy with taurine, epigallocatechin gallate and genistein for protection against hepatic fibrosis induced by alcohol in rats.
Neoplasms
Comparative effect of dietary olive, safflower, and linseed oils on spontaneous liver tumorigenesis in C3H/He mice.
Neoplasms
Comparative Effects and Mechanisms of Chitosan and Its Derivatives on Hypercholesterolemia in High-Fat Diet-Fed Rats.
Neoplasms
Comparison of bone marrow tissue- and adipose tissue-derived mesenchymal stem cells in the treatment of sepsis in a murine model of lipopolysaccharide-induced sepsis.
Neoplasms
Comparison of clinical manifestations and outcomes of noncirrhotic and cirrhotic hepatocellular carcinoma patients with chronic hepatitis B.
Neoplasms
Comparison of long-term survival and immediate postoperative liver function after laparoscopic and open distal gastrectomy for early gastric cancer patients with liver cirrhosis.
Neoplasms
Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
Neoplasms
Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: A Chinese experience.
Neoplasms
Compensatory upregulation of aldo-keto reductase 1B10 to protect hepatocytes against oxidative stress during hepatocarcinogenesis.
Neoplasms
Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.
Neoplasms
Congenital absence of portal vein with multiple hyperplastic nodular lesions in the liver.
Neoplasms
Controlled clinical trial to assess the response of recent heroin abusers with chronic hepatitis C virus infection to treatment with interferon alpha-n2b.
Neoplasms
Correlation between anti-fibrotic effect of baicalin and serum cytokines in rat hepatic fibrosis.
Neoplasms
COX-2 Inhibition Improves Immune System Homeostasis and Decreases Liver Damage in Septic Rats.
Neoplasms
CQMUH-011 mitigates autoimmune hepatitis via inhibiting the function of T lymphocytes.
Neoplasms
Critical role of oxygen radicals in the initiation of hepatic depression after trauma hemorrhage.
Neoplasms
Cyclin B2 Overexpression in Human Hepatocellular Carcinoma is Associated with Poor Prognosis.
Neoplasms
Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic Fatty liver disease.
Neoplasms
Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study.
Neoplasms
Daphnetin alleviates lipopolysaccharide/d-galactosamine-induced acute liver failure via the inhibition of NLRP3, MAPK and NF-?B, and the induction of autophagy.
Neoplasms
Declined Preoperative Aspartate Aminotransferase to Neutrophil Ratio Index Predicts Poor Prognosis in Patients with Intrahepatic Cholangiocarcinoma After Hepatectomy.
Neoplasms
Decrease of heatstroke-induced multiorgan dysfunction by whole body cooling in streptozotocin-induced diabetic rats.
Neoplasms
Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis.
Neoplasms
Delayed ischemic preconditioning protects against liver ischemia-reperfusion injury in vivo.
Neoplasms
Desensitization of the permeability transition pore by cyclosporin a prevents activation of the mitochondrial apoptotic pathway and liver damage by tumor necrosis factor-alpha.
Neoplasms
Detection of serum nitrite and nitrate in primary biliary cirrhosis: possible role of nitric oxide in bile duct injury.
Neoplasms
Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of nitric oxide synthase isoforms.
Neoplasms
Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy.
Neoplasms
Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong.
Neoplasms
Development of a predictive nomogram for early recurrence of hepatocellular carcinoma in patients undergoing liver transplantation.
Neoplasms
Dexamethasone attenuates lipopolysaccharide-induced liver injury by downregulating glucocorticoid-induced tumor necrosis factor receptor ligand in Kupffer cells.
Neoplasms
Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the ?2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-?B Pathway.
Neoplasms
Di(2-ethylhexyl) adipate plasticizer triggers hepatic, brain, and cardiac injury in rats: Mitigating effect of Peganum harmala oil.
Neoplasms
Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
Neoplasms
Dietary polyvinyl alcohol and alginate nanofibers ameliorate hyperglycemia by reducing insulin and glucose-metabolizing enzyme levels in rats with streptozotocin-induced diabetes.
Neoplasms
Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice.
Neoplasms
Diminazene aceturate alleviated lipopolysaccharide/D-galactosamine-induced fulminant hepatitis in mice.
Neoplasms
Dipeptidyl peptidase-4 inhibitors and aerobic exercise synergistically protect against liver injury in ovariectomized rats.
Neoplasms
Disruption of the 12/15-lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease.
Neoplasms
Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic-associated fatty liver disease in mice.
Neoplasms
Dose-related impacts of imidacloprid oral intoxication on brain and liver of rock pigeon (Columba livia domestica), residues analysis in different organs.
Neoplasms
Doxorubicin, L-arginine, or their combination as a prophylactic agent against hepatic carcinoma in mice.
Neoplasms
DR5 mAb-conjugated, DTIC-loaded immuno-nanoparticles effectively and specifically kill malignant melanoma cells in vivo.
Neoplasms
Early Changes in Natural Killer Cell Function Indicate Virologic Response to Interferon Therapy for Hepatitis C.
Neoplasms
Early changes of graft function, cytokines and superoxide dismutase serum levels after donor liver denervation and Kupffer cell depletion in a rat-to-rat liver transplantation model.
Neoplasms
Effect and Mechanism of Portal Blood Stasis Removal on Intestinal Endotoxemia and Hepatic Ischemia Reperfusion Injury.
Neoplasms
Effect of Acanthopanax koreanum Nakai (Araliaceae) on D-galactosamine and lipopolysaccharide-induced fulminant hepatitis.
Neoplasms
Effect of acupuncture combined with Shenqi Yigan Decoction on liver function and T cell subsets in patients with HBV-induced liver fibrosis.
Neoplasms
Effect of Additional Clostridium butyricum on the Intestinal Flora of Chronic Hepatitis B Patients Treated with Entecavir.
Neoplasms
Effect of alfalfa hay and starter feed supplementation on caecal microbiota and fermentation, growth, and health of yak calves.
Neoplasms
Effect of baicalin on toll-like receptor 4-mediated ischemia/reperfusion inflammatory responses in alcoholic fatty liver condition.
Neoplasms
Effect of betaine treatment on the regression of existing hepatic triglyceride accumulation and oxidative stress in rats fed on high fructose diet.
Neoplasms
Effect of Chinese Herbal Monomer Hairy Calycosin on Nonalcoholic Fatty Liver Rats and its Mechanism.
Neoplasms
Effect of dietary astaxanthin administration on the growth performance and innate immunity of juvenile crucian carp (Carassius auratus).
Neoplasms
Effect of diphenyl dimethyl bicarboxylate on concanavalin A-induced liver injury in mice.
Neoplasms
Effect of Entecavir on the Intestinal Microflora in Patients with Chronic Hepatitis B: A Controlled Cross-Sectional and Longitudinal Real-World Study.
Neoplasms
Effect of exogenous melatonin on hepatic energetic status during ischemia/reperfusion: possible role of tumor necrosis factor-alpha and nitric oxide.
Neoplasms
Effect of hesperetin on systemic inflammation and hepatic injury after blunt chest trauma in rats.
Neoplasms
Effect of hydroxyethyl starch priming on the systemic inflammatory response and lung edema following cardiopulmonary bypass in a rat model.
Neoplasms
Effect of lipid metabolism disorder on liver function in patients with malignant tumors after chemotherapy: a case-control study.
Neoplasms
Effect of Liver Ischemia-Reperfusion Injury on the Activity of Neurons in the Rat Brain.
Neoplasms
Effect of livergol on the improvement of fatty liver in patients with cancer undergoing irinotecan- and oxaliplatin-based chemotherapy regimen.
Neoplasms
Effect of Nigella sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Neoplasms
Effect of remote ischemic preconditioning on hepatic ischemia-reperfusion injury in patients undergoing liver resection: a randomized controlled trial.
Neoplasms
Effect of selenium-enriched malt on hepatocarcinogenesis, paraneoplastic syndrome and the hormones regulating blood glucose in rats treated by diethylnitrosamine.
Neoplasms
Effect of sevoflurane on hepatic ischemia-reperfusion injury in rats via JAK2-STAT3 pathway.
Neoplasms
Effect of sevoflurane pretreatment in relieving liver ischemia/reperfusion-induced pulmonary and hepatic injury.
Neoplasms
Effect of thalidomide dithiocarbamate analogs on the intercellular adhesion molecule-1 expression.
Neoplasms
Effect of tocopherol on biochemical blood parameters in pleuritis-induced rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Neoplasms
Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat study.
Neoplasms
Effect of urinary trypsin inhibitor on inflammatory cytokines and organ function in patients with cardiopulmonary bypass.
Neoplasms
Effect of Weight Reduction Diets Containing Fish, Walnut or Fish plus Walnut on Cardiovascular Risk Factors in Overweight and Obese Women.
Neoplasms
Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-? and insulin receptor in a rat model of nonalcoholic fatty liver disease.
Neoplasms
Effects of antimicrobial peptides on serum biochemical parameters, antioxidant activity and non-specific immune responses in Epinephelus coioides.
Neoplasms
Effects of arginase inhibition via jugular infusion of N?-hydroxy-nor-l-arginine on metabolic and immune indices in lactating dairy cows.
Neoplasms
Effects of astragalus and ginseng polysaccharides on growth performance, immune function and intestinal barrier in weaned piglets challenged with lipopolysaccharide.
Neoplasms
Effects of bicyclol on dimethylnitrosamine-induced liver fibrosis in mice and its mechanism of action.
Neoplasms
Effects of cancer chemotherapy on the blood fibrinogen concentrations of cancer patients.
Neoplasms
Effects of CH-100, a chinese herbal medicine, on acute concanavalin A-mediated hepatitis in control and alcohol-fed rats.
Neoplasms
Effects of Clostridium butyricum and Enterococcus faecalis on growth performance, intestinal structure and inflammation in lipopolysaccharide-challenged weaned piglets.
Neoplasms
Effects of Contrast-Enhanced Ultrasonography in Monitoring Hepatic Microcirculation After Rat Liver Ischemia-Reperfusion Injury.
Neoplasms
Effects of Dan-shao-hua-xian on expression of PPAR-gamma and NF-kappa B in rat liver fibrosis.
Neoplasms
Effects of dexmedetomidine on the function of distal organs and oxidative stress after lower limb ischaemia-reperfusion in elderly patients undergoing unilateral knee arthroplasty.
Neoplasms
Effects of exogenous thymosin ?4 on carbon tetrachloride-induced liver injury and fibrosis.
Neoplasms
Effects of glutamine administration on inflammatory responses in chronic ethanol-fed rats.
Neoplasms
Effects of insulin combined with ethyl pyruvate on inflammatory response and oxidative stress in multiple-organ dysfunction syndrome rats with severe burns.
Neoplasms
Effects of liver function, insulin resistance and inflammatory factors on vascular endothelial dilation function and prognosis of coronary heart disease patients complicated with NAFLD.
Neoplasms
Effects of metformin on lipopolysaccharide induced inflammation by activating fibroblast growth factor 21.
Neoplasms
Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease.
Neoplasms
Effects of Ozone Oxidative Preconditioning on Liver Regeneration after Partial Hepatectomy in Rats.
Neoplasms
Effects of Persian leek (Allium ampeloprasum) on hepatic lipids and the expression of proinflammatory gene in hamsters fed a high-fat/ high-cholesterol diet.
Neoplasms
Effects of Phytosterol Supplementation on Serum Levels of Lipid Profiles, Liver Enzymes, Inflammatory Markers, Adiponectin, and Leptin in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Neoplasms
Effects of Pomegranate and Orange Juice on Antioxidant Status in Non-Alcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial.
Neoplasms
Effects of probucol on hepatic tumor necrosis factor-alpha, interleukin-6 and adiponectin receptor-2 expression in diabetic rats.
Neoplasms
Effects of prolonged fasting on levels of metabolites, oxidative stress, immune-related gene expression, histopathology, and DNA damage in the liver and muscle tissues of rainbow trout (Oncorhynchus mykiss).
Neoplasms
Effects of propofol combined with remifentanil anesthesia on the NO, endothelin and inflammatory cytokines in the plasma of patients with liver cirrhosis during the perioperative period.
Neoplasms
Effects of S-adenosylmethionine on liver methionine metabolism and steatosis with ethanol-induced liver injury in rats.
Neoplasms
Effects of selective cyclooxygenase inhibitors on ischemia/reperfusion-induced hepatic microcirculatory dysfunction in mice.
Neoplasms
Effects of selenium-enriched Agaricus blazei Murill on liver metabolic dysfunction in mice, a comparison with selenium-deficient Agaricus blazei Murill and sodium selenite.
Neoplasms
Effects of sildenafil citrate on pancreatic and lung complications in an experimental L-arginine-induced acute pancreatitis model.
Neoplasms
Effects of sublethal concentration of metamifop on hepatic lipid metabolism in adult zebrafish (Danio rerio).
Neoplasms
Effects of tanshinone IIA on fibrosis in a rat model of cirrhosis through heme oxygenase-1, inflammation, oxidative stress and apoptosis.
Neoplasms
Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis.
Neoplasms
Efficacy of decoction from Jieduan Niwan formula on rat model of acute-on-chronic liver failure induced by porcine serum.
Neoplasms
Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
Neoplasms
Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease.
Neoplasms
Efficacy of Synbiotic Supplementation in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Clinical Trials.
Neoplasms
Efficacy of transcatheter arterial chemoembolization followed by sorafenib for intermediate/advanced hepatocellular carcinoma in patients in Japan: a retrospective analysis.
Neoplasms
Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma.
Neoplasms
Elevated rates of transaminitis during ipilimumab therapy for metastatic melanoma.
Neoplasms
Elevated tumour necrosis factor-alpha was associated with intima thickening in obese children.
Neoplasms
Ellagic Acid Prevents Oxidative Stress, Inflammation, and Histopathological Alterations in Acrylamide-Induced Hepatotoxicity in Wistar Rats.
Neoplasms
Endotoxin clearance and its relation to hepatic and renal disturbances in rats with liver cirrhosis.
Neoplasms
Enhanced efficacy with reduced toxicity of chemotherapy drug 5-fluorouracil by synergistic treatment with Abnormal Savda Munziq from Uyghur medicine.
Neoplasms
Enhanced expression of glucose-regulated protein 78 correlates with malondialdehyde levels during the formation of liver cirrhosis in rats.
Neoplasms
Enhancement of Cancer Chemotherapeutic Efficacy of Cyclophosphamide by Curculigo orchioides Gaertn and Its Ameliorative Effects on Cyclophosphamide-Induced Oxidative Stress.
Neoplasms
Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma.
Neoplasms
Ergostatrien-3?-ol (EK100) from Antrodia camphorata Attenuates Oxidative Stress, Inflammation, and Liver Injury In Vitro and In Vivo.
Neoplasms
Erythrocyte membrane fatty acid profile & serum cytokine levels in patients with non-alcoholic fatty liver disease.
Neoplasms
Erythropoietin ameliorates early ischemia-reperfusion injury following the Pringle maneuver.
Neoplasms
Estimating the Number of Organ Donors in Australian Hospitals--Implications for Monitoring Organ Donation Practices.
Neoplasms
Evaluation of in Vivo Antioxidant and Immunity Enhancing Activities of Sodium Aescinate Injection Liquid.
Neoplasms
Evaluation of carcinogenic activities and sperm abnormalities of Gram-negative bacterial metabolites isolated from cancer patients after subcutaneous injection in albino rats.
Neoplasms
Evaluation of effect of hemihepatic vascular occlusion and the Pringle maneuver during hepatic resection for patients with hepatocellular carcinoma and impaired liver function.
Neoplasms
Evaluation of preoperative serum markers for individual patient prognosis in stage I-III rectal cancer.
Neoplasms
Evaluation of the effect of heat shock protein 70 targeted drugs on cirrhotic cardiomyopathy in biliary cirrhotic rats.
Neoplasms
Evaluation of the effect of losartan and methotrexate combined therapy in adjuvant-induced arthritis in rats.
Neoplasms
Excessive inflammation but decreased immunological response renders liver susceptible to infection in bile duct ligated mice.
Neoplasms
Exogenous thioredoxin prevents ethanol-induced oxidative damage and apoptosis in mouse liver.
Neoplasms
Expression analysis of tumour necrosis factor alpha (TNF-?) and alkaline phosphatase in occupational workers exposed to low dose of X-radiation: A case-control study.
Neoplasms
Expression and role of TNIP2 in multiple organ dysfunction syndrome following severe trauma.
Neoplasms
Expression of tubulin folding cofactor B in mouse hepatic ischemia-reperfusion injury.
Neoplasms
Extrahepatic Portal Venous Obstruction With Hepatic Enzyme Elevation Resembling Hepatitis in Patients With Cancer.
Neoplasms
Factors Affecting Oncologic Outcomes of 90Y Radioembolization of Heavily Pre-Treated Patients With Colon Cancer Liver Metastases.
Neoplasms
Factors related to pleural effusion following hepatectomy for primary liver cancer.
Neoplasms
Fasudil alleviates hepatic fibrosis in type 1 diabetic rats: involvement of the inflammation and RhoA/ROCK pathway.
Neoplasms
Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients.
Neoplasms
Febuxostat Improves the Local and Remote Organ Changes Induced by Intestinal Ischemia/Reperfusion in Rats.
Neoplasms
Feeding restriction alleviates high carbohydrate diet-induced oxidative stress and inflammation of Megalobrama amblycephala by activating the AMPK-SIRT1 pathway.
Neoplasms
Fertaric Acid Protects from Octylphenol-Related Hepatotoxicity in Rats: Biochemical, Molecular, and Histopathological Studies.
Neoplasms
Ferulic Acid against Cyclophosphamide-Induced Heart Toxicity in Mice by Inhibiting NF-?B Pathway.
Neoplasms
Ferulic acid combined with astragaloside IV protects against vascular endothelial dysfunction in diabetic rats.
Neoplasms
Fraxin inhibits lipopolysaccharide-induced inflammatory cytokines and protects against endotoxic shock in mice.
Neoplasms
Freeze-dried Si-Ni-San powder can ameliorate high fat diet-induced non-alcoholic fatty liver disease.
Neoplasms
Freshwater clam extract ameliorates acute liver injury induced by hemorrhage in rats.
Neoplasms
Freshwater Clam Extract Decreased Hemorrhagic Shock-Induced Liver Injury by Attenuating TNF-{alpha} Production.
Neoplasms
Fucoidan Ameliorates Oxidative Stress, Inflammation, DNA Damage, and Hepatorenal Injuries in Diabetic Rats Intoxicated with Aflatoxin B1.
Neoplasms
Fucoidan protects against subacute diazinon-induced oxidative damage in cardiac, hepatic, and renal tissues.
Neoplasms
Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk.
Neoplasms
Gamma glutamyltransferase, alanine aminotransferase and risk of cancer: Systematic review and meta-analysis.
Neoplasms
Gemfibrozil attenuates the inflammatory response and protects rats from abdominal sepsis.
Neoplasms
Gender-related differences in concanavalin A-induced liver injury and cytokine production in mice.
Neoplasms
Gene knockout or inhibition of macrophage migration inhibitory factor alleviates lipopolysaccharide-induced liver injury via inhibiting inflammatory response.
Neoplasms
Genome?wide identification of long noncoding RNAs in CCl4?induced liver fibrosis via RNA sequencing.
Neoplasms
Geranylgeranylacetone preconditioning may attenuate heat-induced inflammation and multiorgan dysfunction in rats.
Neoplasms
Geranylgeranylacetone suppresses inflammatory responses and improves survival after massive hepatectomy in rats.
Neoplasms
Ginkgo biloba extract improves oxidative organ damage in a rat model of thermal trauma.
Neoplasms
Ginsenoside Rg1 inhibits inflammatory responses via modulation of the nuclear factor??B pathway and inhibition of inflammasome activation in alcoholic hepatitis.
Neoplasms
Ginsenoside Rk1 ameliorates paracetamol-induced hepatotoxicity in mice through inhibition of inflammation, oxidative stress, nitrative stress and apoptosis.
Neoplasms
Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance.
Neoplasms
Glutamine provides effective protection against deltamethrin-induced acute hepatotoxicity in rats but not against nephrotoxicity.
Neoplasms
Glutathione protects against hepatic injury in a murine model of primary Sjögren's syndrome.
Neoplasms
Glycine attenuates endotoxin-induced liver injury by downregulating TLR4 signaling in Kupffer cells.
Neoplasms
Glycylproline dipeptidyl aminopeptidase isoenzyme in diagnosis of primary hepatocellular carcinoma.
Neoplasms
Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial.
Neoplasms
Green tea infusion protects against alcoholic liver injury by attenuating inflammation and regulating the PI3K/Akt/eNOS pathway in C57BL/6 mice.
Neoplasms
Green-tea Polyphenols Downregulate Cyclooxygenase and Bcl-2 Activity in Acetaminophen-induced Hepatotoxicity.
Neoplasms
Heat Shock Protein 70 (HSP70) Reduces Hepatic Inflammatory and Oxidative Damage in a Rat Model of Liver Ischemia/Reperfusion Injury with Hyperbaric Oxygen Preconditioning.
Neoplasms
Heme oxygenase 1 protects ethanol-administered liver tissue in Aldh2 knockout mice.
Neoplasms
Heme oxygenase-1 alleviates mouse hepatic failure through suppression of adaptive immune responses.
Neoplasms
Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
Neoplasms
Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model.
Neoplasms
Hepatic ischemia/reperfusion injury is prevented by a novel matrix metalloproteinase inhibitor, ONO-4817.
Neoplasms
Hepatic-portal oleic acid inhibits feeding more potently than hepatic-portal caprylic acid in rats.
Neoplasms
Hepatitis B genotype C correlated with poor surgical outcomes for hepatocellular carcinoma.
Neoplasms
Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.
Neoplasms
Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update.
Neoplasms
Hepato-protective effects of thymoquinone and beta-aminoisobutyric acid in streptozocin induced diabetic rats.
Neoplasms
Hepatoprotective and antioxidant effects of gallic acid in paracetamol-induced liver damage in mice.
Neoplasms
Hepatoprotective effect of ?-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
Neoplasms
Hepatoprotective Effect of Carboxymethyl Pachyman in Fluorouracil-Treated CT26-Bearing Mice.
Neoplasms
Hepatoprotective effect of chiisanoside against acetaminophen-induced acute liver injury in mice.
Neoplasms
Hepatoprotective effect of licorice, the root of Glycyrrhiza uralensis Fischer, in alcohol-induced fatty liver disease.
Neoplasms
Hepatoprotective effects of an active part from Artemisia sacrorum Ledeb. against acetaminophen-induced toxicity in mice.
Neoplasms
Hepatoprotective effects of Dicliptera chinensis polysaccharides on dimethylnitrosamine-induced hepatic fibrosis rats and its underlying mechanism.
Neoplasms
Hepatoprotective effects of green Capsicum annum against ethanol induced oxidative stress, inflammation and apoptosis in rats.
Neoplasms
Hepatoprotective effects of hoveniae semen cum fructus extracts in ethanol intoxicated mice.
Neoplasms
Hepatoprotective effects of licochalcone B on carbon tetrachloride-induced liver toxicity in mice.
Neoplasms
Hepatoprotective effects of purple potato extract against D-galactosamine-induced liver injury in rats.
Neoplasms
Hepatoprotective effects of salidroside on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice.
Neoplasms
Hepatoprotective effects of Tagetes lucida root extract in carbon tetrachloride-induced hepatotoxicity in Wistar albino rats through amelioration of oxidative stress.
Neoplasms
Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury.
Neoplasms
Hepatoprotective, Antihyperlipidemic, and Anti-inflammatory Activity of Moringa oleifera in Diabetic-induced Damage in Male Wistar Rats.
Neoplasms
Hesperetin Mitigates Bile Duct Ligation-Induced Liver Fibrosis by Inhibiting Extracellular Matrix and Cell Apoptosis via the TGF-?1/Smad Pathway.
Neoplasms
Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
Neoplasms
High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Neoplasms
High Levels of TRIM14 Are Associated with Poor Prognosis in Hepatocellular Carcinoma.
Neoplasms
Highly liver-specific heme oxygenase-1 induction by interleukin-11 prevents carbon tetrachloride-induced hepatotoxicity.
Neoplasms
Highly Purified Eicosapentaenoic Acid Treatment Improves Nonalcoholic Steatohepatitis.
Neoplasms
HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer.
Neoplasms
Hot water extracted Lycium barbarum and Rehmannia glutinosa inhibit liver inflammation and fibrosis in rats.
Neoplasms
Humulus japonicus Extracts Protect Against Lipopolysaccharide/d-Galactosamine-Induced Acute Liver Injury in Rats.
Neoplasms
Hydrogen-rich saline protects against liver injury in rats with obstructive jaundice.
Neoplasms
Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice.
Neoplasms
Hyperbaric oxygen treatment and N-acetylcysteine ameliorate acetaminophen-induced liver injury in a rat model.
Neoplasms
Hyperoxygenated hydrogen-rich solution suppresses shock- and resuscitation-induced liver injury.
Neoplasms
Hypothermic machine perfusion with metformin-University of Wisconsin solution for
Neoplasms
Immunodepressants ameliorate normothermic ischemia injury to the rat liver by down-regulating tumor necrosis factor, not by alleviation of lipid peroxidative injury.
Neoplasms
Immunoliposome co-delivery of bufalin and anti-CD40 antibody adjuvant induces synergetic therapeutic efficacy against melanoma.
Neoplasms
Immunotherapy for nonalcoholic steatohepatitis using the multiple cytokine production modulator Y-40138.
Neoplasms
Impact Factors for Microinvasion in Intrahepatic Cholangiocarcinoma: A Possible System for Defining Clinical Target Volume.
Neoplasms
Impact of increased aspartate aminotransferase to alanine aminotransferase (De Ritis) ratio in prognosis of testicular cancer.
Neoplasms
Impact of preoperative steroids administration on ischemia-reperfusion injury and systemic responses in liver surgery: a prospective randomized study.
Neoplasms
Impact of Viral Etiology on Postoperative De Novo Recurrence After Hepatectomy for Hepatocellular Carcinoma in Cirrhotic Patients.
Neoplasms
Impaired expression of caveolin-1 contributes to hepatic ischemia and reperfusion injury.
Neoplasms
Implication of B lymphocytes in endotoxin-induced hepatic injury after partial hepatectomy in rats.
Neoplasms
Implication of Protein Kinase A for a Hepato-Protective Mechanism of Milrinone Pretreatment.
Neoplasms
Importance of pyridoxal-5'-phosphate addition to the assay medium for the measurement of catalytic concentrations of plasma aspartate and alanine aminotransferases in patients undergoing antineoplastic chemotherapy.
Neoplasms
Improved protective effects of American ginseng berry against acetaminophen-induced liver toxicity through TNF-?-mediated caspase-3/-8/-9 signaling pathways.
Neoplasms
In silico and in vivo characterization of cabralealactone, solasodin and salvadorin in a rat model: potential anti-inflammatory agents.
Neoplasms
In vivo hepatoprotective activity of the aqueous extract of Artemisia absinthium L. against chemically and immunologically induced liver injuries in mice.
Neoplasms
In vivo induction of hepatocellular carcinoma by diethylnitrosoamine and pharmacological intervention in Balb C mice using Bergenia ciliata extracts.
Neoplasms
Incorporation of all-trans retinoic acid into lipoplexes inhibits nuclear factor kappaB activation mediated liver injury induced by lipoplexes in mice.
Neoplasms
Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity.
Neoplasms
Increased lipopolysaccharide sensitivity in alcoholic fatty livers is independent of leptin deficiency and toll-like receptor 4 (TLR4) or TLR2 mRNA expression.
Neoplasms
Independent determinants of soluble form of receptor for advanced glycation end products in elderly hypertensive patients.
Neoplasms
Induction of Chronic Subclinical Systemic Inflammation in Sprague-Dawley Rats Stimulated by Intermittent Bolus Injection of Lipopolysaccharide.
Neoplasms
Inflammatory cytokine response to Vibrio vulnificus elicited by peripheral blood mononuclear cells from chronic alcohol users is associated with biomarkers of cellular oxidative stress.
Neoplasms
Influence of Dietary Chitosan Feeding Duration on Glucose and Lipid Metabolism in a Diabetic Rat Model.
Neoplasms
Influences of Jieyu Ruanjian Huoxue prescription on hepatic fibrosis indices and APRI in patients with hepatitis B cirrhosis.
Neoplasms
Inhibition of 5-lipoxygenase pathway attenuates acute liver failure by inhibiting macrophage activation.
Neoplasms
Inhibition of alanine aminotransferase in silico and in vivo promotes mitochondrial metabolism to impair malignant growth.
Neoplasms
Inhibition of chemically induced carcinogenesis by drugs used in homeopathic medicine.
Neoplasms
Inhibition of ghrelin o-acyltransferase attenuated lipotoxicity by inducing autophagy via AMPK-mTOR pathway.
Neoplasms
Inhibition of nitric oxide synthesis by L-name exacerbates acute lung injury induced by hepatic ischemia-reperfusion.
Neoplasms
Inhibitory effect of cordycepin on experimental hepatic metastasis of B16-F0 mouse melanoma cells.
Neoplasms
Inhibitory effect of MIL glycoprotein on expression of pro-inflammatory mediators in carbon tetrachloride-induced mice liver damage.
Neoplasms
Inhibitory Effect of Nelumbo nucifera Leaf Extract on 2-Acetylaminofluorene-induced Hepatocarcinogenesis Through Enhancing Antioxidative Potential and Alleviating Inflammation in Rats.
Neoplasms
Inhibitory potential of methanolic extracts of Aristolochia tagala and Curcuma caesia on hepatocellular carcinoma induced by diethylnitrosamine in BALB/c mice.
Neoplasms
Institutional results of OncoOVARIAN Dx - a novel algorithm for the preoperative evaluation of adnexal masses.
Neoplasms
Insulin Plant (Costus pictus) Extract Restores Thyroid Hormone Levels in Experimental Hypothyroidism.
Neoplasms
Insulin protects against hepatocyte ultrastructural damage induced by type 1 diabetes mellitus in rats.
Neoplasms
Insulin-like growth factor-I, interleukin-1 alpha and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes.
Neoplasms
Integrative transcriptome analysis of liver cancer profiles identifies upstream regulators and clinical significance of ACSM3 gene expression.
Neoplasms
Intra-arterial administration of the angiogenesis inhibitor TNP-470 blocks liver metastasis in a rabbit model.
Neoplasms
Investigation of anti-inflammatory effects of bee venom in experimentally induced adjuvant arthritis.
Neoplasms
Investigation of antioxidant, anti-inflammatory and DNA-protective properties of eugenol in thioacetamide-induced liver injury in rats.
Neoplasms
Involvement of hepatic peroxisome proliferator-activated receptor ?/? in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats.
Neoplasms
Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin.
Neoplasms
Ischemic postconditioning improves the outcome of organs from donors after cardiac death in a pig liver transplantation model and provides synergistic protection with hypothermic machine perfusion.
Neoplasms
Ischemic preconditioning attenuates morphological and biochemical changes in hepatic ischemia/reperfusion in rats.
Neoplasms
Ischemic Preconditioning Preserves Liver Energy Charge and Function on Hepatic Ischemia/Reperfusion Injury in Rats.
Neoplasms
Ischemic Preconditioning-Like Effect of Polyunsaturated Fatty Acid-Rich Diet on Hepatic Ischemia/Reperfusion Injury.
Neoplasms
Japanese herbal medicine, Saiko-keishi-to, prevents gut ischemia/reperfusion-induced liver injury in rats via nitric oxide.
Neoplasms
Jaundice and Elevated Beta-Human Chorionic Gonadotropin in a Female: Duodenal Choriocarcinoma, Not Pregnancy.
Neoplasms
Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis.
Neoplasms
Kupffer cell phagocytosis blockade decreases morbidity in endotoxemic rats with obstructive jaundice.
Neoplasms
L-carnitine alleviates alcohol-induced liver damage in rats: role of tumour necrosis factor-alpha.
Neoplasms
L-carnitine could not improve hepatic warm ischemia-reperfusion injury despite ameliorated blood flow.
Neoplasms
l-Carnitine Supplementation to Diet: A New Tool in Treatment of Nonalcoholic Steatohepatitis-A Randomized and Controlled Clinical Trial.
Neoplasms
Lactobacillus fermentum ZYL0401 Attenuates Lipopolysaccharide-Induced Hepatic TNF-? Expression and Liver Injury via an IL-10- and PGE2-EP4-Dependent Mechanism.
Neoplasms
Lactoferrin dampens high-fructose corn syrup-induced hepatic manifestations of the metabolic syndrome in a murine model.
Neoplasms
Laparoscopic left lateral hepatic sectionectomy was expected to be the standard for the treatment of left hepatic lobe lesions: A meta-analysis.
Neoplasms
Laparoscopic Liver Resection and Enucleation of Liver Hemangioma with Selective Hepatic Vascular Occlusion: Technique and Indications.
Neoplasms
Laparoscopic Microwave Ablation of Hepatocellular Carcinoma at Liver Surface: Technique Effectiveness and Long-Term Outcomes.
Neoplasms
Latent gallbladder carcinoma in a young adult patient with acute cholecystitis: report of a case.
Neoplasms
LBP inhibitory peptide reduces endotoxin-induced macrophage activation and mortality.
Neoplasms
Leucine amino peptidase a better indicator of carcinoma of liver, biliary tract and pancreas.
Neoplasms
Levels of certain tumor markers as differential factors between bilharzial and non-biharzial bladder cancer among Egyptian patients.
Neoplasms
Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
Neoplasms
Lipopolysaccharide/Toll-like receptor 4 signaling pathway involved Qingdu decoction treating severe liver injury merging with endotoxemia.
Neoplasms
Liver injury is most commonly due to hepatic metastases rather than drug hepatotoxicity during pembrolizumab immunotherapy.
Neoplasms
Liver X Receptors Activation Attenuates Ischemia Reperfusion Injury of Liver Graft in Rats.
Neoplasms
LXR? represses LPS-induced inflammatory responses by competing with IRF3 for GRIP1 in Kupffer cells.
Neoplasms
LXRalpha gene downregulation by lentiviral-based RNA interference enhances liver function after fatty liver transplantation in rats.
Neoplasms
Lycopene prevents development of steatohepatitis in experimental nonalcoholic steatohepatitis model induced by high-fat diet.
Neoplasms
Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Neoplasms
Machine Learning Approaches to Identify Factors Associated with Women's Vasomotor Symptoms Using General Hospital Data.
Neoplasms
Macrophage inflammatory protein-1alpha plays a crucial role in concanavalin A-induced liver injury through induction of proinflammatory cytokines in mice.
Neoplasms
Malaysian propolis, metformin and their combination, exert hepatoprotective effect in streptozotocin-induced diabetic rats.
Neoplasms
Malignant biliary strictures in patients with a normal bilirubin and/or normal liver enzymes.
Neoplasms
Maltol, a food flavoring agent, attenuates acute alcohol-induced oxidative damage in mice.
Neoplasms
Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations.
Neoplasms
Mao (Ephedra sinica Stapf) protects against D-galactosamine and lipopolysaccharide-induced hepatic failure.
Neoplasms
Marchantia polymorpha L. Flavonoids Protect Liver From CCl4-Induced Injury by Antioxidant and Gene-Regulatory Effects.
Neoplasms
Markedly Elevated Serum Aspartate Aminotransferase to Alanine Aminotransferase Ratio: A Clue to Hepatic Neoplasia.
Neoplasms
Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection.
Neoplasms
Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.
Neoplasms
Mesenchymal stem cell transplantation in polytrauma: Evaluation of bone and liver healing response in an experimental rat model.
Neoplasms
Metformin and silymarin afford protection in cyclosporine A induced hepatorenal toxicity in rat by modulating redox status and inflammation.
Neoplasms
Metformin inhibits mTOR-HIF-1? axis and profibrogenic and inflammatory biomarkers in thioacetamide-induced hepatic tissue alterations.
Neoplasms
Metformin protects against diabetes-induced heart injury and dunning prostate cancer model.
Neoplasms
Methyl 3,4-dihydroxybenzoate protects against d-galN/LPS-induced acute liver injury by inhibiting inflammation and apoptosis in mice.
Neoplasms
Methylprednisolone injection via the portal vein suppresses inflammation in acute liver failure induced in rats by lipopolysaccharide and d-galactosamine.
Neoplasms
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis.
Neoplasms
Milk enriched with conjugated linoleic Acid fails to alter blood lipids or body composition in moderately overweight, borderline hyperlipidemic individuals.
Neoplasms
Milk?derived hexapeptide PGPIPN prevents and attenuates acute alcoholic liver injury in mice by reducing endoplasmic reticulum stress.
Neoplasms
Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.
Neoplasms
mir-221, mir-190b, mir-363-3p, mir-200c are involved in rat liver ischaemia-reperfusion injury through oxidative stress, apoptosis and endoplasmic reticulum stress.
Neoplasms
miR-34b-3p protects against acute kidney injury in sepsis mice via targeting ubiquitin-like protein 4A.
Neoplasms
miR-942 promotes proliferation and metastasis of hepatocellular carcinoma cells by inhibiting RRM2B.
Neoplasms
Modulation of the cannabinoid receptors by andrographolide attenuates hepatic apoptosis following bile duct ligation in rats with fibrosis.
Neoplasms
Modulatory effects of artichoke (Cynara scolymus L.) leaf extract against oxidative stress and hepatic TNF-? gene expression in acute diazinon-induced liver injury in rats.
Neoplasms
Modulatory effects of lxora coccinea flower on Cyclophosphamidetoxicity in tumour bearing mice.
Neoplasms
Modulatory effects of some natural products on hepatotoxicity induced by combination of sodium valproate and paracetamol in rats.
Neoplasms
Molecular mechanism of inflammatory response in mouse liver caused by exposure to CeCl(3).
Neoplasms
Montelukast, a leukotriene receptor antagonist abrogates lipopolysaccharide-induced toxicity and oxidative stress in rat liver.
Neoplasms
Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction.
Neoplasms
MRI with hyperpolarised [1-13C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model.
Neoplasms
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Neoplasms
NBD Peptides Protect Against Ischemia Reperfusion After Orthotopic Liver Transplantation in Rats.
Neoplasms
Neonatal overfeeding in mice aggravates the development of methionine and choline-deficient diet-induced steatohepatitis in adulthood.
Neoplasms
New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress.
Neoplasms
Nobiletin attenuates lipopolysaccharide/D?galactosamine?induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF??B?mediated cytokine production.
Neoplasms
Nobiletin Protects against Acute Liver Injury via Targeting c-Jun N-Terminal Kinase (JNK)-Induced Apoptosis of Hepatocytes.
Neoplasms
NOD receptor and TLR9 modulation in severe acute pancreatitis?induced intestinal injury.
Neoplasms
Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI.
Neoplasms
Nomograms in Hepatectomy Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.
Neoplasms
Non-specific elevation of serum Mac-2 binding protein glycosylation isomer levels in patients with biliary disease.
Neoplasms
Novel cuminaldehyde self-emulsified nanoemulsion for enhanced antihepatotoxicity in carbon tetrachloride-treated mice.
Neoplasms
Novel recombinant fibrinogenase of Agkistrodon acutus venom protects against LPS-induced DIC.
Neoplasms
Nrf2 participates in mechanisms for reducing the toxicity and enhancing the antitumour effect of Radix Tripterygium wilfordii to S180-bearing mice by herbal-processing technology.
Neoplasms
Obestatin improves hepatic injury induced by ischemia/reperfusion in rats: Role of nitric oxide.
Neoplasms
Oil rich in carotenoids instead of vitamins C and E as a better option to reduce doxorubicin-induced damage to normal cells of Ehrlich tumor-bearing mice: hematological, toxicological and histopathological evaluations.
Neoplasms
Oldenlandia diffusa Promotes Antiproliferative and Apoptotic Effects in a Rat Hepatocellular Carcinoma with Liver Cirrhosis.
Neoplasms
Omega-3 fatty acids decreases oxidative stress, tumor necrosis factor-alpha, and interleukin-1 beta in hyperthyroidism-induced hepatic dysfunction rat model.
Neoplasms
Oral administration of cilostazol improves survival rate after rat liver ischemia/reperfusion injury.
Neoplasms
Orthotopic liver transplantation from cardiac death donors in the mouse: a new model and evaluation of cardiac death time.
Neoplasms
Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.
Neoplasms
Oxidative Stress Parameters in the Liver of Growing Male Rats Receiving Various Alcoholic Beverages.
Neoplasms
Oxymatrine Induces Liver Injury through JNK Signalling Pathway Mediated by TNF-? In Vivo.
Neoplasms
P38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver.
Neoplasms
Panaxynol from Saposhnikovia diviaricata exhibits a hepatoprotective effect against lipopolysaccharide + D-Gal N induced acute liver injury by inhibiting Nf-?B/I?B-? and activating Nrf2/HO-1 signaling pathways.
Neoplasms
Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fas-antibody-induced liver injury.
Neoplasms
Pathological mechanisms of liver injury caused by continuous intraperitoneal injection of silica nanoparticles.
Neoplasms
Pathophysiological role of the acute inflammatory response during acetaminophen hepatotoxicity.
Neoplasms
PEDIATRIC VISCERAL ADIPOSITY INDEX ADAPTATION CORRELATES WITH HOMA-IR, MATSUDA, AND TRANSAMINASES.
Neoplasms
Pediococcus pentosaceus PP04 Ameliorates High-Fat Diet-Induced Hyperlipidemia by Regulating Lipid Metabolism in C57BL/6N Mice.
Neoplasms
Perfusion using oxygenated buffer containing prostaglandin E1 before cold preservation prevents warm ischemia-reperfusion injury in liver grafts from non-heart-beating donors.
Neoplasms
Peritumoral Dilation Radiomics of Gadoxetate Disodium-Enhanced MRI Excellently Predicts Early Recurrence of Hepatocellular Carcinoma without Macrovascular Invasion After Hepatectomy.
Neoplasms
Peroxisome proliferator activated receptor-gamma in pathogenesis of experimental fatty liver disease.
Neoplasms
Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study.
Neoplasms
Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factors.
Neoplasms
PGE from Octopus aegina Induces Apoptosis in Ehrlich's Ascites Carcinoma of Mice.
Neoplasms
Phosphorylation of Histone H2A.X in Peripheral Blood Mononuclear Cells May Be a Useful Marker for Monitoring Cardiometabolic Risk in Nondiabetic Individuals.
Neoplasms
Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats.
Neoplasms
Platonin, a cyanine photosensitizing dye, is effective for attenuation of heatstroke in rats.
Neoplasms
Polyherbal formula SC-E3 inhibits rheumatoid arthritis activity in a mouse model of type-II collagen-induced arthritis.
Neoplasms
Polymyxin B Protects Against Hepatic Ischemia/Reperfusion Injury in a Rat Model of Obstructive Jaundice.
Neoplasms
Population pharmacokinetic modeling of Sepantronium bromide (YM155), a small molecule survivin suppressant, in patients with non-small cell lung cancer, hormone refractory prostate cancer, or unresectable stage III or IV melanoma.
Neoplasms
Porous SiO2 -coated ultrasmall selenium particles nanospheres attenuate cerulein-induce acute pancreatitis in mice by downregulating oxidative stress.
Neoplasms
Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.
Neoplasms
Post-operative blood tests and multicentric recurrence of hepatocellular carcinoma.
Neoplasms
Posthepatectomy hepatitis shortens tumor-free intervals in hepatitis C virus-associated hepatocellular carcinoma patients.
Neoplasms
Potential effects of the combination of nicotinamide, vitamin B2 and vitamin C on oxidative-mediated hepatotoxicity induced by thioacetamide.
Neoplasms
Potential protective effects of oral administration of allicin on acrylamide-induced toxicity in male mice.
Neoplasms
Potential therapeutic effect of thymoquinone and/or bee pollen on fluvastatin-induced hepatitis in rats.
Neoplasms
PPAR-alpha agonist treatment increases trefoil factor family-3 expression and attenuates apoptosis in the liver tissue of bile duct-ligated rats.
Neoplasms
Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Neoplasms
Predictors of distant metastasis on exploration in patients with potentially resectable pancreatic cancer.
Neoplasms
Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization.
Neoplasms
Preliminary characterization and potential hepatoprotective effect of polysaccharides from Cipangopaludina chinensis.
Neoplasms
Preoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma.
Neoplasms
Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular Carcinoma.
Neoplasms
Preoperative serum markers for individual patient prognosis in stage I-III colon cancer.
Neoplasms
Preparation of long-acting microspheres loaded with octreotide for the treatment of portal hypertensive.
Neoplasms
Preserving hepatic artery flow during portal triad blood occlusion improves regeneration of the remnant liver in rats with obstructive jaundice following partial hepatectomy.
Neoplasms
Pretreatment of Vitamin D3 Ameliorates Lung and Muscle Injury Induced by Reperfusion of Bilateral Femoral Vessels in a Rat Model.
Neoplasms
Pretreatment serum C-reactive protein level predicts poor prognosis in patients with hepatocellular carcinoma.
Neoplasms
Prevalence, clinical & biochemical correlates of non-alcoholic fatty liver disease in overweight adolescents.
Neoplasms
Prevention of hepatic injury by a traditional Chinese formulation, BJ-JN, in mice treated with Bacille-Calmette-Guérin and lipopolysaccharide.
Neoplasms
Preventive agents against sepsis and new phenylpropanoid glucosides from the fruits of Illicium verum.
Neoplasms
Preventive effect of Agnucastoside C against Isoproterenol-induced myocardial injury.
Neoplasms
Preventive Effect of Blueberry Extract on Liver Injury Induced by Carbon Tetrachloride in Mice.
Neoplasms
Preventive effect of cyclosporin A on experimentally induced acute liver injury in rats.
Neoplasms
Preventive effect of FK 506 (tacrolimus hydrate) on experimentally induced acute liver injury in rats.
Neoplasms
Preventive effect of omega-3 fatty acids in a rat model of stress-induced liver injury.
Neoplasms
Preventive effect of phytoglycoprotein (27 kDa) on inflammatory factors at liver injury in cadmium chloride-exposed ICR mice.
Neoplasms
Preventive effect of phytoglycoprotein (27?kDa) on inflammatory factors at liver injury in cadmium chloride-exposed ICR mice.
Neoplasms
Preventive effect of small-leaved Kuding tea (Ligustrum robustum) on high-diet-induced obesity in C57BL/6J mice.
Neoplasms
Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors.
Neoplasms
Probiotic and glutamine treatments attenuate alcoholic liver disease in a rat model.
Neoplasms
Probiotic and hepatoprotective activity of lactobacillus isolated from Mongolian camel milk products.
Neoplasms
Probiotic Bacillus Spores Protect Against Acetaminophen Induced Acute Liver Injury in Rats.
Neoplasms
Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice.
Neoplasms
Prognostic and diagnostic value of serum pseudocholinesterase, serum aspartate transaminase, and serum alinine transaminase in malignancies treated by radiotherapy.
Neoplasms
Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer.
Neoplasms
Prognostic value of aspartate transaminase to alanine transaminase (De Ritis) ratio in solid tumors: a pooled analysis of 9,400 patients.
Neoplasms
Prognostic-factors-based risk-stratification model for invasive urothelial carcinoma of the urinary bladder in Taiwan.
Neoplasms
Prolonged Changes in Hepatic Mitochondrial Activity and Insulin Sensitivity by High Fructose Intake in Adolescent Rats.
Neoplasms
Prophylactic administration of carnosine and melatonin abates the incidence of apoptosis, inflammation, and DNA damage induced by titanium dioxide nanoparticles in rat livers.
Neoplasms
Prophylactic and therapeutic effects of taurine against aluminum-induced acute hepatotoxicity in mice.
Neoplasms
Prophylactic effect of resveratrol against ethinylestradiol-induced liver cholestasis.
Neoplasms
Prospective association of liver function biomarkers with development of hepatobiliary cancers.
Neoplasms
Prospective randomized study of the benefits of preoperative corticosteroid administration on hepatic ischemia-reperfusion injury and cytokine response in patients undergoing hepatic resection.
Neoplasms
Protection against hepatic ischemia/reperfusion injury via downregulation of toll-like receptor 2 expression by inhibition of Kupffer cell function.
Neoplasms
Protection effect of triptolide to liver injury in rats with severe acute pancreatitis.
Neoplasms
Protection of a polysaccharide from Salvia miltiorrhiza, a Chinese medicinal herb, against immunological liver injury in mice.
Neoplasms
Protective Effect of Acteoside on Immunological Liver Injury Induced by Bacillus Calmette-Guerin plus Lipopolysaccharide.
Neoplasms
Protective effect of Aframomum melegueta phenolics against CCl?-induced rat hepatocytes damage; role of apoptosis and pro-inflammatory cytokines inhibition.
Neoplasms
Protective effect of an L-type calcium channel blocker, amlodipine, on paracetamol-induced hepatotoxicity in rats.
Neoplasms
Protective effect of apigenin on d-galactosamine/LPS-induced hepatocellular injury by increment of Nrf-2 nucleus translocation.
Neoplasms
Protective effect of astaxanthin against multiple organ injury in a rat model of sepsis.
Neoplasms
Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1.
Neoplasms
Protective effect of danhong injection on acute hepatic failure induced by lipopolysaccharide and d-galactosamine in mice.
Neoplasms
Protective effect of dihydromyricetin revents fatty liver through nuclear factor??B/p53/B?cell lymphoma 2?associated X protein signaling pathways in a rat model.
Neoplasms
Protective effect of early enteral feeding on postburn impairment of liver function and its mechanism in rats.
Neoplasms
Protective effect of isoorientin-2?-O-?-L-arabinopyranosyl isolated from Gypsophila elegans on alcohol induced hepatic fibrosis in rats.
Neoplasms
Protective effect of lignans against sepsis from the roots of Saururus chinensis.
Neoplasms
Protective effect of linarin against d-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
Neoplasms
Protective effect of lipopolysaccharide preconditioning in hepatic ischaemia reperfusion injury.
Neoplasms
Protective Effect of Luteolin on D-Galactosamine (D-Gal)/Lipopolysaccharide (LPS) Induced Hepatic Injury by in Mice.
Neoplasms
Protective effect of Momordica charantia water extract against liver injury in restraint-stressed mice and the underlying mechanism.
Neoplasms
Protective Effect of n-Butanol Extract from Viola yedoensis on Immunological Liver Injury.
Neoplasms
Protective effect of oroxylin A against lipopolysaccharide and/or D-galactosamine-induced acute liver injury in mice.
Neoplasms
Protective Effect of Phaleria macrocarpa Water Extract (Proliverenol) against Carbon Tetrachloride-Induced Liver Fibrosis in Rats: Role of TNF-? and TGF-?1.
Neoplasms
Protective effect of pinitol against D-galactosamine-induced hepatotoxicity in rats fed on a high-fat diet.
Neoplasms
Protective effect of protocatechuic acid isopropyl ester against murine models of sepsis: inhibition of TNF-alpha and nitric oxide production and augmentation of IL-10.
Neoplasms
Protective effect of pyrrolidine dithiocarbamate on liver injury induced by intestinal ischemia-reperfusion in rats.
Neoplasms
Protective Effect of Schisandra chinensis Polysaccharides Against the Immunological Liver Injury in Mice Based on Nrf2/ARE and TLR4/NF-?B Signaling Pathway.
Neoplasms
Protective effect of trapidil and l-arginine against renal and hepatic toxicity induced by cyclosporine in rats.
Neoplasms
Protective effects of 2-methoxycinnamaldehyde an active ingredients of Cinnamomum cassia on warm hepatic ischemia reperfusion injury in rat model.
Neoplasms
Protective effects of ?-mangostin against acetaminophen-induced acute liver injury in mice.
Neoplasms
Protective effects of Acanthopanax divaricatus vat. albeofructus and its active compound on ischemia-reperfusion injury of rat liver.
Neoplasms
Protective Effects of Antioxidant Peptide SS-31 Against Multiple Organ Dysfunctions During Endotoxemia.
Neoplasms
Protective effects of antioxidant raxofelast in alcohol-induced liver disease in mice.
Neoplasms
Protective effects of apocynin and allopurinol on ischemia/reperfusion-induced liver injury in mice.
Neoplasms
Protective effects of Asiaticoside on acute liver injury induced by lipopolysaccharide/D-galactosamine in mice.
Neoplasms
Protective effects of coffee-derived compounds on lipopolysaccharide/D-galactosamine induced acute liver injury in rats.
Neoplasms
Protective Effects of Genistein and Puerarin against Chronic Alcohol-Induced Liver Injury in Mice via Antioxidant, Anti-inflammatory, and Anti-apoptotic Mechanisms.
Neoplasms
Protective effects of lupeol against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure in mice.
Neoplasms
Protective effects of luteolin against acetaminophen-induced acute liver failure in mouse.
Neoplasms
Protective effects of melatonin against thioacetamide-induced liver fibrosis in rats.
Neoplasms
Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-?B and activating Nrf2/HO-1 signaling pathways.
Neoplasms
Protective effects of oxymatrine against lipopolysaccharide/D?galactosamine?induced acute liver failure through oxidative damage, via activation of Nrf2/HO?1 and modulation of inflammatory TLR4?signaling pathways.
Neoplasms
Protective effects of phloridzin against methotrexate-induced liver toxicity in rats.
Neoplasms
Protective effects of polydatin from Polygonum cuspidatum against carbon tetrachloride-induced liver injury in mice.
Neoplasms
Protective effects of pterostilbene against acetaminophen-induced hepatotoxicity in rats.
Neoplasms
Protective effects of salidroside against acetaminophen-induced toxicity in mice.
Neoplasms
Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-?B signaling.
Neoplasms
Protective Effects of Silymarin, Alone or in Combination with Chlorogenic Acid and/or Melatonin, Against Carbon Tetrachloride-induced Hepatotoxicity.
Neoplasms
Protective effects of soyasapogenol A on liver injury mediated by immune response in a concanavalin A-induced hepatitis model.
Neoplasms
Protective effects of spironolactone against hepatic ischemia/reperfusion injury in rats.
Neoplasms
Protective effects of St. John's wort in the hepatic ischemia/reperfusion injury in rats.
Neoplasms
Protective Effects of Taraxasterol against Ethanol-Induced Liver Injury by Regulating CYP2E1/Nrf2/HO-1 and NF-?B Signaling Pathways in Mice.
Neoplasms
Protective effects of the active part of Artemisia sacrorum ledeb. against acetaminophen-induced liver injury in mice.
Neoplasms
Protective role of chrysin on thioacetamide-induced hepatic encephalopathy in rats.
Neoplasms
Protective Role of Grape Seed Proanthocyanidins Against Ccl4 Induced Acute Liver Injury in Mice.
Neoplasms
Protective role of heme oxygenase-1 induction in carbon tetrachloride-induced hepatotoxicity.
Neoplasms
Puerarin enhances intestinal function in piglets infected with porcine epidemic diarrhea virus.
Neoplasms
Purification, characterization and bioactivity of polysaccharides from Glossaulax didyma.
Neoplasms
Quercitrin Attenuates Acetaminophen-Induced Acute Liver Injury by Maintaining Mitochondrial Complex I Activity.
Neoplasms
Radiation-synthesis of chitosan/poly (acrylic acid) nanogel for improving the antitumor potential of rutin in hepatocellular carcinoma.
Neoplasms
Raspberry ketone protects rats fed high-fat diets against nonalcoholic steatohepatitis.
Neoplasms
Raw Bowl Tea (Tuocha) Polyphenol Prevention of Nonalcoholic Fatty Liver Disease by Regulating Intestinal Function in Mice.
Neoplasms
Recombinant adenovirus containing hyper-interleukin-6 and hepatocyte growth factor ameliorates acute-on-chronic liver failure in rats.
Neoplasms
Recurrence of Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy.
Neoplasms
Reduced glutathione ameliorates liver function, oxidative stress and inflammation after interventional therapy for hepatocellular carcinoma.
Neoplasms
Regulation of alpha 1-adrenoceptor on rat hepatocyte apoptosis induced by D-galactosamine and lipopolysaccharide.
Neoplasms
Remote Ischemic Conditioning Prevents Lung and Liver Injury After Hemorrhagic Shock/Resuscitation: Potential Role of a Humoral Plasma Factor.
Neoplasms
Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
Neoplasms
Resistance to vemurafenib can be reversible after treatment interruption: a case report of a metastatic melanoma patient.
Neoplasms
Response surface methodology to extraction of tea polysaccharide and its antitumour activity.
Neoplasms
Resveratrol attenuates the progress of liver fibrosis via the Akt/nuclear factor-?B pathways.
Neoplasms
Resveratrol Pretreatment Ameliorates p53-Bax Axis and Augments the Survival Biomarker B-Cell Lymphoma 2 Modulated by Paracetamol Overdose in a Rat Model of Acute Liver Injury.
Neoplasms
Resveratrol prevents liver damage in MCD-induced steatohepatitis mice by promoting SIGIRR gene transcription.
Neoplasms
Retrospective analysis of T-lymphocyte subsets and cytokines in malignant obstructive jaundice before and after external and internal biliary drainage.
Neoplasms
Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot.
Neoplasms
Risk factors for histological progression of non-alcoholic steatohepatitis analyzed from repeated biopsy cases.
Neoplasms
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
Neoplasms
Risk factors for postoperative delirium after liver resection for hepatocellular carcinoma.
Neoplasms
Risk factors for recurrence after curative resection of hepatitis C-related hepatocellular carcinoma in patients without postoperative interferon therapy.
Neoplasms
Risk factors of early re-bleeding and mortality in patients with ruptured gastric varices and concomitant hepatocellular carcinoma.
Neoplasms
Risk of malignancies in autoimmune hepatitis type 1 patients with a long-term follow-up in Japan.
Neoplasms
Risk of Severe Acute Exacerbation of Chronic HBV Infection Cancer Patients Who Underwent Chemotherapy and Did Not Receive Anti-Viral Prophylaxis.
Neoplasms
Rodent models of hepatic ischemia-reperfusion injury: time and percentage-related pathophysiological mechanisms.
Neoplasms
Role of Asxl2 in non?alcoholic steatohepatitis?related hepatocellular carcinoma developed from diabetes.
Neoplasms
Role of Baicalin and Liver X Receptor Alpha in the Formation of Cholesterol Gallstones in Mice.
Neoplasms
Role of IL-10 polymorphisms in susceptibility to hepatitis B virus-related hepatocellular carcinoma.
Neoplasms
Role of inhibition of p38 mitogen-activated protein kinase in liver dysfunction after hemorrhagic shock and resuscitation.
Neoplasms
Role of necroptosis in autophagy signaling during hepatic ischemia and reperfusion.
Neoplasms
Role of the renin-angiotensin system in hepatic ischemia reperfusion injury in rats.
Neoplasms
Role of thromboxane derived from COX-1 and -2 in hepatic microcirculatory dysfunction during endotoxemia in mice.
Neoplasms
Role of toll-like receptor 4 in the pathophysiology of severe acute pancreatitis in mice.
Neoplasms
Rossicaside B Protects against Carbon Tetrachloride-induced Hepatotoxicity in Mice.
Neoplasms
Ruptured hepatocellular carcinoma: treatment strategy and prognostic factor analysis.
Neoplasms
S-allyl cysteine, an active ingredient of garlic, attenuates acute liver dysfunction induced by lipopolysaccharide/ d-galactosamine in mouse: Underlying mechanisms.
Neoplasms
Safe use of capecitabine-cisplatin in metastatic gastric carcinoma with severe liver dysfunction: a case report from Algeria.
Neoplasms
Safety and Efficacy of Infliximab in Severe Alcoholic Hepatitis: A Systematic Review.
Neoplasms
Safety of the intravenous administration of neurotensin-polyplex nanoparticles in BALB/c mice.
Neoplasms
Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice.
Neoplasms
Salvianolic acid B protects against sepsis-induced liver injury via activation of SIRT1/PGC-1? signaling.
Neoplasms
Saponins (Ginsenosides) from the Leaves of Panax quinquefolius Ameliorated Acetaminophen-Induced Hepatotoxicity in Mice.
Neoplasms
Schisandra chinensis acidic polysaccharide partialy reverses acetaminophen-induced liver injury in mice.
Neoplasms
Sea buckthorn (Hippophae rhamnoides L.) fermentation liquid protects against alcoholic liver disease linked to regulation of liver metabolome and the abundance of gut microbiota.
Neoplasms
Selective bowel decontamination of recipients for prevention against liver injury following orthotopic liver transplantation: evaluation with rat models.
Neoplasms
Selenium-biofortified corn peptides: Attenuating concanavalin A-Induced liver injury and structure characterization.
Neoplasms
Selenium-containing soybean antioxidant peptides: Preparation and comprehensive comparison of different selenium supplements.
Neoplasms
Semimechanistic pharmacokinetic/pharmacodynamic model for hepatoprotective effect of dexamethasone on transient transaminitis after trabectedin (ET-743) treatment.
Neoplasms
Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice.
Neoplasms
Serum ALT elevations in survivors of childhood cancer. A report from the St. Jude Lifetime Cohort Study.
Neoplasms
Serum biochemical parameters and cytokine profiles associated with natural African trypanosome infections in cattle.
Neoplasms
Serum enzyme activity in bone tumors and osteomyelitis (LDH, GOT, GPT, CPK, CHE, ALP, AP, PP, ALD).
Neoplasms
Serum exosomal microRNA-122 and microRNA-21 as predictive biomarkers in transarterial chemoembolization-treated hepatocellular carcinoma patients.
Neoplasms
Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival.
Neoplasms
Sesame oil mitigates nutritional steatohepatitis via attenuation of oxidative stress and inflammation: a tale of two-hit hypothesis.
Neoplasms
Sesame oil protects against lead-plus-lipopolysaccharide-induced acute hepatic injury.
Neoplasms
Sex differences of inflammation in target organs, induced by intraperitoneal injection of lipopolysaccharide, depend on its dose.
Neoplasms
Shenfu decoction as adjuvant therapy for improving quality of life and hepatic dysfunction in patients with symptomatic chronic heart failure.
Neoplasms
Shenfu Injection Attenuates Bile Duct Injury in Rats with Acute Obstructive Cholangitis.
Neoplasms
Short-term metabolic fate of L-[13N]glutamate in the Walker 256 carcinosarcoma in vivo.
Neoplasms
Silver-nanoparticle-coated biliary stent inhibits bacterial adhesion in bacterial cholangitis in swine.
Neoplasms
Silymarin preconditioning protected insulin resistant rats from liver ischemia-reperfusion injury: role of endogenous H2S.
Neoplasms
Simvastatin Attenuates Hepatic Sensitization to Lipopolysaccharide After Partial Hepatectomy.
Neoplasms
Sinusoidal endothelial cell damage by activated macrophages in rat liver necrosis.
Neoplasms
SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF??B pathway in mouse kupffer cells.
Neoplasms
Sodium butyrate protects against lipopolysaccharide-induced liver injury partially via the GPR43/ ?-arrestin-2/NF-?B network.
Neoplasms
Sodium Tanshinone IIA Sulfonate Improves Hemodynamic Parameters, Cytokine Release, and Multi-Organ Damage in Endotoxemia Rabbits.
Neoplasms
Soluble ST2, a biomarker of fibrosis, is associated with multiple risk factors, chronic diseases and total mortality in the OPERA study.
Neoplasms
Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in rats.
Neoplasms
Src is Implicated in Hepatic Ischemia Reperfusion-Induced Hippocampus Injury and Long-Term Cognitive Impairment in Young Mice via NMDA Receptor Subunit 2A Activation.
Neoplasms
Study on the synergistic protective effect of Lycium barbarum L. polysaccharides and zinc sulfate on chronic alcoholic liver injury in rats.
Neoplasms
Subclinical involvement of the liver is associated with prognosis in treatment naïve cancer patients.
Neoplasms
Sulforaphane alleviates hepatic ischemia-reperfusion injury through promoting the activation of Nrf-2/HO-1 signaling.
Neoplasms
Suprahepatic vena cava manipulative bleeding alleviates hepatic ischemia-reperfusion injury in rats.
Neoplasms
Surgical treatment of Epstein-Barr virus-associated lymphoepithelioma-like carcinoma occurring in both the posterior mediastinum and liver: Case report.
Neoplasms
Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic.
Neoplasms
Synthesis of endotoxin receptor CD14 protein in Kupffer cells and its role in alcohol-induced liver disease.
Neoplasms
Syringic acid, a novel thyroid hormone receptor-? agonist, ameliorates propylthiouracil-induced thyroid toxicity in rats.
Neoplasms
Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease.
Neoplasms
Systemic and intratumoral balances between monocytes/macrophages and lymphocytes predict prognosis in hepatocellular carcinoma patients after surgery.
Neoplasms
Systemic inflammation after aortic cross clamping is influenced by Toll-like receptor 2 preconditioning and deficiency.
Neoplasms
Taurine alleviates lipopolysaccharide?induced liver injury by anti?inflammation and antioxidants in rats.
Neoplasms
Taurine attenuates multiple organ injury induced by intestinal ischemia reperfusion in rats.
Neoplasms
Tauroursodeoxycholic acid attenuates endoplasmic reticulum stress and protects the liver from chronic intermittent hypoxia induced injury.
Neoplasms
Testing the Effects of Cinnamon Extract Supplementation on Inflammation and Oxidative Stress Induced by Acrylamide.
Neoplasms
The addition of protein-bound amino acids in low-protein diets improves the metabolic and immunological characteristics in fifteen- to thirty-five-kg pigs.
Neoplasms
The ameliorative effect of thymol against hydrocortisone-induced hepatic oxidative stress injury in adult male rats.
Neoplasms
The Ameliorative Effects of Fucoidan in Thioacetaide-Induced Liver Injury in Mice.
Neoplasms
The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease.
Neoplasms
The Carcinogenic Agent Diethylnitrosamine Induces Early Oxidative Stress, Inflammation and Proliferation in Rat Liver, Stomach and Colon: Protective Effect of Ginger Extract.
Neoplasms
The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure.
Neoplasms
The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration.
Neoplasms
The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma.
Neoplasms
The effect of acute ophiobolin A treatment on HO-mediated inflammatory processes.
Neoplasms
The effect of an orally-dosed Gynostemma pentaphyllum extract (ActivAMP®) on body composition in overweight, adult men and women: A double-blind, randomised, placebo-controlled study.
Neoplasms
The effect of C3H mouse mammary tumour on the levels of serum and urine analytes in vivo.
Neoplasms
The effect of platelet activating factor antagonist BN 52021 on bacterial translocation and ICAM-I expression in experimental obstructive jaundice.
Neoplasms
The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: A double-blind randomized clinical trial.
Neoplasms
The Effect of the Mediterranean Diet on Metabolic Health: A Systematic Review and Meta-Analysis of Controlled Trials in Adults.
Neoplasms
The effect of total anthocyanin-base standardized (Cornus mas L.) fruit extract on liver function, tumor necrosis factor ?, malondealdehyde, and adiponectin in patients with non-alcoholic fatty liver: a study protocol for a double-blind randomized clinical trial.
Neoplasms
The effects of acute lipopolysaccharide challenge on dairy goat liver metabolism assessed with (1) HNMR metabonomics.
Neoplasms
The effects of cell surface CD47 downregulation on ischaemia-reperfusion injury during pig liver transplantation.
Neoplasms
The effects of NMDA receptor antagonists over intestinal ischemia/reperfusion injury in rats.
Neoplasms
The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid.
Neoplasms
The effects of two mixed intravenous lipid emulsions on clinical outcomes in infants after gastrointestinal surgery: a prospective, randomized study.
Neoplasms
The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial.
Neoplasms
The growth performance and non-specific immunity of juvenile grass carp (Ctenopharyngodon idella) affected by dietary alginate oligosaccharide.
Neoplasms
The hydroethanolic Litchi chinensis leaf extract alleviate hepatic injury induced by carbon tetrachloride (CCl4) through inhibition of hepatic inflammation.
Neoplasms
The Liver Protection Effects of Maltol, a Flavoring Agent, on Carbon Tetrachloride-Induced Acute Liver Injury in Mice via Inhibiting Apoptosis and Inflammatory Response.
Neoplasms
The Ossabaw Pig Is a Suitable Translational Model to Evaluate Dietary Patterns and Coronary Artery Disease Risk.
Neoplasms
The physiological performance and immune response of juvenile turbot (Scophthalmus maximus) to nitrite exposure.
Neoplasms
The polysaccharides from the Grifola frondosa fruiting body prevent lipopolysaccharide/D-galactosamine-induced acute liver injury via the miR-122-Nrf2/ARE pathways.
Neoplasms
The potential hepatoprotective effects of lovastatin combined with oral hypoglycemic agents in streptozotocin-induced diabetes in rats.
Neoplasms
The potential of antioxidant-rich Maoberry (Antidesma bunius) extract on fat metabolism in liver tissues of rats fed a high-fat diet.
Neoplasms
The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinoma.
Neoplasms
The prognostic role of prognostic nutritional index in nasopharyngeal carcinoma: A systematic review and meta-analysis.
Neoplasms
The protective effect of chrysin against carbon tetrachloride-induced kidney and liver tissue damage in rats.
Neoplasms
The protective effect of erythropoietin on ischaemia/reperfusion injury of liver.
Neoplasms
The protective effect of glycyrrhizin on hepatic ischemia-reperfusion injury in rats and possible related signal pathway.
Neoplasms
The protective effect of juglanin on fructose-induced hepatitis by inhibiting inflammation and apoptosis through TLR4 and JAK2/STAT3 signaling pathways in fructose-fed rats.
Neoplasms
The protective role of ellagitannins flavonoids pretreatment against N-nitrosodiethylamine induced-hepatocellular carcinoma.
Neoplasms
The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study.
Neoplasms
The role of mitogen-activated protein kinases and the participation of intestinal congestion in total hepatic ischemia-reperfusion injury.
Neoplasms
The salubrious effect of tamoxifen [correction of Tamaxifen] on serum marker enzymes, glycoproteins, and lysosomal enzymes level in breast cancer woman.
Neoplasms
The sirtuin 1 activator SRT1720 alleviated endotoxin-induced fulminant hepatitis in mice.
Neoplasms
The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression.
Neoplasms
Therapeutic Benefits of Ipilimumab among Japanese Patients with Nivolumab-Refractory Mucosal Melanoma: A Case Series Study.
Neoplasms
Therapeutic effect of adenosylmethionine on viral hepatitis and related factors inducing diseas.
Neoplasms
Therapeutic effect of carnosine in rat model of experimental liver carcinogenesis.
Neoplasms
Therapeutic effects of melatonin on heatstroke-induced multiple organ dysfunction syndrome in rats.
Neoplasms
Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats.
Neoplasms
Therapy with interleukin-22 alleviates hepatic injury and hemostasis dysregulation in rat model of acute liver failure.
Neoplasms
Thymosin ?1 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure.
Neoplasms
Tim-3 expression on peripheral monocytes and CD3+CD16/CD56+natural killer-like T cells in patients with chronic hepatitis B.
Neoplasms
TLR2 mRNA upregulation in ischemic lobes in mouse partial hepatic ischemia/reperfusion injury model.
Neoplasms
TLR4 PROMOTES CRYPTOSPORIDIUM PARVUM CLEARANCE IN A MOUSE MODEL OF BILIARY CRYPTOSPORIDIOSIS.
Neoplasms
Toll-like Receptor 4 Inhibitor TAK-242 Improves Fulminant Hepatitis by Regulating Accumulation of Myeloid-Derived Suppressor Cell.
Neoplasms
Total body irradiation of donors can alter the course of tolerance and induce acute rejection in a spontaneous tolerance rat liver transplantation model.
Neoplasms
Transarterial oily chemoembolization with lidamycin shows potent therapeutic efficacy in VX2 rabbit liver tumor.
Neoplasms
Transcatheter arterial embolization treatment in patients with hepatocellular carcinoma and risk of pulmonary metastasis.
Neoplasms
Transduced PEP-1-heme oxygenase-1 fusion protein reduces remote organ injury induced by intestinal ischemia/reperfusion.
Neoplasms
Transfusion of cryopreserved platelets exacerbates inflammatory liver and lung injury in a mice model of hemorrhage.
Neoplasms
Translocation of pancreatic juice after ischemia and reperfusion of the intestines and the effects of gabexate mesilate (FOY) in rats.
Neoplasms
TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice.
Neoplasms
Triterpenoids from fruits of Sorbus pohuashanensis inhibit acetaminophen-induced acute liver injury in mice.
Neoplasms
TSG-6 Inhibits Oxidative Stress and Induces M2 Polarization of Hepatic Macrophages in Mice With Alcoholic Hepatitis via Suppression of STAT3 Activation.
Neoplasms
Tumor necrosis factor induces enzymatic changes in liver comparable to those in extrahepatic cancer.
Neoplasms
Urinary trypsin inhibitor treatment ameliorates acute lung and liver injury resulting from sepsis in a rat model.
Neoplasms
Use of a low-dose steroid as an adjunct in the treatment, in mice, of severe sepsis caused by Burkholderia pseudomallei.
Neoplasms
Valproic acid attenuates the multiple-organ dysfunction in a rat model of septic shock.
Neoplasms
Ventilation-induced lung injury in rats is associated with organ injury and systemic inflammation that is attenuated by dexamethasone.
Neoplasms
Vildagliptin Attenuates Hepatic Ischemia/Reperfusion Injury via the TLR4/NF-?B Signaling Pathway.
Neoplasms
Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma.
Neoplasms
Vitamin D supplementation during exercise training does not alter inflammatory biomarkers in overweight and obese subjects.
Neoplasms
Vitamin E protects against monosodium glutamate-induced acute liver injury and hepatocyte ultrastructural alterations in rats.
Neoplasms
Water-soluble polysaccharide from Eleutherococcus senticosus stems attenuates fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice.
Neoplasms
White sweet potato ameliorates hyperglycemia and regenerates pancreatic islets in diabetic mice.
Neoplasms
Wogonoside Shows Antifibrotic Effects in an Experimental Regression Model of Hepatic Fibrosis.
Neoplasms
Yi Guan Jian, a Traditional Chinese Herbal Medicine, Alleviates Carbon Tetrachloride-Induced Liver Injury.
Neoplasms
Zi Qi Decoction Alleviates Liver Fibrosis by Inhibiting the Toll-Like Receptor 4 (TLR4)-Related Nuclear Factor kappa b (NF-?B) and Mitogen-Activated Protein Kinase (MAPK) Signaling Pathways.
Neoplasms
[Activity of metabolic enzymes of saliva with neuroendocrine tumors of the lung of various degrees of malignancy.]
Neoplasms
[Analysis of imatinib trough concentration at steady state in adjuvant therapy of patients with high risk gastrointestinal stromal tumor].
Neoplasms
[Analysis of prognostic factors of patients with hepatocellular carcinoma after radical resection].
Neoplasms
[Changes in aspartic aminotransferase, alanine aminotransferase and creatine phosphokinase in cerebrospinal fluid in focal ischemia and tumors of the brain]
Neoplasms
[Changes of serum markers in acute liver injury induced by oral 1, 2-dichloropropane in BALB/cA-nu mice].
Neoplasms
[Clinical effect evaluation of acupuncture combined with medication for prevention of endometriosis recurrence after surgery].
Neoplasms
[Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma]
Neoplasms
[Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
Neoplasms
[Curative effect of paraquat detoxification recipe combined with continuous hemoperfusion in the treatment of patients with APP and clinical value of Presepsin].
Neoplasms
[Dipyridamole preconditioning protects against ischemia/reperfusion injury of rat liver]
Neoplasms
[Effect and mechanism of ginsenoside Rg1 as an alcoholic hepatitis treatment in a rat model].
Neoplasms
[Effect of nitric oxide on Toll-like receptor 2/4 gene expression in the liver in acute hemorrhagic necrotizing pancreatitis in rats.]
Neoplasms
[Effect of notoginseng extracts and its components on lipopolysaccharide and galactosamine mixture-induced impaired hepatic function in mice].
Neoplasms
[Effect of the amount of portal blood stasis removal on endotoxemia and liver function after liver transplantation]
Neoplasms
[Effects of hypertonic saline on expression of heme oxygenase enzyme-1 in hepatic ischemia/reperfusion injury rats.]
Neoplasms
[Effects of Qushi Huayu Decoction on cathepsin B and tumor necrosis factor-alpha expression in rats with non-alcoholic steatohepatitis]
Neoplasms
[Effects of Yiqi Sanju Formula on non-alcoholic fatty liver disease: a randomized controlled trial]
Neoplasms
[How brain-dead state affects the hepatic morphology and function of Ba-Ma mini pigs and its mechanism]
Neoplasms
[Impact of unfractionated heparin on serum and liver tissue expression of heparanase in the liver injury of mice with sepsis].
Neoplasms
[INHIBITION OF ANAEROBIC GLYCOLYSIS IN CANCER CELLS BY GLUTAMATE-PYRUVATE TRANSAMINASE.]
Neoplasms
[Intervention effect and mechanism of compound Ginkgo biloba preparations on nonalcoholic fatty liver].
Neoplasms
[Isoflurane pretreatment reduced liver injury induced by ischemia/reperfusion combined with lipopolysaccharide in rats]
Neoplasms
[Mechanism of liver injury in severe acute pancreatitis rats and role of melatonin]
Neoplasms
[On the variations in the aldolase and glutamic-pyruvic transaminase index in subjects with neoplasms and in radiotherapeutic treatment.]
Neoplasms
[Pharmacological mechanism of Semen Litchi on antagonizing insulin resistance in rats with type 2 diabetes]
Neoplasms
[Protective effect of Ginkgo biloba extract on paracetamol-induced acute hepatic injury in mice].
Neoplasms
[Protective effect of N-acetyl-L-cysteine on liver and lung injury in mice after partial hepatic ischemia/reperfusion.]
Neoplasms
[Protective effect of p38 mitogen activated protein kinase inhibitor on organs in sepsis in rats]
Neoplasms
[Protective effect of Saccharomyces boulardii against intestinal mucosal barrier injury in rats with nonalcoholic fatty liver disease].
Neoplasms
[Relationship between alcoholic liver injury and endotoxin leakage from gut and intervention effect of jianpi liqi huoxue decoction]
Neoplasms
[Role of NF-?B p65 and related cytokines in rats with liver function injury induced by dibutyl phthalate and benzo (a) pyrene].
Neoplasms
[Sodium butyrate inhibits HMGB1 expression and release and attenuates concanavalin A-induced acute liver injury in mice].
Neoplasms
[Study of R2* value to evaluate regulation of liver regeneration by hepatic warm ischemia-reperfusion injury after partial hepatectomy in rabbits].
Neoplasms
[Study on the expressions and roles of renal heat shock protein 72 and Toll-like receptor 4 in hepatorenal syndrome in rat]
Neoplasms
[The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma]
Neoplasms
[Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats]
Neoplasms
[Xuebijing improves clinical prognosis and reduces mortality in patients with acute paraquat poisoning: a Meta-analysis included 1 429 patients].
Nephrotic Syndrome
Activity of serum enzymes in puromycin aminonucleoside-induced nephrotic syndrome.
Neurodegenerative Diseases
gene2drug: a Computational Tool for Pathway-based Rational Drug Repositioning.
Neuromuscular Diseases
[Studies on enzyme activities relating to amino acid mobilization in biopsied muscles]
Neutropenia
A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia.
Neutropenia
A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer.
Neutropenia
A Multicenter Study of Docetaxel at a Dose of 100 mg/m2 in Japanese Patients with Advanced or Recurrent Breast Cancer.
Neutropenia
A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC).
Neutropenia
A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.
Neutropenia
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers.
Neutropenia
A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma.
Neutropenia
A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma.
Neutropenia
A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08).
Neutropenia
A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma.
Neutropenia
A phase II trial of dose-dense (biweekly) paclitaxel plus carboplatin as neoadjuvant chemotherapy for operable breast cancer.
Neutropenia
A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Neutropenia
A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902).
Neutropenia
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
Neutropenia
A review of phase II studies of ZD9331 treatment for relapsed or refractory solid tumours.
Neutropenia
A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue Sarcoma.
Neutropenia
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.
Neutropenia
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Neutropenia
An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma.
Neutropenia
An Open-Label, Multicenter, Single-Dose Pharmacokinetic Study of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Preschool-Aged Children.
Neutropenia
An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanoma.
Neutropenia
Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas: A Nonrandomized Phase 1/2 Clinical Trial.
Neutropenia
Benefit-Risk Summary of Crizotinib for the Treatment of Patients With ROS1 Alteration-Positive, Metastatic Non-Small Cell Lung Cancer.
Neutropenia
Children hospitalized with severe acute respiratory syndrome-related illness in Toronto.
Neutropenia
Clinical Benefits and Safety of FMS-Like Tyrosine Kinase 3 Inhibitors in Various Treatment Stages of Acute Myeloid Leukemia: A Systematic Review, Meta-Analysis, and Network Meta-Analysis.
Neutropenia
Clinical characteristics and outcome of invasive fungal infections in pediatric acute myeloid leukemia patients in a medical center in Taiwan.
Neutropenia
Comparison of efficacy and safety of S-1 and capecitabine in patients with metastatic colorectal carcinoma: A systematic review and meta-analysis.
Neutropenia
Cooperative activity of cytotoxic chemotherapy with antiangiogenic thrombospondin-I peptides, ABT-526 in pet dogs with relapsed lymphoma.
Neutropenia
Deferiprone or Deferoxamine vs. Combination Therapyin Patients with beta-Thalassemia Major: A Case Studyin Taiwan.
Neutropenia
Duvelisib, a novel oral dual inhibitor of PI3K-?,?, is clinically active in advanced hematologic malignancies.
Neutropenia
Efficacies and adverse reactions of modified vitamin supplement programs before pemetrexed chemotherapy as a second-line treatment against epidermal growth factor receptor (EGFR) mutant wild-type lung adenocarcinoma.
Neutropenia
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study.
Neutropenia
Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis: A Subgroup Analysis of the Phase 3 TOWER Study.
Neutropenia
Efficacy and toxicity of antiretroviral therapy using 4 or more agents: application of a strategy for antiretroviral management in human immunodeficiency virus-infected children.
Neutropenia
First-Line Pazopanib Treatment in Metastatic Renal Cell Carcinoma: Real-World Data From a Single Chinese Center.
Neutropenia
Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase 3, Randomized, Open-label, Multi-center FESTnd Study.
Neutropenia
Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.
Neutropenia
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
Neutropenia
Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study.
Neutropenia
Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients.
Neutropenia
Integrated safety summary of phase II and III studies comparing oral nemonoxacin and levofloxacin in community-acquired pneumonia.
Neutropenia
Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.
Neutropenia
Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.
Neutropenia
Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO study.
Neutropenia
Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Linezolid Pediatric Pneumonia Study Group.
Neutropenia
Modified-FOLFIRINOX in metastatic pancreatic cancer: A prospective study in Chinese population.
Neutropenia
Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial.
Neutropenia
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial.
Neutropenia
Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): an exploratory, open-label, phase 2 study.
Neutropenia
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial.
Neutropenia
Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study.
Neutropenia
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.
Neutropenia
Occurrence of abscesses during treatment with pazopanib in metastatic renal cancer: a case report.
Neutropenia
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial.
Neutropenia
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial.
Neutropenia
Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours.
Neutropenia
Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan.
Neutropenia
Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
Neutropenia
Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: A Children's Oncology Group study.
Neutropenia
Phase I combination study of trabectedin and Doxorubicin in patients with soft-tissue sarcoma.
Neutropenia
Phase I dose-escalation and pharmacokinetic study of ispinesib, a kinesin spindle protein inhibitor, administered on days 1 and 15 of a 28-day schedule in patients with no prior treatment for advanced breast cancer.
Neutropenia
Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in Patients with Refractory Solid Tumors.
Neutropenia
Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumors.
Neutropenia
Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors.
Neutropenia
Phase I/II Study of Hepatic Arterial Infusion Chemotherapy With Gemcitabine in Patients With Unresectable Intrahepatic Cholangiocarcinoma (JIVROSG-0301).
Neutropenia
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
Neutropenia
Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas.
Neutropenia
Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma.
Neutropenia
Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer.
Neutropenia
Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma.
Neutropenia
Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065).
Neutropenia
Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study.
Neutropenia
Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer.
Neutropenia
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
Neutropenia
Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma.
Neutropenia
Preoperative Chemoradiation With Irinotecan and Capecitabine in Patients With Locally Advanced Resectable Rectal Cancer: Long-Term Results of a Phase II Study.
Neutropenia
Randomized double-blind, placebo-controlled trial of twice-daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1. European-Australian Haemophilia Collaborative Study Group.
Neutropenia
Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison.
Neutropenia
Results of a phase II multicenter trial of single-agent gemcitabine in patients with relapsed or chemotherapy-refractory Hodgkin's lymphoma.
Neutropenia
Retrospective Analysis of the Risk Factors for Grade IV Neutropenia in Oesophageal Cancer Patients Treated with a Docetaxel, Cisplatin, and 5-Fluorouracil Regimen.
Neutropenia
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial.
Neutropenia
Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients.
Neutropenia
Ruxolitinib for the treatment of chronic GVHD and overlap syndrome in children and young adults.
Neutropenia
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial.
Neutropenia
Safety and tolerability of subcutaneous methotrexate in routine clinical practice.
Neutropenia
SARC025 arms 1 and 2: A phase 1 study of the poly(ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma.
Neutropenia
Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review.
Neutropenia
Side effects of CDK4/6 inhibitors in the treatment of HR+/HER2- advanced breast cancer: a systematic review and meta-analysis of randomized controlled trials.
Neutropenia
Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial.
Neutropenia
Successful treatment of Yersinia pseudotuberculosis hepatitis in a cat presenting with neurological abnormalities.
Neutropenia
The Efficacy of Intra-Arterial Plus Intravesical Chemotherapy Versus Intravesical Chemotherapy Alone After Bladder-Sparing Surgery in High-Risk Bladder Cancer: A Systematic Review and Meta-Analysis of Comparative Study.
Neutropenia
Tolerability and Outcomes of First-line Pemetrexed+Cisplatin Followed by Gefitinib Maintenance Therapy versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial.
Neutropenia
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.
Neutropenia
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
Neutropenia
Trabectedin plus pegylated liposomal doxorubicin: retrospective analysis in heavily pretreated platinum-sensitive ovarian cancer.
Neutropenia
Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial.
Neutropenia
Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in Korea.
Neutropenia
Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes.
Neutropenia
Utility of Laboratory Test Result Monitoring in Patients Taking Oral Terbinafine or Griseofulvin for Dermatophyte Infections.
Neutropenia
Vatalanib in malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B (CALGB 30107).
Neutropenia
Vorinostat in Combination With Lenalidomide and Dexamethasone in Lenalidomide-Refractory Multiple Myeloma.
Neutropenia
Zidovudine prophylaxis after accidental exposure to HIV: the Italian experience. The Italian Study Group on Occupational Risk of HIV Infection.
Neutropenia
[Efficacy and safety of neoadjuvant apatinib in combination with dose-dense paclitaxel and carboplatin in locally advanced triple negative breast cancer patients].
Nevus
Clinical factors that affect blood gases in non-smoking women with chronic liver disease.
Newcastle Disease
Dietary supplementation of Aspergillus oryzae meal and its effect on performance, carcass characteristics, blood variables, and immunity of broiler chickens.
Newcastle Disease
The advantages and synergistic effects of Gunnera (Gundelia tournefortii L.) extract and protexin in chicken production.
Non-alcoholic Fatty Liver Disease
"Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country.
Non-alcoholic Fatty Liver Disease
6-Amino[1,2,5]oxadiazolo[3,4-b]pyrazin-5-ol Derivatives as Efficacious Mitochondrial Uncouplers in STAM Mouse Model of Nonalcoholic Steatohepatitis.
Non-alcoholic Fatty Liver Disease
A Common Variant in the PNPLA3 Gene is a Risk Factor for Non-Alcoholic Fatty Liver Disease in Obese Taiwanese Children.
Non-alcoholic Fatty Liver Disease
A comparison of associations of alanine aminotransferase and gamma-glutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes.
Non-alcoholic Fatty Liver Disease
A comparison of treatments offered to patients with nonalcoholic steatohepatitis.
Non-alcoholic Fatty Liver Disease
A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid.
Non-alcoholic Fatty Liver Disease
A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients.
Non-alcoholic Fatty Liver Disease
Abnormal aminotransferase activity in women with polycystic ovary syndrome.
Non-alcoholic Fatty Liver Disease
Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Abnormal Serum Alanine Aminotransferase Levels are Associated with Impaired Insulin Sensitivity in Young Women With Polycystic Ovary Syndrome.
Non-alcoholic Fatty Liver Disease
Adipokines in a group of Mexican patients with nonalcoholic steatohepatitis.
Non-alcoholic Fatty Liver Disease
Agreement Between the Prevalence of Nonalcoholic Fatty Liver Disease Determined by Transient Elastography and Fatty Liver Indices.
Non-alcoholic Fatty Liver Disease
Alanine Aminotransferase and Gamma Glutamyl Transpeptidase Predict Histologic Improvement in Pediatric Nonalcoholic Steatohepatitis.
Non-alcoholic Fatty Liver Disease
Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
Non-alcoholic Fatty Liver Disease
Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease: A Secondary Analysis Using TONIC Trial Data.
Non-alcoholic Fatty Liver Disease
Alanine aminotransferase as an independent predictor of incident nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Alanine aminotransferase elevation in obese infants and children: a marker of early onset non alcoholic Fatty liver disease.
Non-alcoholic Fatty Liver Disease
Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.
Non-alcoholic Fatty Liver Disease
Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth.
Non-alcoholic Fatty Liver Disease
Alanine-aminotransferase: an early marker for insulin resistance?
Non-alcoholic Fatty Liver Disease
Alkaline phosphatase is independently associated with renal function in normoalbuminuric type 1 diabetic patients.
Non-alcoholic Fatty Liver Disease
Allopurinol potentiates the hepatoprotective effect of metformin and vitamin E in fructose-induced fatty liver in rats.
Non-alcoholic Fatty Liver Disease
ALT Trends through Childhood and Adolescence Associated with Hepatic Steatosis at 24 Years: A Population-Based UK Cohort Study.
Non-alcoholic Fatty Liver Disease
Ameliorative Potential of Tamarindus indica on High Fat Diet Induced Nonalcoholic Fatty Liver Disease in Rats.
Non-alcoholic Fatty Liver Disease
American ancestry is a risk factor for suspected non-alcoholic fatty liver disease in Hispanic/Latino adults.
Non-alcoholic Fatty Liver Disease
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Non-alcoholic Fatty Liver Disease
Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.
Non-alcoholic Fatty Liver Disease
An open-label randomized control study to compare the efficacy of vitamin e versus ursodeoxycholic acid in nondiabetic and noncirrhotic Indian NAFLD patients.
Non-alcoholic Fatty Liver Disease
Angiopoietin-like protein 2 and angiopoietin-like protein 6 levels in patients with nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients.
Non-alcoholic Fatty Liver Disease
Application of Machine Learning Techniques for Clinical Predictive Modeling: A Cross-Sectional Study on Nonalcoholic Fatty Liver Disease in China.
Non-alcoholic Fatty Liver Disease
Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?
Non-alcoholic Fatty Liver Disease
Assessment of diagnostic biomarkers of liver injury in the setting of microcystin-LR (MC-LR) hepatotoxicity.
Non-alcoholic Fatty Liver Disease
Assessment of NAFLD cases and its correlation to BMI and metabolic syndrome in healthy blood donors in Kerman.
Non-alcoholic Fatty Liver Disease
Association between eosinophil count and cholelithiasis among a population with Clonorchis sinensis infection in Foshan City, China.
Non-alcoholic Fatty Liver Disease
Association between exposures to brominated trihalomethanes, hepatic injury and type II diabetes mellitus.
Non-alcoholic Fatty Liver Disease
Association between Markers of Fatty Liver Disease and Impaired Glucose Regulation in Men and Women from the General Population: The KORA-F4-Study.
Non-alcoholic Fatty Liver Disease
Association between non-alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community.
Non-alcoholic Fatty Liver Disease
Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Risk in Obese Children and Adolescents.
Non-alcoholic Fatty Liver Disease
Association between obstructive sleep apnea and non-alcoholic fatty liver disease in pediatric patients: a meta-analysis.
Non-alcoholic Fatty Liver Disease
Association Between Severity of Obstructive Sleep Apnea and Blood Markers of Liver Injury.
Non-alcoholic Fatty Liver Disease
Association between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Type 2 Diabetes Patients.
Non-alcoholic Fatty Liver Disease
Association Between Vitamin D Deficiency and Suspected Nonalcoholic Fatty Liver Disease in an Adolescent Population.
Non-alcoholic Fatty Liver Disease
Association of 11?-hydroxysteroid dehydrogenase type 1 gene polymorphisms with serum alanine aminotransferase activity.
Non-alcoholic Fatty Liver Disease
Association of adult weight gain and nonalcoholic fatty liver in a cross-sectional study in Wan Song Community, China.
Non-alcoholic Fatty Liver Disease
Association of ALT and the metabolic syndrome among Mexican children.
Non-alcoholic Fatty Liver Disease
Association of APPL1 Gene Polymorphism with Non-Alcoholic Fatty Liver Disease Susceptibility in a Chinese Han Population.
Non-alcoholic Fatty Liver Disease
Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Association of CTRP13 with Liver Enzymes and Cognitive Symptoms in Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Association of dietary insulinaemic potential and odds of non-alcoholic fatty liver disease among adults: A case-control study.
Non-alcoholic Fatty Liver Disease
Association of elevated serum aminotransferase levels with chronic kidney disease measures: hispanic community health study/study of latinos.
Non-alcoholic Fatty Liver Disease
Association of high-sensitivity C-reactive protein (hs-CRP) with non-alcoholic fatty liver disease (NAFLD) in Asian Indians: A cross-sectional study.
Non-alcoholic Fatty Liver Disease
Association of MBOAT7 gene variant with plasma ALT levels in children: the PANIC study.
Non-alcoholic Fatty Liver Disease
Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits.
Non-alcoholic Fatty Liver Disease
Association of resting heart rate with nonalcoholic fatty liver disease in postmenopausal women.
Non-alcoholic Fatty Liver Disease
Association of serum alanine aminotransferase and ?-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Association of serum ferritin levels with non-alcoholic fatty liver disease in postmenopausal women.
Non-alcoholic Fatty Liver Disease
Association of the I148M/PNPLA3 variant with elevated alanine transaminase levels in normal-weight and overweight/obese Mexican children.
Non-alcoholic Fatty Liver Disease
Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
Non-alcoholic Fatty Liver Disease
Associations Between Body Fat, Muscle Mass, and Nonalcoholic Fatty Liver Disease: A Population-Based Study.
Non-alcoholic Fatty Liver Disease
Associations between mercury exposure and the risk of nonalcoholic fatty liver disease (NAFLD) in US adolescents.
Non-alcoholic Fatty Liver Disease
Associations Between Nonalcoholic Fatty Liver Disease and Cancers in a Large Cohort in China.
Non-alcoholic Fatty Liver Disease
Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study.
Non-alcoholic Fatty Liver Disease
Associations of Liver Disease with Alcohol Use among People Living with HIV and the Role of Hepatitis C: The New Orleans Alcohol Use in HIV Study.
Non-alcoholic Fatty Liver Disease
Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients.
Non-alcoholic Fatty Liver Disease
Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients.
Non-alcoholic Fatty Liver Disease
Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Biochemical characteristics and risk factors in non-alcoholic fatty liver.
Non-alcoholic Fatty Liver Disease
Biochemical markers and lipid profile in nonalcoholic fatty liver disease patients in the PERSIAN Guilan cohort study (PGCS), Iran.
Non-alcoholic Fatty Liver Disease
Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men.
Non-alcoholic Fatty Liver Disease
Branched chain amino acids are associated with the heterogeneity of the area of lipid droplets in hepatocytes of patients with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population.
Non-alcoholic Fatty Liver Disease
Can hepatokines be regarded as novel non-invasive serum biomarkers of intrahepatic lipid content in obese children?
Non-alcoholic Fatty Liver Disease
Capparis spinosa improves the high fat diet-induced non-alcoholic steatohepatitis in rats: the possible role of FGF21.
Non-alcoholic Fatty Liver Disease
Capybara Oil Improves Hepatic Mitochondrial Dysfunction, Steatosis, and Inflammation in a Murine Model of Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Cardiorespiratory fitness, waist circumference, and alanine aminotransferase in youth.
Non-alcoholic Fatty Liver Disease
Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy.
Non-alcoholic Fatty Liver Disease
Causes of mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol related Fatty Liver Disease (AFLD).
Non-alcoholic Fatty Liver Disease
Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression.
Non-alcoholic Fatty Liver Disease
Changes in Liver Enzymes and Metabolic Profile in Adolescents with Fatty Liver following Exercise Interventions.
Non-alcoholic Fatty Liver Disease
Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
Non-alcoholic Fatty Liver Disease
Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome.
Non-alcoholic Fatty Liver Disease
Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort.
Non-alcoholic Fatty Liver Disease
Childhood Adiposity and Nonalcoholic Fatty Liver Disease in Adulthood.
Non-alcoholic Fatty Liver Disease
Chinese herb extract improves liver steatosis by promoting the expression of high molecular weight adiponectin in NAFLD rats.
Non-alcoholic Fatty Liver Disease
Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
Non-alcoholic Fatty Liver Disease
Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal miR-122-5p.
Non-alcoholic Fatty Liver Disease
Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Chronic hepatitis B, nonalcoholic steatohepatitis and physical fitness of military males: CHIEF study.
Non-alcoholic Fatty Liver Disease
Circulating ALT Levels in Healthy Volunteers Over Life-Span: Assessing Aging Paradox and Nutritional Implications.
Non-alcoholic Fatty Liver Disease
Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.
Non-alcoholic Fatty Liver Disease
Clinical and Esophagoenteroduodenoscopy Findings in Pediatric Patients with Severe Obesity Evaluated Prior to Bariatric Surgery.
Non-alcoholic Fatty Liver Disease
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
Non-alcoholic Fatty Liver Disease
Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry.
Non-alcoholic Fatty Liver Disease
Clinical and pathological features of sarcopenia-related indices in patients with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Clinical characteristics of platelets and its possible gender dimorphism in patients with nonalcoholic fatty liver disease (NAFLD).
Non-alcoholic Fatty Liver Disease
Clinical significance of serum alanine aminotransferase and lifestyle intervention in children with nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
Non-alcoholic Fatty Liver Disease
Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males.
Non-alcoholic Fatty Liver Disease
Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe(-/-) mice.
Non-alcoholic Fatty Liver Disease
Combination of Probiotics and Salvia miltiorrhiza Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD Mice.
Non-alcoholic Fatty Liver Disease
Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels.
Non-alcoholic Fatty Liver Disease
Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients.
Non-alcoholic Fatty Liver Disease
Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescents.
Non-alcoholic Fatty Liver Disease
Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.
Non-alcoholic Fatty Liver Disease
Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Comparison of fenofibrate and pioglitazone effects on patients with nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Complement C3 and Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease Patients: A Pilot Study.
Non-alcoholic Fatty Liver Disease
Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea.
Non-alcoholic Fatty Liver Disease
Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease.
Non-alcoholic Fatty Liver Disease
Correlation between Helicobacter pylori Infection and Metabolic Abnormality in General Population: A Cross-Sectional Study.
Non-alcoholic Fatty Liver Disease
Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients.
Non-alcoholic Fatty Liver Disease
Correlation of Serum Transaminase Levels with Liver Fibrosis Assessed by Transient Elastography in Vietnamese Patients with Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Cranberry extract attenuates hepatic inflammation in high-fat-fed obese mice.
Non-alcoholic Fatty Liver Disease
Cytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis.
Non-alcoholic Fatty Liver Disease
Dallas Steatosis Index Identifies Patients With Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Decrease in fat de novo synthesis and chemokine ligand expression in non-alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain-like pseudokinase.
Non-alcoholic Fatty Liver Disease
Decreased Muscle-to-Fat Mass Ratio Is Associated with Low Muscular Fitness and High Alanine Aminotransferase in Children and Adolescent Boys in Organized Sports Clubs.
Non-alcoholic Fatty Liver Disease
Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Deletion of Smad4 reduces hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis progression.
Non-alcoholic Fatty Liver Disease
Demethylenetetrahydroberberine alleviates nonalcoholic fatty liver disease by inhibiting the NLRP3 inflammasome and oxidative stress in mice.
Non-alcoholic Fatty Liver Disease
Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine.
Non-alcoholic Fatty Liver Disease
Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance.
Non-alcoholic Fatty Liver Disease
Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy.
Non-alcoholic Fatty Liver Disease
Diagnostic performance of fibroscan and computed tomography in 322 normal alanine aminotransferase non-obese non-alcoholic fatty liver disease patients diagnosed by ultrasound.
Non-alcoholic Fatty Liver Disease
Dietary Broccoli Lessens Development of Fatty Liver and Liver Cancer in Mice Given Diethylnitrosamine and Fed a Western or Control Diet.
Non-alcoholic Fatty Liver Disease
Dietary fatty acid oxidation is decreased in non-alcoholic fatty liver disease: A palmitate breath test study.
Non-alcoholic Fatty Liver Disease
Dietary Saturated Fat Promotes Development of Hepatic Inflammation through Toll-Like Receptor 4 in Mice.
Non-alcoholic Fatty Liver Disease
Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome.
Non-alcoholic Fatty Liver Disease
Differing clinical phenotype for higher alanine-aminotransferase (ALT) compared with high-risk NAFLD fibrosis score in type 2 diabetes mellitus.
Non-alcoholic Fatty Liver Disease
Discovery of a role of the novel hepatokine, hepassocin, in obesity.
Non-alcoholic Fatty Liver Disease
Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial.
Non-alcoholic Fatty Liver Disease
Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.
Non-alcoholic Fatty Liver Disease
Early menarche is associated with insulin-resistance and non-alcoholic fatty liver disease in adolescents with obesity.
Non-alcoholic Fatty Liver Disease
Early-onset metabolic syndrome in prepubertal obese children and the possible role of alanine aminotransferase as marker of metabolic syndrome.
Non-alcoholic Fatty Liver Disease
Eating Fast and Until Full Is Associated with Elevated Alanine Aminotransferase Activity in Japanese Schoolchildren: A Cross-Sectional Study.
Non-alcoholic Fatty Liver Disease
Eating quickly is associated with a low aspartate aminotransferase to alanine aminotransferase ratio in middle-aged adults: a large-scale cross-sectional survey in Japan.
Non-alcoholic Fatty Liver Disease
Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial.
Non-alcoholic Fatty Liver Disease
Effect of Dapagliflozin on Alanine Aminotransferase Improvement in Type 2 Diabetes Mellitus with Non-alcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Effect of dietary carbohydrate and lipid modification on clinical and anthropometric parameters in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Non-alcoholic Fatty Liver Disease
Effect of Different Exercise Methods on Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression.
Non-alcoholic Fatty Liver Disease
Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
Non-alcoholic Fatty Liver Disease
Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity.
Non-alcoholic Fatty Liver Disease
Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat study.
Non-alcoholic Fatty Liver Disease
Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials.
Non-alcoholic Fatty Liver Disease
Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis.
Non-alcoholic Fatty Liver Disease
Effects of a new sustained-release microsphere formulation of exenatide, DA-3091, on obese and non-alcoholic fatty liver disease mice.
Non-alcoholic Fatty Liver Disease
Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Effects of liver function, insulin resistance and inflammatory factors on vascular endothelial dilation function and prognosis of coronary heart disease patients complicated with NAFLD.
Non-alcoholic Fatty Liver Disease
Effects of Metformin and Weight Loss on Serum Alanine Aminotransferase Activity in the Diabetes Prevention Program.
Non-alcoholic Fatty Liver Disease
Effects of Phytosterol Supplementation on Serum Levels of Lipid Profiles, Liver Enzymes, Inflammatory Markers, Adiponectin, and Leptin in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Non-alcoholic Fatty Liver Disease
Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial.
Non-alcoholic Fatty Liver Disease
Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Efficacy of resveratrol supplementation on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Non-alcoholic Fatty Liver Disease
Efficacy of Synbiotic Supplementation in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Clinical Trials.
Non-alcoholic Fatty Liver Disease
Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: The LUBIPRONE, double-blind, randomised, placebo-controlled study design.
Non-alcoholic Fatty Liver Disease
Electron Therapy Attenuated Elevated Alanine Aminotransferase and Oxidative Stress Values in Type 2 Diabetes-Induced Nonalcoholic Steatohepatitis of Rats.
Non-alcoholic Fatty Liver Disease
Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Elevated alanine aminotransferase and low aspartate aminotransferase/alanine aminotransferase ratio are associated with chronic kidney disease among middle-aged women: a cross-sectional study.
Non-alcoholic Fatty Liver Disease
Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia.
Non-alcoholic Fatty Liver Disease
Elevated alanine aminotransferase independently predicts new onset of depression in employees undergoing health screening examinations.
Non-alcoholic Fatty Liver Disease
Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans.
Non-alcoholic Fatty Liver Disease
Elevated Hemoglobin Level Is Associated With Advanced Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Elevated levels of alanine transaminase and triglycerides within normal limits are associated with fatty liver.
Non-alcoholic Fatty Liver Disease
Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: the bogalusa heart study.
Non-alcoholic Fatty Liver Disease
Elevated peripheral blood monocyte fraction in nonalcoholic Fatty liver disease.
Non-alcoholic Fatty Liver Disease
Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States.
Non-alcoholic Fatty Liver Disease
Elevated transaminase levels among overweight adolescents in eastern China.
Non-alcoholic Fatty Liver Disease
Elevated transaminases potentiate the risk for emerging dysglycemia in children with overweight and obesity.
Non-alcoholic Fatty Liver Disease
Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States.
Non-alcoholic Fatty Liver Disease
Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Elucidation of SIRT-1/PGC-1?-associated mitochondrial dysfunction and autophagy in nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Non-alcoholic Fatty Liver Disease
Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome.
Non-alcoholic Fatty Liver Disease
Epidemiological, clinical, and biochemical characteristics of Saudi patients with nonalcoholic fatty liver disease: a hospital-based study.
Non-alcoholic Fatty Liver Disease
Estimated Prevalence of Adolescents with Nonalcoholic Fatty Liver Disease in Korea.
Non-alcoholic Fatty Liver Disease
Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology.
Non-alcoholic Fatty Liver Disease
Estimation of the risk of fibrosis in children with nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Ethnic and Sex Differences in the Association Between Metabolic Syndrome and Suspected Nonalcoholic Fatty Liver Disease in a Nationally Representative Sample of US Adolescents.
Non-alcoholic Fatty Liver Disease
Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography.
Non-alcoholic Fatty Liver Disease
Examining the Relationship Between Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome in Nondiabetic Subjects.
Non-alcoholic Fatty Liver Disease
Exosomal miRNAs Profile in Children's Nonalcoholic Fatty Liver Disease and the Correlation with Transaminase and Uric Acid.
Non-alcoholic Fatty Liver Disease
Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
Non-alcoholic Fatty Liver Disease
Fasting C-peptide is a significant indicator of nonalcoholic fatty liver disease in obese children.
Non-alcoholic Fatty Liver Disease
Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity.
Non-alcoholic Fatty Liver Disease
Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Non-alcoholic Fatty Liver Disease
Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis.
Non-alcoholic Fatty Liver Disease
Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Gamma-glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community-based cross-sectional study.
Non-alcoholic Fatty Liver Disease
Gender difference on the relationship between hyperuricemia and nonalcoholic fatty liver disease among Chinese: An observational study.
Non-alcoholic Fatty Liver Disease
Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
Non-alcoholic Fatty Liver Disease
Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population.
Non-alcoholic Fatty Liver Disease
Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.
Non-alcoholic Fatty Liver Disease
Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance.
Non-alcoholic Fatty Liver Disease
Glutamate-Serine-Glycine Index: A Novel Potential Biomarker in Pediatric Non-Alcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Gut-derived lymphocyte recruitment to liver and induce liver injury in non-alcoholic fatty liver disease mouse model.
Non-alcoholic Fatty Liver Disease
H. pylori is related to NAFLD but only in female: A Cross-sectional Study.
Non-alcoholic Fatty Liver Disease
Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis.
Non-alcoholic Fatty Liver Disease
Hepatic CXCL16 is increased in gallstone accompanied with liver injury.
Non-alcoholic Fatty Liver Disease
Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification.
Non-alcoholic Fatty Liver Disease
Hepatic functional and pathological changes of type 1 diabetic mice in growing and maturation time.
Non-alcoholic Fatty Liver Disease
Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
Non-alcoholic Fatty Liver Disease
Hepatoprotective mechanism of freshwater clam extract alleviates non-alcoholic fatty liver disease: elucidated in vitro and in vivo models.
Non-alcoholic Fatty Liver Disease
High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study.
Non-alcoholic Fatty Liver Disease
High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity.
Non-alcoholic Fatty Liver Disease
High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study.
Non-alcoholic Fatty Liver Disease
High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery.
Non-alcoholic Fatty Liver Disease
Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Histamine H2-Receptor Antagonist Use Is Associated With Lower Prevalence of Nonalcoholic Fatty Liver Disease: A Population-based Study From the National Health and Nutrition Examination Survey, 2001-2006.
Non-alcoholic Fatty Liver Disease
Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels.
Non-alcoholic Fatty Liver Disease
Histological abnormalities in children with nonalcoholic Fatty liver disease and normal or mildly elevated alanine aminotransferase levels.
Non-alcoholic Fatty Liver Disease
How healthy are the "Healthy volunteers"? Penetrance of NAFLD in the biomedical research volunteer pool.
Non-alcoholic Fatty Liver Disease
Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations.
Non-alcoholic Fatty Liver Disease
Hyperlipidemia and Nonalcoholic Steatohepatitis Predispose to Hepatocellular Carcinoma Development Without Cirrhosis.
Non-alcoholic Fatty Liver Disease
Hypertension and non-alcoholic fatty liver disease proven by transient elastography.
Non-alcoholic Fatty Liver Disease
Hypertension is an important predictor of recurrent colorectal adenoma after screening colonoscopy with adenoma polypectomy.
Non-alcoholic Fatty Liver Disease
Ilexgenin A enhances the effects of simvastatin on non-alcoholic fatty liver disease without changes in simvastatin pharmacokinetics.
Non-alcoholic Fatty Liver Disease
Impact of continuous positive airway pressure therapy for nonalcoholic fatty liver disease in patients with obstructive sleep apnea.
Non-alcoholic Fatty Liver Disease
Impact of lifestyle and cardiovascular risk factors on early atherosclerosis in a large cohort of healthy adolescents: The Early Vascular Ageing (EVA)-Tyrol Study.
Non-alcoholic Fatty Liver Disease
Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Impact of Weight-Loss Surgery and Diabetes Status on Serum ALT Levels.
Non-alcoholic Fatty Liver Disease
Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
Non-alcoholic Fatty Liver Disease
In Utero Exposure to Mercury Is Associated With Increased Susceptibility to Liver Injury and Inflammation in Childhood.
Non-alcoholic Fatty Liver Disease
Inactivation of the superoxide dismutase by malondialdehyde in the nonalcoholic fatty liver disease: a combined molecular docking approach to clinical studies.
Non-alcoholic Fatty Liver Disease
Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial.
Non-alcoholic Fatty Liver Disease
Incidence of Depression and Anxiety in a Cohort of Adolescents with Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity.
Non-alcoholic Fatty Liver Disease
Increased hepatic expression is a major determinant of serum alanine aminotransferase elevation in mice with nonalcoholic steatohepatitis.
Non-alcoholic Fatty Liver Disease
Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic.
Non-alcoholic Fatty Liver Disease
Independent Association of Physical Activity with Nonalcoholic Fatty Liver Disease and Alanine Aminotransferase Levels.
Non-alcoholic Fatty Liver Disease
Independent markers of nonalcoholic fatty liver disease in a gentrifying population-based Chinese cohort.
Non-alcoholic Fatty Liver Disease
Industrial Trans Fatty Acids Stimulate SREBP2-Mediated Cholesterogenesis and Promote Non-Alcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Influence of Plasma Cortisol and Other Laboratory Parameters on Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Inhibition of CCL19 benefits non?alcoholic fatty liver disease by inhibiting TLR4/NF??B?p65 signaling.
Non-alcoholic Fatty Liver Disease
Inhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice.
Non-alcoholic Fatty Liver Disease
Inhibitory effect of blueberry polyphenolic compounds on oleic acid-induced hepatic steatosis in vitro.
Non-alcoholic Fatty Liver Disease
Insecticide and metal exposures are associated with a surrogate biomarker for non-alcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003-2004.
Non-alcoholic Fatty Liver Disease
INSULIN AND INSULIN RECEPTOR GENE POLYMORPHISMS AND SUSCEPTIBILITY TO NONALCOHOLIC FATTY LIVER DISEASE.
Non-alcoholic Fatty Liver Disease
Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.
Non-alcoholic Fatty Liver Disease
Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients.
Non-alcoholic Fatty Liver Disease
Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study.
Non-alcoholic Fatty Liver Disease
Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients Without Diabetes.
Non-alcoholic Fatty Liver Disease
Integrative proteomic and lipidomic analysis of Kaili Sour Soup-mediated attenuation of high-fat diet-induced nonalcoholic fatty liver disease in a rat model.
Non-alcoholic Fatty Liver Disease
Intrahepatic cholestasis in nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Intrahepatic Fat Content and Markers of Hepatic Fibrosis in Obese Children.
Non-alcoholic Fatty Liver Disease
Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States.
Non-alcoholic Fatty Liver Disease
Investigation of the effects of chlorella vulgaris supplementation in patients with non-alcoholic Fatty liver disease: a randomized clinical trial.
Non-alcoholic Fatty Liver Disease
IRGM Gene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn's Disease.
Non-alcoholic Fatty Liver Disease
Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease?
Non-alcoholic Fatty Liver Disease
Is There an Association of Vascular Disease and Atherosclerosis in Children and Adolescents With Obesity and Non-alcoholic Fatty Liver Disease?
Non-alcoholic Fatty Liver Disease
Joint associations of serum uric acid and ALT with NAFLD in elderly men and women: a Chinese cross-sectional study.
Non-alcoholic Fatty Liver Disease
Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway.
Non-alcoholic Fatty Liver Disease
KLB gene polymorphism is associated with obesity and non-alcoholic fatty liver disease in the Han Chinese.
Non-alcoholic Fatty Liver Disease
Large-scale analysis of factors influencing nonalcoholic fatty liver disease and its relationship with liver enzymes.
Non-alcoholic Fatty Liver Disease
Lead, mercury, and cadmium exposures are associated with obesity but not with diabetes mellitus: Korean National Environmental Health Survey (KoNEHS) 2015-2017.
Non-alcoholic Fatty Liver Disease
Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis.
Non-alcoholic Fatty Liver Disease
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Non-alcoholic Fatty Liver Disease
Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers.
Non-alcoholic Fatty Liver Disease
Lipid Targets During Statin Treatment in Dyslipidemic Patients Affected by Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Lipoprotein A, combined with alanine aminotransferase and aspartate aminotransferase, contributes to predicting the occurrence of NASH: a cross-sectional study.
Non-alcoholic Fatty Liver Disease
Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus.
Non-alcoholic Fatty Liver Disease
Liver enzymes and histology in obese patients with obstructive sleep apnea.
Non-alcoholic Fatty Liver Disease
Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study.
Non-alcoholic Fatty Liver Disease
Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.
Non-alcoholic Fatty Liver Disease
Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease.
Non-alcoholic Fatty Liver Disease
Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction.
Non-alcoholic Fatty Liver Disease
Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.
Non-alcoholic Fatty Liver Disease
Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure.
Non-alcoholic Fatty Liver Disease
Long-term dietary potential renal acid load during adolescence is prospectively associated with indices of nonalcoholic fatty liver disease in young women.
Non-alcoholic Fatty Liver Disease
Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents.
Non-alcoholic Fatty Liver Disease
Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years.
Non-alcoholic Fatty Liver Disease
Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
Non-alcoholic Fatty Liver Disease
Low docosahexaenoic acid content in plasma phospholipids is associated with increased non-alcoholic fatty liver disease in China.
Non-alcoholic Fatty Liver Disease
Low Hepatic Tissue Copper in Pediatric Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Low urine pH is a risk for non-alcoholic fatty liver disease: A population-based longitudinal study.
Non-alcoholic Fatty Liver Disease
Low vitamin D levels are associated with increased risk for fatty liver disease among non-obese adults.
Non-alcoholic Fatty Liver Disease
Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial.
Non-alcoholic Fatty Liver Disease
Lycium ruthenicum extract alleviates high-fat diet-induced nonalcoholic fatty liver disease via enhancing the AMPK signaling pathway.
Non-alcoholic Fatty Liver Disease
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
Non-alcoholic Fatty Liver Disease
Marginal iron deficiency enhances liver triglyceride accumulation in rats fed a high-sucrose diet.
Non-alcoholic Fatty Liver Disease
Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children.
Non-alcoholic Fatty Liver Disease
Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipients.
Non-alcoholic Fatty Liver Disease
Mastiha (Pistacia lentiscus) Improves Gut Microbiota Diversity, Hepatic Steatosis, and Disease Activity in a Biopsy-Confirmed Mouse Model of Advanced Non-Alcoholic Steatohepatitis and Fibrosis.
Non-alcoholic Fatty Liver Disease
Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
Non-alcoholic Fatty Liver Disease
Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study.
Non-alcoholic Fatty Liver Disease
Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population.
Non-alcoholic Fatty Liver Disease
Metabolomic Study of High-Fat Diet-Induced Obese (DIO) and DIO Plus CCl4-Induced NASH Mice and the Effect of Obeticholic Acid.
Non-alcoholic Fatty Liver Disease
Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design.
Non-alcoholic Fatty Liver Disease
Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study.
Non-alcoholic Fatty Liver Disease
Motion - all patients with NASH need to have a liver biopsy: arguments for the motion.
Non-alcoholic Fatty Liver Disease
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Non-alcoholic Fatty Liver Disease
Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies.
Non-alcoholic Fatty Liver Disease
New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence.
Non-alcoholic Fatty Liver Disease
Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake.
Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease among sasang constitutional types: a population-based study in Korea.
Non-alcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver Disease and Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia.
Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics.
Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease and outcomes in persons with acute coronary syndromes: insights from the GRACE-ALT analysis.
Non-alcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).
Non-alcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.
Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease in patients with migraine.
Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study.
Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension.
Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease is not associated with vitamin D deficiency in essential hypertension.
Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese.
Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort.
Non-alcoholic Fatty Liver Disease
Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.
Non-alcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease and Fibrosis Risk in Patients With Obstructive Sleep Apnea: A Retrospective Analysis.
Non-alcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease and Risk of Diabetes: A Prospective Study in China.
Non-alcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease as a Risk Factor for Prolonged Corrected QT Interval in Apparently Healthy Korean Women.
Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease in patients with acute ischemic stroke is associated with more severe stroke and worse outcome.
Non-alcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease in University Rugby Football Players.
Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center.
Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status.
Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase.
Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease is associated with coronary artery calcification.
Non-alcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease is Underrecognized in the Primary Care Setting.
Non-alcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease Markers Are Associated with Insulin Resistance in Type 1 Diabetes.
Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in U.S. adults.
Non-alcoholic Fatty Liver Disease
Noninvasive indices for predicting nonalcoholic fatty liver disease in patients with chronic kidney disease.
Non-alcoholic Fatty Liver Disease
Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels.
Non-alcoholic Fatty Liver Disease
Normal limit for serum alanine aminotransferase level and distribution of metabolic factors in old population of kalaleh, iran.
Non-alcoholic Fatty Liver Disease
Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010-2015.
Non-alcoholic Fatty Liver Disease
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial.
Non-alcoholic Fatty Liver Disease
Nuclear size measurement is a simple method for the assessment of hepatocellular aging in non-alcoholic fatty liver disease: Comparison with telomere-specific quantitative FISH and p21 immunohistochemistry.
Non-alcoholic Fatty Liver Disease
Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents.
Non-alcoholic Fatty Liver Disease
Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study.
Non-alcoholic Fatty Liver Disease
Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial.
Non-alcoholic Fatty Liver Disease
Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant.
Non-alcoholic Fatty Liver Disease
Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge.
Non-alcoholic Fatty Liver Disease
PEDIATRIC VISCERAL ADIPOSITY INDEX ADAPTATION CORRELATES WITH HOMA-IR, MATSUDA, AND TRANSAMINASES.
Non-alcoholic Fatty Liver Disease
Performance and Utility of Transient Elastography and Non-Invasive Markers of Liver Fiibrosis in Patients with Autoimmune Hepatitis: A Single Centre Experience.
Non-alcoholic Fatty Liver Disease
Performance of fibrosis prediction scores in paediatric non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Periodontitis and prevalence of elevated aminotransferases in the Hispanic Community Health Study/Study of Latinos.
Non-alcoholic Fatty Liver Disease
Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study.
Non-alcoholic Fatty Liver Disease
Persistent organic pollutants and non-alcoholic fatty liver disease in morbidly obese patients: a cohort study.
Non-alcoholic Fatty Liver Disease
Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats.
Non-alcoholic Fatty Liver Disease
Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-(PEMT) deficient mice.
Non-alcoholic Fatty Liver Disease
Plasma interleukin-18/interleukin-18 binding protein ratio in Chinese with NAFLD.
Non-alcoholic Fatty Liver Disease
Plasma reactive carbonyl species levels and risk of nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders.
Non-alcoholic Fatty Liver Disease
Platelet counts and liver enzymes after bariatric surgery.
Non-alcoholic Fatty Liver Disease
Platelet Counts and Liver Enzymes After Gastric Bypass Surgery.
Non-alcoholic Fatty Liver Disease
Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Non-alcoholic Fatty Liver Disease
Prediction and Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) and Identification of Its Associated Factors Using the Classification Tree Method.
Non-alcoholic Fatty Liver Disease
Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
Non-alcoholic Fatty Liver Disease
Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) Study.
Non-alcoholic Fatty Liver Disease
Predictive Values of Serum Uric Acid and Alanine-aminotransferase for Fatty Liver Index in Montenegrin Population.
Non-alcoholic Fatty Liver Disease
Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.
Non-alcoholic Fatty Liver Disease
Predictors of Nonalcoholic Fatty Liver Disease Among Middle-Aged Iranians.
Non-alcoholic Fatty Liver Disease
Predictors of nonalcoholic steatohepatitis in patients with elevated alanine aminotransferase activity.
Non-alcoholic Fatty Liver Disease
Predictors reflecting the pathological severity of non-alcoholic fatty liver disease: comprehensive study of clinical and immunohistochemical findings in younger Asian patients.
Non-alcoholic Fatty Liver Disease
Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus.
Non-alcoholic Fatty Liver Disease
Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes.
Non-alcoholic Fatty Liver Disease
Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese Children.
Non-alcoholic Fatty Liver Disease
Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
Non-alcoholic Fatty Liver Disease
Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain.
Non-alcoholic Fatty Liver Disease
Prevalence and predictors of non-alcoholic fatty liver disease as defined by the fatty liver index in a type 2 diabetes population.
Non-alcoholic Fatty Liver Disease
Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
Non-alcoholic Fatty Liver Disease
Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Prevalence and risk factors for nonalcoholic fatty liver disease in obese children in rural Punjab, India.
Non-alcoholic Fatty Liver Disease
Prevalence and risk factors of elevated alanine aminotransferase among Korean adolescents: 2001-2014.
Non-alcoholic Fatty Liver Disease
Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.
Non-alcoholic Fatty Liver Disease
Prevalence and risk factors of nonalcoholic fatty liver disease in breast cancer patients.
Non-alcoholic Fatty Liver Disease
Prevalence of increased transaminases and its association with sex, age, and metabolic parameters in children and adolescents with obesity - a nationwide cross-sectional cohort study.
Non-alcoholic Fatty Liver Disease
Prevalence of NAFLD in Guatemala following exposure to a protein-energy nutrition intervention in early life.
Non-alcoholic Fatty Liver Disease
Prevalence of non-alcoholic fatty liver disease among patients with non-diabetic chronic kidney disease detected by transient elastography.
Non-alcoholic Fatty Liver Disease
Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran.
Non-alcoholic Fatty Liver Disease
Prevalence of non-alcoholic fatty liver disease in regional Victoria: a prospective population-based study.
Non-alcoholic Fatty Liver Disease
Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity.
Non-alcoholic Fatty Liver Disease
Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures.
Non-alcoholic Fatty Liver Disease
Prevalence of Suspected Nonalcoholic Fatty Liver Disease In Lean Adolescents In The United States.
Non-alcoholic Fatty Liver Disease
Prevalence, clinical & biochemical correlates of non-alcoholic fatty liver disease in overweight adolescents.
Non-alcoholic Fatty Liver Disease
Prevalence, predictors and severity of lean non-alcoholic fatty liver disease in HIV-infected patients.
Non-alcoholic Fatty Liver Disease
Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia.
Non-alcoholic Fatty Liver Disease
Probable NAFLD, by ALT levels, and diabetes among Filipino-American women.
Non-alcoholic Fatty Liver Disease
Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes.
Non-alcoholic Fatty Liver Disease
Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Prospective study of perceived dietary salt intake and the risk of non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Protective effect of probiotics in patients with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Raised liver enzymes in newly diagnosed Type 2 diabetes are associated with weight and lipids, but not glycaemic control.
Non-alcoholic Fatty Liver Disease
Randomised Double-Blind Placebo-Controlled Trial of Inulin with Metronidazole in Non-Alcoholic Fatty Liver Disease (NAFLD).
Non-alcoholic Fatty Liver Disease
Raw Bowl Tea (Tuocha) Polyphenol Prevention of Nonalcoholic Fatty Liver Disease by Regulating Intestinal Function in Mice.
Non-alcoholic Fatty Liver Disease
Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study.
Non-alcoholic Fatty Liver Disease
Relation between alanine aminotransferase concentrations and visceral fat accumulation among nondiabetic overweight Korean women.
Non-alcoholic Fatty Liver Disease
Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Relationship between body mass index and alanine aminotransferase concentration in non-diabetic Korean adults.
Non-alcoholic Fatty Liver Disease
Relationship between grip strength and newly diagnosed nonalcoholic fatty liver disease in a large-scale adult population.
Non-alcoholic Fatty Liver Disease
Relationship between hemoglobin levels and risk for suspected non-alcoholic fatty liver in Taiwanese adults.
Non-alcoholic Fatty Liver Disease
Relationship Between Hepatic Steatosis and the Elevation of Aminotransferases in HBV-Infected Patients With HBe-Antigen Negativity and a Low Viral Load.
Non-alcoholic Fatty Liver Disease
Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
Non-alcoholic Fatty Liver Disease
Relationship between non-alcoholic fatty liver disease during pregnancy and abnormal glucose metabolism during and after pregnancy.
Non-alcoholic Fatty Liver Disease
Relationship between periodontitis and hepatic abnormalities in young adults.
Non-alcoholic Fatty Liver Disease
Relationship between plasma 12,13-diHOME level and nonalcoholic fatty liver disease in patients with type 2 diabetes and obesity.
Non-alcoholic Fatty Liver Disease
Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients.
Non-alcoholic Fatty Liver Disease
Relationships Between Alanine Aminotransferase, Serum Triglycerides, Body Mass Index and Nonalcoholic Fatty Liver Disease in an Outpatient Pediatric Clinic Population.
Non-alcoholic Fatty Liver Disease
Resveratrol Reduces Glucolipid Metabolic Dysfunction and Learning and Memory Impairment in a NAFLD Rat Model: Involvement in Regulating the Imbalance of Nesfatin-1 Abundance and Copine 6 Expression.
Non-alcoholic Fatty Liver Disease
Revision of serum ALT upper limits of normal facilitates assessment of mild liver injury in obese children with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Rhus verniciflua and Eucommia ulmoides Protects Against High-Fat Diet-Induced Hepatic Steatosis by Enhancing Anti-Oxidation and AMPK Activation.
Non-alcoholic Fatty Liver Disease
Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females.
Non-alcoholic Fatty Liver Disease
Risk factors and characteristics associated with nonalcoholic fatty liver disease in patients with ischemic colitis.
Non-alcoholic Fatty Liver Disease
Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile.
Non-alcoholic Fatty Liver Disease
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
Non-alcoholic Fatty Liver Disease
Role of APN and TNF-? in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.
Non-alcoholic Fatty Liver Disease
Screening for elevated risk of liver disease in preschool children (aged 2-5?years) being seen for obesity management.
Non-alcoholic Fatty Liver Disease
Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
Non-alcoholic Fatty Liver Disease
Screening of Family Members of Nonalcoholic Fatty Liver Disease Patients can Detect Undiagnosed Nonalcoholic Fatty Liver Disease Among Them: Is There a Genetic Link?
Non-alcoholic Fatty Liver Disease
SeP is elevated in NAFLD and participates in NAFLD pathogenesis through AMPK/ACC pathway.
Non-alcoholic Fatty Liver Disease
Serum alanine aminotransferase as a biomarker of treatment response in nonalcoholic steatohepatitis.
Non-alcoholic Fatty Liver Disease
Serum alanine aminotransferase independently correlates with intrahepatic triglyceride contents in obese subjects.
Non-alcoholic Fatty Liver Disease
Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults.
Non-alcoholic Fatty Liver Disease
Serum alanine aminotransferase predicts interventricular septum thickness and left ventricular mass in patients with nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Serum Alanine Transaminase Is an Inadequate Nonalcoholic Fatty Liver Screening Test in Adolescents: Results From the National Health and Nutrition Examination Survey 2017-2018.
Non-alcoholic Fatty Liver Disease
Serum biomarkers combined with ultrasonography for early diagnosis of non-alcoholic fatty liver disease confirmed by magnetic resonance spectroscopy.
Non-alcoholic Fatty Liver Disease
Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Serum carcinoembryonic antigen is associated with non-alcoholic fatty liver disease in healthy Korean non-smokers.
Non-alcoholic Fatty Liver Disease
Serum cytokeratin 18 M30 antigen level and its correlation with nutritional parameters in middle-aged Japanese males with nonalcoholic fatty liver disease (NAFLD).
Non-alcoholic Fatty Liver Disease
Serum fetuin A level is associated with nonalcoholic fatty liver disease in Chinese population.
Non-alcoholic Fatty Liver Disease
Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels.
Non-alcoholic Fatty Liver Disease
Serum glycated albumin levels, but not glycated hemoglobin, is low in relation to glycemia in non-diabetic men with nonalcoholic fatty liver disease with high alanine aminotransferase levels.
Non-alcoholic Fatty Liver Disease
Serum Golgi Protein 73 as a Potential Biomarker for Hepatic Necroinflammation in Population with Nonalcoholic Steatohepatitis.
Non-alcoholic Fatty Liver Disease
Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Serum Monounsaturated Triacylglycerol Predicts Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease and Chronic Hepatitis B.
Non-alcoholic Fatty Liver Disease
Serum Osteocalcin Levels in Children With Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
Non-alcoholic Fatty Liver Disease
Serum selenium and non-alcoholic fatty liver disease (NAFLD) in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2011-2016.
Non-alcoholic Fatty Liver Disease
Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in patients with type 2 diabetes.
Non-alcoholic Fatty Liver Disease
Serum Soluble Receptor for AGE (sRAGE) Levels Are Associated With Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Serum testosterone and non-alcoholic fatty liver disease in men and women in the US.
Non-alcoholic Fatty Liver Disease
Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men.
Non-alcoholic Fatty Liver Disease
Serum vascular endothelial cadherin and thrombomodulin are markers of non-alcoholic fatty liver disease in children.
Non-alcoholic Fatty Liver Disease
Serum visfatin level as a noninvasive marker for nonalcoholic fatty liver disease in children and adolescents with obesity: relation to transient elastography with controlled attenuation parameter.
Non-alcoholic Fatty Liver Disease
Severity of metabolic syndrome is greater among nonalcoholic adults with elevated ALT and advanced fibrosis.
Non-alcoholic Fatty Liver Disease
Sex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathway.
Non-alcoholic Fatty Liver Disease
Sex influenced association of directly measured insulin sensitivity and serum transaminase levels: Why alanine aminotransferase only predicts cardiovascular risk in men?
Non-alcoholic Fatty Liver Disease
Sex-Specific Metabolite Biomarkers of NAFLD in Youth: A Prospective Study in the EPOCH Cohort.
Non-alcoholic Fatty Liver Disease
SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.
Non-alcoholic Fatty Liver Disease
SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews.
Non-alcoholic Fatty Liver Disease
Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey.
Non-alcoholic Fatty Liver Disease
Short sleep duration is a risk of incident nonalcoholic fatty liver disease: a population-based longitudinal study.
Non-alcoholic Fatty Liver Disease
Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Shorter Leukocyte Telomere Length in Relation to Presumed Nonalcoholic Fatty Liver Disease in Mexican-American Men in NHANES 1999-2002.
Non-alcoholic Fatty Liver Disease
Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Simple resistance exercise decreases cytokeratin 18 and fibroblast growth factor 21 levels in patients with nonalcoholic fatty liver disease: A retrospective clinical study.
Non-alcoholic Fatty Liver Disease
Simple Resistance Exercise for 24 Weeks Decreases Alanine Aminotransferase Levels in Patients with Non-Alcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Sirtuin3 rs28365927 functional variant confers to the high risk of non-alcoholic fatty liver disease in Chinese Han population.
Non-alcoholic Fatty Liver Disease
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
Non-alcoholic Fatty Liver Disease
Small intestinal bacterial overgrowth and orocecal transit time in patients of nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician's Guide.
Non-alcoholic Fatty Liver Disease
Soft drinks consumption is associated with nonalcoholic fatty liver disease independent of metabolic syndrome in Chinese population.
Non-alcoholic Fatty Liver Disease
Soy diet for nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials.
Non-alcoholic Fatty Liver Disease
Statin liver safety in non-alcoholic fatty liver disease: A systematic review and metanalysis.
Non-alcoholic Fatty Liver Disease
Study of Family Clustering and PNPLA3 Gene Polymorphism in Pediatric Non Alcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Study on the independent effect of thyroid hormone based on uric acid level on NAFLD.
Non-alcoholic Fatty Liver Disease
Study on the new strategy and key techniques for accurate prevention and treatment of nonalcoholic steatohepatitis based on intestinal target bacteria.
Non-alcoholic Fatty Liver Disease
Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria.
Non-alcoholic Fatty Liver Disease
Targeted next-generation sequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PARVB with the severity of nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
The 'donations for decreased ALT (D4D)' prosocial behavior incentive scheme for NAFLD patients.
Non-alcoholic Fatty Liver Disease
The alanine aminotransferase to triglycerides ratio as a marker to identify nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program.
Non-alcoholic Fatty Liver Disease
The association between dietary lifestyles and hepatocellular injury in Japanese workers.
Non-alcoholic Fatty Liver Disease
The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels.
Non-alcoholic Fatty Liver Disease
The association between the serum levels of uric acid and alanine aminotransferase in a population-based cohort.
Non-alcoholic Fatty Liver Disease
The association of early unexplained elevated alanine aminotransferase with large-for-gestational-age birthweight.
Non-alcoholic Fatty Liver Disease
The association of lipid metabolism and non-alcoholic fatty liver disease in children with obesity.
Non-alcoholic Fatty Liver Disease
The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
Non-alcoholic Fatty Liver Disease
The association of non-alcoholic fatty liver disease with lung function: A survey design analysis using propensity score.
Non-alcoholic Fatty Liver Disease
The association of obstructive sleep apnea with dyslipidemia in Korean children and adolescents: a single-center, cross-sectional study.
Non-alcoholic Fatty Liver Disease
The association of sex steroid hormone concentrations with non-alcoholic fatty liver disease and liver enzymes in US men.
Non-alcoholic Fatty Liver Disease
The association of vitamin D deficiency with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
The change in prevalence of suspected non-alcoholic fatty liver disease in Korean adolescents from 2001 to 2017.
Non-alcoholic Fatty Liver Disease
The Changing Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Turkey in the Last Decade.
Non-alcoholic Fatty Liver Disease
The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPK?.
Non-alcoholic Fatty Liver Disease
The Clinical Investigation of Disparity of Nonalcoholic Fatty Liver Disease in a Chinese Occupational Population in Taipei, Taiwan: Experience at a Teaching Hospital.
Non-alcoholic Fatty Liver Disease
The effect of aerobic, resistance, and combined training on PPAR-?, SIRT1 gene expression, and insulin resistance in high-fat diet-induced NAFLD male rats.
Non-alcoholic Fatty Liver Disease
The Effect of Artichoke Leaf Extract on Alanine Aminotransferase and Aspartate Aminotransferase in the Patients with Nonalcoholic Steatohepatitis.
Non-alcoholic Fatty Liver Disease
The effect of metformin on aminotransferase levels, metabolic parameters and body mass index in nonalcoholic fatty liver disease patients: a meta-analysis.
Non-alcoholic Fatty Liver Disease
The effect of omega-3 unsaturated fatty acids on non-alcoholic fatty liver disease: A systematic review and meta-analysis of RCTs.
Non-alcoholic Fatty Liver Disease
The effect of the spanish ketogenic mediterranean diet on nonalcoholic Fatty liver disease: a pilot study.
Non-alcoholic Fatty Liver Disease
The effect of total anthocyanin-base standardized (Cornus mas L.) fruit extract on liver function, tumor necrosis factor ?, malondealdehyde, and adiponectin in patients with non-alcoholic fatty liver: a study protocol for a double-blind randomized clinical trial.
Non-alcoholic Fatty Liver Disease
The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.
Non-alcoholic Fatty Liver Disease
The effects of low carbohydrate diets on liver function tests in nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials.
Non-alcoholic Fatty Liver Disease
The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid.
Non-alcoholic Fatty Liver Disease
The efficacy of vitamin E in reducing non-alcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.
Non-alcoholic Fatty Liver Disease
The ERLIN1-CHUK-CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart Study.
Non-alcoholic Fatty Liver Disease
The Evaluation of Effective Drugs for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis.
Non-alcoholic Fatty Liver Disease
The Expression of PNPLA3 Polymorphism could be the Key for Severe Liver Disease in NAFLD in Hispanic Population.
Non-alcoholic Fatty Liver Disease
The glycated albumin to glycated haemoglobin ratio increases along with the fibrosis stage in non-alcoholic steatohepatitis.
Non-alcoholic Fatty Liver Disease
The grade of nonalcoholic fatty liver disease is an independent risk factor for gallstone disease: An observational Study.
Non-alcoholic Fatty Liver Disease
The identify role and molecular mechanism of the MALAT1/hsa-mir-20b-5p/TXNIP axis in liver inflammation caused by CHB in patients with chronic HBV infection complicated with NAFLD.
Non-alcoholic Fatty Liver Disease
The impact of turmeric or its curcumin extract on nonalcoholic fatty liver disease: a systematic review of clinical trials.
Non-alcoholic Fatty Liver Disease
The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD).
Non-alcoholic Fatty Liver Disease
The lipid accumulation product is highly related to serum alanine aminotransferase level in male adults.
Non-alcoholic Fatty Liver Disease
The overall computer/mobile devices usage time is related to newly diagnosed non-alcoholic fatty liver disease: a population-based study.
Non-alcoholic Fatty Liver Disease
The prevalence and correlates of T-wave inversion in lead III in non-obese men.
Non-alcoholic Fatty Liver Disease
The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis.
Non-alcoholic Fatty Liver Disease
The prevalence of non-alcoholic fatty liver disease in healthy young persons.
Non-alcoholic Fatty Liver Disease
The Prevalence of Nonalcoholic Fatty Liver Disease and Its Risk Factors in Children and Young Adults with Type 1 Diabetes Mellitus.
Non-alcoholic Fatty Liver Disease
The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
Non-alcoholic Fatty Liver Disease
The Relationship Between Serum Uric Acid Levels and The Major Risk Factors for The Development of Non-Alcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
The Relationship Between Tamoxifen-associated Nonalcoholic Fatty Liver Disease and the Prognosis of Patients With Early-stage Breast Cancer.
Non-alcoholic Fatty Liver Disease
The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents.
Non-alcoholic Fatty Liver Disease
The role of ADIPOQ methylation in curcumin-administrated experimental nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
The role of bilio-pancreatic limb in nonalcoholic steatohepatitis improvement after duodenal-jejunal bypass in rats.
Non-alcoholic Fatty Liver Disease
The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
The role of SAMM50 in non-alcoholic fatty liver disease: from genetics to mechanisms.
Non-alcoholic Fatty Liver Disease
The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
Non-alcoholic Fatty Liver Disease
The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects.
Non-alcoholic Fatty Liver Disease
The Symptoms of Gastroesophageal Reflux Disease Correlate with High Body Mass Index, the Aspartate Aminotransferase/Alanine Aminotransferase Ratio and Insulin Resistance in Japanese Patients with Non-alcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
There's More under the Nonalcoholic Fatty Liver Disease Umbrella Than an Elevated Alanine Aminotransferase Level.
Non-alcoholic Fatty Liver Disease
TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice.
Non-alcoholic Fatty Liver Disease
Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Non-alcoholic Fatty Liver Disease
Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus.
Non-alcoholic Fatty Liver Disease
Treatment strategies in nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Triglyceride Levels and Not Adipokine Concentrations Are Closely Related to Severity of Nonalcoholic Fatty Liver Disease in an Obesity Surgery Cohort.
Non-alcoholic Fatty Liver Disease
Type 1 Diabetes and Non-Alcoholic Fatty Liver Disease: When Should We Be Concerned? A Nationwide Study in Brazil.
Non-alcoholic Fatty Liver Disease
Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase.
Non-alcoholic Fatty Liver Disease
Ultrasound measurement of pediatric visceral fat thickness: correlations with metabolic and liver profiles.
Non-alcoholic Fatty Liver Disease
Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).
Non-alcoholic Fatty Liver Disease
Urine uric acid excretion is associated with nonalcoholic fatty liver disease in patients with type 2 diabetes.
Non-alcoholic Fatty Liver Disease
Utility of ALT Concentration in Men and Women with Nonalcoholic Fatty Liver Disease: Cohort Study.
Non-alcoholic Fatty Liver Disease
Variations in alanine aminotransferase levels within the normal range predict metabolic and androgenic phenotypes in women of reproductive age.
Non-alcoholic Fatty Liver Disease
Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-?B?
Non-alcoholic Fatty Liver Disease
Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trial.
Non-alcoholic Fatty Liver Disease
What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis?
Non-alcoholic Fatty Liver Disease
Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice.
Non-alcoholic Fatty Liver Disease
Xuefu Zhuyu decoction for nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis.
Non-alcoholic Fatty Liver Disease
Yield of diagnostic tests in obese children with an elevated alanine aminotransferase.
Non-alcoholic Fatty Liver Disease
[Assessment of high sensitivity C-reactive protein (HS-CRP) as a marker of liver inflammation in patients with metabolic syndrome]
Non-alcoholic Fatty Liver Disease
[Association between glycosylated hemoglobin and ?non-alcoholic fatty liver disease in ?health examination population].
Non-alcoholic Fatty Liver Disease
[Association of abnormality of liver enzymes and metabolic syndrome in patients with nonalcoholic fatty liver disease]
Non-alcoholic Fatty Liver Disease
[Clinical features of non-alcoholic fatty liver disease and its relationship with serum C-peptide levels in patients with latent autoimmune diabetes in adults].
Non-alcoholic Fatty Liver Disease
[Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
Non-alcoholic Fatty Liver Disease
[Correlation between serum uric acid and risk of new-onset nonalcoholic fatty liver disease: a 5-year observational cohort study].
Non-alcoholic Fatty Liver Disease
[Fat distribution and its relationship with genetic polymorphism in patients with nonalcoholic liver disease].
Non-alcoholic Fatty Liver Disease
[Hepatic parenchimatous damage and perfusion disturbance in the progression of nonalcoholic fatty liver disease].
Non-alcoholic Fatty Liver Disease
[Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease; Relation of non-alcoholic fatty liver disease to carotid atherosclerosis.]
Non-alcoholic Fatty Liver Disease
[Prevalence and risk factors for fatty liver in Tunisian adults with obstructive sleep apnea].
Non-alcoholic Fatty Liver Disease
[Relationship between non-alcoholic fatty liver disease and incidence of type 2 diabetes mellitus in Chinese adults: a prospective cohort study].
Non-alcoholic Fatty Liver Disease
[Relationship between nonalcoholic fatty liver disease markers and renal function in patients with type 1 diabetes].
Non-alcoholic Fatty Liver Disease
[Relationship of visceral adiposity index with serum aminotransferase and nonalcoholic fatty liver disease in patients with sleep apnea].
Non-alcoholic Fatty Liver Disease
[The relationship between non-alcoholic fatty liver disease and metabolic syndrome in patients with latent autoimmune diabetes in adults].
Non-alcoholic Fatty Liver Disease
[The relationship between serum adiponectin level and serum alanine aminotransferase elevation in korean male with nonalcoholic fatty liver disease]
Non-alcoholic Fatty Liver Disease
[Waist circumference as a marker for screening nonalcoholic fatty liver disease in obese adolescents].
Obesity
A better parameter in predicting insulin resistance: obesity plus elevated alanine aminotransferase.
Obesity
A predictive model for area under the concentration versus time curve of cyclosporin A using several routine monitoring results in renal transplant patients.
Obesity
A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology.
Obesity
Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.
Obesity
Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth.
Obesity
Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer's disease and myocardial infarction.
Obesity
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Obesity
Aminotransferase activity in morbid and uncomplicated obesity: predictive role of fasting insulin.
Obesity
Antiobesity Effects of Salvia plebeia R. Br. Extract in High-Fat Diet-Induced Obese Mice.
Obesity
Association between metabolic syndrome and the development of non-alcoholic fatty liver disease.
Obesity
Association between serum alanine aminotransferase level and obesity indices in Korean adolescents.
Obesity
Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes.
Obesity
Association of Alanine Aminotransferase With Different Metabolic Phenotypes of Obesity in Children and Adolescents: The CASPIAN-V Study.
Obesity
Association of elevated alanine aminotransferase with BMI and diabetes in older veteran outpatients.
Obesity
Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
Obesity
Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children.
Obesity
Associations between markers of liver injury and cytokine markers for insulin sensitivity and inflammation in middle-aged Japanese men not being treated for metabolic diseases.
Obesity
Bilobalide Enhances AMPK Activity to Improve Liver Injury and Metabolic Disorders in STZ-Induced Diabetes in Immature Rats via Regulating HMGB1/TLR4/NF-?B Signaling Pathway.
Obesity
Body mass index, waist circumference, and chronic disease risk factors in Australian adolescents.
Obesity
Changes in alanine aminotransferase in adults with severe and complicated obesity during a milk-based meal replacement programme.
Obesity
CHDH-PNPLA3 Gene-Gene Interactions Predict Insulin Resistance in Children with Obesity.
Obesity
Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity.
Obesity
Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
Obesity
Co-occurrence of obesity and patterns of alcohol use associated with elevated serum hepatic enzymes in US adults.
Obesity
Co-variation of alanine aminotransferase levels with relative weight in blood donors.
Obesity
Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease.
Obesity
Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease.
Obesity
Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes.
Obesity
Dietary fatty acid oxidation is decreased in non-alcoholic fatty liver disease: A palmitate breath test study.
Obesity
Early-onset metabolic syndrome in prepubertal obese children and the possible role of alanine aminotransferase as marker of metabolic syndrome.
Obesity
Effects of alcohol intake and obesity on serum liver enzyme activity in obese men with mild hypertension.
Obesity
Elevated Alanine Aminotransferase in Current National Football League Players: Correlation with Cardiometabolic Syndrome Markers, Obesity, and Insulin Resistance.
Obesity
Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography.
Obesity
Extended-release naltrexone/bupropion and liver health: Pooled, post hoc analysis from four randomized controlled trials.
Obesity
Fermented Castanea crenata Inner Shell Extract Increases Fat Metabolism and Decreases Obesity in High-Fat Diet-Induced Obese Mice.
Obesity
Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins.
Obesity
Heat-killed Lactobacillus plantarum L-137 attenuates obesity and associated metabolic abnormalities in C57BL/6?J mice on a high-fat diet.
Obesity
Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.
Obesity
Hepatic lesions induced by feeding Western diets to Zucker fatty rats, an insulin-resistant model.
Obesity
Higher levels of alanine aminotransferase within the reference range predict unhealthy metabolic phenotypes of obesity in normoglycemic first-degree relatives of patients with type 2 diabetes mellitus.
Obesity
Homeostasis model assessment of insulin resistance in a general adult population in Korea: Additive association of sarcopenia and obesity with insulin resistance.
Obesity
Hyperandrogenemia Is Independently Associated with Elevated Alanine Aminotransferase Activity in Young Women with Polycystic Ovary Syndrome.
Obesity
Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.
Obesity
Independent associations of alanine aminotransferase (ALT) levels with cardiovascular risk factor clustering in Chinese adolescents.
Obesity
Influences of pregravid liver enzyme levels on the development of gestational diabetes mellitus.
Obesity
Interaction between obesity and the Hypoxia Inducible Factor 3 Alpha Subunit rs3826795 polymorphism in relation with plasma alanine aminotransferase.
Obesity
Interactions between uncoupling protein 2 gene polymorphisms, obesity and alcohol intake on liver function: a large meta-analysed population-based study.
Obesity
Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease.
Obesity
Lack of Associations between Elevated Serum Uric Acid and Components of Metabolic Syndrome Such as Hypertension, Dyslipidemia, and T2DM in Overweight and Obese Chinese Adults.
Obesity
Liver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes.
Obesity
Liver enzymes as mediators of association between obesity and diabetes: the Guangzhou Biobank Cohort Study.
Obesity
Liver Enzymes Correlate With Metabolic Syndrome, Inflammation, and Endothelial Dysfunction in Prepubertal Children With Obesity.
Obesity
Liver enzymes, type 2 diabetes, and metabolic syndrome in middle-aged, urban chinese men.
Obesity
Magnesium isoglycyrrhizinate alleviates liver injury in obese rats with acute necrotizing pancreatitis.
Obesity
Molecular Differences Based on Erythrocyte Fatty Acid Profile to Personalize Dietary Strategies between Adults and Children with Obesity.
Obesity
Newly identified set of obesity-related genotypes and abdominal fat influence the risk of insulin resistance in a Korean population.
Obesity
Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases.
Obesity
Obesity and diabetic hyperglycemia were associated with serum alanine aminotransferase activity in patients with hepatitis B infection.
Obesity
Obesity is a potential risk factor contributing to clinical manifestations of COVID-19.
Obesity
Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study.
Obesity
Obesity, insulin resistance, and the risk of an elevated alanine aminotransferase activity in the Korean adolescent population.
Obesity
Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study.
Obesity
Persistent alanine aminotransferase elevation in healthy Swedish blood donors--mainly caused by obesity.
Obesity
Persistent organic pollutants and non-alcoholic fatty liver disease in morbidly obese patients: a cohort study.
Obesity
Physalis alkekengi Exhibits Antiobesity Effects in Mice with Potential of Inducing White Adipose Tissue Browning.
Obesity
Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet.
Obesity
Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) Study.
Obesity
Predictors of poor response to urate-lowering therapy in patients with gout and hyperuricemia: a post-hoc analysis of a multicenter randomized trial.
Obesity
Prevalence and risk factors of metabolic syndrome in obese children and adolescents: the role of the severity of obesity.
Obesity
Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.
Obesity
Prevalence of metabolic syndrome and risks of abnormal serum alanine aminotransferase in Hispanics: a population-based study.
Obesity
Relation of coffee consumption and serum liver enzymes in Japanese men and women with reference to effect modification of alcohol use and body mass index.
Obesity
Relationship between body mass index and alanine aminotransferase concentration in non-diabetic Korean adults.
Obesity
Review article: the treatment of non-alcoholic steatohepatitis with thiazolidinediones.
Obesity
Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004.
Obesity
Risk factors for liver disease among adults of Mexican descent in the United States and Mexico.
Obesity
Screening for elevated risk of liver disease in preschool children (aged 2-5?years) being seen for obesity management.
Obesity
Self-reported faster eating associated with higher ALT activity in middle-aged, apparently healthy Japanese women.
Obesity
Self-reported rate of eating is associated with higher circulating ALT activity in middle-aged apparently healthy Japanese men.
Obesity
Serum alanine aminotransferase levels among volunteer blood donors: effect of sex, alcohol intake and obesity.
Obesity
Serum alanine aminotransferase levels are closely associated with metabolic disturbances in apparently healthy young adolescents independent of obesity.
Obesity
Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014.
Obesity
Serum gamma-glutamyl transpeptidase is a determinant of insulin resistance independently of adiposity in Pima Indian children.
Obesity
Serum Phenylalanine Concentration as a Marker of Liver Function in Obese Patients Before and After Bariatric Surgery.
Obesity
Serum visfatin level as a noninvasive marker for nonalcoholic fatty liver disease in children and adolescents with obesity: relation to transient elastography with controlled attenuation parameter.
Obesity
Severe obesity is associated with liver disease severity in pediatric non-alcoholic fatty liver disease.
Obesity
Short-Term Soy Protein Isolate Feeding Prevents Liver Steatosis and Reduces Serum ALT and AST Levels in Obese Female Zucker Rats.
Obesity
Shorter Leukocyte Telomere Length in Relation to Presumed Nonalcoholic Fatty Liver Disease in Mexican-American Men in NHANES 1999-2002.
Obesity
Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.
Obesity
The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
Obesity
The Association Between Self-Reported Sleep Quality and Overweight in A Chinese Population.
Obesity
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Obesity
The Pediatric Obesity Microbiome and Metabolism Study (POMMS): Methods, Baseline Data, and Early Insights.
Obesity
The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis.
Obesity
Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort.
Obesity
Zonulin level, a marker of intestinal permeability, is increased in association with liver enzymes in young adolescents.
Obesity
[Clinical observation on acupoint catgut embedding for treatment of non-alcoholic steatohepatitis].
Obesity
[Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency].
Obesity
[Earthquake-induced stress: relationships and trends noticed in health examination data from survivors of the great Hanshin-Awaji earthquake (Jan. 17, 1995)]
Obesity
[Fatty hepatosis. Non-alcoholic steatohepatitis (evolution of the knowledge about clinico-morphological features, prognosis, treatment)]
Obesity
[Non-alcoholic fatty liver in children and adolescents with excess weight and obesity.]
Obesity
[Peripheral blood albumin level in significantly correlated with the severity of atherosclerosis in hypertensive patients].
Obesity
[Relationship between alanine aminotransferase and overweight or obesity in children].
Obesity, Abdominal
Abdominal obesity validates the association between elevated alanine aminotransferase and newly diagnosed diabetes mellitus.
Obesity, Abdominal
Abnormal liver function and central obesity associate with work-related fatigue among the Taiwanese workers.
Obesity, Abdominal
Association between obesity, hypertriglyceridemia and low hepatitis B viral load.
Obesity, Abdominal
Association of Alanine Aminotransferase With Different Metabolic Phenotypes of Obesity in Children and Adolescents: The CASPIAN-V Study.
Obesity, Abdominal
Consumption of a High Fat Diet Rapidly Exacerbates the Development of Fatty Liver Disease that Occurs with Chronically Elevated Glucocorticoids.
Obesity, Abdominal
Discordant Effects on Central Obesity, Hepatic Insulin Resistance, and Alanine Aminotransferase of Low-dose Metformin and Thiazolidinedione Combination Therapy in Patients with Impaired Glucose Tolerance.
Obesity, Abdominal
Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease.
Obesity, Abdominal
Impact of Obstructive Sleep Apnea on Liver Fat Accumulation According to Sex and Visceral Obesity.
Obesity, Abdominal
Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease.
Obesity, Abdominal
Metabolic Syndrome and Mild Cognitive Impairment: A Case-Control Study among Elderly in a Shanghai Suburb.
Obesity, Abdominal
Recurrence of insulin resistant metabolic syndrome following liver transplantation.
Obesity, Abdominal
Relationship between parental hypertension and cardiometabolic risk factors in adolescents.
Obesity, Abdominal
Risk factors for liver disease among adults of Mexican descent in the United States and Mexico.
Obesity, Abdominal
Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
Obesity, Abdominal
Shorter Leukocyte Telomere Length in Relation to Presumed Nonalcoholic Fatty Liver Disease in Mexican-American Men in NHANES 1999-2002.
Obesity, Abdominal
The cross-sectional association between insulin resistance and circulating complement C3 is partly explained by plasma alanine aminotransferase, independent of central obesity and general inflammation (the CODAM study).
Obesity, Morbid
Characteristics of Youth Presenting for Weight Management: Retrospective National Data from the POWER Study Group.
Obstetric Labor, Premature
Analysis on the outcomes of hepatitis B virus perinatal vertical transmission: nested case-control study.
Obstetric Labor, Premature
Maternal serum uric acid level and maternal and neonatal complications in preeclamptic women: A cross-sectional study.
Oliguria
Factors associated with acute renal failure in falciparum malaria infected patients.
Opisthorchiasis
A combination of praziquantel and the traditional medicinal plant Thunbergia laurifolia on Opisthorchis viverrini infection and cholangiocarcinoma in a hamster model.
Opisthorchiasis
[Biochemical characteristics of hepatic functions in different clinical forms of chronic opisthorchiasis]
Ornithine Carbamoyltransferase Deficiency Disease
Ornithine transcarbamylase deficiency: enzyme studies on a further case and a method of diagnosis using plasma enzyme ratios.
Osteoarthritis
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Osteoarthritis
Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials.
Osteomyelitis
Serum enzyme activity in bone tumors and osteomyelitis (LDH, GOT, GPT, CPK, CHE, ALP, AP, PP, ALD).
Osteoporosis
Blood levels related to the Z-score of bone mineral density in young males and females.
Osteosarcoma
Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
Ototoxicity
Addition of Zoledronate to Chemotherapy in Patients with Osteosarcoma Treated with Limb-Sparing Surgery: A Phase III Clinical Trial.
Ovarian Cysts
[Research of gestrinone-related abnormal uterine bleeding and the intervention in the treatment: a multi-center, randomized, controlled clinical trial].
Ovarian Neoplasms
Genetic epidemiology of breast cancer and associated cancers in high-risk families. II. Linkage analysis.
Overweight
A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE.
Overweight
Adolescent Obesity and Its Association with Diet Quality and Cardiovascular Risk Factors.
Overweight
Alanine aminotransferase and high sensitivity C-reactive protein: correlates of cardiovascular risk factors in youth.
Overweight
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Overweight
Analysis of correlation between liver fat fraction and AST and ALT levels in overweight and obese children by using new magnetic resonance imaging technique.
Overweight
Association between leptin and transaminases: 1-year follow-up study in 180 overweight children.
Overweight
Association of Apelin Levels in Overweight-obese Children with Pubertal Development, but Not with Insulin Sensitivity: 6.5 Years Follow up Evaluation.
Overweight
Association of serum alanine aminotransferase levels with cardiometabolic risk factors in normal-weight and overweight children.
Overweight
Associations between liver enzymes, psychopathological and clinical features in eating disorders.
Overweight
Body mass index, waist circumference, and chronic disease risk factors in Australian adolescents.
Overweight
Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort.
Overweight
Circulating periostin in relation to insulin resistance and nonalcoholic fatty liver disease among overweight and obese subjects.
Overweight
Clinical significance of elevated alanine aminotransferase in blood donors: a follow-up study.
Overweight
Costs of managing conditions associated with obesity among Australian teenagers.
Overweight
Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children.
Overweight
Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease.
Overweight
Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.
Overweight
Diagnostic performance of individual characteristics and anthropometric measurements in detecting elevated serum alanine aminotransferase among children and adolescents.
Overweight
Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.
Overweight
Effects of a Single Oral Megadose of Vitamin D3 on Inflammation and Oxidative Stress Markers in Overweight and Obese Women: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Overweight
Elevated vaspin and leptin levels are associated with obesity in prepubertal Korean children.
Overweight
Epicardial adipose tissue and cardiometabolic risk factors in overweight and obese children and adolescents.
Overweight
Extended-release naltrexone/bupropion and liver health: Pooled, post hoc analysis from four randomized controlled trials.
Overweight
Factors Associated with Insulin Resistance in Patients with Chronic HCV Genotype 1 Infection without Obesity or Type 2 Diabetes.
Overweight
Health behavior associated with liver enzymes among obese Korean adolescents, 2009-2014.
Overweight
Lifestyle intervention in obese children with non-alcoholic fatty liver disease: two years follow-up study.
Overweight
Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design.
Overweight
Milk enriched with conjugated linoleic Acid fails to alter blood lipids or body composition in moderately overweight, borderline hyperlipidemic individuals.
Overweight
Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life.
Overweight
Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents.
Overweight
Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.
Overweight
Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function.
Overweight
Prevalence and predictors of alanine aminotransferase elevation among normal weight, overweight and obese youth in Mexico.
Overweight
Relation between alanine aminotransferase concentrations and visceral fat accumulation among nondiabetic overweight Korean women.
Overweight
Relationships between an index of body fat distribution (based on waist and hip circumferences) and stature, and biochemical complications in obese children.
Overweight
Risk factors for incident type 2 diabetes in individuals with a BMI of <27 kg/m2: the role of gamma-glutamyltransferase. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).
Overweight
Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile.
Overweight
Risk of developing pre-diabetes or diabetes over time in a cohort of Mexican health workers.
Overweight
Serum Alanine Transaminase Is an Inadequate Nonalcoholic Fatty Liver Screening Test in Adolescents: Results From the National Health and Nutrition Examination Survey 2017-2018.
Overweight
Serum Transaminase Concentrations and the Presence of Irritable Bowel Syndrome Are Associated with Serum 25-Hydroxy Vitamin D Concentrations in Adolescent Girls Who Are Overweight and Obese.
Overweight
Substitution of TAG oil with diacylglycerol oil in food items improves the predicted 10 years cardiovascular risk score in healthy, overweight subjects.
Overweight
The alanine aminotransferase to triglycerides ratio as a marker to identify nonalcoholic fatty liver disease.
Overweight
The Association Between Self-Reported Sleep Quality and Overweight in A Chinese Population.
Overweight
The association of elevated alanine aminotransferase and the metabolic syndrome in an overweight and obese pediatric population of multi-ethnic origin.
Overweight
The impact of TNF-? 308G>A gene polymorphism on children's overweight risk and an assessment of biochemical variables: A cross-sectional single-center experience.
Overweight
The triglyceride-to-high density lipoprotein cholesterol ratio in overweight Korean children and adolescents.
Overweight
Zonulin level, a marker of intestinal permeability, is increased in association with liver enzymes in young adolescents.
Overweight
[Relationship between alanine aminotransferase and overweight or obesity in children].
Pancreatic Diseases
Pancreatic juice gamma-glutamyltransferase, alanine transaminase, and alkaline phosphatase in pancreatic disease.
Pancreatic Neoplasms
Insulin-like growth factor-I, interleukin-1 alpha and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes.
Pancreatitis
Acute pancreatitis complicating acute exacerbation of chronic hepatitis B infection carries a poor prognosis.
Pancreatitis
Adverse event profile of tigecycline: data mining of the public version of the U.S. Food and Drug Administration adverse event reporting system.
Pancreatitis
Alanine transaminase rather than abdominal ultrasound alone is an important investigation to justify cholecystectomy in patients presenting with acute pancreatitis.
Pancreatitis
Automated development of artificial neural networks for clinical purposes: Application for predicting the outcome of choledocholithiasis surgery.
Pancreatitis
Baseline Serum Cystatin C Is a Potential Predictor for Acute Kidney Injury in Patients with Acute Pancreatitis.
Pancreatitis
Brucellosis-related acute pancreatitis: A rare complication of a universal disease.
Pancreatitis
CLINICAL AND GENETIC PREDICTORS AND PROGNOSTIC MODEL OF RAPIDLY PROGRESSIVE HEPATIC FIBROSIS IN CHRONIC HEPATITIS C.
Pancreatitis
Clinico-biochemical prediction of biliary cause of acute pancreatitis in the era of endoscopic ultrasonography.
Pancreatitis
Clinicobiochemical factors in predicting gallstones in necrotizing pancreatitis.
Pancreatitis
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study.
Pancreatitis
Contribution of pancreatic edema and short-term ischemia to experimental acute pancreatitis in the rat. II. Behaviour of serum parameters.
Pancreatitis
Diagnostic criteria in predicting a biliary origin of acute pancreatitis in the era of endoscopic ultrasound: multicentre prospective evaluation of 213 patients.
Pancreatitis
Disturbances of electrolytes and blood chemistry in acute alcohol intoxication.
Pancreatitis
Effects of acute pancreatitis on hepatic secretion of lysosomal enzymes into bile and hepatic lysosomal fragility: protective effects of a new synthetic protease inhibitor, ONO 3307.
Pancreatitis
Effects of Castanospermine on Inflammatory Response in a Rat Model of Experimental Severe Acute Pancreatitis.
Pancreatitis
Effects of selected antibiotics on pancreatitis induced liver and pulmonary injury.
Pancreatitis
Enzymatic markers of gallstone-induced pancreatitis identified by ROC curve analysis, discriminant analysis, logistic regression, likelihood ratios, and information theory.
Pancreatitis
Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis.
Pancreatitis
Ethyl pyruvate ameliorates liver injury secondary to severe acute pancreatitis.
Pancreatitis
Ethyl pyruvate treatment ameliorates pancreatic damage: evidence from a rat model of acute necrotizing pancreatitis.
Pancreatitis
IL-8 gene polymorphism in acute biliary and non biliary pancreatitis: probable cause of high level parameters?
Pancreatitis
Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients.
Pancreatitis
Macrophage pacification reduces rodent pancreatitis-induced hepatocellular injury through down-regulation of hepatic tumor necrosis factor alpha and interleukin-1beta.
Pancreatitis
Macrophage-derived transforming growth factor-beta1 induces hepatocellular injury via apoptosis in rat severe acute pancreatitis.
Pancreatitis
MRI with hyperpolarised [1-13C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model.
Pancreatitis
Phase I/II Multicenter Study of Transarterial Chemoembolization with a Cisplatin Fine Powder and Porous Gelatin Particles for Unresectable Hepatocellular Carcinoma: Japan Interventional Radiology in Oncology Study Group Study 0401.
Pancreatitis
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164.
Pancreatitis
Predictivity of Biochemical Markers on Aetiology and Length of Hospitalisation in Acute Pancreatitis.
Pancreatitis
Re: Alanine transaminase rather than abdominal ultrasound alone is an important investigation to justify cholecystectomy in patients presenting with acute pancreatitis.
Pancreatitis
Role of endoscopic ultrasonography in the diagnostic work-up of idiopathic acute pancreatitis (PICUS): study protocol for a nationwide prospective cohort study.
Pancreatitis
Significant Expression of Interleukin 15 in Rat Experimental Severe Acute Pancreatitis.
Pancreatitis
Use of amylase and alanine transaminase to predict acute gallstone pancreatitis in a population with high HIV prevalence.
Pancreatitis
Usefulness of alanine and aspartate aminotransferases in the diagnosis of microlithiasis in idiopathic acute pancreatitis.
Pancreatitis
What predicts gastroenterologists' and surgeons' diagnosis and management of common bile duct stones?
Pancreatitis
When is pancreatitis considered to be of biliary origin and what are the implications for management?
Pancreatitis
[Informativeness of the methods of early clinical laboratory diagnosis of acute pancreatitis]
Pancreatitis
[Integration of operative endoscopy and laparoscopic surgery in the treatment of cholecysto-choledocholithiasis]
Pancreatitis
[Value of laboratory tests and echography in the diagnosis of biliary disease in the initial phase of acute pancreatitis]
Pancreatitis, Acute Necrotizing
Acute lipotoxicity regulates severity of biliary acute pancreatitis without affecting its initiation.
Pancreatitis, Acute Necrotizing
Clinicobiochemical factors in predicting gallstones in necrotizing pancreatitis.
Pancreatitis, Acute Necrotizing
Effects of Clotrimazol on the Acute Necrotizing Pancreatitis in Rats.
Pancreatitis, Acute Necrotizing
Effects of enalaprilat on acute necrotizing pancreatitis in rats.
Pancreatitis, Acute Necrotizing
Effects of glutamine alone on the acute necrotizing pancreatitis in rats.
Pancreatitis, Acute Necrotizing
Effects of Lazaroid U-74389G on Acute Necrotizing Pancreatitis in Rats.
Pancreatitis, Acute Necrotizing
N-acetylcysteine amid reduces pancreatic damage in a rat model of acute necrotizing pancreatitis.
Pancytopenia
Association of Nonimmune Hydrops Fetalis With Familial Hemophagocytic Lymphohistiocytosis in Identical Twin Neonates With Perforin His222Arg (c665A>G) Mutation.
Pancytopenia
Case Report: Analytically Confirmed Severe Albenzadole Overdose Presenting with Alopecia and Pancytopenia.
Pancytopenia
Diagnostic Splenectomy in Patients with Fever of Unknown Origin and Splenomegaly.
Pancytopenia
Effect of Febuxostat on the Endothelial Dysfunction in Hemodialysis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study.
Panniculitis, Peritoneal
Mesenteric Panniculitis with Raised Alanine Transaminase Levels: A Rare Case Report from Pakistan.
Papillomavirus Infections
[Specific features of a change in some blood biochemical indicators in virus urogenital infections].
Parakeratosis
High-density diet improves growth performance and beef yield but affects negatively on serum metabolism and visceral morphology of Holstein steers.
Paraplegia
Diagnostic and prognostic value of serum creatine-kinase activity in ill cats: a retrospective study of 601 cases.
Parasitemia
Clinical chemistry of congenic mice with quantitative trait loci for predicted responses to Trypanosoma congolense infection.
Parasitemia
In vitro and in vivo trypanocidal activity of a benzofuroxan derivative against Trypanosoma cruzi.
Parasitemia
Laboratory findings in acute Cytauxzoon felis infection in cougars (Puma concolor couguar) in Florida.
Parasitic Diseases
Selected enzymatic activities in fresh water snails, specific intermediate host for human schistosomiasis.
Parasitic Diseases
Trypanocidal activity of the phenyl-substituted analogue of furamidine DB569 against Trypanosoma cruzi infection in vivo.
Parkinsonian Disorders
Hepatocellular injury with distinctive mitochondrial changes induced by lergotrile mesylate: a dopaminergic ergot derivative.
Paronychia
Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050).
Paronychia
Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.
Pediatric Obesity
Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat.
Pediatric Obesity
Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents.
Pediatric Obesity
Prevalence of increased transaminases and its association with sex, age, and metabolic parameters in children and adolescents with obesity - a nationwide cross-sectional cohort study.
Peptic Ulcer
Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Pericardial Effusion
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study.
Pericardial Effusion
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial.
Pericarditis
Use of Anakinra in steroid dependent recurrent pericarditis: a case report and review of literature.
Perinatal Death
[Serum soluble Endoglin, plasma endothelin-1 and coagulation function in early onset severe preeclampsia with organ dysfunction]
Periodontal Diseases
Evaluation of salivary biomarkers of periodontitis among smokers and nonsmokers: A novel study.
Periodontal Diseases
Salivary aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase: possible markers in periodontal diseases?
Periodontal Pocket
Serum ?-glutamyltransferase level is associated with periodontal disease independent of drinking habits in Japanese adults.
Periodontitis
Association of Alanine Aminotransferase and Periodontitis: A Cross-Sectional Analysis-NHANES 2009-2012.
Periodontitis
Bromelain reduces the non-alcoholic fatty liver disease and periodontal damages caused by ligature-induced periodontitis.
Periodontitis
Evaluation of Biochemical Parameters Present in the Saliva of Patients with Chronic Periodontitis: Results from a Meta-Analysis.
Periodontitis
Evaluation of salivary biomarkers of periodontitis among smokers and nonsmokers: A novel study.
Peripheral Arterial Disease
Does Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predict Acute Kidney Injury After Cardiac Surgery?
Peripheral Nervous System Diseases
A Phase II Study of XELOX and Cetuximab as First-Line Therapy in Patients With KRAS Wild Type Metastatic Colorectal Cancer (FLEET2 Study).
Peripheral Nervous System Diseases
Comparison of efficacy and safety of S-1 and capecitabine in patients with metastatic colorectal carcinoma: A systematic review and meta-analysis.
Peripheral Nervous System Diseases
Efficacies and adverse reactions of modified vitamin supplement programs before pemetrexed chemotherapy as a second-line treatment against epidermal growth factor receptor (EGFR) mutant wild-type lung adenocarcinoma.
Peripheral Nervous System Diseases
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study.
Peripheral Nervous System Diseases
Efficiencies of Low-Level Laser Therapy (LLLT) and Gabapentin in the Management of Peripheral Neuropathy: Diabetic Neuropathy.
Peripheral Nervous System Diseases
Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients.
Peripheral Nervous System Diseases
Micronutrient supplementation in adults with HIV infection.
Peripheral Nervous System Diseases
Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
Peripheral Nervous System Diseases
Risk factors for and clinical characteristics of severe hyperlactataemia in patients receiving antiretroviral therapy: a case-control study.
Peripheral Nervous System Diseases
Safety and efficacy of the addition of pertuzumab to T-DM1 ± taxane in patients with HER2-positive, locally advanced or metastatic breast cancer: a pooled analysis.
Peripheral Nervous System Diseases
Study of paclitaxel and dose escalation of cisplatin in patients with advanced non-small cell lung cancer.
Peripheral Nervous System Diseases
TOTAL BODY ADIPOSITY, TRIGLYCERIDES, AND LEG FAT ARE INDEPENDENT RISK FACTORS FOR DIABETIC PERIPHERAL NEUROPATHY IN CHINESE PATIENTS WITH TYPE 2 DIABETES MELLITUS.
Peripheral Vascular Diseases
Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong.
Peripheral Vascular Diseases
Estimating the Number of Organ Donors in Australian Hospitals--Implications for Monitoring Organ Donation Practices.
Peritonitis
A New Scoring System to Predict Blood Stream Infections in Patients with Complicated Intra-Abdominal Infections: Experience from a Tertiary Referral Hospital in China.
Peritonitis
Changes of hepatic sinusoids in experimental septicemia of rats are correlated with the production of nitrogen monoxide. A morphometrical and immunohistochemical study.
Peritonitis
Effect of bile on liver function tests in experimental E. coli peritonitis in the rat.
Persistent Infection
Are there optimal alanine aminotransferase and HBV DNA thresholds for discriminating HBeAg-positive chronic infection from chronic hepatitis? An evaluation of 215 young and male cases.
Persistent Infection
Change of hepatitis B virus genotypes in acute and chronic infections in Japan.
Persistent Infection
Characteristics of hepatitis B X antigen, antibodies to X antigen, and antibodies to the viral polymerase during hepatitis B virus infection.
Persistent Infection
Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy.
Persistent Infection
Deletions in the hepatitis B virus core gene may influence the clinical outcome in hepatitis B e antigen-positive asymptomatic healthy carriers.
Persistent Infection
Frequencies and characterization of HBV-specific cytotoxic T lymphocytes in self-limited and chronic hepatitis B viral infection in China.
Persistent Infection
Genetic and physicochemical analyses of a novel ferret hepatitis E virus, and clinical signs of infection after birth.
Persistent Infection
Incident hepatitis C virus infection in a community-based population in Japan.
Persistent Infection
Interferon sensitivity-determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection.
Persistent Infection
Long-Term Persistent GBV-B Infection and Development of a Chronic and Progressive Hepatitis C-Like Disease in Marmosets.
Persistent Infection
Mortality in adults with chronic hepatitis B infection in the United States: a population-based study.
Persistent Infection
Outcome in Caucasian patients with hepatitis B e antigen negative chronic infection: A long-term observational cohort study.
Persistent Infection
Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.
Persistent Infection
Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion.
Persistent Infection
Variant in CD209 promoter is associated with severity of liver disease in chronic hepatitis C virus infection.
Persistent Infection
[Research of hepatic pathology and clinical characteristics of patients chronic infected with hepatitis B virus in immune tolerant stage]
Phlebitis
Synthetic Peptides Containing Three Neutralizing Epitopes of Genotype 4 Swine Hepatitis E Virus ORF2 induced Protection against Swine HEV Infection in Rabbit.
Pituitary ACTH Hypersecretion
Efficacy of Transsphenoidal Surgery on Endocrinological Status and Serum Chemistry Parameters in Dogs with Cushing's Disease.
Pleural Effusion
Clinical Outcome of Residual Liver Volume and Hepatic Steatosis After Right-Lobe Living-Donor Hepatectomy.
Pleural Effusion
Comparative factor analysis of the effect of postoperative peripheral parenteral nutrition on recovery of right lobe liver donors.
Pleural Effusion
Enhanced recovery after surgery strategy for cirrhosis patients undergoing hepatectomy: experience in a single research center.
Pleural Effusion
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials.
Pleural Effusion
Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer.
Pneumonia
"Efficacy and safety of the Qiguiyin formula in severe pneumonia: study protocol for a randomized, double-blind, placebo-controlled clinical trial".
Pneumonia
A Nomogram Prediction of Length of Hospital Stay in Patients with COVID-19 Pneumonia: A Retrospective Cohort Study.
Pneumonia
A Simplified Risk Scoring System to Predict Mortality in Cardiovascular Intensive Care Unit.
Pneumonia
An outbreak of Legionnaires' disease associated with a circulating bathwater system at a public bathhouse. II: radiological findings of pneumonia.
Pneumonia
Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis.
Pneumonia
Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients.
Pneumonia
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.
Pneumonia
Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia?
Pneumonia
CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations.
Pneumonia
Chronic hepatitis infected with hepatitis GB virus type C/hepatitis G virus presenting as non-alcoholic steatohepatitis.
Pneumonia
Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses.
Pneumonia
Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond.
Pneumonia
Duvelisib, a novel oral dual inhibitor of PI3K-?,?, is clinically active in advanced hematologic malignancies.
Pneumonia
Elevated serum alanine aminotransferase (ALT) levels in patients with serologically verified Mycoplasma pneumoniae pneumonia.
Pneumonia
Inhibition of I?B kinase reduces the multiple organ dysfunction caused by sepsis in the mouse.
Pneumonia
Lactate Dehydrogenase as a Biomarker for Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children.
Pneumonia
Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study.
Pneumonia
Osimertinib for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLC: Tolerability and Diagnostic Methods From an Expanded Access Program.
Pneumonia
Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
Pneumonia
Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer.
Pneumonia
Phase II study of a combination regimen of gefitinib and pemetrexed as first-line treatment in patients with advanced non-small cell lung cancer harboring a sensitive EGFR mutation.
Pneumonia
Predictive criteria of severe cases in COVID-19 patients of early stage: A retrospective observational study.
Pneumonia
Predictors of Mortality During Initial Liver Transplant Hospitalization and Investigation of Causes of Death.
Pneumonia
Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients.
Pneumonia
Short-term laboratory and related safety outcomes for the multiple sclerosis oral disease-modifying therapies: an observational study.
Pneumonia
Study of Gefitinib and Pemetrexed as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation.
Pneumonia
The common risk factors for progression and mortality in COVID-19 patients: a meta-analysis.
Pneumonia
The importance of overweight in COVID-19: A retrospective analysis in a single center of Wuhan, China.
Pneumonia
Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma - systematic review and meta-analysis.
Pneumonia
Top POEMs of 2019 Consistent with the Principles of the Choosing Wisely Campaign.
Pneumonia
U.S. Food and Drug Administration Approval Summary: Atezolizumab for Metastatic Non-Small Cell Lung Cancer.
Pneumonia
Variation in plasma lipid and lipoprotein concentrations in community-acquired pneumonia a six-month prospective study.
Pneumonia
[ALAT (Latin American Thoracic Association) recommendations on community-acquired pneumonia]
Pneumonia, Bacterial
[Results of various biochemical studies in secondary bacterial pneumonia]
Pneumonia, Mycoplasma
Features Discriminating COVID-19 From Community-Acquired Pneumonia in Pediatric Patients.
Pneumonia, Viral
Features Discriminating COVID-19 From Community-Acquired Pneumonia in Pediatric Patients.
Pneumonia, Viral
[Comparison of serum biochemical features between SARS and other viral pneumonias]
Pneumoperitoneum
Glycine Protects the Liver from Reperfusion Injury following Pneumoperitoneum.
Polycystic Kidney, Autosomal Dominant
Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors.
Polycystic Ovary Syndrome
Abnormal aminotransferase activity in women with polycystic ovary syndrome.
Polycystic Ovary Syndrome
Abnormal Serum Alanine Aminotransferase Levels are Associated with Impaired Insulin Sensitivity in Young Women With Polycystic Ovary Syndrome.
Polycystic Ovary Syndrome
Alanine Aminotransferase Is a Marker of Lipotoxicity Consequences and Hyperandrogenemia in Women with Polycystic Ovary Syndrome.
Polycystic Ovary Syndrome
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Polycystic Ovary Syndrome
Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss.
Polycystic Ovary Syndrome
Hyperandrogenemia Is Independently Associated with Elevated Alanine Aminotransferase Activity in Young Women with Polycystic Ovary Syndrome.
Polycystic Ovary Syndrome
Risk Factors for Medication-Induced Diabetes and Type 2 Diabetes.
Polycythemia Vera
Elevation of the Hepatitis B Virus DNA during the Treatment of Polycythemia Vera with the JAK Kinase Inhibitor Ruxolitinib.
Polymyositis
Correlation between tests of muscle involvement and clinical muscle weakness in polymyositis and dermatomyositis.
Polymyositis
Elevated alanine aminotransferase levels associated with polymyositis: can this be due to muscle injury?
Polymyositis
Elevated Alt and Ast in an Asymptomatic Person: What the primary care doctor should do?
Polymyositis
Marked increase of serum hepatitis C virus (HCV) RNA titer during treatment with high-dose prednisolone in a case of polymyositis.
Polyneuropathies
"Hepatitic flare", asthenia, peripheral polyneuropathy and diffuse liver steatosis in a hepatitis C virus asymptomatic chronic carrier.
Porphyria Cutanea Tarda
The HLA-A1-B8 haplotype hitchhiking with the hemochromatosis mutation: does it affect the phenotype?
Porphyria, Acute Intermittent
[Acute intermittent porphyria and chronic transaminase elevation]
Porphyrias
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
Porphyrias
The HLA-A1-B8 haplotype hitchhiking with the hemochromatosis mutation: does it affect the phenotype?
Posterior Leukoencephalopathy Syndrome
Incidence of posterior reversible encephalopathy syndrome in eclamptic and patients with preeclampsia with neurologic symptoms.
Pre-Eclampsia
Alanine Aminotransferase and Total Bilirubin Concentration in Preeclampsia and Eclampsia.
Pre-Eclampsia
Altered alanine aminotransferase and gamma-glutamyl transpeptidase in women with history of preeclampsia: association with waist-to-hip ratio and body mass index.
Pre-Eclampsia
Analysis on the outcomes of hepatitis B virus perinatal vertical transmission: nested case-control study.
Pre-Eclampsia
Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia.
Pre-Eclampsia
Evaluation of serum biomarkers for detection of preeclampsia severity in pregnant women.
Pre-Eclampsia
Is there a correlation between maternal venous hemodynamic dysfunction and proteinuria of preeclampsia?
Pre-Eclampsia
Laboratory testing for preeclampsia: result trends and screening recommendations.
Pre-Eclampsia
Maternal serum uric acid level and maternal and neonatal complications in preeclamptic women: A cross-sectional study.
Pre-Eclampsia
Plasma glutathione S-transferase alpha 1-1: a more sensitive marker for hepatocellular damage than serum alanine aminotransferase in hypertensive disorders of pregnancy.
Pre-Eclampsia
Prediction of preeclampsia: liver function tests during the first 20 gestational weeks.
Pre-Eclampsia
Prepregnancy liver enzyme levels and risk of preeclampsia in a subsequent pregnancy: A population-based cohort study.
Pre-Eclampsia
Serum glutamic-oxalacetic transaminase and serum glutamic-pyruvic transaminase in toxemia of pregnancy.
Pre-Eclampsia
Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Elevated serum transaminase activity at diagnosis is associated with rapidly progressing disease in children with acute lymphoblastic leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Methylenetetrahydrofolate reductase C677T polymorphism: association with risk for childhood acute lymphoblastic leukemia and response during the initial phase of chemotherapy in greek patients.
Prediabetic State
Care for Adolescents With Polycystic Ovary Syndrome: Development and Prescribing Patterns of a Multidisciplinary Clinic.
Prediabetic State
Development of type 2 diabetes in adolescent girls with polycystic ovary syndrome and obesity.
Prediabetic State
Effects of hepatitis B virus infection, alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase on prediabetes and diabetes mellitus: A cohort study.
Prediabetic State
Evolution of 29 Anthropometric, Nutritional, and Cardiometabolic Parameters Among Morbidly Obese Adolescents 2 Years Post Sleeve Gastrectomy.
Prediabetic State
Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
Prediabetic State
Reverse Engineering and Evaluation of Prediction Models for Progression to Type 2 Diabetes: An Application of Machine Learning Using Electronic Health Records.
Pregnancy, High-Risk
PP044. Profile of pregnant women with pre-eclampsia treated in priority area.
Prehypertension
Association of Hematocrit and Pre-hypertension Among Chinese Adults: The CRC Study.
Premature Birth
Efficacy of Ursodeoxycholic Acid in Treating Intrahepatic Cholestasis of Pregnancy: A Meta-analysis.
Premature Birth
Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
Primary Graft Dysfunction
Effects of the Hypnotic Agent on Primary Graft Dysfunction After Liver Transplantation.
Prostatic Hyperplasia
Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
Prostatic Neoplasms
Anticancer drug cis-4-hydroxy-L-proline: Correlation of preclinical toxicology with clinical parameters of liver function.
Prostatic Neoplasms
Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
Protein Deficiency
Ineffectiveness of nickel in augmenting the hepatotoxicity in protein deficient rats.
Protein-Energy Malnutrition
Serum aspartate and alanine aminotransferase activities in protein energy malnutrition.
Protein-Losing Enteropathies
The nondietary determinants of vitamin D status in pediatric inflammatory bowel disease.
Proteinuria
Angiogenic Markers Predict Pregnancy Complications and Prolongation in Preeclampsia: Continuous Versus Cutoff Values.
Proteinuria
Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706).
Proteinuria
Benign acute childhood myositis complicating influenza B infection in a boy with idiopathic nephrotic syndrome.
Proteinuria
Combination nivolumab and bevacizumab for metastatic myxofibrosarcoma: A case report and review of the literature.
Proteinuria
Comparison of prednisolone and lamivudine combined therapy with prednisolone monotherapy on carriers of hepatitis B virus with IgA nephropathy: a prospective cohort study.
Proteinuria
Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial).
Proteinuria
Complement C3 and Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease Patients: A Pilot Study.
Proteinuria
Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation.
Proteinuria
FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Proteinuria
Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study.
Proteinuria
Induction of transient proteinuria, hematuria, and glucosuria by ethanol consumption in Japanese alcoholics.
Proteinuria
Is there a correlation between maternal venous hemodynamic dysfunction and proteinuria of preeclampsia?
Proteinuria
Kinin B1 Receptor Inhibition With BI113823 Reduces Inflammatory Response, Mitigates Organ Injury, and Improves Survival Among Rats With Severe Sepsis.
Proteinuria
Macroenzyme creatine kinase (CK) type 2 in HIV-infected patients is significantly associated with TDF and consists of ubiquitous mitochondrial CK.
Proteinuria
Meta-analysis of the efficacy and safety of nucleotide/nucleoside analog monotherapy for hepatitis B virus-associated glomerulonephritis.
Proteinuria
Naturally Acquired Infectious Canine Hepatitis in Two Captive Maned Wolf (Chrysocyon brachyurus) Puppies.
Proteinuria
Occurrence of abscesses during treatment with pazopanib in metastatic renal cancer: a case report.
Proteinuria
Prediction of progression to a high risk situation in women with gestational hypertension or mild pre-eclampsia at term.
Proteinuria
Serum amyloid A, procalcitonin, highly sensitive C reactive protein and tumor necrosis factor alpha levels and acute inflammatory response in patients with hemolysis, elevated liver enzymes, low platelet count (HELLP) and eclampsia.
Proteinuria
Short-term laboratory and related safety outcomes for the multiple sclerosis oral disease-modifying therapies: an observational study.
Proteinuria
Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes.
Proteinuria
Surufatinib in Advanced Well-Differentiated Neuroendocrine Tumors: A Multicenter, Single-Arm, Open-Label, Phase Ib/II Trial.
Proteinuria
Switching patients with non-dialysis chronic kidney disease from oral iron to intravenous ferric carboxymaltose: effects on erythropoiesis-stimulating agent requirements, costs, hemoglobin and iron status.
Proteinuria
The efficacy of folk medicines in the management of type 2 diabetes mellitus: results of a randomized controlled trial of Syzygium cumini (L.) Skeels.
Proteinuria
Urinalysis and Clinical Correlations in Patients with P. vivax or P. falciparum Malaria from Colombia.
Proteinuria
[Clinical presentation of Ixodes tick-borne borreliosis caused by Borrelia miyamotoi in the context of an immune response to the pathogen].
Proteinuria
[Hemorrhagic fever with renal syndrome: imported or native disease in the Zadar region]
Proteinuria
[Results of annual health examination for the aged provided by the law that are predictive of increased mortality risk]
Pruritus
72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension.
Pruritus
A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis.
Pruritus
ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy.
Pruritus
Combination therapy of bezafibrate and ursodeoxycholic acid for primary biliary cirrhosis: A meta-analysis.
Pruritus
Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis.
Pruritus
Effect of ursodeoxycholic acid therapy on hepatic function in children with intrahepatic cholestatic liver disease.
Pruritus
Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy.
Pruritus
Efficacy of Ursodeoxycholic Acid in Treating Intrahepatic Cholestasis of Pregnancy: A Meta-analysis.
Pruritus
Epidemiological and clinical analysis of the outbreak of dengue fever in Zhangshu City, Jiangxi Province, in 2019.
Pruritus
Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
Pruritus
Exacerbation of allopurinol-induced drug reaction with eosinophilia and systemic symptoms by teicoplanin: A case report.
Pruritus
From Pruritus to Cholestasis: Building a Statistical Model and Online Application to Predict a Diagnosis Prior to Bile Acid Determination.
Pruritus
Interleukin-31 is associated with uremic pruritus in patients receiving hemodialysis.
Pruritus
Intrahepatic cholestasis of pregnancy (ICP): case report and review of the literature.
Pruritus
Intrahepatic Cholestasis of Pregnancy with Severe Elevation of Bile Acids in the Setting of Acute Hepatitis C Infection.
Pruritus
Long-term Safety of Ketoconazole Foam, 2% in the Treatment of Seborrheic Dermatitis: Results of a Phase IV, Open-Label Study.
Pruritus
Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial.
Pruritus
Management of Intrahepatic Cholestasis of Pregnancy: Recommendations of the Working Group on Obstetrics and Prenatal Medicine - Section on Maternal Disorders.
Pruritus
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials.
Pruritus
Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma.
Pruritus
Retargeting of bile salt export pump and favorable outcome in children with progressive familial intrahepatic cholestasis type 2.
Pruritus
Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients.
Pruritus
Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study.
Pruritus
Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
Pruritus
Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature.
Pruritus
Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine Group.
Pruritus
Ursodeoxycholic Acid and S-adenosylmethionine for the Treatment of Intrahepatic Cholestasis of Pregnancy: A Meta-analysis.
Pruritus
Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo.
Pruritus
Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience.
Pruritus
[A meta-analysis of therapeutic trials with ademetionine in the treatment of intrahepatic cholestasis]
Pruritus
[Clinical practice guidelines of the Team of Experts of the Polish Gynecological Society: management of the intrahepatic cholestasis of pregnancy].
Pruritus
[Effect of integrative Chinese and Western medicine in treating pregnant women with intrahepatic cholestasis]
Pruritus
[Infant with 3?-hydroxy-?(5)-C27 steroid dehydrogenase deficiency: report of two cases and literatures review].
Pruritus
[Primary biliary liver cirrhosis in patients treated at Szczecin hospitals in 1978-1988]
Pruritus
[The changes of serum nitric oxide level in patients with intrahepatic cholestasis of pregnancy]
Psoriasis
A Case of Severe Transaminase Elevation Following a Single Ustekinumab Dose with Remission After Drug Withdrawal.
Psoriasis
Association between tumor necrosis factor inhibitor (TNFi) therapy and changes in C-reactive protein (CRP), blood pressure, and alanine aminotransferase (ALT) among patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis.
Psoriasis
Clinical trial: the safety of terbinafine in patients over the age of 60 years: a multicenter trial in onychomycosis of the feet.
Psoriasis
Does a correlation between transaminase activity and the size of the liver in psoriatic children exist?
Psoriasis
The Association of Psoriasis and Elevated Blood Lipids in Overweight and Obese Children.
Psoriasis
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
Psychomotor Agitation
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
Psychomotor Agitation
The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin.
Pulmonary Atelectasis
Comparative factor analysis of the effect of postoperative peripheral parenteral nutrition on recovery of right lobe liver donors.
Pulmonary Disease, Chronic Obstructive
A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exacerbation of chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
AMPK protects against alcohol-induced liver injury through UQCRC2 to up-regulate mitophagy.
Pulmonary Disease, Chronic Obstructive
Association of TSH Elevation with All-Cause Mortality in Elderly Patients with Chronic Kidney Disease.
Pulmonary Disease, Chronic Obstructive
Classification of patients with chronic obstructive pulmonary disease according to the Latin American Thoracic Association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (GOLD).
Pulmonary Disease, Chronic Obstructive
Enzyme catalytic activities in chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Global Initiative for Chronic Obstructive Lung Disease (GOLD)-2017: The alat perspective.
Pulmonary Disease, Chronic Obstructive
Low alanine aminotransferase as a risk factor for chronic obstructive pulmonary disease in males.
Pulmonary Disease, Chronic Obstructive
Using PICO Methodology to Answer Questions About Smoking in COPD Patients.
Pulmonary Disease, Chronic Obstructive
[ALAT (Latin American Thoracic Association) recommendations on infectious exacerbation of COPD]
Pulmonary Edema
Immunomodulatory and protective properties of tacrolimus in experimental scorpion envenomation.
Pulmonary Edema
Massive hepatic infarction in preeclampsia: successful treatment with continuous hemodiafiltration and corticosteroid therapy.
Pulmonary Edema
Patterns of serum aspartic and alanine aminotransferase as well as aldolase activity in attacks of bronchial asthma, paroxysmal tachycardia and pulmonary edema.
Pulmonary Edema
[Acute hepatic ischemia and cardiogenic shock in patients with dilated cardiomyopathy]
Pulmonary Edema
[Behavior of the activity of aspartate aminotransferase and alanine aminotransferase in attacks of bronchial asthma, pulmonary edema and paroxysmal tachycardia]
Pulmonary Edema
[Pattern of activity of aspartic aminotransferase, alanine aminotransferase and aldolase in attacks of bronchial asthma, paroxysmal tachycardia and pulmonary edema]
Pulmonary Embolism
Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study.
Pulmonary Embolism
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study.
Pulmonary Emphysema
[Toxicity of volatile thermal degradation products of conveyer belts studied in guinea pigs]
Pulmonary Fibrosis
Repeated amiodarone exposure in the rat: toxicity and effects on hepatic and extrahepatic monooxygenase activities.
Purpura
Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry.
Purpura, Thrombocytopenic
Hepato-splenic lymphoma: a rare entity mimicking acute hepatitis: a case report.
Purpura, Thrombocytopenic, Idiopathic
"Liver function tests" are not always tests of liver function.
Pyelonephritis
Alanine-aminotransferase activities in the renal tissue during experimental and chronic human pyelonephritis.
Pyelonephritis
Association between Elevated Alanine Aminotransferase and Urosepsis in Children with Acute Pyelonephritis.
Pyelonephritis
[Enzymological evaluation of the hepatotoxicity of ampicillin and its therapeutic form, roscillin, in the treatment of pyelonephritis in pregnancy]
Pyuria
The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection: use of clinical features and a rapid direct fluorescent antigen test.
Q Fever
The difference in clinical characteristics between acute Q fever and scrub typhus in southern Taiwan.
Radiation Pneumonitis
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
receptor protein-tyrosine kinase deficiency
Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis.
Rectal Neoplasms
A case of idiosyncratic liver injury after oxaliplatin-induced thrombocytopenia.
Renal Insufficiency
Acute respiratory failure in adult patients with dengue virus infection.
Renal Insufficiency
Anemia, myopathy, and pansteatitis in vitamin E-deficient captive marmosets (Callithrix spp.).
Renal Insufficiency
Biomarkers in newborns with hypoxic-ischemic encephalopathy treated with therapeutic hypothermia.
Renal Insufficiency
Case report study of the first five COVID-19 patients treated with remdesivir in France.
Renal Insufficiency
Clinical Implication of Performance Status in Patients with Hepatocellular Carcinoma Complicating with Cirrhosis.
Renal Insufficiency
Effect of methyl jasmonate and 3-bromopyruvate combination therapy on mice bearing the 4 T1 breast cancer cell line.
Renal Insufficiency
Human herpesvirus 6-related fulminant myocarditis and hepatitis in an immunocompetent adult with fatal outcome.
Renal Insufficiency
Human umbilical cord blood-derived CD34+ cells cause attenuation of multiorgan dysfunction during experimental heatstroke.
Renal Insufficiency
Massive hepatic infarction in preeclampsia: successful treatment with continuous hemodiafiltration and corticosteroid therapy.
Renal Insufficiency
Novel Prediction Score Including Pre- and Intraoperative Parameters Best Predicts Acute Kidney Injury after Liver Surgery.
Renal Insufficiency
Plasma pyridoxal 5'-phosphate concentrations in relation to apo-aminotransferase levels in normal, uraemic, and post-myocardial infarct sera.
Renal Insufficiency
Relationship between genotypes and clinical manifestation, pathology, and cccDNA in Chinese children with hepatitis B virus-associated glomerulonephritis.
Renal Insufficiency
Subnormal alanine aminotransferase values in blood of patients with Crohn disease.
Renal Insufficiency
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
Renal Insufficiency
Thrombotic Microangiopathy Associated with Macrophage Activation Syndrome: A Multinational Study of 23 Patients.
Renal Insufficiency
Transient acute liver failure complicating transurethral resection syndrome.
Renal Insufficiency
Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
Renal Insufficiency
[Clinical and pathological differences between children with various genotypes of hepatitis B virus-associated glomerulonephritis].
Renal Insufficiency, Chronic
Absence of increased liver-related inflammatory markers in type 1 diabetes with metabolic syndrome: a nested case-control study from Brazil.
Renal Insufficiency, Chronic
Alterations of Hematological Parameters, Hemoglobin and Hematocrit With Liver Enzymes, Aspartate Transaminase and Alanine Transaminase Among Patients With Chronic Kidney Disease Undergoing Hemodialysis in Aljouf Region, Saudi Arabia.
Renal Insufficiency, Chronic
Assessment of liver and renal functions in human immunodeficiency virus-infected persons on highly active antiretroviral therapy: A mixed cohort study.
Renal Insufficiency, Chronic
Clinical characteristics, risk factors, and outcomes in adults experiencing dengue hemorrhagic fever complicated with acute renal failure.
Renal Insufficiency, Chronic
Clinical Risk Factors for Adverse Events in Allopurinol Users.
Renal Insufficiency, Chronic
Clinical risk factors for adverse events in allopurinol users.
Renal Insufficiency, Chronic
Clinical Risk Factors for Adverse Events in Allopurinol Users.
Renal Insufficiency, Chronic
Development of a Multivariable Prediction Model for Citrate Accumulation in Liver Transplant Patients Undergoing Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation.
Renal Insufficiency, Chronic
Effects of Bardoxolone Methyl on Hepatic Enzymes in Patients with Type 2 Diabetes Mellitus and Stage 4 CKD.
Renal Insufficiency, Chronic
Elevated alanine aminotransferase and low aspartate aminotransferase/alanine aminotransferase ratio are associated with chronic kidney disease among middle-aged women: a cross-sectional study.
Renal Insufficiency, Chronic
Evaluation of hepatic and kidney dysfunction among newly diagnosed HIV patients with viral hepatitis infection in Cape Coast, Ghana.
Renal Insufficiency, Chronic
In-Hospital Mortality and Prediction in an Urban U.S. Population With COVID-19.
Renal Insufficiency, Chronic
Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review.
Renal Insufficiency, Chronic
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
Renal Insufficiency, Chronic
The reduction of serum aminotransferase levels is proportional to the decline of the glomerular filtration rate in patients with chronic kidney disease.
Renal Insufficiency, Chronic
Unique Clinical Characteristics and Prognosis of Allopurinol-Induced Severe Cutaneous Adverse Reactions.
Reperfusion Injury
A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
Reperfusion Injury
Arterial ketone index in assessing liver function and its detoxicative capability after ischemia-reperfusion injury.
Reperfusion Injury
Assessing steatotic liver function after ischemia-reperfusion injury by in vivo multiphoton imaging of fluorescein disposition.
Reperfusion Injury
Comparison of hepatic artery and portal vein reperfusion during orthotopic liver transplantation.
Reperfusion Injury
Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
Reperfusion Injury
Difference in onset of warm ischemia and reperfusion injury between parenchymal and endothelial cells of the liver. Evaluation by purine nucleoside phosphorylase and hyaluronic acid.
Reperfusion Injury
GSH attenuates organ injury and improves function after transplantation of fatty livers.
Reperfusion Injury
Hepatoprotective effects of limb ischemic post-conditioning in hepatic ischemic rat model and liver cancer patients via PI3K/ERK pathways.
Reperfusion Injury
Impact of hepatic rearterialization on reperfusion injury and outcome after mouse liver transplantation.
Reperfusion Injury
Inhibition of nitric oxide synthase attenuates peroxynitrite generation, but augments neutrophil accumulation in hepatic ischemia-reperfusion in rats.
Reperfusion Injury
Inhibition of Plexin C1 Protects Against Hepatic Ischemia-Reperfusion Injury.
Reperfusion Injury
Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence.
Reperfusion Injury
Lung injury after hepatoenteric ischemia-reperfusion: role of xanthine oxidase.
Reperfusion Injury
Metabolic, cardiovascular, and acid-base status after hepatic artery or portal vein reperfusion during orthotopic liver transplantation.
Reperfusion Injury
Oxothiazolidine carboxylate provides protection against hepatocellular injury seen after porta hepatis occlusion (Pringle maneuver) under hypovolemic conditions.
Reperfusion Injury
Significance of Portal Venous Velocity in Short-term Graft Function in Living Donor Liver Transplantation.
Reperfusion Injury
Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review.
Reproductive Tract Infections
Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Respiratory Distress Syndrome
Covid-19: contribution of clinical characteristics and laboratory features for early detection of patients with high risk of severe evolution.
Respiratory Distress Syndrome
Efficacy of Ursodeoxycholic Acid in Treating Intrahepatic Cholestasis of Pregnancy: A Meta-analysis.
Respiratory Distress Syndrome
Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
Respiratory Distress Syndrome
Mortality risk factors in children with severe influenza virus infection admitted to the pediatric intensive care unit.
Respiratory Distress Syndrome
[Clinical characteristics and outcome of 64 patients with severe COVID-19].
Respiratory Distress Syndrome
[Relationship between changes of increased amylase or lipase levels and pancreas injury in critically ill children].
Respiratory Distress Syndrome
[Risk factors for poor prognosis in children with severe adenovirus pneumonia].
Respiratory Insufficiency
Clinical manifestations, microbiology and prognosis of 42 patients with necrotizing fasciitis.
Respiratory Insufficiency
Development of a Novel Simple Model to Predict Mortality in Patients With Systemic Lupus Erythematosus Admitted to the Intensive Care Unit.
Respiratory Insufficiency
Effect of Caspofungin vs Fluconazole Prophylaxis on Invasive Fungal Disease Among Children and Young Adults With Acute Myeloid Leukemia: A Randomized Clinical Trial.
Respiratory Insufficiency
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity.
Respiratory Insufficiency
Prevalence and Characteristics of Hypoxic Hepatitis in COVID-19 Patients in the Intensive Care Unit: A First Retrospective Study.
Respiratory Insufficiency
[Clinical effect of haemoperfusion combined with continuous veno-veno haemofiltration in treatment of paraquat poisoning: a Meta-analysis].
Respiratory Insufficiency
[Effect of immune function on prognosis of patients with sepsis].
Respiratory Insufficiency
[Evaluation of the effects of immunotherapy and mesenchymal stem cells transplantation in the treatment of critically ill coronavirus disease 2019 patients].
Respiratory Tract Infections
Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.
Respiratory Tract Infections
Randomized Clinical Trial on the Effect of Bardoxolone Methyl on GFR in Diabetic Kidney Disease Patients (TSUBAKI Study).
Respiratory Tract Infections
Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study.
Respiratory Tract Infections
Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trial.
Respiratory Tract Infections
Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes.
Retinal Detachment
A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1-4, as a single dose and multiple doses in patients with solid malignancies.
Rhabdomyolysis
A Cross-Sectional Study of the Relationship between Serum Creatine Kinase and Liver Biochemistry in Patients with Rhabdomyolysis.
Rhabdomyolysis
Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
Rhabdomyolysis
Daily and intermittent rosuvastatin 5?mg therapy in statin intolerant patients: an observational study.
Rhabdomyolysis
Effect of marathon running on hematologic and biochemical laboratory parameters, including cardiac markers.
Rhabdomyolysis
Effect of rosuvastatin 5-20mg on triglycerides and other lipid parameters in Japanese patients with hypertriglyceridemia.
Rhabdomyolysis
Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver.
Rhabdomyolysis
Liver Aminotransferases Are Elevated with Rhabdomyolysis in the Absence of Significant Liver Injury.
Rhabdomyolysis
The associative factors of delayed-onset rhabdomyolysis in patients with doxylamine overdose.
Rhabdomyolysis
Transaminase and Creatine Kinase Ratios for Differentiating Delayed Acetaminophen Overdose from Rhabdomyolysis.
Rheumatic Diseases
Outcomes of chronic hepatitis B infection in Oriental patients with rheumatic diseases.
Rheumatic Diseases
[Activity of glutamic-pyruvic transaminase (GPT) in the blood serum in rheumatic diseases.]
Rheumatic Diseases
[DETERMINATION OF THE ACTIVITY OF GLUTAMIC-OXALOACETIC AND GLUTAMIC-PYRUVIC TRANSAMINASE IN THE ACTIVE PHASE OF RHEUMATISM IN CHILDREN.]
Rheumatic Fever
[Aspartate- and alanine aminotransferase activity of the blood serum in the course of rheumatic fever in children]
Rheumatic Fever
[Variations in glutamic-oxalacetic transaminase and glutamic-pyruvic transaminase in rheumatic fever.]
Rhinitis
A multiple-dose, safety, tolerability, pharmacokinetics and pharmacodynamic study of oral recombinant human interleukin-11 (oprelvekin).
Rotavirus Infections
Systemic Manifestation of Rotavirus Infection in Children: A Report of Three Cases.
Salmonella Infections
Salmonella bacteraemia in Turkish children: 37 cases seen in a university hospital between 1993 and 2002.
Salmonella Infections
The roles of intrahepatic Valpha14(+) NK1.1(+) T cells for liver injury induced by Salmonella infection in mice.
Sarcoidosis
Sarcoidosis with Arteriovenous Malformation in a 15-Year-Old Girl - The Rarest of the Rare.
Sarcoma
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ?50%: real-world data.
Sarcoma
[Hexokinase, aspartate and alanine aminotransferase activity in transplanted rat sarcomas]
Sarcopenia
Association of Low Alanine Aminotransferase Values with Extubation Failure in Adult Critically Ill Patients: A Retrospective Cohort Study.
Sarcopenia
Disentangling Associations Between Serum Muscle Biomarkers and Sarcopenia in the Presence of Pain and Inflammation Among Patients With Osteoarthritis: The SPSS-OK Study.
Sarcopenia
Homeostasis model assessment of insulin resistance in a general adult population in Korea: Additive association of sarcopenia and obesity with insulin resistance.
Sarcopenia
L3 skeletal muscle index (L3SMI) is a surrogate marker of sarcopenia and frailty in non-small cell lung cancer patients.
Sarcopenia
Low Alanine Aminotransferase Levels in the Elderly: Frailty, Disability, Sarcopenia and Reduced Survival.
Scarlet Fever
[Activity of alanine aminotransferase and aspartate aminotransferase in scarlet fever and in cardiac damage in its course]
Schistosomiasis
Correlation of biological serum markers with the degree of hepatic fibrosis and necroinflammatory activity in hepatitis C and schistosomiasis patients.
Schistosomiasis
Fever after a stay in the tropics: diagnostic predictors of the leading tropical conditions.
Schistosomiasis
Selected enzymatic activities in fresh water snails, specific intermediate host for human schistosomiasis.
Schistosomiasis
The relationship between uncomplicated schistosomiasis and hepatitis B infection.
Schistosomiasis
Variation of transaminases and lactate dehydrogenase in irradiated Biomphalaria alexandrina snails.
Scrub Typhus
A comparative study of hepatitis caused by scrub typhus and viral hepatitis A in South Korea.
Scrub Typhus
The difference in clinical characteristics between acute Q fever and scrub typhus in southern Taiwan.
Scrub Typhus
The Utility of Platelet Indices in Predicting Multiorgan Dysfunction in Scrub Typhus.
Seizures
Clinical profiles and factors associated with mortality in adults with yellow fever admitted to an intensive care unit in Minas Gerais, Brazil.
Seizures
Early risk factors for mortality in children with seizure and/or impaired consciousness accompanied by fever without known etiology.
Seizures
Hypoglycemic Toxins and Enteroviruses as Causes of Outbreaks of Acute Encephalitis-Like Syndrome in Children, Bac Giang Province, Northern Vietnam.
Seizures
Longitudinal changes in insulin resistance in children with epilepsy on ketogenic diet: Prevalence and risk factors.
Seizures
Safety Study of Sodium Pentosan Polysulfate for Adult Patients with Mucopolysaccharidosis Type II.
Seizures
The correlation of dystonia severity and serum transaminases in a child with a brain injury.
Seizures
The potential toxic effects of magnesium oxide nanoparticles and valproate on liver tissue.
Seizures
Validity of carbohydrate deficient transferrin and other markers as diagnostic aids in the detection of alcohol related seizures.
Seizures
[Relationship between changes of increased amylase or lipase levels and pancreas injury in critically ill children].
Seizures
[Risk factors analysis of reversible posterior leukoencephalopathy syndrome in pre-eclampsia or eclampsia gravida].
Sepsis
A1 adenosine receptor knockout mice exhibit increased mortality, renal dysfunction, and hepatic injury in murine septic peritonitis.
Sepsis
A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis.
Sepsis
Antegrade Arterial and Portal Flushing Versus Portal Flushing Only for Right Lobe Live Donor Liver Transplantation-A Randomized Control Trial.
Sepsis
Asiatic acid attenuates lipopolysaccharide-induced injury by suppressing activation of the Notch signaling pathway.
Sepsis
AST to ALT Ratio is elevated in disseminated histoplasmosis as compared to localized pulmonary disease and other endemic mycoses.
Sepsis
Attenuation of mitochondrial unfolded protein response is associated with hepatic dysfunction in septic rats.
Sepsis
Augmenter of liver regeneration (ALR) is a novel biomarker of hepatocellular stress/inflammation: in vitro, in vivo and in silico studies.
Sepsis
Biomarkers of hepatic injury and function in neonatal hypoxic ischemic encephalopathy and with therapeutic hypothermia.
Sepsis
Cardiac and hepatic role of r-AtHSP70: basal effects and protection against ischemic and sepsis conditions.
Sepsis
Clinical characteristics and predictors of mortality in 67 patients with primary pyomyositis: a study from North India.
Sepsis
Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency.
Sepsis
Comparison of clinical findings between dogs with suspected anaphylaxis and dogs with confirmed sepsis.
Sepsis
De Ritis Ratio as a Significant Prognostic Factor in Patients with Sepsis: A Retrospective Analysis.
Sepsis
Decreased plasma glutamate in early phases of septic shock with acute liver dysfunction is an independent predictor of survival.
Sepsis
Deficiency of alpha-calcitonin gene-related peptide induces inflammatory responses and lethality in sepsis.
Sepsis
Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study.
Sepsis
Heart-type fatty acid-binding protein is a useful marker for organ dysfunction and leptin alleviates sepsis-induced organ injuries by restraining its tissue levels.
Sepsis
Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury.
Sepsis
Lactate as a Potential Biomarker of Sepsis in a Rat Cecal Ligation and Puncture Model.
Sepsis
Leptin protects vital organ functions after sepsis through recovering tissue myeloperoxidase activity: an anti-inflammatory role resonating with indomethacin.
Sepsis
microRNA-103a-3p confers protection against lipopolysaccharide-induced sepsis and consequent multiple organ dysfunction syndrome by targeting HMGB1.
Sepsis
microRNA-15a-5p participates in sepsis by regulating the inflammatory response of macrophages and targeting TNIP2.
Sepsis
miR-34b-3p protects against acute kidney injury in sepsis mice via targeting ubiquitin-like protein 4A.
Sepsis
Monitoring liver damage using hepatocyte-specific methylation markers in cell-free circulating DNA.
Sepsis
Mycobacterium tuberculosis PPE18 Protein Reduces Inflammation and Increases Survival in Animal Model of Sepsis.
Sepsis
Overexpression of homeodomain-interacting protein kinase 2 (HIPK2) attenuates sepsis-mediated liver injury by restoring autophagy.
Sepsis
Parsaclisib, a potent and highly selective PI3K? inhibitor, in patients with relapsed or refractory B-cell malignancies.
Sepsis
Protective constituents against sepsis in mice from the root cortex of Paeonia suffruticosa.
Sepsis
Protective effect of astaxanthin against multiple organ injury in a rat model of sepsis.
Sepsis
Recombinant fibrinogenase from Agkistrodon acutus venom protects against sepsis via direct degradation of fibrin and TNF-alpha.
Sepsis
Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials.
Sepsis
Serum cholestasis markers as predictors of early outcome after liver transplantation.
Sepsis
The fibrinopeptide b?15-42 reduces inflammation in mice subjected to polymicrobial sepsis.
Sepsis
[Effect of inhibiting the activity of double-stranded RNA-dependent protein kinase in sepsis mice].
Sepsis
[Observation on clinical effects of recombinant human growth hormone on the treatment of children with severe burn].
Sepsis
[Relationship between changes of increased amylase or lipase levels and pancreas injury in critically ill children].
Severe Acute Respiratory Syndrome
Clinical significance of hepatic derangement in severe acute respiratory syndrome.
Severe Acute Respiratory Syndrome
Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19.
Severe Dengue
A novel predictor of severe dengue: The aspartate aminotransferase/platelet count ratio index (APRI).
Severe Dengue
Clinical characteristics, risk factors, and outcomes in adults experiencing dengue hemorrhagic fever complicated with acute renal failure.
Severe Dengue
Factors associated with severe clinical manifestation of dengue among adults in Thailand.
Severe Dengue
Role of C- reactive proteins and liver function tests in assessing the severity of dengue fever.
Severe Dengue
Serum levels of soluble vascular cell adhesion molecules may correlate with the severity of dengue virus-1 infection in adults.
Severe Fever with Thrombocytopenia Syndrome
Risk factors associated with fatality of severe fever with thrombocytopenia syndrome: a meta-analysis.
Sexually Transmitted Diseases
Characteristics of a population volunteering for human immunodeficiency virus immunization. NIAID AIDS Clinical Trials Network.
Sexually Transmitted Diseases
Prevalence of antibodies to hepatitis C virus and other markers in Jamaica.
Shock, Cardiogenic
Aminotransferase levels in relation to short-term use of acetaminophen four grams daily in postoperative cardiothoracic patients in the intensive care unit.
Shock, Cardiogenic
[Acute hepatic ischemia and cardiogenic shock in patients with dilated cardiomyopathy]
Shock, Septic
Alleviation of LPS-Induced Inflammation and Septic Shock by Lactiplantibacillus plantarum K8 Lysates.
Shock, Septic
De Ritis Ratio as a Significant Prognostic Factor in Patients with Sepsis: A Retrospective Analysis.
Shock, Septic
Mortality risk factors in children with severe influenza virus infection admitted to the pediatric intensive care unit.
Shock, Septic
Predictors of fifty days in-hospital mortality in patients with culture negative neutrocytic ascites.
Shock, Septic
Preventive agents against sepsis and new phenylpropanoid glucosides from the fruits of Illicium verum.
Shock, Septic
Risk factors for mortality from severe community-acquired pneumonia in hospitalized children transferred to the pediatric intensive care unit.
Shock, Septic
Trypanosoma cruzi sensitizes mice to fulminant SEB-induced shock: overrelease of inflammatory cytokines and independence of Chagas' disease or TCR Vbeta-usage.
Sialorrhea
Evaluation of topically applied enilconazole for the treatment of dermatophytosis in a Persian cattery.
Siderosis
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
Skin Abnormalities
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
Skin Diseases, Vesiculobullous
[Problem of the behavior of glutamic acid-pyruvic acid transaminase in the blood and vesicular skin serum in eczema and bullous dermatoses.]
Skin Ulcer
Fever after a stay in the tropics: diagnostic predictors of the leading tropical conditions.
Sleep Apnea Syndromes
A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients.
Sleep Apnea Syndromes
[Metabolic syndrome: jumble syndrome of obesity or specific entity? Which treatment: diet or polypill?]
Sleep Apnea, Obstructive
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Sleep Apnea, Obstructive
The association of obstructive sleep apnea with dyslipidemia in Korean children and adolescents: a single-center, cross-sectional study.
Sleep Wake Disorders
Potential Hepatotoxicity of Efavirenz and Saquinavir/Ritonavir Coadministration in Healthy Volunteers.
Spinal Cord Diseases
Description of breed ancestry and genetic health traits in arctic sled dog breeds.
Spondylitis, Ankylosing
[The analysis of clinical characteristics and disease activity in ankylosing spondylitis patients with hyperuircemia].
ST Elevation Myocardial Infarction
Combined biomarker testing for the prediction of left ventricular remodelling in ST-elevation myocardial infarction.
Staphylococcal Infections
Bioprotective potential of bacteriocinogenic Enterococcus gallinarum strains isolated from some Nigerian fermented foods, and of their bacteriocins.
Starvation
Alterations in protein and amino acid metabolism in rats fed a branched-chain amino acid- or leucine-enriched diet during postprandial and postabsorptive states.
Starvation
Control of hepatic utilization of serine, glycine and threonine in fed and starved rats.
Starvation
Effect of LED light spectra on starvation-induced oxidative stress in the cinnamon clownfish Amphiprion melanopus.
Starvation
Effect of starvation and refeeding on the blood and liver of domesticated rabbits.
Starvation
Effects of cortisol or starvation on the activities of four enzymes in small intestine and liver of the rat during development.
Starvation
Effects of OP 2507, a stable analogue of prostaglandin I2, on carbon tetrachloride-induced liver damage in starved rats.
Starvation
Hypoglycemic effects of Coccinia indica: inhibition of key gluconeogenic enzyme, glucose-6-phosphatase.
Starvation
Impact of short-term starvation and refeeding on the expression of KLF15 and regulatory mechanism of branched-chain amino acids metabolism in muscle of Chinese soft-shelled turtle (Pelodiscus sinensis).
Starvation
Increased sinusoidal efflux of reduced and oxidized glutathione in rats with endotoxin/D-galactosamine hepatitis.
Starvation
Long-term nutritional effects on the primary liver and kidney metabolism in rainbow trout. Adaptive response to starvation and a high-protein, carbohydrate-free diet on glutamate dehydrogenase and alanine aminotransferase kinetics.
Starvation
Long-term starvation in Xenopus laevis Daudin--III. Effects on enzymes in several tissues.
Starvation
Metabolic changes in the African fruit beetle, Pachnoda sinuata, during starvation.
Starvation
MiR-125a-3p-KLF15-BCAA Regulates the Skeletal Muscle Branched-Chain Amino Acid Metabolism in Nile Tilapia (Oreochromis niloticus) During Starvation.
Starvation
Rac-Mediated Macropinocytosis of Extracellular Protein Promotes Glucose Independence in Non-Small Cell Lung Cancer.
Starvation
The activities of phosphatases and aminotransferases in the epithelium of the small intestine and caecum of white rock cockerels during starvation.
Starvation
[The effect of prolonged starvation on changes in the activity of selected adaptive enzymes in rat liver]
Stillbirth
Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
Stillbirth
Predictors of oedema type in reversible posterior leukoencephalopathy syndrome with preeclampsia or eclampsia.
Stomach Neoplasms
[Effect of preoperative serum alanine aminotransferase and asparagine aminotransferase ratio on prognosis of patients with gastric cancer].
Stomach Ulcer
Anti-stress activity of hydro-alcoholic extract of Eugenia caryophyllus buds (clove).
Stomach Ulcer
Effectiveness and safety of iguratimod treatment in patients with active rheumatoid arthritis in Chinese: A nationwide, prospective real-world study.
Stomach Ulcer
[Non-proteolytic enzymes of human gastric and duodenal mucosa in peptic ulcer]
Stomatitis
A Phase 1 Clinical Study of Temsirolimus (CCI-779) in Japanese Patients with Advanced Solid Tumors.
Stomatitis
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors.
Stomatitis
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Stomatitis
Analysis of the time course and prognostic factors determining toxicity due to infused fluorouracil.
Stomatitis
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials.
Stomatitis
Comparison of efficacy and safety of S-1 and capecitabine in patients with metastatic colorectal carcinoma: A systematic review and meta-analysis.
Stomatitis
Efficacies and adverse reactions of modified vitamin supplement programs before pemetrexed chemotherapy as a second-line treatment against epidermal growth factor receptor (EGFR) mutant wild-type lung adenocarcinoma.
Stomatitis
Efficacy and safety assessment of S-1-based regimens comparing to intravenous fluorouracil-based ones in Asian patients with metastatic colorectal carcinoma: A system review and meta-analysis.
Stomatitis
Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent-based analysis.
Stomatitis
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer.
Stomatitis
Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): an exploratory, open-label, phase 2 study.
Stomatitis
Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours.
Stomatitis
Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study.
Stomatitis
Randomized study of the clinical effects of ?-3 fatty acid-containing enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer.
Stomatitis
Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES.
Stomatitis
Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050).
Stomatitis
Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial.
Stomatitis
Safety, pharmacokinetics, and preliminary efficacy of the PARP inhibitor talazoparib in Japanese patients with advanced solid tumors: phase 1 study.
Stomatitis
Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma - systematic review and meta-analysis.
Stomatitis
Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.
Streptococcal Infections
Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group.
Stroke
30-day and 60-day rates and predictors of mortality among adult stroke patients: Prospective cohort study.
Stroke
Association of Lactate Dehydrogenase with In-Hospital Mortality in Patients with Acute Aortic Dissection: A Retrospective Observational Study.
Stroke
Clinical characteristics, risk factors, and outcomes in adults experiencing dengue hemorrhagic fever complicated with acute renal failure.
Stroke
Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong.
Stroke
Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials.
Stroke
Gastrointestinal bleeding in patients admitted to cardiology: risk factors and a new risk score.
Stroke
International Classification of Disease Coding of Exertional Heat Illness in U.S. Army Soldiers.
Stroke
Liver Function Indicators Performed Better to Eliminate Cardioembolic Stroke than to Identify It from Stroke Subtypes.
Stroke
Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort.
Stroke
Pharmacokinetics of glutamate-oxaloacetate transaminase and glutamate-pyruvate transaminase and their blood glutamate-lowering activity in naïve rats.
Stroke
Poor Quality of Warfarin Treatment Increases the Risk of All Types of Intracranial Hemorrhage in Atrial Fibrillation.
Stroke
Stroke Induces Prolonged Changes in Lipid Metabolism, the Liver and Body Composition in Mice.
Stroke
The Association between Nonalcoholic Fatty Liver Disease and Stroke: Results from the Korean Genome and Epidemiology Study (KoGES).
Stroke
The Effect of the Mediterranean Diet on Metabolic Health: A Systematic Review and Meta-Analysis of Controlled Trials in Adults.
Stroke
The impact of ischemic preconditioning on hemodynamic, biochemical and inflammatory alterations induced by intra-abdominal hypertension: an experimental study in a porcine model.
Stroke
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Subarachnoid Hemorrhage
Alanine aminotransferase predicts outcomes in elderly patients with aneurysmal subarachnoid hemorrhage.
Superinfection
Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease.
Superinfection
Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood.
Superinfection
Nuclear HBcAg and histology activity index as independent predictors of the expression of singly spliced HBV-RNA.
Surgical Wound Infection
A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China.
Syncope
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial.
Syncope
Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in Patients with Refractory Solid Tumors.
Syphilis
An analysis of risk factors for human immunodeficiency virus infection among Chinese blood donors.
Syphilis
Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study.
Syphilis
Effectiveness of mandatory transmissible diseases screening in Indian blood donors.
Syphilis
The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations.
Syphilis
Trends of recent hepatitis C virus infection among HIV-positive men who have sex with men in Taiwan, 2011-2018.
Syphilis
[Electrocardiographic and serum enzyme study with special reference to glutamic-oxalacetic and glutamic-pyruvic transaminase, lactate dehydrogenase and creatine phosphokinase in syphilis. Preliminary results]
Tachycardia
An Open-Label, Multicenter, Single-Dose Pharmacokinetic Study of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Preschool-Aged Children.
Tachycardia
Clinical and laboratory associations of severity in a Sri Lankan cohort of patients with serologically confirmed leptospirosis: a prospective study.
Tachycardia
Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?
Tachycardia
Potential drug-drug interactions in pediatric patients admitted to intensive care unit of Khyber Teaching Hospital, Peshawar, Pakistan: A cross-sectional study.
Tachycardia
Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging and Treatment Management of Neuroendocrine Tumors.
Tachycardia
[The streptococcal and staphylococcal toxic shock syndrome. Comments on 4 cases]
Tachycardia, Paroxysmal
Patterns of serum aspartic and alanine aminotransferase as well as aldolase activity in attacks of bronchial asthma, paroxysmal tachycardia and pulmonary edema.
Tachycardia, Paroxysmal
[Behavior of the activity of aspartate aminotransferase and alanine aminotransferase in attacks of bronchial asthma, pulmonary edema and paroxysmal tachycardia]
Tachycardia, Paroxysmal
[Pattern of activity of aspartic aminotransferase, alanine aminotransferase and aldolase in attacks of bronchial asthma, paroxysmal tachycardia and pulmonary edema]
Teratoma
Elevated aspartate aminotransferase and alanine aminotransferase in the torsion of ovarian mature cystic teratoma: normalised after operation for torsion.
Testicular Neoplasms
Impact of increased aspartate aminotransferase to alanine aminotransferase (De Ritis) ratio in prognosis of testicular cancer.
Testicular Neoplasms
The pattern of gamma-glutamyl transpeptidase, alkaline phosphatase, serum glutamyl oxalate transaminase and serum glutamyl pyruvate transaminase in patients with disseminated non-seminomatous testicular tumors.
Testicular Neoplasms
Toxicity studies on one-year treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate.
Tetanus
35 mM K(+)-stimulated 45Ca2+ uptake in cerebellar granule cell cultures mainly results from NMDA receptor activation.
Thalassemia
Effect of iron overload on renal functions and oxidative stress in beta thalassemia patients.
Thalassemia
Iron overload correlates with serum liver fibrotic markers and liver dysfunction: Potential new methods to predict iron overload-related liver fibrosis in thalassemia patients.
Thalassemia
SEN and hepatitis virus infections in nontransfused children and pediatric thalassemia patients with multiple transfusions in Taiwan.
Thrombocytopenia
A case of massive hepatic infarction in severe preeclampsia as part of the HELLP syndrome.
Thrombocytopenia
A Multicenter Study of Docetaxel at a Dose of 100 mg/m2 in Japanese Patients with Advanced or Recurrent Breast Cancer.
Thrombocytopenia
A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC).
Thrombocytopenia
A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma.
Thrombocytopenia
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors.
Thrombocytopenia
A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma.
Thrombocytopenia
A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma.
Thrombocytopenia
A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas.
Thrombocytopenia
A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08).
Thrombocytopenia
A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma.
Thrombocytopenia
A phase II trial of dose-dense (biweekly) paclitaxel plus carboplatin as neoadjuvant chemotherapy for operable breast cancer.
Thrombocytopenia
A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Thrombocytopenia
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
Thrombocytopenia
A sandfly fever virus outbreak in the East Mediterranean region of Turkey.
Thrombocytopenia
Accidental fatal aflatoxicosis due to contaminated commercial diet in 50 dogs.
Thrombocytopenia
Acute megakaryoblastic leukemia with erythrophagocytosis and thrombosis in a dog.
Thrombocytopenia
An emerging hemorrhagic fever in China caused by a novel bunyavirus SFTSV.
Thrombocytopenia
An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma.
Thrombocytopenia
An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanoma.
Thrombocytopenia
An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey.
Thrombocytopenia
Association of ABCC2 with levels and toxicity of methotrexate in Malaysian Childhood Acute Lymphoblastic Leukemia (ALL).
Thrombocytopenia
Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
Thrombocytopenia
Baseline laboratory test abnormalities are common in early arthritis but rarely contraindicate methotrexate: Study of three cohorts (ESPOIR, VErA, and Brittany).
Thrombocytopenia
Candidatus Rickettsia tarasevichiae Infection in Eastern Central China: A Case Series.
Thrombocytopenia
Characteristics and outcome of dengue infection; clinical perspective from a secondary care hospital of Karachi.
Thrombocytopenia
Children hospitalized with severe acute respiratory syndrome-related illness in Toronto.
Thrombocytopenia
Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever.
Thrombocytopenia
Clinical and laboratory findings of a sandfly fever Turkey Virus outbreak in Ankara.
Thrombocytopenia
Clinical Benefits and Safety of FMS-Like Tyrosine Kinase 3 Inhibitors in Various Treatment Stages of Acute Myeloid Leukemia: A Systematic Review, Meta-Analysis, and Network Meta-Analysis.
Thrombocytopenia
Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study.
Thrombocytopenia
Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting.
Thrombocytopenia
Clinical manifestations, microbiology and prognosis of 42 patients with necrotizing fasciitis.
Thrombocytopenia
Clinical symptoms and laboratory findings supporting early diagnosis of Crimean-Congo hemorrhagic fever in Iran.
Thrombocytopenia
Clinical, morphological, and molecular characterization of an undetermined Babesia species in a maned wolf (Chrysocyon brachyurus).
Thrombocytopenia
Clinicopathologic findings of naturally occurring Rabbit Hemorrhagic Disease Virus 2 infection in pet rabbits.
Thrombocytopenia
Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in Wave Five: Clinical and virological findings.
Thrombocytopenia
Comparison of efficacy and safety of S-1 and capecitabine in patients with metastatic colorectal carcinoma: A systematic review and meta-analysis.
Thrombocytopenia
Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1.
Thrombocytopenia
Comparison of the clinical features and outcome of children with hemophagocytic lymphohistiocytosis (HLH) secondary to visceral leishmaniasis and primary HLH: a single-center study.
Thrombocytopenia
Cooperative activity of cytotoxic chemotherapy with antiangiogenic thrombospondin-I peptides, ABT-526 in pet dogs with relapsed lymphoma.
Thrombocytopenia
Deferoxamine Attenuates Lipid Peroxidation, Blocks Interleukin-6 Production, Ameliorates Sepsis Inflammatory Response Syndrome, and Confers Renoprotection After Acute Hepatic Ischemia in Pigs.
Thrombocytopenia
Dengue virus infection in travellers returning to Berlin, Germany: clinical, laboratory, and diagnostic aspects.
Thrombocytopenia
Diagnosing Microcystin Intoxication of Canines: Clinicopathological Indications, Pathological Characteristics, and Analytical Detection in Postmortem and Antemortem Samples.
Thrombocytopenia
Differentiation of typhoid fever from fulminant hepatic failure in patients presenting with jaundice and encephalopathy.
Thrombocytopenia
Dose-escalation study of tabalumab with bortezomib and dexamethasone in Japanese patients with multiple myeloma.
Thrombocytopenia
Duvelisib, a novel oral dual inhibitor of PI3K-?,?, is clinically active in advanced hematologic malignancies.
Thrombocytopenia
Efficacies and adverse reactions of modified vitamin supplement programs before pemetrexed chemotherapy as a second-line treatment against epidermal growth factor receptor (EGFR) mutant wild-type lung adenocarcinoma.
Thrombocytopenia
Efficacy and safety assessment of S-1-based regimens comparing to intravenous fluorouracil-based ones in Asian patients with metastatic colorectal carcinoma: A system review and meta-analysis.
Thrombocytopenia
Efficacy and safety of linezolid in treating gram-positive bacterial infection in the elderly: a retrospective study.
Thrombocytopenia
Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma.
Thrombocytopenia
Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) in China: an integrated data analysis.
Thrombocytopenia
Erythema multiforme major and disseminated intravascular coagulation in a dog following application of a d-limonene-based insecticidal dip.
Thrombocytopenia
Evaluation of clinically asymptomatic high risk infants with congenital cytomegalovirus infection.
Thrombocytopenia
Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
Thrombocytopenia
Fatal hepatic sarcocystosis in a puppy with eosinophilia and eosinophilic peritoneal effusion.
Thrombocytopenia
Fever after a stay in the tropics: diagnostic predictors of the leading tropical conditions.
Thrombocytopenia
First study of the safety, tolerability, and pharmacokinetics of CP-724,714 in patients with advanced malignant solid HER2-expressing tumors.
Thrombocytopenia
First-Line Pazopanib Treatment in Metastatic Renal Cell Carcinoma: Real-World Data From a Single Chinese Center.
Thrombocytopenia
Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study.
Thrombocytopenia
Hepatic Arterial Infusion Chemotherapy with Modified FOLFOX as an Alternative Treatment Option in Advanced Hepatocellular Carcinoma Patients with Failed or Unsuitability for Transarterial Chemoembolization.
Thrombocytopenia
Hepatitis C virus and human T-cell lymphotropic virus type 1 co-infection: impact on liver disease, virological markers, and neurological outcomes.
Thrombocytopenia
Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation.
Thrombocytopenia
Human lymphoblastoid interferon in the treatment of small cell lung cancer.
Thrombocytopenia
Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients.
Thrombocytopenia
Impact of mycophenolate mofetil intolerance on early results of kidney transplantation.
Thrombocytopenia
Infection with Sin Nombre hantavirus: clinical presentation and outcome in children and adolescents.
Thrombocytopenia
Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.
Thrombocytopenia
Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review.
Thrombocytopenia
Maternal serum uric acid level and maternal and neonatal complications in preeclamptic women: A cross-sectional study.
Thrombocytopenia
Myositis associated with Salmonella paratyphi A bacteremia appears to be common.
Thrombocytopenia
Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial.
Thrombocytopenia
Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies.
Thrombocytopenia
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial.
Thrombocytopenia
Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study.
Thrombocytopenia
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.
Thrombocytopenia
NTP Toxicology and Carcinogenesis Studies of Chloroprene (CAS No. 126-99-8) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
Thrombocytopenia
Occurrence of abscesses during treatment with pazopanib in metastatic renal cancer: a case report.
Thrombocytopenia
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study.
Thrombocytopenia
Pathology of Experimental Aerosol Zaire Ebolavirus Infection in Rhesus Macaques.
Thrombocytopenia
Patients with culture negative pyogenic liver abscess have the same outcomes compared to those with Klebsiella pneumoniae pyogenic liver abscess.
Thrombocytopenia
Pediatric multisystem SARS COV2 with versus without cardiac involvement: a multicenter study from Latin America.
Thrombocytopenia
Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan.
Thrombocytopenia
Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
Thrombocytopenia
Phase 2 Study of Adjuvant Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.
Thrombocytopenia
Phase I combination study of trabectedin and Doxorubicin in patients with soft-tissue sarcoma.
Thrombocytopenia
Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas.
Thrombocytopenia
Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in Patients with Refractory Solid Tumors.
Thrombocytopenia
Phase I/II Multicenter Study of Transarterial Chemoembolization with a Cisplatin Fine Powder and Porous Gelatin Particles for Unresectable Hepatocellular Carcinoma: Japan Interventional Radiology in Oncology Study Group Study 0401.
Thrombocytopenia
Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma.
Thrombocytopenia
Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer.
Thrombocytopenia
Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma.
Thrombocytopenia
Phase II study of lenvatinib for metastatic colorectal cancer refractory to standard chemotherapy: the LEMON study (NCCH1503).
Thrombocytopenia
Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065).
Thrombocytopenia
Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study.
Thrombocytopenia
Poor Quality of Warfarin Treatment Increases the Risk of All Types of Intracranial Hemorrhage in Atrial Fibrillation.
Thrombocytopenia
Prediction of HCV load using genotype, liver biomarkers, and clinical symptoms by a mathematical model in patients with HCV infection.
Thrombocytopenia
Predictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study.
Thrombocytopenia
Predictors of Crimean-Congo hemorrhagic fever in the Emergency Department.
Thrombocytopenia
Prospective study of Chikungunya virus acute infection in the Island of La Réunion during the 2005-2006 outbreak.
Thrombocytopenia
Real-World Delivery of Rucaparib to Patients with Ovarian Cancer: Recommendations Based on an Integrated Safety Analysis of ARIEL2 and Study 10.
Thrombocytopenia
Results of a phase II multicenter trial of single-agent gemcitabine in patients with relapsed or chemotherapy-refractory Hodgkin's lymphoma.
Thrombocytopenia
Revisiting clinico-epidemiological pattern of human rickettsial infections in the central region of Sri Lanka: a hospital based descriptive study.
Thrombocytopenia
Risk factors associated with fatality of severe fever with thrombocytopenia syndrome: a meta-analysis.
Thrombocytopenia
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.
Thrombocytopenia
Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients.
Thrombocytopenia
Ruxolitinib for the treatment of chronic GVHD and overlap syndrome in children and young adults.
Thrombocytopenia
Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study.
Thrombocytopenia
Safety and efficacy of the addition of pertuzumab to T-DM1 ± taxane in patients with HER2-positive, locally advanced or metastatic breast cancer: a pooled analysis.
Thrombocytopenia
Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2-positive breast cancer: An open-label, dose-escalation, phase I study.
Thrombocytopenia
Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study.
Thrombocytopenia
Septic Shock and Hypofibrinogenemia Predict a Fatal Outcome in Childhood Acute Acalculous Cholecystitis.
Thrombocytopenia
Sequential assessment of clinical and laboratory parameters in patients with hemorrhagic fever with renal syndrome.
Thrombocytopenia
Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review.
Thrombocytopenia
Serotonin syndrome masquerading as disease flare in lupus nephritis with end-stage renal disease.
Thrombocytopenia
Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease.
Thrombocytopenia
Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong.
Thrombocytopenia
Severe acute respiratory syndrome: clinical and laboratory manifestations.
Thrombocytopenia
Severe Fever with Thrombocytopenia Syndrome Accompanied by Invasive Pulmonary Aspergillosis: An Autopsy Case.
Thrombocytopenia
Severe fever with thrombocytopenia syndrome with myocardial dysfunction and encephalopathy: A case report.
Thrombocytopenia
Side effects of CDK4/6 inhibitors in the treatment of HR+/HER2- advanced breast cancer: a systematic review and meta-analysis of randomized controlled trials.
Thrombocytopenia
Stent placement combined with intraluminal radiofrequency ablation and hepatic arterial infusion chemotherapy for advanced biliary tract cancers with biliary obstruction: a multicentre, retrospective, controlled study.
Thrombocytopenia
Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial.
Thrombocytopenia
Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection.
Thrombocytopenia
Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality.
Thrombocytopenia
The differences of clinical manifestations and laboratory findings in children and adults with dengue virus infection.
Thrombocytopenia
The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation.
Thrombocytopenia
The Utility of Platelet Indices in Predicting Multiorgan Dysfunction in Scrub Typhus.
Thrombocytopenia
Thioacetamide-induced liver damage and thrombocytopenia is associated with induction of antiplatelet autoantibody in mice.
Thrombocytopenia
Thrombotic Microangiopathy Associated with Macrophage Activation Syndrome: A Multinational Study of 23 Patients.
Thrombocytopenia
Tissue Hypoperfusion, Hypercoagulopathy, and Kidney and Liver Dysfunction after Ingestion of a Naphazoline-Containing Antiseptic.
Thrombocytopenia
Tolerability of metronomic administration of lomustine in dogs with cancer.
Thrombocytopenia
Toxoplasma gondii-like organisms in skin aspirates from a cat with disseminated protozoal infection.
Thrombocytopenia
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.
Thrombocytopenia
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
Thrombocytopenia
Transarterial Chemoembolization With Cisplatin as Second-Line Treatment for Hepatocellular Carcinoma Unresponsive to Chemoembolization With Epirubicin-Lipiodol Emulsion.
Thrombocytopenia
Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial.
Thrombocytopenia
Using characteristic changes in laboratory values to assist in the diagnosis of hemorrhagic shock and encephalopathy syndrome.
Thrombocytopenia
Vorinostat in Combination With Lenalidomide and Dexamethasone in Lenalidomide-Refractory Multiple Myeloma.
Thrombocytopenia
[A case report of acute Q fever showing Kawasaki disease-like symptoms in a 9-year-old girl]
Thrombocytopenia
[Analysis of clinical characteristic of 158 inpatients with dengue fever in Guangzhou area during the 2014 epidemic].
Thrombocytopenia
[Clinical characteristics of the patients with dengue fever seen from 2002 to 2006 in Guangzhou]
Thrombocytopenia
[Clinical features and therapy of 106 cases of severe acute respiratory syndrome]
Thrombocytopenia
[Clinical presentation of Ixodes tick-borne borreliosis caused by Borrelia miyamotoi in the context of an immune response to the pathogen].
Thrombocytopenia
[Dengue fever among 44 Danish travellers investigated in the department of epidemics at the Rigshospitalet during 1988-1998]
Thrombocytopenia
[Dengue: a re-emerging disease. A clinical and epidemiological study in 57 Spanish travelers]
Thrombocytopenia
[Efficacy and safety of neoadjuvant apatinib in combination with dose-dense paclitaxel and carboplatin in locally advanced triple negative breast cancer patients].
Thrombocytopenia
[Leukopenia due to anti-tuberculous chemotherapy including rifampicin and isoniazid]
Thrombocytopenia
[Seroprevalence of Anaplasma phagocytophilum infection in dogs in Germany]
Thrombocytosis
Epidemiology of massive hepatocellular carcinoma in dogs: A 4-year retrospective study.
Thrombocytosis
Hepatoblastoma in infancy and childhood: a clinical and pathological study of 32 cases.
Thrombocytosis
Imipenem-cilastatin in pediatric patients: an overview of safety and efficacy in studies conducted in the United States.
Thrombophlebitis
Ten-year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan.
Thrombosis
A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas.
Thrombosis
A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08).
Thrombosis
Cyclin B2 Overexpression in Human Hepatocellular Carcinoma is Associated with Poor Prognosis.
Thrombosis
Development of a predictive nomogram for early recurrence of hepatocellular carcinoma in patients undergoing liver transplantation.
Thrombosis
Graft histology characteristics in long-term survivors of pediatric liver transplantation.
Thrombosis
Interleukin-2-induced hepatic injury involves temporal patterns of cell adhesion in the microcirculation.
Thrombosis
Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial.
Thrombosis
Noncirrhotic Portal Hypertension in HIV-Infected Patients: A Case Control Evaluation and Review of the Literature.
Thrombosis
Osimertinib for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLC: Tolerability and Diagnostic Methods From an Expanded Access Program.
Thrombosis
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Thrombosis
Preoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma.
Thrombosis
Risk factors for recurrence after curative resection of hepatitis C-related hepatocellular carcinoma in patients without postoperative interferon therapy.
Thrombosis
Ruptured hepatocellular carcinoma: treatment strategy and prognostic factor analysis.
Thyroid Diseases
Clinical and laboratory characteristics of patients with thyroid diseases with and without alanine aminotransferase levels above the upper tertile - Cross-sectional analytical study.
Thyroid Neoplasms
Associations Between Nonalcoholic Fatty Liver Disease and Cancers in a Large Cohort in China.
Thyroid Nodule
Biochemical and hormonal composition, cytological examination of thyroid cyst fluid, and comparison according to gender and color of cyst fluid.
Thyroid Nodule
Observations on factors that influence thyroid nodules in diabetic and non-diabetic patients in the Zhejiang province of China.
Thyrotoxicosis
[Melatonin influence on free radical homeostasis in rat tissues at thyrotoxicosis]
Tooth Mobility
Bromelain reduces the non-alcoholic fatty liver disease and periodontal damages caused by ligature-induced periodontitis.
Tooth Mobility
One or two ligatures inducing periodontitis are sufficient to cause fatty liver.
Tooth Mobility
Periodontal disease may induce liver fibrosis in an experimental study on Wistar rats.
Toxemia
Serum glutamic-oxalacetic transaminase and serum glutamic-pyruvic transaminase in toxemia of pregnancy.
Transfusion Reaction
Metagenomic profiling of the viromes of plasma collected from blood donors with elevated serum alanine aminotransferase levels.
Tremor
Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure.
Triple Negative Breast Neoplasms
Abrogating GPT2 in triple-negative breast cancer inhibits tumor growth and promotes autophagy.
Tuberculosis
Determinants of Anemia Among Human Immunodeficiency Virus-Positive Adults at Care and Treatment Clinics in Dar es Salaam, Tanzania.
Tuberculosis
Dietary Intake of Vegetables and Cooking Oil Was Associated With Drug-Induced Liver Injury During Tuberculosis Treatment: A Preliminary Cohort Study.
Tuberculosis
Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity.
Tuberculosis
Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.
Tuberculosis
Significant increases in the levels of liver enzymes in mice treated with anti-tuberculosis drugs.
Tuberculosis
[Blastocystis hominis and nonpathogenic enteric protozoa in patients with pulmonary tuberculosis and those with HIV infection]
Tuberculosis
[New aspects of the effect of isoniazid on transaminase activity in tuberculosis]
Tuberculosis
[Treatment outcome of latent tuberculosis infection in persons with fibrotic pulmonary lesions].
Tuberculosis, Pulmonary
LIMITED ELEVATIONS IN ANTITUBERCULOSIS DRUG-INDUCED SERUM ALANINE AMINOTRANSFERASE (ALT) LEVELS IN A COHORT OF NIGERIANS ON TREATMENT FOR PULMONARY TUBERCULOSIS AND HIV INFECTION IN YENAGOA.
Tuberculosis, Pulmonary
[Comparative study of the concordance of results of determination of the activity of ornithine carbamoyltransferase, alanine transaminase and bilirubin in blood serum and the assessment of hepatic function in patients with pulmonary tuberculosis treated with drugs with special reference to hepatotoxic drugs]
Tuberculosis, Pulmonary
[Glutamic-pyruvic transaminase activity in pulmonary tuberculosis.]
Tuberous Sclerosis
Serum and tissue proteins in tuberous sclerosis. I. Serum and red-cell polymorphic systems.
Typhoid Fever
Differentiation of typhoid fever from fulminant hepatic failure in patients presenting with jaundice and encephalopathy.
Typhoid Fever
Fever after a stay in the tropics: diagnostic predictors of the leading tropical conditions.
Typhoid Fever
Salmonella bacteraemia in Turkish children: 37 cases seen in a university hospital between 1993 and 2002.
Typhoid Fever
[GLUTAMIC-OXALACETIC TRANSAMINASE AND GLUTAMIC-PYRUVIC TRANSAMINASE IN TYPHOID PATIENTS TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE IN THE COURSE OF CHLORAMPHENICOL-PREDNISONE THERAPY.]
Unconsciousness
Establishment and Application of Early Risk Stratification Method for Acute Abdominal Pain in Adults.
Unconsciousness
[Relationship between changes of increased amylase or lipase levels and pancreas injury in critically ill children].
Uremia
Clinical features in coronavirus disease 2019 (COVID-19) patients with early clearance and prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA.
Urinary Tract Infections
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer.
Urogenital Neoplasms
Effect of streptococcal preparation (picibanil) on the postoperative rise in serum alanine aminotransferase activity in patients with urogenital cancer.
Urticaria
One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency.
Urticaria
Role of Helicobacter pylori Eradication in Chronic Spontaneous Urticaria: A Propensity Score Matching Analysis.
Uterine Cervical Neoplasms
Prognostic and diagnostic value of serum pseudocholinesterase, serum aspartate transaminase, and serum alinine transaminase in malignancies treated by radiotherapy.
Uterine Cervical Neoplasms
[Glutamic-oxalacetic transaminase and glutamic-pyruvic transaminase activity in the blood of patients with cervical cancer treated with ionizing radiation]
Uterine Hemorrhage
[Research of gestrinone-related abnormal uterine bleeding and the intervention in the treatment: a multi-center, randomized, controlled clinical trial].
Vaccinia
[Alanine aminotransferase and aspartate aminotransferase activity in cultured chicken fibroblasts in the process of growing and after infection by vaccinia virus]
Varicose Veins
Association between age and overall survival of patients with hepatocellular carcinoma after hepatic resection.
Varicose Veins
Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
Varicose Veins
Clinical presentation and predictors of survival in patients with Budd Chiari syndrome: experience from a tertiary care hospital in Pakistan.
Vascular Diseases
[Serum and cerebrospinal fluid activity of aspartate and alanine aminotransferase in acute cerebral vascular diseases]
Vasculitis
Prognostic nutritional index is associated with disease severity and relapse in ANCA-associated vasculitis.
Venous Thromboembolism
Safety of fondaparinux versus enoxaparin after TKA in Japanese patients.
Venous Thrombosis
Evaluation of factors associated with stability of anticoagulation therapy.
Venous Thrombosis
Osimertinib for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLC: Tolerability and Diagnostic Methods From an Expanded Access Program.
Ventricular Dysfunction, Right
Usefulness of admission gamma-glutamyltransferase level for predicting new-onset heart failure in patients with acute coronary syndrome with left ventricular systolic dysfunction.
Vesicular Stomatitis
Neutralization of pseudotyped vesicular stomatitis virus expressing hepatitis C virus envelope glycoprotein 1 or 2 by serum from patients.
Viremia
3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China.
Viremia
A controlled randomised trial of t-UDCA as adjuvant to interferon for treatment of chronic hepatitis C: an interferon sparing effect of t-UDCA.
Viremia
Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients.
Viremia
Acute hepatitis C treatment in advanced renal failure using 8 weeks of pan-genotypic daclatasvir and reduced-dose sofosbuvir.
Viremia
Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection.
Viremia
Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses.
Viremia
Analysis of ELISA hepatitis C virus-positive blood donors population by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA.
Viremia
Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection.
Viremia
Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy.
Viremia
Baseline Hepatitis B Virus Titer Predicts Initial Postpartum Hepatic Flare: A Multicenter Prospective Study.
Viremia
BCX4430, a novel nucleoside analog, effectively treats yellow fever in a Hamster model.
Viremia
Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA.
Viremia
Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin.
Viremia
Clinical implications of coinfection with a novel DNA virus (TTV) in hepatitis C virus carriers on maintenance hemodialysis.
Viremia
Clinical significance of serum hepatitis C virus (HCV) RNA as marker of HCV infection.
Viremia
Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
Viremia
Correlation between the serum level of hepatitis C virus RNA and disease activities in acute and chronic hepatitis C.
Viremia
Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection.
Viremia
Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.
Viremia
Decreased egg production in laying hens associated with infection with genotype 3 avian hepatitis E virus strain from China.
Viremia
Detection and quantitation of serum HCV-RNA by branched DNA amplification in anti-HCV positive blood donors.
Viremia
Detection of serum hepatitis B, C, and D viral nucleic acids and its implications in hepatocellular carcinoma patients.
Viremia
Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
Viremia
Diagnostic Dilemma for Low Viremia with Significant Fibrosis; is Hepatitis B Virus DNA Threshold Level a Good Indicator for Predicting Liver Damage?
Viremia
Disappearance of hepatitis C virus RNA in plasma during interferon alpha-2B treatment in hemophilia patients.
Viremia
Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C.
Viremia
Effectiveness of Sofosbuvir, Ribavirin and PEG-IFN?-2a in the Treatment of Naïve Egyptian Patients With Chronic Hepatitis C Virus Genotype 4.
Viremia
Evolution of a Cell Culture-Derived Genotype 1a Hepatitis C Virus (H77S.2) during Persistent Infection with Chronic Hepatitis in a Chimpanzee.
Viremia
Experimental studies on subclinical hepatitis E virus infection in cynomolgus macaques.
Viremia
Frequent detection of hepatitis A viral RNA in serum during the early convalescent phase of acute hepatitis A.
Viremia
Genetic Analysis of Serum-Derived Defective Hepatitis C Virus Genomes Revealed Novel Viral
Viremia
Genetic variations in humans associated with differences in the course of hepatitis C.
Viremia
Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers.
Viremia
Hepatitis B virus of genotype C persistence after recovery from acute hepatitis B virus infection in Japan.
Viremia
Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group.
Viremia
Hepatitis C viremia in German blood donors: serum alanine aminotransferase is not a valid marker for screening.
Viremia
Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease.
Viremia
Hepatitis C virus and GB virus C/hepatitis G virus viremia in Swedish blood donors with different alanine aminotransferase levels.
Viremia
Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees.
Viremia
Hepatitis C virus serum markers and liver disease in children with leukemia during and after chemotherapy.
Viremia
Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo.
Viremia
Hepatogastroenterologists' knowledge of inactive carriers and immunotolerant hepatitis B virus patients in France: results of a practice survey.
Viremia
Immune response of Th17-associated cytokines by peripheral blood mononuclear cells from patients with chronic hepatitis C virus infection.
Viremia
Impact of Human Immunodeficiency Virus Coinfection on the Progression of Mother-to-child Transmitted Hepatitis C Virus Infection.
Viremia
Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.
Viremia
Improvement of alanine aminotransferase by administration of suplatast tosilate plus ursodeoxycholic acid in patients with resistance to ursodeoxycholic acid monotherapy on hepatitis C virus-related chronic liver disease.
Viremia
Incidences and Determinants of Functional Cure during Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.
Viremia
Induction of interleukin-12 production in chronic hepatitis C virus infection correlates with the hepatocellular damage.
Viremia
Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection.
Viremia
Interferon treatment in patients with chronic hepatitis C with normal alanine-aminotransferase activity.
Viremia
Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
Viremia
Lamivudine resistance in patients with chronic hepatitis B: role of clinical and virological factors.
Viremia
Long-term histological prognosis and serum fibrosis markers in chronic hepatitis C patients treated with interferon.
Viremia
Long-Term Persistent GBV-B Infection and Development of a Chronic and Progressive Hepatitis C-Like Disease in Marmosets.
Viremia
Modified range of alanine aminotransferase is insufficient for screening of hepatitis C virus infection in hemodialysis patients.
Viremia
Molecular detection of transfusion transmitted virus coinfection with some hepatotropic viruses.
Viremia
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B.
Viremia
Non-isotopic detection of hepatitis C virus quasispecies by single strand conformation polymorphism.
Viremia
Potential impact of long-term nucleoside therapy on the mortality and morbidity of active chronic hepatitis B.
Viremia
Prediction of efficacy of interferon treatment of chronic hepatitis C by multivariate analysis and a new classification.
Viremia
Prevalence and clinical characteristics of TT virus (TTV) in patients with sporadic acute hepatitis of unknown etiology.
Viremia
Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations.
Viremia
Prevalence of GB virus C (also called hepatitis G virus) markers in Norwegian blood donors.
Viremia
Prevalence of GB virus C/Hepatitis G virus infection among various populations in Surabaya, Indonesia, and identification of novel groups of sequence variants.
Viremia
Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis.
Viremia
Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis B.
Viremia
Relationship Between Viremia and Specific Organ Damage in Ebola Patients: A Cohort Study.
Viremia
Remote development of hepatocellular carcinoma in patients with liver cirrhosis type B serologically cured for HBs antigenemia with long-standing normalization of ALT values.
Viremia
Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus.
Viremia
Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma.
Viremia
Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors.
Viremia
SEN virus infection in children in Taiwan: transmission route and role in blood transfusion and liver diseases.
Viremia
SEN virus infection in Egyptian patients undergoing maintenance hemodialysis: prevalence and clinical importance.
Viremia
Serological and histological findings in infection and transmission of GBV-C/HGV to macaques.
Viremia
Serological markers of autoimmunity in renal transplant patients with chronic hepatitis C.
Viremia
Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia.
Viremia
SPF rabbits infected with rabbit hepatitis E virus isolate experimentally showing the chronicity of hepatitis.
Viremia
Spontaneous Clearance After Relapse Following Direct-Acting Antiviral Treatment for Chronic HCV Infection.
Viremia
Strenuous physical labor is important as a cause of elevated alanine aminotransferase levels in Japanese patients with chronic hepatitis C viremia.
Viremia
Swine hepatitis E virus in rural southern China: genetic characterization and experimental infection in rhesus monkeys (Macaca mulatta).
Viremia
Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3.
Viremia
Synthetic Peptides Containing Three Neutralizing Epitopes of Genotype 4 Swine Hepatitis E Virus ORF2 induced Protection against Swine HEV Infection in Rabbit.
Viremia
The risk of hepatocellular carcinoma among chronic hepatitis B virus-infected patients outside current treatment criteria.
Viremia
The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.
Viremia
The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-? 2b plus ribavirin.
Viremia
Transmission of and liver injury by TT virus in patients on maintenance hemodialysis.
Viremia
Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study.
Viremia
Virological course of hepatitis A virus as determined by real time RT-PCR: Correlation with biochemical, immunological and genotypic profiles.
Viremia
What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis?
Viremia
[Amantadine-HCL in the treatment of chronic hepatitis C in non-responders to alpha-interferon. Effect on ALT serum levels and viral load]
Viremia
[Epidemiology of HBV infections and possibilities for therapeutic actions in children and adolescents with end-stage renal failure treated with dialysis]
Viremia
[Investigation of Anti-HCV S/CO Value in Detecting Viremia in Patients with Hepatitis C Virus Infection].
Viremia
[Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal].
Virus Diseases
"Hepatitic flare", asthenia, peripheral polyneuropathy and diffuse liver steatosis in a hepatitis C virus asymptomatic chronic carrier.
Virus Diseases
Abnormal serum porphyrin levels in patients with the acquired immunodeficiency syndrome with or without hepatitis C virus infection.
Virus Diseases
Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection.
Virus Diseases
Antibodies to hepatitis E virus among several populations in Greece: increased prevalence in an hemodialysis unit.
Virus Diseases
Association between serum liver enzymes and all-cause mortality: The Japan Public Health Center-based Prospective Study.
Virus Diseases
Body mass index is a good predictor of an elevated alanine transaminase level in the general population: hints from the Dionysos study.
Virus Diseases
Characteristics of hepatitis viruses among Egyptian children with acute hepatitis.
Virus Diseases
Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.
Virus Diseases
Chronic hepatitis C virus infection after treatment for pediatric malignancy.
Virus Diseases
Clinical impact of normal alanine aminotransferase on direct-acting antiviral outcome in patients with chronic hepatitis C virus infection.
Virus Diseases
Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study.
Virus Diseases
Dietary choline and folate relationships with serum hepatic inflammatory injury markers in Taiwanese adults.
Virus Diseases
Dysfunction of Immune Systems and Host Genetic Factors in Hepatitis C Virus Infection with Persistent Normal ALT.
Virus Diseases
Effect of caffeine-containing beverage consumption on serum alanine aminotransferase levels in patients with chronic hepatitis C virus infection: a hospital-based cohort study.
Virus Diseases
Efficacy of long-term dietary restriction of total calories, fat, iron, and protein in patients with chronic hepatitis C virus.
Virus Diseases
Efficacy of post-exposure treatment of yellow fever with ribavirin in a hamster model of the disease.
Virus Diseases
Elevated alanine aminotransferase in blood donors: role of different factors and multiple viral infections.
Virus Diseases
Genetic variants associated with serum alanine aminotransferase levels among patients with hepatitis C virus infection: A genome-wide association study.
Virus Diseases
Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers.
Virus Diseases
Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients.
Virus Diseases
Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town.
Virus Diseases
Hepatitis G virus infection in a high-risk subgroup of hospitalized dental patients.
Virus Diseases
Immunosuppressive effect of chenodeoxycholic acid on natural killer cell activity in patients with biliary atresia and hepatitis C virus-related liver cirrhosis.
Virus Diseases
Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy.
Virus Diseases
Influence of viral load and alanine aminotransferase on viral genetic heterogeneity in patients with chronic hepatitis C virus infection.
Virus Diseases
Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity.
Virus Diseases
Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C.
Virus Diseases
Levels of Alanine Aminotransferase Confound Use of Transient Elastography to Diagnose Fibrosis in Patients With Chronic Hepatitis C Virus Infection.
Virus Diseases
Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels.
Virus Diseases
Matrix metalloproteinases 2 and 9 correlate with alanine aminotransferase and hepatitis C virus in blood donors.
Virus Diseases
Modified range of alanine aminotransferase is insufficient for screening of hepatitis C virus infection in hemodialysis patients.
Virus Diseases
Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.
Virus Diseases
Peginterferon-based therapy for chronic hepatitis C virus infection in patients with normal alanine aminotransferase levels.
Virus Diseases
Pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C virus genotype 4 infection in patients with normal serum ALT.
Virus Diseases
Prediction of Sustained Virological Response to Peginterferon-based Therapy for Chronic Hepatitis C: Regression Analysis of a Cohort from Rio Grande do Sul, Brazil.
Virus Diseases
Prevalence and clinical characteristics of TT virus (TTV) in patients with sporadic acute hepatitis of unknown etiology.
Virus Diseases
Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
Virus Diseases
Prospective multicenter clinical evaluation of AMPLICOR and COBAS AMPLICOR hepatitis C virus tests.
Virus Diseases
Relation between incidence of hepatic carcinogenesis and integration value of alanine aminotransferase in patients with hepatitis C virus infection.
Virus Diseases
Relationship of TT virus infection with prevalence of hepatitis C virus infection and elevated alanine aminotransferase levels.
Virus Diseases
Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity.
Virus Diseases
SEN virus infection in children in Taiwan: transmission route and role in blood transfusion and liver diseases.
Virus Diseases
Serum alanine aminotransferase level in relation to hepatitis B and C virus infections among blood donors.
Virus Diseases
Serum alanine aminotransferase levels in relation to hepatitis B and C virus infections among drug abusers in an area hyperendemic for hepatitis B.
Virus Diseases
Serum alanine aminotransferase measurement as a guide to selective testing for hepatitis C during medical checkup.
Virus Diseases
Serum aspartate but not alanine aminotransferase levels help to predict the histological features of chronic hepatitis C viral infections in adults.
Virus Diseases
Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression.
Virus Diseases
Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels.
Virus Diseases
The association of elevated alanine aminotransferase levels with hepatitis E virus infections among blood donors in China.
Virus Diseases
The effect of alanine aminotransferase dynamics on predicting sustained virological response in chronic hepatitis C virus infection.
Virus Diseases
The effect of antioxidant supplementation on hepatitis C viral load, transaminases and oxidative status: a randomized trial among chronic hepatitis C virus-infected patients.
Virus Diseases
The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels.
Virus Diseases
Unexpected elevated alanine aminotransferase, aspartate aminotransferase levels and hepatitis E virus infection among persons who work with pigs in accra, Ghana.
Virus Diseases
Using the prevalence of an elevated serum alanine aminotransferase level for identifying communities with a high prevalence of hepatitis C virus infection.
Virus Diseases
Viral clearance in HCV viraemic patients with normal alanine aminotransferase after combination therapy: a controlled, open-labelled study.
Virus Diseases
[Long term study of the treatment with recombinant alfa 2b interferon in chronic active hepatitis due to B virus in children and adolescents]
Virus Diseases
[The blood biochemical indicators in drug addicted patients with HIV-infection and viral hepatitis].
Vision Disorders
Benefit-Risk Summary of Crizotinib for the Treatment of Patients With ROS1 Alteration-Positive, Metastatic Non-Small Cell Lung Cancer.
Vision Disorders
Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond.
Vitamin B 6 Deficiency
Age-related effects of nutritional vitamin B6 deficiency on B6-dependent enzymes of glutamate, gamma-aminobutyrate and glutamine systems in the rat brain.
Vitamin B 6 Deficiency
Association of Low Alanine Aminotransferase with Loss of Independence or Death: a 5-year Population-based Cohort Study.
Vitamin B 6 Deficiency
Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal.
Vitamin B 6 Deficiency
Pyridoxine deficiency and postnatal development of brain aspartate and alanine aminotransferase activities, and cholesterol levels in chicks.
Vitamin B 6 Deficiency
The pathogenesis of decreased aspartate aminotransferase and alanine aminotransferase activity in the plasma of hemodialysis patients: the role of vitamin B6 deficiency.
Vitamin B 6 Deficiency
Vitamin B6 deficiency presenting with low alanine aminotransferase in a critically ill child.
Vitamin B 6 Deficiency
Vitamin B6 status in cirrhotic patients in relation to apoenzyme of serum alanine aminotransferase.
Vitamin D Deficiency
Association Between Vitamin D Deficiency and Suspected Nonalcoholic Fatty Liver Disease in an Adolescent Population.
Vitamin D Deficiency
Association of vitamin D deficiency with poor glycaemic control in diabetic patients.
Vitamin D Deficiency
COMPARISON OF VITAMIN D REPLACEMENT STRATEGIES WITH HIGH-DOSE INTRAMUSCULAR OR ORAL CHOLECALCIFEROL: A PROSPECTIVE INTERVENTION STUDY.
Vitamin D Deficiency
Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trial.
Vitamin E Deficiency
Dietary vitamin E deficiency inhibits fat metabolism, antioxidant capacity, and immune regulation of inflammatory response in genetically improved farmed tilapia (GIFT, Oreochromis niloticus) fingerlings following Streptococcus iniae infection.
Vitamin E Deficiency
Selenium and vitamin E deficiency in pigs. II. Influence on plasma selenium, vitamin E, ASAT and ALAT and on tissue selenium.
Vitelliform Macular Dystrophy
Linkage of atypical vitelliform macular dystrophy (VMD-1) to the soluble glutamate pyruvate transaminase (GPT1) locus.
Wound Infection
Efficacy and safety of Seprafilm for preventing intestinal obstruction after gastrointestinal neoplasms surgery: a systematic review and meta-analysis.
Yellow Fever
Development of a Hyperglycosylated IFN Alfacon-1 (CIFN): Toward Bimonthly or Monthly Dosing for Antiviral Therapies.
Yellow Fever
Predictors of mortality in patients with yellow fever: an observational cohort study.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Ki VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SPECIFIC ACTIVITY [µmol/min/mg]
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
pH RANGE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ORGANISM
COMMENTARY
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
SOURCE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY
GeneOntology No.
LITERATURE
SOURCE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable).
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). ALAT1_HUMAN
496
0
54637
Swiss-Prot
other Location (Reliability: 5)
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SUBUNIT
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
analysis
-
electrochemical immunosensor system for enzyme with detection limit of 10 pg/ml and 26.3 nA/(ng/ml), application as indicator for hepatocellular damage
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
STORAGE STABILITY
ORGANISM
UNIPROT
LITERATURE
-80°C, 20 mM Tris-HCl, pH 7.5, 20% loss of activity in first two days, thereafter stable for at least 20 days. Addition of 25% glycerol preserves most of the activity
-
-80°C, 20 mM Tris-HCl, pH 7.5, stable for at least 20 days. Addition of 25% glycerol preserves most of the activity
-
25°C, 20 mM Tris-HCl, pH 7.5, 56% loss of activity in first two days. Addition of 25% glycerol preserves most of the activity
-
25°C, 20 mM Tris-HCl, pH 7.5, 80-90% residual activity after 10 days, 60% residual activity after 20 days. Addition of 25% glycerol preserves most of the activity
-
37°C, 20 mM Tris-HCl, pH 7.5, 50% loss of activity in 24 h, and complete loss of activity within one week
-
4°C, 20 mM Tris-HCl, pH 7.5, 53% loss of activity in first two days. Addition of 25% glycerol preserves most of the activity
-
4°C, 20 mM Tris-HCl, pH 7.5, stable for at least 20 days. Addition of 25% glycerol preserves most of the activity
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
ammonium sulfate, DEAE-Sepharose, partial purification of cytosolic and mitochondrial isoenzymes
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
EXPRESSION
ORGANISM
UNIPROT
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
APPLICATION
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
synthesis
for synthesis of monoclonal antibodies in Chinese hamster ovary cells, cooverexpression of alanine aminotransferase in a taurine transporter-overexpressing host cell line gives a higher monoclonal anitbody yield in a shorter culture period. Forced cooverexpression of taurine transporter TAUT and ALT1 in results in a higher proliferation, with an ideal balance between cell viability and productivity
analysis
-
sequential online capillary electrophoresis assay to study enzyme inhibitors. Evolution of the inhibition reaction can be achieved by automatically and simultaneously monitoring the substrate consumption and product formation as a function of reaction time
medicine
medicine
-
patients with hepatitis C treated with NS3-4A protease inhibitor telaprevir and/or peginterferon alpha-2a. Patients receiving telaprevir alone show a decrease in mean neopterin and alanine aminotransferase levels. Patients receiving peginterferon alpha-2a plus telaprevir or peginterferon alpha-2a plus placebo show an ioncrease in neopterin levels and decrease in alanine aminotransferase level, suggesting that treatment of chronic hepatitis C patients with an NS3-4A protease inhibitor ameliorates inflammation. Interferon-mediated immunomodulatory effects remain intact when interferon is combined with telaprevir
medicine
-
treatment of HIV/HCV co-infected patients with pegylated interferon and ribavirin. At week 1, serum HCV RNA levels and changes in alanine aminotransferase levels relative to baseline can identify likely responders better than plasma ribavirin levels. During the first four weeks of treatment, median plasma ribavirin levels and area under the ribavirin curve are significantly lower in sustained responders compared with nonresponders
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Noguchi, T.; Takada, Y.; Kido, R.
Glutamate-glyoxylate aminotransferase in rat liver cytosol. Purification, properties and identity with alanine-2-oxoglutarate aminotransferase
Hoppe-Seyler's Z. Physiol. Chem.
358
1533-1542
1977
Canis lupus familiaris, Felis catus, Homo sapiens, Rattus norvegicus
brenda
Gubern, G.; Imperial, S.; Busquets, M.; Cortes, A.
Partial characterization of the alanine aminotransferase isoenzymes from human liver
Biochem. Soc. Trans.
18
1288-1289
1990
Homo sapiens
brenda
Richens, A.; McEwan, J.R.; Deybach, J.C.; Mumford, J.P.
Evidence for both in vivo and in vitro interaction between vigabatrin and alanine transaminase
Br. J. Clin. Pharmacol.
43
163-168
1997
Homo sapiens
brenda
Vozarova, B.; Stefan, N.; Lindsay, R.S.; Saremi, A.; Pratley, R.E.; Bogardus, C.; Tataranni, P.A.
High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes
Diabetes
51
1889-1895
2002
Homo sapiens
brenda
Xuan, G.S.; Oh, S.W.; Choi, E.Y.
Development of an electrochemical immunosensor for alanine aminotransferase
Biosens. Bioelectron.
19
365-371
2003
Homo sapiens
brenda
Chang, Y.; Ryu, S.; Sung, E.; Jang, Y.
Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease
Clin. Chem.
53
686-692
2007
Homo sapiens
brenda
Totan, A.; Greabu, M.; Totan, C.; Spinu, T.
Salivary aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase: possible markers in periodontal diseases?
Clin. Chem. Lab. Med.
44
612-615
2006
Homo sapiens
brenda
Nathwani, R.A.; Pais, S.; Reynolds, T.B.; Kaplowitz, N.
Serum alanine aminotransferase in skeletal muscle diseases
Hepatology
41
380-382
2005
Homo sapiens
brenda
Kazumi, T.; Kawaguchi, A.; Hirano, T.; Yoshino, G.
Serum alanine aminotransferase is associated with serum adiponectin, C-reactive protein and apolipoprotein B in young healthy men
Horm. Metab. Res.
38
119-124
2006
Homo sapiens
brenda
Harenberg, J.; Joerg, I.; Weiss, C.
Observations of alanine aminotransferase and aspartate aminotransferase in THRIVE studies treated orally with ximelagatran
Int. J. Toxicol.
25
165-169
2006
Homo sapiens
brenda
Lopes, E.P.; Gouveia, E.C.; Albuquerque, A.C.; Sette, L.H.; Mello, L.A.; Moreira, R.C.; Coelho, M.R.
Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia
J. Clin. Virol.
35
298-302
2006
Homo sapiens
brenda
Prati, D.; Shiffman, M.L.; Diago, M.; Gane, E.; Rajender Reddy, K.; Pockros, P.; Farci, P.; OBrien, C.B.; Lardelli, P.; Blotner, S.; Zeuzem, S.
Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C
J. Hepatol.
44
679-685
2006
Homo sapiens
brenda
Dahari, H.; Markatou, M.; Zeremski, M.; Haller, I.; Ribeiro, R.M.; Licholai, T.; Perelson, A.S.; Talal, A.H.
Early ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirin
J. Hepatol.
47
23-30
2007
Homo sapiens
brenda
Oh, S.Y.; Cho, Y.K.; Kang, M.S.; Yoo, T.W.; Park, J.H.; Kim, H.J.; Park, D.I.; Sohn, C.I.; Jeon, W.K.; Kim, B.I.; Son, B.H.; Shin, J.H.
The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease
Metab. Clin. Exp.
55
1604-1609
2006
Homo sapiens
brenda
Khedmat, H.; Fallahian, F.; Abolghasemi, H.; Hajibeigi, B.; Attarchi, Z.; Alaeddini, F.; Holisaz, M.T.; Pourali, M.; Sharifi, S.; Zarei, N.
Serum gamma-glutamyltransferase, alanine aminotransferase, and aspartate aminotransferase activity in Iranian healthy blood donor men
World J. Gastroenterol.
13
889-894
2007
Homo sapiens
brenda
Liu, L.; Zhong, S.; Yang, R.; Hu, H.; Yu, D.; Zhu, D.; Hua, Z.; Shuldiner, A.R.; Goldstein, R.; Reagan, W.J.; Gong, D.W.
Expression, purification, and initial characterization of human alanine aminotransferase (ALT) isoenzyme 1 and 2 in High-five insect cells
Protein Expr. Purif.
60
225-231
2008
Homo sapiens
brenda
Gelderblom, H.C.; Zeuzem, S.; Weegink, C.J.; Forestier, N.; Mcnair, L.; Purdy, S.; Dijkgraf, M.g.W.; Jansen, P.L.M.; Reesnik, H.W.
Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3-4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a
Scand. J. Gastroenterol.
43
1122-1127
2008
Homo sapiens
brenda
Mu, X.; Qi, L.; Qiao, J.; Zhang, H.; Ma, H.
Study on alanine aminotransferase kinetics by microchip electrophoresis
Anal. Biochem.
421
499-505
2012
Homo sapiens
brenda
Donini, S.; Ferrari, M.; Fedeli, C.; Faini, M.; Lamberto, I.; Marletta, A.S.; Mellini, L.; Panini, M.; Percudani, R.; Pollegioni, L.; Caldinelli, L.; Petrucco, S.; Peracchi, A.
Recombinant production of eight human cytosolic aminotransferases and assessment of their potential involvement in glyoxylate metabolism
Biochem. J.
422
265-272
2009
Homo sapiens (P24298)
brenda
Liu, L.; Chen, Y.; Yang, L.
Inhibition study of alanine aminotransferase enzyme using sequential online capillary electrophoresis analysis
Anal. Biochem.
467
28-30
2014
Homo sapiens
brenda
Tabuchi, H.; Sugiyama, T.
Cooverexpression of alanine aminotransferase 1 in Chinese hamster ovary cells overexpressing taurine transporter further stimulates metabolism and enhances product yield
Biotechnol. Bioeng.
110
2208-2215
2013
Homo sapiens (P24298)
brenda
Hajarizadeh, B.; Lamoury, F.M.; Feld, J.J.; Amin, J.; Keoshkerian, E.; Matthews, G.V.; Hellard, M.; Dore, G.J.; Lloyd, A.R.; Grebely, J.; Applegate, T.L.
Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection
Virol. J.
13
32
2016
Homo sapiens
brenda
EXTERNAL LINKS (specific for EC-Number 2.6.1.2)
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
About BRENDA
Social media
Help
Survey
Download
Contribution
Legal
Curated at
Member of
